PREFERRED_AB VARIANT_AB EXPANSION +dP/dt +dP/dt:18|+dp/dt:3 contractility +dP/dt +dP/dt:6 rate of left ventricular pressure development 1,5-AG 1,5-AG:10|1,5AG:3 anhydrodglucitol 1,5-AG 1,5-AG:14|1,5AG:11 anhydroglucitol 14C 14C:8 labeled with radioactive carbon 14C 14C:10 radiocarbon 15N' 15N':28 n excess 15N' 15N':10 atom nexcess 17-KS 17-KS:38|17KS:2 ketosteroids 17-KS 17-KS:11|17KS:1 urinary ketosteroid 17-OHP 17-OHP:83|17OHP:22|17-OH-P:3|17OH-P:2 alphahydroxyprogesterone 17-OHP 17-OHP:11|17-OH-P:10|17OHP:2|17OH-P:1 ohprogesterone 1RM 1RM:49|1-RM:1 repetition maximum 1RM 1RM:31|1-RM:13 one repetition maximum 2,3-DPG 2,3-DPG:291|2,3DPG:6 diphosphoglycerate 2,3-DPG 2,3-DPG:8 diphosphoglycerate concentration 2,4-D 2,4-D:39|2,4-d:2 dichlorophenoxyacetate 2,4-D 2,4-D:462|2,4D:4|2,4-d:3 dichlorophenoxyacetic acid 2-AG 2-AG:87|2AG:1 arachidonoylglycerol 2-AG 2-AG:31 arachidonylglycerol 2-APB 2-APB:47|2APB:5 aminoethoxydiphenyl borate 2-APB 2-APB:8 aminoethyl diphenylborate 2DE 2DE:14|2-DE:6 twodimensional 2DE 2DE:9|2-DE:1 twodimensional echocardiograms 2DE 2DE:16|2-DE:6 twodimensional echocardiographic 2-DG 2-DG:9|2DG:2 cdeoxydglucose 2-DG 2-DG:6|2DG:3 hdeoxyglucose 2-PAM 2-PAM:8 pyridine aldoxime methiodide 2-PAM 2-PAM:4 pyridine aldoxime methochloride 2-PAM 2-PAM:8 pralidoxime chloride 2-PAM 2-PAM:5 pyridinealdoxime methochloride 2PN 2PN:8 two pronuclear 2PN 2PN:5|2-PN:1 two pronuclei 2VO 2VO:3|2-VO:1|2-vo:1 carotid artery occlusion 2VO 2VO:1 permanent bilateral occlusion of common carotid arteries 2VO 2VO:6 permanent occlusion of bilateral common carotid arteries 2C 2C:25|2c:15 diploid 2C 2C:5 diploid cells 32P 32P:48|32-P:2|32p:1 radioactive phosphorus 32P 32P:11 radiophosphorus 3-CLT 3-CLT:8|3CLT:4 lissajous trajectory 3-CLT 3-CLT:4|3CLT:3 threechannel lissajous trajectories 3D-CRT 3D-CRT:39|3DCRT:26|3-DCRT:3 threedimensional conformal radiation therapy 3D-CRT 3D-CRT:69|3DCRT:25|3-D-CRT:1|3-DCRT:1 threedimensional conformal radiotherapy 3D-CT 3D-CT:20|3DCT:9|3-D-CT:2|3-DCT:2 threedimensional computed tomography 3D-CT 3D-CT:9|3DCT:2|3-DCT:1 threedimensional ct 3DFT 3DFT:12 fourier transformation 3DFT 3DFT:21|3-DFT:3 threedimensional fourier transform 3MS 3MS:13 modified minimental state 3MS 3MS:9|3-MS:1 modified minimental state exam 3MS 3MS:20 modified minimental state examination 3D 3D:29|3-D:10 three dimensions 3D 3D:10|3-D:4 threedimensionally 3D 3D:8|3-D:5 tridimensional 3H 3H:18|3-H:1 tritiated 3H 3H:28 tritium 4-AP 4-AP:5 mmaminopyridine 4-AP 4-AP:11 aminophenol 4-DAMP 4-DAMP:22 diphenylacetoxynmethylpiperidine 4-DAMP 4-DAMP:50|4DAMP:2 diphenylacetoxynmethylpiperidine methiodide 4-DAMP 4-DAMP:11 diphenylacetoxynmethylpiperidine methobromide 4E-BP1 4E-BP1:8 eifebinding protein 4E-BP1 4E-BP1:6 eukaryotic initiation factor ebinding protein 4-HBA 4-HBA:10|4HBA:4 hydroxybenzoate 4-HBA 4-HBA:8|4HBA:2 hydroxybenzoic acid 4-HPR 4-HPR:12 hydroxyphenylretinamide 4-HPR 4-HPR:44|4HPR:11 fenretinide 4-OHA 4-OHA:8|4-OH-A:7 hydroxyandrostenedione 4-OHA 4-OHA:5|4OHA:4 hydroxyantipyrine 5-ALA 5-ALA:24 aminolaevulinic acid 5-ALA 5-ALA:78|5-Ala:1 aminolevulinic acid 5-ASA 5-ASA:15|5ASA:1 aminosalicylate 5-ASA 5-ASA:9 mesalamine 5-ASA 5-ASA:14 mesalazine 5-CT 5-CT:190|5CT:2 carboxamidotryptamine 5-CT 5-CT:17 carboxyamidotryptamine 5-FC 5-FC:156|5FC:58|5-Fc:4|5-fc:1 fluorocytosine 5-FC 5-FC:40|5FC:27 flucytosine 5-HIAA 5-HIAA:206|5HIAA:32|5hiaa:1 hydroxyindole acetic acid 5-HIAA 5-HIAA:11|5HIAA:1 hydroxyindoleacetic 5-HT3 5-HT3:19|5HT3:2 hydroxytryptamine type 5-HT3 5-HT3:12|5HT3:3 serotonin receptor 5-HTP 5-HTP:41|5HTP:2 hydroxyltryptophan 5-HTP 5-HTP:11 hydroxytryptophane 5-HTT 5-HTT:4 ht transporters 5-HTT 5-HTT:1 serotonin ht transporter 5-HT 5-HT:7|5HT:2 chydroxytryptamine 5-HT 5-HT:9 hydroxytrypamine 5-HT 5-HT:25|5HT:1 central serotonergic 5-HT 5-HT:10|5HT:1 serotonine 5-HT 5-HT:65|5HT:9 serotoninergic 5-TG 5-TG:10|5TG:9|5-T-G:3 thiodglucose 5-TG 5-TG:6|5TG:4 thioglucose 6MWD 6MWD:11|6-MWD:1 min walking distance 6MWD 6MWD:29|6-MWD:2|6mwD:1|6MWd:1 walk distance 6MWD 6MWD:6 walking distance test 8-SPT 8-SPT:13|8SPT:1 psulfophenyltheophylline 8-SPT 8-SPT:10|8SPT:4 sulfophenyltheophylline 8-oxodG 8-oxodG:10 hydrooxodeoxyguanosine 8-oxodG 8-oxodG:4|8-oxo-dG:4 formation of dihydrooxodeoxyguanosine 9-AC 9-AC:9|9AC:3 aminoscamptothecin 9-AC 9-AC:48|9AC:9 aminocamptothecin A&E A&E:654 accident and emergency A&E A&E:40 accidentemergency A23187 A23187:20 calcium ionophore a A23187 A23187:4 ionophore calcimycin A549 A549:6 human alveolar epithelial A549 A549:15 human alveolar epithelial cells A549 A549:17 human lung epithelial A549 A549:14|A-549:2 lung adenocarcinoma A6 A6:12 distal nephron cell line A6 A6:5 distal nephron epithelium A6 A6:11 kidney cells AA-2G AA-2G:17 oalphadglucopyranosyllascorbic acid AA-2G AA-2G:10 ascorbic acid oalphaglucoside AAA AAA:7 abdominal aortic aneurysm repair AAA AAA:6 aleuria aurantia agglutinin AAA AAA:8 anguilla anguilla agglutinin AAA AAA:5 antialbumin antibodies AAA AAA:5 autolyzed antigenextracted allogeneic AAA AAA:14 cellular activities AACN AACN:13 american association of colleges of nursing AACN AACN:9 atypical acinar cell nodules AAC AAC:48 adpatp carrier AAC AAC:14 antibioticassociated colitis AAC AAC:1 area above curve AAC AAC:52 augmentative and alternative communication AAD AAD:25 acute aortic dissection AAD AAD:13 american academy of dermatology AAD AAD:31 antibioticassociated diarrhea AAH AAH:15 acute alcoholic hepatitis AAH AAH:126 atypical adenomatous hyperplasia AAI AAI:52 adult attachment interview AAI AAI:11 agrobacterium autoinducer AAI AAI:18|AA-I:5 aristolochic acid i AAMI AAMI:5 acute anterior myocardial infarction AAMI AAMI:52 ageassociated memory impairment AAMI AAMI:66 association for the advancement of medical instrumentation AAM AAM:12 africanamerican men AAM AAM:14 aggressive angiomyxoma AAPCC AAPCC:23 adjusted average per capita cost AAPCC AAPCC:19 american association of poison control centers AAP AAP:16 alanineaminopeptidase AAP AAP:199 american academy of pediatrics AAP AAP:12 aminopeptidase from aeromonas proteolytica AAP AAP:8 amplitude of the action potential AAP AAP:10 antiarrhythmic peptide AAR AAR:13 active anterior rhinomanometry AAR AAR:11 rejection AAS AAS:7 aids attitude scale AAS AAS:4 alcohol abstinence syndrome AAs AAs:16 anaplastic astrocytomas AAS AAS:5 aplastic anemia serum AAs AAs:10 aromatic amines AAS AAS:157 atomic absorption spectrometry AAS AAS:14 transacetylaminostilbene AAT AAT:15 aachen aphasia test AAT AAT:16 acute acoustic trauma AAT AAT:12 animalassisted therapy AAV AAV:65 adenoassociated viral AAV AAV:26 adenoassociated virus AAN AAN:9 alphaamino nitrogen AAN AAN:27 american academy of neurology AAN AAN:6 amino acid nitrogen AAN AAN:21|AAn:1 aminoacetonitrile AAN AAN:9 analgesicassociated nephropathy AAN AAN:8 aristolochic acid nephropathy AAO AAO:18 age at onset AAO AAO:8 anodic aluminum oxide AA AA:10 active avoidance AA AA:26 acupuncture analgesia AA AA:34|aA:1 acute appendicitis AA AA:17 adjuvant arthritic AA AA:206 adjuvant arthritis AA AA:7 adjuvantinduced arthritic AA AA:17 adrenal androgen AA AA:5 adrenal autoantibodies AA AA:9 afferent arteriolar AA AA:8 aggregative adherence AA AA:9 alcohol abuse AA AA:16 alcoholpreferring AA AA:2 alcoholpreferring alko alcohol AA AA:14|aA:1 allergic asthma AA AA:27 allyl alcohol AA AA:164|Aa:2 alopecia areata AA AA:8 ambient air AA AA:6|aa:4 aminoacid AA AA:13 amyloid angiopathy AA AA:1 amyloid protein AA AA:10 androgen ablation AA AA:141 aplastic anaemia AA AA:357|Aa:1 aplastic anemia AA AA:64 arachidonate AA AA:45 arachidonic AA AA:3321|Aa:4 arachidonic acid AA AA:42 aromatase activity AA AA:6 ascaris antigen AA AA:22 atomic absorption AA AA:8 atopic asthmatic AA AA:19 normal haemoglobin AA AA:14 rats with adjuvantinduced arthritis AA AA:27 secondary AA AA:8 secondary amyloidosis Ab3 Ab3:8|AB3:1 antiantiid Ab3 Ab3:14|ab3:7|Ab-3:2 antiantiidiotypic ABA ABA:721 abscisic acid ABA ABA:10 activitybased anorexia ABA ABA:9 atopic bronchial asthma ABA ABA:6 hapten azobenzenearsonate ABCA1 ABCA1:14 atpbinding cassette transporter ABCA1 ABCA1:5 cassette transporter ABC ABC:17 active breathing control ABC ABC:26 activitybased costing ABC ABC:14 activitiesspecific balance confidence ABC ABC:8 activitiesspecific balance confidence scale ABC ABC:7 adenoid basal carcinoma ABC ABC:49 advanced breast cancer ABC ABC:4 advanced breast carcinoma ABC ABC:27 antibody binding capacity ABC ABC:14 antigenbinding cells ABC ABC:23 argon beam coagulator ABC ABC:31 aspiration biopsy cytology ABC ABC:36 behavior checklist ABD ABD:17|Abd:4 abdominal ABD ABD:15 actinbinding domain ABD ABD:27 adynamic bone disease ABD ABD:18 autologous blood donation ABD ABD:24 automated border detection ABD ABD:6 automatic boundary detection ABG ABG:25 airbone gap ABG ABG:99 arterial blood gas ABG ABG:11 atrophic body gastritis ABI ABI:137 anklebrachial index ABI ABI:9 ankle brachial indices ABI ABI:10 applied biosystems ABI ABI:16 atherothrombotic brain infarction ABI ABI:39 auditory brainstem implant ABL ABL:4 acute basophilic leukemia ABL ABL:8 agaricus bisporus lectin ABL ABL:7 alveolar bone level ABL ABL:28 alveolar bone loss ABL ABL:9 antigenbinding lymphocytes ABL ABL:8 patients with abetalipoproteinemia ABMS ABMS:15 american board of medical specialties ABMS ABMS:10 autologous bone marrow support ABMT ABMT:21|A-BMT:1 autologous bmt ABMT ABMT:15 autologous bone marrow ABMT ABMT:58|aBMT:1|-ABMT:1 autologous bone marrow transplant ABP1 ABP1:15 auxinbinding protein ABP1 ABP1:10|ABP-1:1 auxinbinding protein ABPM ABPM:12 allergic bronchopulmonary mycosis ABPM ABPM:9 ambulatory blood pressure monitor ABPM ABPM:453 ambulatory blood pressure monitoring ABP ABP:24 acute biliary pancreatitis ABP ABP:6 albuminbinding proteins ABP ABP:39|aBP:1 ambulatory bp ABP ABP:11 human bladder carcinogen aminobiphenyl ABRM ABRM:12|abrm:1 anterior byssal retractor muscle ABRM ABRM:34 anterior byssus retractor muscle ABR ABR:17 american board of radiology ABR ABR:12 auditory brainstem ABR ABR:7 response testing ABS ABS:12 acrylonitrilebutadienestyrene ABS ABS:9 acute bacterial sinusitis ABS ABS:28 adaptive behavior scale ABS ABS:7 adult bovine serum ABs ABs:13 alveolar buds ABS ABS:14 american board of surgery ABS ABS:20 american brachytherapy society ABS ABS:16 amniotic band syndrome ABS ABS:12 antleybixler syndrome ABs ABs:10 apoptotic bodies ABS ABS:5 aqueous biphasic systems ABs ABs:18 asbestos bodies ABS ABS:31 australian bureau of statistics ABT ABT:7 allogeneic blood transfusions ABT ABT:42 aminopyrine breath test ABT ABT:33 blood transfusion ABZSO ABZSO:17|ABZ-SO:3 albendazole sulfoxide ABZSO ABZSO:25|ABZ-SO:6 albendazole sulphoxide AB AB:45|A-B:2 ablebodied AB AB:8 acute bronchitis AB AB:79 alcian blue AB AB:9 amobarbital AB AB:29 anterior burster AB AB:9|Ab:1 aortic banding AB ab:4|AB:4|A-B:3|a-b:2 apicaltobasolateral AB AB:53 attentional blink AB AB:6 autogenous bone AB AB:20 autologous blood AB AB:13 autonomic blockade AC/A AC/A:16 accommodative convergenceaccommodation AC/A AC/A:8 accommodative convergence to accommodation ACB ACB:46 antibodycoated bacteria ACB ACB:20 aortocoronary bypass ACCESS ACCESS:17 access to community care and effective services and supports ACCESS ACCESS:7 case control etiologic study of sarcoidosis ACC ACC:112 aminocyclopropanecarboxylate ACC ACC:8 accident compensation corporation ACC ACC:45 adrenocortical carcinoma ACC ACC:40 agenesis of the corpus callosum ACC ACC:37 american college of cardiology ACC ACC:273|acc:1|ACc:1 anterior cingulate cortex ACC ACC:14 antibodycontaining cells ACC ACC:27 aplasia cutis congenita ACC ACC:13 articular chondrocalcinosis ACD ACD:38 active compressiondecompression ACD ACD:208 allergic contact dermatitis ACD ACD:10 alveolar capillary dysplasia ACD ACD:47 anemia of chronic disease ACD ACD:11 anterior cervical discectomy ACD ACD:107 anterior chamber depth ACD ACD:9 available chemicals directory ACD ACD:21 chronic disorders ACE ACE:9 addenbrookes cognitive examination ACE ACE:61 affinity capillary electrophoresis ACE ACE:10|ACe:9 amygdaloid central nucleus ACE ACE:8 angiotensin converting enzyme gene ACE ACE:23 antegrade continence enema ACE ACE:6 arm crank ergometer ACE ACE:5 arm crank ergometry ACE ACE:3 cyclophosphamide and etoposide ACFs ACFs:15 aberrant crypt foci ACFs ACFs:9 activated carbon fibers ACF ACF:11 aberrant crypt focus ACF ACF:9 activated carbon fiber ACF ACF:30 aortocaval fistula ACF ACF:12|acf:1 apobec complementation factor ACF ACF:20 autocorrelation function ACF ACF:3 corpectomy and fusion ACG ACG:8|Acg:3 acycloguanosine ACG ACG:5 ambulatory care group ACG ACG:9 american college of gastroenterology ACG ACG:14|Acg:1|acg:1 anterior cingulate gyrus ACG ACG:17 apexcardiogram ACI ACI:13 acute cardiac ischemia ACI ACI:10 acute coronary insufficiency ACI ACI:10 andersen cascade impactor ACI ACI:11 aortic calcification index ACI ACI:27 autologous chondrocyte implantation ACM ACM:28 aclacinomycin ACM ACM:9 aclacinomycina ACM ACM:9 alcoholic cardiomyopathy ACM ACM:13 anterior chamber maintainer ACM ACM:25 arnoldchiari malformation ACM ACM:8 asbestoscontaining materials ACM ACM:23 astrocyteconditioned medium AcP AcP:11|ACP:2|acP:2|Ac-P:1 acetyl phosphate ACP ACP:6|AcP:3|acP:1 acid phosphatase activity ACP ACP:184 acyl carrier protein ACP ACP:17 advance care planning ACP ACP:9 alcoholic chronic pancreatitis ACP ACP:44 alternative complement pathway ACP ACP:27 american college of physicians ACP ACP:64 amorphous calcium phosphate ACP ACP:9 antegrade cerebral perfusion ACP ACP:16 anterior clinoid process ACP ACP:8 antrochoanal polyp AcP AcP:9 muscle acylphosphatase ACQ ACQ:5 agoraphobic cognitions questionnaire ACQ ACQ:11 asthma control questionnaire ACR ACR:16 acquired cellular resistance ACR ACR:14|acr:3 acrolein ACR ACR:77 acute cellular rejection ACR ACR:35 adenomatosis of the colon and rectum ACR ACR:7 adequate clinical response ACR ACR:9 albumin creatinine ratio ACR ACR:89 american college of radiology ACR ACR:303 american college of rheumatology ACR ACR:10 urinary albumintocreatinine ratio ACS ACS:84 abdominal compartment syndrome ACS ACS:14|Acs:10|acs:1 acetylcoa synthetase ACS ACS:15 acute confusional state ACs ACs:34|Acs:1 adenylyl cyclases ACs ACs:12 amacrine cells ACS ACS:11 ambulatory care sensitive ACS ACS:100 american cancer society ACS ACS:33 american college of surgeons ACS ACS:14 anterior cricoid split ACS ACS:5 anticoagulation service ACS ACS:14 ars consensus sequence ACS ACS:10 asymptomatic carotid stenosis ACS ACS:10 automated corneal shaper ACTA1 ACTA1:6|acta1:1 skeletal muscle alphaactin ACTA1 ACTA1:7 skeletal muscle alphaactin gene ACTH ACTH:10 adrenocorticotrophic ACTH ACTH:17 adrenocorticotropic ACTH ACTH:2106|Acth:2 adrenocorticotropic hormone ACTH ACTH:1027 adrenocorticotropin ACTH ACTH:99 corticotrophin ACTH ACTH:598 corticotropin ACTH ACTH:23 plasma adrenocorticotrophin Act Act:13|act:7|ACT:4 actinorhodin ACT ACT:87 activated coagulation time ACT ACT:7 adrenocortical tumors ACT ACT:57 alphaantichymotrypsin ACT ACT:10 american college testing ACT ACT:11 anticoagulant therapy ACT ACT:87 assertive community treatment ACT ACT:38 australian capital territory ACT ACT:23 autologous chondrocyte transplantation ACT ACT:9 combination therapy Act Act:10 cytotoxic enterotoxin ACV ACV:9 hydroxyethoxymethylguanine ACV ACV:17|Acv:1 aciclovir ACV ACV:406|acv:2|Acv:1 acyclovir ACV ACV:6 assistcontrol ventilation ACV ACV:27 deltalalphaaminoadipyllcysteinyldvaline ACV ACV:6 tripeptide deltalalphaaminoadipoyllcysteinyldvaline AChE AChE:28|Ach-E:1|AchE:1 acetylcholinesterase activity AChE AChE:6 acetylcholinesterase enzyme AChR AChR:6 acetylcholine receptor channel AChR AChR:8|AchR:2 acetylcholine receptor protein AChR AChR:9 channel complex ACh ACh:23 cacetylcholine ACh ACh:19|Ach:3|ACH:1 acetylcholine chloride ACH ACH:6 active chronic hepatitis ACH ACH:8|ach:3 air changes per hour ACH ACH:9|a-CH:1|aCH:1 alphachlorohydrin ACH ACH:4 arkansas childrens hospital ACh ACh:25|Ach:3 cholinergic ACh ACh:1 release hacetylcholine AC AC:15 aberrant crypts AC AC:10 acebutolol AC AC:9|Ac:5|ac:1 acetone AC AC:9 acid ceramidase AC AC:66|A-C:2 acromioclavicular AC AC:36 activated carbon AC AC:60 activated charcoal AC AC:8 activation coefficient AC AC:9 activity coefficient AC AC:39 acute cholecystitis AC AC:22 adherent cells AC AC:28 aesthetic component AC AC:13 affinity chromatography AC AC:15 air conduction AC AC:15 allergic conjunctivitis AC AC:7 allyl chloride AC AC:9 alternating AC AC:21 amniocentesis AC AC:13 amygdaloid complex AC AC:12 anchor cell AC AC:157 anterior chamber AC AC:64|ac:1 anterior commissure AC AC:15|ac:1|Ac:1 anticoagulant AC AC:19 anticoagulation AC AC:23 aortic constriction AC AC:6 apatite cement AC AC:8 arachnoid cysts AC AC:22 arm circumference AC AC:18 arterial compliance AC AC:30 articular cartilage AC AC:8 artificial circulation AC AC:6 asbestos cement AC AC:12 attenuationcorrected AC AC:38 attenuation correction AC AC:21 atypical carcinoid AC AC:8 axillary clearance AC AC:21 doxorubicin and cyclophosphamide Ac Ac:16|AC:1 maize activator Ac Ac:15 maize transposable element activator AC AC:1 patients had alcoholic cirrhosis ADAM ADAM:37 anthryldiazomethane ADAM ADAM:13 alkenyldiarylmethane ADAM ADAM:13 disintegrin and metalloprotease ADAM ADAM:19 disintegrin and metalloproteinase ADA ADA:29 adenosine deaminase activity ADA ADA:6|Ada:1 adenosine deaminase gene ADA ADA:6 alcohol dependence and abuse ADA ADA:47 american dental association ADA ADA:183 american diabetes association ADA ADA:337 americans with disabilities act ADA ADA:17 americans with disabilities act of ADA ADA:10 azodicarbonamide ADCC ADCC:17 antibodydependent ADCC ADCC:15 antibodydependent cellmediated cytolysis ADCC ADCC:16 antibodydependent cellmediated cytotoxic ADCC ADCC:833 antibodydependent cellular cytotoxicity ADCC ADCC:9 cytoxicity ADC ADC:136 aids dementia complex ADC ADC:5 analogtodigital conversion ADC ADC:59|adc:2 arginine decarboxylase ADC ADC:10 converter ADD1 ADD1:5 adipocyte determination and differentiationdependent factor ADD1 ADD1:7 adipocyte determination and differentiation factor ADE ADE:22 alcohol deprivation effect ADE ADE:39 antibodydependent enhancement ADE ADE:24 arrhythmogenic dose of epinephrine ADF ADF:25 actin depolymerizing factor ADF ADF:5 australian defence force ADH ADH:14 adipic acid dihydrazide ADH ADH:738|adh:1 antidiuretic hormone ADH ADH:103 atypical ductal hyperplasia ADH ADH:17 autosomal dominant hypocalcemia ADIs ADIs:25 acceptable daily intakes ADIs ADIs:12 aidsdefining illnesses ADI ADI:11 aidsdefining illness ADI ADI:19 arginine deiminase ADI ADI:11 autism diagnostic interview ADL ADL:16 acid detergent lignin ADL ADL:39 activities of daily life ADL ADL:11 activities of daily living scale ADL ADL:6 acute adenolymphangitis ADL ADL:8 aerobic dive limit ADL ADL:5 daily activities ADMA ADMA:7 asymmetric dimethyl arginine ADMA ADMA:6 asymmetric dimethyllarginine ADMA ADMA:176 asymmetric dimethylarginine ADMA ADMA:36 asymmetrical dimethylarginine ADPRT ADPRT:13 adenosine diphosphate ribosyl transferase ADPRT ADPRT:27|ADPrT:1|ADP-RT:1 adpribosyltransferase ADP ADP:7 aortic diastolic pressure ADP ADP:11 death protein ADP ADP:5 presence of atp ADs ADs:45 advance directives ADs ADs:11 afterdischarges ADS ADS:14 alcohol dependence scale ADS ADS:6 alcohol dependence syndrome ADs ADs:22|ADS:1 antidepressants ADs ADs:9|ADS:2 antidepressant drugs ADs ADs:5 cortical epileptic afterdischarges ADTN ADTN:14 aminodihydroxytetrahydronaphthalene ADTN ADTN:6 anterodorsal thalami nuclei ADT ADT:15 afterdischarge threshold ADT ADT:8 agar diffusion test ADT ADT:76 androgen deprivation therapy ADV ADV:23 adefovir dipivoxil ADV ADV:48 aleutian mink disease parvovirus ADV ADV:116 aujeszkys disease virus AEA AEA:5 antiendomysium antibody AEA AEA:16 arachidonylethanolamide AECG AECG:14 ambulatory ecg AECG AECG:9 ambulatory electrocardiography AEC AEC:9 absolute eosinophil count AEC AEC:36 adenylate energy charge AEC AEC:8 anionexchange chromatography AEC AEC:5 apical epithelial cap AEC AEC:17 automatic exposure control AEDs AEDs:920|AEDS:5 antiepileptic drugs AEDs AEDs:86 automated external defibrillators AED AED:10 aminoethyldextran AED AED:12 anhidrotic ectodermal dysplasia AED AED:50 automated external defibrillator AED AED:12 emission detection AED AED:11 external defibrillation AED AED:27 external defibrillators AEF AEF:23 allogeneic effect factor AEF AEF:37 amyloid enhancing factor AEF AEF:18 aortoenteric fistula AEF AEF:19 aortoesophageal fistula AEF AEF:7 auditory evoked magnetic field AEF AEF:8 axolemmaenriched fractions AEM AEM:10 ambulatory ecg monitoring AEM AEM:17 ambulatory electrocardiographic monitoring AEP AEP:7 aminoethylphosphonic acid AEP AEP:8 acute edematous pancreatitis AEP AEP:33 acute eosinophilic pneumonia AEP AEP:21 acute experimental pancreatitis AEP AEP:17 alkaline extracellular protease AEP AEP:10 artificial endocrine pancreas AEP AEP:5 asparaginyl endopeptidase AEP AEP:11 auditory AER AER:15 agranular endoplasmic reticulum AER AER:181|aer:1 apical ectodermal ridge AES AES:8 advanced expert system AEs AEs:298 adverse events AEs AEs:16 adverse experiences AES AES:10 affinity enhancement system AES AES:11 anal endosonography AES AES:22|AEs:2 anterior ectosylvian sulcus AES AES:13 apathy evaluation scale AES AES:32 auger electron spectroscopy AET AET:16 aminoethylisothiouronium bromide AET AET:11 atrial ectopic tachycardia AET AET:27 bromide hydrobromide AEV AEV:12 anterior ectosylvian visual area AEV AEV:22 avian encephalomyelitis virus AEV AEV:84 avian erythroblastosis virus AE AE:5 absence epilepsy AE AE:10 absolute error AE AE:28 acoustic emission AE AE:8 acridinium ester AE AE:27 acrodermatitis enteropathica AE AE:9 acute exacerbation AE AE:6 aerobic exercise AE AE:15 aldrin epoxidase AE AE:9 allylestrenol AE AE:110 alveolar echinococcosis AE AE:11 anion exchange AE AE:11 aqueous extract AE AE:12 assimilation efficiency AE AE:72 atopic eczema AE AE:11 avian encephalomyelitis AF-2 AF-2:21|AF2:1 furylnitrofurylacrylamide AF-2 AF-2:17|AF2:3 furylfuramide AF64A AF64A:36|AF-64A:1 ethylcholine aziridinium AF64A AF64A:37 ethylcholine aziridinium ion AFB AFB:29 acetatefree biofiltration AFB AFB:29 acidfast bacillus AFB AFB:9 aortofemoral bypass AFC AFC:7 aminotrifluoromethyl coumarin AFC AFC:20 alveolar fluid clearance AFC AFC:13 antral follicle count AFC AFC:14 nacetylsfarnesyllcysteine AFD AFD:11|AFd:5 andersonfabry disease AFD AFD:9 appropriatefordate AFD AFD:11 averagefordates AFE AFE:11 age at first egg AFE AFE:40 amniotic fluid embolism AFLP AFLP:40 acute fatty liver of pregnancy AFLP AFLP:8 amplified fragment length polymorphic AFM AFM:324 atomic force microscope AFM AFM:9 atomic force microscopic AFP AFP:12 afetoprotein AFP AFP:166 acute flaccid paralysis AFP AFP:16 alfafetoprotein AFP AFP:6 anterior fontanel pressure AFP AFP:7 anterior fontanelle pressure AFP AFP:17 anterior forebrain pathway AFP AFP:14 antialphafetoprotein AFP AFP:12 antifreeze polypeptide AFP AFP:17 antifungal protein AFP AFP:16 atypical facial pain AFP AFP:38 serum alphafetoprotein AFs AFs:16 actin filaments AFs AFs:13|Afs:1 aflatoxins AFS AFS:55 allergic fungal sinusitis AFS AFS:41 american fertility society AFS AFS:16 atomic fluorescence spectrometry AFT AFT:6 accelerated failure time AFT AFT:10 anodic fenton treatment AFT AFT:12 atrial fibrillation threshold AF AF:14 abdominal fat AF AF:19 accelerated fractionation AF AF:7 accessory function AF AF:14 aggregation factor AF AF:8 aggressive fibromatosis AF AF:13 aldehyde fuchsin AF AF:23 amaurosis fugax AF AF:9 ameloblastic fibroma AF AF:10 anaerobic filter AF AF:11 anchoring fibrils AF AF:33 annulus fibrosus AF AF:15 anulus fibrosus AF AF:6 arterial filter AF AF:9 attributable fraction AF AF:23 autonomic failure AF AF:9 factors AGA AGA:6 alphaglycyrrhetinic acid AGA AGA:5 allergic granulomatosis and angiitis AGA AGA:11 allergic granulomatous angiitis AGA AGA:68 androgenetic alopecia AGA AGA:23 antigliadin antibodies AGA AGA:9 antibodies to gliadin AGA AGA:15 appropriate AGA AGA:39 aspartylglucosaminidase AGA AGA:11 presents the official recommendations of the american gastroenterological association AGC AGC:22 absolute granulocyte count AGC AGC:29 advanced gastric cancer AGC AGC:12 advanced gastric carcinoma AGC AGC:13 atypical glandular cells AGC AGC:22 automatic gain control AGD AGD:13 agar gel diffusion AGD AGD:18 amoebic gill disease AGD AGD:47 anogenital distance AGD AGD:23|AgD:10 argyrophilic grain disease AGEPC AGEPC:12 oalkylacetylsnglycerophosphocholine AGEPC AGEPC:28 acetyl glyceryl ether phosphorylcholine AGHD AGHD:5 adult gh deficiency AGHD AGHD:9 adult growth hormone deficiency AGL AGL:8 acute granulocytic leukemia AGL AGL:1 caused by the deficiency of glycogendebranching enzyme AGP AGP:88 alphaacid glycoprotein AGP AGP:16 arabinogalactanprotein AGP AGP:5 growth promoter AGT AGT:3 alanine glyoxylate aminotransferase AGT AGT:32|Agt:5 angiotensinogen gene AGT AGT:11|AgT:1|agT:1 antiglobulin test AGT AGT:23 average generation time AGT AGT:12 oalkylguaninednaalkyltransferase AGU AGU:68 aspartylglucosaminuria AGU AGU:22 aspartylglycosaminuria AHAS AHAS:21 acetohydroxy acid synthase AHAS AHAS:27 acetohydroxyacid synthase AHA AHA:12 aminonhydroxyadenine AHA AHA:33|Aha:1 acetohydroxamic acid AHA AHA:44 american hospital association AHA AHA:76 anterior hypothalamic area AHD AHD:17 alveolar hydatid disease AHD AHD:6 antihypertensive drugs AHF AHF:15 acute heart failure AHF AHF:32 acute hepatic failure AHF AHF:58 altered hepatic foci AHF AHF:41 antihemophilic factor AHF AHF:8 aqueous humor formation AHF AHF:39 argentine hemorrhagic fever AHG AHG:7 aggregated human igg AHG AHG:53 globulin AHH AHH:552 aryl hydrocarbon hydroxylase AHH AHH:8 aryl hydrocarbon hydroxylase activity AHL AHL:15|Ahl:3|ahl:1 agerelated hearing loss AHL AHL:10 lactones AHL AHL:19 nacyl homoserine lactone AHL AHL:18 nacylhomoserine lactone AHO AHO:13 acute hematogenous osteomyelitis AHO AHO:61 hereditary osteodystrophy AhpC AhpC:17|ahpC:4 alkyl hydroperoxide reductase AhpC AhpC:3|ahpC:2 alkyl hydroperoxide reductase subunit c AHP AHP:9 acute hemorrhagic pancreatitis AHP AHP:7 afterhyperpolarizing potential AHP AHP:32 analytic hierarchy process AHP AHP:9 anosognosia for hemiplegia AHRF AHRF:8 acute hypercapnic respiratory failure AHRF AHRF:11 acute hypoxemic respiratory failure AHSV AHSV:56 african horse sickness virus AHSV AHSV:39 african horsesickness virus AHS AHS:48 african horse sickness AHS AHS:15 african horsesickness AHS AHS:11 alien hand syndrome AHS AHS:5 alphahaemolytic streptococci AHS AHS:6 alphahemolytic streptococci AHS AHS:24 ammons horn sclerosis AHS AHS:12 anticonvulsant hypersensitivity syndrome AHS AHS:24 health study AHC AHC:18 acute haemorrhagic conjunctivitis AHC AHC:52 acute hemorrhagic conjunctivitis AHC AHC:13|AH-C:2|aHC:1 acute hepatitis c AHC AHC:46 adrenal hypoplasia congenita AHC AHC:2 alternating hemiplegia in childhood AHC AHC:9 congenital adrenal hypoplasia AIA AIA:69 adjuvantinduced arthritis AIA AIA:48|aia:1 allylisopropylacetamide AIA AIA:74|AiA:6 antigeninduced arthritis AIA AIA:52 aspirininduced asthma AIA AIA:16 aspirinintolerant asthma AIB AIB:10|Aib:1 aminoisobutyrate AIB AIB:5 airflowinduced bronchoconstriction AIB AIB:14 alphaaminoisobutyrate AIB AIB:204|Aib:53 alphaaminoisobutyric acid AICAR AICAR:30 aminoimidazolecarboxamidebetadribofuranoside AICAR AICAR:34 aminoimidazolecarboxamide ribonucleoside AICAR AICAR:12 aminoimidazolecarboxamide ribonucleotide AICAR AICAR:6 aminoimidazolecarboxamide ribotide AICD AICD:217 activationinduced cell death AICD AICD:13 app intracellular domain AIC AIC:12 autoimmune cholangitis AIC AIC:10 information criteria AIC AIC:93 information criterion AIDP AIDP:37 acute inflammatory demyelinating polyneuropathy AIDP AIDP:18 acute inflammatory demyelinating polyradiculoneuropathy AIDS AIDS:13 acquired immune deficiency AIDS AIDS:2376 acquired immune deficiency syndrome AIDS AIDS:12 acquired immunodeficiency AIDS AIDS:18 acquired immunodeficiency disease AIDS AIDS:11 acquired immunodeficiency virus AID AID:129 activationinduced cytidine deaminase AID AID:37 agency for international development AID AID:69 artificial insemination by donor AID AID:22|aid:1 artificial insemination with donor semen AID AID:6 artificial insemination with donor sperm AID AID:6 donor artificial insemination AIF AIF:51 arterial input function AIF AIF:20 cytochrome c and apoptosisinducing factor AIH AIH:5 amiodaroneinduced hypothyroidism AIH AIH:8 anastomotic intimal hyperplasia AIH AIH:7 artificial insemination by husband AIH AIH:2 artificial insemination using the husbands semen AIH AIH:337|AiH:2|AI-H:1 autoimmune hepatitis AIH AIH:11 homologous artificial insemination AIIt AIIt:7 annexin ii heterotetramer AIIt AIIt:14|A-IIt:1 annexin ii tetramer AILD AILD:9 angioimmunoblastic lymphadenopathy with dysproteinaemia AILD AILD:60 angioimmunoblastic lymphadenopathy with dysproteinemia AIMS AIMS:127 abnormal involuntary movement scale AIMS AIMS:18 anesthesia information management system AIMS AIMS:7 first incidents reported to the australian incident monitoring study AIM AIM:6 activation inducer molecule AIM AIM:13 acute infectious mononucleosis AIM AIM:16 acute myocardial infarction AIM AIM:6 analytical ion microscopy AIM AIM:6 artificial intelligence in medicine AIN AIN:66 acute interstitial nephritis AIN AIN:36 anal intraepithelial neoplasia AIN AIN:10 anterior interosseous nerve AIN AIN:25 autoimmune neutropenia AION AION:22 anterior ischaemic optic neuropathy AION AION:88 anterior ischemic optic neuropathy AIP1 AIP1:5|Aip1:1 actininteracting protein AIP1 AIP1:6|Aip1:1 interacting protein AIP AIP:6 aminoindanphosphonic acid AIP AIP:241 acute intermittent porphyria AIP AIP:27 acute interstitial pneumonia AIP AIP:15 autoimmune pancreatitis AIP AIP:9 autoinducing peptide AIP AIP:7 inhibitory peptide AIRE AIRE:13 acute infarction ramipril efficacy AIRE AIRE:50|Aire:5|aire:1 autoimmune regulator AIRE Aire:4|AIRE:4 autoimmune regulator gene AISA AISA:11 acquired idiopathic sideroblastic anaemia AISA AISA:12 acquired idiopathic sideroblastic anemia AIS AIS:140 abbreviated injury scale AIS AIS:23 abbreviated injury score AIS AIS:6 acute ischaemic stroke AIS AIS:33 acute ischemic stroke AIS AIS:84 adolescent idiopathic scoliosis AIs AIs:11 american indians AIS AIS:7 anemiainducing substance AIS AIS:7 antiinsulin serum AIs AIs:51 aromatase inhibitors AIs AIs:9 asymmetry indices AIT AIT:42 adoptive immunotherapy AIT AIT:33 amiodaroneinduced thyrotoxicosis AIV AIV:17 anterior interventricular vein AIV AIV:58 avian influenza virus AIV AIV:9 influenza viruses AJC AJC:17 american joint committee AJC AJC:7 ankle joint complex AJC AJC:7 apical junctional complex AKAP AKAP:13 akinase anchoring protein AKAP AKAP:12 kinase anchoring protein AKAPs AKAPs:14 akinase anchor proteins AKAPs AKAPs:55 akinase anchoring proteins AKAPs AKAPs:9 kinase anchor proteins AKAPs AKAPs:6 protein kinase a anchoring proteins AKA AKA:8 aboveknee amputation AKA AKA:9 alcoholic ketoacidosis ALA ALA:22 aminolevulinate ALA ALA:8 antilymphocyte antibodies ALA ALA:13 antilysozyme activity ALA ALA:10 deltaaminolaevulinate ALA ALA:40 deltaaminolevulinate ALA ALA:69 liver abscess ALC ALC:29 absolute lymphocyte count ALC ALC:7 adult leydig cells ALC ALC:30 alcoholic liver cirrhosis ALC ALC:8|Alc:1 alcoholism ALC ALC:10 allogeneic lymphocyte cytotoxicity ALC ALC:12 alveolar liquid clearance ALC ALC:20 anaplastic large cell ALD ALD:9 adrenoleukodystrophy ALD ALD:10 adrenoleucodystrophy ALD ALD:239 alcoholic liver disease ALD ALD:54|Ald:4 aldolase ALD ALD:108|ald:1 anterior latissimus dorsi ALD ALD:9 anterior latissimus dorsi muscle ALD ALD:11 atomic layer deposition ALE ALE:9 active life expectancy ALE ALE:8 artichoke leaf extract ALF ALF:165 acute liver failure ALF ALF:7 alveolar lining fluid ALH ALH:10 allan hills ALH ALH:70|Alh:1 amplitude of lateral head displacement ALH ALH:21 atypical lobular hyperplasia ALI ALI:437 acute lung injury ALI ALI:22 airliquid interface ALI ALI:5 annual limit of intake ALK ALK:149|Alk:3|alk:1|AlK:1 anaplastic lymphoma kinase ALK ALK:11 automated lamellar keratoplasty ALLN ALLN:18 nacetylleuleunorleucinal ALLN ALLN:23 nacetylleucylleucylnorleucinal ALL ALL:36 acute lymphoblastic ALL ALL:5 acute lymphoblastic leukemic ALL ALL:12 acute lymphocytic ALL ALL:716 acute lymphocytic leukemia ALL ALL:8 acute lymphoid ALL ALL:10 anterior longitudinal ligament ALM ALM:28 acral lentiginous melanoma ALM ALM:7|Alm:2 almitrine bismesylate ALM ALM:6 autoclaved leishmania major ALP ALP:10|AlP:2|Alp:1 alkaline ALP ALP:9|AlP:6 aluminium phosphide ALP ALP:21 antileukoprotease ALP ALP:13|aLP:1 antileukoproteinase ALP ALP:13 atherogenic lipoprotein phenotype ALP ALP:6 lim protein ALS ALS:49 acetolactate synthase ALS ALS:23 acid labile subunit ALS ALS:228 advanced life support ALS ALS:10 alternating least squares ALS ALS:2625 amyotrophic lateral sclerosis ALS ALS:8 antilymphocyte sera ALTS ALTS:5 ascuslsil triage study ALTS ALTS:5 squamous intraepithelial lesion triage study ALT ALT:14 alanine aminotransaminase ALT ALT:18 alanine aminotransferase activity ALT ALT:36 alternative lengthening of telomeres ALT ALT:9 altitude ALT ALT:13 anterolateral thigh ALT ALT:112 argon laser trabeculoplasty ALT ALT:16 autolymphocyte therapy ALT ALT:8 auxiliary liver transplantation ALT ALT:117 serum alanine transaminase ALT ALT:14 serum alanine transferase ALV-J ALV-J:16 avian leukosis virus subgroup j ALV-J ALV-J:1 subgroup j of avian leukosis virus AL AL:39 acute leukaemia AL AL:15 ad lib AL AL:257|A-L:1 ad libitum AL AL:10 adductor longus Al Al:7|AL:4 albumin Al Al:193|AL:1 aluminium AL AL:10 amyotrophic leukospongiosis AL AL:34 annulate lamellae AL AL:46 antennal lobe AL AL:59 anterior lobe AL AL:20|al:2|A-L:1 anterolateral AL AL:10 argon laser AL AL:9 assisted living AL AL:9 attachment levels AL AL:6 atypical lymphocytes AL AL:48 axial length AL AL:2 lateral nucleus of amygdala AL AL:9 ligament AL AL:12 light chain amyloidosis AL AL:11 patients with primary amyloidosis AL AL:43 primary systemic amyloidosis AMA AMA:14 advanced maternal age AMA AMA:45|ama:1 against medical advice AMA AMA:14|ama:3 amantadine AMA AMA:19 antimitochondrial autoantibodies AMA AMA:30 arm muscle area AMD AMD:30 acid maltase deficiency AMD AMD:56 acid mine drainage AMD AMD:7 agerelated macular disease AMD AMD:13 automated multiple development AMD AMD:10 dactinomycin AME AME:12 absolute magnitude estimation AME AME:29|AmE:1 amphotericin b methyl ester AME AME:24 apparent metabolisable energy AME AME:9 apparent metabolizable energy AME AME:55 apparent mineralocorticoid excess AMFR AMFR:9 amplitudemodulation following response AMFR AMFR:11|AMF-R:9 autocrine motility factor receptor AMF AMF:14 alternating magnetic field AMF AMF:9 angiomyofibroblastoma AMF AMF:48 arbuscular mycorrhizal fungi AMF AMF:59 autocrine motility factor AMG AMG:10 acoustic myography AMG AMG:10 alpha macroglobulin AMG AMG:9 alphamethylglucoside AMG AMG:10 aminoglutethimide AMG AMG:30|amG:1|AmG:1 aminoguanidine AMG AMG:12 autometallographic AMG AMG:23 autometallography AMH AMH:10 accreditation manual for hospitals AMH AMH:163|Amh:9 antimullerian hormone AMI AMI:17 acute mesenteric ischemia AMI AMI:30|aMI:1|Ami:1 acute myocardial infarct AMI AMI:14 acute myocardial ischemia AMI AMI:9|Ami:2 amifostine AMKL AMKL:46|AMkL:4 acute megakaryoblastic leukemia AMKL AMKL:10|AMkL:1 acute megakaryocytic leukemia AMLR AMLR:8 auditory middle latency response AMLR AMLR:14 autologous mixed lymphocyte response AML AML:14 acute myeloblastic AML AML:8 acute myelogenous AML AML:169 acute myelogenous leukaemia AML AML:27 acute myeloid AML AML:19 acute myeloid leukemic AML AML:13 amlodipine AML AML:11 anatomic medullary locking AML AML:26 anterior mitral leaflet AMPA AMPA:10 aminohydroxymethylisoxazolepropionate AMPA AMPA:11 acid hydrobromide AMPA AMPA:13 alphaaminohydroxymethylisoxazole AMPA AMPA:165 alphaaminohydroxymethylisoxazole propionic acid AMPA AMPA:6 alphaaminohydroxymethylisoxazole proprionate AMPA AMPA:9 alphaaminohydroxymethylisoxazoleproprionate AMPA AMPA:22 alphaaminohydroxymethylisoxazolepropionate AMPA AMPA:9 lalphaaminohydroxymethylisoxazolepropionate AMP-PNP AMP-PNP:14|AMPPNP:7 adenylyl imidodiphosphate AMP-PNP AMP-PNP:12|AMPPNP:5|AMP--PNP:1 adenylylimidodiphosphate AMP-PNP AMP-PNP:3|AMPPNP:1 atp analogue adenylylimidodiphosphate AMP AMP:9 aminomethylpropanol AMP AMP:7 allosteric activator AMP AMP:10 antimicrobial peptide AMP AMP:10 antimicrobial prophylaxis AMR AMR:7|amr:2|Amr:2 amrinone AMR AMR:9 antibodymediated rejection AMS AMS:86 accelerator mass spectrometry AMS AMS:16 acute maxillary sinusitis AMS AMS:210 acute mountain sickness AMS AMS:7 altered mental status AMS AMS:8 antimacrophage serum AMS AMS:12 atypical mole syndrome AMS AMS:6 automatic milking systems AMS AMS:12 automatic mode switching AMS AMS:20 automicrobic system AMT AMT:16 aminodihydromethylhthiazine AMT AMT:31 aminodeoxythymidine AMT AMT:13 aminomethyltrimethylpsoralen AMT AMT:25 abbreviated mental test AMT AMT:9|aMT:1 active motor threshold AMT AMT:8 aea membrane transporter AMT AMT:63 amniotic membrane transplantation AMT AMT:9 autobiographical memory test AMV AMV:13 ammonium metavanadate AMV AMV:20 anterior medullary velum AMV AMV:17 apical membrane vesicles AMV AMV:8 assisted mechanical ventilation AMV AMV:190 avian myeloblastosis virus AM AM:22 acetoxymethyl AM AM:28 acetoxymethyl ester AM AM:13 actomyosin AM AM:25 adrenal medulla AM AM:11 alternative medicine AM AM:10 alveolar AM AM:8 ambulatory monitoring AM AM:64 amniotic membrane AM AM:29 amplitude modulated AM AM:83 amplitude modulation AM AM:17 amygdaloid AM AM:19|Am:1|A-m:1 anteromedial AM AM:7 anteromedial nucleus AM AM:21 apparent motion AM AM:12 arbuscular mycorrhiza AM AM:165 arbuscular mycorrhizal AM AM:10 arithmetic mean AM AM:9 artemether AM AM:25 aseptic meningitis AM AM:29 astragalus membranaceus AM AM:7 autobiographical memory AM AM:11 sinusoidally amplitudemodulated ANA ANA:7 aortic nerve activity ANA ANA:13 nuclear antigens ANCAs ANCAs:44 antineutrophil cytoplasmic antibodies ANCAs ANCAs:12 antineutrophil cytoplasmic autoantibodies ANCA ANCA:48 antineutrophil cytoplasmic antibody ANCA ANCA:27 neutrophil cytoplasmic antigens ANC ANC:10 active noise control ANC ANC:46 antenatal care ANH ANH:15 acute normovolaemic haemodilution ANH ANH:83 acute normovolemic hemodilution ANH ANH:12 artificial nutrition and hydration ANH ANH:52 atrial natriuretic hormone A-NK A-NK:7|ANK:1 activated nk A-NK A-NK:5|ANK:3 ilactivated nk A-NK A-NK:44|ANK:1 natural killer ANN ANN:10 alloimmune neonatal neutropenia ANN ANN:9 auditory nerve neurophonic ANN ANN:6 axillary nodenegative ANP ANP:67 acute necrotizing pancreatitis ANP ANP:175 atrial natriuretic polypeptide ANP ANP:12 atrial np ANR ANR:9 active noise reduction ANR ANR:10 neural ridge ANS ANS:9 anilinonaphthalenesulphonate ANS ANS:17 anilinonaphthalene sulfonic acid ANS ANS:8|Ans:1 anterior nasal spine ANS ANS:11 anthocyanidin synthase ANS ANS:19 antineutrophil serum ANS ANS:386 autonomic nervous system ANS ANS:6|Ans:1 probe anilinonaphthalenesulfonate ANT ANT:12|ant:2 aintegumenta ANT ANT:10 alcoholsensitive ANT ANT:13|Ant:5 anthracene ANT ANT:7 attention network test ANV ANV:17 anticipatory nausea and vomiting ANV ANV:14 avian nephritis virus AN AN:52 acanthosis nigricans AN AN:5 acceptor number AN AN:6 accessory nuclei AN AN:25 alae nasi AN AN:16 analgesic nephropathy AN AN:14|an:1 aneuploid AN AN:13 aniline AN AN:10 anticipatory nausea AN AN:10|an:2 area of necrosis AN AN:10 areca nut AN AN:11 artificial nutrition AN AN:7 aseptic necrosis AN AN:18 auditory neuropathy AN AN:74 autonomic neuropathy AN AN:5 stimulation of the aortic nerve AOA AOA:14 alpha omega alpha AOA AOA:7 american optometric association AOA AOA:12 american osteopathic association AOA AOA:9 aminooxyacetate AOA AOA:26 antioxidative activity AOB AOB:135 accessory olfactory bulb AOB AOB:52 ammoniaoxidizing bacteria AOB AOB:11 anterior open bite AOC AOC:12 advanced ovarian cancer AOC AOC:27 assimilable organic carbon AOD AOD:19 accumulated oxygen deficit AOD AOD:66 alcohol and other drug AOD AOD:13 antioxidant defense AOD AOD:5 antioxidative defense AOD AOD:10 atlantooccipital dislocation AOD AOD:55 occlusive disease AOM AOM:512 acute otitis media AOM AOM:12 angular overlap model AOM AOM:13 colon carcinogen azoxymethane AOM AOM:7 number and histology of colon tumors induced by azoxymethane AON AON:5 accessory optic nuclei AON AON:28 anterior olfactory nucleus AON AON:9 aseptic osteonecrosis AOP AOP:16 advanced oxidation process AOP AOP:7 anemia of prematurity AOP AOP:19 antioxidant potential AOP AOP:10|AoP:1 apnea of prematurity AOS AOS:56 accessory optic system AOS AOS:65|aos:1 active oxygen species AOS AOS:9 adamsoliver syndrome AOS AOS:28 allene oxide synthase AOS AOS:14 apraxia of speech AOT AOT:13 aerosolot AOT AOT:17 sodium bisethylhexylsulfosuccinate AOX AOX:10 adsorbable organic halogens AOX AOX:74|Aox:4|aox:1 alternative oxidase AO AO:330 acridine orange AO AO:10 active oxygen AO AO:11 adaptive optics AO AO:9 adultonset AO AO:8 adverse outcome AO AO:11 age of onset AO AO:12 airway obstruction AO AO:10 albino oxford AO AO:41|Ao:3 aldehyde oxidase AO AO:10 antisense oligonucleotide AO AO:7 aortic output AO AO:6 aqueous oxygen AO AO:10 arbeitsgemeinschaft fur osteosynthesefragen AO AO:8 arterial occlusion AP-1 AP-1:3 activated by the fosjun heterodimeric complex AP-1 AP-1:22|AP1:5 activator protein AP3 AP3:11|AP-3:1 aminophosphonopropionate AP3 AP3:11|AP-3:3 aminophosphonopropionic acid APAs APAs:11 aldosteroneproducing adenomas APAs APAs:30 anticipatory postural adjustments APA APA:9 abrus precatorius agglutinin APA APA:73 action potential amplitude APA APA:32 american psychiatric association APA APA:33 american psychological association APA APA:13 amplitude of action potential APA APA:13 ap amplitude APA APA:10 atypical polypoid adenomyoma APB APB:67 aminophosphonobutyrate APB APB:130 abductor pollicis brevis APB APB:21 abductor pollicis brevis muscle APB APB:25|aPB:1 adult peripheral blood APC/C APC/C:11 anaphasepromoting complex APC/C APC/C:19 anaphasepromoting complex or cyclosome APC APC:19|aPC:2 activated pc APC APC:725|aPC:22 activated protein c APC APC:7|Apc:1 adenomatous polyposis APC APC:765|Apc:38|apc:3 adenomatous polyposis coli APC APC:21|Apc:5 adenomatous polyposis coli gene APC APC:9 adenomatous polyposis coli gene product APC APC:20 adenomatous polyposis coli protein APC APC:20|apc:1 ageperiodcohort APC APC:12 air pollution control APC APC:35|apc:1 allophycocyanin APC APC:17 alternative pathway of complement APC APC:13 anaphasepromoting complexcyclosome APC APC:17 anesthetic preconditioning APC APC:21|aPC:4 anterior piriform cortex APC APC:9 aqueous protein concentration APC APC:111 argon plasma coagulation APD90 APD90:7 action potential duration at of repolarization APD90 APD90:4 action potential duration at repolarisation APDs APDs:22 action potential durations APDs APDs:56 antipsychotic drugs APDs APDs:10 atrial premature depolarizations APD APD:15 aminohydroxypropylidenebisphosphonate APD APD:9 aminohydroxypropylidene bisphosphonate APD APD:9 aminohydroxypropylidene diphosphonate APD APD:6 anteroposterior diameter APD APD:7 auditory processing disorders APD APD:22 automated pd APD APD:122 automated peritoneal dialysis APD APD:22 avoidant personality disorder APD APD:11 disodium pamidronate APE APE:8 abdominoperineal excision APE APE:10 acute pulmonary edema APE APE:29 acute pulmonary embolism APE APE:11 ap endonuclease APE APE:17 arecaidine propargyl ester APE APE:4 atom percent excess APF APF:66 acidulated phosphate fluoride APF APF:6 anionic polypeptide fraction APF APF:54 antiperinuclear factor API API:12 achromobacter protease i API API:36 active pharmaceutical ingredient API API:13 acute panic inventory API API:20 aminopeptidase i API API:13 ankle pressure index API API:13 annual parasite incidence API API:11 approximal plaque index API API:35 atmospheric pressure ionization APLD APLD:10 adult polycystic liver disease APLD APLD:17 automated percutaneous lumbar discectomy APLs APLs:9 acute promyelocytic leukemias APLs APLs:30 altered peptide ligands APL APL:24 abductor pollicis longus APL APL:8 accreditation of prior learning APL APL:173 acute promyelocytic leukaemia APL APL:4|aPL:3 antibodies to phospholipids APL APL:10 atrichia with papular lesions APM APM:17 affectedpedigreemember APM APM:29|AP-M:6 aminopeptidase m APM APM:9 antigen processing machinery APM APM:11|apm:1 apical plasma membrane APM APM:24 aspartame APM APM:2 mhc class i antigenprocessing machinery APN APN:44 acute pyelonephritis APN APN:67 advanced practice nurse APP APP:17|AP-P:3 aminopeptidase p APP APP:97 amyloid protein precursor APP APP:46|aPP:7 avian pancreatic polypeptide APP APP:18 precursor protein gene APRT APRT:32|aprt:10|Aprt:1 adenine phosphoribosyl transferase APRT APRT:4|aprt:1 adenine phosphoribosyltransferase gene APS APS:10 adenylylsulfate APs APs:52|Aps:2|APS:1 accessory pathways APS APS:5 activated sulfate APS APS:40 acute physiology score APS APS:5 addiction potential scale APS APS:5 adult protective services APS APS:13 aerodynamic particle sizer APs APs:25 alkylphenols APS APS:11 american pain society APs APs:12 aminopeptidases APS APS:9 ammonium persulfate APs APs:12 anterior pituitaries APs APs:11|Aps:1 anterior pituitary glands APS APS:11 antiplatelet serum APS APS:6 atypical parkinsonian syndromes APS APS:6 autoimmune polyglandular syndromes APS APS:7 automatic positioning system APS APS:8 platelet serum APTT APTT:7|aPTT:5 activated partial thromboplastin APTT APTT:4|aPTT:1 partial thromboplastin time test APV APV:40|apv:1 amprenavir APV APV:9 artificial pulmonary ventilation APV APV:30 average peak velocity APV APV:74 avian pneumovirus APV APV:18 avian polyomavirus APV APV:4 nmda antagonist daminophosphonovalerate APV APV:4 nmda receptor antagonist dlaminophosphonovalerate APV APV:9 nmda receptor antagonist dlaminophosphonovaleric acid APV APV:6 peak flow velocity APW APW:10 alkaline peptone water APW APW:7 artificial pond water APH APH:21 acetylphenylhydrazine APH APH:12 antepartum haemorrhage AP AP:68 abasic AP AP:20 absolute pitch AP AP:7 absolute power AP AP:61 accelerated phase AP AP:6 accessory processes AP AP:5 accumulation of caminopyrine AP AP:19 actinic prurigo AP AP:7|ap:2 activation peptide AP AP:19 acupuncture AP AP:424 acute pancreatitis AP AP:22 acute pneumonia AP AP:31 adaptor protein AP AP:30 adductor pollicis AP AP:146 adult periodontitis AP AP:29 aerosolized pentamidine AP AP:14 alpha antiplasmin AP AP:61 alternative pathway AP AP:7 alveolar permeability AP AP:12 ammonium perchlorate AP AP:11 amyloid p AP AP:12 anaphylactoid purpura AP AP:153 angina pectoris AP AP:5 annular pancreas AP AP:20|ap:1 anterior pagoda AP AP:8|A-P:2 anteriorposterior AP AP:4|A-P:1 anterior to posterior AP AP:10 antigen presentation AP AP:9 antiplasmin AP AP:10 antipsychotic AP AP:76|Ap:1|ap:1 antipyrine AP AP:8|ap:3 apatite AP AP:15|ap:3 apomorphine AP AP:34 apurinic AP AP:309|ap:9 area postrema AP AP:13 artificial perilymph AP AP:9 ascorbyl palmitate AP AP:8 asthmatic patients AP AP:6 autologous plasma AP AP:12|aP:8 available p AP AP:11|aP:4 available phosphorus AP AP:11 average power AP AP:6 pseudomonas aeruginosa alkaline protease AQ AQ:27 acoustic quantification AQ AQ:7 aggression questionnaire AQ AQ:52|Aq:1 amodiaquine AQ AQ:17 anthraquinone AQ AQ:5|Aq:3|aq:1 aqueous AQ AQ:14 areca quid AR4-2J AR4-2J:4|AR42J:1 pancreatic acinar cells AR4-2J AR4-2J:6|AR42J:3 pancreatic acinar cell line ARAS ARAS:9 ascending reticular activating system ARAS ARAS:23 atherosclerotic renal artery stenosis ARA ARA:5 acetylene reduction activity ARA ARA:9 action research arm ARA ARA:9 action research arm test ARA ARA:80 american rheumatism association ARA ARA:19 anorectal angle ARA ARA:5 antiradical activity ARA ARA:5 antireticulin antibodies ARB ARB:22 angiotensin ii type receptor blocker ARB ARB:8 receptor blockade ARC ARC:23 accessory radula closer ARC ARC:15 active renin concentration ARC ARC:15 adult rat cardiomyocytes ARC ARC:14 american red cross ARC ARC:15 anomalous retinal correspondence ARC ARC:8|Arc:1 arcuate nuclei ARC ARC:5 arthritis and rheumatism council ARDRA ARDRA:16 amplified rdna restriction analysis ARDRA ARDRA:58 amplified ribosomal dna restriction analysis ARDS ARDS:10 acute respiratory failure ARDS ARDS:1352 adult respiratory distress syndrome ARDS ARDS:6 lung failure ARF ARF:1717|arf:1 acute renal failure ARF ARF:140 acute rheumatic fever ARIC ARIC:302 atherosclerosis risk in communities ARIC ARIC:12 atherosclerosis risk in communities study ARIS ARIS:9 acrosome reactioninducing substance ARIs ARIs:8 activationrecovery intervals ARIs ARIs:34 acute respiratory infections ARIs ARIs:38 aldose reductase inhibitors ARIS ARIS:12 apoenzyme reactivation immunoassay system ARI ARI:17 acute renal insufficiency ARI ARI:19 acute respiratory illness ARI ARI:17 acute respiratory insufficiency ARI ARI:23 acute respiratory tract infection ARI ARI:40 adhesive remnant index ARI ARI:14 autoregulatory index ARM ARM:1 adriamycin in a rat model ARM ARM:157 agerelated maculopathy ARM ARM:14 anorectal manometry ARM ARM:17 argininerich motif ARM ARM:13|Arm:1 armstrong ARM ARM:6 atpregulated module ARN ARN:82 acute retinal necrosis ARN ARN:16 acute retinal necrosis syndrome ARN ARN:9 afferent renal nerves ARPKD ARPKD:8 autosomal recessive pkd ARPKD ARPKD:111 autosomal recessive polycystic kidney disease ARP ARP:13 absolute refractory period ARP ARP:11 aldehyde reactive probe ARP ARP:13 arthromyces ramosus peroxidase ARS ARS:9 acute radiation sickness ARs ARs:13 adrenoceptors ARS ARS:12 agricultural research service ARS ARS:16|AR-S:1 alizarin red s ARS ARS:5 aminoacyltrna synthetase ARs ARs:60|ARS:1|Ars:1 androgen receptors ARS ARS:10 antigen recognition site ARS ARS:8 antireflux surgery ARS ARS:7|ars:1 autonomous replication sequences ARS ARS:10 axenfeldrieger syndrome ARTs ARTs:12 acoustic reflex thresholds ARTs ARTs:24 assisted reproductive technologies ART ART:18|art:1 acoustic reflex threshold ART ART:15 adaptive resonance theory ART ART:5|aRT:1 adjuvant radiotherapy ART ART:19 algebraic reconstruction technique ART ART:41 antiretroviral treatment ART ART:11 armretina time ART ART:7|Art:3 artemisinin ART ART:22 assisted reproduction techniques ART ART:18 assisted reproduction technologies ART ART:83 atraumatic restorative treatment ART ART:9 auditory reaction time ART ART:9 tachycardia ARVD ARVD:138 arrhythmogenic right ventricular dysplasia ARVD ARVD:11 atherosclerotic renovascular disease ARV ARV:13 aidsassociated retrovirus ARV ARV:128 antiretroviral ARV ARV:8 average rectified value ARV ARV:27 avian reovirus AR AR:13 access recirculation AR AR:8 acid resistance AR AR:24 acoustic reflex AR AR:60 acoustic rhinometry AR AR:13 acrosomereacted AR AR:9 active recovery AR AR:33 active renin AR AR:9 acute allograft rejection AR AR:237 acute rejection AR AR:25 adaptive response AR AR:22 adrenoceptor AR AR:12 airway reactivity AR AR:52 airway responsiveness AR AR:197 allergic rhinitis AR AR:117|Ar:5 amphiregulin AR AR:12 anaphylactoid reactions AR AR:35 androgen receptor gene AR AR:12 anhydroretinol AR AR:22 anterior resection AR AR:37 antigen retrieval AR AR:417 aortic regurgitation AR AR:14 apoptotic rate AR AR:11 applied relaxation AR AR:31 artificially reared AR AR:10 aspect ratio AR AR:41 atrophic rhinitis AR AR:35 attributable risk AR AR:18 augmented reality AR AR:165 autoregressive AR AR:10 autoregulation AR AR:104|ar:3 autosomal recessive ASA ASA:25 accessible surface area ASA ASA:12 acetylsalicylate ASA ASA:22 active systemic anaphylaxis ASA ASA:8 acute severe asthma ASA ASA:15 american society of anaesthesiologists ASA ASA:50 american society of anesthesiology ASA ASA:16 anterior spinal artery ASA ASA:9 aspirinsensitive asthma ASA ASA:56 atrial septal aneurysm ASB ASB:7 anencephaly and spina bifida ASB ASB:14 antisocial behavior ASB ASB:21|AS-B:1 arylsulfatase b ASCA ASCA:28 antisaccharomyces cerevisiae antibodies ASCA ASCA:15 cerevisiae antibody ASCRS ASCRS:6 american society of colon and rectal surgeons ASCRS ASCRS:7 members of the american society of cataract and refractive surgery ASCs ASCs:10 ambulatory surgery centers ASCs ASCs:29 antibodysecreting cells ASC ASC:11 acidified sodium chlorite ASC ASC:19 adenosquamous carcinoma ASC ASC:9 altered states of consciousness ASC ASC:18 ambulatory surgical center ASC ASC:8 asthma symptom checklist ASC AsC:3|ASC:3 asymptomatic hbv carriers ASDs ASDs:74 atrial septal defects ASDs ASDs:17 autism spectrum disorders ASDs ASDs:13 autistic spectrum disorders ASD ASD:61 acute stress disorder ASD ASD:21 adult stills disease ASD ASD:6 antisiphon device ASD ASD:18 arthroscopic subacromial decompression ASES ASES:11 aerosol solvent extraction system ASES ASES:19 american shoulder and elbow surgeons ASE ASE:47 accelerated solvent extraction ASE ASE:5 adaptive signal enhancer ASE ASE:15 american society of echocardiography ASE ASE:12 amplified spontaneous emission ASE ASE:5 left sidespecific enhancer ASF ASF:122 african swine fever ASF ASF:15 airway surface fluid ASF ASF:9 animal source foods ASF ASF:34 asialofetuin ASF ASF:7 intensity function ASH ASH:9 abnormal sperm heads ASH ASH:81 asymmetric septal hypertrophy ASI ASI:9 active specific immunization ASI ASI:25 active specific immunotherapy ASI ASI:169 addiction severity index ASI ASI:12 anterior segment ischemia ASI ASI:53 anxiety sensitivity index ASL ASL:62 airway surface liquid ASL ASL:91 american sign language ASL ASL:11 angiosarcoma of the liver ASL ASL:53 argininosuccinate lyase ASL ASL:46 arterial spin labeling ASO ASO:23 allelespecific oligonucleotides ASO ASO:37 amplatzer septal occluder ASO ASO:72 arterial switch operation ASO ASO:89 arteriosclerosis obliterans ASPs ASPs:5 acid shock proteins ASPs ASPs:16 affected sib pairs ASPs ASPs:21 affected sibling pairs ASP ASP:15 affected sibling pair ASP ASP:15 amnesic shellfish poisoning ASP ASP:25 antisocial personality ASP ASP:13|Asp:1 asparaginase ASR ASR:12 absolute synthesis rate ASR ASR:34 acoustic startle reflex ASR ASR:12 aldosterone secretion rate ASR ASR:12 androgensterilized rats ASR ASR:10 speech recognition ASST ASST:12 arylsulfate sulfotransferase ASST ASST:18 autologous serum skin test ASTM ASTM:6 american society for testing materials ASTM ASTM:19 astromicin AST AST:11 acute suppurative thyroiditis AST AST:4 androgen suppression therapy AST AST:15 antimicrobial susceptibility testing AST AST:6 arginine stimulation test AST AST:11 aryl sulfotransferase AST AST:32 aspartate AST AST:17 aspartateaminotransferase AST AST:15 aspartate transferase AST AST:44|AsT:1 serum aspartate transaminase ASV ASV:8 adaptive support ventilation ASV ASV:2 aneurysm of sinus of valsalva ASV ASV:32 anodic stripping voltammetry ASV ASV:14 autogenous saphenous vein ASW ASW:34 artificial sea water ASW ASW:41 artificial seawater AT1 AT1:7 ang ii receptor AT1 AT1:112 angiotensin type AT1 AT1:8|AT-1:1 subtype AT1 AT1:6 type ang ii AT1 AT1:7 type angiotensin AT1 AT1:12 type angiotensin ii receptor ATA ATA:14|ata:2 atmosphere absolute ATA ATA:6 absolute atmospheres ATA ATA:11 american thyroid association ATA ATA:5 antithyroglobulin antibody ATA ATA:12 antithyroid antibodies ATA ATA:10 aspirintolerant asthma ATA ATA:86|ata:3 atmospheres absolute ATA ATA:5 atmospheres of absolute pressure ATA ATA:22 aurin tricarboxylic acid ATA ATA:120 aurintricarboxylic acid ATA ATA:9 thermolabile antigen ATC ATC:14 air traffic control ATC ATC:10 anaplastic thyroid cancer ATC ATC:39 anaplastic thyroid carcinoma ATC ATC:6|atc:5|ATc:2|aTc:2 anhydrotetracycline ATC ATC:8 autologous tumor cells ATC ATC:21 automatic tube compensation ATD ATD:40 acute tryptophan depletion ATD ATD:9 alpha antitrypsin deficiency ATD ATD:22 amplatz thrombectomy device ATD ATD:13 aqueous tear deficiency ATD ATD:14 aromatase inhibitor androstatrienedione ATD ATD:31 autoimmune thyroid disease ATD ATD:9 test dummy ATII ATII:70|AT-II:3 alveolar type ii ATII ATII:9|AT-II:3 type ii cells ATI ATI:16 abdominal trauma index ATI ATI:7 treatment interaction ATLS ATLS:15 acute tumor lysis syndrome ATLS ATLS:105 advanced trauma life support ATL ATL:16 adult tcell leukaemialymphoma ATL ATL:7 adult tcell lymphoma ATL ATL:16 american tegumentary leishmaniasis ATL ATL:96 anterior temporal lobectomy ATL ATL:11 ascending thin limb ATM ATM:32 acute transverse myelitis ATM ATM:19 acute transverse myelopathy ATM ATM:24 asynchronous transfer mode ATM ATM:9|Atm:1 ataxiatelangiectasia gene ATM ATM:7 mutated protein ATN ATN:316 acute tubular necrosis ATN ATN:10 anterior thalamic nuclei ATP ATP:10 adenosine triphosphoric acid ATP ATP:41 adenosinetriphosphate ATP ATP:14 annual transmission potential ATP ATP:41 antitachycardia pacing ATP ATP:34 substrate ATR-X ATR-X:7 xlinked alphathalassemiamental retardation ATR-X ATR-X:8 xlinked alphathalassemiamental retardation syndrome ATR ATR:8 achilles tendon reflex ATR ATR:48 acid tolerance response ATR ATR:12|Atr:3 atractyloside ATR ATR:52 attenuated total reflectance ATR ATR:73 attenuated total reflection ATR ATR:12 radrelated protein ATS ATS:150 american thoracic society ATS ATS:9 rabbit antirat thymocyte serum ATS ATS:5 thymocyte antiserum ATV ATV:19 allterrain vehicle ATV ATV:7|Atv:2 atorvastatin ATx ATx:8|ATX:3|aTx:1 adult thymectomized ATx ATx:18|ATX:2|aTx:1|A-Tx:1 adult thymectomy AUC(0-24) AUC(0-24):6|AUC(0--24):1 area under the concentrationtime curve from to h AUC(0-24) AUC(0-24):4 concentrationtime curve from time zero to h AUC0-24 AUC0-24:7 concentrationtime curve from to hours AUC0-24 AUC0-24:5 under the concentrationtime curve from to h AUCs AUCs:9 area under the concentrationtime curves AUCs AUCs:17 under the plasma concentrationtime curves AUC AUC:23 analytical ultracentrifugation AUC AUC:3 areas under concentrationtime curves AUC AUC:15 areaundercurve AUC AUC:13 area under the concentration AUC AUC:8 area under the curve of concentration versus time AUC AUC:4 area under the plasma concentration AUC AUC:8 concentration timecurve AUC AUC:7 concentrationtime profiles AUC AUC:4 concentration vs time curves AUC AUC:5 curve values AUC AUC:13 drug exposure AUC AUC:8 extent of absorption AUC AUC:28 plasma concentrationtime curve from time zero to time infinity AUC AUC:12 systemic exposure AUC AUC:4 under the plasma concentrationtime profile AUL AUL:13 acute undifferentiated leukaemia AUL AUL:48 acute undifferentiated leukemia AUMC AUMC:6 area under the first moment curve AUMC AUMC:6|AuMC:1 area under the moment curve AUR AUR:54 acute urinary retention AUR AUR:11 auromomycin AV3V AV3V:6 anteroventral third ventricle region AV3V AV3V:8 anteroventral third ventricular AV3V AV3V:7 anteroventral third ventricular region AVA AVA:11 anthrax vaccine adsorbed AVA AVA:51 aortic valve area AVA AVA:1 main metabolite apovincaminic acid AVCN AVCN:12 anteroventral AVCN AVCN:96 anteroventral cochlear nucleus AVDO2 AVDO2:4|AVDo2:1 arteriovenous difference of oxygen AVDO2 AVDO2:5 oxygen differences AVD AVD:12 aortic valve disease AVD AVD:15 apoptotic volume decrease AVD AVD:14|AVd:1 atrioventricular delay AVD AVD:12 vascular disease AVED AVED:6 ataxia with isolated vitamin e deficiency AVED AVED:8 ataxia with vitamin e deficiency AVE AVE:10 active voluntary euthanasia AVE AVE:20 anterior visceral endoderm AVG AVG:6 autogenous vein grafts AVG AVG:6 inhibitor aminoethoxyvinylglycine AVL AVL:33 american visceral leishmaniasis AVL AVL:9 artificial ventilation of the lungs AVM AVM:9 avermectin ba AVM AVM:9 avian vacuolar myelinopathy AVN AVN:25 atrioventricular nodal AVN AVN:77 atrioventricular node AVN AVN:11 avascular necrosis of bone AVP AVP:13 adenovirus proteinase AVP AVP:28 ambulatory venous pressure AVP AVP:24 argvasopressin AVP AVP:11 argininvasopressin AVP AVP:8 arginine vasopression AVP AVP:29 arteriovenous passage time AVRT AVRT:27 atrioventricular reciprocating tachycardia AVRT AVRT:27 atrioventricular reentrant tachycardia AVRT AVRT:10 av reentrant tachycardia AVR AVR:43 acute vascular rejection AVR AVR:9 arterioletovenule ratio AVR AVR:27 ascending vasa recta AVS AVS:13 aortic valve sclerosis AVS AVS:6 arteriovenous shunt AVS AVS:6 visualization system AV AV:12 abomasal volvulus AV AV:5 adriamycin and vincristine AV AV:5 adriamycin plus vincristine A-V A-V:5|AV:4|a-v:1 animalvegetal AV AV:6 annexin v AV AV:14 anterior ventral AV AV:5 anteroventral nucleus AV AV:32 aortic valve A-V A-V:14|a-v:2|AV:1 arterialvenous AV AV:9 artificial vagina AV AV:8 artificial ventilation AV AV:7 assisted ventilation AV AV:14 audiovisual AV AV:11|A-V:3 auditoryvisual AV AV:7 femoral anteversion A-V A-V:5|AV:3|A--V:1 venous AWD AWD:13 abdominal wall defects AWD AWD:8 alive with disease AZF AZF:48 azoospermia factor AZF AZF:14 bovine adrenal zona fasciculata AZQ AZQ:33 aziridinylbenzoquinone AZQ AZQ:55 diaziquone AZT AZT:77|az-T:1 azidodideoxythymidine AZT AZT:9 clinical studies on aztreonam ABM ABM:32 acute bacterial meningitis ABM ABM:10 bone matrix AcMNPV AcMNPV:22 autographa californica mnpv AcMNPV AcMNPV:37 autographa californica multicapsid nucleopolyhedrovirus AcSDKP AcSDKP:11|Ac-SDKP:1 nacetylserasplyspro AcSDKP AcSDKP:11 tetrapeptide acetylnserasplyspro AcSDKP AcSDKP:6 tetrapeptide acetylserasplyspro Ad5 Ad5:49 adenovirus serotype Ad5 Ad5:18 type adenovirus ADM ADM:86 abductor digiti minimi ADM ADM:14 abductor digiti minimi muscle ADM ADM:20 acellular dermal matrix ADM ADM:14|Adm:2|AdM:1 adrenodemedullated ADM ADM:15 amyopathic dermatomyositis ADO ADO:14 amplatzer duct occluder ADO ADO:12 autosomal dominant osteopetrosis ADX ADX:9|Adx:1 adrenalectomised ADX ADX:9|AdX:1 adrenalectomized rats ADX ADX:350|Adx:21|adx:7|ADx:1 adrenalectomy AD AD:12 acute diarrhea Ad Ad:7|AD:6 adherent Ad Ad:8|AD:2 adrenodoxin AD AD:9|Ad:5 adult AD AD:9 adultdirected AD AD:9 affective disorders AD AD:21 afterdischarge AD AD:40 alcohol dependence AD AD:6 alzheimers disease patients AD AD:15 alzheimertype dementia AD AD:31 androgen deprivation AD AD:30 anoxic depolarization AD AD:12 anterodorsal AD AD:5 anterodorsal thalamic nucleus AD AD:13 aortic diameter AD AD:35 aortic dissection AD AD:11 apparent digestibility AD AD:6 arrhythmogenic dose AD AD:12 atherogenic diet AD AD:1352|Ad:9|ad:1 atopic dermatitis AD AD:10 atypical depression AD AD:8 autoimmune diseases AD AD:8 autonomic dysfunction AD AD:37 autonomic dysreflexia AD AD:96|ad:2 autosomal dominant AD AD:12 axillary dissection AD AD:1 dementia of an alzheimers type AD AD:19 dementia of the alzheimer type AFL AFL:21|Afl:6 aflatoxicol AFL AFL:9 australian football league AGE AGE:19 advanced glycosylation endproducts AGE AGE:42|age:1 agarose gel electrophoresis AGE AGE:44 aged garlic extract AGE AGE:20 arterial gas embolism AgNORs AgNORs:4 identified by silver staining AgNORs AgNORs:4|Ag-NORs:2 silverstained nors AgNORs AgNORs:5 silverstained nucleolar organizer regions protein AgNOR AgNOR:71|Ag-NOR:7 argyrophilic nucleolar organizer region AgNOR AgNOR:5|Ag-NOR:1 argyrophilic technique AgNOR AgNOR:5|Ag-NOR:5 silver staining AGS AGS:22 adrenogenital syndrome AGS AGS:55 alagille syndrome AGs AGs:18|Ags:1 aminoglycosides AGs AGs:13 aminoglycoside antibiotics AGS AGS:10 human gastric adenocarcinoma AHRR AHRR:6|AhRR:2 ahr repressor AHRR AHRR:5|AhRR:4 aryl hydrocarbon receptor repressor AHR AHR:19 acute humoral rejection AHR AHR:10|aHR:1 adjusted hazard ratio Al2O3 Al2O3:8 alumina ceramic Al2O3 Al2O3:17 aluminum oxide AlF4- AlF4-:18 aluminum fluoride AlF4- AlF4-:13 fluoroaluminate ALB ALB:6|Alb:3 albumin concentration ALB ALB:12 anxietylike behavior AMC AMC:19 academic medical center AMC AMC:7 agematched controls AMC AMC:8 amoeboid microglial cells AMC AMC:10 anteromedial cortex AMC AMC:61 arthrogryposis multiplex congenita AMC AMC:11 medical centre Ap3A Ap3A:7|AP3A:2 diadenosine pptriphosphate Ap3A Ap3A:24|AP3A:3 diadenosine triphosphate APCR APCR:68|APC-R:27|APC-r:3|aPCR:2|APCr:2 activated protein c resistance APCR APCR:17|APC-R:9|APCr:2|aPCR:1|aPCr:1 resistance to activated protein c APR APR:5 absolute production rate APR APR:11 absolute proximal reabsorption APR APR:4 absolute proximal reabsorption rate APR APR:11 accessory planta retractor APR APR:5 adenosine phosphosulphate reductase APR APR:7 proximal tubular reabsorption ARE ARE:9 ampicillinresistant enterococci ARE are:3|ARE:3 androgen response elements ARE ARE:85|are:10 antioxidant response element ARE ARE:31|are:4 antioxidant responsive element ara-U ara-U:11|Ara-U:4|araU:2 betadarabinofuranosyluracil ara-U ara-U:7|Ara-U:5|araU:2|ARA-U:1|AraU:1 uracil arabinoside Arg Arg:4|ARG:3 ablrelated gene Arg Arg:180|ARG:60|arg:4 arginine ARG ARG:16 autoradiographic ARG ARG:41 autoradiography AS AS:11 absence seizures AS AS:9 acetosyringone AS AS:20 active AS AS:6 actual survival AS AS:7 actuarial survival AS AS:10 affective style AS AS:21 aggregation substance AS AS:6|As:1 alkaline secretion AS AS:7|as:2 alphasynuclein AS AS:58 alport syndrome AS AS:14 alternative splicing AS AS:22 ammonium sulfate AS AS:11 ammonium sulphate AS AS:17|As:1 anabolic steroids AS AS:15 anaphylactic shock AS AS:6 androgen suppression AS AS:11 angelis salt AS AS:31 angiosarcoma AS AS:8 ankylosing spondylarthritis AS AS:9 antisaccades AS AS:173|As:9|as:8 antisense AS AS:18|As:1 antiserum AS AS:62 anxiety sensitivity AS AS:9|As:2 argininosuccinate synthase As As:233|AS:1 arsenic AS AS:9 arteriosclerosis AS AS:9 artificial saliva AS AS:32|As:8 asparagine synthetase AS AS:3|As:2 assisted suicide AS AS:7 atherometric system AS AS:9 atherosclerotic As As:6 autism and asperger syndrome AS AS:19 autologous serum AS AS:16 plasmodium chabaudi chabaudi AS AS:8 sickle trait AS AS:14|A-S:1 stress ATT ATT:12 anterior tibial translation ATT ATT:5 antitubercular treatment ATT ATT:6 antituberculous therapy att att:24 attachment att att:8 attachment site att att:12 attenuated ATT ATT:13 tolerance test att att:1 ts and attenuation ATP7B ATP7B:13 coppertransporting ptype adenosine triphosphatase ATP7B ATP7B:5 wilson disease protein AT AT:47|At:3 acceleration time AT AT:16 acetyltransferase AT AT:20 achilles tendon AT AT:26 activation time AT AT:15 active tension AT AT:13|A-T:9 adeninethymine AT AT:153 adipose tissue AT AT:8 alopecia totalis AT AT:5 ambient temperature AT AT:13 anterior tibialis AT AT:314|At:2 antithrombin AT AT:15 area tempestas AT AT:30 assistive technology AT AT:64|At:6|A-T:1 atrial tachycardia AT AT:29 autogenic training A-T A-T:9|AT:3|At:1 autosomal recessive disorder ataxiatelangiectasia AT AT:5 catalase inhibitor aminotriazole A-T A-T:5|AT:2 cells from patients with ataxiatelangiectasia A-T A-T:21|AT:2 human genetic disorder ataxiatelangiectasia AU AU:11 alopecia universalis AU AU:38 anterior uveitis Az Az:12|AZ:1 areas Az Az:8|AZ:1 azone B-PLL B-PLL:12 bcell prolymphocytic leukemia B-PLL B-PLL:10 bprolymphocytic leukaemia B-PLL B-PLL:9 bprolymphocytic leukemia B/W B/W:9 f hybrid B/W B/W:19 nzbnzw f B/W B/W:11 nzb x nzw B1 B-1:6|B1:6 b cells B1 B1:15 thiamine B6 B6:23 cb B6 B6:679 cbl B6 B6:13 cblby B6 B6:11 cblbyj B6 B6:387|B-6:1 cblj B6 B6:16 cbln BACs BACs:127 bacterial artificial chromosomes BACs BACs:98|BACS:1 blood alcohol concentrations BACs BACs:12 bronchioloalveolar carcinomas BAC BAC:12|Bac:2 baclofen BAC BAC:7 biological activated carbon BAC BAC:18 blood alcohol content BAC BAC:7 bovine adrenal fasciculata cells BAC BAC:14 bovine adrenocortical BAC BAC:121 bronchioloalveolar carcinoma BAC BAC:18 bronchoalveolar cells BAEC BAEC:10 bovine aorta BAEC BAEC:10 bovine aortic ec BAE BAE:95 bovine aortic endothelial BAE BAE:28 bronchial artery embolization BAFF BAFF:6 b cellactivating factor belonging to the tnf family BAFF BAFF:1 factor from the tnf family BAF BAF:22 barriertoautointegration factor BAF BAF:8 biological aerated filter BAF BAF:6 bronchoalveolar fluid BAH BAH:11 bilateral adrenal hyperplasia BAH BAH:7 borderline arterial hypertension BAI BAI:12 blunt aortic injury BAI BAI:6 brain atrophy index BAI BAI:15 bronchial arterial infusion BAI BAI:9|B-AI:1 bronchial artery infusion B-ALL B-ALL:48|BALL:2 acute lymphoblastic leukemia B-ALL B-ALL:12 bcell acute lymphoblastic leukaemia BAL BAL:100 bioartificial liver BAL BAL:8 biphenotypic acute leukemia BAL BAL:15|Bal:1 british antilewisite BAL BAL:37 bronchoalveolar BAM BAM:28 bacteriological analytical manual BAM BAM:11 bidirectional associative memory BAM BAM:27|bAM:5 bovine alveolar macrophages BAM BAM:28 brewster angle microscopy BAM BAM:20 bronchoalveolar macrophages BAM BAM:4 metabolite dichlorobenzamide BAR BAR:28 biofragmentable anastomosis ring BAR BAR:17 biofragmentable anastomotic ring BAS BAS:24 balloon atrial septostomy BAS BAS:10 barnes akathisia scale BAS BAS:10 behavioral activation system BAS BAS:9 biologically active substances BAT BAT:16 basophil activation test BAT BAT:32 blunt abdominal trauma BAT BAT:7 brain adjacent to tumor BAV BAV:18 balloon aortic valvuloplasty BAV BAV:31 bicuspid aortic valve BAV BAV:9 bovine adenovirus BAW BAW:8 bronchoalveolar washings BAW BAW:20 bulk acoustic wave BA BA:36 bacillary angiomatosis BA BA:7 background activity BA BA:11 basilar BA BA:9 benzaldehyde BA BA:12 benzamide BA BA:62 benzoic acid BA BA:18 benzyl alcohol BA BA:201 biliary atresia BA BA:43 bioavailability BA BA:12 biogenic amines BA BA:19 blood agar BA BA:118 bone age BA BA:31|ba:1|Ba:1 brachial artery BA BA:289 bronchial asthma BA BA:7 butyl acrylate BA BA:45 butyric acid BA BA:6 lymphoma cell bioassay BA BA:9 mgl benzylaminopurine BA BA:5 nbutyl acrylate BA BA:14 nbenzyladenine BBA BBA:34 balanced budget act BBA BBA:22 balanced budget act of BBA BBA:9 born before arrival BBB BBB:1 basso beattie bresnahan BBB BBB:68 bundle branch block BBdp BBdp:15|BB-DP:7|BBDP:4 diabetesprone BBdp BBdp:7|BBDP:3|BB-DP:1 diabetesprone bb BBdp BBdp:7|BB-DP:1 diabetesprone biobreeding BBE BBE:9 berberine bridge enzyme BBE BBE:15 bickerstaffs brainstem encephalitis BBIC BBIC:9 bbi concentrate BBIC BBIC:5 bowmanbirk inhibitor concentrate BBI BBI:48 bowmanbirk inhibitor BBI BBI:29 bowmanbirk protease inhibitor BBN BBN:17 bayesian belief network BBN BBN:13 broadband noise BBP BBP:7 bilinbinding protein BBP BBP:39 butyl benzyl phthalate BBP BBP:17 butylbenzyl phthalate BBS BBS:75 bardetbiedl syndrome BBS BBS:29 berg balance scale BBS BBS:7 bulletin board system BB BB:12 bachmanns bundle BB BB:11|bb:1 benzyl benzoate BB BB:64|Bb:1 biceps brachii BB BB:24 biobreeding Bb Bb:7|BB:7 bisbenzimide Bb Bb:5|BB:4 bordetella bronchiseptica Bb Bb:60|BB:10 borrelia burgdorferi BB BB:13 brain BB BB:38 bromobenzene BB BB:9 broth BB BB:6 diabetes in the biobreeding BB BB:9 spontaneously diabetic BCA BCA:5 balloon coronary angioplasty BCA BCA:33 bicinchoninic acid BCA BCA:6 bifunctional chelating agent BCA BCA:11 bronchial crosssectional area BCB BCB:10|bcb:1 bloodcsf barrier BCB BCB:16 brilliant cresyl blue BCCA BCCA:8 bilateral clamping of carotid arteries BCCA BCCA:13 british columbia cancer agency BCCA BCCA:4 min to bilateral clamping of the common carotid arteries BCCs BCCs:229|BCCS:1 basal cell carcinomas BCCs BCCs:9 breast cancer cells BCC BCC:8 basal cell BCC BCC:9 basal cell cancer BCC BCC:9 breast cancer cell BCC BCC:6 chromaffin cells BCEs BCEs:9 basal cell epitheliomas BCEs BCEs:6 bovine capillary endothelial cells BCE BCE:28|bce:2 basal cell epithelioma BCE BCE:39 bovine capillary endothelial BCE BCE:20 bovine corneal endothelial BCF BCF:24 beat cross frequency BCF BCF:37|bcf:1 breast cyst fluid BCG-CWS BCG-CWS:7 bcg cellwall skeleton BCG-CWS BCG-CWS:7 cell wall skeleton BCG BCG:63 bacille calmette guerin BCG BCG:9 bacilluscalmetteguerin BCG BCG:14 bacillus of calmette and guerin BCG BCG:11 ballistocardiogram BCG BCG:16 bromcresol green BCG BCG:24 bromocresol green BCG BCG:25 calmetteguerin bacillus BCG BCG:8 calmetteguerin vaccine BCG BCG:131 mycobacterium bovis BCKA BCKA:11 branchedchain alphaketo acid BCKA BCKA:10 branchedchain keto acids BCL1 BCL1:23 b cell leukemia BCL1 BCL1:11 murine bcell leukemia Bcl-2 Bcl-2:7|bcl-2:4 antiapoptotic Bcl-2 Bcl-2:9|bcl-2:3 bcl protein B-CLL B-CLL:8|BCLL:1 chronic lymphocytic leukemias B-CLL B-CLL:3 chronic lymphocytic leukemia of bcell type B-CLL B-CLL:4 leukemia of bcell origin B-CLL B-CLL:7 lymphocytic leukemia cells BCM BCM:6 blue cone monochromatism BCM BCM:120|bcm:2 body cell mass BCM BCM:9 bovine cervical mucus BCM BCM:7 bulbocavernosus muscle BCNS BCNS:9 basal cell naevus syndrome BCNS BCNS:21 basal cell nevus syndrome BCNU BCNU:9 bischlorethylnitrosourea BCNU BCNU:285 carmustine BCNU BCNU:18 nnbischloroethylnnitrosourea BCP BCP:24 blood cardioplegia BCP BCP:9 bromcresol purple BCP BCP:19 bromocresol purple BCR BCR:8 antigen receptors BCR BCR:34 bulbocavernosus reflex BCR BCR:25 community bureau of reference BCR BCR:11|BcR:1 receptor complex BCs BCs:8 basket cells BCS BCS:8 bathocuproinedisulfonic acid BCS BCS:29 biopharmaceutics classification system BCs BCs:12 bipolar cells BCS BCS:12 bovine calf serum BCS BCS:11 breast cancer survivors BCS BCS:116|B-CS:1 buddchiari syndrome BCs BCs:11 buffy coats BCT BCT:11 basic combat training BCT BCT:15 blood cell transplantation BCT BCT:40 breast conservation therapy BCT BCT:105 breastconserving therapy BCT BCT:9 buffy coat technique BC BC:8|Bc:1 bacitracin BC BC:17 bacterial cellulose BC BC:9 basaloid carcinoma BC BC:9 basic copy BC BC:11 bile canaliculi BC BC:7|bc:1 biliary complications BC BC:5 biochemical control BC BC:15 biotin carboxylase BC BC:9 biventer cervicis BC BC:36 black carbon BC BC:11 bladder capacity BC BC:85 blast crisis BC BC:31 blastic crisis BC BC:27 body composition BC BC:9 body condition BC BC:20 brachium conjunctivum BC BC:23 bronchoconstriction BC BC:9 bronchogenic cyst BC BC:43 bulbocavernosus BDA BDA:23 anterograde tracer biotinylated dextran amine BDA BDA:11 beclomethasone dipropionate aerosol BDA BDA:10 british diabetic association BDD BDD:9 butenediol BDD BDD:98 body dysmorphic disorder BDD BDD:13 borondoped diamond BDE BDE:17 bond dissociation energy BDE BDE:12 bond dissociation enthalpy BDEs BDEs:16 bond dissociation energies BDEs BDEs:13 bond dissociation enthalpies BDI BDI:23 baseline dyspnea index BDI BDI:889 beck depression inventory BDI BDI:14 bile duct injury BDI BDI:6 bleomycindetectable iron BDL BDL:192|bdl:1 bile duct ligation BDL BDL:8 ligation of the common bile duct BDR BDR:12 background diabetic retinopathy BDR BDR:15 bile duct resection BDR BDR:9 bronchodilator response BD BD:39 basal diet BD BD:45 base deficit BD BD:492|Bd:1 behcets disease BD BD:11 bicarbonate dialysis BD BD:10 biotinylated dextran BD BD:16 bladder drainage BD BD:11 body dissatisfaction BD BD:48 bone density BD BD:12 bony defect BD BD:66 brain death BD BD:33 brownian dynamics BEA BEA:9 bromoethanamine BEA BEA:17 bromoethylamine hydrobromide BEA BEA:10 beauvericin BEC BEC:15 boseeinstein condensate BEC BEC:9 boseeinstein condensation BEF BEF:5 best excitatory frequency BEF BEF:28 bovine ephemeral fever BEF BEF:7 enhancing factor BEI BEI:27 backscattered electron imaging BEI BEI:13 binary ethylenimine BEI BEI:26 biological exposure index BEL BEL:11 bovine epithelial lens BEL BEL:49 bromoenol lactone BER BER:350 base excision repair BER BER:14 basic electric rhythm BER BER:29 basic electrical rhythm Ber Ber:8|BER:3 berbamine Ber Ber:11|BER:1 berberine BES BES:10 balanced electrolyte solution BES BES:17 binge eating scale BEV BEV:21 beams eye view BEV BEV:9 berne virus BEV BEV:15 bovine enterovirus BE BE:34 butoxyethanol BE BE:39 bacterial endocarditis BE BE:35 barium enema BE BE:139|-BE:1 base excess BE BE:20 bioequivalence BE BE:14 brain edema BE BE:15 bronchiectasis BE BE:9 cocaine and benzoylecgonine BE BE:11 cocaine metabolite benzoylecgonine BFA BFA:9 bifunctional antibody BFA BFA:10 brefeldina BFDV BFDV:13 beak and feather disease virus BFDV BFDV:13 budgerigar fledgling disease virus BFI BFI:9 blood flow index BFI BFI:10 brief fatigue inventory BFM BFM:44 berlinfrankfurtmunster BFM BFM:23 body fat mass BFP BFP:27 basic fetoprotein BFP BFP:9 biological false positive BFP BFP:19 blue fluorescent protein BFP BFP:11 buccal fat pad BFP BFP:16|bfp:2 bundleforming pili BFP BFP:24|bfp:5|Bfp:1 bundleforming pilus BFU-E BFU-E:19|BFU-e:1 erythroid burstforming cells BFU-E BFU-E:48|BFUe:3|bfu-E:1 erythroid burstforming unit BFU-E BFU-E:11|BFUe:1|BFU-e:1 erythroid precursors BFU-E BFU-E:35|BFU-e:4|BFUe:3|BFUE:1 erythroid progenitor cells BFV BFV:5|BFv:1 barmah forest virus BFV BFV:9 blood flow volume BF BF:17 backfat BF BF:103|Bf:1 basal forebrain BF BF:86|bf:1 biceps femoris BF BF:20|bF:4 biochemical failure BF BF:21 biofiltration BF BF:9 blister fluid BF BF:7 blocking factors BF BF:11 boutonneuse fever BF BF:22 breastfed BF BF:19 breastfeeding BF BF:36 bursa of fabricius BGA BGA:6 blood gas analysis BGA BGA:13|bga:1 blood group antigens BGA BGA:9 brilliant green agar BGM BGM:9 blood glucose monitoring BGM BGM:21 buffalo green monkey BG BG:13 background BG BG:113 basal ganglia BG BG:28|B-G:1 basenjigreyhound BG BG:10 bioglass BG BG:13 brilliant green BHA BHA:12 tbutylmethoxyphenol BHA BHA:10 benzhydroxamic acid BHA BHA:16|Bha:1 benzohydroxamic acid BHA BHA:12 butylated hydroxy anisole BHA BHA:12 butylated hydroxyanisol BHA BHA:468 butylated hydroxyanisole BHA BHA:12 butylhydroxyanisole BHC BHC:26 benzene hexachloride BHC BHC:10 hexachlorocyclohexane BHI BHI:41 biosynthetic human insulin BHI BHI:12 breathholding index BHL BHL:21 bilateral hilar lymphadenopathy BHL BHL:5 nbutanoyllhomoserine lactone BHMT BHMT:16 betainehomocysteine methyltransferase BHMT BHMT:6 betainehomocysteine smethyltransferase BHS BHS:18 beck hopelessness scale BHS BHS:10 betahemolytic streptococci BHS BHS:53 british hypertension society BHS BHS:8 congenitally bronchialhypersensitive BHT BHT:18 ditertbutylmethylphenol BHT BHT:13 ditertbutylhydroxytoluene BHT BHT:5 antioxidant ionol BHT BHT:12 breathholding time BHT BHT:10 breath hydrogen test BHT BHT:31 butylhydroxytoluene BHV BHV:8 bioprosthetic heart valves BHV BHV:12 bovine herpesvirus BH BH:25 bcl homology BH BH:13 bleomycin hydrolase BH BH:10 blood hypertension BH BH:19 body height BH BH:15 breathhold BIC BIC:16 bayesian information criterion BIC BIC:75|Bic:16 bicuculline BIC BIC:17 binaural interaction component BIC BIC:11 boneimplant contact BIC BIC:17 bonetoimplant contact BII BII:11|B-II:4 billroth ii BII BII:10 bph impact index BIR BIR:23 baculovirus iap repeat BIR BIR:9 breakinduced replication BIS BIS:7 barratt impulsivity scale BIS BIS:17 behavioral inhibition system BIS BIS:20 bioelectrical impedance spectroscopy BIS BIS:19 bioimpedance spectroscopy BIS BIS:15 bispectral BIS BIS:6 bispectral analysis BIS BIS:400|Bis:1 bispectral index BIS BIS:7 bispectral index scale BIS BIS:5 bispectral index score BIS BIS:1 pkc inhibitor bisindolylmaleimide BJP BJP:22 bence jones protein BJP BJP:8 bence jones proteinuria BKA BKA:12 belowknee amputation BKA BKA:9 bongkrekic acid BLA BLA:11 bacillus licheniformis alphaamylase BLA BLA:52|Bla:4 basolateral nucleus of the amygdala BLA BLA:6 biologics license application BLA BLA:15 bovine alphalactalbumin BLA BLA:4 submitted a biologics licence application bLF bLF:31|bLf:13|BLF:11|BLf:9|b-LF:1 bovine lactoferrin bLF bLF:12|bLf:5|BLf:2|BLF:1|b-LF:1 bovine lf BLI BLI:28 bombesinlike immunoreactivity BLI BLI:12 vivo bioluminescence imaging BLM BLM:47|blm:1 basolateral membranes BLM BLM:35 biotic ligand model BLM BLM:6 syndrome protein BLNAR BLNAR:10 betalactamasenegative ampicillinresistant BLNAR BLNAR:1 negative but ampicillin resistant BLSS BLSS:6 bioartificial liver support system BLSS BLSS:6 bioregenerative life support system BLS BLS:32 bare lymphocyte syndrome BLS BLS:139 basic life support BLS BLS:23 bureau of labor statistics BLT BLT:13 bilateral lung transplantation BLT BLT:8 bright light therapy BLT BLT:13 thiobenzyl ester BLV BLV:130 bovine leukaemia virus BLV BLV:530 bovine leukemia virus BL BL:8 bacterial levan BL BL:74 basal lamina BL BL:28 bilateral BL BL:5 blood loss BL BL:8 blood lymphocytes BL BL:21 blue light BL BL:20 body length BL BL:6 bone loss BL BL:11 borderline BL BL:65 borderline lepromatous BL BL:8 borderline lepromatous leprosy BL BL:26 brassinolide BL BL:17 bright light BL BL:31 bronchial lavage BMAA BMAA:7 aminomethylaminopropanoic acid BMAA BMAA:26 betanmethylaminolalanine BMA BMA:9 bone marrow aspirate BMA BMA:11 bone marrow aspiration BMA BMA:7 bovine mesenteric arteries BMA BMA:18 british medical association BMA BMA:13 butyl methacrylate BMC BMC:14 balloon mitral commissurotomy BMC BMC:5 benchmark concentration BMC BMC:5 bicuculline methochloride BMC BMC:16 biopartitioning micellar chromatography BMC BMC:10 bone mass BMD BMD:43 benchmark dose BMD BMD:12 bone mineral densitometry BMD BMD:15 broth microdilution BME BME:9 basal medium eagle BME BME:9 bovine microvascular endothelial BMF BMF:8 best modulation frequency BMF BMF:9 biomagnification factor BMF BMF:14 bone marrow fibroblasts BMG BMG:27 benign monoclonal gammopathy BMG BMG:40 beta microglobulin BMG BMG:13 bilirubin monoglucuronide BMG BMG:22 bone matrix gelatin BMI BMI:9 bone marrow involvement BMI BMI:9 brainmachine interface BMK1 BMK1:10 big map kinase BMK1 BMK1:9 big mitogenactivated protein kinase BmK BmK:12 scorpion buthus martensi karsch BmK BmK:13|BMK:3 scorpion buthus martensii karsch BMPs BMPs:14 bacterial magnetic particles BMPs BMPs:22 best management practices BMPs BMPs:721|Bmps:18 bone morphogenetic proteins BMs BMs:80 basement membranes BMS BMS:11 black mexican sweet BMs BMs:4|BMS:1 body movements BMS BMS:9 bone marrow stromal BMs BMs:5|bms:1 bowel movements BMS BMS:16 bristolmyers squibb BMS BMS:11 bulk magnetic susceptibility BMS BMS:88 burning mouth syndrome BMT BMT:11 basement membrane thickness BMT BMT:15 basic military training BMT BMT:18 behavioral marital therapy BMT BMT:8 bone marrow transplanted BMV BMV:20 balloon mitral valvotomy BMV BMV:31 balloon mitral valvuloplasty BMV BMV:14 brome mosaic bromovirus BMV BMV:196 brome mosaic virus BM BM:46 bacterial meningitis BM BM:18 barretts metaplasia BM BM:9 basal medium BM BM:11 biological monitoring BM BM:24 blood meal BM BM:16 bone metastases BM BM:10 bone metastasis BM BM:30 brain metastases BM BM:9 breast milk BM BM:6 bronchial mucosa BM BM:8 buccal mucosa BNC BNC:17 binucleate cells BNC BNC:13 boron neutron capture BNF BNF:9 betanapthoflavone BNF BNF:10 british national formulary BNML BNML:9 leukemia model BNML BNML:9 rat model for human acute myelocytic leukemia BNP BNP:332 btype natriuretic peptide BNP BNP:16 brain natriuretic peptides BNs BNs:6 ballooned neurons BNs BNs:8 burst neurons BN BN:11 balkan nephropathy BN BN:18 binucleated BN BN:13 bladder neck BN BN:11 boron nitride Boc Boc:11|BOC:1 tertbutoxycarbonyl Boc Boc:7|BOC:2 tertbutyloxycarbonyl BOP BOP:164|BoP:5 bleeding on probing BOP BOP:174 nnitrosobisoxopropylamine BOR BOR:65 branchiootorenal BOR BOR:9 branchiootorenal syndrome BOT BOT:8 borderline ovarian tumor BOT BOT:19 botzinger complex BO BO:18 barretts oesophagus BO BO:9 benzene oxide BO BO:12 borage oil BO BO:9 bronchial obstruction BO BO:73 bronchiolitis obliterans BPb BPb:6|B-Pb:1 blood lead concentration BPb BPb:6 blood lead levels BPDE BPDE:12 benzoapyrene diolepoxide BPDE BPDE:5 beta alphadihydroxy alpha alphaepoxytetrahydrobenzoapyrene BPD BPD:32 benzoporphyrin derivative BPD BPD:101 biliopancreatic diversion BPD BPD:272 biparietal diameter BPD BPD:687 bronchopulmonary dysplasia BPF BPF:21 brain parenchymal fraction BPF BPF:8|BPf:1 brazilian pemphigus foliaceus BPF BPF:35 brazilian purpuric fever BPF BPF:44 bronchopleural fistula BPH BPH:18 benign hyperplasia of the prostate BPH BPH:12 benign hyperplastic BPH BPH:386|bph:3 benign prostatic hypertrophy BPH BPH:10 benzoapyrene hydroxylase BPH BPH:10 brown planthopper BPH BPH:6 hyperplastic prostate tissue BPI BPI:10 basic personality inventory BPI BPI:17|BP-I:6 bipolar i BPI BPI:8|BP-I:6 bipolar i disorder BPI BPI:10 brachial plexus injury BPI BPI:13 brain perfusion index BPI BPI:48 brief pain inventory bpm bpm:36|BPM:2 beatsmin bpm bpm:12|BPM:2 beats per min bpm bpm:138|BPM:11 beats per minute BPM BPM:13 behavioral pattern monitor BPM BPM:9 bovine peripheral nerve myelin BPM BPM:11 plasma membrane BPN BPN:4 backpropagation neural network BPN BPN:22 basilar pontine nuclei BPO BPO:9 antibenzylpenicilloyl BPO BPO:13 benzylpenicilloyl BPP BPP:19 biophysical profile BPP BPP:35|bPP:8 bovine pancreatic polypeptide BPS BPS:35 beraprost sodium BPs BPs:66|Bps:2|BPS:1 bisphosphonates BPs BPs:61 blood pressures BPS BPS:7 branch point sequence BPS BPS:16 branchpoint sequence BPV BPV:16 balloon pulmonary valvuloplasty BPV BPV:11 benign paroxysmal vertigo BPV BPV:19 benign positional vertigo BPV BPV:9 bordetella pertussis vaccine BPV BPV:50 bovine papilloma virus BPV BPV:25 bovine parvovirus BPV BPV:6 pulmonary vein Bpa Bpa:5 amino acid pbenzoylphenylalanine Bpa Bpa:14 bare patches BPA BPA:26 bauhinia purpurea BPA BPA:13|BpA:1 bauhinia purpurea agglutinin BPA BPA:11 bauhinia purpurea lectin BPA BPA:52|BP-A:4 bisphenola BPA BPA:37 boronophenylalanine BPA BPA:15 bovine plasma albumin BPA BPA:11 bovine pulmonary artery Bpa Bpa:16|BPA:1 pbenzoyllphenylalanine BPA BPA:36 pboronophenylalanine BP BP:15 hbenzoapyrene BP BP:16 backpropagation BP BP:9 bacterial pneumonia BP BP:16|bp:1 basilar papilla BP BP:11 beet pulp BP BP:10 bells palsy BP BP:17 bench press BP BP:36 benzapyrene BP BP:274 benzoapyrene BP BP:19 benzophenone BP BP:73|Bp:2 bereitschaftspotential BP BP:122 binding potential BP BP:18 biphenyl BP BP:56|bp:1 bipolar BP BP:28|bp:1 blastic phase BP BP:16 blood plasma BP BP:20 bodily pain BP BP:20 bovine pericardium BP BP:21 bowenoid papulosis BP BP:11 brachial plexus BP BP:7|bp:3 brevipedicellus BP BP:15 british pharmacopoeia BP BP:444 bullous pemphigoid BP BP:38 metabolism of benzoapyrene BP BP:149 myelin basic protein BP BP:18 systolic and diastolic blood pressures BP BP:5 total biopterin BQR BQR:10 brequinar BQR BQR:13 brequinar sodium BQ BQ:6 barriers questionnaire BQ BQ:35 betel quid BRAC BRAC:24 bangladesh rural advancement committee BRAC BRAC:9 basic restactivity cycle BRCA1 BRCA1:14 breast cancer susceptibility gene BRCA1 BRCA1:14 cancer susceptibility gene BRMS BRMS:5 bechrafaelsen mania scale BRMS BRMS:7 bechrafaelsen melancholia scale BRP BRP:10 bacteriocin release protein BRP BRP:13 biological reference preparation BRP BRP:7 bovine retinal pericytes BRP BRP:13 bovine retractor penis BSCC BSCC:35 basaloid squamous cell carcinoma BSCC BSCC:14|BScc:8|BS-CC:1 bjorkshiley convexoconcave BSC BSC:13 balanced scorecard BSC BSC:17 basaloid squamous carcinoma BSC BSC:39 best supportive care BSC BSC:9 bundle sheath cells BSE BSE:627 bovine spongiform encephalopathy BSE BSE:13 breast selfexam BSF BSF:7 b cell stimulatory factors BSF BSF:7 benzene soluble fraction BSH BSH:19|bsh:2|Bsh:1 bile salt hydrolase BSH BSH:19 borocaptate sodium BSH BSH:10 mercaptoundecahydrododecaborate BSH BSH:16 nabhsh BSH BSH:14 sodium borocaptate BSI BSI:10 blood stream infections BSI BSI:6 blunt splenic injury BSI BSI:10 bone strength index BSI BSI:144 brief symptom inventory BSL BSL:8|bsL:1 benign symmetric lipomatosis BSL BSL:9 british sign language BSM BSM:9 body surface maps BSM BSM:12 body surface mapping BSM BSM:33 bovine submaxillary mucin BSM BSM:13 bronchial smooth muscle BSN BSN:16 bachelor of science in nursing BSN BSN:12 bismuth subnitrate BSO BSO:9 buthionine sulfoximide BSO BSO:507 buthionine sulfoximine BSO BSO:65 buthionine sulphoximine BSO BSO:16 dlbuthioninesrsulfoximine BSO BSO:13 lbuthioninesrsulfoximine BSO BSO:14 rsulfoximine BSP BSP:11 blepharospasm BSP BSP:336|bSP:2|Bsp:1|bsp:1 bone sialoprotein BSP BSP:13|bSP:1 bovine seminal plasma BSP BSP:59 bromosulfophthalein BSP BSP:17 bromosulphophthalein BSP BSP:21 bromosulphthalein BSP BSP:18 bromsulphthalein BSP BSP:174 sulfobromophthalein BSP BSP:27 sulfobromophthalein sodium BSP BSP:21 sulphobromophthalein BSR BSR:10 blood sedimentation rate BSR BSR:36 brain stimulation reward BSS BSS:82|B-SS:1|BSs:1|B-Ss:1 bernardsoulier syndrome BSS BSS:39 bismuth subsalicylate BSS BSS:22 blind source separation BSS BSS:9 satiety sequence bST bST:9|BST:6 bovine somatotrophin bST bST:132|BST:28|bSt:4|BSt:1 bovine somatotropin BSV BSV:8 banana streak virus BSV BSV:11 binocular single vision BSV BSV:7 bovine syncytial virus Bs Bs:12 b chromosomes Bs Bs:32|BS:5|bs:1 bacillus subtilis BS BS:22|B-S:18 bjorkshiley BS BS:25 black smoke BS BS:10 blasticidin s BS BS:7 blood serum BS BS:37 blood sugar BS BS:6|bs:1 body surface BS BS:15 bone scan BS BS:34|Bs:1 bone scintigraphy BS BS:8 borg scale BS BS:40|Bs:3 brain stem BS BS:20 brainstem BS BS:9 bronchial secretions BS BS:11 bulbospongiosus BS BS:12 bundle sheath BS BS:8 bursting strength BS BS:15 patients with behcets syndrome BTB BTB:32 bloodtestis barrier BTB BTB:11|bTB:1|bTb:1 bovine tuberculosis BTB BTB:18 breakthrough bleeding BTB BTB:12 bromothymol blue BTE BTE:12 basic transcription element BTE BTE:12 basic treatment equivalent BTE BTE:31 behindtheear BTE BTE:13 biphasic truncated exponential BTS BTS:9 blalocktaussig shunt BTS BTS:9 blood transfusion service BTS BTS:43 british thoracic society BTs BTs:11 butyltins BTs BTs:9 butyltin compounds BTG BTG:6|B-TG:2|b-TG:1 bthromboglobulin BTG BTG:5|bTG:3|BTg:2|bTg:2 bovine thyroglobulin BT BT:19 benzenetriol Bt Bt:13 bacillus thuringiensis berliner BT BT:202|Bt:1 bacterial translocation BT BT:36|Bt:1 beef tallow BT BT:9 behavior therapy BT BT:14|bT:3 bioavailable testosterone BT BT:7 blast transformation BT BT:15 blastic transformation BT BT:152 bleeding time Bt Bt:23|BT:2 blomia tropicalis BT BT:65 borderline tuberculoid BT BT:9 borderline tuberculoid leprosy BT BT:8 bovine trypsin BT BT:10 bovine turbinate BT BT:5 brain tumors BT BT:16 bretylium tosylate BT BT:8|B-T:3 modified blalocktaussig BUN BUN:939 blood urea nitrogen BUN BUN:6 blood urea nitrogen concentration BUP BUP:13|bup:3 bupivacaine BUP BUP:13|bup:1 bupropion BU BU:11 bromouracil BU BU:33 bethesda units BU BU:12 buruli ulcer BU BU:103|Bu:41 busulfan BU BU:17|Bu:9 busulphan BV/TV BV/TV:123 bone volume BV/TV BV/TV:29 bone volume fraction BVB BVB:13 baroreflex vagal bradycardia BVB BVB:12 biventricular bypass BVD-MD BVD-MD:9 bovine viral diarrheamucosal disease BVD-MD BVD-MD:7 bovine virus diarrhoeamucosal disease BVD BVD:86 bovine viral diarrhea BVD BVD:40 bovine viral diarrhoea BVD BVD:35 bovine virus diarrhoea BVI BVI:19 blood vessel invasion BVI BVI:8 volume index BVP BVP:22|BV-P:1 biventricular pacing BVP BVP:11 blood volume pulse BV BV:305 bacterial vaginosis BV BV:11|bv:1 baculovirus BV BV:5 bed volumes BV BV:42|bv:1 bee venom BV BV:5 betachain variable BV BV:17|Bv:1 biliverdin BV BV:5 biological values BV BV:18 blood viscosity BV BV:5 breeding values BV BV:10|B-V:1 bronchovaxom BV BV:30 budded virus BV BV:7 monkey b virus BWS BWS:170 beckwithwiedemann syndrome BWS BWS:24 body weight support BW BW:14|Bw:2 bandwidth BW BW:14 biological warfare BW BW:9 birth weights BW BW:43|bw:1 birthweight BW BW:9 bronchial wash BW BW:8 bronchial washings BYV BYV:16 beet yellows closterovirus BYV BYV:12 beet yellows virus BZ BZ:13 belousovzhabotinsky BZ BZ:22|Bz:3|bz:2 benzene BZ BZ:9|Bz:8 benzylamine BZ BZ:13 border zone BaMV BaMV:14 bamboo mosaic potexvirus BaMV BaMV:10 bamboo mosaic virus BAP BAP:19 benzylaminopurine BAP BAP:6 bioartificial pancreas BAP BAP:6 biotin acceptor peptide BAP BAP:6|BA-P:1 brachial artery pressure BAK BAK:9 bagby and kuslich BAK BAK:8 bcgactivated killer BeWo BeWo:11 cultured human choriocarcinoma BeWo BeWo:8 human placental choriocarcinoma BI BI:9 balloon injury BI BI:175 barthel index BI BI:9 basein BI BI:7 behavioral inhibition Bi Bi:12|B-I:4 billroth i Bi Bi:12|BI:8 binaural interaction Bi Bi:22 bismuth BI BI:14 bovine insulin BI BI:25 brain infarction BI BI:10 brief intervention Bi BI:3|Bi:3 partial gastrectomy BK BK:44|B-K:2 belowknee BK BK:2 below the knee BK BK:1559|Bk:75|bk:3 bradykinin BK BK:7 potassium channel BmNPV BmNPV:9 bombyx mori npv BmNPV BmNPV:33 bombyx mori nuclear polyhedrosis virus BmNPV BmNPV:48 bombyx mori nucleopolyhedrovirus Bmax Bmax:49 binding capacities Bmax Bmax:7 binding maximum Bmax Bmax:64 maximal binding Bmax Bmax:115 maximal number of binding sites Bmax Bmax:84 maximum binding Bmax Bmax:4 maximum binding value Bmax Bmax:161 maximum number of binding sites Bmax Bmax:9 maximum specific binding Bmax Bmax:6 number of betaadrenoceptors Bmax Bmax:10 receptor concentration Bmax Bmax:8 receptor numbers BOS BOS:9|BoS:3 base of support BOS BOS:16 birds own song BOS BOS:164 bronchiolitis obliterans syndrome BR BR:49 balbiani ring BR BR:7 base rate BR BR:7 basic region BR BR:66 bed rest BR BR:15 benzamide riboside BR BR:8 biochemical response BR BR:7 blink rate BR BR:64|Br:4 blink reflex BR BR:11 bone resorption BR BR:29|Br:5 brassinosteroid BR BR:6|Br:1 breathing rate BR BR:10|Br:1 bronchial reactivity Btk Btk:1 bacillus thuringiensis var kurstaki Btk Btk:182|BTK:53|btk:10|BtK:1 brutons tyrosine kinase C/N C/N:12 carbon to nitrogen C/N C/N:33 contrasttonoise C10 C10:6 capric acid C10 C10:7|C-10:5 decamethonium C10 C10:8 decanoic acid C10 C10:16 sodium caprate C12 C12:15 lauric acid C12 C12:7 sodium laurate C1 C1:21|C-1:2 atlas C1 C1:13 first complement component C1 C1:7 first component C1 C1:15 first component of human complement C1 C1:10 large C1 C1:10 onecarbon C2 C2:8 hours postdose C2 C2:4 after administration C2 C2:19|C-2:1 cervical C2 C2:10 levels C2 C2:8|C-2:1 second cervical vertebra C2 C2:13 second complement component C2 C2:10 second component C2 C2:38 second component of complement C2 C2:10 second component of human complement C3 C3:21 chhej C3 C3:5 clostridium botulinum c exoenzyme C3 C3:7 complement c C3 C3:26 complement factor C3 C3:7 flaveria pringlei C3 C3:12 third carpal bone C3 C3:41 third complement component C3 C3:23 third component C4 C4:1 f trinervia C4 C4:11 flaveria trinervia C4 C4:18 fourth complement component C4 C4:100|C-4:1 fourth component of complement C5a C5a:11 complement factor a C5a C5a:6 complement fragment ca C5 C5:6 fifth complement component C5 C5:8 fifth component C5 C5:54 fifth component of complement C5 C5:6 five or more coughs C6 C6:24|C-6:5 rat glioma C6 C6:10 sixth C6 C6:4|C-6:1 sixth cervical C6 C6:5 sixth complement component C6 C6:5 sixth component C6 C6:24 sixth component of complement C7 C7:5 seventh cervical C7 C7:12 seventh component of complement C8 C8:12 eighth component of complement C8 C8:15 eighth component of human complement C9 C9:5 ninth component C9 C9:18 ninth component of complement CAA CAA:8 amino acid CAA CAA:226|CAa:1 cerebral amyloid angiopathy CAA CAA:11 chicken anaemia agent CAA CAA:27 chicken anemia agent CAA CAA:20 chronic aplastic anemia CAA CAA:70 circulating anodic antigen CAA CAA:19 coloanal anastomosis CAA CAA:8 coronary artery atherosclerosis CABG CABG:7 bypass graft operation CABG CABG:2554 coronary artery bypass grafting CABG CABG:14 coronary bypass CAB CAB:26|Cab:1 cabergoline CAB CAB:13|CA-B:1 carbonic anhydrase b CAB CAB:21 cellulose acetate butyrate CAB CAB:42 combined androgen blockade CAC CAC:6 calcium aluminate cement CAC CAC:10 chronic acalculous cholecystitis CAC CAC:11 citric acid cycle CAC CAC:18 conjunctival allergen challenge CAC CAC:101 coronary artery calcification CAC CAC:62 coronary artery calcium CAC CAC:11|cac:8 critical aggregation concentration CAC CAC:13|cac:2 critical association concentration CAD CAD:19 cadaveric CAD CAD:10 caspaseactivated deoxyribonuclease CAD CAD:40 caspaseactivated dnase CAD CAD:21 cervical artery dissection CAD CAD:31 chronic actinic dermatitis CAD CAD:9 chronic allograft dysfunction CAD CAD:19 cinnamyl alcohol dehydrogenase CAD CAD:18 collisionactivated dissociation CAD CAD:14 collisionally activated decomposition CAD CAD:62 collisionally activated dissociation CAD CAD:98 computeraided detection CAD CAD:119 computeraided diagnosis CAD CAD:15 computeraided diagnostic CAD CAD:6 constitutive activation domain CAEBV CAEBV:19 chronic active ebv infection CAEBV CAEBV:10 chronic active epsteinbarr virus CAEBV CAEBV:23 chronic active epsteinbarr virus infection CAE CAE:24 capillary array electrophoresis CAE CAE:13 caprine arthritisencephalitis CAE CAE:10 cefuroxime axetil CAE CAE:16 cellulose acetate electrophoresis CAE CAE:50 childhood absence epilepsy CAE CAE:19 chloroacetate esterase CAE CAE:17 coronary artery ectasia CAF CAF:19 antiviral factor CAF CAF:4 carotid artery flow CAF CAF:8 chronic af CAF CAF:9 chronic allograft failure CAF CAF:28 chronic atrial fibrillation CAF CAF:16 coronary artery fistula CagA CagA:6|cagA:1 cytotoxinassociated antigen CagA CagA:9|cagA:4 cytotoxinassociated protein CAG CAG:84 chronic atrophic gastritis CAG CAG:11 coronary angiogram CAG CAG:53 trinucleotide CAHPS CAHPS:15 consumer assessment of health plans CAHPS CAHPS:29 consumer assessment of health plans study CAHPS CAHPS:7 consumer assessment of health plans survey CAI CAI:22 clinical activity index CAI CAI:26 codon adaptation index CAI CAI:8 computerassisted instructional CALB CALB:10|Calb:1 calbindindk CALB CALB:12|CAL-B:4 candida antarctica lipase b CALUX CALUX:11 luciferase expression CALUX CALUX:7 luciferase gene expression CAL CAL:50 chronic airflow limitation CAL CAL:35 clinical attachment levels CAL CAL:9 coracoacromial ligament CAL CAL:25 coronary artery lesions CAL CAL:32 coronary artery ligation CAMDEX CAMDEX:18|CAM-DEX:1 cambridge examination for mental disorders of the elderly CAMDEX CAMDEX:14 cambridge mental disorders of the elderly examination CA-MRSA CA-MRSA:19|CAMRSA:2 communityacquired methicillinresistant staphylococcus aureus CA-MRSA CA-MRSA:11|CAMRSA:2 communityacquired mrsa CAMs CAMs:319|CAMS:3 cell adhesion molecules CAMs CAMs:5|CAMS:1 complementary and alternative medicines CaM CaM:20 cacalmodulin CaM CaM:15 calciumcalmodulin CAM CAM:139 chick chorioallantoic membrane CAM CAM:86 chick embryo chorioallantoic membrane CAM CAM:20 chorioamnionitis CAM CAM:26 complementary and alternative medical CAM CAM:4 complementary and alternative medical therapies CAM CAM:4 complementary and alternative therapies CAM CAM:39 confusion assessment method CAM CAM:8 congenital adenomatoid malformation CAM CAM:14 constitutively active mutant CAM CAM:59 crassulacean acid metabolism CAM CAM:17 cystic adenomatoid malformation CAM CAM:8 topoisomerase i inhibitor camptothecin CAN CAN:6 amygdaloid nucleus CAN CAN:17 camberwell assessment of need CAN CAN:44 cardiac autonomic neuropathy CAN CAN:30 cardiovascular autonomic neuropathy CAN CAN:3 child abuse or neglect CAN CAN:10 chloroacetonitrile CAN CAN:164 chronic allograft nephropathy CAOD CAOD:6 carotid artery occlusive disease CAOD CAOD:5 chronic arterial obstructive disease CAO CAO:6|Cao:1 chlorophyll a oxygenase CAO CAO:6 chlorophyllide a oxygenase CAO CAO:17 chronic airway obstruction CAO CAO:61 coronary artery occlusion CAPD CAPD:18 continuous ambulatory pd CAPD CAPD:2816|capd:1 continuous ambulatory peritoneal dialysis CAPD CAPD:7 continuous ambulatory peritoneal dialysis patients cap cap:1|CAP:1 ace inhibitor captopril CaP CaP:13|CAP:1 adenocarcinoma of the prostate cap cap:2|CAP:1 angiotensinconverting enzyme inhibitor captopril CAP CAP:7 artery pressure CaP CaP:14 calponin CaP CaP:25|CAP:6 cancer of the prostate CAP CAP:85|cap:12|Cap:7 capsaicin CaP CaP:28|CAP:11|cap:2 carcinoma of the prostate CAP CAP:10 carotid arterial pressure CAP CAP:41 catabolite activator protein CAP CAP:34 cellulose acetate phthalate CAP CAP:11 cellulose acetate polymer CAP CAP:9 central auditory processing CAP CAP:10 chronic alcoholic pancreatitis CAP CAP:88 college of american pathologists CAP CAP:584 communityacquired pneumonia CAP CAP:5 compound action potential of the auditory nerve CAP CAP:58 cyclic alternating pattern CAP CAP:13 cyclic amp receptor protein CAP CAP:26 cystine aminopeptidase CAP CAP:4 pharmacia cap system cap cap:8|CAP:3 transcription initiation CARD CARD:53 caspase recruitment domain CARD CARD:30 catalyzed reporter deposition CARE CARE:12 comprehensive assessment and referral evaluation CARE CARE:25 ryan white comprehensive aids resources emergency CARS CARS:33 childhood autism rating scale CARS CARS:22 coherent antistokes raman scattering CAR CAR:52 cancerassociated retinopathy CAR CAR:8 central activation ratio CAR CAR:49 central african republic CAR CAR:39 ciliaassociated respiratory CAR CAR:14 conditioned avoidance responding CAR CAR:9 coronary artery reperfusion CAR CAR:45 coxsackie and adenovirus receptor CAR CAR:88 coxsackievirus and adenovirus receptor CASA CASA:13 cancerassociated serum antigen CASA CASA:35 computeraided sperm analysis CASA CASA:47 computerassisted semen analysis CASA CASA:5 computerassisted semen analyzer CASA CASA:60 computerassisted sperm analysis CASH CASH:8 cancer and steroid hormone CASH CASH:14 cardiac arrest study hamburg CAST CAST:106 cardiac arrhythmia suppression trial CAST CAST:7 cellular allergen stimulation test CAST CAST:8 cellular antigen stimulation test CAST CAST:20 children of alcoholics screening test CATT CATT:9 card agglutination test CATT CATT:17 card agglutination test for trypanosomiasis CAVB CAVB:33 complete atrioventricular block CAVB CAVB:11 complete av block CAVH CAVH:23 continuous arteriovenous haemofiltration CAVH CAVH:111 continuous arteriovenous hemofiltration CAVHD CAVHD:17|CAVH-D:1 continuous arteriovenous hemodiafiltration CAVHD CAVHD:21 continuous arteriovenous hemodialysis CAS CAS:8 analogue scale CAS CAS:13 analysis system CAs CAs:28 carbonic anhydrases CAS CAS:5 carotid angioplasty and stent placement CAS CAS:41 carotid angioplasty and stenting CAs CAs:7 carotid arteries CAS CAS:14 carotid artery stenosis CAS CAS:61 carotid artery stenting CAS CAS:11 caspofungin CAs CAs:93|CAS:1 catecholamines CAS CAS:10 central anticholinergic syndrome CAS CAS:12 child assessment schedule CAS CAS:19 chrome azurol s CAS CAS:22 clinical activity score CAs CAs:8 cold agglutinins CAS CAS:8 contralateral acoustic stimulation CAs CAs:11 contrast agents CAs CAs:9 coronary arteries CAS CAS:15 coronary artery spasm CAS CAS:9 coronary artery stenosis CAS CAS:7 harvard school of public health college alcohol study CA CA:11 abnormalities CA CA:12 assay CA CA:48 caffeic acid CA CA:26|Ca:7|ca:1 cancer CA CA:32 cancer antigen CA CA:57|Ca:5 candida albicans CA CA:97 capsid CA CA:5 carbonate apatite CA CA:116 cardiac arrest CA CA:83 catecholaminergic CA CA:10 catheter ablation CA CA:6 caucasian american CA CA:20 cellular automata CA CA:9 cellular automaton CA CA:97 cellulose acetate CA CA:13 cerebellar atrophy CA CA:14 cerebral atrophy CA CA:30 cerebral autoregulation CA CA:9 choanal atresia CA CA:14 cholate CA CA:18 cholic CA CA:150 chronological age CA CA:21 cluster analysis CA CA:5 cobblestone areas CA CA:15 cochlear aqueduct CA CA:38|C-A:1 coldacclimated CA CA:10 coldacclimated rats ca ca:6|CA:1 cold adapted CA CA:14|C-A:1 communityacquired CA CA:9 condyloma acuminata CA CA:20 condyloma acuminatum CA CA:10 condylomata acuminata CA CA:6 congruence angle CA CA:14 conjoint analysis ca CA:3|ca:3 constitutively activated CA CA:17|ca:11|Ca:2|c-a:1 constitutively active CA CA:7 contact angle CA CA:15 contrast arteriography CA CA:8 controlled atmosphere CA CA:17 conventional angiography CA CA:8 conventional arteriography CA CA:14 conversation analysis CA CA:38 cornu ammonis CA CA:95 corpora allata CA CA:25 corpora amylacea CA CA:32 corpus allatum CA CA:17 correspondence analysis CA CA:19 cortical area CA CA:33 cortisone acetate CA CA:22 cytosine arabinoside CA CA:5 highly polymorphic CA CA:7 isolated a polymorphic dinucleotide ca ca:4 live attenuated coldadapted CA CA:4 measurement of compressed air CA CA:32|Ca:1 plasma catecholamines CA CA:4 weeks of conceptional age CB-154 CB-154:18|CB154:2 bralphaergocryptine CB-154 CB-154:30|CB154:5 bromoalphaergocryptine CB-154 CB-154:11|CB154:2 bromocryptine CB1 CB1:20 cannabinoid receptor CB1 CB1:14 cannabinoid receptor type CB1 CB1:13 cannabinoid type CBA CBA:5 binding activity CBA CBA:9 congenital biliary atresia CBA CBA:47 costbenefit analysis CBA CBA:20 cutting balloon angioplasty CBA CBA:13 cytochemical bioassay CBB CBB:11 calvinbensonbassham CBB CBB:40 coomassie brilliant blue CBC CBC:12 cannabichromene CBC CBC:6 cerebralbuccal connective CBC CBC:126 complete blood count CBC CBC:16 contralateral breast cancer CBC CBC:11 nuclear capbinding complex CBD CBD:11 carotid bodydenervated CBD CBD:23|cbd:1 carotid body denervation CBD CBD:87 chronic beryllium disease CBD CBD:659|cbd:1 common bile duct CBD CBD:27 communitybased distribution CBD CBD:18 congenital biliary dilatation CBE CBE:14 clinical breast exam CBE CBE:96 clinical breast examination CBE CBE:6 communitybased education CBE CBE:13 conduritol b epoxide CBE CBE:11 cotton bracts CBF CBF:18 ccaatbinding factor CBF CBF:9 cerebral CBF CBF:25 cholinergic basal forebrain CBF CBF:265 ciliary beat frequency CBG CBG:17|cBG:1 capillary blood glucose CBG CBG:40 cortisol binding globulin CBG CBG:21 transcortin CBH CBH:9|Cbh:1 cellobiohydrolase CBH CBH:42 cutaneous basophil hypersensitivity CBM CBM:7 capillary basement membrane CBM CBM:27 carbohydratebinding module CBP CBP:6 calmodulinbinding peptide CBP CBP:12 chronic back pain CBP CBP:19 chronic bacterial prostatitis CBP CBP:127 creb binding protein CBR CBR:13 carotid baroreflex CBR CBR:22 casebased reasoning CBR CBR:12 clinical benefit response CBR CBR:9 critical body residue CBR CBR:24 crude birth rate CBs CBs:30 cajal bodies CBs CBs:9 cannabinoids CBs CBs:12 carotid bodies CBS CBS:9 central bureau of statistics CBS CBS:15 cerebroside sulfate CBS CBS:27 charles bonnet syndrome CBs CBs:9 chlorinated biphenyls CBs CBs:12 chlorobiphenyls CBs CBs:15 coiled bodies CBS CBS:83 colloidal bismuth subcitrate CBS CBS:6 combined behavioral score CBV CBV:30 capillary blood cell velocity CBV CBV:7 capillary blood velocity CBV CBV:11 cerebral blood velocity CBZ-E CBZ-E:3|CBZ-e:1 active metabolite carbamazepineepoxide CBZ-E CBZ-E:5|CBZE:2 carbamazepine epoxide CBZ CBZ:1117|Cbz:1 carbamazepine CBZ CBZ:9 carbimazole CB CB:9 branch CB CB:10 calciumbinding proteins calbindin CB CB:40 carbon black CB CB:9|cb:2|Cb:1 centroblastic CB CB:22 chlorobenzene CB CB:139 chronic bronchitis CB CB:14|Cb:5 clenbuterol CB CB:11 cocoa butter CB CB:17|C-B:3 cognitivebehavioral CB CB:28 conduction block CB CB:545|cb:1 cord blood CB CB:11 core biopsy CB CB:12 covalent binding CB CB:19 cuprolinic blue CB CB:14 cutting balloon CC16 CC16:50|CC-16:3 clara cell protein CC16 CC16:3|CC-16:2 clara cell protein CCAM CCAM:84 congenital cystic adenomatoid malformation CCAM CCAM:26 congenital cystic adenomatoid malformation of the lung CCA CCA:11 canonical correlation analysis CCA CCA:19 canonical correspondence analysis CCA CCA:8 cerebellar cortical atrophy CCA CCA:12 chick cellagglutinating CCA CCA:33 chromated copper arsenate CCA CCA:8 clear cell acanthoma CCA CCA:17 clear cell adenocarcinoma CCA CCA:6 closedcircuit anesthesia CCA CCA:9 common carotid arterial CCA CCA:30 congenital contractural arachnodactyly CCA CCA:6 conjugated cholic acid CCA CCA:5 conventional cerebral angiography CCA CCA:6 conventional coronary angiography CCA CCA:11 conventional cytogenetic analysis CCA CCA:13 cortical cerebellar atrophy CCA CCA:6 cyclohexane carboxylic acid CCA CCA:18 lobenzarit disodium CCCP CCCP:178|cccp:1 carbonyl cyanide mchlorophenylhydrazone CCCP CCCP:18 carbonylcyanidemchlorophenylhydrazone CCCs CCCs:4 child care centers CCCs CCCs:8 cholangiocellular carcinomas CCD CCD:66|Ccd:2 cleidocranial dysplasia CCD CCD:9 contactless conductivity detection CCD CCD:41 crossed cerebellar diaschisis CCE CCE:42 capacitative calcium entry CCE CCE:14 cholesterol crystal embolization CCE CCE:7 citrate cleavage enzyme CCE CCE:49 counterflow centrifugal elutriation CCF CCF:33 chronic cardiac failure CCF CCF:26 congestive cardiac failure CCF CCF:5 controlled continuous flow CCF CCF:12|ccf:1 crosscorrelation function CCF CCF:11 fistulae CCHB CCHB:14 complete congenital heart block CCHB CCHB:27 congenital complete heart block CCHS CCHS:14 canadian community health survey CCHS CCHS:74 congenital central hypoventilation syndrome CCI CCI:24 charlson comorbidity index CCI CCI:203 chronic constriction injury CCI CCI:9 color confusion index CCI CCI:6 complete cerebral ischemia CCI CCI:66 controlled cortical impact CCI CCI:7 craniocerebral injuries CCI CCI:6 patients with chronic cardiac insufficiency CCK-8S CCK-8S:13|CCK-8s:6|CCK8s:2|CCK-8-S:1|CCK8-S:1 sulfated cholecystokinin octapeptide CCK-8S CCK8S:1|CCK-8S:1 sulfated octapeptide cholecystokinin CCK-8 CCK-8:26|CCK8:1 cterminal octapeptide of cholecystokinin CCK-8 CCK-8:13|CCK8:9 cckoctapeptide CCL CCL:9 canine ceroidlipofuscinosis CCL CCL:93|CCl:2 cefaclor CCL CCL:11 centrocytelike CCM CCM:11 chemical cleavage of mismatch CCM CCM:7 chronic care model CCM CCM:7 coconcentrating mechanism CCM CCM:9 critical care medicine CCN CCN:24 central cervical nucleus CCN CCN:13 cerebrocortical necrosis CCPA CCPA:6 adenosine a receptor agonist chloroncyclopentyladenosine CCPA CCPA:7 agonist chloroncyclopentyladenosine CCP CCP:9 chronic calcific pancreatitis CCP CCP:24 chronic calcifying pancreatitis CCP CCP:17 chronic cor pulmonale CCP CCP:6 classical complement pathway CCP CCP:46 complement control protein CCP CCP:6 conditioned cue preference CCP CCP:18 cooperative cardiovascular project CCP CCP:10|ccp:5 corpus cavernosum penis CCP CCP:13 critical closing pressure CCP CCP:59|CcP:51|ccp:1|Ccp:1 cytochrome c peroxidase CCS CCS:52 canadian cardiovascular society CCS CCS:20 cardiac conduction system CCS CCS:8 central cord syndrome CCS CCS:13 chronic cerebellar stimulation CCS CCS:14 chronic compartment syndrome CCS CCS:27 clear cell sarcoma CCS CCS:8 copper chaperone for sod CCS CCS:2 copper chaperone for the superoxide dismutase CCS CCS:4 coronary calcium score CCS CCS:8|C-C-S:1 cronkhitecanada syndrome CCT CCT:10 california consonant test CCT CCT:119 central conduction time CCT CCT:131 central corneal thickness CCT CCT:7 chaperonin containing tcomplex polypeptide CCT CCT:11 computed cranial tomography CCT CCT:6 computerized cranial tomography CCT CCT:10|C-CT:1 conventional ct CCT CCT:42|cCT:1 cranial computed tomography CCT CCT:17|cCT:3 cranial computerized tomography CCT CCT:30 craniocerebral trauma CCT CCT:9 crude coal tar CC CC:12 cage control CC CC:7 calf circumference CC CC:14 cell culture CC CC:5 central complex CC CC:6|cc:3|Cc:3 centrocytic CC CC:43 cervical cancer CC CC:15 cervical carcinoma CC CC:11|cc:1 chest circumference CC CC:14 cholangiocarcinomas CC CC:22 choledochal cyst CC CC:12 chondrocalcinosis CC CC:12 choriocapillaris CC CC:13 choriocarcinoma CC CC:9 clear cell CC CC:10|cc:1 clomiphene CC CC:39 closing capacity CC CC:16|C-C:1 coiledcoil CC CC:26 collagenous colitis CC CC:9|cc:1 colloidal carbon CC CC:14 colon cancer CC CC:13 colorectal cancer CC CC:7 community care CC CC:12 complete chimerism CC CC:6 complete donor chimerism CC CC:12 compliance coefficient CC CC:6 contractile component CC CC:6 conventional chemotherapy CC CC:6 conventional cholecystectomy CC CC:13 conventional colonoscopy CC CC:27 conventional cytogenetics CC CC:7 coronary calcification CC CC:8 coronary calcium CC CC:34|cc:1 corpora cardiaca CC CC:13 corpora cavernosa CC CC:219|cc:3 corpus callosum CC CC:19 corpus cardiacum CC CC:50|cc:1 corpus cavernosum CC CC:9 crosscorrelation CC CC:6 crosssectional compliance CC CC:11 cryptogenic cirrhosis CC CC:8|cC:1|Cc:1 cyclocytidine CC CC:9 nisoldipine coat core CD16 CD16:9 fc gamma receptor iii CD16 CD16:8 fc gammariii CD16 CD16:30 fcgammariii CD16 CD16:7 receptor type iii CD18 CD18:5 beta integrins CD18 CD18:8|CD-18:1 common betachain CD25 CD25:10 ilr alpha chain CD25 CD25:7 receptor alpha CD4+ CD4+:17 cdpositive CD4+ CD4+:9 helper t cells CD43 CD43:36 leukosialin CD43 CD43:23 sialophorin CD4 CD4:23 antilt CD4 CD4:5 t helperinducer CD8 CD8:15 antilyt CD8 CD8:9 cytotoxicsuppressor CD8 CD8:16 suppressorcytotoxic CDAD CDAD:36 clostridium difficileassociated diarrhea CDAD CDAD:21|CdAD:1 clostridium difficileassociated diarrhoea CDAD CDAD:14 clostridium difficileassociated disease CDA CDA:10 calciumdependent antibiotic CDA CDA:11 california dental association CDA CDA:4 canonical discriminant analysis CDA CDA:7 cellulose diacetate CDA CDA:7 chloridedepletion alkalosis CDA CDA:4 chloridedepletion metabolic alkalosis CDA CDA:17 clinical document architecture CDA CDA:1 cold dry air CDA CDA:35 congenital dyserythropoietic anaemia CDA CDA:39 congenital dyserythropoietic anemia CDC CDC:1 center disease control CDC CDC:485 centers for disease control CDC CDC:26 collecting duct carcinoma CDC CDC:13 disease controls CDDP CDDP:9|cDDP:1 cisdiaminedichloroplatinum CDDP CDDP:11 cisdichlorodiammine platinum CDD CDD:9 cardiodilatin CDD CDD:9 childhood disintegrative disorder CDD CDD:10 choledochoduodenostomy CDD CDD:10 control of diarrhoeal diseases CDF CDF:13 cartilagederived factor CDF CDF:23 cation diffusion facilitator CDF CDF:9|Cdf:2 chlordimeform CDH CDH:44 cellobiose dehydrogenase CDH CDH:9 ceramide dihexoside CDH CDH:95 chronic daily headache CDH CDH:88 congenital dislocation of the hip CDH CDH:15 congenital dysplasia of the hip CDH CDH:9 cutaneous delayed hypersensitivity CDI CDI:16 carbonyldiimidazole CDI CDI:6 cadependent inactivation CDI CDI:45 central diabetes insipidus CDI CDI:103 childrens depression inventory CDI CDI:113 color doppler imaging CDI CDI:30 cotreldubousset instrumentation CDI CDI:4 cyclindependent kinase inhibitor CDMS CDMS:28|CD-MS:1 clinically definite ms CDMS CDMS:22 clinically definite multiple sclerosis CDO CDO:29 cysteine dioxygenase CDO CDO:10 duodenal obstruction CDP CDP:9 chloroquine diphosphate CDP CDP:9 collagenasedigestible CDP CDP:21 computerized dynamic posturography CDP CDP:6 constitutional delay of puberty CDP CDP:5 constitutional delayed puberty CDP CDP:10 continuous distending pressure CDP CDP:11 cord dorsum potential CDP CDP:11 decongestive physiotherapy CDP CDP:13 incorporation of hproline into collagenasedigestible protein CDR2 CDR2:12|CDR-2:1 complementaritydetermining region CDR2 CDR2:7 second complementarity determining region CDR CDR:120 clinical dementia rating CDR CDR:25 clinical dementia rating scale CDR CDR:15 cognitive drug research CDR CDR:5 confluence dependent resistance CDR CDR:6 crude death rate CDR CDR:7 regulator protein CDSS CDSS:15 calgary depression scale for schizophrenia CDSS CDSS:16 clinical decision support system CDSS CDSS:15 decision support systems CDS CDS:10 allogeneic cultured dermal substitute CDS CDS:10 calgary depression scale CDS CDS:8 cdpdiacylglycerol synthase CDS CDS:10 cervical dentine sensitivity CDS CDS:15 chronic disease score CDS CDS:7 clinical decision support CDS CDS:36 color doppler sonography CDS CDS:7 color duplex sonography CDS CDS:20 community dental service CDT CDT:272 carbohydratedeficient transferrin CDT CDT:36 clock drawing test CDT CDT:5 contralateral descended testis CDT CDT:7 cystic dysplasia of the testis CDV CDV:398 canine distemper virus CDV CDV:37 cidofovir CD CD:9 alphacyclodextrin CD CD:12 cadaver donor Cd Cd:1213|CD:11|cd:1 cadmium CD CD:21|Cd:1 campomelic dysplasia CD CD:41 capillary density CD CD:10 carbidopa CD CD:13 cardiac death CD CD:10 cardiacdenervated CD CD:5 cardiac denervation CD CD:16|cd:3 catalytic domain Cd Cd:10|CD:3 caudate CD CD:8 cerebellar degeneration CD CD:58 cervical dystonia CD CD:10 cesarean delivery CD CD:6 characteristic delay CD CD:54|Cd:4 chlordecone CD CD:9 choline deficiency CD CD:16 cholinedevoid CD CD:11 choroidal detachment CD CD:118|cd:1 circular dichroic CD CD:26 circular dichroism spectroscopy CD CD:15|Cd:3 clostridium difficile CD CD:16 cluster designation CD CD:5 cocaine dependent CD CD:5 coefficient of dispersion CD CD:6 colloidal dispersion CD CD:27 color doppler CD CD:14 colostrumdeprived CD CD:19 communication deviance CD CD:10 compact disc CD CD:8 compact disk CD CD:6 conduction delay CD CD:20 contact dermatitis CD CD:13|C-D:4 contrastdetail CD CD:4 cool dry CD CD:8 coronary diameter CD CD:44 cortical dysplasia CD CD:38|C-D:3 cotreldubousset CD CD:1592|Cd:1 crohns disease CD CD:6|cd:1 cumulative dose CD CD:131|cd:4 cytosine deaminase CD CD:4 rats fed a cholinedeficient CE-LIF CE-LIF:15 capillary electrophoresis with laserinduced fluorescence CE-LIF CE-LIF:22 capillary electrophoresis with laserinduced fluorescence detection CE-LIF CE-LIF:4 capillary electrophoresis with laserinduced fluorescence detector CEA CEA:10 carcinoembryonic CEA CEA:7 carcinoembryonic ag CEA CEA:8 continuous epidural analgesia CEA CEA:100 costeffectiveness analysis CEA CEA:8 cultured epidermal autograft CEA CEA:6 enzyme activity CECT CECT:22|CE-CT:13 contrastenhanced computed tomography CECT CECT:9|CE-CT:3|ceCT:1 contrastenhanced ct CEC CEC:18 capillary electrochromatographic CEC CEC:327 capillary electrochromatography CEC CEC:47 cation exchange capacity CEC CEC:14 chicken embryo cells CEC CEC:31 chlorethylclonidine CEC CEC:82 chloroethylclonidine CEC CEC:33|cEC:1 circulating endothelial cells CEC CEC:13 commission of the european communities CEC CEC:20 critical electrolyte concentration CED CED:26 chronic energy deficiency CED CED:28 convectionenhanced delivery CEF CEF:7 cauda epididymal fluid CEF CEF:1 cyclophosphamide epirubicin and fluorouracil CEH CEH:20|CeH:1 cervicogenic headache CEH CEH:45 cholesteryl ester hydrolase CEH CEH:13 cystic endometrial hyperplasia CEL CEL:27 carboxyl ester lipase CEL CEL:8|cel:4 celecoxib CEL CEL:9 chronic eosinophilic leukemia CEM CEM:21 cellulose ester membranes CEM CEM:35 contagious equine metritis CEM CEM:8 leukemia cells CEN CEN:16 centromere CEN CEN:6 centromere dna CEN CEN:7 continuous enteral nutrition CEOs CEOs:34 chief executive officers CEOs CEOs:8 cumulusenclosed oocytes CEO CEO:11 cyanoethylene oxide CEO CEO:28 chief executive officer CEO CEO:15 chloroethylene oxide CEO CEO:13 cumulus cellenclosed oocytes CEP CEP:5 care evaluation program CEP CEP:59 chronic eosinophilic pneumonia CEP CEP:44 congenital erythropoietic porphyria CEP CEP:8 cortical evoked potentials CEP CEP:20 counterelectrophoresis CEP CEP:7 evoked potential CER CER:8 cholesterol esterification rate CER CER:70 conditioned emotional response CER CER:17 costeffectiveness ratio CES-D CES-D:29|CESD:1 center for epidemiological studiesdepression CES-D CES-D:28|CESD:1 center for epidemiological studiesdepression scale CESD CESD:1 center of epidemiological studies depression CESD CESD:45 cholesteryl ester storage disease CES CES:8 carbohydrateelectrolyte solution CES CES:21 cat eye syndrome CES CES:18 cauda equina syndrome CES CES:9 central excitatory state CEs CEs:11|CES:1 cholesterol esters CEs CEs:40 cholesteryl esters CES CES:13 congenital esophageal stenosis CEs CEs:7 cornified envelopes CES CES:9 cranial electrotherapy stimulation CET CET:44 cephalothin CET CET:33 cholesteryl ester transfer CET CET:18 chronic ethanol treatment CET CET:8 competition exercise test CET CET:7 computed eeg topography CET CET:5 computerized electroencephalographic topography CEZ CEZ:140 cefazolin CEZ CEZ:10 cefazolin sodium CE CE:24 california encephalitis CE CE:72 capillary electrophoretic CE CE:22 capsule endoscopy CE CE:10 carbohydrateelectrolyte CE CE:7 carboplatin and etoposide CE CE:5 cardiac events CE CE:82 carotid endarterectomy CE CE:18|C-E:15 carpentieredwards CE CE:6 cataract extraction CE CE:10 catechol estrogens CE CE:6 cell extracts CE CE:15|Ce:6 central CE CE:14 centrifugal elutriation CE CE:9 chemoembolization CE CE:8 chest expansion CE CE:8 chicken embryo CE CE:67 cholesterol ester CE CE:19 ciliary epithelium CE CE:9 clinical engineering CE CE:12 clinical examination CE CE:25 cloning efficiency CE CE:11 coefficient of error CE CE:9 cold exposure CE CE:13 collection efficiency CE CE:14 combinatorial extension CE CE:40 competitive exclusion CE CE:10 constant estrous CE CE:6 constant estrus CE CE:124 continuing education CE CE:15 contractile element CE CE:18 contrast echocardiography CE CE:7 contrast enema CE CE:28 contrast enhancement CE CE:43 converting enzyme CE CE:9 corneal endothelial CE CE:14 cornified envelope CE CE:23 crude extract CE CE:11 cycle ergometer CE CE:15 cycle ergometry CE CE:121 cystic echinococcosis CE CE:8 cytochalasin e CE CE:6 included examination of the constant error CE CE:6 liver carboxylesterase CF1 CF1:5 chloroplast atpase CF1 CF1:25 chloroplast coupling factor CF1 CF1:58 chloroplast coupling factor CF1 CF1:15 chloroplast fatpase CFA CFA:6 caudal forelimb area CFA CFA:18 cellular fatty acid CFA CFA:17 chicken fetal antigen CFA CFA:21 circulating filarial antigen CFA CFA:11 coal fly ash CFA CFA:50 common femoral artery CFA CFA:657|cFA:3 complete freunds adjuvant CFA CFA:19 confirmatory factor analyses CFA CFA:93 confirmatory factor analysis CFA CFA:11 coronafacic acid CFA CFA:11 craniofacial anomalies CFA CFA:84 cryptogenic fibrosing alveolitis CFA CFA:8|cfa:1 cyclopropane fatty acid CFC CFC:18 cytokine flow cytometry CFC CFC:10 fear conditioning CFF CFF:45|cff:1 critical flicker frequency CFF CFF:59|cff:1 critical flicker fusion CFF CFF:26 critical flicker fusion frequency CFF CFF:13 critical fusion frequency CFI CFI:34 camberwell family interview CFI CFI:20 chemotactic factor inactivator CFI CFI:19 collateral flow index CFI CFI:10 color flow imaging CFM CFM:45 cerebral function monitor CFM CFM:6 confocal fluorescence microscopy CFM CFM:13 flow mapping cFN cFN:4|CFN:3 caudal fastigial nucleus cFN cFN:7 caudal part of the fastigial nucleus cFN cFN:8|cFn:4|c-FN:1 cellular fn CFP CFP:15 center of foot pressure CFP CFP:8 centre of foot pressure CFP CFP:13 common foundation programme CFP CFP:9 culture filtrate proteins CFP CFP:50 cyan fluorescent protein CFRs CFRs:6 casefatality rates CFRs CFRs:9 climbing fiber responses CFRs CFRs:29 cyclic flow reductions CFR CFR:7 case fatality ratio CFR CFR:25 code of federal regulations CFR CFR:12 complement fixation reaction CFR CFR:24 coronary flow rate CFR CFR:225 coronary flow reserve CFR CFR:8 cyclic flow reduction CFS CFS:4 canada fitness survey CFs CFs:15 cardiac fibroblasts CFS CFS:50 cefsulodin CFs CFs:61|CFS:1 characteristic frequencies CFS CFS:924|cfs:1 chronic fatigue syndrome CFs CFs:26 climbing fibers CFs CFs:20 colonization factors CFS CFS:4 colorflow duplex scanning CFS CFS:12 conditioned fear stress CFS CFS:9 congenital fibrosarcoma CFS CFS:6 continuous flow system CFS CFS:7 fatigue scale CFTR CFTR:16|cftr:1 cystic fibrosis gene CFTR CFTR:9 cystic fibrosis gene product CFTR CFTR:1596|Cftr:8|cftr:4 cystic fibrosis transmembrane conductance regulator CFTR CFTR:45|Cftr:1 cystic fibrosis transmembrane conductance regulator gene CFTR CFTR:16 cystic fibrosis transmembrane conductance regulator protein CFU-F CFU-F:8 bone marrow fibroblast colonyforming cells CFU-F CFU-F:8|CFU-f:4 colonyforming unit CFU-F CFU-F:17|CFUF:1 fibroblast colonyforming units CFU-GM CFU-GM:2 colonyforming units for granulocytemacrophage CFU-GM CFU-GM:3 colonyforming units of granulocytes and macrophages CFU-GM CFU-GM:11 granulocytemacrophage cfu CFU-GM CFU-GM:4|CFU-gm:1 granulocytemacrophage colony CFU-GM CFU-GM:79|CFU-gm:3 granulocytemacrophage progenitor cells CFU-GM CFU-GM:9 granulocytemonocyte CFU-GM CFU-GM:38|CFUGM:1|CFU-gm:1 myeloid progenitor cells CFU-GM CFU-GM:20 progenitor cell CFU-S CFU-S:7|CFUs:3 colonyforming units in the spleen CFU-S CFU-S:14|CFUS:2|CFU-s:1 pluripotent CFU-S CFU-S:16|CFUs:3|CFU-s:1 spleen colonies CFV CFV:21 common femoral vein CFV CFV:19 constantflow ventilation CF CF:15 canadian forces CF CF:21 cardiac failure CF CF:11 cascade filtration CF CF:10 case fatality CF CF:29 cationic ferritin CF CF:130 cationized ferritin CF CF:8|c-f:1 cellfree CF CF:13 charcoalfiltered air CF CF:7 chicken fat CF CF:33 chloroform CF CF:20 chronic fatigue CF CF:8 clastogenic factors CF CF:12 climbing fibre CF CF:11 coelomic fluid CF CF:10 colostrumfed CF CF:26 complement fixation test CF CF:8 concentration factors CF CF:13 constantfrequency CF CF:17 continuousflow CF CF:40 contractile force CF CF:22 conventional fractionation CF CF:208 coronary flow CF CF:10 cortical fibroblasts CF CF:4|cf:1 counting fingers CF CF:20 crevicular fluid CF CF:12 crude fiber CF CF:15 crude fibre CF CF:47 culture filtrate CF CF:6 cytosolic fraction CF CF:42 cytotoxic factor CF CF:9 folinic acid CF CF:14 function CGA CGA:25 chlorogenic acid CGA CGA:78 comprehensive geriatric assessment CGD CGD:573 chronic granulomatous disease CGD CGD:10 chronic granulomatous disease of childhood CGD CGD:19 constitutional growth delay CGE CGE:64 capillary gel electrophoresis CGE CGE:18 cobalt gray equivalent CGI-I CGI-I:11 clinical global impressionsimprovement scale CGI-I CGI-I:6 clinical global impression of improvement CGI-S CGI-S:14 clinical global impression of severity CGI-S CGI-S:11 clinical global impressionsseverity of illness CGI-S CGI-S:14 clinical global impressionsseverity of illness scale CGL CGL:126|cgl:1 chronic granulocytic leukaemia CGL CGL:146 chronic granulocytic leukemia CGL CGL:19 congenital generalized lipodystrophy cGMP cGMP:489|C-GMP:2|Cgmp:1|CGMP:1|c-GMP:1 guanosine cyclic monophosphate cGMP cGMP:6 guanosine cyclic phosphate CGM CGM:34|-CGM:1 corn gluten meal CGM CGM:4|cGM:3 cortical gray matter CGRP-LI CGRP-LI:9 calcitonin generelated peptide CGRP-LI CGRP-LI:7 calcitonin generelated peptidelike immunoreactive CGRP-LI CGRP-LI:26|CGRP-li:2|CGRPLI:1 cgrplike immunoreactivity CGRP-IR CGRP-IR:10|CGRP-ir:1 calcitonin generelated peptide immunoreactivity CGRP-IR CGRP-IR:12 cgrpimmunoreactive CGRP CGRP:6 calcitonin generelated polypeptide CGRP CGRP:12 calcitonin generelated protein CGTase CGTase:24 cyclodextrin glucanotransferase CGTase CGTase:41 cyclodextrin glycosyltransferase CGs CGs:10 caregivers CGs CGs:17 cortical granules CG CG:9 capsular glaucoma CG CG:8 cardiac glycosides CG CG:6|Cg:2 catechin gallate CG CG:48 central gray CG CG:9 centre of gravity CG CG:6|-CG:1 cerebral ganglia CG CG:17 cholylglycine CG CG:11 choriogonadotropin CG CG:10|Cg:9 chromogranin CG CG:9 ciliary ganglia CG CG:72 ciliary ganglion CG CG:14 coagulating gland CG CG:11|C-G:4 cockcroftgault CG CG:14 collapsing glomerulopathy CG CG:10 colloidal gold CG CG:9 computer graphics CG CG:11 conjugate gradient CG CG:11|Cg:1 cryoglobulins CG CG:9 cycloguanil CG CG:10|cg:1 groups CG CG:10 mesencephalic central gray area CG CG:4 porous collagenglycosaminoglycan CH50 CH50:15 complement hemolytic activity CH50 CH50:8 total hemolytic activity CH50 CH50:39 total hemolytic complement CH50 CH50:19 total hemolytic complement activity CHB CHB:9 cyanohydroxybutene CHB CHB:163|CH-B:17|chB:1|cHB:1 chronic hepatitis b CHB CHB:150 heart block CHCs CHCs:47 community health centers CHCs CHCs:14 community health centres CHCs CHCs:9 cuticular hydrocarbons CHD CHD:9 cyclohexanedione CHD CHD:17 canine hip dysplasia CHD CHD:9 chronic haemodialysis CHD CHD:56|cHD:1 chronic hemodialysis CHD CHD:19 common hepatic duct CHD CHD:35 congenital heart diseases CHD CHD:20 conventional hemodialysis CHEF CHEF:52 contourclamped homogeneous electric field CHEF CHEF:8 homogeneous electric fields CHEF CHEF:5 homogeneous electric field electrophoresis ChE ChE:4|CHE:1 choline esterase ChE ChE:18|CHE:3|Ch-E:1 cholinesterase activity CHF CHF:26 congenital hepatic fibrosis CHF CHF:3285 congestive heart failure CHF CHF:22 continuous hemofiltration CHF CHF:6 crimean haemorrhagic fever CHF CHF:7 crimean hemorrhagic fever CHF CHF:340|cHF:1 patients with chronic heart failure CHIP CHIP:8 carboxyl terminus of hscinteracting protein CHIP CHIP:23 childrens health insurance program CHIP CHIP:11 platinum iv CHLs CHLs:12 chlordanes CHLs CHLs:23 chlordane compounds CHL CHL:13 combined hyperlipidemia CHL CHL:15 conductive hearing loss CHL CHL:13|C-HL:1 crownheel length CHM CHM:19 chinese herbal medicine CHM CHM:28 choroideremia CHN CHN:22 chinese herbs nephropathy CHN CHN:13 community health nursing CHN CHN:8 congenital hypomyelinating neuropathy CHO-K1 CHO-K1:68|CHO-k1:2 chinese hamster ovary cells CHO-K1 CHO-K1:10 chinese hamster ovary k CHOP CHOP:18 cebp homologous protein CHOP CHOP:11 cyclophosphamidedoxorubicinvincristineprednisone CHO CHO:42 chinese hamster ovarian CHO CHO:11|cho:1 cyclohexene oxide CHO CHO:20 highcarbohydrate CHP CHP:10 chandipura CHP CHP:17|chp:1 cricohyoidopexy CHP CHP:12 cytophagic histiocytic panniculitis CHP CHP:12 pullulan CHRNA4 CHRNA4:8 neuronal nicotinic acetylcholine receptor alpha subunit CHRNA4 CHRNA4:4 neuronal nicotinic acetylcholine receptor alpha subunit CHRNA4 CHRNA4:6 nicotinic acetylcholine receptor alpha subunit gene CHT CHT:9 choline transporter CHT CHT:20 closed head trauma CHX CHX:18 chlorhexidine digluconate CHX CHX:64|Chx:1 protein synthesis inhibitor cycloheximide CH CH:26 calponin homology CH CH:10 cardiac hypertrophy CH CH:9 central hemodynamics CH CH:17 cerebral hemispheres CH CH:28 cerebral hemorrhage CH CH:14|C-H:3 chediakhigashi CH CH:94 chloral hydrate CH CH:181 chronic hepatitis CH CH:45 chronic hypoxia CH CH:23 chronically hypoxic CH CH:116 cluster headache CH CH:6 community hospital CH CH:8 concentric hypertrophy CH CH:5|ch:4 congenital hydrocephalus CH CH:9 congenital hypothyroid CH CH:5 crypt height CH CH:11|ch:1 cyclic hematopoiesis CH CH:10 heavy chain constant CH CH:15 heavy chain constant region CIA CIA:11 carbon immunoassay CIA CIA:539 collageninduced arthritis CIA CIA:25 common iliac artery CIC CIC:12|Cic:1 cicletanine CIC CIC:20 clean intermittent catheterisation CIC CIC:96 clean intermittent catheterization CIC CIC:36 conjunctival impression cytology CIDP CIDP:15 chronic inflammatory demyelinating neuropathy CIDP CIDP:289 chronic inflammatory demyelinating polyneuropathy CIDP CIDP:134 chronic inflammatory demyelinating polyradiculoneuropathy CIDR CIDR:18 controlled internal drug release CIDR CIDR:7 controlled internal drug releasing CID CID:10 central institute for the deaf CID CID:342 collisioninduced dissociation CID CID:20 combined immunodeficiency CID CID:6 combined immunodeficiency disease CID CID:8 cytomegalic inclusion disease CIEF CIEF:81|cIEF:38 capillary isoelectric focusing CIEF CIEF:9 crossed immunoelectrofocusing CIE CIE:5 capillary ion electrophoresis CIE CIE:9 chronic intermittent ethanol cIg cIg:5|CIg:3|c-Ig:1 cytoplasmic ig cIg cIg:21|CIg:13|C-Ig:2|cig:1 cytoplasmic immunoglobulin CIH CIH:14 chronic intermittent hypoxia CIH CIH:9 colloidal iron hydroxide CII CII:28 collagen type ii CII CII:291|cII:3|C-II:2 type ii collagen CIMT CIMT:29|c-IMT:1|cIMT:1 carotid intimamedia thickness CIMT CIMT:20 constraintinduced movement therapy CIM CIM:6 cardia intestinal metaplasia CIM CIM:12 cimaterol CIM CIM:23 composite interval mapping CIM CIM:6 critical illness myopathy CIN3 CIN3:8|CIN-3:1 cervical intraepithelial neoplasia CIN3 CIN3:10 cervical intraepithelial neoplasia grade CINCA CINCA:2 chronic infantile neurologic cutaneous and articular CINCA CINCA:6 chronic infantile neurological cutaneous and articular CIP CIP:13 caeruleininduced pancreatitis CIP CIP:7|Cip:2 ciprofibrate CIP CIP:10|CiP:3 coprinus cinereus peroxidase CIP CIP:7 corticotropininhibiting peptide CIP CIP:33 critical illness polyneuropathy CISH CISH:8 chromogenic in situ hybridisation CISH CISH:41 chromogenic in situ hybridization CISH CISH:5 intrafascial supracervical hysterectomy CISS CISS:23 chromosomal in situ suppression CISS CISS:4 constructive interference in the steady state CISS CISS:2 constructive interference steadystate CISS CISS:14 coping inventory for stressful situations CIS CIS:45 cancer information service CIS CIS:4|Cis:1 carcinoma in situ testis CIS CIS:5 cellular injury score CIS CIS:5 chronic immobilization stress CIS CIS:32 clinical interview schedule CIS CIS:12 commonwealth of independent states CIS CIS:11 continuous interleaved sampler CIS CIS:41 continuous interleaved sampling CIS CIS:5 critical incident stress CIS CIS:10 cytokineinducible shcontaining protein CIS CIS:5|Cis:1 cytokineinducible sh protein CIV CIV:25 chilo iridescent virus CIV CIV:12|C-IV:5 collagen iv CIV CIV:16|C-IV:8 collagen type iv CIV CIV:10 continuous intravenous CIN CIN:12 cefsulodinirgasannovobiocin CIN CIN:5 cervical intraepithelial lesions CIN CIN:70 chromosomal instability CIN CIN:14 chromosome instability CIN CIN:12 chronic idiopathic neutropenia CIN CIN:23 contrastinduced nephropathy CI CI:11 confidence internal CI CI:12 confidence limits CI CI:8 carbonyl iron CI CI:9 cationindependent CI CI:7 cerebral infarct CI CI:6 cervical incompetence CI CI:8 chemical intolerance CI CI:10 chilling injury CI CI:9 chronotropic incompetence CI CI:24 cochlear implantation CI CI:12 cold ischemia CI CI:11 colloidal iron CI CI:9 conditioned inhibition CI CI:7 configuration interaction CI CI:10 constraintinduced CI CI:5 continuous improvement CI CI:12 conventional imaging CI CI:14 convergence insufficiency CI CI:14 cumulative incidence CI CI:12 cylindrical inclusion CI CI:7 cytoplasmic inclusion CI CI:70 cytoplasmic incompatibility Ci Ci:6 intercellular co concentration Ci Ci:15|CI:1 transcription factor cubitus interruptus CK-BB CK-BB:23|CKBB:7 creatine kinase bb CK-BB CK-BB:14|CKBB:1 creatine kinase bb isoenzyme CK-BB CK-BB:20 creatine kinase isoenzyme bb CK-MB CK-MB:37|CKMB:11 creatine kinase isoenzyme mb CK-MB CKMB:3|CK-MB:3 creatine kinase mb fraction CK-MB CK-MB:35|CKMB:4 creatine kinase mb isoenzyme CK-MB CK-MB:5|CKMB:1 isoenzyme of ck CKs CKs:131|Cks:10 cytokeratins CKs CKs:8|Cks:3 cytokinins CK CK:11 anticytokeratin CK CK:6 casein kinases CK CK:11 chick kidney CK CK:11 chicken kidney CK CK:14 color kinesis CK CK:3|C-K:2 compound k CK CK:18 conductive keratoplasty CK CK:35 creatine kinase activity CK CK:12 creatinkinase CK CK:13|ck:1 expression of cytokeratins CK CK:10 serum creatinekinase CLA CLA:14 caseous lymphadenitis CLA CLA:6|cla:1 cationic leukocyte antigen CLA CLA:13 common leukocyte antigen CLA CLA:6 cutaneous lymphocyte ag CLA CLA:39 cutaneous lymphocyte antigen CLA CLA:7 cutaneous lymphocyteassociated ag CLA CLA:78 cutaneous lymphocyteassociated antigen CLC CLC:12|cLC:2 capillary liquid chromatography CLC CLC:11 cardiotrophinlike cytokine CLD CLD:11 central lung distance CLD CLD:367 chronic lung disease CLD CLD:22 chronic lung disease of prematurity CLD CLD:14 congenital chloride diarrhea CLH CLH:13 chronic lobular hepatitis CLH CLH:11 cutaneous lymphoid hyperplasia CLIA CLIA:6 chemiluminescent assay CLIA CLIA:22 chemiluminescent immunoassay CLIA CLIA:11 clinical laboratory improvement amendments CLIA CLIA:28 clinical laboratory improvement amendments of CLIP CLIP:21 cancer of the liver italian program CLIP CLIP:26 corticotropinlike intermediate lobe peptide CLL CLL:9 chronic lymphocytic CLL CLL:5 chronic lymphocytic leukemia cells CLL CLL:14 chronic lymphocytic leukemic CLM CLM:8 colorectal liver metastases CLM CLM:17 cutaneous larva migrans CLO CLO:25 cod liver oil CLO CLO:10 oesophagus CLO CLO:7 rapid urease CLPs CLPs:6 ctype lectinlike proteins CLPs CLPs:12 common lymphoid progenitors CLPs CLPs:20 corelike particles CLSM CLSM:91|cLSM:1 confocal laser scanning microscope CLSM CLSM:491|cLSM:3 confocal laser scanning microscopy CLS CLS:12 capillary leak syndrome CLS CLS:9 classical leastsquares CLS CLS:29 clinical laboratory science CLS CLS:36 coffinlowry syndrome CLs CLs:16 contact lenses CLs CLs:25 cycle lengths CLZ CLZ:13 chlorozotocin CLZ CLZ:40 clozapine CLP CLP:48 cecal ligation and perforation CLP CLP:11 cecal ligationpuncture CLP CLP:120|clp:1 cleft lip and palate CLP CLP:2 cleft lip or cleft palate CLP CLP:8 coactosinlike protein CLP CLP:12 cytotoxic lymphocyte precursors CLP CLP:5 human calmodulinlike protein Cl Cl:111|CL:1 confidence interval CL CL:268 cardiolipin CL CL:17 cathodoluminescence CL CL:18|cl:3 central lateral CL CL:26 central lateral nucleus CL CL:18|Cl:1 centralis lateralis CL CL:1262|Cl:6|cl:1 chemiluminescence CL CL:7 chemiluminescence response CL CL:64 chemiluminescent CL CL:12 chemoluminescence CL CL:5 chromosome loss Cl Cl:13|CL:12 clearances CL CL:13|Cl:8 clearance rate CL CL:50 cleft lip CL CL:6 confidence level CL CL:11 contralateral CL CL:7 control line CL CL:16 coriaria lactone CL CL:594|Cl:1 corpus luteum CL CL:10 crithidia luciliae CL CL:193 cutaneous leishmaniasis CL CL:18 epsiloncaprolactone CL CL:9 liver CL CL:46|Cl:5 lung compliance CL CL:13 lymph CL CL:5|Cl:1 lymph protein concentration CL CL:6 patients with cholelithiasis CL CL:27|Cl:21|-Cl:1 total plasma clearance CMA CMA:6 canadian medical association CMA CMA:28 chronic metabolic acidosis CMA CMA:18 cingulate motor area CMA CMA:7 coronamic acid CMA CMA:15 cortical masticatory area CMA CMA:9 corticomedial amygdala CMA CMA:75 cows milk allergy CMA CMA:9 mesenteric artery CMB CMB:20 chemical mass balance CMB CMB:19 cosmic microwave background CMCase CMCase:17 carboxymethyl cellulase CMCase CMCase:27|CMC-ase:1 carboxymethylcellulase CMC CMC:52 carpometacarpal CMC CMC:8 cellmediated cytolysis CMC CMC:19 closed mitral commissurotomy CMC CMC:9 computermediated communication CMD CMD:13 cassava mosaic disease CMD CMD:24 cefamandole CMD CMD:17 common mental disorders CMD CMD:13 corticomedullary differentiation CMD CMD:16 craniomandibular disorder CMD CMD:27 craniomandibular dysfunction CMD CMD:17 craniometaphyseal dysplasia CMD CMD:11 signs and symptoms of craniomandibular disorders CME CME:10 chemically modified electrode CME CME:409 continuing medical education CME CME:183 cystoid macular edema CMF CMF:24 chondromyxoid fibroma CMF CMF:9 conditioned medium factor CMF CMF:20 constant magnetic field CMF CMF:8 cows milk formula CMG CMG:9 carboxymethylglucan CMG CMG:22 cystometrogram CMG CMG:9 cystometrography CMG CMG:18 cystometry CMH CMH:13 ceramide monohexoside CMH CMH:8 community mental health CMI CMI:149 cellmediated immune CMI CMI:9 chronic mental illness CMI CMI:10 chronic mesenteric ischemia CMI CMI:48 cornell medical index CMI CMI:7 cows milk intolerance CMI CMI:16 craniomandibular index CML-BC CML-BC:5|CMLbc:1 chronic myelogenous leukemia CML-BC CML-BC:11 chronic myelogenous leukemia in blast crisis CML-BC CML-BC:9|CMLBC:1 chronic myeloid leukemia in blast crisis CML CML:38 carboxymethyllysine CML CML:17 cellmediated lymphocytotoxicity CML CML:12 cellmediated lysis CML CML:215 chronic myelogenous leukaemia CML CML:527 chronic myeloid leukaemia CML CML:11 chronic myeloid leukemic CML CML:8 mediated lysis CML CML:11 n epsiloncarboxymethyllysine CML CML:27 nepsiloncarboxymethyllysine CMM CMM:5 color mmode CMM CMM:14 crossmodality matching CMM CMM:162 cutaneous malignant melanoma CMN CMN:6 caudal mediastinal lymph node CMN CMN:5 caudal mediastinal node CMN CMN:19 congenital melanocytic nevi CMN CMN:54 congenital mesoblastic nephroma CMO CMO:7|Cmo:1 choline monooxygenase CMO CMO:21 cystoid macular oedema CMP CMP:23 cartilage matrix protein CMP CMP:12 caseinomacropeptide CMP CMP:7 chemical mechanical polishing CMP CMP:7 dynamic cardiomyoplasty CMRglc CMRglc:8 cerebral glucose metabolic rate CMRglc CMRglc:10|CMRGlc:5 cerebral glucose metabolism CMRO2 CMRO2:15|CMRo2:1 cerebral metabolic rate CMRO2 CMRO2:7 cerebral oxygen metabolic rate CMRO2 CMRO2:5|CMRo2:1 cerebral oxygen uptake CMR CMR:6 caffeine metabolic ratio CMR CMR:5 calculated maximal response CMR CMR:22 cardiac magnetic resonance CMR CMR:86 cardiovascular magnetic resonance CMR CMR:5 cellophane macular reflex CMR CMR:63 comodulation masking release CMR CMR:17 contact microradiography CMR CMR:6 crude mortality rate CMs CMs:20 cavernous malformations CMS CMS:46 centers for medicare and medicaid services CMS CMS:21 centers for medicaremedicaid services CMS CMS:19 cervical magnetic stimulation CMS CMS:53 chronic mild stress CMS CMS:29 chronic mountain sickness CMs CMs:12 chylomicrons CMs CMs:15 cochlear microphonics CMS CMS:7 cystadenoma with mesenchymal stroma CMS CMS:72|cms:6 cytoplasmic male sterility CMS CMS:9 solubilization CMT1A CMT1A:75|CMT1a:4|CMT-1A:2 charcotmarietooth disease type a CMT1A CMT1A:23|CMT-1A:1 charcotmarietooth type a CMTC CMTC:31 cutis marmorata telangiectatica congenita CMTC CMTC:13 cytoplasmic microtubule complex CMT CMT:37 california mastitis test CMT CMT:156 charcotmarietooth CMT CMT:14 choline magnesium trisalicylate CMT CMT:11 combined modality treatment CMT CMT:14 congenital muscular torticollis CMT CMT:6 crossmodal transfer CMV CMV:46 anticytomegalovirus CMV CMV:151 conventional mechanical ventilation CMV CMV:21 cucumber mosaic cucumovirus CMV CMV:226 cucumber mosaic virus CMV CMV:22 cytomegaloviral CMV CMV:21 cytomegalovirus infection CMZ CMZ:136 cefmetazole CMZ CMZ:10 ciliary marginal zone CMZ CMZ:11 clomethiazole CM CM:14 canola meal CM CM:16 carbomedics CM CM:28 carboxymethyl CM CM:6 cardiac mucosa CM CM:9 cardiac myosin CM CM:10 cardiomyocyte CM CM:46 cardiomyopathic CM CM:9|Cm:2 cell membrane CM CM:48 center of mass CM CM:12 centromedian CM CM:7 centromedian nucleus CM CM:23 centrum medianum CM CM:108 cerebral malaria CM CM:54 cervical mucus CM CM:12 chiari malformation CM CM:12|C-M:4 chloroformmethanol CM CM:16 chorismate mutase CM CM:15 chronic migraine CM CM:27 ciliary muscle CM CM:13 clinical mastitis CM CM:6 common migraine CM CM:27 complementary medicine CM CM:10 complete hydatidiform mole CM CM:7 complete mole CM CM:20 congenital malformations CM CM:9 consistent mapping CM CM:21 contingency management CM CM:9|cm:2 contrast material CM CM:31 corticomotoneuronal CM CM:51 cows milk CM CM:18 cryptococcal meningitis CM CM:7 culture material CM CM:45 cutaneous melanoma CM CM:6 cytokine mixture CM CM:23 cytoplasmic membrane CM CM:6 media conditioned CM CM:10|-CM:1 medium conditioned CM CM:23|Cm:1|cm:1 membranes CM CM:6 neonatal rat cardiac myocytes CM CM:5 neonatal rat cardiomyocytes CM CM:13 vivo confocal microscopy CNAP CNAP:23 compound nerve action potential CNAP CNAP:9 continuous negative airway pressure CNAs CNAs:29|CNAS:1 certified nursing assistants CNAs CNAs:9 copy number aberrations CNAs CNAs:9 copy number alterations CNA CNA:7 canadian nurses association CNA CNA:3|cna:3 collagen adhesin CNL CNL:9 chronic neutrophilic leukaemia CNL CNL:50 chronic neutrophilic leukemia CNM CNM:11 cat nictitating membrane CNM CNM:14 centronuclear myopathy CNM CNM:9 congenital nemaline myopathy CNP CNP:16 chlornitrofen CNP CNP:12|cnp:1 continuous negative pressure CNP CNP:15 nucleotide phosphodiesterase CNQX CNQX:6 cyanonitroquinoxaline dione CNQX CNQX:5 antagonist cyanonitroquinoxalinedione CNSHA CNSHA:9 chronic nonspherocytic hemolytic anemia CNSHA CNSHA:10 haemolytic anaemia CNSs CNSs:81 clinical nurse specialists CNSs CNSs:8 conserved noncoding sequences CNS CNS:19 canadian neurological scale CNS CNS:13 central nervous CNS CNS:27 congenital nephrotic syndrome CNV CNV:72 choroidal neovascularisation CNV CNV:547 choroidal neovascularization CNV CNV:22 cucumber necrosis virus CN CN:12 chloroacetophenone CN CN:13 caudate nuclei CN CN:11 cavernous nerve CN CN:15 cerebellar nuclei CN CN:9 cochlear nerve CN CN:8 cochlear nuclear complex CN CN:22 cochlear nuclei CN CN:138 cochlear nucleus CN CN:8 cognitively normal CN CN:13 congenital neutropenia CN CN:68 congenital nystagmus CN CN:9 contrast nephropathy CN CN:10 coordination number CN CN:9 criglernajjar CN CN:13 cyanopropyl CN CN:24 cyclic neutropenia CN CN:12 cyclic nucleotides CN CN:13 necrosis cob cob:16|COB:7 apocytochrome b cob cob:9 cobalamin biosynthetic COC COC:38 calcifying odontogenic cyst COC COC:9 continuity of care COD COD:31 calcium oxalate dihydrate COD COD:413 chemical oxygen demand COD COD:12 cystic ovarian disease COH COH:9|CoH:1 coefficient of haze COH COH:23 compensatory ovarian hypertrophy COH COH:212 controlled ovarian hyperstimulation COH COH:22|CoH:1|Coh:1 coumarin hydroxylase COL7A1 COL7A1:5 gene encoding type vii collagen COL7A1 COL7A1:81|Col7a1:3 type vii collagen gene COMT COMT:5 catecholomethyltransferase gene COMT COMT:9 catecholamineomethyltransferase COM COM:151 calcium oxalate monohydrate COM COM:15|CoM:10 centre of mass COM COM:57 chronic otitis media COPp COPp:6|COPP:1 colloid osmotic pressure in plasma COPp COPp:7|COPP:1 plasma colloid osmotic pressure COP COP:19|CoP:1 centerofpressure COP COP:18 circumoval precipitin COP COP:23|Cop:15 copenhagen COP COP:18 cryptogenic organizing pneumonia COR COR:10 center of rotation COR COR:28 cervicoocular reflex COR COR:6|cor:3 coldregulated COR COR:15 phytotoxin coronatine COSY COSY:6 twodimensional correlated COSY COSY:15 twodimensional correlated spectroscopy COS COS:21 carbonyl sulfide COS COS:27 childhoodonset schizophrenia cos cos:10 cohesive ends cos cos:8 cohesive end site COS COS:18 controlled ovarian stimulation COX-2 COX-2:4|Cox-2:1 cox isoform COX-2 COX-2:8 cyclooxygenase ii COX-2 COX-2:16|Cox-2:2 cycloxygenase COX-2 COX-2:13 inducible cox COI COI:6 cardiac output index COI COI:5 cytochrome c oxidase subunit COI COI:5 cytochrome c oxidase subunit i gene COI COI:62 cytochrome oxidase i COI COI:10 cytochrome oxidase i gene CO CO:12 centric occlusion CO CO:9|co:1 childhoodonset CO CO:23 cholesteryl oleate CO CO:27|Co:1 coconut oil CO CO:32|co:1 constans CO CO:203|Co:3 corn oil CO CO:20 coronary occlusion CPAP CPAP:1239|C-PAP:2 continuous positive airway pressure CPAP CPAP:5 continuous positive airway pressure breathing CPA CPA:28 cardiopulmonary arrest CPA CPA:12 care programme approach CPA CPA:9 carotid phonoangiography CPA CPA:13 caudal pressor area CPA CPA:200|cpa:2 cerebellopontine angle CPA CPA:17 circulating platelet aggregates CPA CPA:35 conditioned place aversion CPA CPA:8 corneal polarization axis CPA CPA:13 cryoprotective agent CPA CPA:327 cyclopiazonic acid CPA CPA:7 ncyclopentyl adenosine CPA CPA:13 physical abuse CPA CPA:5 receptor agonist cyclopentyladenosine CPB CPB:22|CpB:8 carboxypeptidase b CPB CPB:9 cardiopulmonary bypass surgery CPB CPB:6 cetylpyridinium bromide CPB CPB:13 colorado potato beetle CPB CPB:19 competitive protein binding CPB CPB:10 plexus block cPCR cPCR:14|C-PCR:4|CPCR:1 competitive pcr cPCR cPCR:15|C-PCR:2|c-PCR:2|CPCR:1 competitive polymerase chain reaction CPCs CPCs:14 calcium phosphate cements CPCs CPCs:6 choroid plexus carcinomas CPC CPC:11 calcium phosphate ceramic CPC CPC:8 capsular polysaccharide complex CPC CPC:15 cephalosporin c CPC CPC:134 cetylpyridinium chloride CPC CPC:8 chest pain center CPC CPC:9 chronic persistent cough CPC CPC:11 circulating progenitor cells CPC CPC:9 coil planet centrifuge CPC CPC:10 cyclophotocoagulation CPD CPD:16 carboxypeptidase d CPD CPD:33 cephalopelvic disproportion CPD CPD:88 chronic peritoneal dialysis CPD CPD:11 chronic pulmonary disease CPD CPD:53 citratephosphatedextrose CPD CPD:11 color pixel density CPD CPD:53 continuing professional development CPD CPD:19 critical point drying CPD CPD:14|cPD:1 cumulative population doublings CPE CPE:31 carbon paste electrode CPE CPE:93|Cpe:4|CpE:2 carboxypeptidase e CPE CPE:15 cardiogenic pulmonary edema CPE CPE:23 chronic pulmonary emphysema CPE CPE:18 clinical pastoral education CPE CPE:46 clostridium perfringens enterotoxin CPE CPE:7 cloudpoint extraction CPE CPE:28 continuing professional education CPE CPE:30 cytoplasmic polyadenylation element CPF CPF:6 cleavage and polyadenylation factor CPF CPF:5 coronary perfusion flow CPGs CPGs:39 central pattern generators CPGs CPGs:102 clinical practice guidelines CPG CPG:174 central pattern generator CPG CPG:18 choline phosphoglycerides CpG CpG:9 cpg motifs CpG CpG:14 cytosinephosphateguanosine CpG CpG:18 dinucleotide CPH CPH:14|CP-H:1 carboxypeptidase h CPH CPH:9 centrophenoxine CPH CPH:45 chronic paroxysmal hemicrania CPH CPH:151|CpH:1 chronic persistent hepatitis CPH CPH:7 chronic pulmonary hypertension CPIB CPIB:15 clofibric acid CPIB CPIB:5 effect of pchlorophenoxyisobutyrate CPI CPI:61 california psychological inventory CPI CPI:8 carboxypeptidase inhibitor CPI CPI:6 chronic placental insufficiency CPI CPI:13 clinical practice improvement CPI CPI:17 community periodontal index CPI CPI:11 cyclopropylpyrroloindole CPK CPK:9 cell proliferation kinetics CPK CPK:9 creatine phosphate kinase CPK CPK:10 creatinephosphokinase CPK CPK:14 phosphokinase activity CPMS CPMS:9|CP-MS:2 chronic progressive ms CPMS CPMS:8|CP-MS:1 chronic progressive multiple sclerosis CPM CPM:17 carboxypeptidase m CPM CPM:47 cefpiramide CPM CPM:115 central pontine myelinolysis CPM CPM:30 chlorpheniramine maleate CPM CPM:47 confined placental mosaicism CPM CPM:102 continuous passive motion cpm cpm:66|CPM:20 counts per minute CPM CPM:8 critical path method cpm cpm:4 percentage of normal cyclesmin CPN CPN:22|CpN:1 carboxypeptidase n CPN CPN:15 caudateputamen nucleus CPN CPN:30 common peroneal nerve CPN CPN:18 community psychiatric nurse CPOE CPOE:49 computerized physician order entry CPOE CPOE:15 computerized provider order entry CPON CPON:5|C-PON:1|c-PON:1 cterminal flanking peptide of neuropeptide y CPON CPON:6|C-PON:1 cterminal flanking peptide of npy CPO CPO:39|Cpo:1 chloroperoxidase CPO CPO:11 chlorpyrifos oxon CPO CPO:16|cpo:1 coproporphyrinogen oxidase CPPD CPPD:254 calcium pyrophosphate dihydrate CPPD CPPD:8 calcium pyrophosphate dihydrate deposition disease CPPV CPPV:40 continuous positive pressure ventilation CPPV CPPV:9 contralateral patent processus vaginalis CPPs CPPs:23 cellpenetrating peptides CPPs CPPs:15 choroid plexus papillomas CPPs CPPs:15 chronic pain patients CPP CPP:10 calcium polyphosphate CPP CPP:24 casein phosphopeptides CPP CPP:103 central precocious puberty CPP CPP:27 choroid plexus papilloma CPP CPP:58 chronic pelvic pain CPP CPP:16 collaborative perinatal project CPP CPP:357 conditioned place preference CPP CPP:14 cyclopentacdpyrene CPP CPP:10 perfusion pressures CPRS CPRS:76 comprehensive psychopathological rating scale CPRS CPRS:8 computerized patient record system CPR CPR:54 cpeptide immunoreactivity CPR CPR:10 cpeptide reactivity CPR CPR:8 carboxypeptidase r CPR CPR:1539 cardiopulmonary resuscitation CPR CPR:40 cefpirome CPR CPR:10 cefpirome sulfate CPR CPR:7 clinical pregnancy rate CPR CPR:51 computerbased patient record CPR CPR:19 computerized patient record CPR CPR:26 contraceptive prevalence rate CPR CPR:8 cortisol production rate CPR CPR:9 cumulative pregnancy rate CPR CPR:6 cytochrome p oxidoreductase cPSA cPSA:12|CPSA:1 complexed prostatespecific antigen cPSA cPSA:29|C-PSA:1 complexed psa CPSI CPSI:6|CpsI:1 carbamyl phosphate synthetase i CPSI CPSI:11 chronic prostatitis symptom index CPT-11 CPT-11:21|CPT11:1 ethylpiperidinopiperidinocarbonyloxycamptothecin CPT-11 CPT-11:86 irinotecan hydrochloride CPT CPT:5 a receptor antagonist cyclopentyltheophylline CPT CPT:355|Cpt:5|cpt:1 camptothecin CPT CPT:27 carnitine palmitoyl transferase CPT CPT:10 carnitine palmityl transferase CPT CPT:11 carnitine palmityltransferase CPT CPT:7 chest physical therapy CPT CPT:22 chest physiotherapy CPT CPT:13 choline phosphotransferase CPT CPT:24|cpt:1 cholinephosphotransferase CPT CPT:159 cold pressor test CPT CPT:12 cold pressor testing CPT CPT:7 congenital pseudarthrosis of the tibia CPT CPT:12 conjunctival provocation tests CPT CPT:50 continuous performance task CPT CPT:179 continuous performance test CPT CPT:48 current perception threshold CPT CPT:60 current procedural terminology CPT CPT:13 cycling probe technology CPT CPT:9 receptor antagonist cyclopentyldimethylxanthine CPU CPU:17 central processing unit CPU CPU:8 chest pain unit CPV CPV:217 canine parvovirus CPV CPV:32 cytoplasmic polyhedrosis virus CPV CPV:20 plasma volume CPX CPX:9 dipropylcyclopentylxanthine CPX CPX:7 antagonist cyclopentyldipropylxanthine CPZ CPZ:5 antagonist capsazepine CPZ CPZ:8 carboxypeptidase z CPZ CPZ:150 cefoperazone CPZ CPZ:19|cpz:1 chlorpromazine hydrochloride CP CP:4|C-p:2|Cp:2|C-P:1 c peptide Cp Cp:11 c promoter Cp CP:8|Cp:8 caeruloplasmin CP CP:46|Cp:6 campylobacter pylori CP CP:9|Cp:2 campylobacter pyloridis CP CP:9 canal paresis CP CP:42 cancer procoagulant CP CP:53 capsular polysaccharide CP CP:18 carbamide peroxide C-P C-P:12 carbonphosphorus CP CP:7 carbopol p CP CP:11 carboxypeptidase CP CP:22|Cp:1 cardioplegia CP CP:19|C-P:2 cardiopulmonary CP CP:9 categorical perception CP CP:10 cationic proteins CP CP:5 cellulose powder CP CP:21 center of pressure cp cp:13|cP:10|Cp:1|CP:1 centipoise CP CP:18 centre of pressure CP CP:16 centrifugal pump CP CP:35|C-P:2|c-p:1 cerebellopontine CP CP:762|cp:2 cerebral palsy CP CP:21 cerebral peduncle CP CP:26 chest pain C-P CP:4|C-P:4 childpugh CP CP:10 chloropicrin cp cp:45|Cp:4 chloroplast CP CP:27 chlorphentermine CP CP:12|Cp:1 chlorpropamide CP CP:6 cholestasis of pregnancy CP CP:13 chronic pain CP CP:317|cP:6 chronic pancreatitis CP CP:49 chronic periodontitis CP CP:130 chronic phase CP CP:17 chronic progressive CP CP:21 chronic prostatitis CP CP:78 cicatricial pemphigoid CP CP:5 ciliary processes CP CP:13 classical CP CP:40 classical pathway CP CP:168 cleft palate CP CP:9|Cp:1 clobetasol propionate Cp Cp:10 clostridium pasteurianum CP CP:12|Cp:4 clostridium perfringens CP CP:485|cp:9|Cp:1 coat protein CP CP:6 coat protein gene cp cp:13|CP:1 coldpassaged CP CP:13 cold pressor CP CP:19 common peroneal CP CP:35 constrictive pericarditis CP CP:8 control patients CP CP:15 cor pulmonale CP CP:11 core particle CP CP:38|cp:4 cortical plate CP CP:17 cricopharyngeal CP CP:14 cricopharyngeus CP CP:29 critical power CP CP:260 crude protein CP CP:10 cryopreserved Cp Cp:12|cp:1 cyclopentadienyl CP CP:9 cyclophosphane CP CP:15 cysteine proteinase cp cp:27|CP:23 cytopathic cp cp:40|CP:12 cytopathogenic CP CP:9|Cp:1 polymer CQ CQ:20 camphorquinone CQ CQ:62 carboquone CQ CQ:7 closed quotient CR/XL CR/XL:7 metoprolol controlled releaseextended release CR/XL CR/XL:7 metoprolol succinate controlled releaseextended release CR1 CR1:33 complement receptor CR1 CR1:11 complement receptor type one CR1 CR1:62|CR-1:1 first complete remission CR1 CR1:17|CR-1:1 first remission CR2 CR2:17 cd receptor CR2 CR2:23 second complete remission CR2 CR2:9 second remission CR3 CR3:13 cbi receptor CR3 CR3:11 complement receptor type three CR3 CR3:6 complement type receptors CR3 CR3:13 icb receptor CR3 CR3:9 type complement receptor CRAds CRAds:7|CRADs:4 conditionally replicating adenoviruses CRAds CRAds:15 conditionally replicative adenoviruses CRA CRA:11 cardiorespiratory arrest CRA CRA:6 caregiver reaction assessment CRA CRA:10 community reinforcement approach CRA CRA:6 comparative risk assessment CRBPII CRBPII:7|CRBP-II:1 cellular retinol binding protein ii CRBPII CRBPII:4 cellular retinolbinding protein type ii CRCs CRCs:63 colorectal cancers CRCs CRCs:28 colorectal carcinomas CRCs CRCs:23 concentrationresponse curves CRC CRC:21 calcium release channel CRC CRC:12 cerebrovascular reserve capacity CRC CRC:12 colorectal adenocarcinoma CRC CRC:6 red cells CRC CRC:12 research center CRD CRD:18|CrD:1 colorectal distention CRD CRD:22 conerod dystrophy CRD CRD:16 crossreacting determinant CRD CRD:41 cysteinerich domain CREAE CREAE:5|CR-EAE:4|cr-EAE:1 chronic relapsing eae CREAE CREAE:29|CR-EAE:19|Cr-EAE:2|crEAE:2|cr-EAE:1 chronic relapsing experimental allergic encephalomyelitis CREB CREB:202 camp response element binding protein CREB CREB:44 element binding CREB CREB:11 response elementbinding CREB CREB:5 response element binding factor CREM CREM:24|crem:1 camp response element modulator CREM CREM:18 campresponsive element modulator CREM CREM:6 modulator protein CRE CRE:10 campresponsive elements CRE CRE:28 cumulative radiation effect CRE CRE:9 cyclic amp response elements CRF-R CRF-R:5|CRFR:2 corticotropinreleasing factor receptor CRF-R CRF-R:6|CRFR:5 crf receptor CRFs CRFs:9 case report forms CRFs CRFs:20 circulating recombinant forms CRF CRF:19 cancerrelated fatigue CRF CRF:17 cardiorespiratory fitness CRF CRF:27|crf:1|cRF:1 classical receptive field CRF CRF:33 continuous reinforcement CRF CRF:14 continuously reinforced CRF CRF:16 corticoliberin CRI CRI:5 cardiac risk index CRI CRI:9 chronic renal impairment CRI CRI:232 chronic renal insufficiency CRI CRI:7 crossreactive idiotope CRM CRM:14 circumferential resection margin CRM CRM:25 continual reassessment method CRM CRM:46 crossreacting material CRM CRM:22 resource management CRs CRs:10 cancer registries CRS CRS:31 catheterrelated sepsis CRS CRS:80 chronic rhinosinusitis CRS CRS:1 cold and restraint stress CRS CRS:10 coldrestraint stress CRs CRs:55|CRS:1 complete remissions Crs Crs:33|CRS:13 compliance of the respiratory system CRs CRs:115|CRS:2|Crs:1 conditioned responses CRS CRS:111 congenital rubella syndrome CRs CRs:9 conserved regions CRS CRS:5 cytoplasmic retention signal CRS CRS:16 risk score Crs Crs:11 total respiratory compliance CRT CRT:154 cardiac resynchronization therapy CRT CRT:25 conformal radiotherapy CRT CRT:9 cortisoneresistant thymocytes CRT CRT:11 cranial radiation CRT CRT:8 preoperative chemoradiation CRT CRT:5 prophylactic cranial radiotherapy CRVO CRVO:12 central retinal vein obstruction CRVO CRVO:211 central retinal vein occlusion CR CR:41|C-R:5 cajalretzius CR CR:16 calciumbinding protein calretinin CR CR:205 caloric restriction CR CR:12 calorierestricted CR CR:76 calorie restriction CR CR:10 capturerecapture CR CR:91 cardiac rehabilitation CR CR:7 cardiac rupture CR CR:8|C-R:1|cr:1 cardiorespiratory CR CR:12 cariesresistant CR CR:28 centric relation CR CR:9 charge recombination CR CR:11 charles river CR CR:96 chronic rejection CR CR:29 circadian rhythm CR CR:13 cockroach CR CR:7 cognitive reserve CR CR:20 colonization resistance CR CR:129 complete CR CR:26 complete regression CR CR:14 complete remission rate CR CR:19 complete response rate CR CR:9 completely CR CR:8 composite resin CR CR:12|Cr:1 compression ratio CR CR:10 computed radiographic CR CR:221 computed radiography CR CR:6|C-R:4|cr:3|c-r:1 concentrationresponse CR CR:7 conditioned reinforcement CR CR:10 conditioned reward CR CR:42 congo red CR CR:8 constant routine CR CR:11 contractile reserve CR CR:8 conventional radiology CR CR:8 coronary risk CR CR:6 cortical reaction CR CR:9 corticosteroidresistant Cr Cr:22 creatine and phosphocreatine CR CR:9 crossreactive CR CR:18|C-R:6|c-r:1 crownrump C-R C-R:6|CR:4 crownrump length CR CR:10 cysteinerich CR CR:21 czech republic Cr Cr:8|CR:2 energy cost of running C-R C-R:8 followed by min of running CR CR:15 reactivity CR CR:9 remodeling CS- CS-:7 ignore a different tone CS- CS-:28 stimulus CS/DS CS/DS:11 chondroitindermatan sulfate CS/DS CS/DS:8 chondroitin sulfatedermatan sulfate CSA CSA:9 canadian standards association CSA CSA:17 catalyzed signal amplification CSA CSA:4 cell surface antigens CSA CSA:29 central sleep apnea CSA CSA:11 central sleep apnoea CSA CSA:51|csa:1 chemical shift anisotropy CSA CSA:15 chicken serum albumin CSA CSA:126 childhood sexual abuse CSA CSA:8|CS-A:3 chondroitinsulfate CSA CSA:12 chronic stable angina CSA CSA:13 clinical skills assessment CSA CSA:7 colonspecific antigen CSA CSA:22 compressed spectral array CSA CSA:6 computer science and applications CSA CSA:11 conformational space annealing CSA CSA:11 continuous spinal anaesthesia CSA CSA:17 continuous spinal anesthesia CSA CSA:13 controlled substances act CSA CSA:20 coronary spastic angina CSA CSA:15 cysteine sulfinic acid CSC CSC:9 antagonist chlorostyrylcaffeine CSC CSC:97 cigarette smoke condensate CSC CSC:6 circulating stem cells CSC CSC:7 correctional service of canada CSC CSC:35 cryogen spray cooling CSD CSD:26 cambridge structural database CSD CSD:13 cardiac support device CSD CSD:8 carotid sinus denervation CSD CSD:7 cervical spine disorders CSD CSD:18 conditioned suppression of drinking CSD CSD:156 cortical spreading depression CSD CSD:5 current source density analysis CSD CSD:22 cysteine sulfinate decarboxylase CSD CSD:10 distribution CSE CSE:8 combined spinalepidural anesthesia CSE CSE:9 conventional se CSE CSE:11 convulsive status epilepticus CSE CSE:9 crosssectional echocardiography CSE CSE:9 cystathionine gammalyase CSF CSF:38 cerebrospinal CSF CSF:10 cerebrospinal fluid samples CSF CSF:152 classical swine fever CSF CSF:7 colonystimulating factors CSF CSF:18 coronary sinus flow CSF CSF:63 cytostatic factor CSH CSH:20 carotid sinus hypersensitivity CSH CSH:32 cell surface hydrophobicity CSH CSH:9 chronic severe hepatitis CSI CSI:14 cervical spine injury CSI CSI:85 chemical shift imaging CSI CSI:53 cholesterol saturation index CSI CSI:6 chromosaponin i CSI CSI:4|CS-I:2 clinical stage i CSI CSI:15 continuous subcutaneous infusion CSI CSI:32 craniospinal irradiation CSI CSI:6 salvia injection CSK CSK:10|Csk:1 cytoskeletal CSK CSK:32 cytoskeleton CSLM CSLM:11 confocal scanning laser microscope CSLM CSLM:74 confocal scanning laser microscopy CSL CSL:13 cerebellar soluble lectin CSL CSL:17 corn steep liquor CSM CSM:27 carotid sinus massage CSM CSM:68 cervical spondylotic myelopathy CSM CSM:19 committee on safety of medicines CSM CSM:17 contraceptive social marketing CSM CSM:36 cottonseed meal CSN CSN:15 carotid sinus CSN CSN:49 cop signalosome CSN CSN:8 corticospinal neurons CSO CSO:6 clarified slurry oil CSO CSO:5 statistical office CSPs CSPs:106 chiral stationary phases CSPs CSPs:11|Csps:7|csps:2 cold shock proteins CSPs CSPs:11|csps:6|Csps:5 cysteine string proteins CSP CSP:47 carotid sinus pressure CSP CSP:33 cavum septi pellucidi CSP CSP:13 cavum septum pellucidum CSP CSP:7 community support program CSP CSP:19 competencestimulating peptide CSP CSP:7 cooperative studies program CSP CSP:5|csp:4 corpus spongiosum penis CSP CSP:23|csp:8|Csp:3 cysteine string protein CSP CSP:8 cystosarcoma phyllodes CSR CSR:25|csr:1 central serous retinopathy CSR CSR:51 cheynestokes respiration CSR CSR:109 class switch recombination CSR CSR:11 combat stress reaction CSR CSR:19 cumulative survival rate CSS CSS:6 canadian stroke scale CSS CSS:14 cancerspecific survival CSS CSS:14 chronic serum sickness CSS CSS:9 chronic sinusitis survey CSS CSS:159|CSs:1 churgstrauss syndrome CSs CSs:5 composite scores CSs CSs:18 conditional stimuli CSS CSS:16 constitutional short stature CSs CSs:15 corticosteroids CSS CSS:17 cultured skin substitutes Css Css:13 steady state Css Css:6 steadystate plasma levels CST CST:12 cavernous sinus thrombosis CST CST:15|Cst:1 cerebroside sulfotransferase CST CST:31 cervical sympathetic trunk CST CST:16 connected speech test CST CST:28 contraction stress test CST CST:115 corticospinal tract CST CST:18 cortistatin CST CST:14 skills training CST CST:11 stand trial Cst Cst:21|CST:2 static compliance Cst Cst:14 static lung compliance CSV CSV:7 canine saphenous vein CSV CSV:4 chick syncytial virus CSWS CSWS:17 cerebral salt wasting syndrome CSWS CSWS:10 continuous spikes and waves during slow sleep CS CS:14 chlorobenzylidene malonitrile CS CS:10 chlorobenzylidene malononitrile CS CS:47 calf serum CS CS:8 campaniform sensilla CS CS:10 carcinosarcoma CS CS:11 cardiac surgery CS CS:54 cardiogenic shock CS CS:6 carotid stenting CS CS:5|Cs:4 casein CS CS:52 cavernous sinus CS CS:11 celiac sprue CS CS:9 cell saver CS CS:15 central sulcus CS CS:12 cervical spondylosis CS CS:10 cervical stimulation CS CS:6 charge separation CS CS:19 chemical shift CS CS:20 chinese spring CS CS:34 cholesterol sulfate CS CS:85 chondroitin sulphate CS CS:13 chondrosarcoma CS CS:9 chorionic somatomammotropin CS CS:7 chromogenic substrate CS CS:23 chronic sinusitis CS CS:95 cigarette smoke CS CS:13 cigarette smoking CS CS:11 citrate synthetase CS CS:9 clinical score CS CS:9 clinical supervision CS CS:31 cold storage CS CS:14 cold stress CS CS:7 completed stroke CS CS:28 complex spike CS CS:16 compressive strength CS CS:13 conditioned CS CS:10 conditioning stimulation CS CS:10 conduction system CS CS:22 congenital syphilis CS CS:14 conscious sedation CS CS:28 conservative surgery CS CS:133 contact sensitivity CS CS:25|Cs:5 cordyceps sinensis CS CS:8 corn silage CS CS:5 cornsoybean meal diet CS CS:5 corn starch CS CS:7 coronal scaling CS CS:333|cs:7 coronary sinus CS CS:11 coronary stenosis CS CS:7 coronary stenting CS CS:42 corpus striatum CS CS:34 corpuscles of stannius CS CS:30 corticospinal CS CS:10 corticosteroidsensitive CS CS:15 cromolyn sodium CS CS:11|cs:1 current smokers CS CS:11 hb constant spring CS CS:12 light CS CS:27 ochlorobenzylidene malononitrile CS CS:4 patients with cerebral stroke CS CS:24 patients with cushings syndrome CS CS:57 plasma corticosterone CS CS:26 plasmodium falciparum circumsporozoite CS CS:10 saccharin CS CS:7|cs:4 sensitive CS CS:9 sequence CS CS:9 sites CS CS:10 steroids CS CS:16|cs:1 strain CTAP CTAP:32|CT-AP:4 computed tomography during arterial portography CTAP CTAP:69|CT-AP:1 ct during arterial portography CTAP CTAP:16 dphecystyrdtrpargthrpenthrnh CTAs CTAs:6 cancertestis antigens CTAs CTAs:15 conditioned taste aversions CTA CTA:10 cell transit analyzer CTA CTA:9 composite tissue allograft CTA CTA:6 computed tomographic angiographic CTA CTA:112 computed tomographic angiography CTA CTA:12|CT-A:1 computed tomographic arteriography CTA CTA:5 computed tomographic arthrography CTA CTA:60 computed tomography angiography CTA CTA:8 conditioned taste avoidance CTA CTA:11 cortical taste area CTA CTA:1 ct during arteriography CTA CTA:6 ct hepatic arteriography CTA CTA:5 task analysis CTB CTB:24|CTb:6|CT-B:3 cholera toxin b CTB CTB:14 cytotrophoblastic cells CTC CTC:23 cyanoditolyl tetrazolium chloride CTC CTC:43 chlorotetracycline CTC CTC:188|cTc:4 chlortetracycline CTC CTC:46 common toxicity criteria CTC CTC:14 computed tomographic colonography CTC CTC:9 computed tomography colonography CTC CTC:11 ct cisternography CTC CTC:17 ct colonography CTC CTC:17 cultured t cells CTDs CTDs:29 connective tissue diseases CTDs CTDs:26 cumulative trauma disorders CTD CTD:203|C-td:2 cterminal domain CTD CTD:8 connective tissue disorders CTE CTE:11 cterminal extension CTE CTE:14 chronic toxic encephalopathy CTE CTE:8 coefficient of thermal expansion CTE CTE:51 constitutive transport element CTF CTF:17|Ctf:1 cterminal fragment CTF CTF:9 central tegmental field CTF CTF:17 colorado tick fever CTF CTF:8 computed tomography fluoroscopy CTF CTF:7 contrast transfer function CTF CTF:7 ct fluoroscopy CTG CTG:28 cardiotocogram CTG CTG:22 cardiotocograph CTG CTG:17 cardiotocographic CTG CTG:69 cardiotocography CTG CTG:10 connective tissue graft CTG CTG:16 cytosinethymineguanine CTH CTH:16|CTh:1 ceramide trihexoside CTH CTH:6 chronic tension headache CTI CTI:9|CTi:1 cardiothoracic index CTI CTI:24 cavotricuspid isthmus CTLA-4 CTLA-4:43|CTLA4:5 cytotoxic t lymphocyteassociated antigen CTLA-4 CTLA-4:7 cytotoxic t lymphocyteassociated molecule CTL CTL:6 comet tail length CTL CTL:13 cytolytic tcell CTL CTL:290 cytolytic t lymphocytes CTM CTM:185 cefotiam CTM CTM:14 computed tomographic myelography CTM CTM:11|CT-M:2 ct myelography CTM CTM:10 trunci muscle CTPA CTPA:9|CT-PA:2 computed tomographic pulmonary angiography CTPA CTPA:14|CT-PA:1 ct pulmonary angiography CTPV CTPV:8 cavernous transformation of the portal vein CTPV CTPV:7 coal tar pitch volatiles CTP CTP:24 childturcottepugh CTP CTP:8 citrate transport protein CTP CTP:8 ct perfusion CTR CTR:20 capsular tension ring CTR CTR:58 cardiothoracic ratio CTR CTR:13 carpal tunnel release CTR CTR:20 connecticut tumor registry CTR CTR:11 cricotracheal resection CTR CTR:16|CT-R:1 ct receptor CTT CTT:48 cefotetan CTT CTT:30 colonic transit time CTT CTT:12 computerized transaxial tomography CTT CTT:8 computerized transmission tomography CTX CTX:20 cardiotoxin CTX CTX:224|Ctx:6|ctx:1 cefotaxime CTX CTX:160 cerebrotendinous xanthomatosis CTX CTX:17|CTx:1 chemotaxis CTX CTX:24 ciguatoxin CTX CTX:12 omegaconotoxin CTZ CTZ:15 chemoreceptor trigger zone CTZ CTZ:16 chlorothiazide CTZ CTZ:30 cyclothiazide cTnC cTnC:13|CTnC:2 cardiac tnc cTnC cTnC:58|CTnC:3|cTNC:1|C-TnC:1 cardiac troponin c CTS CTS:723|CTs:1|cts:1 carpal tunnel syndrome CTS CTS:12 cataract shionogi CTS CTS:9 central termination sequence CTs CTs:10 chromosome territories CTS CTS:12 circadian timing system CTs CTs:9 complementary therapies CTS CTS:11 conflict tactics scale CTS CTS:12 congenital tracheal stenosis CTs CTs:10 cytotrophoblasts CT CT:7|Ct:2 alone CT CT:10|Ct:1 cterminal CT CT:42|ct:6 calf thymus CT CT:7 carboxyl terminus CT CT:11 cardiac tamponade CT CT:10 cardiac transplantation CT CT:7 celiac trunk CT CT:5 central tendon CT CT:9 cerebral toxoplasmosis CT CT:7 charge transport CT CT:7 chest tube CT CT:9 chlamydia CT CT:36 cholera enterotoxin CT CT:97 chorda tympani CT CT:12 chronic tonsillitis CT CT:10 clinical trial CT CT:27 closure time CT CT:75 cognitive therapy CT CT:14 collecting tubule CT CT:21 computed tomograph CT CT:10 computed tomographic scanning CT CT:7 computed tomography scanning CT CT:9 computed tomograpy CT CT:8 computerized tomograph CT CT:354 computerized tomographic CT CT:20 condensed tannins CT CT:8 congenital toxoplasmosis CT CT:11 connecticut CT CT:16 conservative treatment CT CT:9 conventional treatment CT CT:19 corneal thickness CT CT:7 cortical thickness CT CT:17 corticothalamic CT CT:10 counseling and testing CT CT:15 countertransport CT CT:56 cricothyroid CT CT:13 cricothyroid muscle CT CT:39 crista terminalis CT CT:10 critical thinking CT CT:39 cytoplasmic tail CT CT:7|ct:2|Ct:1 twitch contraction time CUNS CUNS:6 capacity of urean synthesis CUNS CUNS:5 capacity of urea nitrogen synthesis CVA CVA:8 canonical variate analysis CVA CVA:14|cva:1 cerebral vascular accidents CVA CVA:13 clavulanic acid CVA CVA:22 cough variant asthma CVB CVB:8 coxsackieviruses of group b CVB CVB:19 group b coxsackieviruses CVC CVC:15 central venous catheterization CVC CVC:17 citrus variegated chlorosis CVC CVC:40|c-v-c:1 consonantvowelconsonant CVC CVC:56 cutaneous vascular conductance CVD CVD:8|CvD:1 cerebrovascular dementia CVD CVD:56 cerebrovascular diseases CVD CVD:13 cerebrovascular disorders CVD CVD:4 continuous ventricular drainage CVH CVH:33|cvh:1 chronic viral hepatitis CVH CVH:7 common variable hypogammaglobulinaemia CVH CVH:12 common variable hypogammaglobulinemia CVID CVID:12 common variable immune deficiency CVID CVID:9 common variable immunodeficiency syndrome CVI CVI:25 childrens vaccine initiative CVI CVI:263|cvi:2 chronic venous insufficiency CVI CVI:15 content validity index CVI CVI:5 continuous venous infusion CVI CVI:10 cyclic variation index CVI CVI:22 visual impairment CVL CVL:13 canine visceral leishmaniasis CVL CVL:15 central venous line CVL CVL:33 cervicovaginal lavage CVM CVM:9 cardiovascular malformations CVM CVM:9 center for veterinary medicine CVM CVM:10 congenital vascular malformations CVM CVM:8 contingent valuation method CVP CVP:716|cvp:2 central venous pressure CVP CVP:13 chlorphenvinphos CVR-R CVR-R:2|CVRR:2 coefficient of variation of rr intervals CVR-R CVR-R:1|CVRR:1 coefficient of variation of the rr interval CVR CVR:25 cardiovascular reactivity CVR CVR:10 cerebral vasoreactivity CVR CVR:30 cerebrovascular reactivity CVR CVR:20 cerebrovascular reserve CVR CVR:78 cerebrovascular resistance CVR CVR:10 chronic vascular rejection CVR CVR:16 contraceptive vaginal ring CVR CVR:120 coronary vascular resistance CVR CVR:9 coronary vasodilator reserve CVS CVS:32 cardiovascular system CVS CVS:9 centrifugal visual system CVS CVS:12 cerebral vasospasm CVS CVS:12 cervicovaginal secretions CVS CVS:23 challenge virus standard CVS CVS:12 chronic variable stress CVS CVS:30 cyclic vomiting syndrome CVG CVG:16 cochleovestibular ganglion CVG CVG:12 cutis verticis gyrata CV CV:24|cv:1 chorionic villi CV CV:23 chorionic villus CV CV:9 circularvection CV CV:71 closing volume CV CV:11|cv:1 coefficient of variability CV CV:59 coefficient of variance CV CV:30 contingent valuation CV CV:11 contrast venography CV CV:11 contrast ventriculography CV CV:61 conventional ventilation CV CV:13 crossvalidation CV CV:27 crystal violet CV CV:11 curriculum vitae CV CV:165 cyclic voltammetry CV CV:16 dichotic consonantvowel CWA CWA:11 chemical warfare agents CWA CWA:10 correlation waveform analysis CWD CWD:10 canal wall down CWD CWD:61 chronic wasting disease CWD CWD:17 continuous wave doppler CWP CWP:9 chronic widespread pain CWP CWP:58 coal workers pneumoconiosis CWS CWS:8 chest wall stimulation CWS CWS:14 children who stutter CWT CWT:14 circuit weight training CWT CWT:5 colour word test CWT CWT:40 continuous wavelet transform CWT CWT:6 cortical wall thickness CW CW:23 chemical warfare CW CW:20|cw:3|Cw:1 chest wall CW CW:58|cw:3 clockwise CW CW:5 coconut water CW CW:18 constructed wetland CW CW:9 contractional work CW CW:8 control women CXD CXD:28 cefroxadine CXD CXD:13 computed xray densitometry CXRs CXRs:27 chest radiographs CXRs CXRs:11 chest xrays CXR CXR:47 chest radiography CXR CXR:14 chest roentgenogram CYP19 CYP19:10|Cyp19:5 aromatase gene CYP19 CYP19:14|cyp19:1 aromatase p CYP2D6 CYP2D6:110|Cyp2D6:1 cytochrome p d CYP2D6 CYP2D6:49 cytochrome pd CYP2D6 CYP2D6:10 cytochrome piid CYP2E1 CYP2E1:161|CYP2e1:1|Cyp2E1:1 cytochrome p e CYP2E1 CYP2E1:8 cytochrome piie CYP51 CYP51:7|cyp51:2|cYP51:1 alphademethylase CYP51 CYP51:18 lanosterol alphademethylase CYP51 CYP51:13 sterol demethylase p CYP51 CYP51:12 sterol alphademethylase CZE CZE:740 capillary zone electrophoresis CZE CZE:26 capillary zone electrophoretic CZX CZX:89 ceftizoxime CZX CZX:16 chlorzoxazone Ca/Cr Ca/Cr:22|Ca/cr:2 calciumcreatinine Ca/Cr Ca/Cr:7 calciumcreatinine ratio Ca2+i Ca2+i:14 cytoplasmic ca concentration Ca2+i Ca2+i:7 cytoplasmic calcium concentration CASI CASI:6 childhood anxiety sensitivity index CASI CASI:40 cognitive abilities screening instrument Caco-2 Caco-2:19|CaCo-2:5|Caco2:2 colon carcinoma Caco-2 Caco-2:12|CACO-2:1 human colon adenocarcinoma Caco-2 Caco-2:12|CaCo-2:1 human intestinal Caco-2 Caco-2:40|Caco2:1|CACO-2:1 human intestinal epithelial CBI CBI:6 caregiver burden inventory CBI CBI:7 computerbased instruction CBI CBI:18 covalent binding index CBL CBL:5 computerbased learning CBL CBL:40 cord blood lymphocytes CBL CBL:9|CbL:1 cystathionine betalyase CCR CCR:7 california cancer registry CCR CCR:36 carbon catabolite repression CCR CCR:41 cc chemokine receptor CCR CCR:10 central conserved region CCR CCR:11 chemokine receptors CCR CCR:5 cinnamoyl coa reductase CCr CCr:7|Ccr:6 clearance of creatinine CCR CCR:10|cCR:2 complete clinical remission CCR CCR:25 complete cytogenetic response CCR CCR:17 complex chromosomal rearrangement CCR CCR:66|cCR:2 continuous complete remission CCR CCR:12|cCR:1 continuous cr CCr CCr:5|cCr:4 cyclocreatine CEE CEE:19 central and eastern europe CEE CEE:10 central and eastern european CEE CEE:17 chick embryo extract ChAT-IR ChAT-IR:8|ChAT-ir:5 chatimmunoreactive ChAT-IR ChAT-IR:7|ChAT-Ir:1 choline acetyltransferase immunoreactivity CHA CHA:4 adenosine a receptor agonist ncyclohexyladenosine CHA CHA:4|c-HA:2|C-HA:1 carbonated hydroxyapatite CHA CHA:11 catholic health association CHA CHA:16 chlorhexidine diacetate CHA CHA:10 common hepatic artery CHA CHA:9 congenital hypoplastic anemia CHA CHA:6|cHA:1 coralline hydroxyapatite CHA CHA:9 cyclohexylamine CHA CHA:12 ncyclohexyl adenosine CHA CHA:7 receptor agonist cyclohexyladenosine CHA CHA:2 receptor agonist ncyclohexyladenosine CHH CHH:37 cartilagehair hypoplasia CHH CHH:61|cHH:4 crustacean hyperglycemic hormone CHS CHS:71 cardiovascular health study CHS CHS:146|chs:8|Chs:5 chalcone synthase CHS CHS:159|C-HS:5 chediakhigashi syndrome CHS CHS:9 cholesterol hemisuccinate CHS CHS:12 cholesteryl hemisuccinate CHS CHS:10 compression hip screw CHS CHS:11 health services ChAT ChAT:11|Chat:1 cholinacetyltransferase ChAT ChAT:22|CHAT:1 choline acetyltransferase activity ChAT ChAT:13 cholineoacetyltransferase ChAT ChAT:23|CHAT:2 cholineacetyltransferase CHC CHC:8 chlorinated hydrocarbon CHC CHC:225|CH-C:37|cHC:5|C-HC:1 chronic hepatitis c CHC CHC:11|Chc:3 clathrin heavy chain CHC CHC:21 community health center CHC CHC:12 health centre CIT CIT:36|Cit:7 citalopram CIT CIT:42 cold ischemia time CIT CIT:22 conventional insulin therapy CIT CIT:17 conventional insulin treatment CIT CIT:10 cortical imaging technique CIT CIT:8 critical incident technique CLE CLE:10 centrilobular emphysema CLE CLE:17 columnarlined esophagus CLE CLE:24 congenital lobar emphysema CLE CLE:7 crosslinked envelope CLE CLE:21 cutaneous lupus erythematosus CLT CLT:7 chemiluminescence test CLT CLT:5 clot lysis time Clara Clara:11 nonciliated bronchiolar Clara Clara:67 nonciliated bronchiolar epithelial CLI CLI:7 central lymphatic irradiation CLi CLi:8 clearance of lithium CLI CLI:11|Cli:1 clindamycin CLI CLI:52 critical limb ischaemia CLI CLI:53 critical limb ischemia CLi CLi:48|Cli:1|C-Li:1 lithium clearance Cmax Cmax:8 concentrations in plasma Cmax Cmax:250|cmax:2|CMax:1|CMAX:1 maximum concentration Cmax Cmax:7 maximum concentration in serum Cmax Cmax:7|cmax:1 maximum plasma levels Cmax Cmax:18 maximum serum concentrations Cmax Cmax:44 peak concentrations Cmax Cmax:15 peak levels Cmax Cmax:18 peak serum concentrations Cmax Cmax:4 reached the maximum CoNS CoNS:108|CONS:24|ConS:1 coagulasenegative staphylococci CoNS CoNS:10|CONS:2 coagulasenegative staphylococcus COL1A1 COL1A1:5 alpha i procollagen gene COL1A1 COL1A1:9 collagen type i alpha COL1A1 COL1A1:15 type i procollagen COMET COMET:1 carvedilol and metoprolol european trial COMET COMET:11 correction of myopia evaluation trial ConA ConA:16|Con-A:2 canavalia ensiformis ConA ConA:11|Con-A:5|conA:1 ensiformis agglutinin CPSs CPSs:14 capsular polysaccharides CPSs CPSs:21 complex partial seizures CS+ CS+:16 conditional stimulus CS+ CS+:10 one tone CTV CTV:9 cell tracking velocimetry CTV CTV:67|Ctv:3 citrus tristeza virus CTV CTV:161 clinical target volume CTV CTV:10 ct venography CUS CUS:22|C-US:2 compression ultrasonography CUS CUS:6 cranial ultrasound CU CU:45 chronic urticaria CU CU:22 clemson university CU CU:5 clinical units CU CU:25|Cu:22 cuprophan CYP17 CYP17:20|Cyp17:1 alphahydroxylase CYP17 CYP17:8|Cyp17:1 cytochrome pcalpha D&E D&E:26 dilatation and evacuation D&E D&E:18 dilation and evacuation D/P D/P:18 dialysateplasma D/P D/P:15 dialysatetoplasma ratio D1 D1:6 first day D1 D1:6 first diagonal branch D2 D2:27 extended D2 D2:6 extended lymphadenectomy D3T D3T:15 dithiolethione D3T D3T:12 hdithiolethione D3 D3:25 cholecalciferol D3 D3:7|d3:3 diagnosed at the caries into dentine D3 D3:9 type iii deiodinase D3 D3:6 type iii iodothyronine deiodinase D5W D5W:8 dextrose D5W D5W:26 dextrose in water D5W D5W:9 dextrose injection DAA DAA:17|daa:2 after anthesis DAA DAA:4 dispensable amino acids DAA DAA:6 double aortic arch DAA DAA:9 ductus arteriosus aneurysm DAB DAB:9 dideoxyiminodarabinitol DAB DAB:41|dab:3 days after birth DAB DAB:26 nndimethylaminoazobenzene DAB DAB:24 pdimethylaminoazobenzene DAC DAC:7 demethylating agent azadeoxycytidine DAC DAC:8 dry air challenge DAD DAD:10 dianhydrodulcitol DAD DAD:78 diffuse alveolar damage DAD DAD:13 disability assessment for dementia DAEC DAEC:1 diffusely adherent e coli DAEC DAEC:14 diffusely adhering escherichia coli DAF DAF:22|daf:1 days after flowering DAF DAF:313|Daf:1 decayaccelerating factor DAF DAF:48 delayed auditory feedback DAF DAF:23 dissolved air flotation DAF DAF:27 dna amplification fingerprinting DAF DAF:16 drugadmixed food DAGO DAGO:11 dalamepheglyolenkephalin DAGO DAGO:23 enkephalin DAG DAG:16 diacylsnglycerol DAG DAG:14 acyl glucuronide DAG DAG:9 diacyglycerol DAG DAG:22 dianhydrogalactitol DAG DAG:10 directed acyclic graph DAG DAG:52 sndiacylglycerol DAM DAM:10 delayed amelanotic Dam Dam:12|dam:2 deoxyadenosine methylase DAM DAM:12 diacetyl monoxime DAM DAM:11 diacetylmonoxime Dam Dam:17|dam:9 dna adenine methylase Dam Dam:6|DAM:1 dna adenine methyltransferase DAN DAN:18 diaminonaphthalene DAN DAN:42 diabetic autonomic neuropathy DAN DAN:13 diazoacetyldlnorleucine methyl ester DAPs DAPs:14 depolarizing afterpotentials DAPs DAPs:25 dystrophinassociated proteins DAP DAP:22|Dap:2 diaminopropane DAP DAP:32 diaminopurine DAP DAP:23|dap:1 after pollination DAP DAP:12 days after planting DAP DAP:25 depolarizing afterpotential DAP DAP:15 diaminopimelate DAP DAP:10 drawaperson DAP DAP:9 drawaperson test DAP DAP:11 dystrophinassociated protein DARP DARP:8 dopaminereleasing protein DARP DARP:14 drug abuse reporting program DAR DAR:12 differential absorption ratio DAR DAR:6 dual asthmatic response DASH DASH:1 arm shoulder and hand questionnaire DASH DASH:62 dietary approaches to stop hypertension DASH DASH:1 disability of the arm shoulder and hand D-Asp D-Asp:26|D-ASP:2|d-Asp:1|D-asp:1|d-ASP:1 daspartate D-Asp D-Asp:24|D-ASP:2|DAsp:1 daspartic acid DAS DAS:9 decayassociated spectra DAS DAS:18 developmental apraxia of speech DAS DAS:102 diallyl sulfide DAS DAS:11 disability assessment schedule DAS DAS:8 disc angiogenesis system DAS DAS:8 double antibody sandwich DAS DAS:26 dyadic adjustment scale DAS DAS:4 t toxin and diacetoxyscirpenol DAT1 DAT1:21|DAT-1:1 dopamine transporter DAT1 DAT1:43|DAT-1:1 dopamine transporter gene DATOS DATOS:21 drawn from electronic files of data from the drug abuse treatment outcome study DATOS DATOS:12 drug abuse treatment outcome studies DAT DAT:3 cytosine arabinoside and thioguanine DAT DAT:12 days after treatment DAT DAT:8 digital audio tape DAT DAT:114 direct agglutination test DAI DAI:41|dai:1 days after inoculation DAI DAI:38 dental aesthetic index DAI DAI:115 diffuse axonal injury DAI DAI:32 disease activity index DAI DAI:13 drug attitude inventory DA DA:17 degree of acetylation DA DA:21 delayed alternation DA DA:10 diagnostic accuracy DA DA:9 dielsalder DA DA:16 diffuse adherence DA DA:6 digital angiography DA DA:10 direct agglutination DA DA:12 directional asymmetry DA DA:9 directional atherectomy DA DA:36 discriminant analysis DA DA:8 displaced abomasum DA DA:8 dissecting aneurysm DA DA:11 divided attention DA DA:523 dopaminergic DA DA:8 dorsal aorta DA DA:131 ductus arteriosus DA DA:12 duodenal atresia DA DA:24 release of hdopamine DBA DBA:8 bonding agents DBA DBA:25 diamondblackfan anaemia DBA DBA:60 diamondblackfan anemia DBA DBA:13 dibutylamine DBA DBA:80 dolichos biflorus DBA DBA:182 dolichos biflorus agglutinin DBA DBA:9 dolichos biflorus lectin DBC DBC:34 hdibenzocgcarbazole DBC DBC:8 developmental behaviour checklist DBH DBH:25 dibromodimethylhydantoin DBH DBH:28|DbH:1 dopamine beta hydroxylase DBH DBH:11 dopaminebetahydroxylase activity DBH DBH:7 dopamine betahydroxylase gene DBH DBH:12 dot blot hybridization DBMC DBMC:11 bone marrow cell DBMC DBMC:10 donor bone marrow cells DBMIB DBMIB:21 dibromomethylisopropylpbenzoquinone DBMIB DBMIB:12 dibromothymoquinone DBM DBM:139 demineralized bone matrix DBM DBM:12 dibenzoylmethane DBM DBM:9 dibromomethane DBM DBM:9 dopamine betamonooxygenase DBNBS DBNBS:9 dibromonitrosobenzene sulfonate DBNBS DBNBS:8|DB-NBS:1 dibromonitrosobenzenesulfonic acid DBN DBN:10 dibutylnitrosamine DBN DBN:13 downbeat nystagmus DBN DBN:11 nndibutylnitrosamine DBP DBP:10 adenovirus dnabinding protein DBP DBP:34 demineralized bone powder DBP DBP:90 dinbutyl phthalate DBP DBP:73 dibutyl phthalate DBP DBP:25 dibutylphthalate DBP DBP:10 disinfection byproduct DBQ DBQ:9 debrisoquine DBQ DBQ:5 driver behaviour questionnaire DBS DBS:7 dental beliefs survey DBS DBS:9 dentin bonding systems DBS DBS:16 dibutyl sebacate DBS DBS:6 duodenal bicarbonate secretion dbcGMP dbcGMP:8|db-cGMP:6|DbcGMP:2|db-c-GMP:1|DB-cGMP:1|Db-cGMP:1 dibutyryl cyclic gmp dbcGMP dbcGMP:4|dbc-GMP:1|DBcGMP:1 dibutyryl cyclic guanosine monophosphate DB DB:13 database DB DB:10 decidua basalis DB DB:16 deep breathing DB DB:13 dense bodies DB DB:8 diaphragmatic breathing DB DB:13 didemnin b DB DB:10|dB:1 direct bilirubin DB DB:6 dorsal bodies DB DB:11|db:2 downstream box DCA DCA:5 desoxycholate citrate agar DCA DCA:254|-DCA:1 dichloroacetate DCA DCA:100 dichloroacetic acid DCA DCA:148 directional coronary atherectomy DCBE DCBE:29 double contrast barium enema DCBE DCBE:5 doublecontrast barium enema examination DCCD DCCD:8 dicyclohexyl carbodiimide DCCD DCCD:6 nndicyclohexyl carbodiimide DCC DCC:8 data coordinating center DCC DCC:17|Dcc:1 deleted in colon cancer DCC DCC:58|Dcc:2|dcc:1 deleted in colorectal cancer DCC DCC:25 deleted in colorectal carcinoma DCC DCC:8 dextrancoated charcoal assay DCC DCC:14 dextrancoated charcoal method DCC DCC:10 direct current cardioversion DCD DCD:5 after cardiac death DCD DCD:72 developmental coordination disorder DCE-MRI DCE-MRI:42|DCEMRI:3 dynamic contrastenhanced magnetic resonance imaging DCE-MRI DCE-MRI:18|DCEMRI:2 dynamic contrastenhanced mri DCE DCE:5 doublecontrast barium enema DCE DCE:6 doublecontrast enema DCE DCE:15 dynamic contrastenhanced DCG-IV DCG-IV:12 srrrdicarboxycyclopropylglycine DCG-IV DCG-IV:14 srrdicarboxycyclopropylglycine DCIS DCIS:15 ductal carcinoma in situ of the breast DCIS DCIS:1 ductal carcinoma of breast DCIS DCIS:14 intraductal carcinoma DCI DCI:26 dichloroisocoumarin DCI DCI:41 decompression illness DCI DCI:12 delayed cerebral ischemia DCL DCL:41 diffuse cutaneous leishmaniasis DCL DCL:4 metabolite descarboethoxyloratadine DCMU DCMU:11 dichlorophenyldimethyl urea DCMU DCMU:57 dichlorophenyldimethylurea DCN DCN:44|dcn:1 deep cerebellar nuclei DCN DCN:196 dorsal cochlear nucleus DCN DCN:73|DCn:1 dorsal column nuclei DCP DCP:10 dichloropropane DCP DCP:46 desgammacarboxy prothrombin DCP DCP:13 desgammacarboxyprothrombin DCP DCP:21 dicalcium phosphate DCP DCP:12 dicetyl phosphate DCP DCP:23 dicetylphosphate DCP DCP:15 digestible crude protein DCP DCP:39 dynamic compression plate DCR DCR:145 dacryocystorhinostomy DCR DCR:15 decidual cell reaction DCR DCR:9 decidual cell response DCR DCR:20 direct cortical response DCR DCR:11 dominant control region DCR DCR:7 icd diagnostic criteria for research DCS DCS:259 decompression sickness DCS DCS:8|dCS:1 distal coronary sinus DCS DCS:26 dorsal column stimulation DCS DCS:26 dynamic condylar screw DCS DCS:2|D-CS:1 partial agonist dcycloserine DCT DCT:6 direct contact test DCT DCT:39 discrete cosine transform DCT DCT:19|Dct:12|dct:1 dopachrome tautomerase DCT DCT:7|dCT:1|D-CT:1 dynamic ct DCVs DCVs:16|dcvs:2 dense core vesicles DCVs DCVs:13 densecored vesicles DCV DCV:11 distribution of conduction velocities DCV DCV:13 distribution of nerve conduction velocities DCV DCV:13 drosophila c virus DC DC:40 degree of conversion DC DC:17|Dc:1 dichorionic DC DC:8 direct compression DC DC:9 distensibility DC DC:30 distensibility coefficient DC DC:14 dorsal cortex DC DC:17 dupuytrens contracture DC DC:6 dynamic compression DDAVP DDAVP:72|dDAVP:3 desmopressin acetate DDAVP DDAVP:8|dDAVP:3 vasopressin analogue DDA DDA:5|ddA:1 cyclase inhibitor dideoxyadenosine DDA DDA:29 dimethyl dioctadecyl ammonium bromide DDA DDA:31 dimethyldioctadecylammonium bromide DDA DDA:8 disposition decomposition analysis DDB DDB:9 biphenyl dimethyl dicarboxylate DDB DDB:8 damaged dnabinding protein DDB DDB:8 dimethyl diphenyl bicarboxylate DDC DDC:11 diethoxycarbonyldihydrocollidine DDC DDC:11 analogues of diethoxycarbonyldihydrotrimethylpyridine DDC DDC:8 diethyl dithiocarbamate DDC DDC:17 diethyldithiocarbamic acid DDC DDC:97|Ddc:27 dopa decarboxylase DDD DDD:14 av universal DDD DDD:12 degenerative disc disease DDD DDD:8 dense deposit disease DDD DDD:10 dichlorodiphenyldichloroethane DDD DDD:9 digital differential display DDD DDD:14 dual chamber pacing DDE DDE:36 dichlorobispchlorophenylethylene DDE DDE:11 developmental defects of enamel DDE DDE:11 ethylene DDE DDE:12 ppdichlorodiphenyldichloroethylene DDQ DDQ:19 dichlorodicyanobenzoquinone DDQ DDQ:10|ddq:1 direct dialysis quantification DDR DDR:6 diastolic descent rate DDR DDR:9 discoidin domain receptor DDS DDS:30 denysdrash syndrome DDS DDS:4 diamino diphenyl sulphone DDS DDS:5 dietary diversity score DDT DDT:17 trichlorobischlorophenylethane DDT DDT:19 dichlorodiphenyl trichloroethane DDT DDT:1 pchlorophenyl ethane DDT DDT:17 ppdichlorodiphenyltrichloroethane DEA DEA:73 data envelopment analysis DEA DEA:16 deethylatrazine DEA DEA:26|dea:1 diethanolamine DEA DEA:38 diethylamine DEA DEA:31 drug enforcement administration DEA DEA:8 metabolite desethylamiodarone DED DED:13 deepidermized dermis DED DED:23 death effector domain DEET DEET:6|deet:2|Deet:1 diethyltoluamide DEET DEET:20 insect repellent nndiethylmtoluamide DEF DEF:13|def:3 deficiens DEF DEF:6 dose enhancement factor DEF DEF:14 ssstributyl phosphorotrithioate DEH DEH:13 delayed endolymphatic hydrops DEH DEH:9 dysplasia epiphysealis hemimelica DELFIA DELFIA:18 dissociationenhanced lanthanide fluoroimmunoassay DELFIA DELFIA:9 lanthanide fluorescence immunoassay DEM DEM:10 developmental eye movement DEM DEM:161 diethyl maleate DEM DEM:139|dEM:1 diethylmaleate DEM DEM:8 direct electron microscopy DEN DEN:17 ndiethylnitrosamine DEN DEN:9 nndiethylnitrosamine DEPMPO DEPMPO:9 diethoxyphosphorylmethylpyrrolinenoxide DEPMPO DEPMPO:3 spin trap diethoxyphosphorylmethylpyrrolinenoxide DEP DEP:14 dielectrophoresis DEP DEP:14 dielectrophoretic DEP DEP:9 diethyl phosphate DEP DEP:46 diethyl phthalate DEP DEP:10 diethylphosphate DEP DEP:11 diethylphthalate DER DER:11 dietary energy restriction DER DER:10 disulfiramethanol reaction DER DER:21 drosophila egf receptor DER DER:8 drosophila egf receptor homolog DES DES:17 desflurane DES DES:25|Des:5 desmosine DES DES:15 diethyl sulfate DES DES:17 diethylstibestrol DES DES:29 diethylstilbesterol DES DES:1453|des:1|-DES:1 diethylstilbestrol DES DES:125 diethylstilboestrol DES DES:34 diffuse esophageal spasm DES DES:4 dry eye syndrome DETA/NO DETA/NO:5 diethylenetriamine nitric oxide adduct DETA/NO DETA/NO:9 diethylenetriamineno DET DET:13 dipyridamole echocardiography test DET DET:6 double embryo transfer DEXA DEXA:6 dual energy xray absorptiometer DEXA DEXA:397|DeXA:1|dexa:1 dualenergy xray absorptiometry DE DE:13 degree of esterification DE DE:11 delayedearly DE DE:12 delta efficiency DE DE:7 dermal equivalent DE DE:11 diatomaceous earth DE DE:62 diesel exhaust DE DE:83 digestible energy DE DE:13 dissolution efficiency DE DE:9 dualenergy DE DE:5 dynamic exercise DE DE:13 dyscirculatory encephalopathy DE DE:3 pectins with different degrees of esterification DFA DFA:13 deep femoral artery DFA DFA:31 detrended fluctuation analysis DFA DFA:8 direct fluorescent antibody test DFA DFA:26 direct immunofluorescence assay DFA DFA:5 direct immunofluorescent staining DFA DFA:9 discriminant function analyses DFA DFA:32 discriminant function analysis DFI DFI:4 daily feed intake DFI DFI:4 daily food intake DFI DFI:139 diseasefree interval DFI DFI:15 dna fragmentation index DFP DFP:8|dfp:1 diastolic filling period DFP DFP:160 diisopropyl fluorophosphate DFP DFP:86 diisopropyl phosphorofluoridate DFP DFP:18 diisopropylphosphofluoridate DFP DFP:45 diisopropylphosphorofluoridate DFT DFT:6 dementia of frontal lobe type DFT DFT:2 dementia of the frontal type DFT DFT:5 density functional calculations DFT DFT:5 density functional theoretical DFT DFT:477 density functional theory DFT DFT:9 desferrithiocin DFT DFT:45 discrete fourier transform DFS DFS:2 decayed or filled surfaces DFS DFS:17 dental fear survey DFS DFS:12 diabetic foot syndrome DF DF:5 ankle dorsiflexors DF DF:14|Df:1 defibrotide DF DF:9 delayed fluorescence DF DF:108 dengue fever DF DF:5 deposition fraction DF DF:13 dermal fibroblasts DF DF:26 dermatofibroma DF DF:21|dF:1 developed force DF DF:6 dialysis fluid DF DF:18 dibenzofuran DF DF:55 dietary fiber DF DF:29 dietary fibre DF DF:22 diflunisal DF DF:21 discriminant function DF DF:31 dominant follicle DF DF:20|dF:1 dominant frequency DF DF:26 dorsiflexion dGA dGA:9 days gestation dGA dGA:8|DGA:5|dga:1 days gestational age DGA DGA:11 dental general anaesthesia DGA DGA:11 digeorge anomaly DGA DGA:4|D-GA:3 urinary excretion of dglucaric acid DGC DGC:9 dorsal gray commissure DGC DGC:48 dystrophinglycoprotein complex DGE DGE:36 delayed gastric emptying DGE DGE:9 differential gene expression DGG DGG:9 digestive glandgonad complex DGG DGG:28 gammadglutamylglycine DGI DGI:27 disseminated gonococcal infection DGI DGI:9 dynamic gait index DGS DGS:12 diabetic glomerulosclerosis DGS DGS:8 digeorge sequence DGS DGS:85 digeorge syndrome DG DG:11 dentate granule DG DG:453|Dg:1|dg:1 dentate gyrus DG DG:9 diradylglycerol DG DG:23 distance geometry DG DG:9 dorsal gastric DG DG:26|Dg:1 dystroglycan DHA DHA:17 dihydroxyadenine DHA DHA:8 active metabolite dihydroartemisinin DHA DHA:46 dehydroascorbate DHA DHA:12 dehydroisoandrosterone DHA DHA:49|Dha:5|dha:1 dihydroxyacetone DHA DHA:9 district health authority DHA DHA:14 docosahexaenoate DHBA DHBA:7 and dihydroxybenzoic acids DHBA DHBA:11 dihydroxybenzylamine DHBA DHBA:7 reflected by the nonenzymatic formation of dihydroxybenzoic acid DHC DHC:17 dental health component DHC DHC:12 dihydrocodeine DHC DHC:8|Dhc:5 dynein heavy chain DHE DHE:16 dehydroergosterol DHE DHE:36 dihematoporphyrin ether DHE DHE:161|dhe:1 dihydroergotamine DHE DHE:18 dihydroethidium DHE DHE:17 dihydroetorphine DHF/DSS DHF/DSS:11 dengue haemorrhagic feverdengue shock syndrome DHF/DSS DHF/DSS:6 dengue hemorrhagic fever and dengue shock syndrome DHF/DSS DHF/DSS:23 dengue hemorrhagic feverdengue shock syndrome DHF DHF:89 dengue haemorrhagic fever DHF DHF:172 dengue hemorrhagic fever DHF DHF:29 diastolic heart failure DHF DHF:15 dihydrofolate DHF DHF:9 dihydroxyfumarate DHI DHI:37 dihydroxyindole DHI DHI:15 dairy herd improvement DHI DHI:32 dizziness handicap inventory DHI DHI:7 dose homogeneity index DHPC DHPC:10 dihexadecylphosphatidylcholine DHPC DHPC:15 dihexanoylphosphatidylcholine DHPG DHPG:12 dihydroxyphenylethylene glycol DHPG DHPG:39|dhpG:1 dihydroxypropoxymethylguanine DHPG DHPG:26 agonist rsdihydroxyphenylglycine DHPG DHPG:24 agonist sdihydroxyphenylglycine DHPG DHPG:4 group i mglur agonist rsdihydroxyphenylglycine DHPG DHPG:4 intraneuronal ne metabolite dihydroxyphenylglycol DHPG DHPG:6 metabolites dihydroxyphenylglycol DHP DHP:6 alpha betadihydroxypregnenone DHP DHP:9 alphabetadihydroxypregnenone DHP DHP:10 dihexadecyl phosphate DHP DHP:17 dihydroprogesterone DHP DHP:9 dihydropyrimidinase DHP DHP:36 direct hemoperfusion DHP DHP:9 phthalate DHR DHR:13 delayed hypersensitivity reaction DHR DHR:20 delayed hypersensitivity response DHR DHR:17 dihydrorhodamine DHR DHR:41 dihydrorhodamine DHS DHS:14 deoxyhypusine synthase DHS DHS:6 department of health services DHS DHS:6 hypersensitivity syndrome DHT DHT:5 alphaandrostan betaolone DHT DHT:6 alphaandrostane betaolone DHT DHT:16 androgen alphadihydrotestosterone DHT DHT:40 dihydrotachysterol DH DH:10 day hospital DH DH:13 department of health DH DH:218 dermatitis herpetiformis DH DH:15 detrusor hyperreflexia DH DH:17 diapause hormone DH DH:23 diaphragmatic hernia DH DH:10 diet history DH DH:8 diuretic hormone DH DH:52 dorsal horn DH DH:8 double haploid DH DH:10 ductal hyperplasia DH DH:13 dynamic hyperinflation DH DH:10 dystrophic hamsters DIB DIB:28 diagnostic interview for borderlines DIB DIB:9 diagnostic interview for borderline patients DIC DIC:11 days in culture DIC DIC:11 deviance information criterion DIC DIC:108 differential interference contrast DIC DIC:10 diisopropylcarbodiimide DIC DIC:11 disseminated intravascular clotting DIC DIC:19 disseminated intravascular coagulation syndrome DIC DIC:87 disseminated intravascular coagulopathy DIC DIC:20 dissolved inorganic carbon DIC DIC:7 drip infusion cholangiography DIC DIC:12 drug information center DIDS DIDS:10 diisothiocyanatostilbenedisulfonate DIDS DIDS:11 diisothiocyanatostilbenedisulphonate DIDS DIDS:17 diisothiocyanodisulfonic acid stilbene DIDS DIDS:11 diisothiocyanodisulfonic stilbene DIDS DIDS:7 diisothiocyanostilbene disulfonate DIDS DIDS:44 diisothiocyanostilbenedisulfonate DIDS DIDS:13 diisothiocyanostilbenedisulphonate DID DID:6 delayed ischemic deficit DID DID:44 dissociative identity disorder DID DID:34 double immunodiffusion DID DID:6 inhabitants per day DIG DIG:13 desmoplastic infantile ganglioglioma DIG DIG:7|Dig:4 digastric DIG DIG:19 digitalis investigation group DIG DIG:58|Dig:4|dig:2 digoxigenin DILD DILD:8 diffuse infiltrative lung disease DILD DILD:16 diffuse interstitial lung disease DIOS DIOS:4 desorptionionization on porous silicon DIOS DIOS:10 distal intestinal obstruction syndrome DIO DIO:24|DiO:1 dietinduced obese DIO DIO:51 dietinduced obesity DIP DIP:15 degradable intake protein DIP DIP:39 desquamative interstitial pneumonia DIP DIP:9 desquamative interstitial pneumonitis DIP DIP:10 digital image processing DIP DIP:119 distal interphalangeal DIP DIP:18 distal interphalangeal joint DIP DIP:31 drip infusion pyelography DIP DIP:22 druginduced parkinsonism DISC DISC:106 deathinducing signaling complex DISC DISC:33 diagnostic interview schedule for children DISC DISC:20 dietary intervention study in children DISH DISH:190 diffuse idiopathic skeletal hyperostosis DISH DISH:6 dna in situ hybridization DIS DIS:203 diagnostic interview schedule DIS DIS:8 difficulty initiating sleep DIS DIS:27 dimerization initiation site DIS DIS:5|Dis:4 disinhibition DIS DIS:10 drug information system DIT DIT:18 defining issues test DIT DIT:65 dietinduced thermogenesis DIT DIT:16 diffuse intimal thickening DIT DIT:25|Dit:1 diiodotyrosine DI DI:10 brattleboro homozygous DI DI:8 brattleboro rats DI DI:8 days of incubation DI DI:22 deep inhalation DI DI:34 deep inspiration DI DI:51 detrusor instability DI DI:10 dialyzed iron DI DI:11 diastolic interval DI DI:5 diestrus i DI DI:221 dna index DLA DLA:14 daltons lymphoma ascites DLA DLA:12 dog leukocyte antigen DLA DLA:6|DL-A:3 histocompatibility complex DLB DLB:8 dementia with lb DLB DLB:410 dementia with lewy bodies DLCO DLCO:17|DLco:3 carbon monoxide diffusion capacity DLCO DLCO:17 diffusing capacity for co DLCO DLCO:8|DLco:2 diffusing capacity of the lung DLCO DLCO:44|Dlco:4|DLco:2 diffusing capacity of the lung for carbon monoxide DLCO DLCO:21|DLco:7 diffusion capacity for carbon monoxide DLCO DLCO:11|Dlco:4 diffusion capacity of the lung for carbon monoxide DLC DLC:29 diamondlike carbon DLC DLC:11 differential leukocyte count DLC DLC:8 digitalislike compounds DLC DLC:5 doublelumen catheter DLE DLE:5 dialysable leucocyte extract DLE DLE:18 discoid le DLE DLE:136 discoid lupus erythematosus DLF DLF:16 digitalislike factor DLF DLF:12 dorsolateral funiculi DLF DLF:89 dorsolateral funiculus DLH DLH:40 dlhomocysteic acid DLH DLH:6 excitatory amino acid dlhomocysteic acid DLM DLM:16 dominant lethal mutations DLM DLM:8 dorsal longitudinal flight muscle DLM DLM:13 dorsal longitudinal muscle DLM DLM:4 dorsolateral nucleus of the thalamus DLM DLM:6 dorsolateral thalamus DLPC DLPC:8 dilauroyl phosphatidylcholine DLPC DLPC:22 dilinoleoylphosphatidylcholine DLP DLP:19 dorsolateral prostate DLP DLP:8 dorsolateralis posterior DLP DLP:9 doselength product DLP DLP:12 dyslipoproteinemia DLST DLST:5 dihydrolipoamide succinyltransferase DLST DLST:12 drug lymphocyte stimulation test DLT DLT:18 direct linear transformation DLT DLT:8 donor leukocyte transfusion DLT DLT:53 dose limiting toxicity DLT DLT:8 doublelumen endobronchial tube DLT DLT:5 double lung transplantation DLV DLV:17 delavirdine DLV DLV:12 differential lung ventilation DLW DLW:31 doubly labelled water DLW DLW:7 water method DLS DLS:7 dictyosomelike structures DLs DLs:32 difference limens DLS DLS:10|dls:1 differential light sensitivity DLS DLS:13 digitalislike substance DLS DLS:8 digoxinlike substance DLS DLS:18 dimer linkage structure DLs DLs:11 dose levels DMAP DMAP:17 dimethylaminophenol DMAP DMAP:15 dimethylaminopurine DMA DMA:12 dimethyl adipimidate DMA DMA:11 dimethyl amiloride DMA DMA:31 dimethylamiloride DMA DMA:80|dma:1 dimethylamine DMA DMA:51 dynamic mechanical analysis DMA DMA:30 nndimethylaniline DMCM DMCM:5 inverse agonist methyldimethoxyethylbetacarbolinecarboxylate DMCM DMCM:27 methyl dimethoxyethylbetacarbolinecarboxylate DMC DMC:10 data monitoring committee DMC DMC:8 dimethyl carbonate DMD DMD:12 differentially methylated domain DMD DMD:13 dm digestibility DMD DMD:15 dry matter digestibility DMD DMD:58 duchenne DMD DMD:1412|Dmd:3 duchenne muscular dystrophy DMD DMD:10 dystonia musculorum deformans DMD DMD:4 progressive muscular dystrophy of the duchenne type DME DME:37 diabetic macular edema DME DME:15 dimethyl ether DME DME:5 drugmetabolizing enzymes DME DME:20 durable medical equipment DMFT DMFT:10|DMF-T:3|dmft:2 caries experience DMFT DMFT:4|dmft:3|DMF-T:2 caries prevalence DMF DMF:2 decayed missing and filled DMF DMF:21 dimethyl formamide DMF DMF:11 dimethyl fumarate DMF DMF:189|dmf:2 dimethylformamide DMF DMF:18 dimethylfumarate DMF DMF:30 dose modifying factor DMF DMF:179 nndimethylformamide DMG DMG:15 dimethylglycine DMG DMG:12 dimethylglyoxime DMH DMH:6 dimethyl hydrazine DMH DMH:24 dimethylhydrazine dihydrochloride DMH DMH:9 dorsomedial hypothalamic DMH DMH:55 dorsomedial hypothalamus DMH DMH:14 dorsomedial nucleus of the hypothalamus DMI DMI:9 desimipramine DMI DMI:220 desmethylimipramine DMI DMI:14 diabetic muscle infarction DMI DMI:25 doppler myocardial imaging DMI DMI:117 dry matter intake DMLC DMLC:12|dMLC:1 dynamic multileaf collimation DMLC DMLC:13|dMLC:3|D-MLC:1 dynamic multileaf collimator DMM DMM:19 desmoplastic malignant melanoma DMM DMM:8 diffuse malignant mesothelioma DMN DMN:28 dorsal motor nucleus DMN DMN:5 dorsomedial hypothalamic nuclei DMN DMN:15 dysplastic melanocytic nevi DMN DMN:9 nndimethylnitrosamine DMO DMO:35 dimethyloxazolidinedione DMO DMO:30 dimethadione DMO DMO:3 weak acid dimethyloxazolidinedione DMPA DMPA:13 depoprovera DMPA DMPA:126 depot medroxyprogesterone acetate DMPA DMPA:18 dimyristoylphosphatidic acid DMPC DMPC:48 dimyristoylsnglycerophosphocholine DMPC DMPC:9|dm-PC:1 dimyristoyl DMPC DMPC:10 dimyristoyllalphaphosphatidylcholine DMPC DMPC:18 dimyristoyl phosphatidyl choline DMPC DMPC:549 dimyristoylphosphatidylcholine DMPC DMPC:15 lalphadimyristoylphosphatidylcholine DMPG DMPG:18 dimyristoyl phosphatidylglycerol DMPG DMPG:6 dimyristoylphosphatidyl glycerol DMPG DMPG:62 dimyristoylphosphatidylglycerol DMPK DMPK:5 untranslated region of the myotonic dystrophy protein kinase gene DMPK DMPK:45|DM-PK:3|Dmpk:1 myotonic dystrophy protein kinase DMPO DMPO:17 dimethylpyrroline oxide DMPO DMPO:9 spin trap dimethylpyrrolineoxide DMPO DMPO:9 spin trap dimethylpyrrolinenoxide DMPP DMPP:37 dimethylphenylpiperazinium iodide DMPP DMPP:11 nicotinic agonist dimethylphenylpiperazinium DMPP DMPP:11 piperazinium DMPS DMPS:8 dimercaptopropane sulfonate DMPS DMPS:9 dimercaptopropanesulfonate DMPS DMPS:21 dimercaptopropanesulfonic acid DMPS DMPS:6 dimyristoyl phosphatidylserine DMPS DMPS:16 dimyristoylphosphatidylserine DMPS DMPS:6 sodium dimercaptopropanesulfonate DMP DMP:9 dimethoxypropane DMP DMP:16 deep muscular plexus DMP DMP:25 dimethyl phthalate DMP DMP:11 dimethylphosphate DMP DMP:9 dimethylphthalate DMSP DMSP:23 dimethylsulfoniopropionate DMSP DMSP:9 dimethylsulphoniopropionate DMS DMS:16 delayed matchtosample DMS DMS:19 delayed matchingtosample DMS DMS:9 delusional misidentification syndromes DMS DMS:18 demarcation membrane system DMS DMS:3 difficulty in maintaining sleep DMS DMS:24 diffuse mesangial sclerosis DMS DMS:6 dimercaptosuccinic acid DMS DMS:16 dimethyl suberimidate DMS DMS:68 dimethyl sulfate DMS DMS:60 dimethyl sulfide DMS DMS:26 dimethyl sulphate DMS DMS:9 dimethyl sulphide DMS DMS:16 dimethylsuberimidate DMS DMS:46 dimethylsulfate DMS DMS:16 dimethylsulfide DMS DMS:16 dimethylsulphate DMS DMS:33 nndimethylsphingosine DMTP DMTP:6 delayed matching to position DMTP DMTP:11 dimethylthiophosphate DMTU DMTU:16|dmtu:1 dimethylthiourea DMTU DMTU:12 dimethyl thiourea DMT DMT:14 defense mechanism test DMT DMT:10 dimethyltryptamine DMT DMT:68 nndimethyltryptamine DMV DMV:15 department of motor vehicles DMV DMV:12 dolphin morbillivirus DMZ DMZ:8 demilitarized zone DMZ DMZ:14 dimetridazole DMZ DMZ:10 dorsal marginal zone DNP-KLH DNP-KLH:7 limpet haemocyanin DNP-KLH DNP-KLH:27|DNPKLH:1 limpet hemocyanin DNP-SG DNP-SG:12 dinitrophenylsglutathione DNP-SG DNP-SG:4|Dnp-SG:2 dinitrophenyl sglutathione DNP DNP:66|Dnp:5 dinitrophenyl DNP DNP:18 antidinitrophenyl DNP DNP:26 antidinitrophenol DNP DNP:21 dendroaspis natriuretic peptide DNP DNP:29 deoxyribonucleoprotein DNP DNP:15 dinitrophenylated DNP DNP:13 dorsal nerve of the penis DNP DNP:22 dynamic nuclear polarization DNP DNP:2 mutagen dinitropyrene DNX DNX:8|DNx:1 denervated DNX DNX:23|DNx:2|Dnx:1 renal denervation DOCA DOCA:241|doca:1|Doca:1 deoxycorticosterone acetate DOCA DOCA:52 desoxycorticosterone acetate DOC DOC:9 department of corrections DOC DOC:291 dissolved organic carbon DOD DOD:8 dead of disease DOD DOD:8 died of disease DOE DOE:81|DoE:1 department of energy DOE DOE:9|DoE:5 design of experiments DOI DOI:4 agonist dimethoxyiodophenylaminopropane hcl DOI DOI:4 agonist dimethoxyiodoamphetamine DOI DOI:5 receptor agonist dimethoxyiodophenylaminopropane DOM DOM:39 dimethoxymethylamphetamine DOM DOM:1 da receptor antagonist domperidone DOM DOM:10 hallucinogen dimethoxymethylphenylaminopropane DON DON:62 diazooxolnorleucine DON DON:342 deoxynivalenol DON DON:19 diazooxonorleucine DON DON:9 dissolved organic nitrogen DON DON:11 dysthyroid optic neuropathy DOPA DOPA:8|dopa:1 dihydroxyphenyllalanine DOPA DOPA:7 accumulation of ldihydroxyphenylalanine DOPA DOPA:15|doPA:1 dioleoylphosphatidic acid DOPC DOPC:28 dioleoylsnglycerophosphocholine DOPC DOPC:163 dioleoylphosphatidylcholine DOPE DOPE:22 dioleoylsnglycerophosphoethanolamine DOPE DOPE:6 dioleoyl phosphatidyl ethanolamine DOPE DOPE:143 dioleoylphosphatidylethanolamine DOPS DOPS:9 dihydroxyphenylserine DOPS DOPS:22 dioleoylphosphatidylserine DOT DOT:10 dictionary of occupational titles DOT DOT:19 diffuse optical tomography DOT DOT:108 directly observed therapy DOT DOT:51 directly observed treatment DOT DOT:11 disodium octaborate tetrahydrate DOT DOT:13 dissolved oxygen tension DOX DOX:8|Dox:4 doxazosin DOX DOX:7|dox:1 doxorubicin hydrochloride DOS DOS:30 density of states DOS DOS:10 diabetesobesity syndrome DPAG DPAG:24|dPAG:11|D-PAG:1 dorsal periaqueductal gray DPAG DPAG:18|dPAG:11 dorsal periaqueductal gray matter DPAG DPAG:8|dPAG:3 dorsal periaqueductal grey DPA DPA:15 dinpropylacetate DPA DPA:34 diphenylamine DPA DPA:55|Dpa:1 dipicolinic acid DPA DPA:5 dorsalis pedis artery DPA DPA:8|dpa:2 post anthesis DPB DPB:16|dPB:1 deoxyphorbol isobutyrate DPB DPB:196 diffuse panbronchiolitis DPCPX DPCPX:28 a receptor antagonist cyclopentyldipropylxanthine DPCPX DPCPX:6 adenosine a receptor antagonist dipropylcyclopentylxanthine DPC DPC:3 chloride channel blocker diphenylaminecarboxylate dpc dpc:13 days postcoitus dpc dpc:8 days postconception DPC DPC:7 deep prepiriform cortex DPC DPC:5 deep prepyriform cortex DPC DPC:9 diagnosis procedure combination DPC DPC:12 diagnostic products corporation DPC DPC:26 diphenylaminecarboxylic acid DPC DPC:65 dodecylphosphocholine DPDPE DPDPE:19 agonist dpendpenenkephalin DPDPE DPDPE:10 dpendpenenkephalin DPD DPD:5|Dpd:3 deoxypyridinoline crosslinks DPD DPD:8 depressive personality disorder DPD DPD:40|Dpd:15|dpd:1|dPD:1 urinary deoxypyridinoline DPE DPE:9 dipivalyl epinephrine DPE DPE:14 downstream promoter element DPH DPH:9 diphenyl hexatriene DPH DPH:12 diphenylhexatriene DPI DPI:8 days postimplantation DPI DPI:23 dietary protein intake DPI DPI:24 diphenyleneiodonium chloride DPI DPI:17 diphenyliodonium DPI DPI:15 diphosphoinositide DPI DPI:12 doppler perfusion index DPI DPI:9 dpi DPI DPI:9 dry powder inhalation DPI DPI:3 nadph oxidase inhibitor diphenyleneiodonium DPL DPL:130 diagnostic peritoneal lavage DPL DPL:20 dipalmitoyl lecithin DPN DPN:9 deep peroneal nerve DPN DPN:31 diabetic peripheral neuropathy DPN DPN:9 dippen nanolithography DPN DPN:10 dorsal penile nerve dpo dpo:7 days postoperation dpo dpo:5|DPO:4 days postoperative DPPC DPPC:16 dipalmitoylsnglycerophosphatidylcholine DPPC DPPC:61 dipalmitoylsnglycerophosphocholine DPPC DPPC:13 dipalmitoyl DPPC DPPC:16 dipalmitoyl phosphatidyl choline DPPC DPPC:12 dipalmitoylphosphatidyl choline DPPC DPPC:23 lalphadipalmitoylphosphatidylcholine DPPE DPPE:6 dipalmitoyl phosphatidylethanolamine DPPE DPPE:39 dipalmitoylphosphatidylethanolamine DPPE DPPE:7 nndiethylphenylmethylphenoxyethanamine hcl DPPH DPPH:9 diphenylpicrylhydrazyl radical DPPH DPPH:16 alphaalphadiphenylbetapicrylhydrazyl DPPH DPPH:5 stable free radical diphenylpicrylhydrazyl dpp dpp:11|DPP:3 days postpartum dpp dpp:189|Dpp:101|DPP:21 decapentaplegic DPP DPP:5 dentin phosphophoryn DPP DPP:6 diphloretin phosphate DPP DPP:31 diabetes prevention program DPP DPP:12|dpp:1 differential pulse polarographic DPP DPP:44|dpp:1 differential pulse polarography DPP DPP:37 dipeptidyl peptidase DPS DPS:7 degree of phosphorus saturation DPS DPS:8 dipropyl sulfide DP DP:11|dp:1 degree of polymerisation DP DP:6 delayed puberty DP DP:7 delusional parasitosis DP DP:27 dermal papilla DP DP:21|Dp:5|dp:1 desmoplakin DP DP:16 directed percolation DP DP:24 directional preponderance DP DP:42 disopyramide DP DP:5 disopyramide phosphate DP DP:12 distal pancreatectomy DP DP:14|dp:1 distortion product DP DP:14 dorsal prostate DP DP:115 double positive DP DP:6 double potential DP DP:37 double product DP DP:9 dynamic programming DP DP:15 pattern DR1 DR1:8|DR-1:1 direct repeat DR1 DR1:8|DR-1:4 one nucleotide DRB DRB:10 dichlorobetadribofuranosyl benzimidazole DRB DRB:92 dichlorobetadribofuranosylbenzimidazole DRB DRB:9 dichlorobenzimidazole riboside DRCs DRCs:17 dendritic reticulum cells DRCs DRCs:24 doseresponse curves DRC DRC:4 democratic republic of the congo DRC DRC:24 dna repair capacity DRC DRC:13 dryrolled corn DRC DRC:6 dynamic reaction cell DRE DRE:26 digital rectal exam DRE DRE:7 dioxin response element DRE DRE:12 dioxin responsive element DRE DRE:8 distal regulatory element DRE DRE:11 downstream regulatory element DRG DRG:31 diagnostic related group DRG DRG:39 dorsal respiratory group DRG DRG:1451|drg:3 dorsal root ganglion DRO DRO:24 differential reinforcement of other behavior DRO DRO:10|Dro:1 droloxifene DRPs DRPs:23 dorsal root potentials DRPs DRPs:29 drugrelated problems DRP DRP:32 dissolved reactive phosphorus DRP DRP:16 dystrophinrelated protein DRRs DRRs:36|DRRS:1 digitally reconstructed radiographs DRRs DRRs:9 dorsal root reflexes DRSP DRSP:13 drospirenone DRSP DRSP:12 drugresistant streptococcus pneumoniae DRS DRS:14 diabetic retinopathy study DRs DRs:5 diet records DRS DRS:11 diffuse reflectance spectroscopy DRs DRs:25 direct repeats DRS DRS:24 doseresponse slope DRS DRS:9 renal scintigraphy DR DR:16 dahl saltresistant rats DR DR:18 darkreared DR DR:19 death receptor DR DR:24 delayed response DR DR:9 delivery room DR DR:17 detection rate DR DR:10|dr:1 diabetes resistant DR DR:235|dR:1 diabetic retinopathy DR DR:7 diameter reduction DR DR:9 dietrestricted DR DR:9 dietary records DR DR:10 dietary restricted DR DR:161 dietary restriction DR DR:34 digital radiography DR DR:10 distal radius DR DR:6|dr:1 dose ratios DR DR:14|D-R:6 doseresponse DR DR:14 drug resistance DR DR:9 drugresistant DR DR:8 dynamic range DR DR:12 hladr DSA DSA:22 datura stramonium agglutinin DSA DSA:11 delayed spatial alternation DSA DSA:16 destructive spondyloarthropathy DSA DSA:6 digital subtraction angiograms DSA DSA:23 digital subtraction angiographic DSA DSA:26 digital subtraction arteriography DSA DSA:7 dog serum albumin DSA DSA:5 donorspecific antibodies DSBR DSBR:7 distal small bowel resection DSBR DSBR:11 dna doublestrand break repair DSBR DSBR:10 doublestrandbreak repair DSC-MRI DSC-MRI:6 dynamic susceptibility contrastenhanced magnetic resonance imaging DSC-MRI DSC-MRI:6 dynamic susceptibility contrast magnetic resonance imaging DSC DSC:7 decidual stromal cells DSC DSC:10 delayed sternal closure DSC DSC:12 dermal sheep collagen DSC DSC:9 dextran sulfate cellulose DSC DSC:50 differential scanning calorimeter DSC DSC:36 differential scanning calorimetric DSC DSC:20 differential scanning microcalorimetry DSC DSC:31 dynamic susceptibility contrast DSE DSE:16 distal sequence element DSE DSE:273 dobutamine stress echocardiography DSE DSE:16 dyad symmetry element DSH DSH:7 dexamethasonesuppressible hyperaldosteronism DSH DSH:12 disproportionate share hospital DSH DSH:18 dyschromatosis symmetrica hereditaria DSI DSI:34 depolarizationinduced suppression of inhibition DSI DSI:8 dysphonia severity index DSM-IV DSM-IV:1 diagnostic and statistical manual of mental disorders th edition DSM-IV DSM-IV:5 diagnostic and statistical manual of mental disorders fourth edition DSM-IV DSM-IV:10 diagnostic and statistical manual of mental disordersiv DSM DSM:18 diagnostic and statistical manual DSM DSM:9 dried skim milk DSO DSO:13 daily sperm output DSO DSO:12 diffuse sclerosing osteomyelitis DSP-4 DSP4:4|DSP-4:4 nchloroethylnethylbromobenzylamine hydrochloride DSP-4 DSP-4:7|DSP4:3 noradrenergic neurotoxin nchloroethylnethylbromobenzylamine DSPC DSPC:8 disaturated pc DSPC DSPC:104 disaturated phosphatidylcholine DSPC DSPC:7 phosphatidyl choline DSP DSP:39 daily sperm production DSP DSP:9 deliberate selfpoisoning DSP DSP:67|Dsp:2 dentin sialoprotein DSP DSP:51 diarrhetic shellfish poisoning DSP DSP:30 digital signal processing DSP DSP:15 digital signal processor DSP DSP:14 disseminated superficial porokeratosis DSP DSP:12 distal sensory polyneuropathy DSP DSP:9 distal symmetric polyneuropathy DSP DSP:12 distal symmetrical polyneuropathy DSP DSP:10 dithiobissuccinimidylpropionate DSRS DSRS:10 depression selfrating scale DSRS DSRS:57|D-SRS:1 distal splenorenal shunt DSR DSR:10 dahl saltresistant DSR DSR:10 daily spontaneous running DSR DSR:10 daily symptom report DSR DSR:26 digital subtraction radiography DSR DSR:28 dynamic spatial reconstructor DSS DSS:25 dejerinesottas syndrome DSS DSS:14 demographic surveillance system DSS DSS:49 dextran sodium sulfate DSS DSS:19 dextran sodium sulphate DSS DSS:102 dextran sulfate sodium DSS DSS:30 dextran sulphate sodium DSS DSS:12 digit symbol substitution DSS DSS:14 dioctyl sodium sulfosuccinate DSS DSS:21 disability status scale DSS DSS:20 discrete subaortic stenosis DSS DSS:85 diseasespecific survival DST DST:4 double stapling technique DST DST:15 drug susceptibility testing DST DST:10 dural sinus thrombosis DST DST:5 vitro drug sensitivity testing DT104 DT104:8 definitive phage type DT104 DT104:14 typhimurium definitive type DTCs DTCs:9 distal tip cells DTCs DTCs:13 dithiocarbamates DTG DTG:38 ditolylguanidine DTG DTG:22 diffuse toxic goiter DTG DTG:11 guanidine DTH DTH:16 hypersensitivity response DTH DTH:5 hypersensitivity skin test DTH DTH:6 hypersensitivity test DTIC DTIC:234 dacarbazine DTIC DTIC:7 dimethyl triazeno imidazole carboxamide DTIC DTIC:9 dimethyltriazenoimidazole carboxamide DTIC DTIC:10 imidazolecarboxamide DT-MRI DT-MRI:19|DTMRI:3 diffusion tensor magnetic resonance imaging DT-MRI DT-MRI:12|DTMRI:2 diffusion tensor mri DTPA DTPA:25 diethylenetriaminepentaacetate DTPA DTPA:273|dtpa:2|DT-PA:1 diethylenetriaminepentaacetic acid DTP DTP:10 developmental therapeutics program DTP DTP:8 diphtheria and tetanus toxoids and pertussis vaccine DTP DTP:1 diphtheria and tetanus toxoids with pertussis DTP DTP:17 diphtheriatetanuspertussis vaccine DTT DTT:22 dithiotreitol DTT DTT:20 dldithiothreitol DTaP DTaP:11 diphtheria and tetanus toxoids and acellular pertussis vaccine DTaP DTaP:5 pertussis vaccine combined with diphtheria and tetanus toxoids DTI DTI:211 diffusion tensor imaging DTI DTI:11 direct thrombin inhibitor DTI DTI:7 drug targeting index DTX DTX:7|DTx:2|Dtx:1 alphadendrotoxin DTX DTX:26|DTx:2|Dtx:1|DtX:1 dendrotoxin DT DT:8|dt:2 decayed teeth DT DT:6 decidual tissue DT DT:14 definitive phage type DT DT:25 delirium tremens DT DT:7 desmoid tumor DT DT:68|dt:2 developed tension DT DT:9 diffraction tomography DT DT:16 diphtheria and tetanus toxoids DT DT:19|D-T:2|dT:1 diphtheriatetanus DT DT:9 dipole tracing DT DT:11 drive for thinness dt dt:25 dystonia musculorum dt dt:13 genetically dystonic DT DT:5 impedance detection times DT DT:16 sabinfeldman dye test DT DT:4 salmonella typhimurium definitive type DUE DUE:12 dna unwinding element DUE DUE:52 evaluation DUI DUI:11 doubly uniparental inheritance DUI DUI:23 driving under the influence of alcohol DUs DUs:10 drug users DUs DUs:13|Dus:1 duodenal ulcers DU DU:7 densitometric units DU DU:71 depleted uranium DU DU:21 duodenal DU DU:11 duodenal ulcer disease DU DU:11 duodenal ulcer patients DVA DVA:9 developmental venous anomaly DVA DVA:22 dynamic visual acuity DVC DVC:17 direct viable count DVC DVC:83 dorsal vagal complex DVD DVD:47 dissociated vertical deviation DVD DVD:6 double vessel disease DVR DVR:14 aortic and mitral valve replacement DVR DVR:33 descending vasa recta DVR DVR:13 distribution volume ratio DVR DVR:23 dorsal ventricular ridge DVR DVR:20 double valve replacement DVR DVR:9 valve replacements DVT DVT:7 deep vein thrombophlebitis DVT DVT:11 deep vein thromboses DVT DVT:6 deep venous thrombophlebitis DVT DVT:13 deep venous thromboses DV DV:77 domestic violence DV DV:45 ductus venosus DWI DWI:13 diffusion DWI DWI:34 diffusionweighted images DWI DWI:318|D-WI:1 diffusionweighted imaging DWI DWI:19 driving while impaired DW DW:7 daily wear DW DW:15 deionized water DW DW:53 distilled water dw dw:53|DW:1 dwarf dw dw:8 dwarf gene dw dw:5 sexlinked dwarfing gene DXA DXA:437 dual energy xray absorptiometry DXA DXA:10 xray absorptiometer DXA DXA:15 xray absorptiometric DXA DXA:7 xray densitometry DXR DXR:11|Dxr:1 deoxydxylulose phosphate reductoisomerase DXR DXR:32 delayed xenograft rejection DXR DXR:15 digital xray radiogrammetry DZ DZ:5 definitive zone DZ DZ:15|Dz:2 diazoxide DZ DZ:10 dizygotic twins DAO DAO:211|dao:1 diamine oxidase DAO DAO:24 dorsal accessory olive DD DD:8 disc diameter DD DD:61 constant dark DD DD:206|D-D:1 constant darkness DD DD:6 constant dim red light DD DD:56 continuous darkness DD DD:33 death domain DD DD:10 degree of deacetylation DD DD:6 delayed depolarization DD DD:10 deletion allele DD DD:12 delusional disorder DD DD:8 density dependence DD DD:14 developmental disabilities DD DD:12 developmental dyslexia DD DD:13 diastolic depolarization DD DD:6|Dd:5 diastolic diameter DD DD:12 diastolic dysfunction DD DD:16 dibenzopdioxin DD DD:111|dd:1|Dd:1 differential display DD DD:7 digital dermatitis DD DD:11 disc diameters DD DD:7 disc displacement DD DD:10 disk diffusion DD DD:11 diverticular disease DD DD:10 dopaminedeficient DD DD:11|dd:1 doubling doses DD DD:19 drug discrimination DD DD:9 duchenne dystrophy DD DD:30 dysthymic disorder DEX DEX:14|Dex:4 hdexamethasone Dex Dex:3|DEX:2 agonist dexmedetomidine DEX DEX:6 dexamethasone phosphate DEX DEX:8|Dex:3 dexrazoxane Dex Dex:9|dex:1 dextranase DIA DIA:7|Dia:1 diaphragmatic DIA DIA:23 digital image analysis DIA DIA:21 dot immunobinding assay DL DL:10 decidual lymphocytes DL DL:5 developmental level DL DL:29 diagnostic laparoscopy DL DL:34 dichotic listening DL DL:17 difference limen DL DL:6 diffuse leiomyomatosis DL DL:6 dim light DL DL:11 direct laryngoscopy DL DL:16 distal latency DL DL:14 dominant lethal DL DL:34|dl:3 dorsolateral DL DL:5 dorsolateral area DL DL:7 dorsolateral visual area dl dl:8|DL:1|Dl:1|dL:1 downless DL DL:9 ductal lavage dl dl:6 maternal morphogen dorsal Dmax Dmax:5|dmax:2 displacement limit Dmax Dmax:7|dmax:1 maximum diameter Dmax Dmax:6|dmax:3 maximum dose DM DM:19 defined medium DM DM:9 deltamethrin DM DM:9|Dm:1 dermorphin DM DM:22 descemets membrane DM DM:13 desmoplastic melanoma DM DM:10 deutschmarks DM DM:6 diabetic group DM DM:8 differentiation medium DM DM:38 disease management DM DM:9 dorsal medulla DM DM:14 dorsomedial medulla DM DM:5 dorsomedial nucleus of the intercollicular complex DM DM:12 dorsomedial visual area DM DM:11 doublemuscled Dm Dm:36|dm:1 drosophila melanogaster DM DM:6|dm:5 dry mass DM DM:515|dm:5 dry matter DM DM:9 dura mater DM DM:11|Dm:2 dystrophia myotonica DM DM:18 hladm Dm Dm:18|DM:9 membrane diffusing capacity DM DM:30 patients with dermatomyositis DM DM:249|Dm:1 patients with diabetes mellitus DN DN:25 dentate nucleus DN DN:12 dibucaine number DN DN:8 donor number DN DN:112|dn:1 double negative DN DN:31 dysplastic nevi Dol-P Dol-P:9 dolichyl monophosphate Dol-P Dol-P:29|dol-P:1|dol-p:1|DolP:1 dolichyl phosphate DQ DQ:11 diquat DQ DQ:11 duroquinone DRMs DRMs:43 detergentresistant membranes DRMs DRMs:7 detergentresistant membrane domains DTS DTS:11 davidson trauma scale DTS DTS:11 dense tubular system DTS DTS:35 diametral tensile strength DTS DTS:7 dipyridamole thallium scintigraphy DXS DXS:8|Dxs:1 deoxydxylulose phosphate synthase DXS DXS:8 diagnostic xray spectrometry E(2) E(2):18 estradiol beta E(2) E(2):89 estradiolbeta E(a) E(a):16|E(A):1 activation energies E(a) E(a):4 effective arterial elastance E/A E/A:12 filling velocity E/A E/A:10 velocities E1S E1S:17|E1-S:1 estrone sulphate E1S E1S:24 oestrone sulphate E1 E1:6 fecal elastase E1 E1:12 pyruvate dehydrogenase component E1 E1:71 ubiquitinactivating enzyme E2 E2:5 dihydrolipoamide acetyltransferase component E2 E2:6 dihydrolipoamide acyltransferase E2 E2:28 dihydrolipoyl acetyltransferase E2 E2:21 dihydrolipoyl transacetylase E2 E2:15 dihydrolipoyl transacylase E2 E2:13 lipoate acetyltransferase E2 E2:4 second envelope glycoprotein E2 E2:15 second envelope protein E2 E2:7|e2:2 second extracellular loop E2 E2:32 serum oestradiol E2 E2:8 ubiquitin carrier protein E3 E3:34 dihydrolipoyl dehydrogenase E3 E3:6 lipoamide dehydrogenase component E3 E3:13 ubiquitinprotein isopeptide ligase EAA EAA:19 electroacupuncture analgesia EAA EAA:12 essential aa EAA EAA:73 extrinsic allergic alveolitis EAC EAC:9 air condensate EAC EAC:10 antibody and complement EAC EAC:5 ascites carcinoma cells EAC EAC:9 early arthritis clinic EAC EAC:140 ehrlich ascites carcinoma EAC EAC:13 erythema annulare centrifugum EAC EAC:70 external auditory canal EADs EADs:9 early after depolarizations EADs EADs:115 early afterdepolarizations EAD EAD:11 early after depolarization EAD EAD:5 extracranial arterial disease EAE EAE:31 experimental allergic encephalitis EAE EAE:18 experimental autoimmune encephalitis EAE EAE:1477 experimental autoimmune encephalomyelitis EAF EAF:18 enzymealtered foci EAF EAF:36 epec adherence factor EAG EAG:20 electroantennogram EAG EAG:22 experimental autoimmune glomerulonephritis EAH EAH:15 essential arterial hypertension EAH EAH:8 experimental autoimmune hepatitis EAM EAM:62 experimental autoimmune myocarditis EAM EAM:10 experimental autoimmune myositis EAM EAM:10 external acoustic meatus EAM EAM:18 external auditory meatus EAN EAN:186 experimental allergic neuritis EAN EAN:124 experimental autoimmune neuritis EAO EAO:28 experimental allergic orchitis EAO EAO:54 experimental autoimmune orchitis EAP EAP:19 electroacupuncture EAP EAP:5 embryonic alkaline phosphatase EAP EAP:24 employee assistance program EAP EAP:13 erythrocyte acid phosphatase EAP EAP:14 experimental autoimmune prostatitis EARS EARS:4 electronic appetite rating system EARS EARS:9 european atherosclerosis research study EAS EAS:7 ectopic acth syndrome EAS EAS:15 electronic article surveillance EAs EAs:11|eas:1 european americans EAS EAS:2 euthanasia and assisted suicide EAS EAS:5 euthanasia and physicianassisted suicide EAs EAs:13|eas:1 evolutionary algorithms EAS EAS:85 external anal sphincter EAT EAT:19 ectopic atrial tachycardia EAT EAT:160 experimental autoimmune thyroiditis EAU EAU:153 experimental autoimmune uveitis EAU EAU:279 experimental autoimmune uveoretinitis EAV EAV:9 entityattributevalue EAV EAV:161 equine arteritis virus EAST EAST:13 emory angioplasty versus surgery trial EAST EAST:23 enzyme allergosorbent test EBA EBA:17 early bactericidal activity EBA EBA:6 electron beam angiography EBA EBA:29 endothelial barrier antigen EBA EBA:138 epidermolysis bullosa acquisita EBA EBA:9 epizootic bovine abortion EBA EBA:25 expanded bed adsorption EBC EBC:12 early breast cancer EBC EBC:68 exhaled breath condensate EBER EBER:11 ebv encoded rna EBER EBER:9 ebvencoded small nuclear rnas EBER EBER:5 ebvencoded small rnas EBER EBER:7 epsteinbarr virus encoded rna EBL EBL:12 endoscopic band ligation EBL EBL:42 enzootic bovine leukosis EBL EBL:48 estimated blood loss EBM EBM:320|EbM:14|E-BM:1 evidencebased medicine EBM EBM:18 expressed breast milk EBP EBP:14 elastin binding protein EBP EBP:34 epidural blood patch EBP EBP:74 evidencebased practice EBRT EBRT:4 empty bed retention time EBRT EBRT:130 external beam radiation therapy EBRT EBRT:8 external beam rt EBS EBS:11 electrical brain stimulation EBs EBs:98 elementary bodies EBs EBs:123 embryoid bodies EBS EBS:75 epidermolysis bullosa simplex EBS EBS:9 ets binding site EBUS EBUS:20 endobronchial ultrasonography EBUS EBUS:11 endobronchial ultrasound EBV EBV:37 epsteinbarr viral EBV EBV:19 estimated blood volume EB EB:9 electron beam EB EB:17 empirical bayes EB EB:8 endometrial biopsy EB EB:30 energy balance EB EB:194 epidermolysis bullosa EB EB:8 erythromycin base EB EB:14 ethylbenzene EB EB:152|Eb:2 evans blue EB EB:17 eyeblink EB EB:1 metabolites epoxybutene EC50 EC50:24 effective concentrations EC50 EC50:1 maximal contraction EC50 EC50:4 of maximal response EC50 EC50:4 of the maximal effect EC50 EC50:7 of the maximum effect EC50 EC50:9 apparent affinity EC50 EC50:5 half maximal contraction EC50 EC50:1 half of the maximal effect EC50 EC50:9 relaxation ECA ECA:10 economic commission for africa ECA ECA:33 electrical control activity ECA ECA:67 enterobacterial common antigen ECA ECA:25 eosinophil chemotactic activity ECA ECA:81 epidemiologic catchment area ECA ECA:8 epidemiologic catchment area program ECA ECA:9 erythrina cristagalli ECA ECA:11 erythrina cristagalli agglutinin ECA ECA:10 external carotid ECA ECA:111 external carotid artery ECC ECC:78 early childhood caries ECC ECC:61 endocervical curettage ECC ECC:24 excitationcontraction coupling ECC ECC:5 external cardiac compression ECC ECC:15 extracorporeal circuit ECDs ECDs:61 equivalent current dipoles ECDs ECDs:18 extracellular domains ECD ECD:74 cysteinate dimer ECD ECD:36 electron capture detector ECD ECD:57 electron capture dissociation ECD ECD:16 endocardial cushion defect ECD ECD:50 endothelial cell density ECD ECD:7 endothelial cell dysfunction ECD ECD:35|E-Cd:1 erdheimchester disease ECD ECD:11 expanded criteria donor ECE ECE:11 embryonated chicken eggs ECE ECE:9 embryonating chicken eggs ECE ECE:45 extracapsular extension ECF ECF:53 east coast fever ECF ECF:64 eosinophil chemotactic factor ECF ECF:10 executive cognitive functioning ECF ECF:393|ecf:2 extracellular fluid ECF ECF:36 extracytoplasmic function ECG ECG:90 electrocardiograph ECG ECG:18 electrocardiographically ECG ECG:23|ECg:12 epicatechin gallate eCG eCG:13|ECG:1 equine cg eCG eCG:57|ECG:1 equine chorionic gonadotrophin eCG eCG:76 equine chorionic gonadotropin ECG ECG:43 exercise electrocardiography ECH ECH:8 enoylcoa hydratase ECH ECH:51 epichlorohydrin ECLAM ECLAM:10 european consensus lupus activity measure ECLAM ECLAM:13 european consensus lupus activity measurement ECL ECL:80 electrochemiluminescence ECL ECL:19 electrochemiluminescent ECL ECL:28 electrogenerated chemiluminescence ECL ECL:55 enhanced chemiluminescence ECL ECL:9 enhanced chemiluminescent ECL ECL:7 enterochromaffinlike cells ECl ECl:51 equilibrium potential ECl ECl:3 equilibrium potential for cl ECL ECL:15 extracorporeal lithotripsy ECMO ECMO:1130 extracorporeal membrane oxygenation ECMO ECMO:17 extracorporeal membrane oxygenator ECM ECM:10 caries monitor ECM ECM:11 endothelial cell monolayers ECM ECM:8 energycorrected milk ECM ECM:43 erythema chronicum migrans ECM ECM:15 experimental cerebral malaria ECM ECM:9 extracellular mass ECM ECM:8 extracellular material ECM ECM:28 extracellular matrix components ECM ECM:25|ecm:1 extracellular matrix proteins ecNOS ecNOS:27|ec-NOS:1|ECNOS:1 endothelial cell nitric oxide synthase ecNOS ecNOS:39|ECNOS:1 endothelial constitutive nitric oxide synthase ecNOS ecNOS:13 endothelial constitutive nos ECP ECP:28 energy charge potential ECP ECP:25 estradiol cypionate ECP ECP:12 external counterpulsation ECP ECP:54 extracorporeal photochemotherapy ECP ECP:43 extracorporeal photopheresis EcR EcR:63|ECR:1 ecdysone receptor EcR EcR:20 ecdysteroid receptor EC-SOD EC-SOD:18|ECSOD:6|ecSOD:2|Ec-SOD:1 extracellular sod EC-SOD EC-SOD:116|ecSOD:12|ECSOD:6|Ec-SOD:2 extracellular superoxide dismutase ECS ECS:9 cow serum ECS ECS:6 elective caesarean section ECS ECS:5 elective cesarean section ECS ECS:10 electrocerebral silence ECS ECS:17 electrochemical stimulation ECS ECS:10 electroconvulsive stimulation ECS ECS:13 electroconvulsive stimuli ECS ECS:6 environmental control system ECS ECS:21 extracapsular spread ECT ECT:40 ecarin clotting time ECT ECT:26 electrochemotherapy ECT ECT:1245 electroconvulsive therapy ECT ECT:48 electroconvulsive treatment ECT ECT:12 endocurietherapy ECU ECU:6 care unit ECU ECU:5 environmental control unit ECU ECU:43 extensor carpi ulnaris ECV ECV:13 ethchlorvynol ECV ECV:78 external cephalic version ECV ECV:9 extracellular virus ECV ECV:88 extracellular volume EC EC:9 committee EC EC:12 complex environment EC EC:8|Ec:1 ecadherin EC EC:55 electrochemical EC EC:14 electron capture EC EC:10 elimination capacity EC EC:9 elongation complex EC EC:121 emergency contraception EC EC:21 emulsifiable concentrate EC EC:10 endochondral EC EC:53 endometrial cancer EC EC:33 endothelial EC EC:12 endothelium EC EC:83 energy charge EC EC:7 energy cost EC EC:9 enkephalincontaining EC EC:8 enriched EC EC:11 enriched condition EC EC:8|ec:1 entericcoated EC EC:96|Ec:1 enterochromaffin EC EC:14 enzyme commission EC EC:10 eosinophilic cystitis EC EC:33 epicatechin EC EC:68 esophageal cancer EC EC:6 esophageal candidiasis EC EC:25 ethyl carbamate EC EC:32 ethyl cellulose EC EC:56|Ec:1 ethylcellulose EC EC:30 eurocollins EC EC:45 european commission EC EC:108 european community EC EC:14 experimental immunemediated blepharoconjunctivitis ED50 ED50:1 of its maximal response ED50 ED50:2 half the maximal response EDA EDA:80 electrodermal activity EDA EDA:9 electron donoracceptor EDA EDA:6 electronic dental anesthesia EDA EDA:15|EDa:2 enddiastolic area EDA EDA:15 exploratory data analysis EDB EDB:72 ethylene dibromide EDB EDB:46|Edb:1 extensor digitorum brevis EDB EDB:4|ED-B:3 extra domain b EDCF EDCF:12 contracting factors EDCF EDCF:28 endotheliumderived contracting factor EDC EDC:25 ethyldimethylaminopropylcarbodiimide EDC EDC:8 ethyldimethylaminopropylcarbodiimide hydrochloride EDC EDC:5 ethyldimethylaminopropyl carbodiimide hydrochloride EDC EDC:9 compounds EDC EDC:13 date of confinement EDC EDC:14 endocrine disrupting chemicals EDC EDC:13 epidermal differentiation complex EDC EDC:34 ethanolderived calories EDC EDC:13 ethylene dichloride EDC EDC:68|edc:1 extensor digitorum communis EDC EDC:9 ndimethylaminopropylnethylcarbodiimide EDD EDD:12 date of delivery EDD EDD:29 enddiastolic diameter EDD EDD:13 endotheliumdependent dilation EDD EDD:11 esophageal detector device EDH EDH:18 epidural hematoma EDH EDH:7 extradural haematoma EDH EDH:15 extradural hematoma EDL EDL:12 efferent duct ligation EDL EDL:7 electric double layer EDL EDL:9|edL:3 enddiastolic length EDL EDL:9 enddiastolic segment length EDL EDL:8|edl:1 fasttwitch EDPVR EDPVR:8 enddiastolic pressurevolume relation EDPVR EDPVR:8 enddiastolic pressurevolume relationship EDP EDP:9 elastinderived peptides EDP EDP:20 electronic data processing EDP EDP:10 erythema dyschromicum perstans EDP EDP:13 estradiol dipropionate EDR EDR:70 endotheliumdependent relaxation EDR EDR:8 excess death rate EDR EDR:10 extreme drug resistance EDSS EDSS:5 expanded disability scale score EDSS EDSS:368 expanded disability status scale EDSS EDSS:13 expanded disability status score EDs EDs:61|Eds:1 eating disorders EDS EDS:6 edinburgh depression scale EDs EDs:283|EDS:1 emergency departments EDs EDs:9|EDS:1 endocrine disrupters EDs EDs:22 endocrine disruptors EDS EDS:17 energy dispersive spectrometry EDS EDS:20 energydispersive spectroscopy EDs EDs:15|EDS:1 epileptiform discharges EDS EDS:21 ethane dimethane sulfonate EDS EDS:42 ethane dimethane sulphonate EDS EDS:19 ethane dimethanesulfonate EDS EDS:29 ethane dimethanesulphonate EDS EDS:14 ethylene dimethane sulfonate EDS EDS:9 ethylene dimethanesulphonate EDS EDS:155 excessive daytime sleepiness EDS EDS:22 excessive daytime somnolence EDTA EDTA:16 acid disodium salt EDTA EDTA:6 calcium disodium ethylenediaminetetraacetate EDTA EDTA:23 disodium edetate EDTA EDTA:7 ethylene diamine tetraacetate EDTA EDTA:48 ethylene diamine tetraacetic acid EDTA EDTA:128 ethylenediamine tetraacetic acid EDTA EDTA:573|edta:2 ethylenediaminetetraacetic acid EDU EDU:16|EdU:1 ethyldeoxyuridine EDU EDU:15 ethylenediurea EDV EDV:39 enddiastolic EDV EDV:6 end diastolic velocities EDV EDV:18 enddiastolic volumes EDV EDV:14 endotheliumdependent vasodilatation EDV EDV:23 endotheliumdependent vasodilation EDX EDX:11 edatrexate EDX EDX:16 electrodiagnostic EDX EDX:33 energydispersive xray EDX EDX:8 xray spectrometry ED ED:8|E-D:1 deprivation ED ED:10 early distal ED ED:5 effector domain ED ED:13 electrodialysis ED ED:38 elemental diet ED ED:9 endogenous depression ED ED:10 endolymphatic duct ED ED:30 energy density ED ED:15 enteric drainage ED ED:17|E-D:1 entnerdoudoroff ED ED:10 enumeration district ED ED:16 epithelial dysplasia ED ED:18 equilibrium dialysis ED ED:978 erectile dysfunction ED ED:7 erythrocyte deformability ED ED:9 essential dynamics ED ED:11 external diameter EE2 EE2:19 alphaethynylestradiol EE2 EE2:61|eE2:1 ethinyl estradiol EEA1 EEA1:6 early endosomal autoantigen EEA1 EEA1:14|EEA-1:1 early endosome antigen EEA EEA:21 endtoend anastomosis EEA EEA:8 european economic area EEC EEC:18 ectrodactylyectodermal dysplasiaclefting EEC EEC:8 endogenous erythroid colony EEC EEC:16 endometrial epithelial cells EEC EEC:40 european economic community EEE EEE:87 eastern equine encephalitis EEE EEE:61 eastern equine encephalomyelitis EEG EEG:18 brain electrical activity EEG EEG:6 electrical activity of the brain EEG EEG:128 electroencephalograph EEG EEG:19 electroencephalographic activity EEG EEG:11 electroencephalographically EEG EEG:874 electroencephalography EEG EEG:14 videoelectroencephalographic EEG EEG:13 videoelectroencephalography EEM EEM:12 excitationemission matrix EEM EEM:45 external elastic membrane EEP EEP:27 ethanol extract of propolis EEP EEP:15 ethanolic extract of propolis EER EER:16 electrically evoked response EER EER:10 ethanol elimination rate EE EE:12 alphaethinylestradiol EE EE:9 emotional exhaustion EE EE:14 encapsulation efficiency EE EE:12|E-E:3 endtoend EE EE:9 endocardial endothelial EE EE:20 endocardial endothelium EE EE:15 enriched environment EE EE:13 environmental enrichment EE EE:10 eosinophilic esophagitis EE EE:8 erosive esophagitis EE EE:11 erythromycin estolate EE EE:23 ether extract EE EE:10 exercise echocardiography EE EE:26 exoerythrocytic EE EE:239 expressed emotion EFAD EFAD:13|EFA-D:1 efadeficient EFAD EFAD:66 essential fatty acid deficiency EFA EFA:6 enamelfree area EFA EFA:9 ethoxyformic anhydride EFA EFA:12 euglobulin fibrinolytic activity EFA EFA:18 exploratory factor analysis EFE EFE:23 endocardial fibroelastosis EFE EFE:8 ethyleneforming enzyme EFM EFM:51 electronic fetal monitoring EFM EFM:7 epifluorescence microscopy EFP EFP:17 early follicular phase EFP EFP:18 endoneurial fluid pressure EFs EFs:12 electric fields EFS EFS:668 electrical field stimulation EFs EFs:9 embryonic fibroblasts EFS EFS:11 empty follicle syndrome EFs EFs:12 enantiomer fractions EFs EFs:10 enantiomeric fractions EFS EFS:27 eventfree EFS EFS:742 eventfree survival EFs EFs:10 executive functions EFT EFT:16 embedded figures test EFT EFT:6 emotionally focused therapy EF EF:17 early follicular EF EF:6 enteral feeding EF EF:51 eosinophilic fasciitis EF EF:9 eosinophilic folliculitis EF EF:24 erectile function EF EF:17 executive functioning EF EF:7 exoplasmic face EF EF:11 external fixation EGb EGb:13|EGB:5 extract of ginkgo biloba EGb EGb:6|EGB:1 extract of ginkgo biloba leaves EGFR EGFR:12|egfr:1|Egfr:1 epidermal growth factor receptor gene EGFR EGFR:5|EGF-r:1 receptor for egf EGFP EGFP:35|eGFP:3|egfp:1 enhanced gfp EGFP EGFP:721|eGFP:98|egfp:2|E-GFP:1|EGFp:1 enhanced green fluorescent protein EGP EGP:128 endogenous glucose production EGP EGP:14 ethanolamine glycerophospholipids Egr-1 Egr-1:26|EGR-1:4|egr-1:2|EGR1:1 early growth response factor Egr-1 Egr-1:9|Egr1:1 early growth response protein EGRAC EGRAC:7|EGR-AC:2 erythrocyte glutathione reductase activation coefficient EGRAC EGRAC:9|EGR-AC:2 erythrocyte glutathione reductase activity coefficient EGS EGS:12 equine grass sickness EGS EGS:17 external guide sequence EGTA EGTA:8 calcium chelator EGTA EGTA:7 chelating agent EGR EGR:11 enterogastric reflux EGR EGR:16|E-GR:1|eGR:1 erythrocyte glutathione reductase EG EG:42 embryonic germ EG EG:12 enteroglucagon EG EG:31 eosinophilic granuloma EG EG:248 ethylene glycol EG EG:8 excitable gap EG EG:26 experimental group EG EG:7 local treatment with essaven gel EHC EHC:36 enterohepatic circulation EHC EHC:5 first drafts of environmental health criteria EHD EHD:13 epizootic haemorrhagic disease EHD EHD:25 epizootic hemorrhagic disease EHDP EHDP:25 diphosphonate EHDP EHDP:27 disodium ethanehydroxydiphosphonate EHDP EHDP:23 disodium etidronate EHDP EHDP:18 etidronate disodium EHDV EHDV:21 epizootic haemorrhagic disease virus EHDV EHDV:51 epizootic hemorrhagic disease virus EHEC EHEC:15 coli oh EHEC EHEC:1 enterohaemorrhagic e coli EHEC EHEC:17 enterohemorrhagic EHEC EHEC:189 enterohemorrhagic escherichia coli EHL EHL:47 electrohydraulic lithotripsy EHL EHL:9 evaporative heat loss EHL EHL:25 extensor hallucis longus EHPVO EHPVO:22 extrahepatic portal vein obstruction EHPVO EHPVO:22 extrahepatic portal venous obstruction EHS EHS:89 engelbrethholmswarm EHS EHS:9 exertional heat stroke EHT EHT:8 engineered heart tissue EHT EHT:15 essential hypertensives EHV-4 EHV-4:9|EHV4:3 equine herpesvirus EHV-4 EHV-4:11|EHV4:1 equine herpesvirus type EIA EIA:17 electroimmunoassay EIA EIA:20 environmental impact assessment EIA EIA:6 enzyme immunoassay method EIA EIA:42 enzyme immunosorbent assay EIA EIA:45 enzymeimmunoassay EIA EIA:12 enzymoimmunoassay EIA EIA:40 equine infectious anemia EIA EIA:9 exerciseinduced anaphylaxis EIA EIA:246|E-IA:1 exerciseinduced asthma EIA EIA:20 external iliac artery EIB EIB:88 exerciseinduced bronchoconstriction EIB EIB:87 exerciseinduced bronchospasm EIC EIC:27 elastase inhibitory capacity EIC EIC:18 endometrial intraepithelial carcinoma EIC EIC:41 extensive intraductal component EIEC EIEC:1 enteroinvasive e coli EIEC EIEC:63 enteroinvasive escherichia coli eIF-5A eIF-5A:40|eIF5A:10 eukaryotic initiation factor a eIF-5A eIF-5A:15|eIF5A:10 eukaryotic translation initiation factor a EIH EIH:10 exerciseinduced hypoxaemia EIH EIH:19 exerciseinduced hypoxemia EIPA EIPA:20 ethylisopropyl amiloride EIPA EIPA:70 ethylisopropylamiloride EIPH EIPH:37 exerciseinduced pulmonary haemorrhage EIPH EIPH:31 exerciseinduced pulmonary hemorrhage EIP EIP:10 early intervention program EIP EIP:9 endinspiratory pause EIP EIP:11 extensor indicis proprius EIS EIS:18 electrical impedance scanning EIS EIS:66 electrochemical impedance spectroscopy EIS EIS:94 endoscopic injection sclerotherapy EIS EIS:14 epidemic intelligence service EITB EITB:9 blot technique EITB EITB:65 enzymelinked immunoelectrotransfer blot EITB EITB:10 enzymelinked immunoelectrotransfer blot assay EIT EIT:194 electrical impedance tomography EIT EIT:10 electromagnetically induced transparency EJCs EJCs:10 excitatory junction currents EJCs EJCs:8|ejcs:2 excitatory junctional currents EKC EKC:36 electrokinetic chromatography EKC EKC:40 epidemic keratoconjunctivitis EKC EKC:9 ethylketazocine EKC EKC:96|Ekc:2 ethylketocyclazocine EK EK:10 electrophoretic karyotype EK EK:15 electrophoretic karyotyping EK EK:16 enterokinase EK EK:4 equilibrium potential of k EK EK:38|Ek:4 k equilibrium potential EK EK:8 potential for potassium ELC ELC:4 diagonal earlobe crease ELC ELC:5 ear lobe crease ELC ELC:11 ebiligand chemokine ELC ELC:11 epidermal langerhans cells ELC ELC:14|E-LC:2 essential light chain ELC ELC:9 expressionlinked copy ELC ELC:9 ligand chemokine ELISAs ELISAs:13 enzymelinked immunoassays ELISAs ELISAs:567|ELISAS:2|ELI-SAs:1 enzymelinked immunosorbent assays ELISA ELISA:39 enzymelinked immunosorbent ELISA ELISA:4 enzymelinked immunosorbent analysis ELISA ELISA:15 immunoenzymatic ELISA ELISA:12 immunoenzymatic test ELISA ELISA:10|Elisa:1 immunoenzyme test ELI ELI:13 enkephalinlike immunoreactivity ELI ELI:11 expression library immunization ELP ELP:9 elastaselike protease ELP ELP:11 elastinlike polypeptide ELP ELP:13 endozepinelike peptide ELP ELP:5 lipid pneumonia ELP ELP:6 lipoid pneumonia ELS ELS:6 eatonlambert syndrome ELS ELS:9 extended least squares ELS ELS:6 extralobar pulmonary sequestration ELT ELT:12 endoscopic laser therapy ELT ELT:76 euglobulin lysis time EL EL:6 ejaculation latency EL EL:34 endothelial lipase EL EL:17 erythroleukemia EL EL:22 lung elastance EMAP EMAP:9 echinoderm microtubuleassociated protein EMAP EMAP:7 endothelial monocyteactivating polypeptide EMAP EMAP:10 environmental monitoring and assessment program EMA EMA:10|EmA:2 antiendomysial antibody EMA EMA:13|EmA:2 antiendomysium EMA EMA:12 ecological momentary assessment EMA EMA:9|EmA:3 endomysium EMA EMA:9|EmA:6 endomysium antibodies EMA EMA:16 eosinmaleimide EMA EMA:656 epithelial membrane antigen EMA EMA:9 eyelid myoclonia with absences EMA EMA:4|EmA:3 iga antiendomysial antibodies EMC-D EMC-D:8 d variant of encephalomyocarditis EMC-D EMC-D:20 d variant of encephalomyocarditis virus EMC EMC:12 electromagnetic compatibility EMC EMC:233 encephalomyocarditis EMC EMC:18 epithelialmyoepithelial carcinoma EMC EMC:17 essential mixed cryoglobulinaemia EMC EMC:50 essential mixed cryoglobulinemia EMC EMC:28 extraskeletal myxoid chondrosarcoma EMD EMD:28 electromechanical delay EMD EMD:63 electromechanical dissociation EMD EMD:9 emdogain EMD EMD:10 enzymatic mutation detection EMD EMD:9 extramedullary disease EMD EMD:17 eye movement desensitization EME EME:9 early myoclonic encephalopathy EME EME:39 ecgonine methyl ester EMF EMF:12 electromagnetic flowmeter EMF EMF:11|emf:6 electromotive force EMF EMF:61 endomyocardial fibrosis EMGdi EMGdi:22|EMGdI:1 diaphragmatic electromyogram EMGdi EMGdi:6|EMGDi:1|EMG-DI:1 diaphragmatic emg EMG EMG:75 electromyograph EMG EMG:162 electromyographic activity EMG EMG:30 electromyographical EMG EMG:13 electromyographically EMG EMG:11 experimental myasthenia gravis EMLA EMLA:6|Emla:1 eutectic mixture of lidocaine and prilocaine EMLA EMLA:17 eutectic mixture of local anaesthetics EMND EMND:19 equine motor neuron disease EMND EMND:9 ethylmorphinendemethylase EMR EMR:21 eastern mediterranean region EMR EMR:12 educable mentally retarded EMR EMR:17 electromagnetic radiation EMR EMR:176 endoscopic mucosal resection EMSA EMSA:9 electrophoretic mobility shift analyses EMSA EMSA:262 electrophoretic mobility shift assays EMS EMS:10 electrical muscle stimulation EMS EMS:24 electromyostimulation EMS EMS:14 electrophoretic mobility shift EMS EMS:36 ethyl methane sulfonate EMS EMS:11 ethyl methane sulphonate EMS EMS:306 ethyl methanesulfonate EMS EMS:80 ethyl methanesulphonate EMS EMS:8 ethylmethane sulphonate EMS EMS:42 ethylmethanesulfonate EMS EMS:17 ethylmethanesulphonate EMTALA EMTALA:17 emergency medical treatment and active labor act EMTALA EMTALA:19 emergency medical treatment and labor act EMTs EMTs:104 emergency medical technicians EMTs EMTs:5 epithelialmesenchymal transitions EMT EMT:6 epithelialmesenchymal transdifferentiation EMT EMT:30 epithelialmesenchymal transformation EMT EMT:71 epithelialmesenchymal transition EMT EMT:27 epithelial to mesenchymal transition EMT EMT:18 extraneuronal monoamine transporter EMT EMT:9 transitions EMU EMU:12 early morning urine EMU EMU:5 extravehicular mobility unit Em Em:5|EM:1|em:1 early diastolic velocity EM EM:12 egg mass EM EM:9|Em:3 elastic modulus EM EM:139|em:5 electromagnetic EM EM:9 electron micrographs EM EM:118 electron microscope EM EM:12 electron microscopical EM EM:11 electronmicroscopy EM EM:218 emergency medicine EM EM:14|Em:3 endometriosis EM EM:14 epidural morphine EM EM:5 episodic memory EM EM:9 ergonovine maleate EM EM:83|Em:1 erythema migrans EM EM:87 erythema multiforme EM EM:7 erythrocyte membrane EM EM:6 esophageal manometry EM EM:21 estramustine EM EM:23 ethylmorphine EM EM:19 extracellular matrix EM EM:10 extramedullary EM EM:14 eye movement EM EM:13 eye muscle Em Em:10|E-m:1 midpoint potentials ENA-78 ENA-78:10 neutrophilactivating peptide ENA-78 ENA-78:5 neutrophil activating peptide ENA ENA:1|Ena:1 ace inhibitor enalapril ENA ENA:13 erythrocytic nuclear abnormalities ENG ENG:16 electroneurogram ENG ENG:19 electronystagmogram ENG ENG:40 electronystagmographic ENG ENG:135 electronystagmography ENG ENG:11 endoglin ENL ENL:16|Enl:5 enterolactone ENL ENL:149 erythema nodosum leprosum eNOS eNOS:6 endothelial isoform eNOS eNOS:12|e-NOS:1 endothelial nitric oxide eNOS eNOS:5 endothelial nitric oxide synthetase eNOS eNOS:10|e-NOS:1 endothelial nosynthase ENR ENR:8 enoyl acyl carrier protein reductase ENR ENR:14|Enr:2 enrofloxacin ENS ENS:9 electrical nerve stimulation ENS ENS:192 enteric nervous system ENS ENS:10 epidermal nevus syndrome ENS ENS:5 extranodal spread ENT ENT:3 ear nose and throat ENT ENT:18 earnosethroat ENT ENT:6 embryonic nervous tissue ENT ENT:12|Ent:1 equilibrative nucleoside transporter ENU ENU:13 nethylnitrosourea ENU ENU:10 nnitrosonethylurea EN EN:5 egg number EN EN:9 electronic nose EN EN:16|En:1 enalapril EN EN:13 endemic nephropathy EN EN:9 enteral EN EN:137 enteral nutrition EN EN:11 epinephrine EN EN:66 erythema nodosum EN EN:8 ethyl nicotinate EOAD EOAD:11 earlyonset ad EOAD EOAD:16 earlyonset alzheimers disease EOCA EOCA:7 early onset cerebellar ataxia EOCA EOCA:14 early onset cerebellar ataxia with retained tendon reflexes EOC EOC:113 epithelial ovarian cancer EOC EOC:28 epithelial ovarian carcinoma EOC EOC:10 obstetric care EOD EOD:88 electric organ discharge EOD EOD:21 extent of disease EOF EOF:294 electroosmotic flow EOF EOF:10 erythrocyte osmotic fragility EORTC EORTC:60 european organisation for research and treatment of cancer EORTC EORTC:14 european organization for research on treatment of cancer EOS EOS:10 endogenous opioid system EOS EOS:9 equation of state EOS EOS:10 ethanolamineosulphate EOS EOS:2 gabatransaminase inhibitor ethanolamineosulfate EPA EPA:10 eicosapentaenoate EPA EPA:106 eicosapentaenoic EPA EPA:1006 eicosapentaenoic acid EPA EPA:5 extrapulmonary artery EPC EPC:5 early prostate cancer EPC EPC:26 ectoplacental cone EPC EPC:9 enhanced primary care EPC EPC:44|epc:1|Epc:1 epilepsia partialis continua EPC EPC:13 epithelioma papulosum cyprini EPC EPC:15 erosive prepyloric changes EPC EPC:5 exocrine pancreatic cancer EPC EPC:13 external pneumatic compression EPD EPD:12 eukaryotic promoter database EPD EPD:8 expected progeny differences EPEC EPEC:8 education for physicians on endoflife care EPEC EPEC:57 enteropathogenic EPEC EPEC:2 enteropathogenic e coli EPE EPE:8 eosinophilic pleural effusion EPE EPE:21 extraprostatic extension EPF EPF:113 early pregnancy factor EPF EPF:11 endemic pemphigus foliaceus EPF EPF:26 eosinophilic pustular folliculitis EPIC EPIC:96 european prospective investigation into cancer and nutrition EPIC EPIC:4 european prospective investigation of cancer EPIC EPIC:7 evaluation of e for the prevention of ischemic complications EPI EPI:10 echoplanar Epi Epi:15|EPI:13|epi:4 epicardial Epi Epi:7|epi:4|EPI:3 epicardium EPI EPI:10|Epi:6 epididymal EPI EPI:15 epidoxorubicin EPI EPI:9 epidural EPI EPI:6|Epi:5|epi:1 epimastigotes EPI EPI:34|epi:1 exocrine pancreatic insufficiency EPI EPI:20 expanded program of immunization EPI EPI:3 expanded programme of immunisation EPI EPI:165 expanded programme on immunization EPI EPI:35 extrinsic pathway inhibitor EPI EPI:57 eysenck personality inventory EPI EPI:13|Epi:10|epi:1 subepicardium EPL EPL:11 early pregnancy loss EPL EPL:17 essential phospholipids EPL EPL:10 expressed protein ligation EPL EPL:28 extensor pollicis longus EPL EPL:46|epl:1 external plexiform layer EPL EPL:20 extracorporeal piezoelectric lithotripsy EPMA EPMA:55 electron probe microanalysis EPMA EPMA:7 electron probe microanalyzer EPM EPM:6 electronic performance monitoring EPM EPM:67 equine protozoal myeloencephalitis EPM EPM:13 extrapontine myelinolysis EPM EPM:6 ph monitoring EPN EPN:21 emphysematous pyelonephritis EPN EPN:8 oethyl opnitrophenyl phenylphosphonothioate EPP EPP:118 erythropoietic protoporphyria EPP EPP:8 ethyl phenylpropiolate EPP EPP:11 extrapair paternity EPP EPP:14 extrapleural pneumonectomy EPR EPR:8 earlyphase reaction EPR EPR:53 electron paramagnetic resonance spectroscopy EPs EPs:17 ectopic pregnancies EPS EPS:17 elastosis perforans serpiginosa EPS EPS:5 electrical promontory stimulation EPs EPs:85 emergency physicians EPS EPS:7 emotionalpain stress EPS EPS:29 encapsulating peritoneal sclerosis EPS EPS:10 expanded polystyrene EPS EPS:19 extrapyramidal signs EPS EPS:203 extrapyramidal symptoms EP EP:5 bovine encephalitogenic protein EP EP:25 eprostanoid EP EP:6 early phase EP EP:27 egg production EP EP:58 electrophysiologic EP EP:28 electrophysiological EP EP:32 electrophysiology EP EP:36 emergency physician EP EP:6 encephalitogenic peptide EP EP:206|-EP:1 endocochlear potential EP EP:10 endocrineparacrine EP EP:62 endogenous pyrogen EP EP:9 enzootic pneumonia EP EP:13 eosinophilic pneumonia EP EP:5 equilibrium point EP EP:9 escape protein EP EP:8|E-P:3 estrogenprogesterone EP EP:24 etoposide and cisplatin EP EP:11 etoposide phosphate EP EP:10 etoposide plus cisplatin EP EP:6 pge receptors EP EP:40|E-P:13 phosphoenzyme EP EP:8|E-P:2 phosphoenzyme intermediate EP EP:18|E-P:3 phosphorylated intermediate EP EP:9 vivo electroporation EQA EQA:95 external quality assessment EQA EQA:24 external quality assurance EQ EQ:6 efficiency quotient EQ EQ:39 ethoxyquin ERA ERA:6 early rheumatoid arthritis ERA ERA:23 ecological risk assessment ERA ERA:11 electrical response activity ERA ERA:9 estrogen replacement and atherosclerosis ERCP ERCP:51 endoscopic retrograde cholangiopancreaticography ERCP ERCP:14 endoscopic retrograde cholangiopancreatogram ERCP ERCP:10 endoscopic retrograde cholangiopancreatographic ERCP ERCP:1372|ER-CP:1 endoscopic retrograde cholangiopancreatography ERD ERD:132 eventrelated desynchronization ERD ERD:12 extrapolated response dose ERF ERF:5 excitatory receptive field ERF ERF:13 external respiration function ERF ERF:10 external respiratory function ERGIC ERGIC:14 endoplasmic reticulumgolgi intermediate compartment ERGIC ERGIC:17 ergolgi intermediate compartment ERG ERG:146 electroretinographic ERG ERG:248 electroretinography ERG ERG:6|erg:5 etheragogorelated gene ERISA ERISA:24 employee retirement income security act ERISA ERISA:22 employee retirement income security act of ERK ERK:7|Erk:2 extracellular regulated kinases ERK ERK:11 extracellular regulated protein kinase ERK ERK:10|Erk:1 extracellular signalregulated ERNA ERNA:13 equilibrium radionuclide angiocardiography ERNA ERNA:24 equilibrium radionuclide angiography EROD EROD:5 ethoxyresorufin odealkylation EROD EROD:9 deethylation EROD EROD:8 ethoxyresorufin deethylase EROD EROD:8 odeethylase activity ERPs ERPs:46 effective refractory periods ERPs ERPs:1412|ERPS:4 eventrelated potentials ERP ERP:13 effective ERP ERP:6 eledoisinrelated peptide ERP ERP:7 endoscopic retrograde pancreaticography ERP ERP:5 enzymereleasing peptide ERP ERP:4 exposure and response prevention ERs ERs:8|ers:1 enantiomeric ratios ERs ERs:368|Ers:1 estrogen receptors ERT ERT:11 emergency room thoracotomy ERT ERT:437 estrogen replacement therapy ERT ERT:5 external irradiation ERT ERT:17|eRT:2 external radiotherapy ER ER:7 electrical resistance ER ER:14 electrorheological ER ER:316 emergency room ER ER:11 endoplasmic reticular ER ER:10 endoscopic resection ER ER:10 energyrestricted ER ER:34 energy restriction ER ER:9 energy retention ER ER:12 enhanced reactivation ER ER:8 estrogen receptor status ER ER:15 external rotation ER ER:27 extraction ratio ER ER:94 oestrogen receptors ER ER:6 oestrogen receptor status ER ER:1 receptors of estrogens ESAS ESAS:10 edmonton symptom assessment scale ESAS ESAS:14 edmonton symptom assessment system ESA ESA:4 endocardial surface area ESA ESA:5 epidermal surface antigen ESA ESA:7 ethanesulfonic acid ESA ESA:27 european space agency ESA ESA:5 excited state absorption ESBL-KP ESBL-KP:2|ESBL-Kp:2 betalactamase producing klebsiella pneumoniae ESBL-KP ESBL-KP:5|ESBLKp:1|ESBL-Kp:1 extendedspectrum betalactamaseproducing klebsiella pneumoniae ESC ESC:7 enteric septicemia of catfish ESC ESC:11 environmental stress cracking ESC ESC:15 esophageal squamous cell carcinoma ESC ESC:27 european society of cardiology ESEM ESEM:29 environmental scanning electron microscope ESEM ESEM:54 environmental scanning electron microscopy ESES ESES:7 electrical status epilepticus during sleep ESES ESES:7 epidural spinal electrical stimulation ESF ESF:7 erythropoiesis stimulating factors ESF ESF:11 external skeletal fixator ESI-MS ESI-MS:5|ESIMS:1 electrospray ionization mass spectrometric ESI-MS ESI-MS:11 electrospray ionization mass spectroscopy ESI ESI:77 electron spectroscopic imaging ESI ESI:75 electrospray ionisation ESI ESI:579 electrospray ionization ESI ESI:7 emergency severity index ESM ESM:55 ethosuximide ESM ESM:17 experience sampling method ESP ESP:12 electrostatic potential ESP ESP:17 electrostatic precipitator ESP ESP:14 endsystolic pressure ESP ESP:11 eosinophil stimulation promoter ESP ESP:9 european spine phantom ESP ESP:9 extrasensory perception ESRD ESRD:22 endstage renal failure ESRD ESRD:9 renal disease patients ESs ESs:12 effect sizes ESS ESS:24 empty sella syndrome ESS ESS:16 endsystolic stress ESS ESS:118 endoscopic sinus surgery ESS ESS:176 epworth sleepiness scale ESS ESS:12 epworth sleepiness score ESS ESS:10 euthyroid sick syndrome ESs ESs:13 expression sites ESS ESS:11 splicing silencer EST EST:7 electroshock seizure threshold EST EST:6 electroshock treatment EST EST:12 embryonic stem cell test EST EST:45 estrogen sulfotransferase EST EST:16 exercise stress test EST EST:15 exercise stress testing EST EST:566 expressed sequence tag ESWT ESWT:55 extracorporeal shock wave therapy ESWT ESWT:7 extracorporeal shock wave treatment ESWT ESWT:24 extracorporeal shockwave therapy ES ES:13 ectoplasmic specialization Es Es:9|ES:1 ego strength ES ES:8 electrically stimulated ES ES:24 electrostimulation ES ES:12 embolic signals ES ES:15 emotional stress ES ES:10 endometrial stromal ES ES:17 endostatin ES ES:9 endotoxic shock ES ES:7 endotoxin shock ES ES:9 engraftment syndrome ES ES:20 enzyme estrone sulfatase ES ES:13|E-S:3 enzymesubstrate ES ES:10 enzymesubstrate complex ES ES:6 epilepsy surgery ES ES:25 epileptic seizures ES ES:23 epithelioid sarcoma ES ES:37|Es:1 erector spinae ES ES:11 erythromycin stearate Es Es:8|ES:1 estrogens ES ES:17 exanthem subitum ES ES:9|E-S:2 excretory and secretory ES ES:14 expression site ES ES:15 extent score es es:7|ES:2 external sensory es es:7 nitrobenzylthioinosine nbmprsensitive ES ES:6 sweetened ethanol solution ETAAS ETAAS:5|ET-AAS:4 atomic absorption spectrophotometry ETAAS ETAAS:53|ET-AAS:7 electrothermal atomic absorption spectrometry ETA ETA:8 eicosatetraynoic acid ETA ETA:32|ET-A:10|ETa:1 endothelina ETA ETA:6 endothelin receptor ETA ETA:13|Eta:1 etanidazole ETA ETA:13 european thyroid association ETA ETA:6 extrathoracic airway ETBF ETBF:1 enterotoxigenic b fragilis ETBF ETBF:18 enterotoxigenic bacteroides fragilis ETB ETB:22|ET-B:7 endothelinb ETB ETB:10|ET-B:1|ETb:1 endothelin type b ETCO2 ETCO2:5|EtCO2:1 carbon dioxide concentration ETCO2 ETCO2:12 endtidal co concentration ETC ETC:76 electron transport chain ETC ETC:13 esophageal tracheal combitube ETEC ETEC:12 enterotoxigenic e coli ETEC ETEC:500 enterotoxigenic escherichia coli ETF ETF:39 electron transfer flavoprotein ETF ETF:26 electrontransferring flavoprotein ETF ETF:8 enteral tube feeding ETI ETI:10 eicosatriynoic acid ETI ETI:9 early transient incapacitation ETL ETL:14 echo train length ETL ETL:7 enteropathytype tcell lymphoma ETP ETP:11 electron transport particles ETP ETP:36 endogenous thrombin potential ETR ETR:15 effective thyroxine ratio ETR ETR:6 electron transport rate ETR ETR:12 endoftreatment response ETT ETT:12 epithelioid trophoblastic tumor ETT ETT:6 esophageal transit time ETT ETT:23 exercise tolerance test ETT ETT:6 exercise tolerance time ETT ETT:24 exercise treadmill test ETT ETT:20 exercise treadmill testing ETU ETU:11 erythron transferrin uptake ETU ETU:24 ethylene thiourea ETU ETU:110 ethylenethiourea ETV ETV:69 endoscopic third ventriculostomy ETV ETV:9 extravascular thermal volume ET ET:86 ejection time ET ET:21|et:1|Et:1 endtidal ET ET:11 endometrial thickness ET ET:9 endotoxins ET ET:67 endotracheal ET ET:27|E-T:1 endotracheal tube ET ET:11 endurance training ET ET:15 escherichia coli endotoxin ET ET:14 esotropia ET ET:141 essential thrombocythaemia ET ET:363 essential thrombocythemia ET ET:32 essential thrombocytosis ET ET:251 essential tremor ET ET:20 estrogen therapy ET ET:147 eustachian tube ET ET:9 evapotranspiration ET ET:10 evolutionary trace ET ET:33 exchange transfusion ET ET:30 exercise testing ET ET:11 exercise tolerance ET ET:26 exfoliative toxin EUA EUA:11 examination under anaesthesia EUA EUA:14 examination under anesthesia EUS EUS:7 endoscopic sonography EUS EUS:11 endoscopic ultrasonographic EUS EUS:545 endoscopic ultrasonography EUS EUS:320 endoscopic ultrasound EUS EUS:18 epizootic ulcerative syndrome EUS EUS:58 external urethral sphincter EU EU:15 elisa units EU EU:18 endotoxin units EU EU:11|Eu:1 european EU EU:440 european union EVAR EVAR:30 endovascular abdominal aortic aneurysm repair EVAR EVAR:73 endovascular aneurysm repair EVAR EVAR:19 endovascular aortic aneurysm repair EVA EVA:12 enlarged vestibular aqueduct EVA EVA:15 equine viral arteritis EVA EVA:6 ethylene vinyl acetate copolymer EVD EVD:11 external ventricular drain EVD EVD:24 external ventricular drainage EVLW EVLW:246 extravascular lung water EVLW EVLW:9 extravascular lung water volume EVL EVL:70 endoscopic variceal ligation EVL EVL:12 enveloping layer EVR EVR:6 early virological response EVR EVR:17|evr:1 endocardial viability ratio EVS EVS:11 endophthalmitis vitrectomy study EVS EVS:28 endoscopic variceal sclerotherapy EV EV:24 ectromelia virus ev ev:16 endogenous viral ev ev:6|EV:5 endogenous virus EV EV:9 enteroviral EV EV:105|Ev:2|ev:1 epidermodysplasia verruciformis EV EV:5 erythrocyte volume EV EV:24 esophageal varices EV EV:76 estradiol valerate EW EW:24|E-W:1 edingerwestphal nucleus EW EW:34 egg weight EW EW:9 egg white EW EW:7 emergency ward EW EW:21 extended wear EW EW:23 external work EW EW:7 nucleus of edingerwestphal EXAFS EXAFS:186|EX-AFS:2 extended xray absorption fine structure EXAFS EXAFS:14 extended xray absorption fine structure spectroscopy EZ EZ:20|E-Z:5 edmonstonzagreb EZ EZ:10 epileptogenic zone EA EA:9|Ea:3 early amniocentesis EA EA:62|Ea:2 early antigens EA EA:16 effect of electroacupuncture EA EA:20 effort angina EA EA:45|Ea:5 egg albumin EA EA:12 ehrlich ascites EA EA:18|Ea:1 electrical activity EA EA:9 electron affinity EA EA:60 ellagic acid EA EA:8 endometrial ablation EA EA:9 entorhinal area EA EA:14 epidural anaesthesia EA EA:32 epidural anesthesia EA EA:14 epileptiform activity EA EA:9|Ea:1 erythrocyte EA EA:13 erythrocyte aggregation EA EA:17 erythrocyteantibody EA EA:11 erythromycin acistrate EA EA:114 esophageal atresia EA EA:26 ethyl acetate EA EA:21 ethyl acrylate EA EA:7 evolutionary algorithm EA EA:6 igg antibodies EA EA:17 sensitized sheep erythrocytes Emax Emax:12 contractility index Emax Emax:4 lv contractility Emax Emax:6 maximal contractile response Emax Emax:8 maximal contraction Emax Emax:39 maximal effect Emax Emax:8 maximal elastance Emax Emax:6 maximum contraction Emax Emax:5 slope of the endsystolic pressurevolume relationship Emax Emax:9 systolic elastance emm emm:13 m protein emm emm:7 m protein gene EMP EMP:11 electromagnetic pulse EMP EMP:20 embdenmeyerhofparnas EMP EMP:6 embdenmeyerhof pathway EMP EMP:61 estramustine phosphate Endo Endo:12|ENDO:8|endo:5 endocardial Endo Endo:6|endo:3|ENDO:1 endocardium Endo Endo:8|endo:5 endoglycosidase EOA EOA:58 effective orifice area EOA EOA:12 erosive osteoarthritis EOA EOA:32 esophageal obturator airway EO EO:11 ethanolamine oleate EO EO:9 early onset EO EO:6 electric organ EO EO:17 electrolyzed oxidizing EO EO:10 endocrine ophthalmopathy EO EO:16 endogenous ouabain EO EO:40 eyes open EpRE EpRE:8|EPRE:4 electrophile response element EpRE EpRE:8|EPRE:1 electrophile responsive element ERAD ERAD:59 erassociated degradation ERAD ERAD:19 erassociated protein degradation ESD ESD:8 electrostatic spray deposition ESD ESD:13 endsystolic diameter ESD ESD:22|EsD:1 endsystolic dimension ESD ESD:30 entrance surface dose ESD ESD:11 environmental sex determination ESD ESD:62|EsD:43 esterase d ETS ETS:33 electron transport system ETs ETs:103 electrophoretic types ETs ETs:6 endocrine tumors ETS ETS:13 endoscopic thoracic sympathectomy ETS ETS:10 endoscopic transthoracic sympathicotomy ETs ETs:254|Et-s:1|Ets:1|ETS:1 endothelins ETS ETS:17 endotracheal suctioning ETS ETS:726 environmental tobacco smoke ETs ETs:8 exfoliative toxins ETS ETS:46 external transcribed spacer F0 F0:9 fusion F0 F0:11 membrane sector F0 F0:9 precursor F1 F1:13 beef heart mitochondrial atpase F1 F1:9 crossbred F1 F1:17|f1:1 first formant F1 F1:21|F-1:2 fraction F1 F1:10 fragment F1 F1:6 granulosa cells from the first F1 F1:1 granulosa cells obtained from the largest F1 F1:15 largest follicle F1 F1:7 largest preovulatory follicle F1 F1:52|F-1:2 offspring F2 F2:9 follicle F2 F2:26|f2:1 second formant F2 F2:12 second generation F344 F344:7 fischer rats F344 F344:8|F-344:2 male fischer F9 F9:16 factor ix gene F9 F9:11 mouse embryonal carcinoma FAAH FAAH:131 fatty acid amide hydrolase FAAH FAAH:11 fatty acid amidohydrolase FAA FAA:25 federal aviation administration FAA FAA:100 flavone acetic acid FACE FACE:9 fatality assessment and control evaluation FACE FACE:35 fluorophoreassisted carbohydrate electrophoresis FACE FACE:22 freeair co enrichment FACE FACE:10 freedom of access to clinic entrances act FACS FACS:9 cell scanning FACS FACS:11 facial action coding system FACS FACS:13 fluorescenceactivated cellsorting FACT-G FACT-G:10 functional assessment of cancer therapy FACT-G FACT-G:36|Fact-G:1 functional assessment of cancer therapygeneral FAC FAC:33 ferric ammonium citrate FAC FAC:44 fractional area change FAC FAC:6|fac:1|Fac:1 group c gene FADS FADS:22 factor analysis of dynamic structures FADS FADS:14 fetal akinesia deformation sequence FAD FAD:66 familial ad FAD FAD:227 familial alzheimers disease FAD FAD:47 family assessment device FAD FAD:283 flavin adenine dinucleotide FAD FAD:8 focal acantholytic dyskeratosis FAE FAE:15 fetal alcoholexposed FAE FAE:21 fetal alcohol exposure FAE FAE:6 follicleassociated epithelial FAE FAE:83 follicleassociated epithelium FAE FAE:15 fumaric acid esters FAF FAF:5 auditory feedback FAF FAF:7 familial amyloidosis of the finnish type FAF FAF:10 fibroblastactivating factor FAH FAH:5 caused by a deficiency of fumarylacetoacetate hydrolase FAH FAH:18 foci of altered hepatocytes FAH FAH:12 fumarylacetoacetase FAI FAI:30 frenchay activities index FAI FAI:13 functional aerobic impairment FALS FALS:4 cases are familial FALS FALS:49|fALS:4 familial als FALS FALS:178|fALS:11|F-ALS:1 familial amyotrophic lateral sclerosis FALS FALS:7 forward angle light scatter FAMA FAMA:9 fluorescenceassisted mismatch analysis FAMA FAMA:13 fluorescent antibody to membrane antigen FAMIS FAMIS:9 factor analysis of biomedical image sequences FAMIS FAMIS:17 factor analysis of medical image sequences FAM FAM:2 doxorubicin and mitomycin FAM FAM:7 family assessment measure FAM FAM:10|Fam:3|fam:1 famotidine FAM FAM:9 faschingbauer abbreviated mmpi FAO FAO:14 fatty acid betaoxidation FAO FAO:40 fatty acid oxidation FAO FAO:12 food and agriculture organization of the united nations FAP FAP:886 familial adenomatous polyposis FAP FAP:30 familial adenomatous polyposis coli FAP FAP:131 familial amyloid polyneuropathy FAP FAP:246 familial amyloidotic polyneuropathy FAP FAP:9 femoral artery pressure FAP FAP:24 fibroblast activation protein FAP FAP:8|FAp:3|F-AP:1 fluorapatite FAS FAS:11|fas:2|FA-S:1|Fas:1 acid synthesis FAS FAS:6 facial affective scale FAS FAS:7 fatigue assessment scale FAS FAS:391|fas:2|Fas:1 fatty acid synthase FAS FAS:92|Fas:3 fatty acid synthetase FAS FAS:420 fetal alcohol syndrome FAS FAS:10 fibrin adhesive system FAS FAS:9 fluorescence actin staining FAS FAS:11 fluorescent actin staining FAs FAs:24 focal adhesions FAS FAS:2 fractional area of shortening FAS FAS:16 free alphasubunit FAs FAs:10 frequent attenders FAT FAT:18 fluorescent antibody technique FAT FAT:56 fluorescent antibody test FAT FAT:17 focal adhesion targeting FA FA:8 data were acquired by frontal analysis FA FA:35 factor analysis FA FA:7 fast adapting FA FA:14 femoral FA FA:54 femoral artery FA FA:33 fibrinolytic activity FA FA:22 fibrosing alveolitis FA FA:55 filtered air FA FA:12 flip angle FA FA:98 fluctuating asymmetry FA FA:8 fluid accumulation FA FA:24 fluocinolone acetonide FA FA:18 fly ash FA FA:32 food allergy Fa Fa:4|FA:1 fraction absorbed FA FA:158 fractional anisotropy FA FA:24 freunds adjuvant Fa Fa:6 local absorption ratio FA FA:6 protein phosphatase activating factor FBA FBA:11 flux balance analysis FBA FBA:13 foreign body aspiration FBC FBC:7 brain cells FBC FBC:21 full blood count FBD FBD:17 familial british dementia FBD FBD:6 fibrocystic breast disease FBD FBD:15 functional bowel disorders FBM FBM:74 felbamate FBM FBM:18 fetal bone marrow FBP FBP:7 fetal biophysical profile FBP FBP:81 filtered backprojection FBP FBP:10 fructosebisphosphatase FBR FBR:11 fluidizedbed reactor FBR FBR:8 foreign body reaction FBS FBS:8 fake bad scale FBS FBS:7 fanconibickel syndrome FBS FBS:57 fasting blood sugar FBS FBS:28 fetal blood sampling FBS FBS:12 forepaw barrel subfield FB FB:9 bronchoscope FB FB:205|Fb:1 fast blue FB FB:16|Fb:1 feedback FB FB:10 ferruginous bodies FB FB:6 fetal blood FB FB:9 fetal breathing FB FB:9|Fb:1 fibroblast FB FB:30 flexible bronchoscopy FB FB:10 free breathing FCA FCA:8 flow cytometric assay FCA FCA:316 freunds complete adjuvant FCCL FCCL:9 cell lymphoma FCCL FCCL:6 follicular center cell lymphomas FCCP FCCP:9 carbonyl cyanide ptrifluoromethoxyphenyl hydrazone FCCP FCCP:88 carbonyl cyanide ptrifluoromethoxyphenylhydrazone FCC FCC:8 familycentered care FCC FCC:33 follicular center cell FCD FCD:18 fibrocystic disease FCD FCD:61 focal cortical dysplasia FCD FCD:62 functional capillary density FCE FCE:16 feed conversion efficiency FCE FCE:8 food conversion efficiency FCE FCE:23 functional capacity evaluation FCI FCI:7 after transient focal cerebral ischemia FCI FCI:18 flow cytometric immunophenotyping FCM FCM:11 family and community medicine FCM FCM:20 fatcorrected milk FCM FCM:26 flow cytometer FCM FCM:8 flow cytometric method FCM FCM:9 fluorescence correlation microscopy FCM FCM:31 fuzzy cmeans FCs FCs:12 febrile convulsions FCs FCs:23 fibrillar centers FCS FCS:184 fluorescence correlation spectroscopy FCs FCs:8 fusion cells FCS FCS:11 medium supplemented with fetal calf serum FCT FCT:9 fecal chymotrypsin FCT FCT:14 fever clearance time FCT FCT:20 functional communication training FCU FCU:12 firstcatch urine FCU FCU:42|fcu:3 flexor carpi ulnaris FCV FCV:17 famciclovir FCV FCV:163 feline calicivirus fc fc:10|fC:7|Fc:2|FC:1 cardiac frequency fc fc:9|Fc:7 centroid frequency Fc Fc:7|FC:1 constant region fc fc:11 corner frequency Fc Fc:7 crystallizable fragment FC FC:15 facilitated communication FC FC:15 fecal coliform FC FC:25 feed consumption FC FC:18 feed conversion Fc Fc:10 ferrocene FC FC:8 fibrillar centres FC FC:9 flow convergence FC FC:197|fc:2 flow cytometry FC FC:14 fluorocarbon FC FC:13 fluorocitrate FC FC:29 free carnitine FC FC:151|fC:1 free cholesterol FC FC:8 frequency of contractions FC FC:9 frontal FC FC:45 functional class FC FC:5|F-C:1 fusarin c FC FC:29 fusicoccin FDA FDA:147 fluorescein diacetate FDA FDA:8|F-DA:6 fluosolda FDB FDB:17 familial defective apo b FDB FDB:61 familial defective apolipoprotein b FDB FDB:42|fdb:1 flexor digitorum brevis FDG FDG:14 deoxyffluorodglucose FDG FDG:15 deoxyfluorodglucose FDG FDG:10 fluorine fluorodeoxydglucose FDG FDG:10 f deoxyglucose FDG FDG:12 fluorine deoxyglucose FDG FDG:22 fluorinefluorodeoxyglucose FDH FDH:44 familial dysalbuminemic hyperthyroxinemia FDH FDH:13 focal dermal hypoplasia FDH FDH:48|fdh:1|Fdh:1 formate dehydrogenase FDI FDI:8 disability index FDI FDI:42 first dorsal interosseous muscle FDI FDI:56 first dorsal interosseus FDI FDI:14 first dorsal interosseus muscle FDLE FDLE:11 fetal distal lung epithelial FDLE FDLE:11 fetal distal lung epithelium FDM FDM:10 filter diagonalization method FDM FDM:7 freedom from distant metastasis FD FD:79 familial dysautonomia FD FD:12 familial dysbetalipoproteinemia FD FD:17 fascia dentata FD FD:9 fetal distress FD FD:20 fiber density FD FD:7 fibre density FD FD:45 fibrous dysplasia FD FD:14 field desorption FD FD:9 finite difference FD FD:13 fixation disparity FD FD:22 flavor dilution FD FD:18 food deprivation FD FD:11 freezedried FD FD:12|Fd:1 freezedrying FD FD:9 friedreichs disease FD FD:109 functional dyspepsia FEC FEC:28 egg count FEC FEC:12 epirubicin and cyclophosphamide FELi FELi:18|FeLi:1 fractional excretion of lithium FELi FELi:17|FeLi:1|FE-Li:1 fractional lithium excretion FEM FEM:9 finite element FEM FEM:185 finite element method FEM FEM:20 finite element modeling FEN FEN:10 dlfenfluramine FEN FEN:9|Fen:3 fenoterol FEO FEO:11 familial expansile osteolysis FEO FEO:22 oscillator FEP FEP:7 flash evoked potential FEP FEP:7 fluorinated ethylene propylene FEP FEP:24 free energy perturbation FEP FEP:9 free erythrocyte porphyrin FEP FEP:76 free erythrocyte protoporphyrin FER FER:23|Fer:16 ferritin FER FER:10 food efficiency ratio FER FER:4 fractional esterification rate FES FES:13 falls efficacy scale FES FES:49 family environment scale FES FES:62 fat embolism syndrome FES FES:364 functional electrical stimulation FET FET:7 fieldeffect transistor FET FET:16 fluorescence energy transfer FET FET:11 forced expiration technique FET FET:12 forced expiratory time FET FET:7 frozen embryo transfer FEV(1) FEV(1):71 forced expiratory volume in s FEV(1) FEV(1):22 forced expired volume in sec FEV1 FEV1:15 forced expiratory volume at one second FEV1 FEV1:1 forced expiratory volume during first second of expiration FEV1 FEV1:4 volume of air expelled in the first second of forced expiration FFA FFA:33 fundus fluorescein angiography FFA FFA:22 fusiform face area FFI FFI:12 furoylfuranylhimidazole FFI FFI:7 foot function index FFM FFM:31 fivefactor model FFM FFM:12 fivefactor model of personality FFM FFM:9 fundus flavimaculatus FFP FFP:17 federal financial participation FFP FFP:54 freedom from progression FFR FFR:16 fluid filtration rate FFR FFR:10 forcefrequency relation FFR FFR:13 forcefrequency relationship FFR FFR:88 fractional flow reserve FFR FFR:32 freedom from relapse FFR FFR:14 fructosefed rats FF FF:19 fast fatigable FF FF:15 feeding FF FF:9 fenofibrate FF FF:10 fibrotic focus FF FF:224 filtration fraction FF FF:42|F-F:1 fimbriafornix FF FF:9 fluorescein flowmetry FF FF:22 form factor FF FF:20|ff:1 french francs FF FF:2 rats fed a fiberfree FGD FGD:17 familial glucocorticoid deficiency FGD FGD:18 flue gas desulfurization FGM FGM:90 female genital mutilation FGM FGM:5 fibrous glass membrane FGR FGR:88 fetal growth restriction FGR FGR:28 fetal growth retardation FGS FGS:13 female genital schistosomiasis FGS FGS:56 focal glomerular sclerosis FGS FGS:91 focal glomerulosclerosis FG FG:13 fasting glucose FG FG:61 fibrin glue FG FG:6 fluorescein glucuronide FG FG:9 fourniers gangrene FG FG:18 fusiform gyrus FHA FHA:8 family history of alcoholism FHA FHA:51 forkheadassociated FHA FHA:11 functional hypothalamic amenorrhea FHD FHD:7|FHd:2 focal hand dystonia FHD FHD:10 frontal hypothalamic deafferentation FHH FHH:23 familial hypocalciuric hypercalcaemia FHH FHH:56 familial hypocalciuric hypercalcemia FHI FHI:59 family health international FHI FHI:9 fibrous hamartoma of infancy FHM FHM:88 familial hemiplegic migraine FHM FHM:11 fathead minnow FHP FHP:12 family health program FHP FHP:18 fasting heat production FHR FHR:7 familial hypophosphatemic rickets FHR FHR:13 fawnhooded rat FHS FHS:10 fetal hydantoin syndrome FHS FHS:8|F-HS:1 floatingharbor syndrome FHS FHS:13 framingham heart study FHS FHS:7 nhlbi family heart study FHV FHV:21 feline herpesvirus FHV FHV:43 flock house virus FIA FIA:13 fluorescence immunoassay FIA FIA:7 fluorescent immunoassay FIA FIA:22 fluoroimmunoassay FIA FIA:90 freunds incomplete adjuvant FIC FIC:6 feline interstitial cystitis FIC FIC:77 fractional inhibitory concentration FID FID:44 flame ionization detection FID FID:49 free induction decay FIGO FIGO:277 international federation of gynecology and obstetrics FIGO FIGO:13 international federation of obstetrics and gynecology FIM FIM:13 factor increasing monocytopoiesis FIM FIM:409 functional independence measure FIM FIM:13 functional independence measurement FIO2 FIO2:10 fractional inspired o concentration FIO2 FIO2:30|FiO2:4|FIo2:1|Fio2:1 inspired o FIO2 FIO2:27|FiO2:17|Fio2:1 inspired oxygen fraction FIR FIR:10 farinfrared FIR FIR:40 finite impulse response FIS FIS:3 factor of inversion stimulation FIS FIS:18 fatigue impact scale FI FI:10 fasting insulin FI FI:19 fatigue index FI FI:24 fecal incontinence FI FI:34 feed intake FI FI:43 fixed interval FI FI:58 fluorescence intensity FI FI:11 fluorescent intensity FI FI:91 food intake f-I f-I:11|F-I:7 frequencycurrent FI FI:17 fundamental imaging FI FI:10 furcation involvement f-I f-I:4|F-I:1 injected current FI FI:6 purified fraction FI FI:24 under a fixedinterval FI FI:1 under multiple fixedinterval FJHN FJHN:10 familial juvenile hyperuricaemic nephropathy FJHN FJHN:13 familial juvenile hyperuricemic nephropathy FLC FLC:18 fibrolamellar carcinoma FLC FLC:33 flowering locus c FLC FLC:39 friend leukemia cells FLC FLC:10 friend leukemia complex FLD FLD:20 farmers lung disease FLD FLD:9 frontal lobe degeneration FLD FLD:9 frontal lobe degeneration of nonalzheimer type FLD FLD:27 frontal lobe dementia FLE FLE:9 family life education FLE FLE:48 frontal lobe epilepsy FLF FLF:9 fermented liquid feed FLF FLF:9 fulminant liver failure FLIM FLIM:26 fluorescence lifetime imaging FLIM FLIM:38 fluorescence lifetime imaging microscopy FLM FLM:20 fetal lung maturity FLM FLM:4 fraction of labeled mitoses FLM FLM:9 fraction of labelled mitoses FLS FLS:8 fibroblastlike synovial cells FLS FLS:11 forward light scatter FLU FLU:6|Flu:1 antiandrogen flutamide FLU FLU:13 flumequine FLU FLU:8|flu:1 flunisolide FLU FLU:22|flu:2 fluphenazine FLV FLV:14 fluvoxamine FLV FLV:60 friend leukemia virus FL FL:5 facial lobe FL FL:36 farmers lung FL FL:109 fetal liver FL FL:19 filtration leukapheresis FL FL:7|fl:3 firefly luciferase FL FL:11|Fl:5 fluorescent FL FL:7 fluorescent light FL FL:9 flutamide FL FL:9 foreign language FL FL:11 friend leukemia FL FL:8 frontal lobe FL FL:9 fructoselysine FL FL:25|fl:5|Fl:2|-FL:1 fulllength FMA FMA:15 fluorescein mercuric acetate FMA FMA:10 foundational model of anatomy FMA FMA:10 fuglmeyer assessment FMD FMD:150 fibromuscular dysplasia FMD FMD:8 flowmediated dilation of the brachial artery FMD FMD:22 flowmediated vasodilatation FMD FMD:11 foramen magnum decompression FMF FMF:476|fMf:1 familial mediterranean fever FMF FMF:32 flow microfluorometry FMH FMH:8 fetomaternal haemorrhage FMH FMH:27 fetomaternal hemorrhage FMH FMH:8 fibromuscular hyperplasia FMLP FMLP:12|fMLP:6 chemotactic peptide FMLP FMLP:5|fMLP:5 chemotactic peptide nformylmetleuphe fMLP fMLP:4|FMLP:4|fmlp:1 fmethionylleucylphenylalanine fMLP fMLP:9|FMLP:8|f-MLP:1 formylmethionineleucinephenylalanine fMLP fMLP:6|FMLP:3|f-MLP:1 formyl peptide FMLP FMLP:5|fMLP:4 nformylmethionineleucinephenylalanine FMLP FMLP:5|fMLP:3 nformyl methionylleucylphenylalanine FMN FMN:10 facial motor nucleus FMN FMN:217 flavin mononucleotide FMN FMN:11 riboflavin phosphate FMR1 FMR1:9|FMR-1:6|Fmr1:1 fragile x gene FMR1 FMR1:17 fragile x mental retardation FMRP FMRP:26 fmr protein FMRP FMRP:75 fragile x mental retardation protein FNR FNR:10 ferredoxinnadp oxidoreductase FNR FNR:32 ferredoxinnadp reductase FNR FNR:23|FnR:11|FNr:1|FN-R:1 fibronectin receptor FNS FNS:9 fineneedle sampling FNS FNS:97 functional neuromuscular stimulation FN FN:22 facial nerve FN FN:14 facial nucleus FN FN:41 febrile neutropenia FN FN:9|Fn:1 femoral nerve Fn Fn:7|FN:2 fibrin Fn Fn:12|FN:4 fusobacterium nucleatum FOBT FOBT:31 faecal occult blood test FOBT FOBT:79 fecal occult blood test FOBT FOBT:74 fecal occult blood testing FOBT FOBT:17 occult blood tests FOB FOB:24 faecal occult blood FOB FOB:22 fecal occult blood FOB FOB:9 fiberoptic bronchoscope FOB FOB:68 functional observational battery FOH FOH:12|F-OH:6 farnesol FOH FOH:13 functional ovarian hyperandrogenism FOM FOM:12|FoM:1 figure of merit FOM FOM:13 final oocyte maturation FOM FOM:113 fosfomycin FOR FOR:13 fastigial oculomotor region FOR FOR:8 fractional outflow rate FOR FOR:12 free oxygen radicals FOS FOS:12 framingham offspring study FOS FOS:28 fructooligosaccharides FO FO:8 fasttwitch oxidative FO FO:5 fecal output FO FO:222 fish oil FO FO:26|Fo:1 foramen ovale FO FO:8 forced oscillation FPA FPA:35|fpa:1 family planning association FPA FPA:6|FpA:3|Fp-A:1 fibrinopeptidea FPA FPA:7 flavor profile analysis FPA FPA:17 fluorescence polarization anisotropy FPA FPA:15 fluorescence polarization assay FPA FPA:16 fundus pulsation amplitude FPC FPC:70 familial polyposis coli FPC FPC:17 family planning clinic FPC FPC:10 fish protein concentrate FPD FPD:5 filtered p wave duration FPD FPD:6 fine particle dose FPD FPD:12 flame photometric detector FPD FPD:10 flatpanel detector FPD FPD:4|fPD:2 parkinsons disease FPF FPF:4 fibroblast pneumonocyte factor FPF FPF:35 fine particle fraction FPG FPG:6 endonuclease formamidopyrimidinedna nglycosylase FPG FPG:464|fpg:2|F-PG:1 fasting plasma glucose FPG FPG:18 fluorescence plus giemsa FPG Fpg:3|FPG:3 formamidopyrimidine dna nglycosylase FPI FPI:23 fasting plasma insulin FPI FPI:39 fluid percussion brain injury FPI FPI:53 fluid percussion injury FPI FPI:9 fluorescence polarization immunoassay FPI FPI:15 personality inventory FPIR FPIR:7 first phase insulin release FPIR FPIR:26 firstphase insulin response FPLC FPLC:7 fast protein liquid chromatographic FPLC FPLC:307 fast protein liquid chromatography FPL FPL:35 flexor pollicis longus FPL FPL:16 forcedchoice preferential looking FPP FPP:92 farnesyl diphosphate FPP FPP:63|F-P-P:3|Fpp:2|F-PP:2 farnesyl pyrophosphate FPP FPP:15|Fpp:1 farnesylpyrophosphate FPP FPP:11 fetal pig pancreas FPP FPP:12 free portal pressure FPR FPR:53 fluorescence photobleaching recovery FPR FPR:9 footpad reaction FPR FPR:48|fPR:1 formyl peptide receptor FPR FPR:33 nformyl peptide receptor FPS FPS:13 faces pain scale FPs FPs:62 family physicians FPs FPs:8 family practitioners FPS FPS:17 fearpotentiated startle FPs FPs:13 fluorescent proteins FPT FPT:15 failure of passive transfer FPT FPT:28 farnesyl protein transferase FPU FPU:11 fermipastaulam FPU FPU:6 fetoplacental unit FPV FPV:19 feline parvovirus FPV FPV:8 finger pulse volume FPV FPV:72 fowl plague virus FPV FPV:9 fowl poxvirus FP FP:8 facial paralysis FP FP:13 family physician FP FP:578 family planning FP FP:30 family practice FP FP:16 fast pathway FP FP:14 femoropopliteal FP FP:33 ferriprotoporphyrin ix FP FP:12 fibropapillomatosis FP FP:10|fp:1 firstpass FP FP:17|Fp:1 fixation point FP FP:14 flavopiridol FP FP:14 floor plate FP FP:111 fluorescence polarization FP FP:302 fluticasone propionate FP FP:18 follicular phase FP FP:8 following lateral fluidpercussion FP FP:8|fp:1 footpad FP FP:11 fungal peritonitis FP FP:13 fusion peptide FP FP:22|fp:1 fusion protein FP FP:8 hamster female protein FP F-P:6|FP:6 parasagittal fluidpercussion FP FP:8 pgf alpha FP FP:5 prostaglandin f FQ FQ:9 furoylquinolinecarboxaldehyde FQ FQ:14 fear questionnaire FR3 Fr3:5|FR3:5 framework FR3 FR3:9 framework region FRAP FRAP:21 ferric reducing ability of plasma FRAP FRAP:9 fkbprapamycinassociated protein FRAP FRAP:254 fluorescence recovery after photobleaching FRAP FRAP:30 fluorideresistant acid phosphatase fRa fRa:7|FRa:2 fractional resistance fRa fRa:8|FRa:2|fRA:1|FRA:1 fractional resistance of the apical membrane FRC FRC:900|frc:1 functional residual capacity FRC FRC:6 primary cultures of fetal rat calvaria FRDA FRDA:5 ataxia gene FRDA FRDA:11 ataxia locus FRDA FRDA:59 friedreichs ataxia FRL FRL:46 flinders resistant line FRL FRL:7 future remnant liver FRP FRP:11 follicle regulatory protein FRP FRP:49 functional refractory period FRTL-5 FRTL-5:27|FRTL5:11|FRT-L5:2 rat thyroid cells FRTL-5 FRTL-5:27|FRTL5:11 rat thyroid cell line FRT FRT:9 female reproductive tract FRT FRT:18 fischer rat thyroid FRT FRT:18 flp recognition target FRT FRT:7 flp recombination target FRT FRT:7 functional reach test FRs FRs:12 folate receptors FRs FRs:21 free radicals FR FR:11 family of repeats FR FR:19 farred light FR FR:21 fasciculus retroflexus FR FR:6 fast fatigueresistant FR FR:7 fast resistant FR FR:15 fatigue resistant FR FR:13 fertilization rate FR FR:12 firing rate FR FR:7 flexor reflex FR FR:58 food restriction FR FR:8 fractional reabsorption FR FR:11 framework FR FR:15 functional reach FR FR:35 under a fixedratio FSBA FSBA:12 pfluorosulfonylbenzoyl adenosine FSBA FSBA:35 pfluorosulfonylbenzoyladenosine FSC FSC:14 fetal spinal cord FSC FSC:25 forward scatter FSC FSC:26|fSC:2 free secretory component FSH FSH:8 folliclestimulating hormones FSH FSH:4 patients with facioscapulohumeral FSM FSM:11 federated states of micronesia FSM FSM:15 fluorescent speckle microscopy FSP FSP:16 fallopian tube sperm perfusion FSP FSP:16 familial spastic paraplegia FSP FSP:11 finger systolic pressure FSP FSP:16 split products FSR FSR:7 fractional rate of protein synthesis FSR FSR:35 fragmented sarcoplasmic reticulum FSS FSS:11 daily intake of fluid and salt supplementation FSS FSS:15 familial short stature FSS FSS:56 fatigue severity scale FSS FSS:15 fluid shear stress FST FST:21 finger skin temperature FST FST:69 forced swim test FST FST:97 forced swimming test FSU FSU:35 former soviet union FSU FSU:10 functional spinal unit FSA FSA:8 fractal signature analysis FSA FSA:5 free sialic acid FS FS:20|-FS:3 familial sinistrality FS FS:12|fs:1 fat saturation FS FS:11 fat suppression FS FS:8 fecal streptococci FS FS:7 femoral shaft fs fs:14 femtosecond FS FS:8 fermi surface FS FS:34 fibrin sealant FS FS:21 fibrous sheath FS FS:48 field stimulation FS FS:18 fisher syndrome FS FS:12 flaxseed FS FS:57 flexible sigmoidoscopy FS FS:16 flexural strength FS FS:20 fogo selvagem FS FS:69 follistatin FS FS:12 foot shock FS FS:18 footshock FS FS:5 former smokers FS FS:243|fs:1|Fs:1 fractional shortening FS FS:8 freeze substitution FS FS:11 functional status FS FS:6 functional systems FS FS:11 furosemidesensitive FS FS:16 patients with feltys syndrome fs fs:8 signal frequency FT FT:44 fast twitch FT FT:8 fat thickness FT FT:11 femurtibia FT FT:24 fetal thymus FT FT:8 filled teeth FT FT:20 fixedtime FT FT:23 flowering locus t FT FT:10 free t FT FT:9 freezethaw FT FT:8 frozenthawed FT FT:28 ftorafur FT FT:9 fullterm FT FT:11 futraful FT FT:84 tegafur FTA-ABS FTA-ABS:6|FTA-Abs:3 fluorescent treponemal antibodyabsorbed FTA-ABS FTA-ABS:10|FTA-abs:1 fluorescent treponemal antibody absorption test FTCs FTCs:10 follicular thyroid carcinomas FTCs FTCs:16 frequency tuning curves FTC FTC:14 emtricitabine FTC FTC:42 federal trade commission FTC FTC:6 follicular carcinomas FTC FTC:15 follicular thyroid cancer FTC FTC:9 fumitremorgin c FTD FTD:12 formal thought disorder FTD FTD:12 frontotemporal degeneration FTE FTE:66 fulltime equivalent FTE FTE:5 number of fulltimeequivalent FTIR FTIR:10|FT-IR:2 fourier transform infrared spectrometry FTIR FTIR:6 fourier transform infrared spectrophotometry FTIR FTIR:5|FT-IR:2 fourier transform infrared spectroscopic FTIR FTIR:14|FT-IR:1 fourier transform ir FTIs FTIs:28 farnesyl transferase inhibitors FTIs FTIs:69 farnesyltransferase inhibitors FTI FTI:14 farnesyl transferase inhibitor FTI FTI:14 forcetime integral FTMS FTMS:7 fourier transform mass spectrometer FTMS FTMS:26|FT-MS:2 fourier transform mass spectrometry FTP FTP:9 federal test procedure FTP FTP:11 formycin triphosphate FTR FTR:10 fasttwitch red FTR FTR:10 ferredoxinthioredoxin reductase FTR FTR:8 fractional turnover rate FTS FTS:26 facteur thymique serique FTS FTS:13 farnesylthiosalicylic acid fu fu:6|fU:1 fraction unbound fu fu:28|Fu:3|fU:1 unbound fraction FVa FVa:10 activated factor v FVa FVa:26|fVa:3 factor va FVL FVL:103|fVL:3|FvL:2 factor v leiden FVL FVL:12|FvL:1 factor v leiden mutation FVR FVR:10 feline viral rhinotracheitis FVR FVR:147 forearm vascular resistance FX FX:98|fX:13|F-X:1 factor x FX FX:10|F-X:6 fusarenonx FZ FZ:18 fetal zone FZ FZ:38|Fz:8 furazolidone Fab Fab:41|FAB:1 antibody fragments Fab Fab:12 antigenbinding F-ara-A F-ara-A:15|F-araA:1|Fara-A:1|F-Ara-A:1 betadarabinofuranosylfluoroadenine F-ara-A F-ara-A:9|F-Ara-A:1 arabinosylfluoroadenine FasL Fas-L:5|FasL:5 fas and fasligand FasL FasL:7|Fas-L:5 fasfasligand FCR FCR:52 feed conversion ratio FCR FCR:123 flexor carpi radialis FCR FCR:13|Fcr:1 flexor carpi radialis muscle FCR FCR:25 fuji computed radiography Fe2+ Fe2+:10 ferrous ion Fe2+ Fe2+:22 ferrous iron Fe3+ Fe3+:5 ferric ion Fe3+ Fe3+:14 ferric iron FeLV FeLV:78|FeLv:1 feline leukaemia virus FeLV FeLV:325|FELV:1|FeLv:1 feline leukemia virus FEL FEL:22 familial erythrophagocytic lymphohistiocytosis FEL FEL:6|Fel:3 felodipine FE FE:5|Fe:4 fentanyl FE FE:22 fertilization envelope FE FE:64 fractional excretion FM FM:9 face mask FM FM:9 family medicine FM FM:9|F-M:2 farnsworthmunsell FM FM:10 feather meal FM FM:20 ferromagnetic FM FM:34 fish meal FM FM:20 flunixin meglumine FM FM:21 fluorescence microscopy FM FM:25 fragrance mix FM FM:76 frequency modulation FM FM:10|fM:3 full mutation FM FM:96 patients with fibromyalgia Fur Fur:46|fur:8 ferric uptake regulator Fur Fur:9 ferric uptake repressor FUS FUS:22 focused ultrasound FUS FUS:11 focused ultrasound surgery FV FV:173|F-V:1|fV:1 factor v FV FV:7 fasting volume FV FV:18|fv:2 femoral vein FV FV:34|Fv:5 friend virus FV FV:13 friend virus complex FW FW:13 feed withdrawal FW FW:51 fresh water FW FW:33|fw:14 fresh weight FW FW:85 freshwater G/F G/F:13 gainfeed G/F G/F:11 gainfeed ratio G0 G0:18 quiescence G0 G0:17 quiescent state G0 G0:9 resting state G1 G1:9 activated G1 G1:7 first gap phase G1 G1:7|G-1:1 first group G3P G3P:9|G-3-P:2 glyceraldehydephosphate G3P G3P:7|G-3-P:3 snglycerolphosphate GAA GAA:21 gossypol acetic acid GAA GAA:11 guanidinoacetate GAA GAA:36 guanidinoacetic acid GABA-T GABA-T:9 gabaaminotransferase GABA-T GABA-T:23|GABAT:2 gammaaminobutyric acid transaminase GABA-IR GABA-IR:20|GABAir:6|GABA-ir:6|GABA-Ir:1 gabaimmunoreactive GABA-IR GABA-IR:8|GABA-ir:2 gaba immunoreactivity GABA GABA:12 aminobutyrate GABA GABA:16 gammaaminobutyric GABA GABA:14 inhibitory GABHS GABHS:17 group a betahaemolytic streptococci GABHS GABHS:54 group a betahemolytic streptococcal GABHS GABHS:55 group a betahemolytic streptococci GABHS GABHS:37 group a betahemolytic streptococcus GAD GAD:9 decarboxylase activity GAD GAD:5 general acylcoa dehydrogenase GAD GAD:412 generalized anxiety disorder GAD GAD:21|gad:20 gracile axonal dystrophy GAD GAD:12 graft arterial disease GAF GAF:13 activation factor GAF GAF:15 global assessment of function GAF GAF:141 global assessment of functioning GAF GAF:33 global assessment of functioning scale GA-I GA-I:5|GAI:2 glutaric acidemia type i GA-I GA-I:11|GAI:2 glutaric aciduria type i GALT GALT:45|galT:2|Galt:1 galactosephosphate uridyl transferase GALT GALT:70|galT:2 galactosephosphate uridyltransferase GALT GALT:16|GalT:2 galactosephosphate uridylyltransferase GAN GAN:13 gastrointestinal autonomic nerve GAN GAN:41 giant axonal neuropathy GAO GAO:29 general accounting office GAO GAO:7 glycolic acid oxidase GAP GAP:7 glyceraldehyde phosphate GAP GAP:32 gnrhassociated peptide GAP GAP:6 gonadotropinreleasing hormone associated peptide GAP GAP:6 good agricultural practice GAP GAP:5 guidelines applied in practice GAS GAS:9 activation sequence GAS GAS:9 gammaactivated sequence GAS GAS:22 gastric acid secretion GAS GAS:4|G-A-S:1 general adaptation syndrome GAs GAs:49 genetic algorithms GAs GAs:11 gestational ages GAs GAs:75|gas:3 gibberellins GAS GAS:73 global assessment scale GAS GAS:31 goal attainment scaling GAS GAS:143 group a streptococcal GAS GAS:168 group a streptococci GAS GAS:197 group a streptococcus GAS GAS:15 ifngamma activation site GAT GAT:8 galactosyltransferase associated with tumor GAT GAT:15 gelatin agglutination test GAT GAT:26 goldmann applanation tonometer GAT GAT:20 goldmann applanation tonometry GAT GAT:52 lglutamic acidlalanineltyrosine GA GA:41 gallic acid GA GA:10 gardnerarnstein GA GA:14 general GA GA:83 general anaesthesia GA GA:10 general anaesthetic GA GA:156 general anesthesia GA GA:26 geographic atrophy GA GA:9|Ga:1 georgia GA GA:191 gibberellin GA GA:55 glatiramer acetate GA GA:24 glutaminase GA GA:20 glycated albumin GA GA:31 glycolic acid GA GA:33 glycyrrhetic acid GA GA:88 golgi apparatus GA GA:11 gouty arthritis GA GA:5 granulocyte agglutination GA GA:60 granuloma annulare GA GA:7 graphical analysis GA GA:16 gum arabic GA GA:21 gyrate atrophy GA GA:10 hsp inhibitor geldanamycin GA GA:7 metabolite glycidamide GBA GBA:7 gammaband activity GBA GBA:18|Gba:1 glucocerebrosidase GBA GBA:10 glucocerebrosidase gene GBC GBC:25 gallbladder cancer GBC GBC:27 gallbladder carcinoma GBF GBF:6 gbox binding factor GBF GBF:25 germinated barley foodstuff GBI GBI:13 general behavior inventory GBI GBI:13 glasgow benefit inventory GBMs GBMs:20 glioblastomas GBMs GBMs:22 glioblastomas multiforme GBMs GBMs:12 glomerular basement membranes GBP GBP:15 blood pool GBP GBP:155 gabapentin GBP GBP:18 growthblocking peptide GBRs GBRs:7 induced gamma band responses GBRs GBRs:11 receptor complexes GBR GBR:8 gamma band response GBR GBR:15 great barrier reef GBR GBR:10 group b rotavirus GBR GBR:96|gbr:1 guided bone regeneration GBS GBS:232 group b streptococcal GBS GBS:403 group b streptococci GBS GBS:417 group b streptococcus GBS GBS:946 guillainbarre syndrome GBS GBS:15 streptococcus agalactiae GB GB:3 cell surface protease guanidinobenzoatase GB GB:141 gallbladder GB GB:10 gastric banding GB GB:24 generalized born GB GB:22 glycine betaine GB GB:24 great britain GB GB:21 sarin GB GB:6 surface protease referred to as guanidinobenzoatase GC-ECD GC-ECD:13 gas chromatographyelectron capture detection GC-ECD GC-ECD:14 gas chromatography with electroncapture detection GCAP GCAP:6 cyclaseactivating protein GCAP GCAP:15 germ cell alkaline phosphatase GCA GCA:10 gastric cardia adenocarcinoma GCA GCA:7|gca:2 general combining ability GCA GCA:383 giant cell arteritis GC-A GC-A:7 guanylate cyclasea GC-A GC-A:16 guanylyl cyclasea GCC GCC:6 gastric cardia cancer GCC GCC:5 germ cell cancer GCC GCC:9 glassy cell carcinoma GCD GCD:13 granular corneal dystrophy GCD GCD:8 gross cystic disease GCF GCF:6 gc factor GCF GCF:20 giant cell fibroblastoma GCF GCF:545 gingival crevicular fluid GCI GCI:13 general cognitive index GCI GCI:12 global cerebral ischemia GC-MS GC-MS:12|GCMS:1 gas chromatographmass spectrometer GC-MS GC-MS:12 gas chromatography coupled with mass spectrometry GCs GCs:20|GCS:1 ganglion cells GCs GCs:11 gastric carcinomas GCs GCs:100 germinal centers GCs GCs:13 germinal centres GCS GCS:13 gianotticrosti syndrome GCS GCS:681 glasgow coma scale GCS GCS:25 glasgow coma scale score GCs GCs:296|GCS:13|gcs:1|Gcs:1 glucocorticoids GCS GCS:23|GcS:1 glucosylceramide synthase GCS GCS:10 glycine cleavage system GCs GCs:9|Gcs:1 glycoconjugates GCS GCS:9 graduated compression stockings GCs GCs:80|Gcs:1 granulosa cells GCs GCs:6 guanylate cyclases GCs GCs:14 guanylyl cyclases GCVF GCVF:13 great cardiac vein flow GCVF GCVF:8 great cardiac venous flow GCV GCV:9 gancyclovir GCV GCV:39 great cardiac vein GCV GCV:7 herpes simplex virus thymidine kinase hsvtkganciclovir GCL GCL:33 cells in the ganglion cell layer GCl GCl:15|gCl:11|Gcl:3|gcl:1 chloride conductance GCl GCl:26|gCl:9|Gcl:2 cl conductance GCL GCL:8 ganglion cell GC GC:55 gas chromatograph GC GC:262|gc:1 gas chromatographic GC GC:174|Gc:1 gastric cancer GC GC:6|G-C:1 gemcitabine and cisplatin GC GC:9 genomic control GC GC:54 glassy carbon GC GC:28 gliomatosis cerebri GC GC:16 glucocorticosteroids GC GC:22|Gc:1 glycocalicin GC GC:34 golgi complex GC GC:10|Gc:1 gonococcal GC GC:9|Gc:5 gonococci GC GC:10 gonorrhea GC GC:14 granule cell GC GC:9 growth cartilage GC GC:20|G-C:10 guaninecytosine GC GC:6 guanine plus cytosine GC GC:10 gustatory cortex GC GC:17 human glucocerebrosidase GDC GDC:7 glycine decarboxylase GDC GDC:13 glycine decarboxylase complex GDC GDC:6 sodium glycodeoxycholate GDEE GDEE:22 glutamic acid diethyl ester GDEE GDEE:22 glutamic acid diethylester GDI GDI:52 gdp dissociation inhibitor GDI GDI:27 guanine nucleotide dissociation inhibitor GDL GDL:11 gluconodeltalactone GDL GDL:24 graduated driver licensing GDN GDN:13|GdN:1 gliaderived nexin GDN GDN:5 glyceryl dinitrate GDP GDP:10 general dental practitioner GDP GDP:150 gross domestic product GDP GDP:74 guanosine diphosphate GDP GDP:7 purine nucleotide GDPs GDPs:108|gdps:2 general dental practitioners GDPs GDPs:23 giant depolarizing potentials GDS GDS:14 gdp dissociation stimulator GDS GDS:19 general dental service GDS GDS:58 global deterioration scale GDS GDS:6 gordon diagnostic system Gd Gd:14|GD:1 gadoliniumdtpa GD GD:13 gastroduodenal GD GD:8 germinal disc GD GD:11 glucose deprivation GD GD:11 gonadal dysgenesis GD GD:468|Gd:1 graves disease GD GD:7 growth delay Gd Gd:5|GD:1 patients with graves disease without ophthalmopathy GEA GEA:21 gastric electrical activity GEA GEA:88 gastroepiploic artery GEC GEC:42 galactose elimination capacity GEC GEC:9 gastric emptying coefficient GED GED:9 gastric epithelial dysplasia GED GED:8 gtpase effector domain GEMs GEMs:15|GEMS:1 genetically engineered microorganisms GEMs GEMs:6 glycolipidenriched microdomains GEMs GEMs:7 membrane microdomains GEM GEM:9|gem:3 gemfibrozil GEM GEM:9 genetically engineered mice GEM GEM:29 geriatric evaluation and management GEM GEM:17 glycolipidenriched membrane GEM GEM:8 guideline elements model GEPs GEPs:7 gdpgtp exchange proteins GEPs GEPs:7 guanine nucleotideexchange proteins GEP GEP:5 gdpgtp exchange protein GEP GEP:6 guanine nucleotideexchange protein GER GER:13 gastric emptying rate GER GER:27|gER:3|ger:1 granular endoplasmic reticulum GES GES:24 gastric electrical stimulation GES GES:12 guanidinoethane sulfonate GES GES:7 guanidinoethanesulfonic acid GES GES:11 guanidinoethyl sulfonate GET GET:17 gas exchange threshold GET GET:30 gastric emptying time GE GE:17 ganglionic eminence GE GE:141 gastric emptying GE GE:50 gastroesophageal GE GE:5|ge:1 genome equivalents Ge Ge:16 gerbich Ge Ge:20 germanium GE GE:15 glandular epithelial GE GE:28 glandular epithelium GE GE:11 glycyrrhetinic acid GE GE:62 gradient echo GE GE:9 gross efficiency GE GE:22 gross energy GFA GFA:15 genetic function approximation GFA GFA:97 glial fibrillary acidic GFC GFC:19 gel filtration chromatography GFC GFC:13 global fibrinolytic capacity GFD GFD:100 glutenfree diet GFD GFD:7 growth factor domain GFP GFP:33 gelfiltered platelets GFP GFP:31 global field power GFS GFS:11 geer fear scale GFS GFS:5 glaucoma filtration surgery GF GF:15 gastric fistula GF GF:11 gel filtration GF GF:3|gf:2 gene frequency GF GF:77|Gf:6 germfree GF GF:11 giant fiber GF GF:54 gingival fibroblasts GF GF:5 gingival fluid GF GF:17 glomerular filtrate GF GF:10 graft failure GF GF:14 granulocyte factor GF GF:8 granuloma faciale GF GF:55|Gf:2 griseofulvin GGR GGR:25 global genome repair GGR GGR:19 global genomic repair GGT GGT:51 gamma glutamyltransferase GGT GGT:64 serum gammaglutamyltransferase GG GG:7 geniculate ganglion GG GG:12|gg:1 genioglossal GG GG:68|Gg:5 genioglossus GG GG:9 glucosylglycerol GG GG:33 guar gum GH3 GH3:16 pituitary tumor cells GH3 GH3:7 rat pituitary cells GH3 GH3:12 rat pituitary tumor GHBP GHBP:4|GH-BP:3 ghbinding proteins GHBP GHBP:38|GH-BP:15 growth hormonebinding protein GHC GHC:25 group health cooperative GHC GHC:26 group health cooperative of puget sound GHD GHD:9 genetic hypertension development GHD GHD:371|GH-D:1 gh deficiency GHD GHD:287|GHd:1 growth hormone deficiency GHIS GHIS:8 gh insensitivity syndrome GHIS GHIS:14 growth hormone insensitivity syndrome GHRH-R GHRH-R:7|GHRHR:4|GHRHr:1 ghreleasing hormone receptor GHRH-R GHRH-R:10|GHRHR:4 growth hormonereleasing hormone receptor GHRP-6 GHRP-6:12 ghreleasing hexapeptide GHRP-6 GHRP-6:5|GHRP6:1 growth hormone releasing peptide GHRP-6 GHRP-6:9|GH-RP-6:1 hisdtrpalatrpdphelysnh GHRPs GHRPs:21 ghreleasing peptides GHRPs GHRPs:15 growth hormonereleasing peptides GHR GHR:7 growth hormone receptor gene GHR GHR:5 growth hormone replacement GHSs GHSs:17 gh secretagogues GHSs GHSs:26 growth hormone secretagogues GHS GHS:22 general household survey GHS GHS:11 genetic hypercalciuric stoneforming GH GH:17 genetic haemochromatosis GH GH:31 genetic hemochromatosis GH GH:11|Gh:1 geniohyoid GH GH:14 genital herpes GH GH:31 gestational hypertension GH GH:13 gingival hyperplasia GH GH:7 gland of harder GH GH:12 glenohumeral GH GH:11 glycoside hydrolase GH GH:26 new zealand genetically hypertensive GIA GIA:9 gravitoinertial acceleration GIA GIA:8 growth inhibition assay GIF GIF:22 glycosylationinhibiting factor GIF GIF:6 gravitoinertial force GIF GIF:48 growth inhibitory factor GIH GIH:10 gastrointestinal hemorrhage GIH GIH:8 gonadinhibiting hormone GIP GIP:85 gastric inhibitory peptide GIP GIP:538 gastric inhibitory polypeptide GIP GIP:10 general import pore GIP GIP:56 glucosedependent insulinotropic peptide GIP GIP:176 glucosedependent insulinotropic polypeptide GISH GISH:11 genomic in situ hybridisation GISH GISH:76 genomic in situ hybridization GIT GIT:17 gastrointestinal transit GIT GIT:20 glucoseinduced thermogenesis GIT GIT:11 glucose infusion test GIT GIT:11 glutathioneinsulin transhydrogenase GITR GITR:8 glucocorticoidinduced tumor necrosis factor receptor GITR GITR:5 receptor familyrelated gene GI GI:12 gastroenterology GI GI:12 gigantea GI GI:5 gingival indices GI GI:7 gingival inflammation GI GI:14 glass ionomer GI GI:7 glass ionomer cement GI GI:7|gI:2 global ischemia GI GI:11 glucagon immunoreactivity GI GI:5 glycaemic indices GI GI:96 glycemic index GI GI:34|G-I:7 group i Gi Gi:27 inhibitory gtpbinding protein Gi Gi:12 inhibitory guanine nucleotide regulatory protein GK GK:46|G-K:2 diabetic gotokakizaki GK GK:38 gamma knife GK GK:13 glandular kallikrein gK gK:25 glycoprotein k GK GK:19 guanylate kinase gK gK:17|GK:7|gk:4 k conductance gK gK:21|GK:20|gk:4 potassium conductance GLC GLC:110 gasliquid chromatographic GLC GLC:287|glc:2 gasliquid chromatography gld gld:9 fas ligand gld gld:12 generalized lymphoproliferative disease GLI GLI:7 glucagonlike immunoreactive GLI GLI:79 glucagonlike immunoreactivity GLI GLI:5 grey level index GLM GLM:16 general linear models GLM GLM:22|glm:1 generalized linear model GLO GLO:15|Glo:1 glyoxalase GLO GLO:7 lgulonogammalactone oxidase GLPs GLPs:13 germinlike proteins GLPs GLPs:9 glucagonlike peptides GM-CSA GM-CSA:13|gm-CSA:1 colony stimulating activity GM-CSA GM-CSA:28|gm-CSA:1 granulocytemacrophage colonystimulating activity GM1 GM1:11 ganglioside gm GM1 GM1:11 gm ganglioside GM1 GM1:57|Gm1:1|GM-1:1 monosialoganglioside GMA GMA:8 gastric myoelectrical activity GMA GMA:10 geomagnetic activity GMA GMA:38 glycidyl methacrylate GMA GMA:51 glycol methacrylate GM-CSF GM-CSF:9|GMCSF:1 colony stimulating factors GM-CSF GM-CSF:9 granulocytemacrophage GMCs GMCs:18 geometric mean concentrations GMCs GMCs:17 giant migrating contractions GMC GMC:7 ganglion mother cell GMC GMC:32 general medical council GMC GMC:6 general medicine clinic GME GME:9 glucocorticoid modulatory element GME GME:117 graduate medical education GMF GMF:20 geomagnetic field GMF GMF:45 glia maturation factor GMO GMO:9 glycerol monooleate GMO GMO:11 glyceryl monooleate GMP GMP:8 generalized motor program GMP GMP:14 glycomacropeptide GMP GMP:34 good manufacturing practices GMS GMS:29 general medical services GMs GMs:28 general movements GMs GMs:9 geometric means GMS GMS:15 geriatric mental state GMS GMS:13 geriatric mental state schedule GMS GMS:14 glyceryl monostearate GMS GMS:10 gomori methenamine silver GMTs GMTs:72 geometric mean titers GMTs GMTs:46 geometric mean titres GNB GNB:54 gramnegative bacilli GNB GNB:9 gramnegative bacteremia GNB GNB:31|GnB:1 gramnegative bacteria GN GN:15 gallium nitrate GN GN:10 ganglioneuroma GN GN:7|gn:4|Gn:1 gnotobiotic GN GN:21 gramnegative GN GN:10 guanine nucleotides GN GN:16 gustatory neocortex GON GON:13 glaucomatous optic neuropathy GON GON:14 greater occipital nerve GOS GOS:13 galactooligosaccharides GOS GOS:10|GO-S:1 galactose oxidaseschiff GOS GOS:265 glasgow outcome scale GOS GOS:54 glasgow outcome score GOT GOT:11 transferase GOT GOT:9 transminase GO GO:10 garlic oil GO GO:18 gemtuzumab ozogamicin GO GO:118 gene ontology GO GO:41 gingival overgrowth GO GO:14 glycolate oxidase GO GO:15 glyoxal GO GO:157|Go:1 graves ophthalmopathy GO GO:11 graves orbitopathy GPC GPC:209 gel permeation chromatography GPC GPC:52 giant papillary conjunctivitis GPC GPC:67 glycerophosphocholine GPC GPC:72 glycerophosphorylcholine GPC GPC:27 glycerylphosphorylcholine GPC GPC:22 glycophorin c GPC GPC:16|GP-C:3 glycoprotein precursor GPC GPC:20 grampositive cocci GPC GPC:19 guinea pig complement GPe GPe:12|Gpe:1 external globus pallidus GPe GPe:11 external segment GPE GPE:16 glycerophosphorylethanolamine GPE GPE:12 guinea pig embryo GPi GPi:15 globus pallidus interna GPi GPi:76|GPI:8|Gpi:3 globus pallidus internus GPi GPi:6|GPI:1 globus pallidus pars interna GPI GPI:11 glycoinositol phospholipid GPI GPI:21 glycophosphatidylinositol GPI GPI:15 glycosyl phosphatidyl inositol GPI GPI:71 glycosyl phosphatidylinositol GPI GPI:537|G-PI:1 glycosylphosphatidylinositol GPi GPi:7 internal pallidal segment GPi GPi:15 internal pallidum GPi GPi:8 internal segment GPI GPI:4 plasma membrane by a glycosylphosphatidylinositol GPN GPN:10 glossopharyngeal neuralgia GPN GPN:6|gpn:1 greater petrosal nerve GPP GPP:18 generalized pustular psoriasis GPP GPP:16 geranyl diphosphate GPP GPP:9 geranyl pyrophosphate GPR GPR:10 gastropyloric receptor GPR GPR:9 general practice residency GPR GPR:7 germination protease GPR GPR:8 glucose production rate GPR GPR:6 ground penetrating radar GPS GPS:9|G-P-S:1 gastrocnemiusplantarissoleus GPS GPS:51 global positioning system GPS GPS:16 gray platelet syndrome GPS GPS:20|GpS:2|gps:1 guinea pig serum GPT GPT:6 glucose pump test GPT GPT:9 goniopora toxin gpt gpt:7|GPT:1 guanine phosphoribosyl transferase gpt gpt:11 guanine phosphoribosyltransferase gpt gpt:6|GPT:3 xanthineguanine phosphoribosyl transferase gpt gpt:9|GPT:3 xanthineguanine phosphoribosyltransferase gpt gpt:5 xanthineguanine phosphoribosyltransferase gene GPV GPV:17|gpV:2 glycoprotein v GPV GPV:11 goose parvovirus GP GP:7|Gp:1 against platelet glycoproteins GP GP:25|gp:1|Gp:1 antiglycoprotein GP GP:16 general population GP GP:78 general practice GP GP:24 generalized polarization GP GP:19 genetic programming GP GP:312 globus pallidus GP GP:11 glucose polymer GP GP:8 glycolytic potential GP GP:11 glycophorin GP GP:13 goodpasture GP GP:10 gossypol GP GP:8|Gp:1 grampositive GP GP:13 growth plate GP GP:17 guttapercha GP GP:391|Gp:9 platelet glycoprotein GRE GRE:122 glucocorticoid response element GRE GRE:26 glycopeptideresistant enterococci GRF GRF:12 growth hormonereleasing hormone GRF GRF:9 somatocrinin GRU GRU:10 geriatric rehabilitation unit GRU GRU:19 glucocorticoid response unit GR GR:7 effect of glycyrrhizin GR GR:7 glycyrrhizae radix GR GR:8 good recovery GR GR:9 good response GSD GSD:62 geometric standard deviation GSD GSD:11 sex determination GSE GSE:10 general solubility equation GSE GSE:6 genetic suppressor element GSE GSE:41 glutensensitive enteropathy GSE GSE:7 gonadotropespecific element GSE GSE:27 grape seed extract GSH-Px GSH-Px:26|GSH-px:3|GSH-PX:3|GSHPx:1|GSHpx:1 glutathioneperoxidase GSH-Px GSH-Px:7|GSH-px:2|GSHpx:1|GSH-PX:1 gshperoxidase GSH GSH:11 glucocorticoidsuppressible hyperaldosteronism GSH GSH:26 glutathione content GSH GSH:1 glutathione in reduced GSH GSH:16 glutathione levels GSH GSH:9 gluthathione GSH GSH:17 reduced form GSH GSH:7 reduced glutathion GSH GSH:9 reducedglutathione GSI GSI:10 gametophytic selfincompatibility GSI GSI:93|gsi:1 genuine stress incontinence GSI GSI:25 global severity index GSI GSI:10|gsI:1 glutamine synthetase i GSI GSI:81 gonadosomatic index GSK GSK:11 glaxosmithkline GSK GSK:17 glycogen synthase kinase GSM GSM:13 goat synovial membrane GSM GSM:9 gray scale median GSM GSM:9 grey scale median GSP GSP:19|Gsp:1|gsp:1 general secretory pathway GSP GSP:14 generalized social phobia GSP GSP:9 german shepherd dog pyoderma GSP GSP:13 greater superficial petrosal GSR GSR:12 galvanic skin resistance GSR GSR:40 galvanic skin response GSR GSR:15 generalized shwartzman reaction GSSG GSSG:33 glutathione disulphide GSSG GSSG:24 oxidized form GSSG GSSG:25 oxidized gsh GSS GSS:16 general social survey GSS GSS:29 gerstmannstrausslerscheinker GSS GSS:33 gerstmannstraussler syndrome GSS GSS:11 global seasonality score GSS GSS:9 granulomatous slack skin GSTM1 GSTM1:115 glutathione stransferase m GSTM1 GSTM1:4 glutathione stransferase m gene GSTM1 GSTM1:9 glutathione stransferase mu GSTM1 GSTM1:7 glutathione stransferase mu GST-P GST-P:9 glutathione stransferase pform GST-P GST-P:88|GSTP:3 glutathione stransferase placental form GST-P GST-P:14 glutathione transferase p GST-P GST-P:10 placental type GST-P GST-P:4 placental type of glutathionestransferase GSTs GSTs:467|GSTS:1 glutathione stransferases GSTs GSTs:72 glutathione transferases GST GST:5 general systems theory GST GST:6 generalized seizure triggering threshold GST GST:9 glucagon stimulation test GST GST:8 glutathione stransferase activity GST GST:14 gshstransferase GS GS:9 galactosialidosis GS GS:22|G-S:6 gastrocnemiussoleus GS GS:22|Gs:1 gastroschisis GS GS:12 general surgery GS GS:14 gentamicin sulfate GS GS:12 gestational sac GS GS:17 ginsenosides GS GS:19 gitelmans syndrome GS GS:8 glomerular sclerosis GS GS:50|gs:1 glomerulosclerosis GS GS:9 glucosamine sulfate GS GS:13 glucosesensitive GS GS:167 glycogen synthase GS GS:24|gs:1 graft survival GS GS:6 gram stain GS GS:39 gramicidin s GS GS:16 grip strength GS GS:12 patients with gilberts syndrome Gs Gs:5|GS:1 protein of adenylate cyclase Gs Gs:8 protein of adenylyl cyclase Gs Gs:20|GS:2 stimulatory gtpbinding protein Gs Gs:8 stimulatory guanine nucleotide regulatory protein GTG GTG:46 gold thioglucose GTG GTG:19 goldthioglucose GTH GTH:15|GtH:3 gonadotrophin GTH GTH:10 gonadotropic GTH GTH:17|GtH:9 gonadotropic hormone GTN GTN:39 gestational trophoblastic neoplasia GTN GTN:441 glyceryl trinitrate GTN GTN:23 glyceryltrinitrate GTTs GTTs:10 gestational trophoblastic tumors GTTs GTTs:19 glucose tolerance tests GTC GTC:20 generalized tonicclonic GTC GTC:16 gillthomascosman GTC GTC:19 green tea catechins GTR GTR:5 glutamyltrna reductase GTR GTR:21 gross total resection GTR GTR:335 guided tissue regeneration GT GT:11 gambling task GT GT:12|gt:1 gene therapy GT GT:9 genital tubercle GT GT:8 germ tube GT GT:5 gingival tissue GT GT:9 gliotoxin GT GT:6 glucose transport GT GT:10 glucuronosyltransferase GT GT:18 glutathione transferase GT GT:7 granulation tissue GT GT:13 green tea GT GT:23 lglutamic acidltyrosine GT GT:9 udpglcglycoprotein glucosyltransferase GT GT:10 udpglucuronosyltransferase GU GU:117 genitourinary GU GU:13 gonococcal urethritis GVD GVD:22 graft vascular disease GVD GVD:11 granulovacuolar degeneration GVHD GVHD:20|GvHD:1 acute graftversushostdisease GVHD GVHD:15|GvHD:1 chronic graftversushostdisease GVHD GVHD:28|GvHD:5 graft vs host disease GVL GVL:30|GvL:6 graftversusleukaemia GVL GVL:4|GvL:2 graftversusleukemia effect GVL GVL:12 graftversuslymphoma GV GV:18 gas ventilation GV GV:9 gastric varices GV GV:19|Gv:4 gentian violet GV GV:9 germinal vesicle stage GV GV:8 gilvocarcin v GV GV:42 growth velocity GXT GXT:10 exercise tests GXT GXT:31 graded exercise test GXT GXT:7 graded exercise testing GalNAc GalNAc:48|GalNAC:1 nacetyldgalactosamine GalNAc GalNAc:113|GalNac:9|galNac:1|GalNAC:1 nacetylgalactosamine Gal Gal:130|gal:18 galactose Gal Gal:13 galactosyl Gb4 Gb4:12 globoside Gb4 Gb4:9 globotetraosylceramide Gla Gla:26|GLA:1 gammacarboxyglutamate Gla Gla:181|gla:11|GLA:9 gammacarboxyglutamic acid Gla Gla:16 gammacarboxyglutamyl GlcA GlcA:10 dglucuronic acid GlcA GlcA:20 glucuronic acid GMR GMR:11 geometric mean ratio GMR GMR:10 gmcsf receptor GM GM:26 galactomannan GM GM:10 gastric metaplasia GM GM:19 gastric mucosa GM GM:7 gastrocnemius medialis muscle GM GM:8 gastrocnemius muscle GM GM:160 genetically modified GM GM:9 germinal matrix GM GM:11 gluteus maximus GM GM:15|Gm:1 gluteus medius GM GM:10 glyceryl methacrylate GM GM:141|gm:1|Gm:1 gray matter GM GM:21 grey matter GM GM:10 growth medium GM GM:9 growth monitoring Gm Gm:6 heavy chain allotypes Gm Gm:18|gm:6|GM:2|gM:1 membrane conductance GM GM:5 rat medial gastrocnemius GnRHa GnRHa:3 gnrh agonist daladesglygnrh nethylamide GnRHa GnRHa:1 gnrh and its analogues GnRHa GnRHa:11|GnRH-a:10|GnRHA:1|Gn-RHa:1|GNRHa:1|GN-RH-a:1 gonadotropinreleasing hormone analogue GnRH GnRH:2 frequency lh GnRH GnRH:19 gonadoliberin GPA GPA:11 betaguanidinopropionic acid GPA GPA:7 generalized procrustes analysis GPA GPA:11 global program on aids GPA GPA:12 glomerular polyanion GPA GPA:8|GpA:1 glycophorina GQ GQ:9 general quotient GQ GQ:8 medical school graduation questionnaire GSV GSV:22 great saphenous vein GSV GSV:61 greater saphenous vein GTS GTS:16 ginseng total saponin GTs GTs:5 glutamate transporters GTs GTs:11 glycosyltransferases GTS GTS:15 green tobacco sickness GUS GUS:9|Gus:2|gus:1 betaglucuronidase reporter gene GUS GUS:11 glucuronidase GUS GUS:28 promoterbetaglucuronidase GVBD GVBD:8 breakdown of the germinal vesicle GVBD GVBD:10 germinal vesicle break down H&E H&E:6 hematoxylin and eosin staining H&E H&E:21 stained with haematoxylin and eosin H-12 H-12:9 heterokaryon H-12 H-12:8 twocomponent heterokaryon H2 H2:64 breath hydrogen H2 H2:22 histamine type H-2 H-2:12 histocompatibility H2 H2:12 hydrogen gas H-2 H-2:22 major histocompatibility H-7 H-7:5|H7:3 isoquinoline sulfonylmethylpiperazine H-7 H-7:8|H7:2 isoquinolinesulphonylmethylpiperazine H7 H7:9|H-7:9 protein kinase c inhibitor H-7 H-7:4|H7:2 protein kinase c inhibitor isoquinolinesulfonylmethylpiperazine H7 H7:2|H-7:1 protein kinase c inhibitor isoquinolinesulfonylmethylpiperazine dihydrochloride H7 H7:3|H-7:1 protein kinase inhibitor isoquinolinylsulphonylmethylpiperazine HAA HAA:8 haloacetic acid HAA HAA:11 hospital activity analysis HABR HABR:7 hepatic arterial buffer response HABR HABR:6 hyaluronic acidbinding region HACE HACE:8 hepatic arterial chemoembolization HACE HACE:7 hepatic artery chemoembolization HAC HAC:5 hepatic arterial chemotherapy HAC HAC:6 hepatic artery chemotherapy HAC HAC:10 human articular chondrocytes HAC HAC:24 hydroxyapatite cement HAC HAC:9 hyperadrenocorticism HAD HAD:15 hydroxyacylcoa dehydrogenase HAD HAD:15 haloacid dehalogenase HAD HAd:6|HAD:6|Had:1 hemadsorption HAD HAD:126 hospital anxiety and depression HAEC HAEC:13 human airway epithelial cells HAEC HAEC:14|hAEC:1 human amniotic epithelial cells HAE HAE:10 hepatic arterial embolization HAE HAE:20 hepatic artery embolization HAE HAE:10 hereditary angiooedema HAE HAE:111 hereditary angioedema HAE HAE:12 human amniotic epithelial HAF HAF:9 hepatic arterial flow HAF HAF:13|hAF:1 human amniotic fluid HAI HAI:5|hai:4 h after inoculation HAI HAI:132 hepatic arterial infusion HAI HAI:55 hepatic artery infusion HAI HAI:75 histological activity index HAI HAI:9 inhibition assay HAI HAI:8 titers of hemagglutinationinhibiting HAM/TSP HAM/TSP:11 htlv associated myelopathytropical spastic paraparesis HAM/TSP HAM/TSP:13 htlviassociated myelopathy HAM/TSP HAM/TSP:9 human tcell lymphotropic virus type i htlviassociated myelopathytropical spastic paraparesis HAM/TSP HAM/TSP:16 human t lymphotropic virus type i htlviassociated myelopathytropical spastic paraparesis HAP1 HAP1:6|HAP-1:2 huntingtinassociated protein HAP1 HAP1:10|Hap1:2|HAP-1:1 huntingtinassociated protein HAP HAP:5 base analog nhydroxylaminopurine HAP HAP:12 hepatic arterial phase HAP HAP:33 hospitalacquired pneumonia HAP HAP:11 human activity profile HAP HAP:12 hyperthermic antiblastic perfusion HARP HARP:12 harmonic phase HARP HARP:22 heparin affin regulatory peptide HAS HAS:16 ha synthase HAs HAs:15 haemagglutinins HAs HAs:13 health authorities HAs HAs:11 hearing aids HAS HAS:13 high alcohol sensitivity HAS HAS:8 human albumin solution HAS HAS:37|has:3 hyaluronan synthase HAs HAs:11 hydrophobic agents HAT HAT:7 handgripapexcardiographic test HAT HAT:26 heparinassociated thrombocytopenia HAT HAT:80 hepatic artery thrombosis HAT HAT:12 histone acetyl transferase HAT HAT:81 human african trypanosomiasis HAT HAT:9 humanized antitac HAT HAT:10 hydrogen atom transfer HA HA:9 habitual abortion HA HA:20 haemagglutinating HA HA:92 haemagglutination HA HA:15 head activator HA HA:17 headache HA HA:9 health authority HA HA:23 hearing aid HA HA:6 heart area HA HA:8 heat acclimation HA HA:5 height age HA HA:60 hemagglutinating HA HA:205 hemagglutination HA HA:9 hemagglutination activity HA HA:10 hemagglutination assay HA HA:10 hemagglutinin glycoprotein HA HA:8 hemagglutinin protein HA HA:11 hemolytic anemia HA HA:22 hepatic arterial HA HA:78 hepatic artery HA HA:7 hepatocellular adenoma HA HA:31 hippocampal atrophy HA HA:22 human albumin HA HA:6 hydropic abortion HA HA:16 hydroxyapatitecoated HA HA:13 hyperandrogenism HA HA:26 hyperstriatum accessorium HA HA:24 hypothalamic amenorrhea HA HA:2 influenza a hemagglutinin HA HA:6 influenza a virus haemagglutinin HA HA:182 influenza virus hemagglutinin HA HA:5 lines of chickens selected for high HA HA:1 lines selected for either a high HA HA:9 mice selectively bred for high HA HA:4 minor histocompatibility antigen HA HA:8 sperm hyperactivation HBD HBD:7 heartbeating donor HBD HBD:18 heparinbinding domain HBD HBD:13 hydroxybutyrate dehydrogenase HB-EGF HB-EGF:22 heparinbinding egf HB-EGF HB-EGF:167 heparinbinding epidermal growth factorlike growth factor HBIG HBIG:86|HBIg:22 hepatitis b immune globulin HBIG HBIG:49|HBIg:35 hepatitis b immunoglobulin HBI HBI:18 halfbody irradiation HBI HBI:22 hemibody irradiation HBI HBI:12 human blood index HBL HBL:13 hemolysin bl HBL HBL:9 hepatoblastoma HBL HBL:10 hexagonal bilayer HBL HBL:10 hypobetalipoproteinemia HBP HBP:8 dimethylbenzaanthracene dmbainduced hamster buccal pouch HBP HBP:19 hepatic binding protein HBP HBP:17 hexosamine biosynthesis pathway HBP HBP:7 hexosamine biosynthetic pathway HBP HBP:82 high blood pressure HBP HBP:16 hydrocortisone butyrate propionate HBV-DNA HBV-DNA:9|HBVDNA:1 hepatitis b virus deoxyribonucleic acid HBV-DNA HBV-DNA:27 hepatitis b virus dna HBV HBV:9 hepatitis b infection HBV HBV:52 hepatitis b viral HBV HBV:25 hepatitis b virus infection HBV HBV:10 honey bee venom HBV HBV:8 honeybee venom HBcAb HBcAb:18|HBcAB:2|HbcAb:1|HBc-Ab:1 hepatitis b core antibody HBcAb HBcAb:10 hepatitis b core antigen HbC HbC:6 haemoglobin c HbC HbC:9|Hb-C:1 hemoglobin c HBC HBC:13 hereditary breast cancer HBC HBC:21 human breast carcinoma HBsAg HBsAg:22|HbsAg:1 hepatitis b surface ag HBsAg HBsAg:20|HBSAg:1|HBs-Ag:1 surface antigen of hepatitis b virus HBs HBs:10 hemangioblastomas HbS HbS:36 hemoglobin s HBs HBs:11 hepatoblastomas HbS HbS:17|Hbs:1 sickle cell hemoglobin HbS HbS:9|Hb-S:1 sickle haemoglobin HbS HbS:34 sickle hemoglobin HB HB:13 bodies hb hb:11 gap gene hunchback HB HB:9 heartbeating HB HB:18 hexobarbital HB HB:21|Hb:3 his bundle HB HB:5 homologous blood HB HB:9|H-B:8 housebrackmann HB HB:30 hypocrellin b hb hb:9 segmentation gene hunchback HCA HCA:28 homocysteic acid HCA HCA:4 hurthle cell adenomas HCA HCA:7 hybrid capture assay HCA HCA:36 hydrophobic cluster analysis HCA HCA:6 hydroxycarbonate apatite HCA HCA:9 hydroxycitric acid HCA HCA:88 hypothermic circulatory arrest HCC HCC:22 hepatocarcinoma HCC HCC:14 hepatocellular HCC HCC:44 hepatocellular cancer HCC HCC:19 human corpus cavernosum HCD HCD:25 high cholesterol diet HCD HCD:5|h-CD:2 high molecular weight caldesmon HCD HCD:8 hydrocolloid dressing HCF HCF:11 host cell factor HCF HCF:5 human corneal fibroblasts HCF HCF:16 hydatid cyst fluid hCG hCG:152|HCG:12 human choriogonadotropin hCG hCG:7|HCG:2 human chorionic gonadotropin hormone HCHs HCHs:50 hexachlorocyclohexanes HCHs HCHs:19 hexachlorocyclohexane isomers HCHWA-D HCHWA-D:14 hereditary cerebral hemorrhage with amyloidosisdutch type HCHWA-D HCHWA-D:7 hereditary cerebral hemorrhage with amyloidosis of the dutch type HCI HCI:20 humancomputer interaction HCI HCI:10 translational inhibitor HCM HCM:8|h-CM:1 human ciliary muscle HCM HCM:11 hypertrophic HCN HCN:60 hydrogen cyanide HCN HCN:19 hyperpolarizationactivated cyclic nucleotidegated HCN HCN:3 hyperpolarizationactivated cyclic nucleotidegated cation HCPs HCPs:14 health care professionals HCPs HCPs:20 health care providers HCP HCP:6 health care provider HCP HCP:12 hearing conservation program HCP HCP:11 hematopoietic cell phosphatase HCP HCP:20 hereditary coproporphyria HCP HCP:38 hexachlorophene HCR HCR:4 hemincontrolled translational repressor HCR HCR:10 hyperthermochemoradiotherapy HCS HCS:7 cord serum HCS HCS:5 haemoglobin colour scale HCs HCs:52 hairy cells HCs HCs:26 healthy controls HCs HCs:18|hcs:1 heavy chains HCs HCs:14 hepatocytes HCS HCS:29 holocarboxylase synthetase HCS HCS:6 hybrid capture system HCs HCs:21 hydrocarbons HCT HCT:9 haematocrit centrifugation technique HCT HCT:11 halstead category test HCT HCT:19|hCT:7 helical computed tomography HCT HCT:16|hCT:1 helical ct HCT HCT:13 hematopoietic cell transplant HCU HCU:5 handcarried cardiac ultrasound HCU HCU:6 handcarried ultrasound HCV HCV:15 hepatitis c infection HCV HCV:52 hepatitis c viral HCV HCV:35 hepatitis c virus infection HCWs HCWs:181 health care workers HCWs HCWs:116 healthcare workers HCW HCW:14 healthcare worker HCW HCW:12 hot carcass weight HCL HCL:108 hairy cell leukaemia HCL HCL:581 hairy cell leukemia HCl HCl:141|HCL:2 hydrochloric acid HCl HCl:23|HCL:1 hydrogen chloride HCL HCL:9 patients with hairycell leukaemia HC HC:5 fed a highcholesterol HC HC:16 haemorrhagic colitis HC HC:13 haemorrhagic cystitis HC HC:12 hair cell HC HC:11|Hc:3 haptocorrin HC HC:8 hassalls corpuscles HC HC:11 healthy children HC HC:9 healthy comparison HC HC:16 helper component HC HC:31 hemicrania continua Hc Hc:24|HC:4 hemocyanin HC HC:15 hemorrhagic colitis HC HC:53 hemorrhagic cystitis HC HC:23 hepatic cirrhosis HC HC:21 hepatitis c HC HC:20 high cholesterol HC HC:7 hippocampal commissure Hc Hc:23|HC:8 histoplasma capsulatum HC HC:23 hog cholera HC HC:18 home care HC HC:5 horizontal canal HC HC:6 horizontal semicircular canal HC HC:31 huntingtons chorea HC HC:16 hybrid capture HC HC:10 hydrocephalus HC HC:7 hydrogen clearance HC HC:10 hypercholesterolaemia HC HC:9 plasma homocysteine HDA HDA:5 hexamethylene diamine HDA HDA:5 electrical stimulation of the hypothalamic defense area HDA HDA:12 hypothalamic defence area HDB HDB:13|hDB:2 horizontal limb of the diagonal band HDB HDB:10|hDB:1 horizontal limb of the diagonal band of broca HDCV HDCV:23 human diploid cell rabies vaccine HDCV HDCV:26 human diploid cell vaccine HDFs HDFs:17|hDFs:8 human dermal fibroblasts HDFs HDFs:38 human diploid fibroblasts HDF HDF:24 haemodiafiltration HDF HDF:125 hemodiafiltration HDR HDR:11 headdown rotation HDR HDR:9 hemodynamic response HDR HDR:8 homologydirected repair HDS-R HDS-R:7 hasegawa dementia scale HDS-R HDS-R:3|HDSR:2 revised version of hasegawas dementia scale HDS HDS:13 hasegawas dementia scale HDS HDS:9 headdown suspension HDS HDS:15 highdose sequential HDS HDS:10 hydrodesulfurization HDT HDT:113 highdose therapy HDT HDT:7 highdose treatment HD HD:7 enoylcoa hydratasehydroxyacylcoa dehydrogenase HD HD:9 haemodialysed HD HD:13 haemodialysis patients HD HD:10 hand dermatitis HD HD:21|H-D:19 hanganutziudeicher HD HD:39 healthy donors HD HD:10 heavy distillate HD HD:5 heavy drinkers HD HD:15|hd:1 helperdependent HD HD:9 hemodialyses HD HD:9 hemodialysed HD HD:23 hemodialysis patients HD HD:7 hemodialysis treatment HD HD:29 hemodialyzed HD HD:21 hemodilution HD HD:28 high density HD HD:7 hip dysplasia HD HD:10 hodgkins HD HD:11 hodgkins lymphoma HD HD:78 homeodomain HD HD:9 homozygous deletion HD HD:10 hormonedependent HD HD:31 house dust HD HD:10 huntingtons HD HD:1535 huntingtons disease HD HD:8 hypoxic depolarization HD HD:9 patients on chronic haemodialysis HECs HECs:11 ethics committees HECs HECs:6|hECs:3 human endothelial cells HEC HEC:29 hydroxyethyl cellulose HEC HEC:48 hydroxyethylcellulose HEF HEF:8 hamster embryo fibroblasts HEF HEF:7 hepatic erythropoietic factor HEF HEF:8 hepatic extraction fraction HELLP HELLP:2 elevated liver enzymes and low platelet HELLP HELLP:1 hemolysis elevated liver enzymes and low platelets HEL HEL:152 hen egg lysozyme HEL HEL:60 hen egg white lysozyme HEL HEL:27 human embryo lung HEL HEL:71 human embryonic lung HEL HEL:17 human erythroleukaemia HEL HEL:15 human erythroleukemia cell line HEL HEL:12 human erythroleukemic HEPM HEPM:8 human embryonic palatal mesenchymal HEPM HEPM:6 human embryonic palatal mesenchyme HEPT HEPT:27 hydroxyethoxymethylphenylthiothymine HEPT HEPT:9 hamster egg penetration test HERS HERS:68 heart and estrogenprogestin replacement study HERS HERS:20 hertwigs epithelial root sheath HES HES:10 hetastarch HES HES:15 hospital episode statistics HES HES:10 hydroxyethyl starch solution HES HES:57 hydroxyethylstarch HES HES:193 hypereosinophilic syndrome Hex Hex:9|hex:1|HEX:1 betanacetylhexosaminidase Hex Hex:17|HEX:16|hex:6 hexosaminidase HEp-2 HEp-2:5|Hep-2:2|HEP-2:2|HEp2:1 carcinoma cell line HEp-2 HEp-2:8 human epithelial cell line HEp-2 HEp-2:9|Hep2:7|HEp2:5 laryngeal carcinoma HE HE:13 haemagglutininesterase HE HE:15 haematoxylin and eosin HE HE:6 hamster embryo HE H-E:8|HE:8 hasemanelston HE HE:14 health education HE HE:18 hemorrhagic enteritis HE HE:328 hepatic encephalopathy HE HE:88 hereditary elliptocytosis HE HE:13 hydroalcoholic extract HE HE:18 hypothalamic extract HE HE:4|H-E:1 sections were stained with hematoxylineosin HFA HFA:5 fatty acid HFA HFA:10 hexafluoroacetone HFA HFA:9 high functioning autism HFA HFA:15 human fetal adrenal HFA HFA:9 humanfloraassociated HFA HFA:11 humphrey field analyser HFA HFA:19 humphrey field analyzer HFA HFA:63 hydrofluoroalkane HFA HFA:18 hydrofluoroalkanea HFA HFA:7 hypoglossalfacial nerve anastomosis HFBA HFBA:11 heptafluorobutyric acid HFBA HFBA:24 heptafluorobutyric anhydride HFCs HFCs:6 high sce frequency cells HFCs HFCs:9 hydrofluorocarbons HFE HFE:17 haemochromatosis HFE HFE:55|Hfe:1 hemochromatosis HFE HFE:60|Hfe:3 hemochromatosis gene HFE HFE:5 hemochromatosis protein HFE HFE:16 human factors engineering HFI HFI:51 hereditary fructose intolerance HFI HFI:13|Hfi:1 hyperostosis frontalis interna HFO HFO:18 highfrequency oscillatory ventilation HFO HFO:18 hydrous ferric oxide HFP HFP:11 heterochromatic flicker photometry HFP HFP:5 highfrequency power HFP HFP:9 human fetal pancreas HFRS HFRS:66 haemorrhagic fever with renal syndrome HFRS HFRS:23 hemorrhagic fever with the renal syndrome HFS HFS:17 handfoot syndrome HFS HFS:111 hemifacial spasm HFS HFS:5 highfat sucrose HF HF:31 haemofiltration HF HF:21 hageman factor HF HF:18|Hf:16 halofantrine HF HF:43 hartreefock HF HF:1123 heart failure HF HF:6 hemorrhagic fever HF HF:93 high fat HF HF:5 high fiber HF HF:5 high flow HF HF:10 highflux HF HF:10 high frequencies HF HF:7 high frequency band HF HF:13 highfrequency component HF HF:9 hip fracture HF HF:6 hollow fiber HF HF:11 hydrofluoric HF HF:75 hydrofluoric acid HF HF:43 hydrogen fluoride HF HF:8 hypoxic fraction HF HF:2 rats fed highfat HGEC HGEC:13 human gingival epithelial cells HGEC HGEC:7|hGEC:2 human glomerular epithelial cells HGFA HGFA:21|HGF-A:1 hepatocyte growth factor activator HGFA HGFA:22 hgf activator HGF HGF:35|hGF:1 hematopoietic growth factors HGF HGF:2058|Hgf:1 hepatocyte growth factor HGF HGF:20 hereditary gingival fibromatosis hGH hGH:1076|HGH:187|h-GH:3|hgh:2|hGh:2|hgH:1 human growth hormone hGH hGH:10 human growth hormone gene HGP HGP:183 hepatic glucose production HGP HGP:43 human genome project HGV HGV:10 hepatitis g HGV HGV:363 hepatitis g virus HG HG:32 handgrip HG HG:48|hg:3 harderian gland HG HG:39 herpes gestationis HG HG:25 heschls gyrus HG HG:55 high glucose HG HG:15 histological grade HG HG:23 hyperemesis gravidarum HG HG:15 hyperglycemia HG HG:17|hg:4 hypergravity HG HG:10 hypoglossal HHD HHD:21 haileyhailey disease HHD HHD:10 handheld dynamometer HHD HHD:10 home hemodialysis HHD HHD:41 hypertensive heart disease HHL HHL:9 hippuryllhistidyllleucine HHL HHL:7 nhexanoyllhomoserine lactone HHP HHP:33 high hydrostatic pressure HHP HHP:10 honolulu heart program HHS HHS:27 harris hip score HHS HHS:11 hypothenar hammer syndrome HHT HHT:30 hydroxyheptadecatrienoic acid HHT HHT:55 hereditary haemorrhagic telangiectasia HHT HHT:148 hereditary hemorrhagic telangiectasia HHT HHT:6 hereditary hemorrhagic teleangiectasia HHT HHT:7 heterotopic heart transplantation HHT HHT:50 homoharringtonine HHV-6B HHV-6B:7 human herpesvirus variant b HHV-6B HHV-6B:8 human herpesvirus b HHV-8 HHV-8:11|HHV8:4 herpesvirus HHV-8 HHV-8:10|HHV8:8 human herpes virus type HHV-8 HHV-8:45|HHV8:11 human herpesvirus type HH HH:15|H-H:3 hamburger and hamilton HH HH:11|H-H:2 hamburgerhamilton HH HH:12|H-H:5|hh:2|h-h:1 headtohead HH HH:12 heated humidifier Hh Hh:267|hh:82|HH:15 hedgehog Hh Hh:11 hemopoietic histocompatibility HH HH:12 hemorrhagic hypotension HH HH:62 hereditary haemochromatosis HH HH:16 hereford HH HH:20 hiatal hernia HH HH:11 hiatus hernia HH HH:29|H-H:1 hodgkinhuxley HH HH:9 hyperhidrosis HH HH:7 hypobaric hypoxia HH HH:17 hypogonadotrophic hypogonadism HH HH:6 hyporeninemic hypoaldosteronism HH HH:20 hypothalamic hamartoma HH HH:13 hypoxic hypoxia HIC HIC:14 handlinginduced convulsions HIC HIC:11 head injury criterion HIC HIC:20 health insurance commission HIC HIC:26 hepatic iron concentration HIE HIE:6 hyperimmunoglobulin e HIE HIE:1 hypoxic and ischemic encephalopathy HIE HIE:27 hypoxicischaemic encephalopathy HIE HIE:81 hypoxicischemic encephalopathy HIE HIE:10 rand health insurance experiment HIG HIG:9 haemolysisingel HIG HIG:27|HIg:3|hIg:3 human immunoglobulin HII HII:6 hepatic iron index HII HII:11 hexagonal phase HIPAA HIPAA:103 health insurance portability and accountability act HIPAA HIPAA:47 health insurance portability and accountability act of HIP HIP:11 health insurance plan HIP HIP:9 hypnotic induction profile HIP HIP:15|Hip:4|hip:1 interacting protein HIT HIT:7 haemagglutination inhibition test HIT HIT:11 headache impact test HIT HIT:5 hemagglutination inhibition test HIT HIT:436 heparininduced thrombocytopenia HIT HIT:6 highintensity interval training HIT HIT:19 histidine triad HIT HIT:18 holtzman inkblot technique HIT HIT:10 home infusion therapy HIT HIT:8 hydrothermal isometric tension HIV+ HIV+:31 hivinfected HIV+ HIV+:20 human immunodeficiency viruspositive HIV- HIV-:22 hivnegative HIV- HIV-:22 hivseronegative HIV-1 HIV-1:24 human immunodeficiency virus type HIV-1 HIV-1:9 human immunodeficiency virus type one HIVE HIVE:10 encephalopathy HIVE HIVE:36|HIV-E:1 hiv encephalitis HIV HIV:59 human immunodeficiency HIV HIV:13 human immunodeficiency syndrome HIV HIV:10 human immunodeficiency viral HIV HIV:61 human immunodeficiency virus infection Hib Hib:756|HIB:48|HIb:5|HiB:2 haemophilus influenzae type b Hib Hib:9|HIB:1 haemophilus influenzae type b vaccine HIB HIB:13 hyperpneainduced bronchoconstriction HIB HIB:10 hyperventilationinduced bronchoconstriction HI HI:20|H-I:2 after hypoxiaischemia HI HI:15|H-I:2 cerebral hypoxiaischemia HI HI:7 familial hyperinsulinism HI HI:12 harlequin ichthyosis HI HI:15 harmonic imaging HI HI:41 head injury HI HI:15 healthy individuals HI HI:16 hearingimpaired HI HI:17 hospital insurance HI HI:11 humoral immunity HI HI:5 hyperinsulinism of infancy HI HI:29 hypomelanosis of ito HI HI:14 hypoxiaischaemia HI HI:5|H-I:1 hypoxic ischemia HI HI:60|H-I:14 hypoxicischemic HI HI:17 neonatal hypoxiaischemia HJ HJ:13 highlands j HJ HJ:13 holliday junction HJ HJ:6 rouxeny hepaticojejunostomy hK2 hK2:43 human glandular kallikrein hK2 hK2:45|HK2:1 human glandular kallikrein HK HK:9 head kidney HK HK:17|H-K:1 heatkilled HK HK:1 high in potassium HK HK:9 high k HK HK:8 histidine kinase HK HK:12 hong kong HK HK:6 horseshoe kidney HK HK:79|Hk:2 hypokinesia HL-60 HL-60:51|HL60:5 human leukemia HL-60 HL-60:25|HL60:1 human leukemic HL-60 HL-60:6 human promyelocytes HL-60 HL-60:13|HL60:5 human promyelocytic HL-60 HL-60:11|HL60:2 human promyelocytic leukaemia HL-60 HL-60:130|HL60:11 human promyelocytic leukemia HL-60 HL-60:23|HL60:2 human promyelocytic leukemia cell line HL-60 HL-60:11 human promyelocytic leukemic HL7 HL7:21|HL-7:1 health level HL7 HL7:24 health level seven HLA-DR HLA-DR:15 human leucocyte antigendr HLA-DR HLA-DR:16 human leukocyte antigen HLA HLA:5|HL-A:1 histocompatibility system HLA HLA:8|HL-A:1 human leukocyte HLA HLA:6 human major histocompatibility HLA HLA:23 human major histocompatibility complex HLA HLA:7 human mhc HLA HLA:11 symposium on major histocompatibility antigens HLD HLD:19 hepatolenticular degeneration HLD HLD:5 highlevel disinfection HLE HLE:29 human lens epithelial HLE HLE:151|hLE:3 human leukocyte elastase HLP HLP:50 hyperlipoproteinaemia HLP HLP:10|hlp:1 hyperlipoproteinemias HLP HLP:43 type iii hyperlipoproteinemia HLR HLR:12 hearttolung ratio HLR HLR:13 highlevel resistance HLR HLR:12 hydraulic loading rate HL HL:9 hydroxymethylglutaryl coenzyme a lyase HL HL:17 db hearing level HL HL:11 heatlabile HL HL:15 high light HL HL:10 human lymphocytes HL HL:8|hL:2 human lysozyme HL HL:9 hyaline layer HL HL:9 hybrid layer HL HL:14 hyperlipidemic HMA HMA:20 hydroxymethylantipyrine HMA HMA:15 heteroduplex mobility analysis HMA HMA:99 heteroduplex mobility assay HMA HMA:7 hexamethylene amiloride HMBA HMBA:50 hexamethylenebisacetamide HMBA HMBA:11 nnhexamethylenebisacetamide HMB HMB:37|hmb:1 betahydroxybetamethylbutyrate HMB HMB:13 heavy menstrual bleeding HMB HMB:10 hypersensitivity to mosquito bites HMC-1 HMC-1:8 human leukemic mast cells HMC-1 HMC-1:25 human mast cell line HMEC-1 HMEC-1:9 human dermal microvascular endothelial cell line HMEC-1 HMEC-1:13 human microvascular endothelial cell line HME HME:12 hemimegalencephaly HME HME:9 hereditary multiple exostosis HME HME:36 human monocytic ehrlichiosis HMG1 HMG1:9|HMG-1:4 high mobility group protein HMG1 HMG1:7|HMG-1:4|hmg-1:1 high mobility group protein HMGB1 HMGB1:20 high mobility group box HMGB1 HMGB1:5 high mobility group box protein HMG HMG:15 hydroxymethylglutaric acid HMG HMG:21 hydroxymethylglutaryl HMG HMG:10 high mobility group proteins HMMA HMMA:14 hydroxymethoxymandelic acid HMMA HMMA:11 hydroxymethoxymethamphetamine HMM HMM:233|HmM:1 heavy meromyosin HMM HMM:56 hexamethylmelamine HMPAO HMPAO:7|HM-PAO:2 mtchexamethylpropyleneamineoxime HMPAO HMPAO:8|HM-PAO:1 hexamethylpropyleneamineoxime HMPAO HMPAO:10 tcm hexamethylpropylene amineoxime HMP HMP:43 hexose monophosphate HMP HMP:17 hexose monophosphate pathway HMR HMR:5 hearttomediastinum ratio HMR HMR:13 histiocytic medullary reticulosis HMS HMS:12 hairless mouse skin HMS HMS:6 hypermobility syndrome HMS HMS:6 hyperreactive malarial splenomegaly HMS HMS:8 hyperreactive malarious splenomegaly HMT HMT:7 heparin management test HMT HMT:17 hexamethylenetetramine HMT HMT:12 histamine methyltransferase HMT HMT:6 histone methyltransferase HM HM:5 heuristic method HM HM:26|H-M:1 holter monitoring HM HM:45 human milk HM HM:12 hydromorphone HM HM:9 malignancies HM HM:4 patients with hypercalcaemia of malignancy HN2 HN2:21|HN-2:1 mechlorethamine HN2 HN2:6 mechlorethamine hydrochloride HNA HNA:11 heparin neutralizing activity HNA HNA:24 hereditary neuralgic amyotrophy HNA HNA:8 higher nervous activity HNCM HNCM:17 hypertrophic nonobstructive cardiomyopathy HNCM HNCM:11 patients with hypertrophic nonobstructive cardiomyopathy HNC HNC:5 guinea pig hypothalamoneurohypophyseal complex HNC HNC:72 head and neck cancer HNC HNC:10|hNC:1 human neutrophil collagenase HNE HNE:11 hydroxyenonenal HNE HNE:10 ehydroxynonenal HNE HNE:11 human nasal epithelial HNE HNE:192|hNE:2 human neutrophil elastase HNE HNE:17 transhydroxynonenal HNF HNF:9 heterotrophic nanoflagellates HNF HNF:10 nuclear factors HNL HNL:27 histiocytic necrotizing lymphadenitis HNL HNL:36 human neutrophil lipocalin HN HN:81 haemagglutininneuraminidase HN HN:10 hemagglutininneuraminidase protein HN HN:15 hereditary nephritis hn hn:14 heterogeneous nuclear hn hn:27 heteronuclear HN HN:59 heymann nephritis HN HN:26 humanin HN HN:19 hyaluronectin HN HN:9|Hn:1 hydronephrosis HOA HOA:6 hemoglobinoxygen affinity HOA HOA:51 hypertrophic osteoarthropathy HOCs HOCs:24 hydrophobic organic compounds HOCs HOCs:20 hydrophobic organic contaminants HOME HOME:40 home observation for measurement of the environment HOME HOME:14 human omental microvascular endothelial HOPS HOPS:11 hiv outpatient study HOPS HOPS:9 hypophosphatasia HOP HOP:5 oocyte penetration HOP HOP:10 urinary hydroxyproline HOS HOS:7 health opinion survey HOS HOS:28 holtoram syndrome HOS HOS:14 human osteogenic sarcoma HOS HOS:7 human osteosarcoma cell line HOS HOS:9 medicare health outcomes survey HOS HOS:16 swelling test HOT HOT:46 home oxygen therapy HOT HOT:64 hypertension optimal treatment Ho Ho:7|ho:5|HO:3 cook and medley hostility Ho Ho:6|HO:6|ho:4 cookmedley hostility Ho Ho:5|ho:3|HO:2 hostility scale HPA HPA:8 activity of the hypothalamuspituitaryadrenocortical HPA HPA:17 adrenocortical HPA HPA:9 habitual physical activity HPA HPA:88|HpA:3 helix pomatia agglutinin HPA HPA:4|Hpa:3|hpa:2 heparanase HPA HPA:11 human pancreatic alphaamylase HPA HPA:26 hybridization protection assay HPA HPA:23 hyperphenylalaninaemia HPA HPA:58 hyperphenylalaninemia HPA HPA:68 hypothalamicpituitaryadrenal axis HPA HPA:5 hypothalamicpituitaryadrenal cortical HPA HPA:228|H-P-A:3 hypothalamicpituitaryadrenocortical HPA HPA:17 hypothalamopituitaryadrenal axis HPA HPA:7 hypothalamopituitaryadrenal cortical HPA HPA:130 hypothalamopituitaryadrenocortical HPA HPA:160 hypothalamuspituitaryadrenal HPB HPB:22 hydroxypyridylbutanone HPB HPB:13 portal blood HPCs HPCs:11 hemangiopericytomas HPCs HPCs:119 hematopoietic progenitor cells HPC HPC:12 haemangiopericytoma HPC HPC:38 hereditary prostate cancer HPC HPC:17 hippocampal HPC HPC:13|hPC:6 human protein c HPC HPC:50 hydroxypropyl cellulose HPC HPC:52 hydroxypropylcellulose HPC HPC:6 hypopharyngeal carcinoma HPD HPD:10 hepatopancreatoduodenectomy HPD HPD:8 hereditary progressive dystonia HPD HPD:13 hereditary progressive dystonia with marked diurnal fluctuation HPD HPD:11 high protein diet HPD HPD:11 hypothalamicpituitary disconnection HPD HPD:17 hypothalamopituitary disconnected HPD HPD:17 hypothalamopituitary disconnection HPE HPE:1 h pylori water extract HPE HPE:98 holoprosencephaly HPFH HPFH:25 hereditary persistence of fetal haemoglobin HPFH HPFH:122 hereditary persistence of fetal hemoglobin hpf hpf:24 h postfertilization HPF HPF:12 heparin precipitable fraction HPF HPF:11 highpressure freezing hpf hpf:15|hPF:1 hours postfertilization HPF HPF:20|hpf:11 per highpower field HPH HPH:12 helix pomatia haemocyanin HPH HPH:24 hypoxic pulmonary hypertension hpi hpi:9 h post insemination hpi hpi:6|HPI:1 h postinsemination HPI HPI:12 health practice index HPI HPI:33 hepatic perfusion index HPI HPI:33 highpathogenicity island HPI HPI:11|hPI:4 human proinsulin HPI HPI:9 hydroperoxidase i HPI HPI:9 hypothalamicpituitaryinterrenal hpi hpi:7|HPI:2 postinoculation HPLC-UV HPLC-UV:8 liquid chromatography with ultraviolet detection HPLC-UV HPLC-UV:6 liquid chromatography with uv detection HPLC HPLC:6 highperformance liquid chromatographic assay HPLC HPLC:9 high performance liquid chromotography HPLC HPLC:12 liquid chromatography method HPLC HPLC:5 liquid chromatography system HPMC HPMC:14 hydroxypropyl methyl cellulose HPMC HPMC:160 hydroxypropyl methylcellulose HPMC HPMC:38 hydroxypropylmethyl cellulose HPMC HPMC:160 hydroxypropylmethylcellulose HPMC HPMC:8 propyl methyl cellulose HPNS HPNS:33 high pressure nervous syndrome HPNS HPNS:29 high pressure neurological syndrome HPRT HPRT:83|hprt:22|Hprt:8 hypoxanthine phosphoribosyl transferase HPRT HPRT:183|hprt:35|Hprt:21 hypoxanthine phosphoribosyltransferase HPRT HPRT:7|Hprt:2|hprt:1 hypoxanthine phosphoribosyltransferase gene HPr HPr:32 histidinecontaining phosphocarrier protein HPr HPr:30 histidinecontaining protein HPR HPR:12|Hpr:1 hydroxypyruvate reductase HPR HPR:9 hypoxic pressor response HPR HPR:22 nhydroxyphenylretinamide HPR HPR:5 synthetic retinoid fenretinide HPS HPS:6 hexulosephosphate synthase HPS HPS:166 hantavirus pulmonary syndrome HPS HPS:9 highpressure sodium HPS HPS:40 hispurkinje system HPS HPS:72 hypertrophic pyloric stenosis HPT HPT:16|Hpt:10|hpt:1 haptoglobin HPT HPT:12 hepaplastin test HPT HPT:29 human proximal tubule HPT HPT:10 hypertension prevention trial HPT HPT:8|H-P-T:2 hypothalamicpituitarytesticular HPT HPT:55|H-P-T:1 hypothalamicpituitarythyroid HPT HPT:13 hypothalamopituitarythyroid HPT HPT:14 hypothalamuspituitarythyroid HPT HPT:56 patients with primary hyperparathyroidism HPV HPV:22 heart period variability HPV HPV:10|hpv:1 hepatic portal vein HPV HPV:19 hepatopancreatic parvovirus HPV HPV:20 human papillomavirus infection HPV HPV:289 hypoxic pulmonary vasoconstriction HPP HPP:32 hereditary pyropoikilocytosis HPP HPP:9 highpressure processing HPP HPP:7 pressure processing HP HP:7 atp to hydroxymethyldihydropterin HP HP:17|Hp:6 haematoporphyrin HP HP:9 haemoperfusion HP HP:10 health promotion HP HP:8 healthy persons HP HP:63|Hp:5 heat production HP HP:8 helix pomatia a hemagglutinin HP HP:12 hemangiopericytoma HP HP:56|Hp:29 hematoporphyrin HP HP:24 hemoperfusion HP HP:42|hp:1 hereditary pancreatitis HP HP:12 hewlettpackard HP HP:8|Hp:1 highpass HP HP:23 highly pathogenic HP HP:8|hp:2 highly purified HP HP:16 hotplate HP HP:8 human plasma HP HP:24|hp:1 hydrostatic pressure HP HP:9 hydroxylysyl pyridinoline HP HP:57 hydroxylysylpyridinoline HP HP:15 hyperparathyroidism HP HP:20 hyperpolarized HP HP:214 hypersensitivity pneumonitis HP HP:1 hypertension during pregnancy HP HP:14 hypoparathyroidism HP HP:9|H-P:5|h-p:2 hypothalamicpituitary HP HP:5 protein diet HRA HRA:39 health risk appraisal HRA HRA:13 health risk assessment HRA HRA:40 high right atrium HRA HRA:17 histaminereleasing activity HRA HRA:6 human reliability assessment HRF HRF:27 heidelberg retina flowmeter HRF HRF:12|hrf:1 hemodynamic response function HRG HRG:71|hrg:3|Hrg:1 heregulin HRG HRG:9 heregulinbeta HRG HRG:92|Hrg:1 histidinerich glycoprotein HRI HRI:8 hemeregulated eif alpha kinase HRI HRI:11 hemeregulated inhibitor HRM HRM:8 heme regulatory motif HRM HRM:6 human resource management HRP-WGA HRP-WGA:2 horseradish peroxidase conjugated wheat germ agglutinin HRP-WGA HRP-WGA:18 horseradish peroxidasewheat germ agglutinin HRPC HRPC:8|HRP-C:3 horseradish peroxidase c HRPC HRPC:6|HRP-C:3|HRPc:2 horseradish peroxidase isoenzyme c HRP HRP:20 highpass resolution perimetry HRP HRP:18 horseradishperoxidase HRP HRP:86 retrograde axonal transport of horseradish peroxidase HRP HRP:259 retrograde transport of horseradish peroxidase HRP HRP:44 transganglionic transport of horseradish peroxidase HRR HRR:36 haplotype relative risk HRR HRR:19 hazard rate ratio HRR HRR:16 heart rate recovery HRR HRR:28 heart rate reserve HRR HRR:22 homologous recombination repair HRR HRR:11 homologous recombinational repair HRS HRS:9 florida department of health and rehabilitative services HRS HRS:17 hamilton rating scale HRS HRS:89 hepatorenal syndrome HRS HRS:7 hyperrayleigh scattering HRS HRS:7 lowdose hyperradiosensitivity HRTEM HRTEM:10 highresolution transmission electron microscope HRTEM HRTEM:48|HR-TEM:4|HrTEM:1 highresolution transmission electron microscopy HRT HRT:35 heart rate turbulence HRT HRT:98 heidelberg retina tomograph HRT HRT:8 heidelberg retinal tomography HRT HRT:20 histamine release test HRT HRT:9 hormone replacement HRT HRT:2376 hormone replacement therapy HRT HRT:14 hormone replacement treatment HRV2 HRV2:22|HRV-2:2 human rhinovirus serotype HRV2 HRV2:12|HRV-2:6 human rhinovirus type HRV HRV:1592|HRv:1 heart rate variability HRV HRV:26 heart rate variation HRV HRV:91 human rotavirus hr hr:32|HR:5|Hr:3 hairless HR HR:6|hr:3 hairless gene HR HR:10 heart hr hr:11 hemerythrin HR HR:10|Hr:1 heparinreleasable HR HR:9 hepatic resection HR HR:24 heptad repeat HR HR:5 high responders to novelty HR HR:94 histamine release HR HR:194 homologous recombination hr hr:10 homologous region HR HR:6 hormone receptor hr hr:14|HR:3 host range HR HR:12|Hr:2 hybrid resistance HR HR:39 hypersensitive reaction HR HR:224 hypersensitive response HR HR:3 lightdriven chloride pump halorhodopsin HR HR:8|H-R:1 rutosides HSA HSA:7 heatstable ag HSA HSA:10 hemangiosarcoma HSA HSA:19|Hsa:1 human chromosome HSA HSA:13 human salivary alphaamylase HSA HSA:9 humoral stimulatory activity HSCT HSCT:64 hematopoietic stem cell transplant HSCT HSCT:476|hSCT:1 hematopoietic stem cell transplantation HSCT HSCT:20 stem cell transplants HSC HSC:9 hepatosplenic candidiasis HSC HSC:28 hospital for sick children HSD HSD:24 hallervordenspatz disease HSD HSD:12 hypertonic salinedextran HSD HSD:2 hypertonic saline in dextran HSES HSES:4 haemorrhagic shock encephalopathy syndrome HSES HSES:5 hemorrhagic shock and encephalopathy syndrome HSE HSE:30 health and safety executive HSE HSE:10 hepatic sinusoidal endothelial HSE HSE:10 hepatic sinusoidal endothelium HSE HSE:170 herpes simplex encephalitis HSE HSE:11 human skin equivalent HSF HSF:6 heated soya flour HSF HSF:11 human synovial fibroblasts HSG HSG:17 human salivary gland HSG HSG:27 hysterosalpingogram HSG HSG:217 hysterosalpingography HSG HSG:8 salivary gland tumor HSI HSI:22 hepatosomatic index HSI HSI:11 hippocampal sympathetic ingrowth HSK HSK:50 herpes simplex keratitis HSK HSK:53 herpetic stromal keratitis HSL HSL:6 homoserine lactone HSL HSL:238|hsl:1 hormonesensitive lipase HSN HSN:16 headshaking nystagmus HSN HSN:11 henochschonlein nephritis HSP HSP:219 henochschonlein purpura HSP HSP:27 hereditary spastic paraparesis HSP HSP:73 hereditary spastic paraplegia HSP HSP:18|hsp:1 human seminal plasma HSRs HSRs:72|hsrs:8 homogeneously staining regions HSRs HSRs:27 hypersensitivity reactions HSR HSR:25 health services research HSR HSR:21 heat shock response HSR HSR:4 heavy fraction of sr HSR HSR:8 hypersensitivity reaction HSR HSR:18 hypotonic shock response HSS HSS:11 hallervordenspatz syndrome HSS HSS:33 hepatic stimulator substance HSS HSS:9 hepatosplenic schistosomiasis HSS HSS:7 high speed supernatant HSS HSS:9 homospermidine synthase HSS HSS:57 hospital for special surgery HST HST:5 head shaking test HST HST:11 hydroxysteroid sulfotransferase HSV1-tk HSV1-tk:11|HSV1-TK:9|HSV-1-tk:2|HSV-1-TK:1 herpes simplex virus type thymidine kinase HSV1-tk HSV1-tk:3|HSV1-TK:2|HSV-1-tk:1 type thymidine kinase gene HSV-2 HSV-2:11|HSV2:2 type herpes simplex virus HSV-2 HSV-2:10 type virus HSV-tk HSV-tk:108|HSV-TK:102|HSVtk:64|HSVTK:5|hsvTK:1|hsv-TK:1 herpes simplex virus thymidine kinase HSV-tk HSV-tk:17|HSVtk:10|HSV-TK:10|hsv-tk:1 herpes simplex virus thymidine kinase gene HSV HSV:21 herpes simplex viral HSV HSV:82 highly selective vagotomy HSV HSV:26 human saphenous vein HS HS:9|hs:4 bedtime HS HS:16|hs:1 haemorrhagic septicaemia HS HS:15 harmonic scalpel HS HS:26 headspace HS HS:7 healthy smokers HS HS:112 healthy subjects HS HS:19 heatstable HS HS:70|Hs:2|hs:1 heat stress HS HS:9 heat stroke HS HS:118|hs:1 hemorrhagic shock HS HS:13 hemorrhagic stroke HS HS:26 hemosorption HS HS:116 heparan sulphate HS HS:11 hepatosplenic HS HS:212 hereditary spherocytosis HS HS:23 heterogeneous stock HS HS:37 hidradenitis suppurativa HS HS:6 highsalt diet HS HS:11|hs:1 highspin HS HS:61 hindlimb suspension HS HS:14 hopelessness scale HS HS:5 horizontal system HS HS:45|hS:1 horse serum HS HS:11 hs HS HS:13 hunger sensation HS HS:7 hypertrophic scar HS HS:11 hyposensitization HS HS:7 hypothalamic stimulation HT-1080 HT-1080:10|HT1080:9 human fibrosarcoma HT-1080 HT-1080:11|HT1080:7 human fibrosarcoma cells HT1 HT1:11 hereditary tyrosinemia type HT1 HT1:8 hereditary tyrosinemia type i HTA HTA:110 health technology assessment HTA HTA:18 heteroduplex tracking assay HTB HTB:9 hydroxytrifluoromethylbenzoic acid HTB HTB:7 heterotopically transplanted rat urinary bladder HTC HTC:62 hepatoma tissue culture HTC HTC:50 rat hepatoma HTF HTF:4|hTf:2 human tenons capsule fibroblasts HTF HTF:46 human tubal fluid HTF HTF:7|hTF:1 human tubal fluid medium HTF HTF:9 tiny fragment HTG HTG:15 hightension glaucoma HTG HTG:15 hypertriglyceridaemia HTG HTG:11 hypertriglyceridaemic HTG HTG:78 hypertriglyceridemia HTG HTG:57|HTg:1 hypertriglyceridemic HTH HTH:101|HtH:2|H-T-H:1 helixturnhelix HTH HTH:5 homeostatic thymus hormone HTH HTH:8 hypertrehalosemic hormone HTK HTK:39 histidinetryptophanketoglutarate HTK HTK:9 histidinetryptophanketoglutarate solution HTLV HTLV:10 human tcell leukemia viruses HTLV HTLV:33 human t lymphotropic virus HTLV HTLV:10 retrovirus HTLV-I HTLV-I:6 human tcell leukemia virusi HTLV-I HTLV-I:14 human tcell leukemia virus type HTLV-I HTLV-I:5 human tcell lymphotrophic virusi HTLV-I HTLV-I:12 human tlymphotropic virusi HTLV-I HTLV-I:18 human tlymphotropic virus type HTLV-I HTLV-I:9 lymphotropic virusi HTLV-I HTLV-I:12 type i human tcell leukemia virus HTM HTM:33 haemophilus test medium HTM HTM:40|hTM:1|h-TM:1 human trabecular meshwork HTP HTP:7 heart transplant patients HTP HTP:6 heart transplanted patients HTR HTR:9 hard tissue replacement HTR HTR:32 headtwitch response hTR hTR:78|HTR:1 human telomerase rna hTR hTR:18 rna component of human telomerase hTR hTR:10 rna component of telomerase HUAEC HUAEC:11 human umbilical arterial endothelial cells HUAEC HUAEC:7 human umbilical artery endothelial cells HUMARA HUMARA:5 human androgen receptor assay HUMARA HUMARA:46|Humara:2|HU-MARA:1 human androgen receptor gene HUS HUS:135|hus:1 haemolytic uraemic syndrome HUS HUS:6 head ultrasound HUS HUS:523 hemolytic uremic syndrome HUVEC HUVEC:4 endothelial cells from human umbilical cord veins HUVEC HUVEC:47 human umbilical vein ec HUVEC HUVEC:10 umbilical vein endothelium HUVE HUVE:89|Huve:1 human umbilical vein endothelial HUVE HUVE:17 human umbilical vein endothelium HU HU:47 hindlimb unloading HU HU:16 hindlimb unweighting HU HU:7 htlv uveitis HU HU:791|Hu:9|hu:1 hydroxyurea HVEM HVEM:11 highvoltage electron microscope HVEM HVEM:16 high voltage electron microscopy HVS HVS:156 herpesvirus saimiri HVS HVS:10 high vaginal swab HVS HVS:9 human visual system HVS HVS:36 hyperventilation syndrome HVc HVc:16 caudal nucleus of the ventral hyperstriatum HVC HVC:63|HVc:9 high vocal center HVC HVC:29|HVc:4 higher vocal center HVc HVc:7 hyperstriatum ventrale pars caudale HVc HVc:6 hyperstriatum ventralis pars caudalis HV HV:15 hallux valgus HV HV:9 heart volume HV HV:71 height velocity HV HV:6 hemorrhagic vasculitis HV HV:46 hepatic vein HV HV:13 high voltage HV HV:8 hippocampal volume HV HV:11|H-V:2 hisventricular HV HV:13 hydroa vacciniforme HV HV:11 hydroxyvalerate HV HV:12 hypersensitivity vasculitis HV HV:15 hyperstriatum ventrale HV HV:18 hypervariable HV HV:89|hv:1 hyperventilation HWE HWE:56|HWe:1 hardyweinberg equilibrium HWE HWE:15 hardyweinberg expectations HWE HWE:14 healthy worker effect HWE HWE:10 hornerwadsworthemmons HW HW:3 dogs with heartworm HW HW:10|H-W:7 hardyweinberg HW HW:28 heart weight HW HW:45 hydrostatic weighing Hz Hz:19 hertz Hz Hz:7|HZ:6 hydrazine HaPV HaPV:12|HapV:1 hamster papovavirus HaPV HaPV:16 hamster polyomavirus HAL HAL:10 acute leukemia HAL HAL:29|Hal:11 halothane HAL HAL:13 handassisted laparoscopic HAL HAL:48 hepatic artery ligation HAL HAL:27 hip axis length HAM HAM:5 highdose cytarabine and mitoxantrone HAM HAM:25 htlv associated myelopathy HAM HAM:74 htlvi associated myelopathy HAM HAM:15|h-AM:1 human alveolar macrophages HAM HAM:10|hAM:2 human amniotic membrane HAM HAM:33 patients with htlviassociated myelopathy HbA1c HbA1c:52|HbA1C:3|HBA1c:1 haemoglobin ac HbA1c HbA1c:5 hemoglobin levels HbA HbA:10 adult haemoglobin HbA HbA:19|Hb-A:1 human adult hemoglobin HbA HbA:17 human hemoglobin HbF HbF:38 fetal haemoglobin HbF HbF:224|Hb-F:2 fetal hemoglobin HbF HbF:23 foetal haemoglobin HbF HbF:14 haemoglobin f HbF HbF:33 hemoglobin f HbH HbH:13 haemoglobin h HbH HbH:14 hemoglobin h HbNO HbNO:12 nitrosyl hemoglobin HbNO HbNO:9|HB-NO:1|Hb-NO:1 nitrosylhemoglobin HBOC HBOC:11 hereditary breast and ovarian cancer HBOC HBOC:11 hereditary breastovarian cancer HBOC HBOC:16 oxygen carrier HeLa HeLa:13 cervical carcinoma cells HeLa HeLa:29 human cervical carcinoma He-Ne He-Ne:5 effect of lowenergy laser He-Ne He-Ne:42|HeNe:15 heliumneon He-O2 He-O2:16|HeO2:5 heliumoxygen He-O2 He-O2:3|HeO2:2 mixture of helium and oxygen HepG2 HepG2:8|Hep-G2:2|hepg2:1 human hepatocellular carcinoma HepG2 HepG2:103|Hep-G2:4|HEPG2:2 human hepatoma HFR HFR:8 hemodiafiltration reinfusion HFR HFR:7 high fluorescence reticulocytes Hg0 Hg0:25 elemental mercury Hg0 Hg0:16 mercury vapor HIS HIS:7 hachinski ischemic score HIS HIS:13 health interview survey HIS HIS:7 hyperimmune serum HlyA HlyA:7 escherichia coli alphahemolysin HlyA HlyA:7|Hlya:1 escherichia coli haemolysin HlyA HlyA:30|hlyA:1 escherichia coli hemolysin Hly Hly:7|hly:5|HLY:1 alphahemolysin Hly Hly:12|hly:5|HLY:3 haemolysin Hly Hly:21|hly:16|HLY:4|HLy:1 hemolysin hnRNA hnRNA:65|HnRNA:13|HNRNA:2 heterogeneous nuclear rna hnRNA hnRNA:20|hn-RNA:2 heteronuclear rna HPAI HPAI:11 highpathogenicity avian influenza HPAI HPAI:20 highly pathogenic avian influenza HRE HRE:35 hormone response element HRE HRE:27 hypoxia response element HRE HRE:8 regeneration efficiency HRE HRE:11 responsive elements HT HT:11|Ht:1 harringtonine HT HT:11|H-T:4|h-t:2|ht:1 headtotail HT HT:38 hemorrhagic transformation HT HT:12 high threshold HT HT:8 highly trained HT HT:21 hormonal therapy HT HT:122 hormone therapy HT HT:26 hypertensive patients HT HT:11 hypertensive subjects HT HT:13|Ht:1 hyperthyroidism HT HT:20 hypothermia HT HT:10 hypothyroidism HT HT:25 local hyperthermia HT HT:19 patients with essential hypertension HT HT:40 patients with hashimotos thyroiditis HUD HUD:18 department of housing and urban development HUD HUD:11 headup display HX HX:34|H-X:4|Hx:1 histiocytosis x HX HX:29 hydrogen exchange I-1 I-1:4|I1:2 inhibitor I-1 I-1:7 protein phosphatase inhibitor i3 i3:16|I3:2 third intracellular i3 i3:17|I3:2 third intracellular loop IAA IAA:17 ileoanal anastomosis IAA IAA:9 indispensable amino acids IAA IAA:323 indoleacetic acid IAA IAA:22 insulin autoantibody IAA IAA:8 internal auditory artery IAA IAA:41 interrupted aortic arch IAA IAA:21 interruption of the aortic arch IAA IAA:11 intraabdominal abscess IAA IAA:38 iodoacetate IAA IAA:80 iodoacetic acid IABP IABP:264 balloon pump IABP IABP:113|I-ABP:1 intraaortic balloon pumping IAC IAC:36 immunoaffinity chromatography IAC IAC:14 immunoaffinity column IAC IAC:152 internal auditory canal IAC IAC:10 interposed abdominal compression IAD IAD:10 implantable atrial defibrillator IAD IAD:9 inflammatory airway disease IAD IAD:10 intermittent androgen deprivation IAHA IAHA:32 immune adherence hemagglutination IAHA IAHA:9 immune adherence hemagglutination assay IAHS IAHS:8 idiopathic adult hydrocephalus syndrome IAHS IAHS:8 infectionassociated hemophagocytic syndrome IAM IAM:53 immobilized artificial membrane IAM IAM:11 indoleacetamide IAM IAM:30 internal auditory meatus IAN IAN:9 indoleacetonitrile IAN IAN:121 inferior alveolar nerve IAPs IAPs:32|iaps:1 inhibitors of apoptosis IAPs IAPs:70 inhibitor of apoptosis proteins IAP IAP:14 ciodoantipyrine IAP IAP:163 immunosuppressive acidic protein IAP IAP:21 increased intraabdominal pressure IAP IAP:69|I-AP:4 intestinal alkaline phosphatase IAP IAP:154 intraabdominal pressure IAP IAP:53 intracarotid amobarbital procedure IAP IAP:18 intracellular action potential IAP IAP:12 intrapartum antibiotic prophylaxis IAP IAP:129 isletactivating protein IAR IAR:11 immediate asthmatic reaction IAR IAR:27 immediate asthmatic response IAT IAT:36 implicit association test IAT IAT:48 indirect antiglobulin test IAT IAT:36 individual anaerobic threshold IAT IAT:11 intraarterial thrombolysis IAT IAT:24 intraoperative autotransfusion IBA IBA:8 immunoblot assay IBA IBA:35 indolebutyric acid IBC IBC:74 inflammatory breast cancer IBC IBC:24 inflammatory breast carcinoma IBMX IBMX:10 isobutyl methylxanthine IBMX IBMX:29 isobutyllmethylxanthine IBMX IBMX:9 isobutyl methyl xanthine IBMX IBMX:11 phosphodiesterase inhibitor isobutylmethylxanthine IBO IBO:10 ibogaine IBO IBO:12|Ibo:2|ibo:1 ibotenate IBO IBO:6|ibo:3 ibotenic IBO IBO:9 intestinal bacterial overgrowth IBR IBR:27 immediate breast reconstruction IBR IBR:146 infectious bovine rhinotracheitis IBS IBS:14 ichthyosis bullosa of siemens IBS IBS:5 identical by state IBS IBS:10 imidazoline binding sites IBS IBS:10 injectable bone substitute IBS IBS:1125 irritable bowel syndrome IBS IBS:13 isolated bowel segment IC50 IC50:10 inhibition of cell growth IC50 IC50:9 inhibition of growth IC50 IC50:6 inhibitory dose IC50 IC50:10 cell growth by IC50 IC50:5 inhibition of protein synthesis IC50 IC50:8 inhibitory concentration ICAD ICAD:11 inhibitor of caspaseactivated dnase ICAD ICAD:13 internal carotid artery dissection ICAM-1 ICAM-1:7 adhesion molecule i ICAM-1 ICAM-1:8 intercellular adhesion molecular ICAM-1 ICAM-1:106|ICAM1:1 intercellular adhesion molecule ICAs ICAs:40 internal carotid arteries ICAs ICAs:65 islet cell antibodies ICA ICA:12 arthritis ICa ICa:7 ca channels ICA ICA:25 immunocytochemical assay ICA ICA:198 independent component analysis ICA ICA:29 internal carotid ICa ICa:37|ica:2|Ica:1|iCa:1 inward calcium current ICB ICB:7 intracavitary brachytherapy ICB ICB:28|I-CB:4 irisciliary body ICCs ICCs:11 intraclass correlations ICCs ICCs:208 intraclass correlation coefficients ICCs ICCs:48 isletlike cell clusters ICC ICC:11 fetal porcine isletlike cell clusters ICC ICC:70 immunocytochemical ICC ICC:8 immunoglobulincontaining cells ICC ICC:51 indian childhood cirrhosis ICC ICC:5 intensive consolidation chemotherapy ICC ICC:9 intercompany collaboration for aids drug development ICC ICC:13 intraclass correlation ICC ICC:82 intrahepatic cholangiocarcinoma ICC ICC:36 invasive cervical cancer ICC ICC:15 invasive cervical carcinoma ICD-10 ICD-10:1 international classification of diseases th edition ICD-10 ICD-10:1 international classification of diseases tenth edition ICDS ICDS:40|ICDs:1 integrated child development services ICDS ICDS:6 integrated child development services scheme ICD ICD:18 icell disease ICD ICD:11 idiopathic cervical dystonia ICD ICD:13 immune complex dissociation ICD ICD:24 induced circular dichroism ICD ICD:22 initial claudication distance ICD ICD:10 intercapillary distance ICD ICD:32 intracellular domain ICD ICD:52 irritant contact dermatitis ICE ICE:16 caspase ICE ICE:14 ifosfamidecarboplatinetoposide ICE ICE:4 insulin control element ICE ICE:5 integrative and conjugative element ICE ICE:53 interleukinbeta converting enzyme ICE ICE:7 international collaborative effort ICE ICE:78 intracardiac echocardiography ICE ICE:36 iridocorneal endothelial ICF ICF:3 instability and facial anomalies ICF ICF:10 intermediate care facility ICF ICF:9 intermittent compressive force ICF ICF:4 international classification of functioning disability and health ICF ICF:26 intracellular fluid ICH ICH:11 infectious canine hepatitis ICH ICH:22 international conference on harmonisation ICH ICH:58 intracerebral haemorrhage ICH ICH:45 intracranial haemorrhage ICI ICI:11 interclick interval ICI ICI:9 intracavernosal injection ICI ICI:20 intracavernous injection ICI ICI:12 intracervical insemination ICL ICL:6 idiopathic cd lymphocytopenia ICL ICL:15 implantable contact lens ICL ICL:7 innermost chorionic layer ICL ICL:50|Icl:2|icl:1 isocitrate lyase ICM ICM:10 intensive case management ICM ICM:11 intracytoplasmic membrane ICM ICM:8 introduction to clinical medicine ICM ICM:10 iodinated contrast media ICM ICM:10 ischemic ICM ICM:49 ischemic cardiomyopathy ICN ICN:9 infection control nurse ICN ICN:9 inferior cardiac nerve ICN ICN:21 intensive care nursery ICN ICN:32 international council of nurses ICN ICN:7 intrinsic cardiac nerves ICP-AES ICP-AES:99|ICPAES:4 inductively coupled plasma atomic emission spectrometry ICP-AES ICP-AES:23 inductively coupled plasmaatomic emission spectroscopy ICP-MS ICP-MS:13|ICPMS:6 inductively coupled plasma mass spectrometer ICP-MS ICP-MS:7|ICPMS:2 inductively coupled plasma mass spectrometric ICPs ICPs:19|ICPS:1 infection control practitioners ICPs ICPs:9 infection control professionals ICPs ICPs:12 insecticidal crystal proteins ICPs ICPs:11 integrated care pathways ICP ICP:9 idiopathic chronic pancreatitis ICP ICP:7 immunocompromised patients ICP ICP:62 inductively coupled plasma ICP ICP:5 inductively coupled plasma emission spectroscopy ICP ICP:12 infancychildhoodpuberty ICP ICP:22 infantile cerebral paralysis ICP ICP:9 infected cell protein ICP ICP:12 infection control practitioner ICP ICP:12 insecticidal crystal protein ICP ICP:13 integrated care pathway ICP ICP:78 intrahepatic cholestasis of pregnancy ICP ICP:11|iCP:1 isolated cleft palate ICRS ICRS:9 international cartilage repair society ICRS ICRS:10|ICR-S:1 intracorneal ring segments ICRS ICRS:13|ICRs:1 intrastromal corneal ring segments ICSH ICSH:15 international council for standardization in haematology ICSH ICSH:6 interstitial cellstimulating hormone ICS ICS:7 control scale ICS ICS:16 ileocecal sphincter ICS ICS:11 image correlation spectroscopy ICS ICS:22 immotile cilia syndrome ICS ICS:9 intercellular spaces ICS ICS:9 intercellular substance ICS ICS:6|ics:1 intercostal space ICS ICS:11 interferon consensus sequence ICS ICS:9 intracellular cytokine staining ICS ICS:6 intracellular space ICS ICS:9 intracranial stimulation ICS ICS:9 irritable colon syndrome ICTP ICTP:10 ctelopeptide ICTP ICTP:11 carboxyterminal telopeptide ICTP ICTP:9 telopeptide of collagen i ICTP ICTP:5 telopeptide of collagen type i ICTP ICTP:13 type i collagen carboxyterminal telopeptide ICAT ICAT:31 isotopecoded affinity tag ICAT ICAT:9 isotopecoded affinity tags IDA IDA:16|Ida:1 idazoxan IDA IDA:14 iminodiacetate IDA IDA:70 iminodiacetic acid IDA IDA:8 interdigitated array IDC IDC:11 interdigitating dendritic cells IDC IDC:14 interdigitating reticulum cells IDDM IDDM:11 diabetes mellitus type i IDDM IDDM:5 diabetic mothers IDDM IDDM:16 insulin dependent IDDM IDDM:23 insulindependent diabetic patients IDDM IDDM:11 patients with insulindependent IDDs IDDs:11 insulindependent diabetics IDDs IDDs:7 iodine deficiency disorders IDD IDD:15 insulindependent IDD IDD:84|Idd:10|idd:1 insulindependent diabetes IDD IDD:14 insulindependent diabetes mellitus IDD IDD:19 inventory to diagnose depression IDF IDF:9 defense force IDF IDF:12 insoluble dietary fiber IDF IDF:7 international dairy federation IDF IDF:13 international diabetes federation IDF IDF:23 israel defense forces IDH IDH:10 infectious diseases hospital IDH IDH:18 intradialytic hypotension IDH IDH:9 isolated diastolic hypertension IDPN IDPN:33 iminodipropionitrile IDPN IDPN:6 chronic administration of iminodipropionitrile IDPN IDPN:31 intradialytic parenteral nutrition IDPs IDPs:11 internally displaced persons IDPs IDPs:10 interplanetary dust particles IDR IDR:9 immunodominant region IDR IDR:15 incidence density ratio IDR IDR:5 intradermal reaction IDS IDS:7 deficiency of the lysosomal enzyme iduronatesulfatase IDS IDS:14 iduronatesulphatase IDS IDS:9 sulphatase IDT IDT:6 interdivision time IDT IDT:10 intradermal testing IDT IDT:29 isometric developed tension IDUS IDUS:42 intraductal ultrasonography IDUS IDUS:12 intraductal ultrasound IDU IDU:43 drug user IDU IDU:39|IdU:1 idoxuridine IE1 IE1:6|IE-1:2|ie-1:1 immediate early IE1 IE1:7|IE-1:2 immediate early IEA IEA:14 immediate early antigen IEA IEA:32 inferior epigastric artery IEC IEC:1 information education and communication IEC IEC:17 international electrotechnical commission IEC IEC:29 ionexchange chromatography IEF IEF:27 isoelectric focussing IEF IEF:57 isoelectrofocusing IEL IEL:113 internal elastic lamina IEL IEL:13 intraepithelial IEL IEL:10 intraepithelial leukocytes iEMG iEMG:18|IEMG:10|I-EMG:2 integrated electromyogram IEMG IEMG:30|iEMG:5 integrated electromyographic iEMG iEMG:5|IEMG:4 integrated electromyographic activity IEMG IEMG:8|iEMG:6|I-EMG:3|Iemg:1 integrated electromyography IEMG IEMG:47|iEMG:36|I-EMG:1 integrated emg IEMG IEMG:4|iEMG:3 neural activation IEM IEM:7 isocyanatoethyl methacrylate IEM IEM:80 immune electron microscopy IEM IEM:10 immunoelectron microscopic IEM IEM:40 inborn errors of metabolism IEM IEM:8 ineffective esophageal motility IEM IEM:11 internal elastic membrane IET IET:6 incremental exercise test IET IET:8 intramolecular electron transfer IFA IFA:12 idiopathic fibrosing alveolitis IFA IFA:9 immunofluorescence analysis IFA IFA:36 immunofluorescence assays IFA IFA:17 imported fire ant IFA IFA:170 incomplete freunds adjuvant IFA IFA:8 indirect fluorescent antibody technique IFA IFA:26 indirect fluorescent antibody test IFA IFA:6 isoferulic acid IFM IFM:18 indirect flight muscle IFM IFM:10 interfibrillar mitochondria IFN IFN:8 alpha and gammainterferon IFN IFN:116 alphainterferon IFN IFN:25 betainterferon IFN IFN:14 interferon alfa IFN IFN:15 interferon alfaa IFN IFN:23 interferon alfab IFN IFN:6 interferonalpha IFN IFN:10 interferonalphab IFN IFN:23 interferon gamma IFT IFT:12 interfacial tension IFT IFT:54 intraflagellar transport If If:12|if:7 hyperpolarizationactivated current IF IF:5 immediate function IF IF:10 immunofixation IF IF:8 immunofluorescence method IF IF:7 immunofluorescence technique IF IF:16 integrateandfire IF IF:7 intermediate frequency IF IF:21 interstitial fibrosis IF IF:11 intestinal failure IF IF:125 intrinsic factor IF IF:21 involved field If If:13|if:8 pacemaker current IF IF:9 staining IGC IGC:26 interdisciplinary generalist curriculum IGC IGC:46 inverse gas chromatography IGF-1R IGF-1R:7|Igf1r:1 insulinlike growth factor type receptor IGF-1R IGF-1R:12|IGF1R:11|Igf1r:3|IGF1-R:1 type igf receptor IGFBPs IGFBPs:289|IGF-BPs:5|IG-FBPs:1 igf binding proteins IGFBPs IGFBPs:218|IGF-BPs:7 insulinlike growth factor binding proteins IGHD IGHD:5|iGHD:1 idiopathic ghd IGHD IGHD:8|iGHD:1 isolated ghd IGHD IGHD:51|I-GHD:1 isolated growth hormone deficiency IGL IGL:5 human immunoglobulin lambda IGL IGL:18 internal granular layer IGT IGT:1090|iGT:1 impaired glucose tolerance IGT IGT:10 iowa gambling task IHA IHA:5 idiopathic adrenal hyperplasia IHA IHA:9 immune hemolytic anemia IHA IHA:17 indirect haemagglutination assay IHA IHA:148 indirect hemagglutination IHA IHA:6 indirect hemagglutination antibody IHA IHA:27 indirect hemagglutination assay IHA IHA:12 intermittent high altitude IHC IHC:9 immunohistochemical analysis IHC IHC:24 immunohistochemically IHC IHC:15 induced hypertension chemotherapy IHC IHC:14 intermountain health care IHD IHD:43 intermittent hemodialysis IHD IHD:614 ischaemic heart disease IHH IHH:62 idiopathic hypogonadotropic hypogonadism IHH IHH:16 isolated hypogonadotropic hypogonadism IHN IHN:9 infectious haematopoietic necrosis IHN IHN:10 infectious hematopoietic necrosis IHNV IHNV:27 infectious haematopoietic necrosis virus IHNV IHNV:79 infectious hematopoietic necrosis virus IHP IHP:21 idiopathic hypoparathyroidism IHP IHP:43 isolated hepatic perfusion IHR IHR:19 instantaneous heart rate IHR IHR:22 intrinsic heart rate IHS IHS:115 indian health service IHS IHS:219 international headache society IHT IHT:13 intermittent hypoxic training IHT IHT:6 interstitial hyperthermia IHTT IHTT:12 interhemispheric transfer time IHTT IHTT:7 interhemispheric transmission time Ih Ih:4|ih:4|IH:2 current activated by hyperpolarization Ih Ih:29|IH:3 hyperpolarizationactivated cation current IH IH:8 idiopathic haemochromatosis IH IH:37 idiopathic hirsutism IH IH:12 immunohistology IH IH:8 infantile hydrocephalus IH IH:13 inguinal hernia IH IH:50 intermittent hypoxia IH IH:131 intimal hyperplasia IIDs IIDs:35 interaural intensity differences IIDs IIDs:9 interaural intensity disparities IIF IIF:15 indirect immunofluorescence technique IIF IIF:7 indirect immunofluorescent test IIF IIF:29|iif:1 intracellular ice formation IIP IIP:120 idiopathic interstitial pneumonia IIP IIP:16 inventory of interpersonal problems IKK IKK:55 i kappa b kinase IKK IKK:14 kinase complex IL-1R1 IL-1R1:3|IL-1-R1:1|Il1r1:1 il receptor type IL-1R1 IL-1R1:8 type il receptor IL-1RII IL-1RII:7 il receptor type ii IL-1RII IL-1RII:9 type ii il receptor IL-1RI IL-1RI:27 il receptor type i IL-1RI IL-1RI:11|IL1RI:1|IL-1-RI:1 interleukin receptor type i IL-1RI IL-1RI:27 type i il receptor IL-1RI IL-1RI:20 type i receptor IL-1ra IL-1ra:5|IL-1Ra:2|IL-1RA:1 receptor agonist IL-1ra IL-1ra:3|IL-1RA:2|IL1-Ra:1 receptor antagonists IL-1ra IL-1ra:3|IL-1Ra:1 receptor antagonist of il IL-2R IL-2R:74|IL-2r:1 il receptors IL-2R IL-2R:8|IL-2r:1 interleukinr IL-2R IL-2R:1 receptors of il ILC ILC:10 immobilized liposome chromatography ILC ILC:35 infiltrating lobular carcinoma ILC ILC:38 interstitial laser coagulation ILC ILC:54 invasive lobular carcinoma ILC ILC:11 lobular carcinomas ILDs ILDs:17 interaural level differences ILDs ILDs:22 interstitial lung diseases ILI ILI:73 influenzalike illness ILI ILI:9 isolated limb infusion ILL ILL:15 interlibrary loan ILL ILL:18 intermediate lymphocytic lymphoma ILM ILM:30 inner limiting membrane ILM ILM:158 internal limiting membrane ILM ILM:12 intubating laryngeal mask ILN ILN:8 inferior laryngeal nerve ILN ILN:15 intralaminar nuclei ILO ILO:15|Ilo:4 iloprost ILO ILO:48 international labour office ILO ILO:27 international labour organisation ILR ILR:13 irreversible loss rate ILR ILR:23 loop recorder ILS ILS:14 inbred longsleep ILS ILS:1 increase of lifespan ILS ILS:28 intermittent light stimulation ILS ILS:24 isolated lissencephaly sequence ILT ILT:7 immunoglobulinlike transcript ILT ILT:44 infectious laryngotracheitis ILT ILT:13 interstitial laser therapy ILT ILT:9 interstitial laser thermotherapy ILV ILV:6 indolactam v ILV ILV:14 instantaneous lung volume ILP ILP:14 inductive logic programming ILP ILP:6 insulinlike peptide ILP ILP:33 interstitial laser photocoagulation ILP ILP:138 isolated limb perfusion IL IL:10 independent living IL IL:16|il:2 infralimbic IL IL:8 insertion loss IL IL:94 intermediate lobe IL IL:24 intralipid IL IL:14 intraluminal IL IL:9 ionic liquid IMAC IMAC:111 immobilized metal affinity chromatography IMAC IMAC:45 immobilized metal ion affinity chromatography IMAC IMAC:10 inner membrane anion channel IMB IMB:11 immunomagnetic beads IMB IMB:12 informationmotivationbehavioral skills IMC IMC:7 instrument meteorological conditions IMC IMC:8 interdigestive migrating complex IMC IMC:16 interdigestive migrating contractions IMC IMC:16 internal mammary chain IMC IMC:10 intimamedia complex IMC IMC:6 invasive micropapillary carcinoma IMC IMC:8 isothermal microcalorimetry IMD IMD:5 intramammary device IMD IMD:18 invasive meningococcal disease IMF IMF:5 initial median frequency IMF IMF:38|IMf:1 intermaxillary fixation IMF IMF:18 intramuscular fat IMG IMG:8 inferior mesenteric ganglia IMG IMG:65 inferior mesenteric ganglion IMG IMG:9 international medical graduate IMHV IMHV:25 intermediate and medial part of the hyperstriatum ventrale IMHV IMHV:32 intermediate medial hyperstriatum ventrale IMI IMI:9 imidacloprid IMI IMI:32 inferior myocardial infarction IMI IMI:17 intermeal interval IML IML:28|iml:2 inner molecular layer IML IML:26 intermediolateral IML IML:81 intermediolateral cell column IML IML:36 intermediolateral nucleus IML IML:11 internal medullary lamina IML IML:21 intravascular malignant lymphomatosis IMO IMO:10 inflammationmediated osteopenia IMO IMO:9 intravenous membrane oxygenator IMPs IMPs:13 inner membrane proteins IMPs IMPs:11|Imps:2 integral membrane proteins IMPs IMPs:66|IMPS:1|Imps:1|imps:1 intramembrane particles IMPs IMPs:69|imps:1 intramembranous particles IMP IMP:11 iiodoamphetamine IMP IMP:7 electrical impedance IMP IMP:9 index of myocardial performance IMP IMP:117 inosine monophosphate IMP IMP:15 intramammary pressure IMP IMP:30 intramuscular pressure IMP IMP:26 intramyocardial pressure IMP IMP:41 iodoamphetamine IMP IMP:9 nisopropyl i piodoamphetamine IMP IMP:35 nisopropylpiiodoamphetamine IMP IMP:23 nisopropylpiodoamphetamine IMSS IMSS:36 mexican institute of social security IMSS IMSS:18 mexican social security institute IMS IMS:138 immunomagnetic separation IMS IMS:6 intermediate myasthenia syndrome IMS IMS:21 intermembrane space IMS IMS:33 ion mobility spectrometry IMS IMS:11 mouse serum IMTG IMTG:7 intramuscular triacylglycerol IMTG IMTG:8|imTG:1 intramuscular triglyceride IMT IMT:105 carotid artery intimamedia thickness IMT IMT:8 immunemediated thrombocytopenia IMT IMT:7 immune modulation therapy IMT IMT:52 inflammatory myofibroblastic tumor IMT IMT:47 inspiratory muscle training IMT IMT:12 intimamedia thickening IMT IMT:15 tyrosine IMV IMV:17 inferior mesenteric vein IMV IMV:14 inouemelnick virus IMV IMV:121 intermittent mandatory ventilation IMV IMV:9 intracellular mature virions IMV IMV:45 intracellular mature virus IMZ IMZ:10 iiomazenil IMZ IMZ:7 involuting marginal zone IMZ IMZ:12 iomazenil INA INA:14|iNA:1 dichloroisonicotinic acid INA INA:5|ina:1 ice nucleation active INA INA:5 intradental nerve activity INA INA:11 isonicotinic acid INF INF:9 infected INF INF:7|inf:1|Inf:1 infundibulum INH INH:9 immunoreactive inhibin INH INH:641 isoniazid INH INH:9 isoniazide iNOS iNOS:37 inducible nitric oxide iNOS iNOS:3|i-NOS:1 inducible nitric oxide synthase enzyme iNOS iNOS:7 inducible nitric oxide synthase gene iNOS iNOS:38 inducible nitric oxide synthetase iNOS iNOS:23|iNOs:1 inducible nosynthase Inr Inr:87|INR:7 initiator Inr Inr:29|inr:2|INR:2|InR:1 initiator element INS INS:96|iNS:2 idiopathic nephrotic syndrome INS INS:18 immigration and naturalization service INS INS:21 inelastic neutron scattering Ins Ins:14 inositol INS INS:45|ins:1 insulin gene Ins Ins:35 myoinositol Int Int:9|INT:1 integrin INT INT:6 iodonitrotetrazolium violet Int Int:20 lambda integrase INT INT:9 piodonitrotetrazolium violet INV INV:5 intracellular naked vaccinia virus INV INV:8|Inv:2 invertase INV INV:8|Inv:1|inv:1 involucrin IN IN:8 cerebellar interpositus nucleus IN IN:10 indiana in in:10 indium IN IN:10 infundibular nucleus IN IN:11 intact IN IN:14 integration protein IN IN:12 interstitial nephritis in in:6|IN:3 inulin IOC IOC:11 inferior olivary complex IOC IOC:48 international olympic committee IOC IOC:11 intraoperative cholangiogram IOC IOC:95 intraoperative cholangiography IOERT IOERT:7 intraoperative electron beam radiation therapy IOERT IOERT:6 intraoperative electron beam radiotherapy IOERT IOERT:8 intraoperative electron irradiation IOL IOL:9 interosseous ligament IOL IOL:73 intraocular lenses IOL IOL:11 intraocular lens implantation IOM IOM:8 international organization for migration IOM IOM:19 interosseous membrane ION ION:35|ion:5 infraorbital nerve ION ION:20 ischemic optic neuropathy ION ION:31 isthmooptic nucleus IORT IORT:14 intraoperative irradiation IORT IORT:169 intraoperative radiation therapy IOS IOS:17 impulse oscillometry IOS IOS:7 impulse oscillometry system IOS IOS:15 intrinsic optical signal IOUS IOUS:42 intraoperative ultrasonography IOUS IOUS:52 intraoperative ultrasound IOV IOV:10 insideout vesicles IOV IOV:6 interoccasion variability IO IO:32 inferior oblique IO IO:10 inferior olivary IO IO:84 inferior olive IO IO:9|I-O:4|i-o:1 insideout IO IO:36 intraosseous IO IO:6 transection of the infraorbital IP-10 IP-10:36 interferoninducible protein IP-10 IP-10:3|IP10:1 protein kda IP3 IP3:6 inositol phosphate IP3 IP3:11 inositoltrisphosphate IPA IPA:29 immunoperoxidase assay IPA IPA:12 immunoprecipitation assay IPA IPA:36 independent practice association IPA IPA:9 indolepropionic acid IPA IPA:11 international pharmaceutical abstracts IPA IPA:122 invasive pulmonary aspergillosis IPA IPA:19 isopropanol IPA IPA:46 isopropyl alcohol IPC IPC:6 ifnalpha producing cells IPC IPC:54 intermittent pneumatic compression IPC IPC:7 intraperitoneal chemotherapy IPC IPC:29 intrapulmonary chemoreceptors IPC IPC:7 ionpair chromatography IPD IPD:150|iPD:8 idiopathic parkinsons disease IPD IPD:8|iPD:1 idiopathic pd IPD IPD:17 immediate pigment darkening IPD IPD:25 individual patient data IPD IPD:20 interpupillary distance IPD IPD:47 invasive pneumococcal disease IPD IPD:10 iterated prisoners dilemma IPE IPE:16 interprofessional education IPE IPE:24 iris pigment epithelial IPE IPE:20 iris pigment epithelium IPF IPF:619 idiopathic pulmonary fibrosis IPF IPF:7 immune protection factor IPG IPG:58 impedance plethysmography IPG IPG:9 inositol phosphoglycan IPG IPG:10 pulse generator IPH IPH:75 idiopathic portal hypertension IPH IPH:16 idiopathic pulmonary haemosiderosis IPH IPH:32 idiopathic pulmonary hemosiderosis IPH IPH:10 intraparenchymal hemorrhage IPH IPH:6 isolated postchallenge hyperglycemia IPK IPK:1 isolated and perfused rat kidney IPK IPK:23 isolated perfused kidney IPL IPL:10 inferior parietal lobe IPL IPL:35 inferior parietal lobule IPL IPL:410|ipl:1 inner plexiform layer IPL IPL:47 intense pulsed light IPL IPL:1 isolated and perfused rat lung IPL IPL:9 isolated perfused liver IPM IPM:71 integrated pest management IPM IPM:104 interphotoreceptor matrix IPM IPM:15 isophosphoramide mustard IPM IPM:51 isopropyl myristate IPNS IPNS:56 isopenicillin n synthase IPNS IPNS:17 isopenicillin n synthetase IPN IPN:28 infectious pancreatic necrosis IPN IPN:13 interpenetrating network IPN IPN:13 interpenetrating polymer network IPN IPN:6 polymer networks IPP IPP:11 ileal peyers patch IPP IPP:8 induratio penis plastica IPP IPP:16 inflatable penile prosthesis IPP IPP:17 intraperitoneal pressure IPP IPP:76 isopentenyl diphosphate IPP IPP:31 isopentenyl pyrophosphate IPSS IPSS:20 inferior petrosal sinus sampling IPSS IPSS:62 international prognostic scoring system IPS IPS:34 idiopathic pneumonia syndrome IPS IPS:14 individual placement and support IPS IPS:27 inferior petrosal sinus IPS IPS:28 inspiratory pressure support IPS IPS:6 interim payment system IPS IPS:58 intermittent photic stimulation IPS IPS:10 international prognostic score IPS IPS:7 intracellular polysaccharide IPS IPS:66|IPs:2|iPs:1 intraparietal sulcus IPS IPS:5 iodophilic polysaccharide IPS IPS:14|Ips:1 ipsapirone IPT IPT:7 intermittent preventive treatment IPT IPT:75 interpersonal psychotherapy IPT IPT:15 interpersonal therapy IPV IPV:9 infectious pustular vulvovaginitis IPV IPV:186 intimate partner violence IPV IPV:12 intraperitoneal volume IP IP:12 idiopathic parkinsonism IP IP:19 imaging plate IP IP:14 immunophenotype IP IP:60 immunoprecipitation IP IP:10 inphase IP IP:87|Ip:1 incontinentia pigmenti IP IP:30 inflammatory polyarthritis IP IP:35 integrated project IP IP:18 interference pattern IP IP:53 interphalangeal IP IP:9 interpositus nucleus IP IP:80 interstitial pneumonitis IP IP:29 intestinal permeability IP IP:33 inverted papilloma IP IP:14|Ip:1 ionization potential IP IP:22 ipriflavone IP IP:26 ischaemic preconditioning IP IP:6 nucleus interpositus IP IP:6|ip:5 peripheral IP IP:3 planning nutrition and parasite control project IP IP:21 prostacyclin receptor IRA IRA:17 colectomy with ileorectal anastomosis IRA IRA:6 immunoradiometric assay IRES IRES:124 internal ribosomal entry site IRES IRES:35 internal ribosome entry segment IRE IRE:17 insulin response element IRE IRE:8 iron response element IRF IRF:25 idiopathic retroperitoneal fibrosis IRF IRF:9 immature reticulocyte fraction IRF IRF:11 impaired renal function IRF IRF:16 impulse response function IR-GIP IR-GIP:21|IRGIP:3 immunoreactive gastric inhibitory polypeptide IR-GIP IR-GIP:10 immunoreactive gip IRG IRG:22|IR-G:1 immunoreactive gastrin IRG IRG:157 immunoreactive glucagon IRI IRI:639|IR-I:2 immunoreactive insulin IRI IRI:6 insulin immunoreactivity IRI IRI:11 insulin level IRI IRI:7 insulinlike immunoreactivity IRI IRI:8 interpersonal reactivity index IRL IRL:8 inspiratory resistive load IRL IRL:20 inspiratory resistive loading IRM IRM:34 interference reflection microscopy IRM IRM:17 intermediate restorative material IRMS IRMS:9 isotope ratio mass spectrometer IRMS IRMS:41|IR-MS:2 isotope ratio mass spectrometry IRR IRR:29 insulin receptorrelated receptor IRR IRR:9 interrater reliability IRR IRR:8 intrarenal reflux IRS IRS:18 activation of the inflammatory response system IRS IRS:6 immune rabbit serum IRS IRS:4 immune rat serum IRS IRS:14 immunoreactive score IRS IRS:18 immunoreactive secretin IRS IRS:35 inner root sheath IRS IRS:93 insulin resistance syndrome IRS IRS:8 insulin response sequence IRS IRS:9 interferon response sequence IRS IRS:30 internal revenue service IRT IRT:66 immunoreactive trypsin IRT IRT:33 immunoreactive trypsinogen IRT IRT:11 infrared thermography IRT IRT:19 inhibitorresistant tem IRT IRT:17 intracoronary radiation therapy IRT IRT:90 item response theory IR IR:9|ir:3 calcitonin generelated peptide cgrpimmunoreactive IR IR:17 implantation rate IR IR:19 inactive renin IR IR:9 incomplete repair IR IR:21 inferior rectus IR IR:24 information retrieval IR IR:15 intermediate risk IR IR:16 internal rotation IR IR:8 ionizing irradiation IR IR:403|ir:1|I-R:1 ionizing radiation IR IR:34|I-R:18 ischaemiareperfusion IR IR:2|I-R:2 min of reperfusion IR IR:23 nearinfrared ISAAC ISAAC:155 international study of asthma and allergies in childhood ISAAC ISAAC:6 international study of asthma and allergy in children ISAV ISAV:47 infectious salmon anaemia virus ISAV ISAV:19 infectious salmon anemia virus ISA ISA:11 index of spouse abuse ISA ISA:22 infectious salmon anaemia ISA ISA:12 infectious salmon anemia ISA ISA:8 internal surface area ISA ISA:186 intrinsic sympathomimetic activity ISA ISA:6 isotopomer spectral analysis ISD ISD:7 infantile seborrheic dermatitis ISD ISD:37 intrinsic sphincter deficiency ISF ISF:126|isf:1 interstitial fluid ISF ISF:12 isosafrole ISG ISG:59 immune serum globulin ISG ISG:12 international study group ISH ISH:7 isocapnic hyperventilation ISH ISH:162 isolated systolic hypertension ISH ISH:109 situ hybridisation ISI ISI:116 international sensitivity index ISI ISI:19 interspike intervals ISI ISI:9 sensitivity indices ISO ISO:67 international organization for standardization ISO ISO:10 international standards organisation ISO ISO:68|Iso:13|iso:2 isoflurane ISO ISO:6|Iso:3 isometric ISO ISO:14 isoprinosine ISP ISP:9 intrasinus pressure ISP ISP:19 isepamicin ISP ISP:6 isovolumic systolic pressure ISP ISP:18 rieske ironsulfur protein ISRs ISRs:9 injection site reactions ISRs ISRs:9 insulin secretion rates ISRs ISRs:9 intergenic spacer regions ISR ISR:149 instent restenosis ISR ISR:21 induced systemic resistance ISR ISR:10|Isr:1 isradipine ISSD ISSD:7 infantile free sialic acid storage disease ISSD ISSD:9 infantile sialic acid storage disease ISS ISS:81 idiopathic short stature ISS ISS:17 immunostimulatory dna sequences ISS ISS:16 immunostimulatory sequences ISS ISS:9 internal state scale ISS ISS:159 international space station ISS ISS:7 international staging system ISS ISS:19 istituto superiore di sanita IST IST:12 inappropriate sinus tachycardia IST IST:9 insulin stress test IST IST:8 insulin suppression test IST IST:16 international stroke trial ISV ISV:13 internal spermatic vein ISV ISV:7 interstitial volume ISVPs ISVPs:10 infectious subvirion particles ISVPs ISVPs:6 intermediate subviral particles ITAM ITAM:96 immunoreceptor tyrosinebased activation motif ITAM ITAM:13 tyrosinebased activation motifs ITB ITB:16 iliotibial band ITB ITB:34 intrathecal baclofen ITC ITC:215 isothermal titration calorimetry ITC ITC:16 isothermal titration microcalorimetry ITD ITD:44 idiopathic torsion dystonia ITD ITD:9 impedance threshold device ITD ITD:1 interaural differences of time ITD ITD:7 interaural time ITD ITD:20 interaural time delay ITD ITD:5 ion trap detector ITDs ITDs:20 interaural temporal disparities ITDs ITDs:8 interaural time delays ITDs ITDs:69 interaural time differences ITDs ITDs:22 internal tandem duplications ITE ITE:28 intheear ITE ITE:10 intraining examination ITF ITF:11 infratemporal fossa ITF ITF:48 intestinal trefoil factor ITF ITF:5 tissue fluid ITMS ITMS:11 ion trap mass spectrometer ITMS ITMS:10 ion trap mass spectrometry ITP ITP:29 idiopathic thrombocytopenia ITP ITP:1091 idiopathic thrombocytopenic purpura ITP ITP:63 immune thrombocytopenia ITP ITP:32 intrathoracic pressure ITP ITP:10 ion transport peptide ITP ITP:12 isotachophoretic ITS ITS:12 internal transcribed spacer region ITS ITS:8 interrupted time series ITS ITS:5|ITs:1 interstitial telomeric sequences ITT ITT:6 immune tolerance therapy ITT ITT:91 intenttotreat ITT ITT:105|itt:1 intentiontotreat ITT ITT:6 intentiontotreat analysis ITT ITT:7 intestinal transit time ITT ITT:10 intratesticular testosterone IT IT:12 ca current IT IT:9 immune tolerance IT IT:63 inferior temporal IT IT:26 inferior temporal cortex IT IT:26 inferotemporal IT IT:17 inferotemporal cortex IT IT:212 information technology IT IT:5 information transfer IT IT:17 inspection time IT IT:8 intensive therapy IT IT:16 intermediate trophoblast IT IT:19 intratracheal instillation IUFD IUFD:37 intrauterine fetal death IUFD IUFD:9 intrauterine fetal demise IUGR IUGR:6 growth retarded fetuses IUGR IUGR:316 intrauterine growth restriction IUGR IUGR:850 intrauterine growth retardation IUP IUP:15 intraurethral pressure IUP IUP:52 intrauterine pregnancy IUP IUP:33 intrauterine pressure IUT IUT:19 intrauterine transfusion IUT IUT:8 utero transplantation IU IU:6 idiopathic uveitis IU IU:11 indiana university IU IU:7 intermediate uveitis IVAP IVAP:9 access port IVAP IVAP:11 vitro antibody production IVBT IVBT:9 vitro bleeding test IVBT IVBT:9 vitro bleeding time IVCT IVCT:11 isovolumic contraction time IVCT IVCT:46 vitro contracture test IVDA IVDA:28 intravenous drug abuse IVDA IVDA:24|ivDA:1 intravenous drug addicts IVD IVD:14 interactive videodisc IVD IVD:40 intervertebral disc IVD IVD:22 ischemic vascular dementia IVD IVD:22 isovalerylcoa dehydrogenase IVD IVD:12 vitro diagnostic IVF IVF:6 fertilization in vitro IVF IVF:16 idiopathic ventricular fibrillation IVF IVF:48 invitro fertilisation IVF IVF:10 intravenous fluid IVF IVF:145 vitro fertilisation IVF IVF:1931|ivf:1 vitro fertilization IVH IVH:76 intravenous hyperalimentation IVH IVH:118 intraventricular haemorrhage IVIG IVIG:10|IVIg:1 intravenous igg IVIG IVIG:22|IVIg:9|ivIG:2 intravenous immunoglobulin g IVIG IVIG:8|IVIg:1|ivIg:1 intravenous immunoglobulin preparations IVIG IVIG:8|IVIg:5 intravenous immunoglobulin therapy IVIVC IVIVC:13|IV-IVC:2 vitroin vivo correlation IVIVC IVIVC:7 vivo correlations IVL IVL:25 intravascular lymphoma IVL IVL:17 intravenous leiomyomatosis IVL IVL:10 vitro lipogenesis IVM IVM:23 intravital microscopy IVM IVM:9 maturation in vitro IVM IVM:186 vitro maturation IVN IVN:4|ivn:2 inferior ventricular nerve IVN IVN:25|ivn:1 intravenous nutrition IVP IVP:16 excretory urogram IVP IVP:107|ivp:1 intravenous pyelography IVP IVP:34 intraventricular pressure IVP IVP:11 intravesical pressure IVP IVP:8 vitro embryo production IVP IVP:18 vitro production IVRA IVRA:24 intravenous regional anaesthesia IVRA IVRA:44 intravenous regional anesthesia IVR IVR:38 interactive voice response IVR IVR:7 intramolecular vibrational energy redistribution IVR IVR:9 isovolumetric regulation IVS IVS:20 interventricular septal IVS IVS:7 interventricular septum thickness IVS IVS:6 intravaginal electrical stimulation IVS IVS:9 intravaginal slingplasty IVS IVS:13 vitro sensitization IVS IVS:7 vitro stimulation IVUS IVUS:30 intravascular ultrasonography IVUS IVUS:818 intravascular ultrasound IVUS IVUS:19 intravascular ultrasound imaging IAS IAS:10 illness attitude scales IAS IAS:9 image analysis system IAS IAS:13 insulin autoimmune syndrome IAS IAS:25 interatrial septum IAS IAS:9 intermittent androgen suppression IAS IAS:140 internal anal sphincter IA IA:21|iA:1 acurrent IA IA:15 atype k current Ia Ia:28 class ii mhc IA IA:16 idiopathic anaphylaxis IA IA:21 immune adherence Ia Ia:10 immuneassociated IA IA:56 immunoadsorption IA IA:8 induced abortion IA IA:10 infantile autism IA IA:11 infarct area IA IA:16 inflammatory arthritis IA IA:25 inhibitory avoidance IA IA:7 innominate artery IA IA:20 insulin antibodies IA IA:13 interarytenoid IA IA:10 intestinal atresia IA IA:15 intimal area IA IA:12 intraabdominal IA IA:16 intracranial aneurysm IA IA:116 invasive aspergillosis IA IA:18 transient k current IA IA:14|Ia:1 transient potassium current IB IB:12 binding IB IB:44 infectious bronchitis IB IB:10 intrinsic bursting IB IB:16 intrinsically bursting IB IB:63 ipratropium bromide IC IC:10 iliac crest IC IC:20|Ic:1 immunocytoma IC IC:9 impoverished IC IC:8 impoverished condition IC IC:15 impression cytology IC IC:10 imprint cytology IC IC:23 imprinting center IC IC:27 indeterminate colitis IC IC:36|Ic:1 indirect calorimetry IC IC:20 infection control IC IC:8 infectious centers IC IC:15 inferior cardiac IC IC:22 inferior collicular IC IC:494 inferior colliculus IC IC:18 informed consent ic IC:6|ic:6 inoculated intracerebrally IC IC:110 inspiratory capacity IC IC:15 integrated circuit IC IC:7 integrated concentration IC IC:11 intercalated IC IC:23 intercellular communication IC IC:10 intercostal IC IC:20 intermediate compartment IC IC:11 intermittent catheterization IC IC:123|Ic:1 intermittent claudication IC IC:29|ic:3 internal capsule IC IC:10 internal carotid artery IC IC:24 internal control IC IC:271 interstitial cystitis IC IC:7|ic:2 intracameral IC IC:33|ic:23 intracerebral ic ic:9|IC:8 intracisternally IC IC:8 invasive cancer IC IC:21 ion chromatographic IC IC:131 ion chromatography IC IC:6 ischaemic cardiopathy IC IC:5 ischemic cardiopathy IC IC:18 ischiocavernosus IC IC:8 systemic immunecomplex Id Id:33|id:1 antiidiotype ID ID:30|Id:1 identification ID ID:22|Id:1|id:1 identifier Id Id:31|ID:2|id:2 idiotypic ID ID:116 immunodiffusion ID ID:19 incidence density ID ID:8 index of difficulty ID ID:12 infantdirected ID ID:8 infective dermatitis ID ID:4|Id:4|id:1 inhibitor of differentiation Id Id:6|ID:1 inhibitor of dna binding ID ID:36|id:2 injected dose ID ID:41 internal derangement ID ID:25 iodine deficiency ID ID:66 iron deficiency ID ID:14 isotope dilution ID ID:8 microm inner diameter ID ID:9|I-D:1 onedimensional ID ID:5 primary immunodeficiency IE IE:6 idiopathic epilepsy IE IE:10 idiopathic erythrocytosis IE IE:422 infective endocarditis IE IE:8 isometric exercise IE IE:15 patients with infectious endocarditis IFG IFG:142 impaired fasting glucose IFG IFG:13 impaired fasting glycaemia IFG IFG:10 impaired fasting glycemia IFG IFG:47|ifg:1 inferior frontal gyrus IGD IGD:9 interglobular domain IGD IGD:5 isolated gonadotropin deficiency IgH IgH:12|Igh:1 ig heavychain IgH IgH:9|Igh:1 immunoglobulin h IgH IgH:36|IGH:5 immunoglobulin heavy IGP IGP:7 imidazole glycerol phosphate IGP IGP:19|IgP:1 intragastric pressure IGR IGR:10 impaired glucose regulation IGR IGR:21 insect growth regulator IGR IGR:5 integrated gastrin response IGS IGS:6 immuno gold staining IGS IGS:10 immunogold staining IGS IGS:155 intergenic spacer IGS IGS:13 internal guide sequence IG IG:7|ig:2 administered intragastrically IG IG:1 flavors that were paired with intragastric Ig Ig:9 gating current Ig Ig:26 immunoglobin IG IG:11|ig:2 intergenic IG IG:23|ig:5 intervention group IG IG:5 intraductal growth IM IM:18|im:4 administered intramuscularly IM IM:10|Im:5 imatinib mesylate IM IM:9 induced motion IM IM:13 infant mortality IM IM:20 infantile myofibromatosis IM IM:429|Im:3 infectious mononucleosis IM IM:9 inflammatory myopathy IM IM:31 inner medulla IM IM:12 inner medullary IM IM:26|Im:1 inner membrane IM IM:14 intermetatarsal IM IM:18 internal mammary IM IM:48 internal medicine IM IM:14 interstitial macrophages IM IM:5 interval mapping IM IM:268 intestinal metaplasia IM IM:5 intracellular membranes IM IM:15|im:6 intrahepatic metastasis IM IM:63|Im:2 intramedullary IM IM:10 intramembranous IM IM:377|im:118|Im:1 intramuscular IM IM:34|Im:2 mcurrent ISC ISC:16 igsecreting cells ISC ISC:19|Is-c:1 indian subcontinent ISC ISC:9 intermittent selfcatheterization ISC ISC:11 interstrand crosslinks ISC ISC:14|isc:1 intersystem crossing ISC ISC:6 ironsulfur cluster IS IS:34|is:1 idiopathic scoliosis IS IS:7 immune serum IS IS:18 immune system IS IS:25 immunological synapse IS IS:52 immunoscintigraphy IS IS:9 immunostaining IS IS:13 immunosuppressed IS IS:30 immunosuppression IS IS:34 immunosuppressive IS IS:11 immunosuppressive substance IS IS:15 incentive spirometry IS IS:11 indoxyl sulfate IS IS:55 induced sputum IS IS:32 inescapable shock IS IS:72|Is:2 infantile spasms IS IS:144|Is:4 infarct size IS IS:20 initial segment IS IS:10 inner segments IS IS:7|Is:3 insertion IS IS:12|Is:1 ischaemic stroke IS IS:59|Is:4 ischemic stroke IS IS:8 isotonic saline JAS JAS:7|Jas:5 jasplakinolide JAS JAS:70 jenkins activity survey JA JA:15 jasmonate JA JA:195 jasmonic acid JA JA:39 juvenile arthritis JCML JCML:52 juvenile chronic myelogenous leukemia JCML JCML:8|jCML:1 juvenile chronic myeloid leukaemia JCML JCML:14|jCML:1 juvenile chronic myeloid leukemia JCV JCV:28 human polyomavirus jc JCV JCV:14 jc polyomavirus JE JE:433 japanese encephalitis JE JE:59 junctional epithelium JGCT JGCT:12 juvenile granulosa cell tumor JGCT JGCT:7 juxtaglomerular cell tumor JH JH:9 h secretion JH JH:12 juvenile hemochromatosis JMML JMML:11 juvenile myelomonocytic leukaemia JMML JMML:78 juvenile myelomonocytic leukemia JM JM:38 juxtamedullary JM JM:41 juxtamembrane JNCL JNCL:9 juvenile ncl JNCL JNCL:25 juvenile neuronal ceroid lipofuscinosis JPS JPS:10 japan pancreas society JPS JPS:12 joint position sense JPS JPS:11 juvenile polyposis syndrome JP JP:12 joining peptide JP JP:10 juvenile papillomatosis JP JP:18 juvenile parkinsonism JP JP:80 juvenile periodontitis JP JP:17 juvenile polyposis JP JP:10 psychotropic drugs in japanese pharmacopoeia Jv Jv:32|JV:6 fluid absorption Jv Jv:3|JV:2 fluid absorption rate Jv Jv:10|JV:6 fluid reabsorption Jv Jv:5 net water flux Jv Jv:11 volume flux Jv Jv:6|JV:1 water flow K(m) K(m):94|K(M):4|k(M):1 michaelis constant K(m) K(m):56|k(m):1 michaelismenten constant K8/18 K8/18:8 keratins and K8/18 K8/18:11 keratin polypeptides and KAP KAP:20|Kap:2 kidney androgenregulated protein KAP KAP:1 knowledge attitude and practice KBD KBD:8 diffusive mass transport coefficients KBD KBD:23 kashinbeck disease KB KB:31|Kb:11 dissociation constant KB KB:11 human oral epidermoid carcinoma KB KB:7|K-B:2 kleihauerbetke KB KB:13 knowledge base KCO KCO:15 carbon monoxide transfer coefficient KCO KCO:13 channel opener KCO KCO:4 per unit lung volume KCs KCs:45 keratinocytes KCs KCs:75 kupffer cells KCl KCl:6 high potassium KCl KCl:263|KCL:4 potassium chloride KC KC:20 kangaroo care KC KC:26 keratinocyte KC KC:8 keratinocyte chemoattractant KC KC:15 keratinocytederived chemokine KC KC:18 keratoconus KDO KDO:26|Kdo:1 ketodeoxyoctonate KDO KDO:12|Kdo:2 deoxydmannooctulosonate KDR KDR:10 kinase domain receptor KDR KDR:34|kdr:2 kinase insert domaincontaining receptor KDR KDR:7 kinase insert domaincontaining region KDR KDR:7 kinase insert domain receptor KDR KDR:6 receptor Ke Ke:3|ke:2 elimination rate KE KE:9 kinetic energy KE KE:21 knee extension Ke Ke:6 total exchangeable potassium KFD KFD:15 kikuchifujimoto disease KFD KFD:18 kyasanur forest disease KGFR KGFR:21 keratinocyte growth factor receptor KGFR KGFR:33|KGF-R:3|KgfR:1 kgf receptor KGM KGM:22 keratinocyte growth medium KGM KGM:9 konjac glucomannan KHB KHB:12 krebshenseleit bicarbonate KHB KHB:13 krebshenseleit bicarbonate buffer KHC KHC:17|Khc:3 kinesin heavy chain KHC KHC:16 kurosawa and kusanagihypercholesterolemic KHN KHN:7 knoop hardness KHN KHN:16 knoop hardness number KH KH:13 ketamine hydrochloride KH KH:59|K-H:44 krebshenseleit KIC KIC:29|KIc:8 fracture toughness KIC KIC:14 ketoisocaproate KID KID:16 keratitisichthyosisdeafness KID KID:9 kinaseinducible domain KLC KLC:9 keratosis lichenoides chronica KLC KLC:10|Klc:2 kinesin light chain KLH KLH:175 keyhole limpet haemocyanin KLH KLH:627 keyhole limpet hemocyanin KLH KLH:11 keyhole limpet hemocyanine KO KO:747|ko:20|Ko:2|-KO:1 knockout KO KO:9 knockout mice KPI KPI:19 karyopyknotic index KPI KPI:47 protease inhibitor KRB KRB:13 krebsringer bicarbonate buffer KRB KRB:10 krebsringer bicarbonate solution KR KR:12 ketoreductase KR KR:9 knotted reactor KR KR:66 knowledge of results KSHV KSHV:20|kshv:1 kaposis sarcomaassociated herpes virus KSHV KSHV:349 kaposis sarcomaassociated herpesvirus KSP KSP:77 karolinska scales of personality KSP KSP:15 lysserpro KSS KSS:97 kearnssayre syndrome KSS KSS:9 knee society score KSS KSS:9 sleepiness scale KS KS:9 betaketoacyl synthase KS KS:21 kallmanns syndrome KS KS:7 karnofsky scale KS KS:58 kawasaki syndrome KS KS:150 keratan sulfate KS KS:48 keratan sulphate KS KS:10 ketosynthase KS KS:24 klinefelter syndrome KS KS:13|K-S:9 kolmogorovsmirnov KS KS:8 patients with klinefelters syndrome Kt/V Kt/V:10 dialysis adequacy Kt/V Kt/V:16 dialysis dose Kt/V Kt/V:11|KT/V:1 urea clearance KTA KTA:7 kidney transplant alone KTA KTA:10 kidney transplantation alone KT KT:12 keratinized tissue KT KT:17 ketorolac tromethamine Kw Kw:11|kw:3 weighted kappa Kw Kw:8|kw:2 weighted kappa statistic KYN KYN:30|Kyn:10|kyn:2 kynurenine KYN KYN:5|Kyn:2 receptor antagonist kynurenate Ka Ka:5|ka:2 absorption rate KA KA:10 acid ampakainate KA KA:810|Ka:87 kainic acid KA KA:18|Ka:4 kalaazar Ka Ka:5 weak acids Kd Kd:9|kd:7|KD:3|kD:1 degradation Kd Kd:5|kd:2 disappearance rate KD KD:3|Kd:2 dissociation constant values KD KD:44 ketogenic diet KD KD:6|kd:4 kinasedead KD KD:8 kinase domain KD KD:16|Kd:1 potassium depletion KF KF:8|Kf:5 dna polymerase i Kf Kf:9 filtration capacity Kf Kf:20 glomerular capillary ultrafiltration coefficient KF KF:21|Kf:2 klenow fragment KF KF:10 kollikerfuse KF KF:15 kollikerfuse nucleus KF KF:9 potassium fluoride Ki-67 Ki-67:8|Ki67:2 proliferation marker Ki-67 Ki-67:4|Ki67:2|ki-67:2 proliferative index Kir6.2 Kir6.2:3|KIR6.2:1 inwardly rectifying potassium channel Kir6.2 Kir6.2:8 poreforming subunit Kir Kir:7|KIR:3 inward rectifier k Kir Kir:4|KIR:1 inward rectifier potassium channels KI KI:12|Ki:1 karnofsky index KI KI:78 potassium iodide Km Km:5 apparent michaelis Km Km:6|KM:3 apparent michaelismenten KM KM:21|K-M:6 kaplanmeier KM KM:12 knowledge management Km Km:93|KM:7|kM:1|km:1 michaelis constants Km Km:25|KM:3 michaelismenten constants KPS KPS:63 karnofsky performance scale KPS KPS:49 karnofsky performance score KPS KPS:215 karnofsky performance status KP KP:11 kaiser permanente KP KP:10 kidneypancreas KP KP:5 knob protein KP KP:7 korsakoffs psychosis KP KP:13 kynurenine pathway L-NIL L-NIL:7|l-NIL:2|L-Nil:1 lniminoethyllysine L-NIL L-NIL:9 niminoethylllysine L-NOARG L-NOARG:11 lngnitro arginine L-NOARG L-NOARG:5|L-NOArg:3|L-Noarg:1 lngnitroarginine L/D L/D:11 leveldose L/D L/D:17|l/d:1 lightdark L/P L/P:45 lactatepyruvate L/P L/P:16 lymphplasma L/P L/P:21 lymphtoplasma protein concentration ratio L1210 L1210:7 mouse leukemia cells L1210 L1210:12|L-1210:1 murine leukemia L1CAM L1CAM:11|L1-CAM:3 cell adhesion molecule l L1CAM L1CAM:9|L1-CAM:1 l cell adhesion molecule L1 L1:22 first language L1 L1:8 first larval stage L1 L1:23 firststage larvae L1 L1:17 iron chelator deferiprone L1 L1:53 line L1 L1:9 major L1 L1:10 native language L1 L1:14 oral iron chelator dimethylhydroxypyridone L2 L2:36 second language L2 L2:5 second lumbar L3 L3:22|L-3:1 infective L3 L3:174 infective larvae L3 L3:7 infective larval L3 L3:13 infective stage larvae L3 L3:4 infective thirdstage L3 L3:38 infective thirdstage larvae L3 L3:16 larva L3 L3:8 third larval stage L3 L3:11 third stage L3 L3:69 third stage larvae L4 L4:7 fourth larval stage L4 L4:10 fourth lumbar L4 L4:6 layer L6 L6:5 rat skeletal muscle cell line L6 L6:11|L-6:1 sixth lumbar LAAM LAAM:25 alphaacetylmethadol LAAM LAAM:64 lalphaacetylmethadol LAAM LAAM:39 levoalphaacetylmethadol LAA LAA:28 laboratory animal allergy LAA LAA:129 left atrial appendage LAA LAA:7 leucocyte ascorbic acid LAA LAA:11 leukocyte adhesivenessaggregation LAA LAA:7 low attenuation areas LABC LABC:82 locally advanced breast cancer LABC LABC:12 locally advanced breast carcinoma LABC LABC:8|Labc:1 lymphadenosis benigna cutis LAB LAB:296 lactic acid bacteria LAB LAB:9 lactic acid bacterium LAC LAC:10|L-AC:3|L-Ac:3 lacetylcarnitine LAC LAC:72|LaC:1 la crosse LAC LAC:7 laparoscopicassisted colectomy LAC LAC:10 latin america and the caribbean LAC LAC:18 los angeles county LADA LADA:57 latent autoimmune diabetes in adults LADA LADA:8 latent autoimmune diabetes of the adult LADA LADA:5|LADa:2 left anterior descending artery LAD LAD:916|lad:1 left anterior descending LAD LAD:23 left anterior descending branch LAD LAD:25 left anterior descending coronary LAD LAD:35 left atrial diameter LAD LAD:37|LAd:1 left atrial dimension LAD LAD:23 left axis deviation LAD LAD:76 leukocyte adhesion deficiency LAD LAD:28 ligament augmentation device LAD LAD:10 linear iga dermatosis LAD LAD:37 linear iga disease LAF LAF:15 laminar air flow LAF LAF:9 lone atrial fibrillation LAGB LAGB:9 laparoscopic adjustable gastric band LAGB LAGB:94 laparoscopic adjustable gastric banding LAI LAI:10 adherence inhibition assay LAI LAI:34 leaf area index LAI LAI:5 leukemia associated inhibitor LAI LAI:155 leukocyte adherence inhibition LAI LAI:13 leukocyte adherence inhibition test LAI LAI:10 lupus activity index LAL LAL:197 limulus amebocyte lysate LAL LAL:7 limulus amebocyte lysate test LAL LAL:115 limulus amoebocyte lysate LAL LAL:11 long attack latency LAL LAL:9 lysate assay LAL LAL:18 lysinoalanine LAL LAL:41 lysosomal acid lipase LAM-1 LAM-1:6 leucocyte adhesion molecule LAM-1 LAM-1:7 leukocyte adhesion molecule LAMP-1 LAMP-1:10|Lamp-1:3|LAMP1:1 lysosomeassociated membrane protein LAMP-1 LAMP-1:9|LAMP1:3|Lamp1:2|lamp-1:2 membrane protein LAN LAN:17|Lan:1 lanreotide LAN LAN:54 local area network L-AP4 L-AP4:3 group iii mglur agonist laminophosphonobutyrate L-AP4 L-AP4:11|l-AP4:2|LAP4:1|l-AP-4:1 laminophosphonobutanoate LAP LAP:10 laminaassociated polypeptide LAP LAP:19|lap:3 laparotomy LAP LAP:12 leucine amino peptidase LAP LAP:220|lap:2|Lap:1 leucine aminopeptidase LAP LAP:55|l-AP:1 leukocyte alkaline phosphatase LAP LAP:8 lipid aassociated protein LAP LAP:6 liver activator protein LAP LAP:6 liverenriched activating protein LAP LAP:23 lysosomal acid phosphatase LAR LAR:5 antigenrelated phosphatase LAR LAR:7 late allergic reaction LAR LAR:11 leaf area ratio LAR LAR:23 leukocyte common antigenrelated LAR LAR:6 locus activation region LAR LAR:12 longacting release LAR LAR:46 low anterior resection LAR LAR:7 lymphatic absorption rate LASEK LASEK:26|LasEk:2 laserassisted subepithelial keratectomy LASEK LASEK:27 laser epithelial keratomileusis LASEK LASEK:14 laser subepithelial keratomileusis LAS LAS:7 microv LAS LAS:11 lateral amyotrophic sclerosis LAS LAS:8 linear alkyl benzene sulfonate LAs LAs:9 local anaesthetics LAs LAs:40 local anesthetics LAS LAS:8 low amplitude signal LAs LAs:22 lupus anticoagulants LAS LAS:78 lymphadenopathy syndrome LAT LAT:5 llysine epsilonaminotransferase LAT LAT:18 lactic acidosis threshold LAT LAT:74 linker for activation of t cells LAT LAT:4|lat:2 lysine epsilonaminotransferase LAT LAT:12 lysolecithin acyltransferase LAVH LAVH:52 laparoscopically assisted vaginal hysterectomy LAVH LAVH:11 vaginal hysterectomies LAV LAV:8 left atrial volume LAV LAV:43 lymphadenopathyassociated virus LAMP LAMP:38 limbic systemassociated membrane protein LAMP LAMP:43 loopmediated isothermal amplification LAM LAM:40 lactational amenorrhea method LAM LAM:9 levator ani muscle LAM LAM:50 pulmonary lymphangioleiomyomatosis LAM LAM:12 pulmonary lymphangiomyomatosis LA LA:110|La:3 lactic acid LA LA:10 lactic acidosis LA LA:30 laparoscopic adrenalectomy LA LA:60 laparoscopic appendectomy LA LA:7 large aggregates LA LA:9 large aspiny LA LA:7 large surfactant aggregates LA LA:12 laser ablation LA LA:32 lateral amygdala LA LA:29 lateral nucleus of the amygdala LA LA:155 latex agglutination LA LA:13 left atria LA LA:224 left atrium LA LA:9|La:6 leucoagglutinin LA LA:9|L-A:1|La:1 leukoagglutinin LA LA:24 leukoaraiosis LA LA:34 linoleic LA LA:396 linoleic acid LA LA:44 local anaesthesia LA LA:34 localized adherence LA LA:10 longacting LA LA:21 los angeles LA LA:8 low affinity LA LA:9 low altitude LA LA:7|L-A:2 lowaverage LA LA:27 lumen area LA LA:14 lyme arthritis LA LA:10 lymphadenectomy LA LA:6 lymphoid aggregates LBD LBD:20 left braindamaged LBD LBD:20 lewy body dementia LBD LBD:39 lewy body disease LBD LBD:12 patients with left brain damage LBP LBP:5 ligand binding pocket LBP LBP:71 lipopolysaccharide binding protein LBP LBP:535|lbp:1 low back pain LBP LBP:10 lycium barbarum polysaccharide LBT LBT:21 lupus band test LBT LBT:15 lymphocyte blast transformation LBV LBV:14 lewy body variant LBV LBV:9 lewy body variant of ad LCA LCA:31 latent class analysis LCA LCA:98 left coronary artery LCA LCA:31 lens culinaris LCA LCA:13 lentil lectin LCA LCA:13 littoral cell angioma LCA LCA:10 longitudinal chromatic aberration LCA LCA:7 lymphocytotoxic activity LCA LCA:20 lymphocytotoxic antibodies LCD LCD:17 lattice corneal dystrophy LCD LCD:36 liquid crystal display LCD LCD:26 liver cell dysplasia LCD LCD:10 lowcalorie diet LCF LCF:10 lymphocyte chemoattractant factor LCF LCF:8 lymphocyte chemotactic factor LCG LCG:16 cell granulomatosis LCG LCG:7 liquid cooling garment LCIS LCIS:8 light chain isotype suppression LCIS LCIS:114|LCIs:1 lobular carcinoma in situ LCI LCI:13 lung clearance index LCI LCI:8|LC-I:1 myosin light chain i LCLs LCLs:7 large cell lymphomas LCLs LCLs:237|LCL-s:1 lymphoblastoid cell lines LCL LCL:32 lateral collateral ligament LCL LCL:34 localized cutaneous leishmaniasis LCL LCL:10 luminol chemiluminescence LCL LCL:8 lymphoblastoid cells LCM LCM:168 laser capture microdissection LCM LCM:12 lincomycin LCM LCM:12|L-CM:1 lymphocyteconditioned medium LCM LCM:140 lymphocytic choriomeningitis LCN LCN:44|LCn:1 lateral cervical nucleus LCN LCN:13|lcn:1 low copy number LCP LCP:5 lectin complement pathway LCP LCP:12 leggcalveperthes LCP LCP:13 locking compression plate LCR LCR:7 laparoscopic colon resection LCR LCR:21 laryngeal chemoreflex LCR LCR:176 ligase chain reaction LCS LCS:12 laparosonic coagulating shears LCS LCS:8 low contact stress LCT LCT:11 liquid crystal thermography LCT LCT:8 lower critical temperature LCT LCT:15 lymphocytotoxicity test LC LC:35|L-C:12 lcarnitine LC LC:11 lab chow LC LC:8|lc:3 lactobacillus casei LC LC:10 lake casitas LC LC:14 lamina cribrosa LC LC:9 lateral column LC LC:6 leukemia cutis LC LC:24 lightcycler LC LC:367 liquid chromatographic LC LC:14 liquid crystalline LC LC:390 liver cirrhosis LC LC:70 local control LC LC:120 locus ceruleus LC LC:1365|Lc:1 locus coeruleus LC LC:11 lowcarbohydrate LC LC:25 lumped constant LC LC:72 lung cancer LC LC:12 lysine clonixinate LD50 LD50:35 acute toxicity LD50 LD50:1 lethal dose at LDA LDA:10 larval development assay LDA LDA:16 laser doppler anemometer LDA LDA:32 laser doppler anemometry LDA LDA:18 left displaced abomasum LDA LDA:10|lda:1 left displacement of the abomasum LDA LDA:90 limiting dilution analysis LDA LDA:136 linear discriminant analysis LDA LDA:10 local density approximation LDA LDA:11 low density area LDA LDA:7 lowdose aspirin LDF LDF:37 laser doppler flowmeter LDF LDF:415 laser doppler flowmetry LDF LDF:39|LDf:1 laser doppler fluxmetry LDF LDF:9 linear discriminant function LDH LDH:9 dehydrogenase level LDH LDH:26 lactate dehydrogenase activity LDH LDH:14 lactate dehydrogenase release LDH LDH:18 lactatedehydrogenase LDH LDH:10 layered double hydroxide LDH LDH:9 lowdose heparin LDH LDH:14 lumbar disc herniation LDH LDH:101 serum lactic dehydrogenase LDI LDI:10 laser desorptionionization LDI LDI:13 laser doppler imager LDI LDI:35 laser doppler imaging LDI LDI:9 laser doppler interferometry LDI LDI:6 learning disability index LDLR LDLR:8|Ldlr:1 ldl receptor gene LDLR LDLR:10 low density lipoprotein receptor gene LDLs LDLs:9 loudness discomfort levels LDLs LDLs:124 lowdensity lipoproteins LDR LDR:19 detection reaction LDR LDR:11 longdistance runners LDS LDS:11 lipodermatosclerosis LDS LDS:13 lithium dodecyl sulfate LDT LDT:14 lexical decision task LDT LDT:15 lymphocyte doubling time LDV LDV:114 lactate dehydrogenaseelevating virus LDV LDV:42 lactic dehydrogenase virus LDV LDV:9 laser doppler velocimeter LDV LDV:75 laser doppler velocimetry LDV LDV:11 vesicles LD LD:8|L-D:1 ldopa LD LD:17 lamina densa LD LD:11 lateral dorsal LD LD:10 laterodorsal LD LD:93 latissimus dorsi LD LD:68 legionnaires disease LD LD:6|Ld:3 leishmania donovani ld ld:11|LD:3|Ld:1 lesion depth LD LD:66 levodopa ld ld:20|Ld:2 limb deformity LD LD:43 limiting dilution LD LD:63 linear dichroism LD LD:34 lipodystrophy LD LD:20 loading dose LD LD:29|Ld:1|ld:1 longissimus dorsi LD LD:30 low density LD LD:12 lumen diameter LD LD:9 luminancedefined LD LD:84 lyme disease LD LD:10 lymphocytic depletion LD LD:39 patients with limited disease LD LD:9 photoperiod LD LD:29 under lightdark LECs LECs:127 lens epithelial cells LECs LECs:14 lymphatic endothelial cells LEC LEC:9 cinnamonlike coat color LEC LEC:26 lateral entorhinal cortex LEC LEC:10 leprosy elimination campaign LEC LEC:160 longevans cinnamon LEC LEC:7 lymphoepithelial carcinoma LEC LEC:10 lymphoepithelial cyst LEH LEH:14 linear enamel hypoplasia LEH LEH:36 liposomeencapsulated hemoglobin LEM LEM:24 endogenous mediator LEM LEM:9 lentinus edodes mycelia LEP LEP:7 leptin gene LEP LEP:11 limited english proficiency LEP LEP:8 lupus erythematosus profundus LES LES:6 lamberteaton syndrome LES LES:763|les:1 lower esophageal sphincter LETO LETO:7 longevans tokushima LETO LETO:83 longevans tokushima otsuka LET LET:6 esterase test LET LET:335 linear energy transfer LET LET:9 lupus erythematosus tumidus Le Le:8|LE:1 huifnalpha LE LE:7 labelling efficiency LE LE:9 lateral epicondylitis LE LE:6 left ear LE LE:7 leg exercise LE LE:7 leg extension LE LE:6 lens epithelial LE LE:17 leucine enkephalin LE LE:18 leukocyte elastase LE LE:28 leukocyte esterase Le Le:51|LE:7 lewis LE LE:10 life events LE LE:10 liquidexpanded LE LE:10 liver extract LE LE:18 local excision LE LE:18 longevans rats LE LE:15 loteprednol etabonate LE LE:34 lower extremity LE LE:6 luminal epithelial LE LE:31 luminal epithelium LE LE:307 lupus erythematosus LE LE:11|-LE:1 lymphedema LF/HF LF/HF:16 low frequencyhigh frequency LF/HF LF/HF:5 sympathovagal balance LFA-1 LFA-1:10 functionassociated ag LFA-1 LFA-1:13 function associated antigen LFA-1 LFA-1:11 functionassociated molecule LFA LFA:22 limax flavus LFA LFA:30 limax flavus agglutinin LFS LFS:72 leukemiafree survival LFS LFS:77 lifraumeni syndrome LF LF:1 fed either a lowfat LF LF:370|Lf:185 lactoferrin LF LF:12 laparoscopic fundoplication LF LF:12 laser fluorescence LF LF:10 lassa fever LF LF:12 lateral funiculus LF LF:13 lipofuscin LF LF:6 liver function LF LF:18 local failure LF LF:39 low fat LF LF:9 low flow LF LF:8 low frequency band LF LF:35 lymphatic filariasis LF LF:7 lymphoid follicles LGA LGA:11 left gastric artery LGA LGA:35 local government area LGE LGE:32 lateral ganglionic eminence LGE LGE:9 linear gingival erythema LGL LGL:17 large granular lymphocytic LGL LGL:3 patients with lowgrade lymphoma LGMD LGMD:8 giant movement detector LGMD LGMD:19 muscular dystrophies LGM LGM:16 last glacial maximum LGM LGM:11 lymphogranulomatosis LGS LGS:8|LG-S:3 lateral gastrocnemiussoleus LGS LGS:69 lennoxgastaut syndrome LGV LGV:10 large granular vesicles LGV LGV:12 left gastric vein LGV LGV:72 lymphogranuloma venereum LG LG:9 granules LG LG:22 lacrimal gland LG LG:10 lateral gastric LG LG:87 lateral gastrocnemius LG LG:17 lateral giant LG LG:41 linkage group LG LG:6 loop gain LH/CG LH/CG:13 luteinizing hormonechorionic gonadotropin LH/CG LH/CG:10 lutropinchoriogonadotropin LHCII LHCII:31|LHC-II:5 lightharvesting complex ii LHCII LHCII:13|LHC-II:4 lightharvesting complex of photosystem ii LHCII LHCII:6|LHC-II:2 major lightharvesting complex LHCP LHCP:14 lightharvesting chlorophyll abbinding protein LHCP LHCP:14 lightharvesting chlorophyll ab protein LHD LHD:14 left hemisphere damage LHD LHD:15 local health department LHON LHON:237 lebers hereditary optic neuropathy LHON LHON:10 leber hereditary optic neuroretinopathy LHRHa LHRHa:9 dtrppronetlhrh LHRHa LHRHa:3|LH-RH-a:3|LH-RH-A:2|LHRH-A:2|LH-RHa:1 luteinizing hormonereleasing hormone agonist LHRHa LHRHa:4|LH-RHa:2|LHRH-a:1|LHRHA:1 luteinizing hormonereleasing hormone analog LHR LHR:8 leukocyte histamine release LHR LHR:7 lungheart ratio LHS LHS:10 london handicap scale LHS LHS:11 lung health study LH LH:34 genetically hypertensive LH LH:7 genetically hypertensive rats LH LH:5 hypertensive rats of the lyon strain LH LH:20 laparoscopic hysterectomy LH LH:9 lateral hypothalamic nucleus LH LH:39 learned helplessness LH LH:11 lefthanded LH LH:17 lightharvesting LH LH:13 loop of henle LH LH:9 lung hypoplasia LH LH:32 lyon hypertensive LH LH:25 lysyl hydroxylase LIA LIA:11 inhibitory activity LIA LIA:25 line immunoassay LIFE LIFE:13 fluorescence endoscopy LIFE LIFE:13 longitudinal interval followup evaluation LIFE LIFE:12 losartan intervention for endpoint LIFE LIFE:12 losartan intervention for endpoint reduction LIFE LIFE:48 losartan intervention for endpoint reduction in hypertension LIFR LIFR:32|LIF-R:8 leukemia inhibitory factor receptor LIFR LIFR:29|LIF-R:3 lif receptor LIF LIF:271 laserinduced fluorescence LIF LIF:1040|lif:1 leukemia inhibitory factor LIF LIF:16 local intraarterial fibrinolysis LIMA LIMA:5 large intestinal mucin antigen LIMA LIMA:185 left internal mammary artery LINEs LINEs:19|LINES:2 long interspersed elements LINEs LINEs:15 long interspersed nuclear elements LIPC LIPC:9|Lipc:4 hepatic lipase LIPC LIPC:18 hepatic lipase gene LIPC LIPC:13 left inferior prefrontal cortex LIP LIP:29 labile iron pool LIP LIP:45 lateral intraparietal area LIP LIP:21 lower inflection point LIP LIP:30 lymphocytic interstitial pneumonitis LISS LISS:18 less invasive stabilization system LISS LISS:12 low ionic strength solution LITT LITT:70 laserinduced thermotherapy LITT LITT:5 laser interstitial thermal therapy LLC-PK1 LLC-PK1:9 cultured renal epithelial cells LLC-PK1 LLC-PK1:8 renal epithelial LLD LLD:5 languagelearning disabilities LLD LLD:7 latelife depression LLD LLD:13 leg length discrepancy LLD LLD:5 longlasting depression LLD LLD:14 lower limit of detection LLE LLE:22 largest lyapunov exponent LLE LLE:94 liquidliquid extraction LLO LLO:9 lipidlinked oligosaccharide LLO LLO:129 listeriolysin o L-LTP L-LTP:9 late phase of longterm potentiation L-LTP L-LTP:4 late phase of ltp LL LL:14 constant illumination LL LL:22 continuous illumination LL LL:8 continuous lighting LL LL:12 genetically lean LL LL:12 late luteal LL LL:17 lateral lemniscus LL LL:12 lateral longissimus LL LL:7 left lateral LL LL:10 leg length LL LL:83 lepromatous LL LL:99 lepromatous leprosy LL LL:11 lesion load LL LL:5|ll:1 lining layer LL LL:16 long latency LL LL:19 longissimus lumborum LL LL:24 lymphoid leukosis LL LL:11 lysolecithin LMAT LMAT:10 agarose test LMAT LMAT:5 leucocyte migration agarose technique LMA LMA:450 laryngeal mask airway LMA LMA:6 liver membrane antibodies LMA LMA:7 locomotor and motor activity LMA LMA:30 longissimus muscle area LMC LMC:37 lateral motor column LMC LMC:22 lymphocytemediated cytotoxicity LMG LMG:18 lethal midline granuloma LMG LMG:10 leucomalachite green LMI LMI:12 lateral medullary infarction LMI LMI:80 leukocyte migration inhibition LMI LMI:9 linear matrix inequality LMM LMM:46 lentigo maligna melanoma LMM LMM:58 light meromyosin LMPCR LMPCR:19|LM-PCR:8 ligationmediated pcr LMPCR LMPCR:23|LM-PCR:11 ligationmediated polymerase chain reaction LMP LMP:98 last menstrual period LMP LMP:117|lmp:1 low malignant potential LMP LMP:7 low molecular mass polypeptide LMS LMS:11 effect of levamisole LMS LMS:15 least mean square LMS LMS:9 leucomyosuppressin LMS LMS:10 linearized multistage LMT LMT:26 left main trunk LMT LMT:16 leucocyte migration test LM LM:11 lactose malabsorption LM LM:33 laryngeal mask LM LM:24 lean mass LM LM:57 left main LM LM:49 lentigo maligna LM LM:20 leptomeningeal metastases LM LM:16 leptomeningeal metastasis LM LM:10|L-M:1 levenbergmarquardt LM LM:72 light microscope LM LM:100 light microscopic LM LM:403 light microscopy LM LM:13 lipid microspheres LM LM:12 lipomannan LM LM:89|Lm:18 listeria monocytogenes LM LM:27 liver metastases LM LM:12 logical memory LM LM:40 longitudinal muscle LM LM:11 lymphatic mapping LM LM:7 pretectal nucleus lentiformis mesencephali LM LM:1 studied at the light L-NAME L-NAME:11 lnitroargininemethylester L-NAME L-NAME:46|l-NAME:2|L-Name:1 methyl ester hydrochloride L-NAME L-NAME:30 ngnitrolarginine methylester L-NAME L-NAME:10 nitric oxide synthase inhibitor L-NAME L-NAME:15|l-NAME:2 nitric oxide synthase inhibitor ngnitrolarginine methyl ester L-NAME L-NAME:11|l-NAME:1 nitric oxide synthase inhibitor n omeganitrolarginine methyl ester L-NAME L-NAME:5 synthase inhibitor ngnitrolarginine methylester LNA LNA:21|LnA:2 alphalinolenic acid L-NA L-NA:4|LNA:3|l-NA:1 inhibitor nomeganitrolarginine LNA LNA:7 latent nuclear antigen L-NA L-NA:12|LNA:2 nomeganitrolarginine LNCaP LNCaP:14|LnCaP:2|LNCap:1 androgendependent LNCaP LNCaP:9 androgensensitive LNCaP LNCaP:10 lymph node carcinoma of the prostate LND LND:13 leschnyhan disease LND LND:69 lonidamine L-NMMA L-NMMA:10 lnmonomethyl arginine L-NMMA L-NMMA:12|LNMMA:2 lngmonomethylarginine L-NMMA L-NMMA:11|LNMMA:1 ngmonomethyl larginine L-NMMA L-NMMA:7|l-NMMA:6 ngmonomethyllarginine acetate L-NMMA L-NMMA:6 ngmonomethyllarginine monoacetate L-NMMA L-NMMA:4|LNMMA:1 synthase inhibitor nmonomethyllarginine L-NNA L-NNA:4 nos inhibitor ngnitrolarginine L-NNA L-NNA:3|l-NNA:1 synthase inhibitor ngnitrolarginine LNS LNS:31 leschnyhan syndrome LNS LNS:10 lipid nanosphere LNT LNT:15 lentinan LNT LNT:13 linear nothreshold LN LN:9 laparoscopic nephrectomy LN LN:7 lead nitrate LN LN:11|L-N:2 leschnyhan LN LN:21 lingual nerve LN LN:14 lipoid nephrosis LN LN:148 lupus nephritis LN LN:10 lyon normotensive ln ln:8|Ln:2 natural log ln ln:11|Ln:2|LN:1 natural logarithm LOC LOC:18 lateral occipital complex LOC LOC:11 lateral olivocochlear LOD LOD:11 detection limits LOD LOD:10 laparoscopic ovarian drilling LOD LOD:86|lod:22|Lod:1 logarithm of odds LOOH LOOH:24 linoleic acid hydroperoxide LOOH LOOH:9|L-OOH:1 lipid peroxides LOP LOP:4|L-o-p:1|LoP:1 levels of processing LOP LOP:5 lipid ozonation products LOS LOS:10 lateonset schizophrenia LOS LOS:26 lipooligosaccharide LOS LOS:18|Los:15 losartan LOS LOS:20 low output syndrome LOS LOS:174 lower oesophageal sphincter LOT LOT:104 lateral olfactory tract LOT LOT:13 life orientation test LpA LpA:10 glomerular permeability coefficient LpA LpA:21 glomerular ultrafiltration coefficient LPA LPA:16 latex particle agglutination LPA LPA:45|lPA:1 left pulmonary artery LPA LPA:18 limulus polyphemus LPA LPA:16 limulus polyphemus agglutinin LPA LPA:20 linear polyacrylamide LPA LPA:14 lysophosphatidate LPC LPC:9|L-PC:1 lpropionylcarnitine LPC LPC:13 late positive complex LPC LPC:8 leukemic progenitor cell LPC LPC:38|L-PC:1 lysophosphatidyl choline LPD LPD:5 lag phase duration LPD LPD:9 lateral patellar displacement LPD LPD:40 leiomyomatosis peritonealis disseminata LPD LPD:13 luteal phase deficiency LPG LPG:158 lipophosphoglycan LPG LPG:17 lipoprotein glomerulopathy LPG LPG:27 liquefied petroleum gas LPHD LPHD:10 lymphocyte predominance hodgkins disease LPHD LPHD:10|LP-HD:1 lymphocyte predominant hodgkins disease LPH LPH:66|L-Ph:1 lactasephlorizin hydrolase LPH LPH:10 lipotropin L-PIA L-PIA:25|l-PIA:1 lnphenylisopropyladenosine L-PIA L-PIA:21|LPIA:2 lphenylisopropyladenosine LPI LPI:16 laser peripheral iridotomy LPI LPI:7 learning preference inventory LPI LPI:55 lysinuric protein intolerance LPL LPL:13 lipoprotein lipase gene LPL LPL:23 lymphoplasmacytic lymphoma LPL LPL:8 lymphoplasmacytoid lymphoma LPL LPL:14 lysophospholipase LPO LPO:12 lipid peroxidase LPO LPO:12 lipoperoxidation LPO LPO:48 lobus parolfactorius LPO LPO:6 peroxide oxidation LPP LPP:19 lateral perforant path LPP LPP:25 leak point pressure LPP LPP:11 lichen planus pemphigoides LPS LPS:190 bacterial lipopolysaccharides LPS LPS:6 bacterial products LPS LPS:10 endotoxinlipopolysaccharide LPS LPS:10|LP-s:2 lactoperoxidase system LPs LPs:40|LPS:2 late potentials LPS LPS:16 levator palpebrae superioris LPS LPS:24 lipolysaccharide LPS LPS:10 lipopolisaccharide LPS LPS:41 lipopolysaccaride LPS LPS:7 lipopolysaccharide from escherichia coli LPS LPS:27 lipopolysacharide LPs LPs:16 lumbar punctures LPS LPS:20 lypopolysaccharide LPV LPV:28|Lpv:1 lopinavir LPV LPV:12 lymphotropic papovavirus LPV LPV:6 monkey blymphotropic papovavirus LPN LPN:31 laparoscopic partial nephrectomy LPN LPN:11 lateral plantar nerve LPN LPN:8 licensed practical nurse LRC LRC:15 leukocyte receptor complex LRC LRC:39 lipid research clinics LRC LRC:5 locomotorrespiratory coupling LRC LRC:21 locoregional control LRE LRE:26|lre:1 lamina rara externa LRE LRE:9 leukemic reticuloendotheliosis LRE LRE:5 lightresponsive element LRE LRE:13 localizationrelated epilepsy LRI LRI:13|lri:1 lamina rara interna LRI LRI:22 lower respiratory illness LRP5 LRP5:12 ldl receptorrelated protein LRP5 LRP5:15 lowdensity lipoprotein receptorrelated protein LRP LRP:6 laminin receptor precursor LRP LRP:37 laparoscopic radical prostatectomy LRP LRP:11 late receptor potential LRP LRP:53 lateralized readiness potential LRP LRP:12 low density lipoprotein receptorrelated proteinalpha macroglobulin receptor LRR LRR:14 light reflection rheography LRR LRR:10 localregional recurrence LRR LRR:32 locoregional recurrence LRR LRR:22 loss of righting reflex LRT LRT:17 likelihood ratio test LRT LRT:29 lower respiratory tract LR LR:21 latencyrelated LR LR:27 lateral rectus LR LR:9 leukoregulin LR LR:10 light rough LR LR:11 linear regression LR LR:8 livedo reticularis LR LR:10 liver regeneration LR LR:13 liver resection LR LR:5 local relapse LR LR:65 logistic regression LR LR:12 low level of response LR LR:4 pcna labeling rate LSA LSA:8 latent semantic analysis LSA LSA:12 lateral septal area LSA LSA:11 left subclavian artery LSA LSA:6 lenticulostriate artery LSA LSA:66 lichen sclerosus et atrophicus LSA LSA:9 liverspecific antigen LSCM LSCM:25 laser scanning confocal microscope LSCM LSCM:78 laser scanning confocal microscopy LSD LSD:7 lumpy skin disease LSD LSD:264 lysergic acid diethylamide LSD LSD:16 lysergide LSE LSE:15 living skin equivalent LSE LSE:9 low selfesteem LSF LSF:33 line spread function LSF LSF:21 lisofylline LSI LSI:11 learning style inventory LSI LSI:10 light scattering intensity LSI LSI:16 liver somatic index LSM LSM:5 laser scanning microscope LSM LSM:13 laser scanning microscopy LSM LSM:15 limited sampling model LSN LSN:7|LSn:2|lsn:1 lateral spinal nucleus LSN LSN:12 low score normal LSN LSN:8 lumbar splanchnic nerve LSO LSO:34 lateral superior olivary nucleus LSO LSO:137 lateral superior olive LSO LSO:14 lutetium oxyorthosilicate lSSc lSSc:6|LSSc:1 limited cutaneous systemic sclerosis lSSc lSSc:6 limited ssc LSS LSS:10 laminar shear stress LSS LSS:5 life satisfaction scale LSS LSS:17 life span study LSS LSS:9 limbsparing surgery LSS LSS:24 lumbar spinal stenosis LST LST:13 lateral sinus thrombosis LST LST:30 leishmanin skin test LST LST:9 lifesustaining treatments LST LST:7 lumbar sympathetic trunk LSC LSC:32 laser scanning cytometer LSC LSC:88 laser scanning cytometry LSC LSC:13 least significant change LSC LSC:41 liquid scintillation counting LS LS:91 laparoscopic splenectomy LS LS:14 laparoscopic surgery LS LS:12 laparoscopy LS LS:24 laron syndrome LS LS:83 lateral septum LS LS:29 lateral suprasylvian LS LS:7 lateral suprasylvian area LS LS:14 lateral suprasylvian visual area LS LS:32 leigh syndrome LS LS:7 leukocyte scintigraphy LS LS:77|Ls:1 lichen sclerosus LS LS:11 lichen striatus LS LS:13 liquid scintillation LS LS:10 litter size LS LS:13 low salt LS LS:12|ls:1 lowspin LS LS:172 lumbar spine LS LS:13 lung surfactant LS LS:7 lymphocyte stimulation LS LS:28 lymphoscintigraphy LTA LTA:7 laser thermal ablation LTA LTA:6 laser trabecular ablation LTA LTA:8 latent transition analysis LTA LTA:22 lotus tetragonolobus LTA LTA:10 lotus tetragonolobus agglutinin LTB LTB:8|LT-B:2 escherichia coli heatlabile enterotoxin LTB LTB:5|LT-B:2 escherichia coli heatlabile enterotoxin b subunit LTF LTF:9|ltf:1 lactotransferrin LTF LTF:58 longterm facilitation LTM LTM:42 lean tissue mass LTM LTM:125 longterm memory LTM LTM:7 longterm monitoring LTM LTM:35 lowthreshold mechanoreceptive LTP LTP:19 laser trabeculoplasty LTP LTP:23 lipid transfer particle LTRA LTRA:10 leukotriene receptor antagonist LTRA LTRA:7 longterm repopulating ability LTR LTR:32 laryngotracheal reconstruction LTR LTR:9 longterm retention LTR LTR:14 lung transplant recipients LTS LTS:11 laryngotracheal stenosis LTS LTS:8 longterm survival LTS LTS:33 longterm survivors LTS LTS:23 lowthreshold spike LTV LTV:6 longterm variability LTV LTV:6 lung thermal volume LT LT:9 after lung transplantation LT LT:12 anthrax lethal toxin LT LT:16 cysteinylleukotrienes LT LT:23|lt:1 escherichia coli heatlabile toxin LT LT:10 heatlabile enterotoxin of escherichia coli LT LT:12 heat labile toxin LT LT:169 lactate threshold LT LT:10 lamina terminalis LT LT:21|lT:1 large t LT LT:9 large tumor antigen LT LT:11 laryngeal tube LT LT:8 latency time LT LT:12 light transmittance LT LT:10 lissauers tract LT LT:12|lt:1 longterm LT LT:11 longissimus thoracis LT LT:10 low temperature LT LT:36 lowthreshold LT LT:12 lunotriquetral LT LT:36 lymphocytic thyroiditis LT LT:13 lymphoid tissue luc luc:7|LUC:2 firefly luciferase gene luc luc:7|LUC:3 luciferase reporter gene LUS LUS:25 laparoscopic ultrasonography LUS LUS:23 laparoscopic ultrasound LUS LUS:10 lower uterine segment LVA LVA:37|LV-A:1 left ventricular aneurysm LVA LVA:4|LVa:1 left ventricular apex LVDd LVDd:5|LVDD:4 left ventricular diastolic diameter LVDd LVDd:7|LVDD:1 left ventricular enddiastolic diameter LVD LVD:8 left ventricular diameter LVD LVD:73 left ventricular dysfunction LVD LVD:8 lymphatic vessel density LVF LVF:42 left ventricular failure LVF LVF:74 left visual field LVF LVF:1 presented in either the left LVG LVG:10 left ventriculogram LVG LVG:81 left ventriculography LVI LVI:16 lymphatic vessel invasion LVI LVI:33 lymphovascular invasion LVMM LVMM:7 left ventricular muscle mass LVMM LVMM:8 left ventricular myocardial mass LVP LVP:10 large volume paracentesis LVP LVP:17 late ventricular potentials LVP LVP:20 levator veli palatini LVP LVP:26 lysinevasopressin LVSF LVSF:9 left ventricular shortening fraction LVSF LVSF:8 left ventricular systolic function LVSI LVSI:29 space invasion LVSI LVSI:21 space involvement LVSP LVSP:10 left ventricular systolic LVSP LVSP:112 left ventricular systolic pressure LVs LVs:11 left ventricles LVs LVs:8 lentiviral vectors LV LV:13 fluorouracil fuleucovorin LV LV:9 lassa virus LV LV:1181|lv:3 left ventricle LV LV:10 left ventricule LV LV:23 lelystad virus LV LV:7|Lv:6 lipovitellin LV LV:13 liquid ventilation LV LV:9 lupus vulgaris LW LW:29 large white LW LW:10 lateral wall LW LW:34|lw:2 live weight LY LY:187 lucifer yellow LY LY:23 lucifer yellow ch LB LB:105|L-B:7 langmuirblodgett LB LB:10 large bowel LB LB:13 live births LB LB:9 liver biopsy LB LB:6|Lb:2 low back LB LB:57 luriabertani LB LB:13 luria broth LB LB:71|Lb:1 lyme borreliosis LB LB:11 lymphoblastoid LCH LCH:10 leydig cell hypoplasia LCH LCH:9 lobular capillary hemangioma LDD LDD:28 lhermitteduclos disease LDD LDD:7 lowdose dobutamine LDD LDD:10 lowdose dopamine LEA LEA:11 lateral entorhinal area LEA LEA:5 loin eye area LEA LEA:20 longevans agouti LEA LEA:8 lumbar epidural anesthesia LIS LIS:38 laboratory information system LIS LIS:11|lis:2 lisinopril LIS LIS:14|LiS:1 lithium diiodosalicylate LIS LIS:16|LiS:4 lockedin syndrome LIS LIS:11|lis:1 low ionic strength LIS LIS:39 lung injury score LIS LIS:10 lymphocytic infiltration of the skin LI LI:774|Li:3 labeling index LI LI:11 lacunar infarcts LI LI:11 lacunar infarction LI LI:33 lamellar ichthyosis LI LI:163 latent inhibition LI LI:11 lowintensity LI LI:10 lymphocytic infiltration LO LO:8 leucine oxidation LO LO:24 linseed oil LpA-I LpA-I:4|LpAI:1 containing apo ai but not apo aii LpA-I LpA-I:2 containing apoai but no apoaii LpA-I LpA-I:4|LPA-I:1 containing only apo ai LpA-I LpA-I:6 containing only apoai LpA-I LpA-I:5|Lp-A-I:1|LP-A-I:1 lipoprotein ai LPM LPM:24 lateral plate mesoderm LPM LPM:10|-LPM:1 lateral pterygoid muscle Lp Lp:22|LP:1 hydraulic conductance Lp Lp:29 hydraulic permeability LP LP:10 insulin lispro LP LP:10 late proximal LP LP:6|Lp:1 latency period LP LP:14 latent period LP LP:21 lateral posterior LP LP:31 lateral posterior nucleus LP LP:15 lateral prostate LP LP:46 lateral pyloric LP LP:4|Lp:1 lateroposterior thalamic nucleus LP LP:11 leg press LP LP:5 legionella pneumonia Lp Lp:17|LP:7 legionella pneumophila LP LP:9 leukapheresis LP LP:38 leukocytic pyrogen LP LP:194|Lp:2 lichen planus LP LP:9 light peak LP LP:11 linear prediction LP LP:17 linear programming LP LP:28 link protein Lp Lp:11 lipophorin Lp Lp:3|LP:2 lipoprotein particles LP LP:16 long photoperiod Lp Lp:30 looptail LP LP:5 low passage LP LP:9 lowpressure LP LP:7 low protein diet LP LP:21 lumboperitoneal LP LP:21 luteal phase LP LP:19 lymphocyte predominance LP LP:14 lymphocyte predominant LP LP:33 lymphocyte proliferation LP LP:6 lymphocyte proliferative LP LP:11 lymphocytic predominance LP LP:12|Lp:1 nucleus lateralis posterior LP LP:7|Lp:6 serum lipoprotein Lp Lp:21 water permeability M(r) M(r):16 molecular masses M(r) M(r):69 relative molecular mass M1 M1:8 antagonists pirenzepine M1 M1:9 deacetyldiltiazem M1 M1:5 first transmembrane domain M1 M1:13 metastatic M1 M1:7 metastatic disease M1 M1:9|M-1:1 middle cerebral artery M1 M1:7 mouse myeloid leukemia M1 M1:21 mouse myeloid leukemia cells M2 M2:5 guineapig atria M2 M2:7 muscarinic receptors M2 M2:8 second molar M2 M2:7 transmembrane segment M6G M6G:9 morphinebetadglucuronide M6G M6G:3 morphine and morphinebetaglucuronide MAAs MAAs:19 melanomaassociated antigens MAAs MAAs:19 mycosporinelike amino acids MAA MAA:12 methylaminoantipyrine MAA MAA:19 maackia amurensis MAA MAA:65|maa:1 macroaggregated albumin MAA MAA:6 marketing authorization application MAA MAA:59 methacrylic acid MAA MAA:13 minimum audible angle MAA MAA:6 mitral annular area MAB MAB:29 maximal androgen blockade MAB MAB:12 maximum androgen blockade MAB MAB:22 mesenteric arterial bed MAB MAB:15 nmethylaminoazobenzene MACS MACS:23 cell sorter MACS MACS:18 magnetic cell separation MACs MACs:7 malignancyassociated changes MACs MACs:10 mammalian artificial chromosomes MACs MACs:9 microfloraassociated characteristics mACh mACh:32|m-ACh:2|mAch:2|M-ACh:1 muscarinic acetylcholine mACh mACh:8|M-Ach:2 muscarinic cholinergic MAC MAC:7 aerobic capacity MAC MAC:11 anesthetic requirement MAC MAC:20 macandrew alcoholism scale MAC MAC:8 malignancy associated changes MAC MAC:12 maximum allowable concentrations MAC MAC:9 maximum allowable cost MAC MAC:30 mental adjustment to cancer MAC MAC:43 microcystic adnexal carcinoma MAC MAC:16 midarm circumference MAC MAC:9 minimal auditory capabilities MAC MAC:135 minimum alveolar anesthetic concentration MAC MAC:37 mitral annular calcification MAC MAC:7 mitral annular calcium MAC MAC:19 mitral annulus calcification MAC MAC:9 mitral anular calcium MAC MAC:23 monitored anesthesia care MAC MAC:10 mycobacterium avium MAC MAC:698 mycobacterium avium complex MAC MAC:8 mycobacterium aviumintracellulare MADRS MADRS:45 montgomery and asberg depression rating scale MADRS MADRS:178 montgomeryasberg depression rating scale MAD MAD:7 absolute deviation MAD MAD:6 major affective disorder MAD MAD:7 mandibular advancement device MAD MAD:9 mandibuloacral dysplasia MAD MAD:4 maximum acceptable dose MAD MAD:61 multiwavelength anomalous diffraction MAD MAD:9 myoadenylate deaminase MAE MAE:52 microwaveassisted extraction MAE MAE:70 motion aftereffect MAE MAE:7 myoclonicastatic epilepsy MAF MAF:90 macrophageactivating factor MAF MAF:6|Maf:2|maf:1 mafosfamide MAGE MAGE:8 mean amplitude of glycemic excursions MAGE MAGE:13 melanoma antigen MAGE MAGE:6 melanoma antigen gene MAI MAI:56 mitotic activity index MAI MAI:12 movement assessment of infants MAI MAI:8 multidimensional anger inventory MAI MAI:7 mycobacterium aviumintracellulare complex MAIDS MAIDS:5 immunodeficiency disease MAIDS MAIDS:58 murine acquired immunodeficiency syndrome MAIDS MAIDS:5 retrovirusinduced immunodeficiency MAL MAL:13 medullary thick ascending limb MAL MAL:14 motor activity log MAL MAL:6 myelin and lymphocyte protein MAM MAM:150 methylazoxymethanol MAM MAM:12 mitral annulus motion MAM MAM:10 mycoplasma arthritidis mitogen MAO-A MAO-A:21|maoA:2 monoamine oxidase MAO-A MAO-A:58|MAOA:4|Mao-a:1 monoamine oxidasea MAO MAO:38 medial accessory olive MAO MAO:24 monoamine oxidase activity MAO MAO:15 monoamineoxidase MAO MAO:13 monoaminoxidase MAPs MAPs:13 mean arterial pressures MAPs MAPs:94 monophasic action potentials MAPs MAPs:14 multiple antigen peptides MAPs MAPs:13 multiple antigenic peptides MAP MAP:20 magnesium ammonium phosphate MAP MAP:9|map:2 maprotiline MAP MAP:65 maximum a posteriori MAP MAP:12 maximum a posteriori probability MAP MAP:31 mean arterial MAP MAP:21 mean arterial bp MAP MAP:2766|Map:4 mitogenactivated protein MAP MAP:33 modified atmosphere packaging MAP MAP:9|Map:1 mycobacterium avium subsp paratuberculosis MAP MAP:11|Map:4 mycobacterium avium subspecies paratuberculosis MAP MAP:8 repeated administration of methamphetamine MAR MAR:14 matrix association region MAR MAR:8 mean adequacy ratio MAR MAR:20 melanomaassociated retinopathy MAR MAR:12 microautoradiography MAR MAR:72 mineral apposition rate MAR MAR:25 missing at random MAR MAR:47 mixed antiglobulin reaction mar mar:9 monoclonal antibodyresistant mar mar:28|MAR:14|Mar:12 multiple antibiotic resistance MAR MAR:7 multivariate autoregressive MAST MAST:7 medical antishock trousers MAST MAST:113 michigan alcoholism screening test MAST MAST:8 military antishock trousers MAST MAST:11 motion artifact suppression technique MAS MAS:10 exogenous metabolic activation system MAS MAS:4 german multicentre allergy study MAS MAS:15 mandibular advancement splint MAS MAS:26 manifest anxiety scale MAS MAS:10 maximal aerobic speed MAS MAS:62 mccunealbright syndrome MAS MAS:138 meconium aspiration syndrome MAS MAS:26 minimal access surgery MAS MAS:34 modified ashworth scale MAS MAS:21 motor assessment scale MAS MAS:13 mycoplasma arthritidis MAS MAS:6 mycoplasma arthritidisderived superantigen MAT MAT:42 mean absorption time MAT MAT:72 methionine adenosyltransferase MAT MAT:134 microscopic agglutination test MAT MAT:19 multifocal atrial tachycardia MAV MAV:6 maximal aerobic velocity MAV MAV:10 myeloblastosisassociated virus MA MA:11 dmethamphetamine MA MA:10 macular amyloidosis MA MA:18 maleic anhydride MA MA:45 mandelic acid MA MA:7|ma:5 maximal amplitude MA MA:38|ma:5|mA:1 maximum amplitude MA MA:8 mean acceleration MA MA:106 megestrol acetate MA MA:12 meglumine antimoniate MA MA:11 meningioangiomatosis MA MA:32 mental age MA MA:31 mental arithmetic MA MA:9 mesaconitine MA MA:19 metabolic acidosis MA MA:6 metastatic adenocarcinoma MA MA:15 methyl acrylate MA MA:28 methylamine MA MA:46 microagglutination MA MA:5 microbiological assay MA MA:20 microscopic agglutination MA MA:11 middleaged MA MA:64 migraine with aura MA MA:13 mitotic activity MA MA:23 mitotic apparatus MA MA:19 mitral annulus MA MA:12 monoamine MA MA:11 monoaminergic MA MA:51 motor activity MA MA:2 weeks menstrual age MBC MBC:24 carbendazim MBC MBC:37 maximal binding capacity MBC MBC:26 maximum binding capacity MBC MBC:218|mbc:3 metastatic breast cancer MBC MBC:8 methyl benzimidazolyl carbamate MBD MBD:20 marchiafavabignami disease MBD MBD:8 metabolic bone disease MBD MBD:27 methylcpg binding domain MBD MBD:50 minimal brain dysfunction MBF MBF:8 bite force MBF MBF:377 myocardial blood flow MBG MBG:21 marinobufagenin MBG MBG:24 mean blood glucose MBG MBG:17 myocardial blush grade MBH MBH:11 medial basal hypothalami MBH MBH:41 medial basal hypothalamic MBH MBH:300|mbh:1 medial basal hypothalamus MBH MBH:14 mediobasal hypothalami MBH MBH:23 mediobasal hypothalamic MBH MBH:182 mediobasal hypothalamus MBI MBI:59 maslach burnout inventory MBI MBI:26 modified barthel index MBL MBL:65 menstrual blood loss MBL MBL:9 metallobetalactamase MBP MBP:11|mBP:2 mononbutyl phthalate MBP MBP:8|mBP:1 monobutyl phthalate MBP MBP:6|Mbp:1 myelin basic protein gene MBP MBP:5 myosinbound phosphatase MBRs MBRs:12 membrane bioreactors MBRs MBRs:6 mitochondrial benzodiazepine receptors MBR MBR:34|mbr:29|Mbr:4 major breakpoint region MBR MBR:17 medical birth registry MBR MBR:64 membrane bioreactor MBR MBR:9 mitochondrial benzodiazepine receptor mBSA mBSA:54|MBSA:29|M-BSA:2|m-BSA:2 methylated bovine serum albumin mBSA mBSA:4|MBSA:2 methylated bsa MBT-2 MBT-2:5|MBT2:3 bladder cancer cell line MBT-2 MBT-2:6|MBT2:2 transitional cell carcinoma MBV MBV:14 mean blood velocity MBV MBV:9 mitral balloon valvotomy MBV MBV:10 monodon baculovirus MBS MBS:6 mmaleimidobenzoic acid nhydroxysuccinimide ester MBS MBS:9 mmaleimidobenzoylnhydroxysuccinimide ester MBs MBs:53 mallory bodies MBS MBS:14 martinbell syndrome MBs MBs:21 medulloblastomas MBS MBS:13 modified barium swallow MBs MBs:29|mbs:1 mushroom bodies MBS MBS:21 myosinbinding subunit MBS MBS:14 sodium metabisulfite MBS MBS:8 sodium metabisulphite MCAO MCAO:650|MCAo:112|MCA-O:7 middle cerebral artery occlusion MCAO MCAO:4|MCAo:1 occlusion of middle cerebral artery MCAT MCAT:62 medical college admission test MCAT MCAT:11 transacylase MCA MCA:13 carcinoma associated antigen MCA MCA:28 metabolic control analysis MCA MCA:7 microcytotoxicity assay MCA MCA:43 middle cerebral MCA MCA:12 middle cerebral arterial MCA MCA:19 minimal crosssectional area MCA MCA:12 monochloroacetate MCA MCA:21 monochloroacetic acid MCA MCA:13 monocyte chemotactic activity MCA MCA:33 mucinlike carcinomaassociated antigen MCA MCA:37 multiple congenital anomalies MCA MCA:15 multiple correspondence analysis MCB MCB:8 cell cycle box MCB MCB:9 microcirculatory bed MCB MCB:15 monochlorobenzene MCB MCB:21 monochlorobimane MCC MCC:10 methylcrotonylcoa carboxylase MCC MCC:17 mandibular condylar cartilage MCC MCC:11 maternal cell contamination MCC MCC:7 meningococcal c conjugate MCC MCC:9 meningococcal serogroup c conjugate MCC MCC:14 metacerebral cell MCC MCC:133 microcrystalline cellulose MCC MCC:4 minimum cidal concentration MCC MCC:6 moth cytochrome c MCC MCC:5 multiple conductance channel MCD MCD:30 macular corneal dystrophy MCD MCD:180 magnetic circular dichroism MCD MCD:23 malonylcoa decarboxylase MCD MCD:22 mast cell degranulating MCD MCD:6|mCd:1 mast cell density MCD MCD:6 mean consecutive difference MCD MCD:26 medullary collecting duct MCD MCD:87 minimal change disease MCD MCD:75 multicentric castlemans disease MCD MCD:10 multiple carboxylase deficiency MCE MCE:8 malathion carboxylesterase MCE MCE:6 microchip electrophoresis MCE MCE:228 myocardial contrast echocardiography MCF-7 MCF-7:16|MCF7:4 breast adenocarcinoma MCF-7 MCF-7:16 estrogendependent MCF-7 MCF-7:42|MCF7:6 human breast cancer cell line MCF-7 MCF-7:14|MCF7:2 human breast carcinoma cells MCF-7 MCF-7:12 human breast carcinoma cell line MCF-7 MCF-7:5|MCF7:1 human mammary carcinoma cells MCF-7 MCF-7:5|MCF7:1 human mammary carcinoma cell line MCF MCF:16 macrophage chemotactic factor MCF MCF:81 malignant catarrhal fever MCF MCF:18 mean channel fluorescence MCF MCF:11 middle cranial fossa MCF MCF:43 mink cell focusforming MCF MCF:49 mink cell focusinducing MCF MCF:10 mitochondrial carrier family MCF MCF:5 monocyte cytotoxic factors MCF MCF:20 mononuclear cell factor MCF MCF:11 myocardial contractile force MCGN MCGN:34 mesangiocapillary glomerulonephritis MCGN MCGN:9 mesangiocapillary gn MCI MCI:5 mandibular cortical index MCI MCI:5 mass casualty incident MCI MCI:4|mCI:1 metacarpal cortical index MCI MCI:25 metacarpal index MCI MCI:380 mild cognitive impairment MCLs MCLs:15 magnetite cationic liposomes MCLs MCLs:26 mantle cell lymphomas MCLs MCLs:17 medial collateral ligaments MCL MCL:19 comfortable loudness MCL MCL:11 mast cell leukemia MCL MCL:25 maximum contaminant level MCL MCL:9|mcl:4 mediumchainlength MCL MCL:8|mcl:1 mitral cell layer MCL MCL:23 mucocutaneous leishmaniasis MCL MCL:6 myocardial chord length MCM MCM:76|Mcm:23|mcm:1 minichromosome maintenance MCM MCM:14 monocyteconditioned medium MCM MCM:12 mucous cell metaplasia MCNs MCNs:10 magnocellular neurons MCNS MCNS:184 minimal change nephrotic syndrome MCNs MCNs:11 mucinous cystic neoplasms MCNS MCNS:10 patients with minimalchange nephrotic syndrome MCNU MCNU:10 methyl chloroethylnitrosoureidodeoxyalphadglucopyranoside MCNU MCNU:21 ranimustine MCN MCN:6 main cuneate nucleus MCN MCN:35 minimal change nephropathy MCN MCN:6 musculocutaneous nerve MCO MCO:72 managed care organization MCO MCO:27 metalcatalyzed oxidation MCP-1 MCP-1:29 monocyte chemotactic peptide MCP-1 MCP-1:20 monocyte chemotactic protein MCP-1 MCP-1:81|MCP1:1 monocyte chemotactic protein MCPG MCPG:5 antagonist rsalphamethylcarboxyphenylglycine MCPG MCPG:5 mglur antagonist alphamethylcarboxyphenylglycine MCPG MCPG:5 mglur antagonist rsalphamethylcarboxyphenylglycine MCPG MCPG:4 receptor antagonist alphamethylcarboxyphenylglycine MCPG MCPG:12 salphamethylcarboxyphenylglycine mCPP mCPP:7|m-CPP:5|MCPP:2 metachlorophenylpiperazine mCPP mCPP:3|m-CPP:1 receptor agonist chlorophenylpiperazine mCPP mCPP:8|m-CPP:7|MCPP:3 receptor agonist mchlorophenylpiperazine MCP MCP:11 mean circulatory pressure MCP MCP:6 medial coronoid process MCP MCP:20 methylclofenapate MCP MCP:6 microchannel plate MCP MCP:13 monocrotophos MCP MCP:9 multicatalytic protease MCP MCP:35 multicatalytic proteinase MCP MCP:7 multifocal choroiditis and panuveitis MCRs MCRs:11|MC-Rs:4 melanocortin receptors MCRs MCRs:10 metabolic clearance rates MCR MCR:13 macromomycin MCR MCR:5 major cytogenetic remission MCR MCR:10|Mcr:1 major cytogenetic response MCR MCR:19 methylcoenzyme m reductase MCR MCR:29 micronomicin MCR MCR:19 mineralocorticoid receptor MCR MCR:5 multicomponent reaction MCR MCR:9 multivariate curve resolution MCT1 MCT1:10|MCT-1:1 monocarboxylate transporter MCT1 MCT1:24|MCT-1:1 monocarboxylate transporter MCTs MCTs:13 mediumchain triacylglycerols MCTs MCTs:38 mediumchain triglycerides MCTs MCTs:30 monocarboxylate transporters MCT MCT:11 cell tumor MCT MCT:13 injection of monocrotaline MCT MCT:9 mast cell tryptase MCT MCT:13 mean circulation time MCT MCT:13 medullary carcinoma of the thyroid gland MCT MCT:15 medullary thyroid carcinoma MCT MCT:7 metacontrast technique MCT MCT:6|mCT:2 microcomputed tomography MCT MCT:57 microwave coagulation therapy MCT MCT:16 monocarboxylic acid transporter MCT MCT:6 motor conduction time MCT MCT:24 mucociliary transport MCU MCU:14 micturating cystourethrogram MCU MCU:22 micturating cystourethrography MCV MCV:147 mean cell volume MCV MCV:10 measlescontaining vaccine MCV MCV:10 melanoma cell vaccine MCV MCV:13 middle cardiac vein MCV MCV:60 molluscum contagiosum virus MCh MCh:10|Mch:1 acetylbetamethylcholine MCh MCh:3|Mch:2 intrafemoral artery infusions of the endotheliumdependent vasodilator methacholine chloride MCH MCH:169 maternal and child health MCH MCH:9 mean corpuscular hb MCH MCH:327 melaninconcentrating hormone MCH MCH:9 muscle contraction headache MC MC:30 magnetic coil MC MC:32|Mc:1|mc:1 magnocellular MC MC:14 managed care MC MC:7 marlowecrowne social desirability scale MC MC:6 matched control MC MC:8|Mc:2 melanocytes MC MC:17 meningeal carcinomatosis MC MC:9 menstrual cycle MC MC:112 mesangial cell MC MC:21|mc:1 methyl cellulose MC MC:61|Mc:1|mc:1 methylcellulose MC MC:9 microcirculation MC MC:8 microscopic colitis MC MC:9 minnesota code MC MC:9 mitotic count MC MC:74 mixed cellularity MC MC:11 mixed chimaerism MC MC:45 mixed chimerism MC MC:25 mixed cryoglobulinaemia MC MC:85 mixed cryoglobulinemia MC MC:17|mc:1 moisture content MC MC:34 molluscum contagiosum MC MC:38|Mc:1 monochorionic MC MC:17 monocomponent MC MC:188 monte carlo MC MC:14|m-c:1 musculocutaneous MC MC:12 myocardial contractility MC MC:9 myocarditis MC MC:12 myotonia congenita MDA-LDL MDA-LDL:11 lowdensity lipoprotein MDA-LDL MDA-LDL:15 malondialdehydemodified ldl MDAS MDAS:11 memorial delirium assessment scale MDAS MDAS:8 modified dental anxiety scale MDA MDA:32 methylenedianiline MDA MDA:17 malondiadehyde MDA MDA:3388|mda:1 malondialdehyde MDA MDA:17 malonedialdehyde MDA MDA:111 malonic dialdehyde MDA MDA:10 malonildialdehyde MDA MDA:55 malonyl dialdehyde MDA MDA:215 malonyldialdehyde MDA MDA:26 mass drug administration MDA MDA:17 medical devices agency MDA MDA:21 minimal deviation adenocarcinoma MDA MDA:10 minimum detectable activity MDA MDA:19 multiple displacement amplification MDA MDA:8 multivariate discriminant analysis MDBK MDBK:9 bovine kidney cell line MDBK MDBK:69 madindarby bovine kidney MDCK MDCK:9 canine kidney epithelial cells MDCK MDCK:5 cultured renal epithelial MDCK MDCK:1054|MDCk:1 madindarby canine kidney MDCK MDCK:32 madindarby canine kidney cells MDCT MDCT:16|mDCT:1 immortalized mouse distal convoluted tubule MDCT MDCT:16 multidetector row ct MDCT MDCT:64|MD-CT:2 multidetector ct MDC MDC:12 minimum detectable concentration MDC MDC:26 monodansylcadaverine MDC MDC:12|mDC:7 myeloid dc MDF MDF:10 membrane differential filtration MDF MDF:9 multiple daily fractionation MDF MDF:63 myocardial depressant factor MDI MDI:16 diphenylmethanediisocyanate MDI MDI:41 diphenylmethane diisocyanate MDI MDI:10 isocyanate MDI MDI:11 major depression inventory MDI MDI:52 mental development index MDI MDI:44 mental developmental index MDI MDI:11 modulation detection interference MDL MDL:26 method detection limit MDL MDL:25 minimum description length MDM2 MDM2:12|mdm-2:3|Mdm2:3|MDM-2:2|mdm2:2 double minute MDM2 MDM2:8|mdm2:3|Mdm2:2|MDM-2:1 mouse double minute MDM2 MDM2:23|Mdm2:8|mdm2:4|MDM-2:1|mdm-2:1 murine double minute MDP MDP:10 dihydrogen phosphate MDP MDP:13 major duodenal papilla MDP MDP:7 manicdepressive psychosis MDP MDP:50 maximum diastolic potential MDP MDP:8|mdp:1 minimal distending pressure MDP MDP:54 muramyldipeptide MDR-TB MDR-TB:17|MDRTB:3 multidrugresistant tb MDR-TB MDR-TB:125|MDRTB:17|MDR-Tb:1|MDRTb:1 multidrugresistant tuberculosis MDR MDR:5 dbi receptor MDR MDR:8|mdr:1 macrophage disappearance reaction MDR MDR:7 medium dose rate MDR MDR:8 multidrug resistance phenotype MDR MDR:6 multifactor dimensionality reduction MDS-HC MDS-HC:11 minimum data set for home care MDS-HC MDS-HC:7 minimum data sethome care MDT MDT:32 mean dissolution time MDT MDT:7 mirror drawing test MDT MDT:16 multidisciplinary team MDT MDT:6 multidrug treatment MDS MDS:29 microdialysis system MDS MDS:159 minimum data set MDS MDS:130 multidimensional scaling MDS MDS:21 myelodysplastic MDS MDS:21 patients with myelodysplasia MD MD:70 macula densa MD MD:11 maintenance dose MD MD:5 major depressive disorder MD MD:250|md:1 mareks disease MD MD:13 maternal deprivation MD MD:42 mean defect MD MD:124 mean deviation MD MD:31|Md:1 meckels diverticulum MD MD:10 medial dorsal MD MD:10 medialis dorsalis MD MD:52 mediodorsal MD MD:33 mediodorsal nucleus of the thalamus MD MD:39 mediodorsal thalamic nucleus MD MD:10 mediodorsal thalamus MD MD:9 methyldopa MD MD:19 microdensitometry MD MD:46|mD:1 microdialysis MD MD:9|md:1 mixed dementia MD MD:6 moderate disability MD MD:8|md:1 moderately differentiated MD MD:13 molecular dynamics simulations MD MD:54 monocular deprivation MD MD:20 monocularly deprived MD MD:11 motiondefined MD MD:8 movement disorders md md:5|MD:4 multiple dendritic md md:6 myelin deficiency MD MD:18 patients with menieres disease MD MD:19 thalamic mediodorsal nucleus MEA MEA:7 lhrh release from explants of the median eminence area MEA MEA:7 malt extract agar MEA MEA:10 mean electrical axis MEA MEA:15 medial entorhinal area MEA MEA:10 mercaptoethylamine MEA MEA:10 microelectrode array MEA MEA:12 microwave endometrial ablation MEA MEA:18 monoethanolamine MEA MEA:18 multiple endocrine adenomatosis MED MED:9 male erectile dysfunction MED MED:12|Med:2 medetomidine MED MED:16 medical entities dictionary MED MED:25 minimal effective dose MED MED:61 multiple epiphyseal dysplasia MEE MEE:9 medial edge epithelia MEE MEE:17 medial edge epithelial MEE MEE:20 medial edge epithelium MEF50 MEF50:4 expiratory flow at of fvc MEF50 MEF50:4 expiratory flow at of vital capacity MEFV MEFV:36 flow volume MEFV MEFV:37 maximal expiratory flowvolume MEFs MEFs:165|mEFs:4 mouse embryonic fibroblasts MEFs MEFs:35 murine embryonic fibroblasts MEF MEF:74 middle ear fluid MEF MEF:8 migration enhancement factor MEGX MEGX:11 monoethylglycine xylidide MEGX MEGX:9 monoethylglycinexylide MEGX MEGX:138|MEG-X:2 monoethylglycinexylidide MEG MEG:155 magnetoencephalographic MEG MEG:570 magnetoencephalography MEG MEG:27 mercaptoethylguanidine MEI MEI:5 medicare economic index MEI MEI:19 metabolizable energy intake MEKC MEKC:21 micellar electrokinetic chromatographic MEKC MEKC:307 micellar electrokinetic chromatography MEKK1 MEKK1:11|MEKK-1:2 kinase kinase MEKK1 MEKK1:7|MEKK-1:2 mitogenactivated protein kinase kinase kinase MEMS MEMS:36 medication event monitoring system MEMS MEMS:26|MEMs:1 microelectromechanical systems MEM MEM:45 macrophage electrophoretic mobility MEM MEM:37 maximum entropy method MEM MEM:110 minimal essential medium MEM MEM:10 mitochondrial encephalomyopathy MENT MENT:13 alphamethylnortestosterone MENT MENT:10 alphamethylnortestosterone MEN MEN:29 mitotic exit network MEN MEN:365|Men:1 multiple endocrine neoplasia MEN MEN:9 multiple endocrine neoplasia syndrome MEPM MEPM:7 mouse embryo palate mesenchyme MEPM MEPM:18 murine embryonic palate mesenchymal MEP MEP:21 cmethylderythritol phosphate MEP MEP:22 major excreted protein MEP MEP:10|Mep:1 mepyramine MEP MEP:14 methylerythritol phosphate MEP MEP:11|ME-P:1 middle ear pressure MEP MEP:48 molecular electrostatic potential MEP MEP:6|mEP:2 monoethyl phthalate MEP MEP:20 multiple exposure photography MERRF MERRF:4 epilepsy and raggedred fiber MERRF MERRF:14 epilepsy with ragged red fibers MERRF MERRF:18 myoclonic epilepsy with raggedred fibers MERRF MERRF:10 myoclonus epilepsy and raggedred fibers MERRF MERRF:4 myoclonus epilepsy and raggedred fibres MERRF MERRF:19 myoclonus epilepsy associated with raggedred fibers MESA MESA:10 erythrocyte surface antigen MESA MESA:9 marshfield epidemiologic study area MESA MESA:49|mesa:1 microsurgical epididymal sperm aspiration MESA MESA:9 multiethnic study of atherosclerosis MESA MESA:14 myoepithelial sialadenitis MEST MEST:9 maximal electroshock seizure threshold MEST MEST:21 mouse ear swelling test MES MES:8|Mes:5 nmorpholinoethanesulfonic acid MES MES:6 maximal electrical stimulation MES MES:6 maximal electroconvulsive shock MES MES:170 maximal electroshock MES MES:13 maximal electroshockinduced seizures MES MES:9 melancholia scale MES MES:8|mes:2 mesencephalon MES MES:7|mes:5|Mes:1 mesenteric MES MES:90 microembolic signals MES MES:12 myoelectric signal MET MET:12|Met:4 cmethionine MET MET:4 cochlear mechanoelectric transduction MET MET:7|Met:4 dlmethionine MET MET:13 mechanoelectrical transduction MET MET:21 medical emergency team MET MET:6 melbourne edge test MET MET:16|Met:6 metformin Met Met:188|MET:43|met:9 methionine Met Met:14|MET:1 methoprenetolerant MET MET:10|Met:6 metoprolol MET MET:13 metyrapone MET MET:23 motivational enhancement therapy ME ME:29 methoxyethanol ME ME:12 macular edema ME ME:17 magnitude estimation ME ME:189|me:5 malic enzyme ME ME:8 maximum entropy ME ME:13 mccollough effect ME ME:25 mechanical efficiency ME ME:581 median eminence ME ME:20 medical examiner ME ME:57 metabolisable energy ME ME:10 methanolic extract ME ME:106 middle ear ME ME:11 minimum evolution ME ME:5 moderate exercise ME ME:18 mouse embryo ME ME:20 myalgic encephalomyelitis ME ME:10 myoelectric ME ME:12 myoepithelial MFA MFA:18 metabolic flux analysis MFA MFA:11 musculoskeletal function assessment MFCV MFCV:42 muscle fiber conduction velocity MFCV MFCV:13 muscle fibre conduction velocity MFC MFC:10 fungicidal concentrations MFC MFC:31|mfc:1 medial frontal cortex MFC MFC:9 microbial fuel cell MFD MFD:17 mandibulofacial dysostosis MFD MFD:21 multiple fractions per day MFD MFD:19 mutation frequency decline mfERG mfERG:25|MF-ERG:2|mfERg:1|mf-ERG:1|MFERG:1 multifocal electroretinography mfERG mfERG:12|mf-ERG:2|MF-ERG:2|MFERG:1 multifocal erg M-FISH M-FISH:9|mFISH:6|MFISH:1 multicolor fish M-FISH M-FISH:10 multiplexfish MFI MFI:14 mean fluorescence index MFI MFI:156|mfi:2 mean fluorescence intensity MFI MFI:6 myofibrillar fragmentation index MFM MFM:9 maternalfetal medicine MFM MFM:10 myofibrillar myopathy MFO MFO:5 mixedfunction monooxygenase MFO MFO:11 mixed function oxidase system MFP MFP:15 membrane fusion protein MFP MFP:10 myofascial pain MFR MFR:12 maximum flow rate MFR MFR:11 myocardial flow reserve MFs MFs:10 actin microfilaments MFs MFs:71 magnetic fields MFS MFS:51 major facilitator superfamily MFS MFS:111|MfS:3 marfan syndrome MFS MFS:23 medicare fee schedule MFS MFS:31 metastasisfree survival MFS MFS:5|mFS:4 midwall fractional shortening MFS MFS:76 miller fisher syndrome MFs MFs:14 mossy fibers MFS MFS:12 mossy fiber sprouting MFs MFs:26|Mfs:13|MFS:1 mutant frequencies MFT MFT:19 family therapy MFT MFT:13 magnetic field tomography MGA MGA:8 medial giant axon MGA MGA:84 melengestrol acetate MGC MGC:22 macroglomerular complex MGC MGC:5 mucinous gastric carcinoma MGDG MGDG:11 monogalactosyl diacylglycerol MGDG MGDG:55 monogalactosyldiacylglycerol MGD MGD:17 mean glandular dose MGD MGD:24 meibomian gland dysfunction MGD MGD:24 mixed gonadal dysgenesis MGD MGD:10 molybdopterin guanine dinucleotide MGD MGD:28 mouse genome database MGD MGD:13 multiglandular disease MGD MGD:15 nmethyldglucamine dithiocarbamate MGL MGL:8 mean gray level MGL MGL:7 monoglyceride lipase MGN MGN:151|mGn:1|mGN:1 membranous glomerulonephritis MGN MGN:14 membranous glomerulonephropathy MGN MGN:12 membranous glomerulopathy MGN MGN:17 membranous gn MGP MGP:18 manufactured gas plant MGP MGP:115|Mgp:1 matrix gla protein MGP MGP:8 mucous glycoprotein MGS MGS:5 grading system MGS MGS:6|mgs:1 methylglyoxal synthase MGS MGS:5 morning glory syndrome MG MG:47 malachite green MG MG:21 mammary gland MG MG:9 matrigel MG MG:6 mean gradient MG MG:281 medial gastrocnemius MG MG:15 medial gastrocnemius muscle MG MG:10 medial geniculate MG MG:13 meningeal gliomatosis MG MG:108 methylglyoxal MG MG:55 methylguanidine MG MG:9 microgravity MG MG:20 molten globule MG MG:1353 myasthenia gravis MG MG:198|Mg:5 mycoplasma gallisepticum MG MG:8 serum myoglobin MHA MHA:15 mayhegglin anomaly MHA MHA:9 methylhippuric acid MHA MHA:17 muellerhinton agar MHC-I MHC-I:15|MHCI:1 class i major histocompatibility complex MHC-I MHC-I:75|MHCI:6 major histocompatibility complex class i MHC-I MHC-I:6 major histocompatibility complex class i molecules MHC MHC:10 class i and class ii major histocompatibility MHC MHC:9 major histocompatability MHC MHC:17 major histocompatibility class MHC MHC:9 major histocompatibility complex antigens MHC MHC:8 major histocompatibility complex molecules MHC MHC:10 myosin heavy MHD MHD:20 magnetohydrodynamic MHD MHD:10 maintenance haemodialysis MHD MHD:60 maintenance hemodialysis MHE MHE:9 mh equivocal MHE MHE:11|mHE:3 minimal hepatic encephalopathy MHI MHI:10 malignant histiocytosis of the intestine MHI MHI:7 mental health index MHI MHI:22 mental health inventory MHN MHN:5 mh negative MHN MHN:15 nonsusceptible MHPG MHPG:16 methoxyhydroxyphenethyleneglycol MHPG MHPG:27 methoxyhydroxyphenyl glycol MHS MHS:6 major histocompatibility system MHS MHS:23 malignant hyperthermia susceptibility MHS MHS:6 mh susceptibility MHS MHS:20 milan hypertensive MHS MHS:10 milan hypertensive rats MHS MHS:32 milan hypertensive strain MHS MHS:6 milan hypertensive strain of rats MHS MHS:6 military health system MHS MHS:3 patients were susceptible to mh MHV-A59 MHV-A59:12 mouse hepatitis virus MHV-A59 MHV-A59:28 mouse hepatitis virus strain a MHV MHV:8|mHV:1 medial hyperstriatum ventrale MHV MHV:46 middle hepatic vein MHV MHV:10 mouse hepatitis coronavirus MHV MHV:6 murine coronavirus MHB MHB:37|mhb:2 midbrainhindbrain boundary MHB MHB:20 muellerhinton broth MH MH:24 macular hole MH MH:51 maleic hydrazide MH MH:100 malignant histiocytosis MH MH:33 malignant hyperpyrexia MH MH:10|M-H:2 mantelhaenszel MH MH:10 medial hypothalamic MH MH:37 medial hypothalamus MH MH:57 mental health MH MH:10 metal halide MH MH:18|M-H:1 muellerhinton MH MH:7 myocardial hypertrophy MH MH:5 selection for high MIBG MIBG:17 iodinemetaiodobenzylguanidine MIBG MIBG:22|mIBG:1 miodobenzylguanidine MIBG MIBG:5|mIBG:2 metaiodobenzyl guanidine MIBI MIBI:22 mtcmethoxyisobutylisonitrile MIBI MIBI:26|mibi:3 isobutyl isonitrile MIBI MIBI:9 methoxyisobutylisonitrile MIBI MIBI:20 tcm sestamibi MIBI MIBI:34 technetiumm sestamibi MIB MIB:18 methylisoborneol MIB MIB:18 medical information bus MIC90s MIC90s:7 of strains tested MIC90s MIC90s:8|MIC90S:1 mics at which of the isolates are inhibited MIC90 MIC90:3 of the isolates are inhibited MIC90 MIC90:5 mic for of strains tested MICU MICU:37 medical icu MICU MICU:112 medical intensive care unit MICU MICU:27 mobile intensive care unit MICs MICs:9 activities MICS MICS:6 interaction coding system MICS MICS:9 malnutritioninflammation complex syndrome MICS MICS:15 membrane invasion culture system MICs MICs:13 minimal inhibitory concentration MICS MICS:23 minimally invasive cardiac surgery MICs MICs:702|MICS:3 minimum inhibitory concentrations MIC MIC:7 ifosfamide and cisplatin MIC MIC:16 methacholine inhalation challenge MIC MIC:92 methyl isocyanate MIC MIC:9 methylisocyanate MIC MIC:5 mhc class i chainrelated MIC MIC:12 microinvasive carcinoma MIC MIC:6 minimal inhibitory MIC MIC:7 minimum inhibitory MIDAS MIDAS:30 metal iondependent adhesion site MIDAS MIDAS:34 migraine disability assessment MIDAS MIDAS:8 migraine disability assessment scale MIDCAB MIDCAB:110 minimally invasive direct coronary artery bypass MIDCAB MIDCAB:10|MID-CAB:1 minimally invasive direct coronary artery bypass surgery MID MID:17 important difference MID MID:10 inclusion disease MID MID:224 multiinfarct dementia MID MID:22 multiple indicator dilution MIF MIF:637|Mif:2|mif:1 macrophage migration inhibitory factor MIF MIF:13 maximal isometric force MIF MIF:13 microimmunofluorescence test MIF MIF:6|Mif:6 mifepristone MIF MIF:16 migration inhibition MIG MIG:10 metal inert gas MIG MIG:12|Mig:9|MiG:1 monokine induced by interferongamma MIH MIH:40 moltinhibiting hormone MIH MIH:13 myointimal hyperplasia MIL MIL:11 mean intercept length MIL MIL:9|mil:3 milrinone MIMS MIMS:9 membrane inlet mass spectrometry MIMS MIMS:20 membrane introduction mass spectrometry MIPs MIPs:10 major intrinsic proteins MIPs MIPs:16 maximum intensity projections MIPs MIPs:76 molecularly imprinted polymers MIPs MIPs:4 molluscan insulinrelated peptides MIP MIP:9 imprinted polymers MIP MIP:8 inspiratory pressures MIP MIP:11 main intrinsic polypeptide MIP MIP:8 maximum inspiratory MIP MIP:7 methylation induced premeiotically MIP MIP:23 minimally invasive parathyroidectomy MIP MIP:15|mip:1 mitochondrial intermediate peptidase MIP MIP:67 molecularly imprinted polymer MIR MIR:65 main immunogenic region MIR MIR:23 midinfrared MIR MIR:8 minimum infection rate MIR MIR:13 myocardial infarction registry MIT MIT:8 injection therapy MIT MIT:14 macrophage migration inhibition test MIT MIT:16 magnetic induction tomography MIT MIT:17 massachusetts institute of technology MIT MIT:7 melodic intonation therapy MIT MIT:8 metalinsulator transition MIT MIT:9 minimally invasive therapy MIT MIT:16 monoiodotyrosine MIS MIS:12 information systems MIS MIS:22 management information system MIS MIS:20 maturationinducing steroid MIS MIS:13 medical information system MIS MIS:13 melanoma in situ MIS MIS:18 microbial identification system MIS MIS:75 minimally invasive surgery MI MI:118 after acute myocardial infarction MI MI:10 cardiac remodeling after myocardial infarction MI MI:7 first meiotic division MI MI:5 first meiotic metaphase MI MI:12 intervention MI MI:11 magical ideation MI MI:22 meconium ileus MI MI:23|M-I:2 meiosis i MI MI:37 metabolic inhibition MI MI:13 metabolic intermediate MI MI:77|M-I:7|mi:1 metaphase i MI MI:18 mitotic MI MI:26 mitotic indices MI MI:33|Mi:1 mitral insufficiency MI MI:42 motivational interviewing MI MI:14 motor imagery MI MI:13 multiple imputation MI MI:37 mutual information MI MI:49 myocardial infarct MI MI:9 myocardial infarcted MI MI:45 myocardial ischemia MI MI:9 myometrial invasion MI MI:53|mi:1 patients after myocardial infarction MI MI:201 patients with acute myocardial infarction MI MI:9 ventricular remodeling after myocardial infarction MK-801 MK-801:15 methyldihydrohdibenzoadcycloheptenimine MK-801 MK-801:8|MK801:2 cycloheptenimine MK-801 MK-801:59|MK801:3 hydrogen maleate MK-801 MK-801:8 nmda receptor antagonist dizocilpine maleate MK-801 MK-801:16|MK801:1 noncompetitive MKPs MKPs:15 map kinase phosphatases MKPs MKPs:11 mapk phosphatases MK MK:17|Mk:7 megakaryocytic MK MK:20|Mk:1 mevalonate kinase MK MK:8 microbial keratitis MK MK:202 midkine MLCP MLCP:29 myosin light chain phosphatase MLCP MLCP:5|MLC-P:2|MLC-p:1 myosin light chain phosphorylation MLCs MLCs:11 lethal concentrations MLCs MLCs:26 mixed lymphocyte cultures MLCs MLCs:32 multileaf collimators MLCs MLCs:11 myosin light chains MLC MLC:26 lethal concentration MLC MLC:7 light chain of myosin MLC MLC:7 macrophagelike cells MLC MLC:17 megalencephalic leukoencephalopathy with subcortical cysts MLC MLC:10 metastatic liver cancer MLC MLC:29 micellar liquid chromatography MLC MLC:23 multileaf collimator MLC MLC:13 multileaf collimation MLD MLD:11 lethal doses MLD MLD:5 liver disease MLD MLD:5 manual lymph drainage MLD MLD:5 manual lymphatic drainage MLD MLD:5 marine natural product manoalide MLD MLD:19 mean lung density MLD MLD:15 mean lung dose MLD MLD:15 median lethal dose MLD MLD:18 metachromatic leucodystrophy MLD MLD:212 metachromatic leukodystrophy MLD MLD:79 minimal lumen diameter MLD MLD:55 minimal luminal diameter MLD MLD:10 minimum lethal dose MLD MLD:34 minimum lumen diameter MLEs MLEs:14 marinerlike elements MLEs MLEs:12 maximum likelihood estimates MLE MLE:13 maximum likelihood estimate MLE MLE:30 maximum likelihood estimation MLE MLE:25|mle:1 maximum likelihood estimator MLF MLF:10 logistic function MLF MLF:13 malolactic fermentation MLF MLF:11|mlf:3 medial longitudinal fascicle MLF MLF:104|mlf:3 medial longitudinal fasciculus MLI MLI:8 metenkephalinlike immunoreactivity MLI MLI:10|ML-I:8 mistletoe lectin i MLO MLO:13 mediolateral oblique MLO MLO:10 mycoplasmalike organisms MLP MLP:10 molecular lipophilicity potential MLP MLP:15 multiple lymphomatous polyposis MLP MLP:27 muscle lim protein MLRs MLRs:34 middle latency responses MLRs MLRs:34 mixed lymphocyte reactions MLR MLR:98 mesencephalic locomotor region MLR MLR:16 mixed lymphocyte reactivity MLR MLR:123 multiple linear regression MLR MLR:20 multiple logistic regression MLSS MLSS:22 maximal lactate steady state MLSS MLSS:12 mixed liquor suspended solids MLV MLV:26 multilamellar MLV MLV:17 multilamellar liposomes ML ML:12 machine learning ML ML:8 macrocyclic lactone ML ML:23|M-L:5|m-l:1|M--L:1 mediallateral ML ML:19|ml:1 medial lemniscus ML ML:9 midluteal ML ML:8 mink lung ML ML:8|M-L:1 mitochondriallysosomal ML ML:14 monolayer ML ML:7 mouse lysozyme ML ML:14 mucosal leishmaniasis ML ML:8|M-L:5 mullerlyer ML ML:17 muscle larvae ML ML:8 muscle length ML ML:10|Ml:1 mycobacterium leprae ML ML:10|Ml:2 myeloid leukemia MMA MMA:24 manual metal arc MMA MMA:8 maxillomandibular advancement MMA MMA:1 medicare prescription drug improvement and modernization act MMA MMA:189 methyl methacrylate MMA MMA:7 methyl methacrylate monomer MMA MMA:14 methylmalonic MMA MMA:163 methylmalonic acid MMA MMA:8 methylmalonic acidaemia MMA MMA:22 methylmalonic acidemia MMA MMA:20 methylmalonic aciduria MMA MMA:58 methylmethacrylate MMA MMA:10 methylmethacrylate monomer MMA MMA:25|mmA:1 middle meningeal artery MMA MMA:19 monocyte monolayer assay MMA MMA:11 monomethylamine MMA MMA:16 monomethylarsonate MMA MMA:5 monterrey metropolitan area MMCs MMCs:27 migrating motor complexes MMCs MMCs:30 migrating myoelectric complexes MMCs MMCs:13 mucosal mast cells MMC MMC:6 children with meningomyelocele MMC MMC:17 children with myelomeningocele MMC MMC:26 medicaid managed care MMC MMC:11 metropolis monte carlo MMC MMC:63 mitomycin MMC MMC:12 patients with myelomeningocele MMD MMD:18 mass median diameter MMD MMD:6 minimal melanogenic dose MMD MMD:27 moyamoya disease MMD MMD:18 myotonic muscular dystrophy MMF MMF:11 macrophagic myofasciitis MMF MMF:33 maxillomandibular fixation MMF MMF:17 mismatch field MMG MMG:32 mechanomyogram MMG MMG:40 mechanomyographic MMG MMG:22 mechanomyography MMH MMH:6 methylmercury hydroxide MMH MMH:14 monomethylhydrazine MMMF MMMF:16 manmade mineral fibers MMMF MMMF:11 mineral fibres MMM MMM:5 mass molecules MMM MMM:12 metastatic malignant melanoma MMM MMM:109 myelofibrosis with myeloid metaplasia MMM MMM:9 myeloid metaplasia with myelofibrosis MMN MMN:5 medial mamillary nucleus MMN MMN:96 multifocal motor neuropathy MMO MMO:7 maximal mouth opening MMO MMO:6 maximum mouth opening MMO MMO:46 methane monooxygenase MMP-8 MMP-8:18|Mmp8:1 collagenase MMP-8 MMP-8:38|MMP8:5 neutrophil collagenase MMPIs MMPIs:13 matrix metalloproteinase inhibitors MMPIs MMPIs:18 mmp inhibitors MMPI MMPI:16|MMP-i:1|MMPi:1 matrix metalloproteinase inhibitor MMPI MMPI:7|MMPi:2 mmp inhibitor MMPs MMPs:9 matrix metalloproteinases MMPs MMPs:87|MMPS:1 matrix metalloproteases MMP MMP:6 methadone maintenance program MMP MMP:17 microsatellite mutator phenotype MMP MMP:30 mitochondrial membrane permeabilization MMP MMP:31 mucous membrane pemphigoid MMP MMP:10 peptides MMR MMR:29 maternal mortality rate MMR MMR:38 maternal mortality ratio MMR MMR:15 measlesmumpsrubella vaccine MMR MMR:12 midline malignant reticulosis MMR MMR:12 mild mental retardation MMR MMR:13 mismatch repair system MMR MMR:9 mouthtomouth resuscitation MMR MMR:9 mumpsmeaslesrubella MMSE MMSE:94 minimental state exam MMSE MMSE:5 minimum mean square error MMSE MMSE:9 state evaluation MMs MMs:27 malignant melanomas MMs MMs:14 malignant mesotheliomas MMS MMS:9 methyl methane sulphonate MMS MMS:473 methyl methanesulfonate MMS MMS:102|mms:1 methyl methanesulphonate MMS MMS:52 methylmethane sulfonate MMS MMS:9 methylmethane sulphonate MMS MMS:37 methylmethanesulfonate MMS MMS:12 methylmethanesulphonate MMS MMS:17 minimental state examination MMS MMS:62 mohs micrographic surgery MMS MMS:7 multiple metabolic syndrome MMT MMT:24 manual muscle test MMT MMT:37 manual muscle testing MMT MMT:13 methadone maintenance therapy MMT MMT:76 methadone maintenance treatment MMT MMT:68 methylcyclopentadienyl manganese tricarbonyl MMT MMT:7 mixed mesodermal tumor MMT MMT:8 mixed mullerian tumors MMT MMT:8|mmt:1 montmorillonite MMVF MMVF:28 manmade vitreous fibers MMVF MMVF:10 vitreous fibres MM MM:4|Mm:4 masseter muscle MM MM:16 maternal mortality MM MM:6 meningococcal meningitis MM MM:9 menstrual migraine MM MM:15 mesangial matrix MM MM:11 metanephric mesenchyme MM MM:31 methadone maintenance MM MM:9|M-M:7 michaelismenten MM MM:11 minimal medium MM MM:8 mirror movements MM MM:15 mitochondrial myopathy MM MM:12 mixed micelles MM MM:23 miyoshi myopathy MM MM:12 model MM MM:17|Mm:1 muscle mass MM MM:11 muscularis mucosae MM MM:13 mycoplasma meleagridis MM MM:8 myeloid metaplasia MM MM:12 myelomeningocele MNA MNA:45 mean nuclear area MNA MNA:61 mini nutritional assessment MNA MNA:9 mycn amplification MNC MNC:14 mononuclear MNC MNC:183 mononuclear cell MND MND:24 minor neurological dysfunction MND MND:9 modified neck dissection MND MND:96 motor neurone disease MNNG MNNG:27 methylnitronitrosoguanidine MNNG MNNG:11 nmethylnnitronitrosoguanidine mNTS mNTS:5|m-NTS:1 medial nucleus of the solitary tract mNTS mNTS:14|mnTS:1 medial nucleus tractus solitarius MNT MNT:25 medical nutrition therapy MNT MNT:15 mouse neutralization test MNU MNU:24 methyl nitrosourea MNU MNU:41 nmethylnitrosourea MNs MNs:76|Mns:9|mns:1|MNS:1 motoneurons MNs MNs:24|Mns:3 motoneurones MOC MOC:31 medial olivocochlear MOC MOC:9 myositis ossificans circumscripta MODY MODY:7 diabetes of young people MODY MODY:2 maturityonset diabetes of young MODS MODS:18|MODs:1 multiple organ dysfunction score MODS MODS:279 multiple organ dysfunction syndrome MOD MOD:10 magnetooptical disk MOD MOD:5 maturity onset diabetes MOD MOD:23|mOD:1 mean optical density MOE MOE:12 main olfactory epithelium MOE MOE:7 margin of exposure MOE MOE:9 massive ovarian edema MOF MOF:11 methoxyflurane MOF MOF:374 multiple organ failure MOH MOH:9 medication overuse headache MOH MOH:108|MoH:18|MOh:1 ministry of health MOI MOI:11|moi:3 different multiplicities of infection MOI MOI:8 mechanism of injury MOS MOS:6 main olfactory system MOS MOS:91 medical outcomes study MOX MOX:9|Mox:1 methanol oxidase MOX MOX:12 moxidectin MOX MOX:6|Mox:3 moxonidine MPAG MPAG:8 glucuronide metabolite MPAG MPAG:23 mycophenolic acid glucuronide MPA MPA:34 maclura pomifera MPA MPA:25 maclura pomifera agglutinin MPA MPA:54|mPA:2 main pulmonary artery MPA MPA:34 medroxyprogesterone MPA MPA:17|mPA:3 microscopic polyarteritis MPA MPA:7 multiprobe assembly MPA MPA:384|mPA:1 mycophenolic acid MPA MPA:5 peak amplitude MPB MPB:10 male pattern baldness MPB MPB:32|mPB:9 mobilized peripheral blood MPC MPC:64 methacryloyloxyethyl phosphorylcholine MPC MPC:21 maximum permissible concentration MPC MPC:8 mean platelet component MPC MPC:7 model predictive control MPC MPC:7 mouse plasmacytoma MPC MPC:23 multicatalytic proteinase complex MPC MPC:12 multiple primary cancer MPC MPC:26 mutant prevention concentration MPC MPC:10 partially thiolated polycytidylic acid MPD MPD:26 methylpentanediol MPD MPD:83 main pancreatic duct MPD MPD:5 maximum population density MPD MPD:15 mevalonate pyrophosphate decarboxylase MPD MPD:34 minimal phototoxic dose MPD MPD:73 multiple personality disorder MPE MPE:19 massive pulmonary embolism MPE MPE:11 maximum permissible exposure MPE MPE:6 maximum possible effect MPF MPF:57 mphase promoting factor MPF MPF:161|mpf:2 mean power frequency MPGN MPGN:291 membranoproliferative glomerulonephritis MPGN MPGN:19 membranoproliferative gn MPG MPG:20 major pelvic ganglia MPG MPG:36 major pelvic ganglion MPG MPG:31 nmethylpurinedna glycosylase MPI MPI:22 mannheim peritonitis index MPI MPI:14|Mpi:3 mannose phosphate isomerase MPI MPI:32 maudsley personality inventory MPI MPI:18 mucus proteinase inhibitor MPI MPI:36 multidimensional pain inventory MPI MPI:61 myocardial performance index MPI MPI:96 myocardial perfusion imaging MPL MPL:9 massperlength MPL Mpl:2|MPL:2 tpo receptor MPM MPM:130 malignant pleural mesothelioma MPM MPM:11 minor psychiatric morbidity MPM MPM:8 mortality prediction model MPM MPM:7 mortality probability model MPN MPN:9 omethylpyridoxine MPN MPN:11|mPN:2 male pronucleus MPN MPN:7 modulatory proctolin neuron MPN MPN:47 mostprobablenumber MPN MPN:158 probable number MPO MPO:10 medial preoptic MPO MPO:62 myeloperoxidase activity MPO MPO:5 release of mast cell peroxidase MPP+ MPP+:6 methylphenylpyridinium cation MPP+ MPP+:7 metabolite methylphenylpyridine MPP+ MPP+:21 nmethylphenylpyridinium MPP MPP:15 massive periretinal proliferation MPP MPP:18|mPP:1 medial perforant path MPP MPP:64 mitochondrial processing peptidase MP-RAGE MP-RAGE:7 magnetizationprepared rapid gradientecho MP-RAGE MP-RAGE:6|MPRAGE:2 rapid acquisition gradientecho MPRs MPRs:31 mannose phosphate receptors MPRs MPRs:8|MPRS:1 multiplanar reconstructions MPR MPR:5 cationindependent mannosephosphate receptor MPR MPR:18|MP-R:1|Mpr:1 mannose phosphate receptor MPR MPR:14 medication possession ratio MPR MPR:13 mouse prostate reconstitution MPR MPR:14 multiplanar MPR MPR:11 multiplanar reformatted MPR MPR:15 myocardial perfusion reserve MPS MPS:4 cells of the mononuclear phagocyte series MPS MPS:15 macular photocoagulation study MPs MPs:5 membrane potentials MPs MPs:13 metalloproteinases MPs MPs:24|mps:1 microparticles MPS MPS:133 mononuclear phagocyte system MPS MPS:56 mononuclear phagocytic system MPs MPs:5 motor potentials MPs MPs:24 movement proteins MPS MPS:64 mucopolysaccharidoses MPS MPS:9 multidimensional perfectionism scale MPs MPs:11 muramyl peptides MPS MPS:7 myeloproliferative syndromes MPS MPS:5 myocardial perfusion singlephoton emission computed tomography MPS MPS:10 myocardial perfusion spect MPS MPS:32 myofascial pain syndrome MPS MPS:13 patients with mucopolysaccharidosis MPTP MPTP:11 tetrahydropyridine MPTP MPTP:37 methylphenyltetrahydropyridine MPTP MPTP:21 neurotoxin nmethylphenyltetrahydropyridine MPT MPT:25 maximum phonation time MPT MPT:6 methylprednisolone pulse therapy MPT MPT:244|mPT:21 mitochondrial permeability transition MPT MPT:29 molybdopterin MPT MPT:19|MP-T:1 munich personality test MPT MPT:6 primary cultures of mouse proximal tubular MPV MPV:12 main portal vein MPV MPV:6 masonpfizer virus MPV MPV:5 maximum peak velocity MPV MPV:169 mean platelet volume MPV MPV:8 monkeypox virus MP MP:17 machine perfusion MP MP:32 macular pigment MP MP:8|mp:1 main process MP MP:16 mannoprotein MP MP:23 mastoparan MP MP:12 matching pursuit MP MP:11 meconium peritonitis MP MP:30 melphalan and prednisone MP MP:10|M-P:1 melphalanprednisone mp mp:3|MP:2 melting points MP MP:16|M-P:1 metatarsophalangeal MP MP:21 methapyrilene MP MP:20 methyl palmoxirate MP MP:10 methyl prednisolone MP MP:11 methylphosphonate MP MP:24 micronized progesterone MP MP:8 micturition pressure MP MP:16 migration percentage MP MP:10 mitral prolapse MP MP:10 monopolar MP MP:22 motor potential MP MP:151 movement protein mp mp:8|MP:3 muscularis propria MP MP:5 mycoplasma pneumoniae pneumonia MP MP:35|Mp:11|mp:1 mycoplasma pneumoniae MP MP:11 myenteric plexus MP MP:12 myocardial perfusion MP MP:12 myosin phosphatase MQMAS MQMAS:8 magic angle spinning MQMAS MQMAS:8 multiplequantum magicangle spinning MQSA MQSA:16 mammography quality standards act MQSA MQSA:9 mammography quality standards act of MQ MQ:7 maastricht questionnaire MQ MQ:45 mefloquine MRA MRA:12 magnetic resonance angiogram MRA MRA:10 magnetic resonance angiographic MRA MRA:9 magnetic resonance arteriography MRA MRA:11|MRa:3 magnetic resonance arthrography MRA MRA:14 malignant rheumatoid arthritis MRA MRA:16|MrA:2 mesenteric resistance arteries MRA MRA:6|MRa:1 mr arthrography MRA MRA:22 multiple regression analysis MRCP MRCP:214 magnetic resonance cholangiopancreatography MRCP MRCP:99 mr cholangiopancreatography MRC MRC:10 magnetic resonance colonography MRC MRC:205 medical research council MRC MRC:33 mitochondrial respiratory chain MRC MRC:20 mr cholangiography MRD MRD:11 magnetic relaxation dispersion MRD MRD:653 minimal residual disease MRD MRD:7 modified robbins device MRD MRD:13 rate of depolarization MRE MRE:25 magnetic resonance elastography MRE MRE:13 metal response element MRF MRF:14 markov random field MRF MRF:8 muscle regulatory factor MRHA MRHA:24 mannoseresistant haemagglutination MRHA MRHA:22|MR-HA:1 mannoseresistant hemagglutination MRI MRI:11 magnetic resonance imagery MRI MRI:8 magnetic resonance imaging scan MRI MRI:9 research institute MRLs MRLs:15 maximum residue levels MRLs MRLs:11 minimal risk levels MRM MRM:15|MR-M:1 magnetic resonance mammography MRM MRM:44 magnetic resonance microscopy MRM MRM:9 mechanically recovered meat MRM MRM:63 modified radical mastectomy MRM MRM:17 mr mammography MRM MRM:9 murine respiratory mycoplasmosis MRPs MRPs:25 maillard reaction products MRPs MRPs:24 movementrelated potentials MRPs MRPs:14|Mrps:2 multidrug resistance proteins MRP MRP:11 maximum resting pressure MRP MRP:9 median root prior MRP MRP:10 mitochondrial rna processing MRP MRP:5|mrp:2 protein gene MRP MRP:11 reaction products MRP MRP:9 requirements planning MRR MRR:9 maximal relaxation rate MRR MRR:9 maximum relaxation rate MRR MRR:8 mortality rate ratio MRSA MRSA:17 methicillinresistant s aureus MRSA MRSA:2240|MR-SA:2|mrsa:1 methicillinresistant staphylococcus aureus MRSA MRSA:7 methicillinresistant staphylococcus aureus strains MRSA MRSA:12 methicillinresistant strains MRSA MRSA:15 resistant to methicillin MRS MRS:11 magnetic resonance spectroscopic MRS MRS:14 mania rating scale MRS MRS:43 melkerssonrosenthal syndrome MRS MRS:17 menopause rating scale MRs MRs:11|MRS:1 metabolic ratios MRS MRS:10 methicillinresistant staphylococci MRs MRs:8|MRS:1 mineralocorticoid MRs MRs:41 mineralocorticoid receptors mRS mRS:68|MRS:29|m-RS:3|mRs:2 modified rankin scale mRS mRS:7|MRS:1 modified rankin score MRS MRS:5 rogosa and sharpe MRT MRT:65 malignant rhabdoid tumor MRT MRT:406 mean residence time MRT MRT:9 mental rotations test MRT MRT:6 microbeam radiation therapy MRT MRT:7 microwave resonance therapy MRT MRT:18 milk ring test MRT MRT:11 modified rhyme test MRU MRU:22 magnetic resonance urography MRU MRU:15 mr urography MRV MRV:31 magnetic resonance venography MRV MRV:5 mouse rotavirus MRV MRV:5 murine rotavirus MR MR:10 magnetoresistance MR MR:9 maillard reaction MR MR:12 mandelate racemase MR MR:29 medial rectus MR MR:28 median raphe MR MR:19 menstrual regulation MR MR:11 mental rotation MR MR:42 mentally retarded MR MR:25|M-R:1 methicillinresistant MR MR:12 milk replacer MR MR:50|mr:1 mitochondriarich MR MR:23 mitotic rate MR MR:764 mitral regurgitation MR MR:11 molecular remission MR MR:9 molecular replacement MR MR:5 morbid risk MR MR:7 morphinone reductase MR MR:29 mortality rate MR MR:13 motherreared MR MR:10 multiresistant MS/MS MS/MS:12 tandem mass MS/MS MS/MS:38|ms/ms:1 tandem mass spectrometric MS/MS MS/MS:433|ms/ms:4 tandem mass spectrometry MSAs MSAs:18 medical savings accounts MSAs MSAs:32 metropolitan statistical areas MSA MSA:18 mammary serum antigen MSA MSA:7 mannitol salt agar MSA MSA:28 master settlement agreement MSA MSA:65 medial septal area MSA MSA:17 methanesulfonic acid MSA MSA:16 metropolitan statistical area MSA MSA:13 middle stone age MSA MSA:12 mouse serum albumin MSA MSA:15 multiple sequence alignment MSA MSA:8 multivariate statistical analysis MSA MSA:21 muscle nerve sympathetic activity MSA MSA:18 muscle sympathetic activity MSBP MSBP:4|mSBP:4 mean systemic blood pressure MSBP MSBP:31|MSbP:4 munchausen syndrome by proxy MSCT MSCT:28 multislice computed tomography MSCT MSCT:38|MS-CT:4 multislice ct MSCT MSCT:29|msCT:1 multislice spiral ct MSC MSC:13 magnitudesquared coherence MSC MSC:9 mercurascan MSD MSD:12|msd:1 displacement MSD MSD:8 marble spleen disease MSD MSD:5 mean sac diameter MSD MSD:6 mean segment diameter MSD MSD:12 membranespanning domain MSD MSD:6 merck sharp and dohme MSD MSD:20 multiple sulfatase deficiency MSD MSD:10 multiple sulphatase deficiency MSD MSD:5 multisomatoform disorder MSD MSD:7 sibling donor MSE MSE:11 mean spherical equivalent MSE MSE:35|mse:1 mean square error MSE MSE:32|mse:1 mean squared error MSE MSE:13 monocytespecific esterase MSFC MSFC:15 ms functional composite MSFC MSFC:27 multiple sclerosis functional composite MSF MSF:16 medecins sans frontieres MSF MSF:42 mediterranean spotted fever MSF MSF:10 methanesulfonyl fluoride MSF MSF:33 modified sham feeding MSF MSF:12|msf:1 stimulating factor MSG MSG:8 administration of monosodiumlglutamate MSG MSG:13 minor salivary gland MSG MSG:411 monosodium glutamate MSG MSG:74 monosodium lglutamate MSHA MSHA:7 mannosesensitive hemagglutination MSHA MSHA:19 mannosesensitive hemagglutinin MSHA MSHA:20 mine safety and health administration MSH MSH:34 alphamelanocyte stimulating hormone MSH MSH:17 melanotropin MSH MSH:9 mycothiol MSH MSH:8 stimulating hormones MSI MSI:42 magnetic source imaging MSI MSI:6 marital satisfaction inventory MSI MSI:5 massive splenic injury MSI MSI:5 muscle strength index MSK MSK:18 medullary sponge kidney MSK MSK:22 musculoskeletal MSLR MSLR:6 cell lymphocyte culture reaction MSLR MSLR:6 mixed skin celllymphocyte culture reaction MSL MSL:13|msl:6 malespecific lethal MSL MSL:8 mean sleep latency MSL MSL:34 multiple symmetric lipomatosis MSM MSM:358 men who have sex with men MSM MSM:11 methylsulfonylmethane MSOF MSOF:40 multiple system organ failure MSOF MSOF:18 multisystem organ failure MSO MSO:12 lmethioninedlsulfoximine MSO MSO:11 management services organization MSO MSO:18 medial superior olivary nucleus MSO MSO:60 medial superior olive MSP MSP:48|msp:3 major sperm protein MSP MSP:5|msp:2 major surface protease MSP MSP:13 maximum squeeze pressure MSP MSP:8|msp:1 microspectrophotometric MSP MSP:19|msp:1 microspectrophotometry MSP MSP:8 myelencephalonspecific protease MSRV MSRV:9 modified semisolid rappaportvassiliadis MSRV MSRV:8 multiple sclerosisassociated retrovirus MSR MSR:10 monosynaptic MSR MSR:73 monosynaptic reflex MSSA MSSA:11 methicillinsensitive MSSA MSSA:6 methicillinsensitive s aureus MSSA MSSA:57 methicillinsensitive staphylococcus aureus MSSA MSSA:24 methicillinsusceptible MSSA MSSA:2 methicillinsusceptible s aureus MSSA MSSA:50 methicillinsusceptible staphylococcus aureus MSS MSS:9 marinescosjogren syndrome MSS MSS:7 marshallsmith syndrome MSS MSS:15 maternal serum screening MSS MSS:7 moderate splenomegaly syndrome MST MST:5 maximal stimulation test MST MST:5 mental arithmetic stress test MST MST:5 mental stress test MST MST:8 microbial source tracking MST MST:24 minimum spanning tree MST MST:8 montenegro skin test MST MST:32 multiple subpial transection MST MST:22 multisystemic therapy MSU MSU:87 monosodium urate MSU MSU:10 monosodium urate crystals MSU MSU:9 state university MSWI MSWI:26 municipal solid waste incineration MSWI MSWI:38 municipal solid waste incinerator MS MS:9 chinese meishan MS MS:9 magnetic source MS MS:23 magnetic stimulation MS MS:27 mainstream MS MS:17 mainstream smoke MS MS:7 malignant schwannoma MS MS:5 manchester scale MS MS:8 marbling score MS MS:5 marijuana smokers MS MS:14 mass screening MS MS:8 mass spectral MS MS:46 mass spectrometer MS MS:127 mass spectrometric MS MS:19 maternal separation MS MS:46 maternal serum MS MS:7 meal size MS MS:30 mean sensitivity MS MS:41|Ms:1 mechanosensitive MS MS:35 medial septal MS MS:88 medial septum MS MS:9 median sternotomy MS MS:14 mental stress MS MS:10 methionine synthetase MS MS:9 middle suprasylvian MS MS:12|ms:1 mild steel ms ms:30|MS:1|mS:1 milliseconds MS MS:267 mitral stenosis MS MS:5 molar substitution MS MS:78 morphine sulfate MS MS:31 motion sickness ms ms:5|MS:2|m-s:1|M-S:1 mucosaltoserosal MS MS:9 multiplescattering MS MS:9 multiple sderosis MS MS:9 murashigeskoog MS MS:117|ms:9 mutans streptococci MS MS:7 mutator strain MS MS:49|Ms:1 mycoplasma synoviae MT-MMP MT-MMP:19 membranetype matrix metalloproteinase MT-MMP MT-MMP:7 membranetype mmp MT-MMPs MT-MMPs:27 membranetype matrix metalloproteinases MT-MMPs MT-MMPs:14 membranetype mmps MTAL MTAL:5|mTAL:4 medullary tal MTAL MTAL:9|mTAL:7|mtal:1 medullary thick ascending limb of henle MTA MTA:28 deoxymethylthioadenosine MTA MTA:10 medial temporal lobe atrophy MTA MTA:118 mineral trioxide aggregate MTA MTA:8 moving time average MTA MTA:6 multisite multimodal treatment study of children with attentiondeficithyperactivity disorder MTA MTA:12 multitargeted antifolate MTA MTA:5 myoclonic twitch activity MTC MTC:89 magnetization transfer contrast MTC MTC:29 major translocation cluster MTC MTC:5 mass transfer area coefficients MTC MTC:107 medullary thyroid cancer MTC MTC:9 microwave tissue coagulation MTC MTC:14 microwave tissue coagulator MTC MTC:9 muscletendon complex MTD MTD:23 amplified mycobacterium tuberculosis direct test MTD MTD:136 determine the maximumtolerated dose MTD MTD:5 mannitol dehydrogenase MTD MTD:10 maximum tolerated dosage MTD MTD:9|Mtd:4 methadone MTD MTD:11 tension dysphonia MTF MTF:4 formylation of initiator methionyltrna by methionyltrna formyltransferase MTF MTF:10 metrifonate MTF MTF:6 multipletube fermentation MTF MTF:9 treatment facility MTHFR MTHFR:739|Mthfr:3|MT-HFR:1 methylenetetrahydrofolate reductase MTHFR MTHFR:24 methylenetetrahydrofolate reductase gene MTP-PE MTP-PE:13 muramyl tripeptide MTP-PE MTP-PE:30|MTPPE:2 muramyl tripeptide phosphatidylethanolamine MTP MTP:26 first metatarsophalangeal MTP MTP:14 maltose tetrapalmitate MTP MTP:7 median time to progression MTP MTP:7 median time to tumor progression MTP MTP:14 medical termination of pregnancy MTP MTP:196 microsomal triglyceride transfer protein MTP MTP:5 microtubule proteins MTP MTP:9 treatment project MTR MTR:12 mithramycin MTR MTR:7 mt ratios MTR MTR:7 mucociliary transport rate MTSEA MTSEA:7|MTS-EA:1 aminoethyl methanethiosulfonate MTSEA MTSEA:13|MT-SEA:1 methanethiosulfonate ethylammonium MTSET MTSET:7|MTS-ET:2 trimethylammoniumethylmethanethiosulfonate MTSET MTSET:7|MTS-ET:1 methanethiosulfonate ethyltrimethylammonium MTT MTT:8 malignant triton tumor MTT MTT:19 meal tolerance test MTT MTT:5 mitochondrial dehydrogenase activity MTT MTT:10 myoblast transfer therapy MTT MTT:35 tetrazolium dye MTU MTU:10 malignant teratoma undifferentiated MTU MTU:29 methylthiouracil MTU MTU:5 muscletendon unit MTV MTV:88|Mtv:4 mammary tumor virus MTV MTV:6 maximum tolerable volume MTV MTV:5 maximum tolerated volume MTX MTX:9 hmethotrexate MTX MTX:4|Mtx:1 agonist methoxamine MTX MTX:72 maitotoxin MTX MTX:15 maurotoxin MTX MTX:4|Mtx:3|mtx:1 mosquitocidal toxin MT MT:16 alphamethyltestosterone MT MT:20 alphamethyltestosterone MT MT:2 amt and methoxytryptamine MT MT:259 magnetization transfer MT MT:10 maintenance therapy MT MT:8|Mt:4 malpighian tubules MT MT:10|mt:4 matingtype MT MT:9 membrane type MT MT:19 methanethiol MT MT:27 methyltestosterone MT MT:10 methyltrienolone mT MT:14|mT:14 middle t MT MT:64 middle temporal MT MT:73 middle temporal area MT MT:68 middle temporal visual area mT mT:8|MT:1 millitesla MT MT:8|mt:1 morphological transformation MT MT:65 motor threshold MT MT:7 myoblast transplantation MT MT:8 myogenic tone MUA MUA:7 mercaptoundecanoic acid MUA MUA:57 multiple unit activity MUA MUA:63 multiunit activity MUC MUC:10 mucosal ulcerative colitis MUC MUC:10 transtransmuconaldehyde MUNE MUNE:18 motor unit number estimate MUNE MUNE:38 motor unit number estimation MUPs MUPs:38|mups:2|Mups:1 major urinary proteins MUPs MUPs:51 motor unit potentials MUP MUP:37|Mup:2 major urinary protein MUP MUP:10 maximum urethral pressure MVA MVA:43 manual vacuum aspiration MVA MVA:43 mevalonate MVA MVA:51 mevalonic acid MVA MVA:127 mitral valve area MVA MVA:29 modified vaccinia ankara MVA MVA:92 modified vaccinia virus ankara MVA MVA:18 multivariate analysis MVCs MVCs:38 maximal voluntary contractions MVCs MVCs:23 motor vehicle collisions MVCs MVCs:37 motor vehicle crashes MVC MVC:276 maximum voluntary contraction MVC MVC:9 minute virus of canines MVC MVC:12 motor vehicle collision MVC MVC:25 voluntary contraction force MVC MVC:7 voluntary contraction strength MVD MVD:130 microvascular decompression MVD MVD:19 mitral valve disease MVD MVD:25 multivessel disease MVE-2 MVE-2:6 maleic anhydride divinyl ether MVE-2 MVE-2:9 maleic anhydride divinyl ether copolymer MVE MVE:68 murray valley encephalitis MVE MVE:27 murray valley encephalitis virus MVM MVM:14 microvillous membrane MVM MVM:18 microvillus membrane MVM MVM:6 syncytiotrophoblast microvillous MVO2 MVO2:64|MVo2:4 myocardial o consumption MVO2 MVO2:8|MVo2:1 myocardial oxygen uptake MVO MVO:8 maximal venous outflow MVO MVO:11 maximum venous outflow MVP MVP:44|mvp:1 major vault protein MVP MVP:10 microvascular pressure MVP MVP:1 mitomycin vinblastine and cisplatin MVP MVP:438 mitral valve prolapse MVP MVP:8 mitral valvuloplasty MVR-PCR MVR-PCR:9 minisatellite variant repeat mapping by pcr MVR-PCR MVR-PCR:1 minisatellite variant repeat mapping by the polymerase chain reaction MVR MVR:20 minisatellite variant repeat MVR MVR:7 mitral valve regurgitation MVR MVR:17|MVr:2 mitral valve repair MVT MVT:12 mesenteric vein thrombosis MVT MVT:20 mesenteric venous thrombosis MVT MVT:15 monomorphic ventricular tachycardia MVV MVV:67|mvv:2 maedivisna virus MVV MVV:4 minute ventilation volume MVV MVV:145 voluntary ventilation MV MV:10|M-V:1 maedivisna MV MV:17 maternal vein MV MV:12 maternal venous MV MV:17 maturation value MV MV:14|mv:1|Mv:1 mechanically ventilated MV MV:12 megavoltage MV MV:38 methyl viologen MV MV:9 microvessels MV MV:16 microvibration MV MV:31|mv:2|Mv:1 microvilli MWC MWC:6 maximal working capacity MWC MWC:15 monodwymanchangeux MWC MWC:6 work capacity MWD MWD:12 maximal walking distance MWD MWD:19 maximum walking distance MWD MWD:14 molecular weight distribution MWM MWM:7 mediumweight molecules MWM MWM:135 morris water maze MWT MWT:38 maintenance of wakefulness test MWT MWT:5 walk time MW MW:13 highmolecularweight MW MW:92|mw:3 microwave MW MW:5 millimeter waves MW MW:9 munichwistar Mw Mw:12|MW:2 slope Mw Mw:5 weightaverage molar mass MX MX:10 methoxyamine MX MX:18 musk xylene MZ MZ:14 identical MZ MZ:123 marginal zone MZ MZ:650|mz:1|Mz:1 monozygotic MZ MZ:10 monozygotic twins MZ MZ:42|Mz:2 monozygous ManNAc ManNAc:9 nacetyldmannosamine ManNAc ManNAc:24|manNac:1 nacetylmannosamine MbCO MbCO:10 carbonmonoxy myoglobin MbCO MbCO:13 carboxymyoglobin MB MB:11 marginal band MB MB:13 maternal behavior MB MB:48|Mb:1 medulloblastoma MB MB:10|mb:6|M-B:3 membranebound MB MB:7|mb:3 mesiobuccal MB MB:11 molecular beacon MB MB:130 multibacillary MB MB:11 myocardial bridge MB MB:7 myocardial bridging MDE MDE:13 methylenedioxyethylamphetamine MDE MDE:14 nethylmethylenedioxyamphetamine MeHg MeHg:86|Me-Hg:1|meHg:1 methyl mercury MeHg MeHg:6 methyl mercury chloride MeCP2 MECP2:3|MeCP2:3 methylcpgbinding protein MeCP2 MeCP2:13|MECP2:8 methylcpg binding protein MECs MECs:20|mecs:1 mammary epithelial cells MECs MECs:6 minimal effective concentrations MEL MEL:28|Mel:20 melphalan MEL MEL:17 mouse erythroleukaemia MEL MEL:6 mouse erythroleukemic MEL MEL:27 murine erythroleukaemia MEL MEL:252 murine erythroleukemia MEL MEL:13 murine erythroleukemic MER MER:27 methanol extraction residue MER MER:8 methanol extraction residue of bacillus calmetteguerin MER MER:12 methanol extraction residue of bcg MER MER:5 molar esterification rate mesna mesna:5|MESNA:3 mercaptoethane sulphonate mesna mesna:11|Mesna:4|MESNA:2|MesNa:1 sodium mercaptoethane sulfonate mesna mesna:7|Mesna:3|MESNA:1 sodium mercaptoethanesulfonate MIA MIA:33 melanoma inhibitory activity MIA MIA:7 methylisobutyl amiloride MIA MIA:16|Mia:3 mianserin MLA MLA:23 medical library association MLA MLA:78 methyllycaconitine MLA MLA:7|mLA:1 minimum lumen area MLA MLA:22 mouse lymphoma assay MLS MLS:17 macrolidelincosamidestreptogramin MLS MLS:13 maximum likelihood score MLS MLS:26 microphthalmia with linear skin defects MLS MLS:8 myxoid liposarcomas MLS MLS:9 platelet mean life span MnDPDP MnDPDP:18|Mn-DPDP:9|MN-DPDP:1 mangafodipir trisodium MnDPDP MnDPDP:9|Mn-DPDP:1 manganese dipyridoxyl diphosphate MN MN:9 mauthner neurons MN MN:9 meal number MN MN:26 median nerve MN MN:19 melanocytic nevi MN MN:10 mental nerve MN MN:16 methyl nicotinate MN MN:402|Mn:4 micronucleus MON MON:12|Mon:7 monensin MON MON:6|Mon:3 moniliformin MPH MPH:22 male pseudohermaphroditism MPH MPH:6 methylphenidate hydrochloride MscL MscL:1 mechanosensitive channel with very large conductance MscL MscL:10 mechanosensitive ion channel MTS MTS:13|M-t-S:1 matchingtosample MTS MTS:97 mesial temporal sclerosis MTs MTs:298|Mts:2|MTS:2 metallothioneins MTS MTS:51 methanethiosulfonate MTs MTs:412|Mts:18|mts:3 microtubules MTS MTS:17 mitochondrial targeting sequence MTS MTS:9 mitochondrial targeting signal MTs MTs:7 motor thresholds MTS MTS:34 muirtorre syndrome MTS MTS:7 testing system N0 N0:9 clinically negative N0 N0:6 clinically negative neck N0 N0:5 lymph node involvement N1 N1:16|n1:1 negative peak N1 N1:22 negative wave N1 N1:14 negativity NAA/Cr NAA/Cr:5 creatine ratio NAA/Cr NAA/Cr:10 nacetylaspartatecreatine NAC NAC:13 antioxidant nacetylcysteine NAC NAC:32 antioxidant nacetyllcysteine NAC NAC:5 component of ad amyloid NAC NAC:113|NAc:2|N-ac:1|nAC:1 nacetyl cysteine NAC NAC:14 nacetyl lcysteine NAC NAC:13 nacetylcystein NAC NAC:1008|N-ac:5|N-Ac:5|Nac:2|NAc:2 nacetylcysteine NAC NAC:14 nasal allergen challenge NAC NAC:20 nascent polypeptideassociated complex NAC NAC:9 needle aspiration cytology NAC NAC:9 nippleareola complex NADH-TR NADH-TR:7 nadh tetrazolium reductase NADH-TR NADH-TR:10 nicotinamide adenine dinucleotide tetrazolium reductase NADH NADH:2 nicotinamide adenine dinucleotide reduced NADH NADH:159 reduced nicotinamide adenine dinucleotide NADPH NADPH:2 adenine dinucleotide phosphate reduced form NADPH NADPH:7 nicotinamide adenine dinucleotide phosphate reduced NAGM NAGM:5 normalappearing gray matter NAGM NAGM:5 normal appearing grey matter NAG NAG:11 nacetylbdglucosaminidase NAG NAG:36 nacetylglucosaminidase NAG NAG:11 nacetylglutamate NAG NAG:29 urinary nacetylbetaglucosaminidase NALT NALT:12 lymphoid tissues NALT NALT:53 nasalassociated lymphoid tissue NAL NAL:11 nacystelyn NAL NAL:26|Nal:16 nalidixic acid NAL NAL:7|Nal:3 naltrexone NAPQI NAPQI:4 metabolite nacetylpbenzoquinoneimine NAPQI NAPQI:58 nacetylpbenzoquinone imine NAP NAP:20|Nap:4 naproxen NAP NAP:12 napvsipq NAP NAP:19 nerve action potential NAP NAP:71|N-AP:1 neutrophil alkaline phosphatase NAP NAP:8 nucleoacidic protein NASS NASS:12 national automotive sampling system NASS NASS:12 north american spine society NAS NAS:74|N-aS:1|N-AS:1 nacetylserotonin NAs NAs:7 naphthenic acids NAS NAS:11 national academy of sciences NAS NAS:31 neonatal abstinence syndrome NAS NAS:12 normative aging study NAS NAS:63 nucleus accumbens septi NAs NAs:23 nursing assistants NAT1 NAT1:4|NAT-1:1 arylamine nacetyltransferase NAT1 NAT1:38 nacetyltransferase NAT NAT:15 nacetyl transferase NAT NAT:11 nacetyltransferase activity NAT NAT:11 neospora agglutination test NAT NAT:19|NA-T:1 noradrenaline transporter NAT NAT:8 nucleic acid amplification techniques NAT NAT:30 nucleic acid amplification technology NAT NAT:17 nucleic acid amplification testing NAT NAT:32 nucleic acid testing NAT NAT:14 serotoninnacetyltransferase NACS NACS:18 adaptive capacity scores NACS NACS:7 neurologic and adaptive capacity score NBA NBA:19 born alive NBA NBA:13 nbromoacetamide NBD1 NBD1:13|NBD-1:1 nucleotide binding domain NBD1 NBD1:9|NBD-1:1 nucleotidebinding domain NBD-Cl NBD-Cl:9 chloronitrobenzofurazan NBD-Cl NBD-Cl:10 chloronitrobenzoxadiazole NBD-Cl NBD-Cl:37|NBDCl:1|Nbd-Cl:1 chloronitrobenzooxadiazole NBD NBD:23 nitrobenzoxadiazolyl NBD NBD:11 neurobehcets disease NBF NBF:38 nerve blood flow NBF NBF:10 neutral buffered formalin NBL NBL:11 neuroblastic layer NBL NBL:17 newborn larvae NBMPR NBMPR:6 binding of hnitrobenzylthioinosine NBMPR NBMPR:6 nitrobenzylmercaptopurine ribonucleoside NBMPR NBMPR:11 nitrobenzylmercaptopurine riboside NBMPR NBMPR:9 pnitrobenzylthioinosine NBM NBM:24|N-BM:1 normal bone marrow NBM NBM:237|nbm:35|nBM:27|nbM:20|Nbm:4|NBm:4|NbM:2 nucleus basalis magnocellularis NBP NBP:13 pnitrobenzylpyridine NBP NBP:10 nonbacterial prostatitis NBS NBS:99|N-BS:1 nbromosuccinimide NBS NBS:22 national bureau of standards NBs NBs:19|Nbs:4 neuroblasts NBs NBs:22|NBS:1 neuroblastomas NBS NBS:26 newborn screening NBS NBS:125 nijmegen breakage syndrome NBs NBs:57 nuclear bodies NBTI NBTI:13 snitrobenzylthioinosine NBTI NBTI:11 spnitrobenzylthioinosine NBT NBT:112 nitro blue tetrazolium NBT NBT:11 nitroblue tetrazolium dye NBT NBT:16 nitroblue tetrazolium test NBT NBT:5 nitrotetrazolium blue NBT NBT:8 normal brain tissue NBT NBT:9 reduction test NBW NBW:67 normal birth weight NBW NBW:22 normal birthweight NB NB:9 negative binomial NB NB:9|Nb:2 neurobiotin NB NB:19 neuroborreliosis NB NB:10 neuromedin b NB NB:8 nile blue Nb Nb:34|NB:9 nippostrongylus brasiliensis NB NB:40 nitrobenzene NB NB:40|Nb:2 nitrogen balance NB NB:9 nitrosobenzene Nb Nb:14 noble NB NB:32 normalized blur NB NB:9|Nb:1 novobiocin NB NB:23 nutrient broth NCA NCA:13 nested clade analysis NCA NCA:12 neurocirculatory asthenia NCA NCA:74 neutrophil chemotactic activity NCA NCA:31 nonspecific crossreacting antigen NCA NCA:18 normal coronary arteries NCC NCC:8 cytotoxic cell NCC NCC:99 neurocysticercosis NCC NCC:45 nonspecific cytotoxic cells NCC NCC:8 nucleated cell count NCE NCE:5 naca exchanger NCE NCE:13 new chemical entity NCEP NCEP:9 national cholesterol education panel NCEP NCEP:327 national cholesterol education program NCIs NCIs:8 neuronal cytoplasmic inclusions NCIs NCIs:10 noncompetitive inhibitors NCI NCI:31 negative chemical ionization NCI NCI:18 nuclear contour index NCM NCM:19|Ncm:1 caudomedial neostriatum NCM NCM:9 nailfold capillary microscopy NCM NCM:18 neurocutaneous melanosis NCM NCM:12 nitrocellulose membrane NCP NCP:12 neurocybernetic prosthesis NCP NCP:9|ncp:8 noncytopathic NCP NCP:8 nucleus caudatus putamen NCR NCR:18 natural cytotoxicity receptors NCR NCR:15 nitrogen catabolite repression NCR NCR:7 noncoding regions NCR NCR:26 noncontingent reinforcement NCR NCR:30 normotensive control rats NCSE NCSE:29 neurobehavioral cognitive status examination NCSE NCSE:54 nonconvulsive status epilepticus NCS NCS:15 nchlorosuccinimide NCs NCs:14 nanocrystals NCS NCS:35 national comorbidity survey NCS NCS:17 neurocardiogenic syncope NCS NCS:15 noncrystallographic symmetry NCs NCs:34 normal controls NCs NCS:5|NCs:5 normal control subjects NCS NCS:5 nuclear channel system NCs NCs:14 nucleated cells NCS NCS:14 nucleus centralis superior NCT NCT:13 nchlorotaurine NCT NCT:48 neutron capture therapy NCT NCT:24 number connection test N-CWS N-CWS:7|N-cws:1 cell wall skeleton of nocardia rubra N-CWS N-CWS:50 nocardia rubra cell wall skeleton NC NC:9 noncoding NC NC:204 change NC NC:11 nanocapsules NC NC:14 neck circumference NC NC:20 nephrocalcin NC NC:21|nc:1 nephrocalcinosis NC NC:6 neurological complications NC NC:11 nitrosocimetidine NC NC:14 nonclassical NC NC:5 normal children NC NC:12 normal comparison NC NC:10 normal control group NC NC:5 normal cycling NC NC:15 normocholesterolemic NC NC:29 north carolina NC NC:13 nucleus caudatus NC NC:6|nc:1 nucleus circularis NC NC:8 onto nitrocellulose NC NC:10 patients with neurocysticercosis NDA NDA:23 naphthalenedicarboxaldehyde NDA NDA:49 new drug application NDF NDF:31 neu differentiation factor NDF NDF:164 neutral detergent fiber NDI NDI:29 national death index NDI NDI:20 neck disability index NDI NDI:147|N-DI:1 nephrogenic diabetes insipidus NDO NDO:21 naphthalene dioxygenase NDO NDO:9 neurogenic detrusor overactivity ND ND:11 nadh dehydrogenase ND ND:15|Nd:1 nadphdiaphorase ND ND:37|Nd:1 nandrolone decanoate ND ND:24 neck dissection Nd Nd:15 negative difference Nd Nd:12 neodymium ND ND:9 neurologic deficit ND ND:13 neutral density ND ND:14 nicotine dependence ND ND:9 nocodazole ND ND:9 nondemented ND ND:9 nondisabled ND ND:13 nordiazepam ND ND:34 normal diet ND ND:12 normally developing ND ND:29 norrie disease ND ND:5|nd:3 not detected ND ND:19|nD:1 nucleus of darkschewitsch NEB NEB:10 nebulizer NEB NEB:12 negative energy balance NECA NECA:40 nethylcarboxamideadenosine NECA NECA:4 agonist nethylcarboxamidoadenosine NECA NECA:41 nethylcarboxamidoadenosine NEC NEC:618 necrotizing enterocolitis NEC NEC:17 neuroendocrine carcinoma NEC NEC:8 noise equivalent count NED NED:185|ned:1 evidence of disease NED NED:9 neuroendocrine differentiation NEL NEL:2 net energy of lactation NEL NEL:5 noeffect level NEP NEP:29 needle exchange program NEP NEP:38 negative expiratory pressure NEP NEP:38|Nep:1 neprilysin NEP NEP:9 neuroepithelial NEP NEP:432 neutral endopeptidase NEP NEP:9 neutral endopeptidase NEP NEP:9 neutral endopeptidase ec NEP NEP:16 neutral metalloendopeptidase NES NES:15 neurobehavioral evaluation system NES NES:18 neurological evaluation scale NES NES:11 night eating syndrome NES NES:30 nuclear export sequence Ne Ne:12 effective size Ne Ne:5|NE:2 error negativity NE NE:24 lnorepinephrine NE NE:14 necrotic enteritis NE NE:11 neonatal encephalopathy NE NE:85 nephropathia epidemica NE NE:10 net energy NE NE:335|ne:1 neuroendocrine NE NE:12 neuroepithelium NE NE:12 neutropenic enterocolitis NE NE:225 neutrophil elastase NE NE:24 nocturnal enuresis NE NE:81 noradrenergic NE NE:7 norepinephrine levels NE NE:166 nuclear envelope NE NE:5 nutcracker esophagus NE NE:11 nutritional encephalomalacia NE NE:13 release of hnorepinephrine NF-IL6 NF-IL6:5 nuclear factor for interleukin expression NF-IL6 NF-IL6:5 nuclear factor il NF1 NF1:35|NF-1:9 neurofibromatosis type i NF1 NF1:9|Nf1:1 neurofibromin NF2 NF2:135|NF-2:6|Nf2:1 neurofibromatosis NF2 NF2:215|NF-2:8|Nf2:2 neurofibromatosis type NF2 NF2:11|NF-2:2 neurofibromatosis type ii NFA NFA:13 nearfatal asthma NFA NFA:20 niflumic acid NFCS NFCS:12 nationwide food consumption survey NFCS NFCS:13 neonatal facial coding system NFD NFD:17 nephrogenic fibrosing dermopathy NFD NFD:13 neurofibrillary degeneration NF-H NF-H:4|NFH:2 heavy neurofilament NF-H NF-H:12|NFH:2 heavy neurofilament subunit NF-H NF-H:13|NFH:7|Nf-H:1 high molecular weight neurofilament protein NF-H NF-H:9|NFH:1 neurofilament heavy NF-H NF-H:6|NFH:1 subunit of neurofilaments NFI NFI:16 nerve function impairment NFI NFI:91|NF-I:25 nuclear factor i NF-L NF-L:7 light neurofilament NFL NFL:14 national football league NFL NFL:80 nerve fiber layer NF-L NF-L:11 neurofilamentl NF-L NF-L:17|NFL:5 neurofilament light NF-L NF-L:12|NFL:1 neurofilament light chain NF-L NF-L:6|NFL:1 neurofilament light subunit NF-M NF-M:6 middle molecular weight neurofilament protein NF-M NF-M:14|NFM:5 neurofilament NFP NFP:130 natural family planning NFP NFP:11 notforprofit NFS NFS:6 fertility survey NFS NFS:5 national food survey NFs NFs:123|Nfs:1 neurofilaments NFs NFs:9 nod factors NFs NFs:10 nursing facilities NF NF:9 hearts NF NF:39 nanofiltration NF NF:25 native ferritin NF NF:80 necrotizing fasciitis NF NF:172 neurofibromatosis NF NF:9 nissen fundoplication NF NF:13 nitrofurazone NF NF:15|nF:1 nodular fasciitis NF NF:17 nonfailing NF NF:6 normal fibroblasts NGA NGA:14 galactosylneoglycoalbumin NGA NGA:9 neuroglandular antigen NGC NGC:11 neuroglycan c NGC NGC:9|nGC:1|NGc:1 nucleus gigantocellularis NGT NGT:17 nominal group technique NGT NGT:276|nGT:1 normal glucose tolerance NHBE NHBE:65 normal human bronchial epithelial NHBE NHBE:15 normal human bronchial epithelial cells NHC NHC:15 nheterocyclic carbene NHC NHC:6 nonhistone chromosomal NHP NHP:14 natural head position NHP NHP:15 natural head posture NHP NHP:4|Nhp:1|NhP:1|nhp:1 nonhuman primate NHP NHP:13 nonhistone proteins NHP NHP:18 normal human plasma NHP NHP:290 nottingham health profile NHP NHP:14 nursing home placement NHS NHS:11 nancehoran syndrome NHS NHS:20 national health system NHS NHS:5 normal healthy subjects NHS NHS:29 normal human sera NHS NHS:274|nHS:1 normal human serum NHS NHS:7 normal human subjects NHS NHS:18 nurses health study NIA NIA:28 national institute on aging NIA NIA:27 neurolepticinduced akathisia NIA NIA:11 nucleus interpositus anterior NICTH NICTH:10 cell tumor hypoglycemia NICTH NICTH:5 nonislet cell tumour hypoglycaemia NIDDM NIDDM:7 diabetes mellitus type ii NIDDM NIDDM:10 diabetic subjects NIDDM NIDDM:18 noninsulin dependent NIDDM NIDDM:2455 noninsulindependent diabetes mellitus NIDDM NIDDM:6 noninsulindependent dm NIDDM NIDDM:12 noninsulindependent NIH NIH:582 national institutes of health NIH NIH:16 neointimal hyperplasia NIH NIH:19 normalized index of hemolysis NIL NIL:9 nearisogenic line NIL NIL:17 neurointermediate lobe of the pituitary NIP NIP:9 negative inspiratory pressure NIP NIP:13 neurolepticinduced parkinsonism NIP NIP:5|Nip:4 normal immunosuppressive protein NIP NIP:8 nucleus interpositus posterior NIRF NIRF:10 nearinfrared fluorescence NIRF NIRF:7 nearinfrared fluorescent NIS NIS:10 information system NIS NIS:50 nai symporter NIS NIS:40 national immunization survey NIS NIS:28 nationwide inpatient sample NIS NIS:10 neuropsychological impairment scale NIS NIS:26 newly independent states NIS NIS:73 sodium iodide symporter Ni Ni:9 inhibitory guanine nucleotidebinding protein NI NI:10 intake NI NI:7 neurological impairment NI NI:10 neurologically impaired Ni Ni:197 nickel NI NI:16 northern ireland NI NI:22|Ni:1 nucleus isthmi NI NI:14 water immersion to the neck NJ NJ:10|N-J:1 neighbourjoining NJ NJ:37 new jersey NK1 NK1:4|NK-1:1 neurokinin receptors NK1 NK1:19|NK-1:4 substance p receptor NKCC NKCC:30 natural killer cell cytotoxicity NKCC NKCC:12 nk cell cytotoxicity NKC NKC:18 natural killer cytotoxicity NKC NKC:13 nk gene complex NKH NKH:13 nonketotic hyperglycinaemia NKH NKH:8 nonketotic hyperglycemia NKH NKH:33 nonketotic hyperglycinemia NK NK:9 natural NK NK:7 natural killer activity NK NK:70 natural killing NK NK:8 normal kidneys NLA NLA:11 naphthoxylactic acid NLA NLA:27 neuroleptanalgesia NLD NLD:16 nasolacrimal duct NLD NLD:11 necrobiosis lipoidica diabeticorum NLD NLD:17 nonverbal learning disabilities NLK NLK:7|Nlk:3 nemolike kinase NLK NLK:15 neuroleukin NLP NLP:59 natural language processing NLP NLP:10 programming NLSs NLSs:37 nuclear localization sequences NLSs NLSs:123 nuclear localization signals NLS NLS:9 neonatal lupus syndrome NLS NLS:8 nonlinear least squares NLS NLS:11 nonlinear schrodinger NL NL:13 children with normal language NL NL:6 native liver NL NL:22 necrobiosis lipoidica NL NL:27 neural lobe NL NL:8 normal liver NL NL:10 normolipidemic NMA NMA:11 nmethylacetamide NMA NMA:10 nnitrosonmethylaniline NMA NMA:10 nnitrosomethylaniline NMA NMA:7 national medical association NMA NMA:9 normal mode analysis NMB NMB:34 neuromuscular block NMB NMB:31 neuromuscular blockade NMB NMB:16 neuromuscular blocking NMC NMC:13|NmC:1 neuromedin c NMC NMC:8 nucleus magnocellularis NMDAR1 NMDAR1:7 nmethyldaspartate receptor NMDAR1 NMDAR1:7 nmda receptor subunit NMDA NMDA:34 nmethyldasparate NMDA NMDA:10 nmethyldaspartic NMDA NMDA:524|NM-DA:1 nmethyldaspartic acid NMD NMD:37 nonsensemediated decay NMD NMD:105 nonsensemediated mrna decay NMES NMES:26 national medical expenditure survey NMES NMES:59 neuromuscular electrical stimulation NMES NMES:9 nonmilk extrinsic sugars NMN NMN:11|NM-N:3 neuromedin n NMN NMN:38 nicotinamide mononucleotide NMP NMP:11 methylpyrrolidinone NMP NMP:15 nucleoside monophosphate NMRD NMRD:33 nuclear magnetic relaxation dispersion NMRD NMRD:12 respiratory disease NMR NMR:9 classically conditioned nictitating membrane response NMR NMR:15 neonatal mortality rate NMS NMS:6 antagonist nmethylscopolamine NMS NMS:24 neurally mediated syncope NMS NMS:338 neuroleptic malignant syndrome NMS NMS:31 normal mouse serum NMTT NMTT:16 nmethyltetrazolethiol NMTT NMTT:8|N-MTT:1 nmethylthiotetrazole NMT NMT:30|Nmt:7 myristoylcoaprotein nmyristoyltransferase NMT NMT:12 nmyristoyl transferase NMT NMT:10|nmt:1 neuromuscular transmission NMT NMT:6 norepinephrine nmethyltransferase NMU NMU:54 nnitrosomethylurea NMU NMU:34|NmU:16 neuromedin u NMU NMU:47 nitrosomethylurea NM NM:17 nemaline myopathy NM NM:14 neoplastic meningitis NM NM:31 neuromelanin NM NM:24|N-M:3|nm:2|n-m:2 neuromuscular NM NM:58 nictitating membrane NM NM:11 nitrosomorpholine NM NM:27 nodular melanoma NM NM:8 normal mice NM NM:9 normal mucosa NM NM:11 normorphine NM NM:59 nuclear matrix NM NM:15 nuclear medicine NNK NNK:17 methylnitrosaminopyridylbutanone NNK NNK:27 nmethylnnitrosaminopyridylbutanone NNK NNK:19 nnitrosomethylaminopyridylbutanone NNN NNN:31 nnitrosonornicotine NNN NNN:12 nitrosonornicotine nNOS nNOS:5 neuronal isoform nNOS nNOS:9 neuronal nosynthase NNS NNS:6 national natality survey NNS NNS:11 national nutrition survey NNT NNT:3 calculate the relative benefit and the numberneededtotreat NNT NNT:7 needed to be treated NO(x) NO(x):6 nitrate and nitrite NO(x) NO(x):7 nitric oxide metabolites NO(x) NO(x):7 nitrite and nitrate NOAEL NOAEL:19 observable adverse effect level NOAEL NOAEL:66 observed adverse effect level NOA NOA:5 men with nonobstructive azoospermia NOA NOA:18 nonobstructive azoospermia NOD NOD:8 nocturnal oxygen desaturation NOD NOD:7 nocturnal oxyhemoglobin desaturation NOD NOD:714 nonobese diabetic NOD NOD:7 nonobese diabetic mouse NOESY NOESY:92 nuclear overhauser effect spectroscopy NOESY NOESY:9 nuclear overhauser enhancement NOESY NOESY:6 twodimensional noe NOF NOF:12 national osteoporosis foundation NOF NOF:17 neurite outgrowth factor NOM NOM:170 natural organic matter NOM NOM:16|Nom:7|nom:1 nomifensine NOM NOM:25 nonoperative management NOM NOM:19 normal oral mucosa NOR NOR:17|Nor:5|nor:3 nitric oxide reductase NOR NOR:7|Nor:1|nor:1 norgestomet NOR NOR:60|nor:1 nucleolus organizer region NOR NOR:15 nucleolus organizing region NOR NOR:12 nucleus olfactoretinalis NOS NOS:10|NOs:2 nitric oxide synthesis NOS NOS:45 nitric oxide synthetase NOS NOS:60 nosynthase NOS NOS:111|nos:2 not otherwise specified NOX NOX:10|Nox:3|nox:1 nadh oxidase NOX NOX:8|Nox:7 nadph oxidase NOx NOx:15 nitrite plus nitrate NOx NOx:18 plasma nitritenitrate NO NO:8 nitric oxide gas NO NO:64|no:1 nitrogen monoxide NO NO:7|N-o:1|no:1 nodes NO NO:7 nucleolus organizer NP1 NP1:7 neuronal pentraxin NP1 NP1:9 nuclease p NPA NPA:4 agonist npropylnorapomorphine NPA NPA:12 asparagineprolinealanine NPA NPA:25 nnpropylnorapomorphine NPCs NPCs:31 nasopharyngeal carcinomas NPCs NPCs:32 neural progenitor cells NPCs NPCs:139 nuclear pore complexes NPC NPC:92 nasopharyngeal cancer NPC NPC:5 near point of convergence NPC NPC:5 nearpoint of convergence NPC NPC:13 net protein catabolism NPC NPC:50|NP-C:23 niemannpick disease type c NPC NPC:11|NP-C:4 niemannpick type c disease NPC NPC:10 nonparenchymal liver cells NPC NPC:5|nPC:1 nucleus of the posterior commissure NPD NPD:13 narcissistic personality disorder NPD NPD:14 nasal potential difference NPD NPD:10 nocturnal paroxysmal dystonia NPD NPD:6 normal protein diet NPEOs NPEOs:11 nonylphenol ethoxylates NPEOs NPEOs:9 nonylphenol polyethoxylates NPE NPE:46 neurogenic pulmonary edema NPE NPE:26 nonpigmented ciliary epithelial NPE NPE:9 nonpigmented ciliary epithelium NPE NPE:23 nonpigmented epithelial NPE NPE:8 nonpigmented epithelium NPF NPF:5 neuritepromoting factor NPF NPF:28 neuropeptide f NPG NPG:10 nphenylglycine NPG n-PG:4|NPG:4|nPG:1 npropyl gallate NPG NPG:23 normal pressure glaucoma NPHS NPHS:83 national population health survey NPHS NPHS:10 northwick park heart study NPH NPH:51 neutral protamine hagedorn NPH NPH:218 normal pressure hydrocephalus NPH NPH:8 nph insulin NPH NPH:19|nph:4 nucleus prepositus hypoglossi NPH NPH:16 patients with normalpressure hydrocephalus NPL NPL:10 linkage analysis NPL NPL:13 national physical laboratory NPM NPM:9 npyrenylmaleimide NPM NPM:13 nphenylmaleimide NPM NPM:68 nucleophosmin NPM NPM:12 nucleophosminb NPN NPN:8 nonprotein n NPN NPN:4 probe nphenylnaphthylamine NPO NPO:10 nucleus pontis oralis NPO NPO:27|nPO:1|npo:1|Npo:1 nucleus preopticus NPPB NPPB:8 channel blocker nitrophenylpropylaminobenzoate NPPB NPPB:10 normal perfusion pressure breakthrough NPP NPP:13 net primary production NPP NPP:14 net primary productivity NPP NPP:7 new permeation pathways NPP NPP:13|nPP:4 nonphytate p NPP NPP:11|nPP:1 nonphytate phosphorus NPP NPP:15 nuclear power plant NPP NPP:16|npp:1 nucleus preopticus periventricularis NPRO NPRO:69|N-Pro:1|NPro:1 nnitrosoproline NPRO NPRO:12|NPro:1 nitrosoproline NPSH NPSH:5|NP-SH:1 nonprotein sulfhydryl groups NPSH NPSH:7|NP-SH:4 nonprotein sulphydryl NPSH NPSH:8 nonprotein thiols NPSLE NPSLE:11|NP-SLE:1 neuropsychiatric sle NPSLE NPSLE:32|NP-SLE:5 neuropsychiatric systemic lupus erythematosus NPTR NPTR:15 national pediatric trauma registry NPTR NPTR:14 nocturnal penile tumescence and rigidity NPT NPT:7 nasal provocation testing NPT NPT:16 nasopharyngeal temperature NPT NPT:9 near patient testing NPT NPT:125 nocturnal penile tumescence NPT NPT:12|npt:2 nonpermissive temperature NPY-LI NPY-LI:9 neuropeptide y NPY-LI NPY-LI:4|NPYLI:1 neuropeptide ylike immunoreactive NPY-LI NPY-LI:85|NPYLI:11|NPY-li:2|NPY-Li:1 neuropeptide ylike immunoreactivity NPY-LI NPY-LI:34|NPY-li:3|NPYLI:1|NPY-Li:1 npylike immunoreactivity NPY-IR NPY-IR:9|NPY-ir:7 neuropeptide yimmunoreactive NPY-IR NPY-IR:8|NPY-ir:3|NPYir:1 npyimmunoreactive NPY NPY:12 neuropeptide NPY NPY:93 neuropeptide tyrosine NPs NPs:27 nanoparticles NPs NPs:12|Nps:1 nasal polyps NPs NPs:53 natriuretic peptides NPs NPs:29 neuritic plaques NPS NPS:12 neuropathic pain scale NPS NPS:14 noise power spectra NPS NPS:8 nonpoint source NPs NPs:9 noun phrases NP NP:20 hydroxynitrophenyl acetyl NP NP:9 hydroxynitrophenylacetyl NP NP:7 alcohol nonpreferring NP NP:19 antihydroxynitrophenylacetyl NP NP:18 hapten hydroxynitrophenylacetyl NP NP:45 influenza virus nucleoprotein NP NP:5 metabolite norpropoxyphene NP NP:35 nasal polyposis NP NP:80 nasopharyngeal NP NP:17 nasopharynx NP NP:16 neck pressure NP NP:15 necrotizing pancreatitis NP NP:23 negative priming NP NP:11 neuritic plaque NP NP:11 neuropathic pain NP NP:36|Np:4 neurophysin NP NP:32 neuropsychiatric NP NP:97 neuropsychological NP NP:8 normal plasma NP NP:11 normal pregnancy NP NP:9 normal pregnant NP NP:6 normal pregnant women NP NP:8 normal prostate NP NP:52 nosocomial pneumonia NP NP:13 noun phrase NP NP:12 nucleoproteins NP NP:31|Np:2 nucleoside phosphorylase NP NP:57 nucleus pulposus NP NP:29 pnonylphenol NQR NQR:10 nadhquinone reductase NQR NQR:15 nuclear quadrupole resonance NR2B NR2B:6 nmda receptor b NR2B NR2B:8|NR2b:1 receptor subunit b NRA NRA:10 neuroretinal rim area NRA NRA:14 nitrate reductase activity NRA NRA:19 nucleus retroambiguus NRC NRC:14 conditioner NRC NRC:90 national research council NRC NRC:12 neo red cells NRC NRC:49 nuclear regulatory commission NREM NREM:16 eye movement sleep NREM NREM:14 nonrapideyemovement NRH NRH:42 nodular regenerative hyperplasia NRH NRH:9 nodular regenerative hyperplasia of the liver NRK NRK:11 normal rat kidney cells NRK NRK:6 rat kidney fibroblasts NRL NRL:151 natural rubber latex NRL NRL:4|Nrl:3 neural retina leucine zipper NRL NRL:10|nrl:1 nucleus recessus lateralis NRL NRL:11 nucleus reticularis lateralis NRS NRS:18|nrs:1 negative regulator of splicing NRS NRS:126 normal rabbit serum NRT NRT:26 neural response telemetry NRT NRT:21|nRT:8|nRt:5 nucleus reticularis thalami NR NR:10 natural resistance NR NR:23 neural retina NR NR:19 neuroretina NR NR:124 neutral red NR NR:17 nitroreductase NR NR:29 normotensive rats NR NR:12 responders NSC NSC:25 neurosecretory cells NSC NSC:8 nonstructural carbohydrate NSF NSF:83 nethylmaleimidesensitive factor NSF NSF:78 nethylmaleimidesensitive fusion protein NSF NSF:42 national service framework NSG NSG:9 necrotizing sarcoid granulomatosis NSG NSG:34|nsg:1 neurosecretory granules NSI NSI:6 needlestick injury NSI NSI:6 nitrogen solubility index NSI NSI:16 nonsyncytiuminducing NSI NSI:7 normalized slope index NSI NSI:11 nutrition screening initiative NSN NSN:26 nephrotoxic serum nephritis NSN NSN:5 nicotinestimulated neurophysin NSOM NSOM:16 nearfield scanning optical microscope NSOM NSOM:32 nearfield scanning optical microscopy NSP NSP:7 neuroendocrinespecific protein NSP NSP:10 neurotoxic shellfish poisoning NSP NSP:23 neurotropin NSP NSP:8 neutrophil storage pool NSR NSR:11 negative slope resistance NSR NSR:68 normal sinus rhythm NSS NSS:25 neurological severity score NSS NSS:32 neurological soft signs NSS NSS:11 neuropathy symptom score NSS NSS:15 normal sheep serum NSTs NSTs:8 nerve sheath tumors NSTs NSTs:27|NSTS:1 nonstress tests NST NST:9 nocistatin NST NST:37 nonstress test NST NST:6 nondirective supportive therapy NST NST:9 nonstress testing NST NST:12 nutrition support team NSV NSV:11 neuroadapted sindbis virus NSV NSV:19 noscalpel vasectomy NS NS:21 nacl NS NS:16|Ns:1 nanospheres NS NS:10 naproxen sodium NS NS:8 nasal secretions NS NS:73 natural suppressor NS NS:15 neck suction NS NS:6|N-S:1 negative symptoms NS NS:13|Ns:1 neostriatum NS NS:26 nervous system NS NS:10|ns:1 neurosecretory NS NS:9 nevus sebaceus NS NS:9 nigrostriatal NS NS:20 nodular sclerosing NS NS:69 nodular sclerosis NS NS:9|ns:2 nonsignificant NS NS:51 noonan syndrome NS NS:8 normal salt NS NS:8|ns:2|Ns:1 normal serum NS NS:10 normal skin NS NS:67 novelty seeking NS NS:15 nutritional status NS NS:7 nutritional support NTA NTA:12 natural thymocytotoxic autoantibody NTA NTA:60|nta:1 nitrilotriacetate NTA NTA:10 thymocytotoxic autoantibodies NTB NTB:33 naltriben NTB NTB:13 necrotizing tracheobronchitis NTB NTB:16 netobimin NTD NTD:42|N-td:2|NtD:1 nterminal domain NTD NTD:12 normalized total dose NTE NTE:10 nasal transitional epithelium NTE NTE:160 neuropathy target esterase NTE NTE:88 neurotoxic esterase NTG NTG:5 nontoxic goiter NTG NTG:11 normotriglyceridemic NTI NTI:3 delta opioid receptor antagonist naltrindole NTI NTI:8 patients with nonthyroidal illnesses NTL NTL:9 neartotal laryngectomy NTL NTL:31 netilmicin NTM NTM:9 nontuberculous mycobacteriosis NTM NTM:10 nontuberculous mycobacterium NTPase NTPase:37 nucleoside triphosphatase NTPase NTPase:11 nucleoside triphosphate hydrolase NTP NTP:5 national tb control programme NTP NTP:214 national toxicology program NTP NTP:10 national tuberculosis control programme NTP NTP:23 national tuberculosis programme NTR NTR:5|ntr:1 escherichia coli nitroreductase NTR NTR:5 nadpthioredoxin reductase NTR NTR:18|NT-r:1|NT-R:1 neurotensin receptor ntr ntr:6|Ntr:4 nitrogen regulation ntr ntr:5|NTR:3|Ntr:1 nitrogen regulatory NTS NTS:50 nephrotoxic serum NTs NTs:9 neuroblastic tumors NTs NTs:63|Nts:1 neurotrophins NTS NTS:20 nevada test site NTS NTS:7 nontranscribed strand NTS NTS:5 nontyphi salmonellae NTS NTS:10 nontyphoidal salmonella NTS NTS:5 nucleolar targeting signal NTS NTS:451|nTS:24|nts:3|Nts:1 nucleus tractus solitarii NTS NTS:597|nTS:24|nts:4|nTs:1 nucleus tractus solitarius NTS NTS:8|nTS:1 solitary nucleus NTS NTS:20|nTS:1 solitary tract nucleus NTx NTX:2|Ntx:2|NTx:2 collagen i NTx NTx:6|NTX:3 i collagen crosslinked ntelopeptide NTx NTx:4|NTX:2 nterminal telopeptide NTx NTx:14|NTX:3|nTx:3 neonatally thymectomized NTX NTX:20|NTx:2 noxiustoxin NTX NTX:8 opioid antagonist naltrexone NTx NTx:7|NTX:2 telopeptides NTx NTx:5|NTX:1|N-Tx:1 type i collagen crosslinked ntelopeptides NTX NTX:6|NTx:5|Ntx:1 urinary ntelopeptide NT NT:25 botulinum neurotoxin NT NT:18|Nt:4 nterminal NT NT:14 natural t NT NT:10 neural tube NT NT:869|Nt:1 neurotensin NT NT:56|Nt:6 neutralization NT NT:38|Nt:10 neutralizing NT NT:9 nick translation NT NT:12|N-T:1 nontrained NT NT:13 nontypeable NT NT:5 normal training NT NT:9 normotension NT NT:65 normotensive subjects NT NT:10 normotest NT NT:9 normothermia NT NT:48 northern territory NT NT:175 nuchal translucency NT NT:25 nuchal translucency thickness NT NT:149 nuclear transfer NT NT:17 nucleation time NVB NVB:16 navelbine NVB NVB:16 neurovascular bundle NVD NVD:6 neovascularization of the disc NVD NVD:9 neurovesical dysfunction NVD NVD:8 optic disc NVP NVP:6 nausea and vomiting during pregnancy NVP NVP:117|Nvp:4 nevirapine NVSS NVSS:10 national vital statistics system NVSS NVSS:6 normal variant short stature NV NV:11 nausea and vomiting NV NV:21 normal volunteers NV NV:81 norwalk virus NV NV:6|Nv:5 per unit volume NV NV:10 retinal neovascularization NW NW:25|Nw:1 normal weight NW NW:7 normal wistar NW NW:5 normal women NW NW:6 normotensive wistar NYHA NYHA:985 new york heart association NYHA NYHA:4 new york heart association classification NYS NYS:48 new york state NYS NYS:10|Nys:3 nystatin NY NY:24 new york NY NY:39 nuclear yellow Na/K Na/K:11 sodiumpotassium Na/K Na/K:5 sodiumpotassium ratio Na/K Na/K:4 sodium to potassium NAA NAA:41 nacetyllaspartate NAA NAA:424|Naa:5 nacetylaspartate NAA NAA:14 nacetylaspartic acid NAA NAA:13 naphthalene acetic acid NAA NAA:12 neutral amino acids NAA NAA:105 neutron activation analysis NAA NAA:17 nucleic acid amplification NAE NAE:10 neoplastic angioendotheliomatosis NAE NAE:9 neoplastic angioendotheliosis NAE NAE:33 net acid excretion NAF NAF:18|Naf:2|naf:1 nafenopin NAF NAF:9 national abortion federation NAF NAF:8 neutrophilactivating factor NAF NAF:44 nipple aspirate fluid NAI NAI:9|N-AI:1 nacetylimidazole NAI NAI:19 nonaccidental injury NAO NAO:17 nonyl acridine orange NAO NAO:26 north atlantic oscillation Neoral Neoral:18|neoral:1 cyclosporine microemulsion Neoral Neoral:9 formulation of cyclosporin NeuN NeuN:17 neuronspecific nuclear protein NeuN NeuN:14 neuronal nuclear antigen NG NG:71|ng:1 nasogastric NG NG:9 net grainsnucleus NG NG:7 neutrophil granulocytes NG NG:9 nitrosoguanidine NG NG:21 nodose ganglia NG NG:26 nodose ganglion NG NG:12|Ng:2 norgestrel NG NG:11 normal glucose NG NG:20|ng:1 nuclear grade NIR NIR:15 nearinfrared interactance NIR NIR:5 nearinfrared radiation NiSO4 NiSO4:15 nickel sulfate NiSO4 NiSO4:9 nickel sulphate NIC NIC:14 neonatal intensive care NIC NIC:12|Nic:7|nic:1 nicorandil NIC NIC:48|Nic:21 nicotine NIC NIC:7|Nic:1 nicotinic acid NIC NIC:51 nursing interventions classification NN NN:7|nn:1|N-N:1|n-n:1 nearestneighbor NN NN:8 neoplastic nodules NPI NPI:132 neuropsychiatric inventory NPI NPI:54 nottingham prognostic index NuMA NuMA:9 nuclear mitotic apparatus NuMA NuMA:32 nuclear mitotic apparatus protein O2- O2-:15 superoxide ion O2- O2-:8 superoxide production OA1 OA1:15 ocular albinism OA1 OA1:17|Oa1:1 ocular albinism type OAD OAD:21 obliterative airway disease OAD OAD:15 obstructive airways disease OAD OAD:10 overanxious disorder OAG OAG:16 oleoylacetylracglycerol OAG OAG:86|OaG:1 oleoylacetylsnglycerol OAG OAG:9 oleylacetylglycerol OAG OAG:1 tpa and oleoylacetylglycerol OAR OAR:11 office of aids research OAR OAR:17 ottawa ankle rules OASIS OASIS:11 organization to assess strategies for ischemic syndromes OASIS OASIS:13 outcome and assessment information set OAS OAS:30 oacetyllserine OAS OAS:45 oral allergy syndrome OAS OAS:24 overt aggression scale OA OA:16 actively sensitized to ovalbumin OA OA:2 guinea pigs sensitized with ovalbumin OA OA:38 human osteoarthritic OA OA:41 normal and osteoarthritic OA OA:11 obstructive azoospermia OA OA:96 occupational asthma OA OA:29 oesophageal atresia OA OA:11 oleic OA OA:233 oleic acid OA OA:11 open adrenalectomy OA OA:40 open appendectomy OA OA:95 ophthalmic artery OA OA:10 oral appliance OA OA:3255 osteoarthritis OA OA:23 patients with osteoarthrosis OA OA:48 phosphatase inhibitor okadaic acid OA OA:1 rats sensitized to ovalbumin OBP OBP:5 hsv originbinding protein OBP OBP:18 odorantbinding protein OBP OBP:19|oBP:1 office blood pressure OBP OBP:19 origin binding protein OBR OBR:5 origin of bidirectional dna replication OBR OBR:9 origin of bidirectional replication OBs OBs:8 olfactory bulbs OBs OBs:18|Obs:3 osteoblasts OB OB:18|ob:8|Ob:1 leptin ob ob:14|OB:3 obese gene OB OB:130 obliterative bronchiolitis OB OB:22 olfactory bulbectomized OB OB:9 oligoclonal igg bands ob ob:16|OB:1 osteoblastenriched OB OB:12|ob:1 osteoblastlike OB OB:9|ob:3 osteoblastic OB OB:8 otilonium bromide OB OB:20 oxidative burst OB OB:5|ob:4 product of the obesity OCB OCB:29 olivocochlear bundle OCB OCB:13 organizational citizenship behavior OCD OCD:15 occupational contact dermatitis OCD OCD:5 organconfined disease OCD OCD:9 oxygen cost diagram OCLs OCLs:38|Ocls:1 osteoclastlike cells OCLs OCLs:15 osteoclastlike multinucleated cells OCP OCP:90|ocp:1 octacalcium phosphate OCP OCP:64 ocular cicatricial pemphigoid OCP OCP:11 onchocerciasis control program OCP OCP:23 onchocerciasis control programme OCP OCP:22 onchocerciasis control programme in west africa OCP OCP:11 open circuit potential OCR OCR:20 cancer registry OCR OCR:17 ocular counterrolling OCR OCR:21 oculocardiac reflex OCT OCT:47 oxacalcitriol OCT OCT:17 optical coherence tomographic OCT OCT:719 optical coherence tomography OCT OCT:24|Oct:1 organic cation transporter OCT OCT:16|Oct:1 ornithine carbamoyl transferase OCT OCT:20 ornithine carbamyl transferase OCL OCL:23|Ocl:1|ocl:1 osteoclast OCL OCL:12|Ocl:2 osteoclastlike cell OCs OCs:6 concentrations of persistent organochlorines OCS OCS:25 obsessivecompulsive symptoms OCs OCs:34 obstetric complications OCS OCS:17 octachlorostyrene OCS OCS:45 open canalicular system OCS OCS:29|OCs:1 oral contraceptive steroids OCS OCS:8|OCs:1 oral corticosteroids OCs OCs:9 organic cations OCs OCs:15 organochlorine contaminants OC OC:1 obsessive or compulsive OC OC:11 occipital cortex OC OC:11 oleoresin capsicum OC OC:36 olivocochlear OC OC:11 open cholecystectomies OC OC:10 open colectomy OC OC:20 oral candidiasis OC OC:124 oral contraception OC OC:11 organ culture OC OC:39 organ of corti OC OC:106 organic carbon OC OC:123 organochlorine OC OC:19 osteochondrosis OC OC:9 outer cortex OC OC:56 ovarian cancer OC OC:7 oxidized cellulose ODC ODC:2353|odc:8|Odc:7 ornithine decarboxylase ODC ODC:34 ornithine decarboxylase activity ODE ODE:6 odemethyl encainide ODE ODE:8 odesmethyl encainide ODE ODE:11 ordinary differential equation ODF ODF:42|Odf:1 osteoclast differentiation factor ODF ODF:20 outer dense fibers ODI ODI:33 oswestry disability index ODI ODI:47 oxygen desaturation index ODN ODN:2 endogenous benzodiazepine receptor ligand octadecaneuropeptide ODN ODN:16 open donor nephrectomy ODQ ODQ:9 guanylate cyclase inhibitor ODQ ODQ:4 inhibitor hoxadiazoloalphaquinoxalinone ODQ ODQ:11 oswestry disability questionnaire ODQ ODQ:4 soluble guanylyl cyclase inhibitor hoxadiazoloaquinoxalinone ODV ODV:3 active metabolite odesmethylvenlafaxine ODV ODV:24 occlusionderived virus ODS ODS:34 octadecylsilane ODS ODS:29 octadecylsilica ODS ODS:6 osmotic demyelination syndrome ODS ODS:33 osteogenic disorder shionogi ODS ODS:9 silica gel OD OD:10 development OD OD:32 ocular dominance OD OD:17 oesophageal dysfunction OD OD:7 oocyte donation OD OD:10 orthostatic dysregulation OD OD:15|od:1 outer diameter OEC OEC:10 olfactory ensheathing cell OEC OEC:10 oviductal epithelial cells OEC OEC:50 oxygenevolving complex OEP OEP:19 common antigen OEP OEP:9 common protective antigen OE OE:120|oe:1 olfactory epithelium OE OE:11 otitis externa OE OE:11 outer envelope OFC OFC:14 head circumference OFC OFC:16 occipitofrontal circumference OFC OFC:95|OfC:1 orbitofrontal cortex OFD OFD:13 open flap debridement OFD OFD:12|O-F-D:1 oralfacialdigital OF OF:27 opacity factor OF OF:7 oral fluid OF OF:8 orbital fibroblasts OF OF:9 organ failure OF OF:19 osmotic fragility OF OF:10 osteitis fibrosa OGD OGD:17 oesophagogastroduodenoscopy OGD OGD:46 oxygen and glucose deprivation OGD OGD:107 oxygenglucose deprivation OGP OGP:24 osteogenic growth peptide OGP OGP:8 oviductspecific glycoprotein OGT OGT:5 effects of orengedokuto OGT OGT:16 oglcnac transferase OG OG:11 noctylbetadglucopyranoside OG OG:26 octyl glucoside OG OG:16 octylglucoside OHAs OHAs:13 oral hypoglycaemic agents OHAs OHAs:14 oral hypoglycemic agents OHP OHP:26 high pressure OHP OHP:13 oregon health plan OHS OHS:23 obesity hypoventilation syndrome OHS OHS:22 occupational health and safety OHS OHS:11 ontario health survey OHS OHS:7 oxford hip score OHT OHT:100 ocular hypertension OHT OHT:10 orthotopic heart transplant OHT OHT:49|oHT:1 orthotopic heart transplantation OH OH:9 hydroxy OH OH:18 occupational health OH OH:108 orthostatic hypotension OIA OIA:8 oilinduced arthritis OIA OIA:15 optical immunoassay OIH OIH:13 iorthoiodohippurate OIH OIH:18 orthoiodohippurate OI OI:32 orthostatic intolerance OI OI:8 ovulation induction OI OI:108 oxygenation index OJ OJ:41 obstructive jaundice OJ OJ:11 orange juice OKT3 OKT3:6|OKT-3:1 anticd antibodies OKT3 OKT3:7 murine monoclonal anticd antibody OKT3 OKT3:13|OKT-3:2 muromonabcd OLA OLA:37 oligonucleotide ligation assay OLA OLA:6 ouabainlike activity OLC OLC:6 oligodendrocytelike cells OLC OLC:17 ouabainlike compound OLF OLF:19 ossification of the ligamentum flavum OLF OLF:17 ouabainlike factor OLM OLM:9 ocular larva migrans OLM OLM:15 outer limiting membrane OLP OLP:255 oral lichen planus OLP OLP:11 oropharyngeal leak pressure OL OL:6 optic layer OL OL:11 oral leukoplakia OMC OMC:33 open mitral commissurotomy OMC OMC:12 ostiomeatal complex OMI OMI:78 old myocardial infarction OMI OMI:11 oocyte maturation inhibitor OMPC OMPC:10 otitis media purulenta chronica OMPC OMPC:10 outer membrane protein complex OMP OMP:129 olfactory marker protein OMP OMP:22|Omp:1 orotidine monophosphate OMT OMT:14 omethyltransferase OMT OMT:10 ocular microtremor OMT OMT:44 osteopathic manipulative treatment OM OM:9 occupational medicine OM OM:15 olfactory mucosa OM OM:9 oncomodulin OM OM:62 oncostatin m OM OM:24 operative mortality OM OM:24 optical microscopy OM OM:9 oral mucosa OM OM:14 oral mucositis OM OM:21|O-M:5 osbornemendel OM OM:26 osteomalacia OM OM:20 osteomyelitis OM OM:201 otitis media OM OM:25 outer medulla OM OM:11 ovulation method ONH ONH:190|onh:1 optic nerve head ONH ONH:15 optic nerve hypoplasia ONSD ONSD:11 optic nerve sheath decompression ONSD ONSD:8 optic nerve sheath diameter ONS ONS:19 office for national statistics ONS ONS:33 oncology nursing society ONS ONS:9 optic nerve section ON ON:8|on:1 depolarizing ON ON:26 olfactory nerve ON ON:5|on:4 onset ON ON:5 onufs nucleus ON ON:178 optic neuritis ON ON:63 osteonecrosis OO OO:21|oo:3 orbicularis oculi OO OO:10 osteoid osteoma OPA OPA:11 derivatization with ophthaldialdehyde OPA OPA:6|opa:1 occupational physical activity OPA OPA:22 ocular pulse amplitude Opa Opa:14 opacityassociated Opa Opa:7 opacity proteins OPA OPA:6 opsonophagocytic activity OPA OPA:7 opsonophagocytic assay OPA OPA:20 orthophthalaldehyde OPA OPA:18 ovine pulmonary adenocarcinoma OPCAB OPCAB:147|OP-CAB:3 offpump coronary artery bypass OPCAB OPCAB:11 offpump coronary artery bypass surgery OPCs OPCs:43 oligodendrocyte precursor cells OPCs OPCs:36 oligodendrocyte progenitor cells OPC OPC:6 involuntary outpatient commitment OPC OPC:39 oropharyngeal candidiasis OPC OPC:9 ovine pulmonary carcinoma OPD OPD:26|o-PD:9|opd:1 ophenylenediamine OPD OPD:8 other personality disorders OPD OPD:11 otopalatodigital OPG OPG:19 oculoplethysmography OPG OPG:537|opg:1 osteoprotegerin OPIDN OPIDN:61 delayed neuropathy OPIDN OPIDN:17 organophosphorus compoundinduced delayed neurotoxicity OPIDN OPIDN:18 organophosphorus esterinduced delayed neurotoxicity OPLL OPLL:170|opll:1 ossification of the posterior longitudinal ligament OPLL OPLL:22 ossification of the posterior longitudinal ligament of the spine OPO OPO:22 optical parametric oscillator OPO OPO:21 organ procurement organization OPP OPP:33|o-PP:1 ophenylphenol OPP OPP:40 ocular perfusion pressure OPP OPP:13 office of pesticide programs Opp Opp:19|opp:10 oligopeptide permease Opp Opp:10 oligopeptide transport system OPP OPP:9 organophosphate poisoning OPP OPP:17 orthophenylphenol OPP OPP:13 ovine progressive pneumonia OPU OPU:8 oocyte pickup OPU OPU:27 ovum pickup OPV OPV:14 oral poliovaccine OPV OPV:11 oral poliovirus OPV OPV:159 oral poliovirus vaccine OPV OPV:9 orthopoxvirus OPZ OPZ:18 oltipraz OPZ OPZ:27|OpZ:12 opsonized zymosan OPS OPS:11 objective pain scale OPS OPS:5 objective pain score OPs OPs:51 organophosphates OPs OPs:7 organophosphate insecticides OPs OPs:7|OPS:1 organophosphate pesticides OPs OPs:16 organophosphorus insecticides OPS OPS:5 orpington prognostic score OPS OPS:20 orthogonal polarization spectral OPs OPs:134|Ops:2 oscillatory potentials OP OP:42 tertoctylphenol OP OP:10 ophenanthroline OP OP:9 obesityprone OP OP:7 opening pressure OP OP:10 opponens pollicis OP OP:17 organizing pneumonia OP OP:23 organophosphorous OP OP:215 organophosphorus OP OP:10 oropharyngeal OP OP:8|op:1 oropharynx OP OP:8 osmotic pressure OP OP:95|Op:1 osteoporosis OP OP:9 osteoporotic OP OP:13 outpatient ORBC ORBC:7 ox erythrocytes ORBC ORBC:11 ox red blood cells ORCC ORCC:13 outwardly rectifying chloride channel ORCC ORCC:5 outwardly rectifying cl channels ORD ORD:21 optical rotatory dispersion ORD ORD:14 outer ring deiodination ORL1 ORL1:6|ORL-1:1 endogenous ligand of the opioid receptorlike ORL1 ORL1:7|ORL-1:5 opioid receptorlike receptor ORs ORs:20 odorant receptors ORs ORs:30|ors:1 olfactory receptors ORs ORs:20 operating rooms ORs ORs:10 orienting responses ORT ORT:271 oral rehydration therapy ORT ORT:14 ornithobacterium rhinotracheale ORT ORT:7 orthodromic reciprocating tachycardia ORX ORX:13|orx:3 orchidectomy ORX ORX:16|orx:1 orchiectomized OSA OSA:315 obstructive sleep apnoea OSA OSA:5 ordered subset analysis OSA OSA:23 osteosarcoma OSC OSC:11 orthogonal signal correction OSC OSC:19 oxidosqualene cyclase OSE OSE:26 ovarian surface epithelial OSE OSE:92 ovarian surface epithelium OS OS:10 core oligosaccharide OS OS:9|os:1 ocimum sanctum OS OS:16 oligosaccharides OS OS:9 omenn syndrome OS OS:13 onestep OS OS:28 open splenectomy OS OS:9 open surgery OS OS:8 opitz syndrome OS OS:9 oppositesex OS OS:18|O-S:1 ouabainsensitive OS OS:18|os:1 overshoot OTA OTA:15 office of technology assessment OTA OTA:11 oxytocin antagonist OTB OTB:10 ochratoxin b OTB OTB:10 operant test battery OTB OTB:9 oxitropium bromide OTC OTC:17 loxothiazolidinecarboxylate OTC OTC:17 loxothiazolidinecarboxylic acid OTC OTC:203|otc:2 oxytetracycline OTM OTM:14 olive tail moment OTM OTM:11 orthodontic tooth movement OTS OTS:14 octadecyltrichlorosilane OTS OTS:10 overtraining syndrome OTR OTR:12 ocular tilt reaction OTR OTR:11|OTr:1|OT-R:1 ot receptors OTR OTR:11 oxygen transfer rate OT OT:11 occlusion time OT OT:11 ocular torsion OT OT:9 old tuberculin OT OT:58 olfactory tubercle OT OT:15 oligosaccharyl transferase OT OT:7 operating theatre OT OT:32 optic tectum OT OT:35 optic tract OT OT:12 oral tolerance OT OT:18 orthostatic tremor OVD OVD:19 occlusal vertical dimension OVD OVD:9 ophthalmic viscosurgical device OVLT OVLT:86|ovlt:1 organum vasculosum laminae terminalis OVLT OVLT:103 organum vasculosum of the lamina terminalis OVX OVX:54|ovx:7|Ovx:3 after ovariectomy OVX OVX:11|ovx:2|Ovx:1 oophorectomized OVX OVX:28|ovx:2|OvX:2|Ovx:1 ovariectomised OVX OVX:12|ovx:2 ovariectomized rats OV OV:4 liver fluke opisthorchis viverrini OV OV:19 orf virus OWAS OWAS:7 ovako working posture analysing system OWAS OWAS:6 ovako working posture analysis system OND OND:18|Ond:5 ondansetron OND OND:14 other neurological disease OND OND:65 patients with other neurological diseases OND OND:8 patients with other neurological disorders OpMNPV OpMNPV:6 multicapsid nuclear polyhedrosis virus of orgyia pseudotsugata OpMNPV OpMNPV:9 orgyia pseudotsugata mnpv OpMNPV OpMNPV:14 orgyia pseudotsugata multicapsid nuclear polyhedrosis virus OpMNPV OpMNPV:6 orgyia pseudotsugata multicapsid nucleopolyhedrovirus OpMNPV OpMNPV:14 orgyia pseudotsugata multinucleocapsid nuclear polyhedrosis virus Orn Orn:7|ORN:3 lornithine Orn Orn:42|ORN:10|orn:1 ornithine OU OU:11 observation unit OU OU:7|O-U:2 ornsteinuhlenbeck OX OX:23 optic chiasm Ox Ox:23|OX:2|ox:1 oxalate Ox Ox:6|OX:5 oxandrolone OX OX:19|Ox:3 oxazepam Ox Ox:7|ox:5|OX:1 oxidized P/S P/S:7 fatty acid ratio P/S P/S:19 polyunsaturatedsaturated P/S P/S:9 polyunsaturatedsaturated fatty acid P/S P/S:6 polyunsaturated to saturated fat P/S P/S:14 polyunsaturated to saturated fatty acid P0.1 P0.1:7 after the onset of inspiration P0.1 P0.1:88|p0.1:1 mouth occlusion pressure P0.1 P0.1:10|p0.1:1 respiratory drive P0 P0:9 isometric tension P0 P0:5 major myelin glycoprotein P0 P0:18|P-0:1 newborn P0 P0:64 protein zero P1CP P1CP:6 carboxyterminal propeptide of type procollagen P1CP P1CP:8 carboxyterminal propeptide P1 P1:6|P-1:1 first peak P1 P1:5 first phalanx P1 P1:10 first positive peak P1 P1:9 first postnatal day p21 p21:6 cyclindependent kinase inhibitor pwafcip p21 p21:7 inhibitor pwafcip p21 p21:8|P21:1 protein product p21 p21:10 ras gene product P2 P2:9 crude mitochondrial P2 P2:5 crude mitochondrial pellet P2 P2:20 crude synaptosomal P2 P2:7 positive peak P2 P2:9 purinergic P50 P50:9|p50:1 halfsaturation pressure P50 P50:7 halfsaturation pressure of hemoglobin P50 P50:3|p50:1 hemoglobin is saturated P50 P50:16|p50:2|P-50:1 oxygen affinity P5C P5C:6 delta pyrrolinecarboxylate P5C P5C:19|P-5-C:2 pyrrolinecarboxylate PAA PAA:5 period amplitude analysis PAA PAA:13 phosphonoacetate PAA PAA:7 pulmonary artery aneurysm PABA PABA:9|pABA:3 paminobenzoate PABA PABA:197|pABA:11|p-ABA:1 paminobenzoic acid PABA PABA:96|pABA:8 paraaminobenzoic acid PACNS PACNS:17 primary angiitis of the central nervous system PACNS PACNS:8 primary angiitis of the cns PACs PACs:12 premature atrial contractions PACs PACs:8 prostatic adenocarcinomas PACs PACs:15 pulmonary artery catheters PACT PACT:13 prescribing analysis and cost PACT PACT:3 program for assertive community treatment PAC PAC:11|pac:2 penicillin acylase PAC PAC:11 perennial allergic conjunctivitis PAC PAC:7 peritoneal adherent cells PAC PAC:13 perturbed angular correlation PAC PAC:6 perturbed angular correlation of gammarays PAC PAC:9 plasma arc curing PAC PAC:10 portacath PAC PAC:13 postacute care PAC PAC:48 powdered activated carbon PAC PAC:10 premature atrial contraction PAC PAC:11 pulmonary artery catheterization PAC PAC:8 pulmonary artery constriction PAD PAD:26 peptidylarginine deiminase PAD PAD:18 percutaneous abscess drainage PAD PAD:492 peripheral arterial disease PAD PAD:21 preoperative autologous donation PAD PAD:8 primary affective disorders PAD PAD:80 primary afferent depolarization PAD PAD:18 public access defibrillation PAD PAD:7 pulsatile assist device PAEs PAEs:16 phthalic acid esters PAEs PAEs:36 postantibiotic effects PAE PAE:18 air embolism PAE PAE:31 porcine aortic endothelial PAF PAF:19|pAF:1 paroxysmal af PAF PAF:178|Paf:8|PAf:6|paf:1 paroxysmal atrial fibrillation PAF PAF:20 population attributable fraction PAF PAF:6 posterior auditory field PAF PAF:22 premenstrual assessment form PAF PAF:52 pure autonomic failure PAGE PAGE:14 polyacrylamide gels PAGE PAGE:992 polyacrylamide gel electrophoresis PAGE PAGE:12 polyacrylamide gel electrophoretic PAG PAG:9 midbrain periaqueductal grey region PAG PAG:12 periaqueductal gray area PAG PAG:14 periaqueductal gray region PAG PAG:122 periaqueductal grey PAG PAG:6 periaqueductal grey area PAG PAG:49 periaqueductal grey matter PAG PAG:13|pAg:10 protein agold PAH PAH:1 inulin or paraaminohippurate PAH PAH:5 pamino hippurate PAH PAH:395 paminohippurate PAH PAH:121 paminohippuric acid PAH PAH:5 paraamino hippurate PAH PAH:20 paraaminohippurate PAH PAH:13 phenylalanine hydroxylase gene PAH PAH:6 postatrophic hyperplasia PAH PAH:21 predicted adult height PAH PAH:5 primary adrenal hyperplasia PAH PAH:201 pulmonary arterial hypertension PAH PAH:31 pulmonary artery hypertension PAI-1 PAI-1:9 inhibitor of plasminogen activator PAI-1 PAI-1:15|pAI-1:1 plasminogen activatorinhibitor PAI-1 PAI-1:5 plasminogen activator inhibitor antigen PAI-1 PAI-1:16|PAI1:1 plasminogen activator inhibitor type i PAI-1 PAI-1:108 type plasminogen activator inhibitor PAIS PAIS:10 partial androgen insensitivity syndrome PAIs PAIs:25|Pais:2|pais:1 pathogenicity islands PAIs PAIs:24 plasminogen activator inhibitors PAIS PAIS:30 psychosocial adjustment to illness scale PAI PAI:10 percutaneous acetic acid injection PAI PAI:7 percutaneous alcohol injection PAI PAI:12 periapical index PAI PAI:17 personality assessment inventory PAI PAI:21 physical activity index PAI PAI:6 primary adrenal insufficiency PALA PALA:36 nphosphonacetyllaspartic acid PALA PALA:10 phosphonacetyllaspartate PALS PALS:28 pediatric advanced life support PALS PALS:12 periarterial lymphatic sheath PALS PALS:9 periarterial lymphoid sheath PAL PAL:10 attachment loss PAL PAL:5 passive avoidance learning PAL PAL:26|Pal:2 peptidoglycanassociated lipoprotein PAL PAL:68 physical activity level PAL PAL:10 probing attachment levels PAL PAL:33 pyothoraxassociated lymphoma PAMPA PAMPA:8 parallel artificial membrane permeability assay PAMPA PAMPA:9 parallel artificial membrane permeation assay PAM PAM:9 alphaamidating monooxygenase PAM PAM:108 peptidylglycine alphaamidating monooxygenase PAM PAM:5 periodic acidmethenamine silver PAM PAM:30 potential acuity meter PAM PAM:14 pregnancyassociated malaria PAM PAM:24 primary acquired melanosis PAM PAM:21 primary amebic meningoencephalitis PAM PAM:12 primary amoebic meningoencephalitis PAM PAM:19 pulmonary alveolar microlithiasis PANDAS PANDAS:7 autoimmune neuropsychiatric disorders associated with streptococcal infection PANDAS PANDAS:13|PANDAs:1 pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections PANSS PANSS:385 positive and negative syndrome scale PANSS PANSS:12 positive and negative syndrome scale for schizophrenia PAN PAN:15 aminonucleoside of puromycin PAN PAN:16 periodic alternating nystagmus PAN PAN:28 peroxyacetyl nitrate PAN PAN:11 positional alcohol nystagmus PAN PAN:21 posterior articular nerve PAN PAN:27 puromycin aminonucleoside nephrosis Pao Pao:20|PaO:2|PAO:1 airway opening Pao Pao:32|PaO:5 airway opening pressure PAO PAO:37 peak acid output PAO PAO:9|pAO:1 peripheral arterial occlusion PAO PAO:61 polyamine oxidase PAPS PAPS:9 phosphoadenosine phosphosulphate PAPS PAPS:33 adenosine phosphate phosphosulfate PAPS PAPS:12 adenosine phosphate phosphosulphate PAPS PAPS:16|pAPS:2 primary aps PAPs PAPs:7 pulmonary artery pressures PAPs PAPs:14 purple acid phosphatases PAR-2 PAR-2:72|PAR2:9 proteaseactivated receptor PAR-2 PAR-2:33|PAR2:12 proteinaseactivated receptor PARP PARP:4|Parp:1 cleavage of polyadpribosepolymerase PARP PARP:2 cleavage of the polyadpribosepolymerase PARP PARP:33|parp:2 procyclic acidic repetitive protein PARs PARs:8 population attributable risks PARs PARs:125 proteaseactivated receptors PARs PARs:34 proteinaseactivated receptors PAR PAR:20 pyridylazoresorcinol PAR PAR:11|par:1 paracetamol PAR PAR:37 participatory action research PAR PAR:9 passive anterior rhinomanometry PAR PAR:10 passive avoidance reaction PAR PAR:27 passive avoidance response PAR PAR:52 peer assessment rating PAR PAR:59 perennial allergic rhinitis PAR PAR:50 photosynthetically active radiation PAR PAR:11 physical activity recall PAR PAR:11 platelet aggregate ratio PAR PAR:9 platelet aggregation rate PAR PAR:7 pulmonary arterial resistance PAR PAR:18|PaR:1 pulmonary arteriolar resistance PASAT PASAT:24 paced auditory serial addition task PASAT PASAT:41 paced auditory serial addition test PASP PASP:7 pancreasspecific protein PASP PASP:11 polymerassisted solutionphase PASP PASP:32|PAsP:3 pulmonary artery systolic pressure PAT PAT:17 paroxysmal atrial tachycardia PAT PAT:12|pat:1 patagialis PAT PAT:8 phosphinothricin acetyltransferase PAT PAT:12 platelet aggregation test PAT PAT:12 proficiency analytical testing PAV PAV:7 porcine aortic valve PAV PAV:57 proportional assist ventilation PAS PAS:7 atrial stimulation PAS PAS:9 paminosalicylate PAS PAS:5 paired associative stimulation PAS PAS:57|pas:1 paraaminosalicylic acid PAS PAS:10 patient administration system PAS PAS:35 perarntsim PAS PAS:12 perceptual aberration scale PAS PAS:17 periodic acidschiff reagent PAS PAS:13 peripheral anionic site PAS PAS:8 peripheral anterior synechia PAS PAS:25 peripheral anterior synechiae PAS PAS:6 personality assessment schedule PAs PAs:6 phosphatidic acids PAS PAS:15 photoacoustic spectroscopy PAS PAS:8 physical activity score PAS PAS:13 physical anhedonia scale PAS PAS:72 physicianassisted suicide PAS PAS:4 platelet additive solution PAs PAs:9 pleomorphic adenomas PAs PAs:31 polyamines PAS PAS:13|pas:1 posterior airway space PAS PAS:6 preautophagosomal structure PAS PAS:19 premorbid adjustment scale PAS PAS:6 psychiatric assessment schedule PAs PAs:65 pyrrolizidine alkaloids PA PA:17 abscess Pa Pa:4|PA:3 acidic protein PA PA:6|Pa:2|pa:1 agreement Pa Pa:1 apparent permeability coefficient to albumin Pa Pa:10|PA:1 childrens hospital of philadelphia Pa Pa:7|PA:2 childrens hospital of pittsburgh PA PA:11 paleostriatum augmentatum PA PA:13 panic attacks Pa Pa:9|PA:1 paranoia PA PA:65 particle agglutination PA PA:5 particle agglutination test PA PA:69 passive avoidance PA PA:15 pennsylvania PA PA:8 perceptual asymmetry PA PA:8 performance assessment PA PA:29 perinatal asphyxia PA PA:7 permeabilityarea product PA PA:10 permeabilitysurface area product PA PA:39 pernicious anaemia PA PA:43 pernicious anemia PA PA:39 phenylacetate PA PA:6 phonological awareness PA PA:42 phosphatidate PA PA:30 photoacoustic PA PA:31 phthalic anhydride PA PA:31 physician assistant PA PA:16 pilocytic astrocytoma PA PA:13 plaque area PA PA:21 plasminogen activation PA PA:26 polyacrylate PA PA:17 polyamide PA PA:39 positive affect PA PA:9 positive affectivity PA PA:11|pa:1 postabsorptive PA PA:36|P-A:4|pa:1 posterioranterior Pa Pa:6|PA:4 pregnancyassociated PA PA:8 preinfarction angina PA PA:17 premature adrenarche PA PA:9 primary angioplasty PA PA:14 proanthocyanidin PA PA:89 procainamide PA PA:5 progressive aphasia PA PA:10 propionic acidaemia PA PA:23 propionic acidemia PA PA:11 proton affinity PA PA:17 pseudoaneurysm PA PA:112|Pa:28 pseudomonas aeruginosa PA PA:6 psoriatic arthropathy PA PA:6 pullulan acetate PA PA:14 pulmonary angiography PA PA:22 pulmonary atresia PA PA:26 pulse amplitude PA PA:10 pyloric atresia PA PA:6 pyrophosphate arthropathy PA PA:5 solitary parathyroid adenoma Pa Pa:7 university of pittsburgh PBC PBC:1400 primary biliary cirrhosis PBC PBC:5 protected brush catheter PBDEs PBDEs:200|PBDES:1 polybrominated diphenyl ethers PBDEs PBDEs:14 polybrominated diphenylethers PBD PBD:25 biliary drainage PBD PBD:20 pancreaticobiliary diversion PBD PBD:12 pigeon breeders disease PBD PBD:11 polybutadiene PBD PBD:10 proliferative breast disease PBD PBD:10 pyrrolocbenzodiazepine PBE PBE:12 bifunctional enzyme PBE PBE:9 peripheral blood eosinophils PBF PBF:8 binding factor PBF PBF:16 percent body fat PBF PBF:11 percentage body fat PBG PBG:36 phenylbiguanide PBG PBG:9 photonic band gap PBG PBG:8 pressure breathing during g PBG PBG:10 progesteronebinding globulin PBI PBI:23 papillary bleeding index PBI PBI:102 parental bonding instrument PBI PBI:8 partial breast irradiation PBI PBI:16 penile brachial index PBI PBI:36|pbi:2 proteinbound iodine PBL PBL:7 plasmablastic lymphoma PBL PBL:21 portal branch ligation PBL PBL:9 primary breast lymphoma PBMA PBMA:7 program budgeting and marginal analysis PBMA PBMA:15 programme budgeting and marginal analysis PBMV PBMV:12 percutaneous balloon mitral valvotomy PBMV PBMV:31 percutaneous balloon mitral valvuloplasty PBM PBM:6 benefit management PBM PBM:34 pancreaticobiliary maljunction PBM PBM:19 peak bone mass PBM PBM:13|pbm:1 peribacteroid membrane PBM PBM:6 pharmacy benefit manager PBM PBM:6 poultry byproduct meal PBN PBN:6 agent alphaphenylntbutylnitrone PBN PBN:47 alphaphenylntertbutylnitrone PBN PBN:17 ntbutylalphaphenylnitrone PBN PBN:24|PbN:6 parabrachial nuclei PBN PBN:9 phenyl ntertbutyl nitrone PBN PBN:6 spin trap alphaphenyl ntertbutyl nitrone PBN PBN:12 spin trap ntertbutylalphaphenylnitrone PBPK PBPK:293|PB-PK:45|pbpk:3 physiologically based pharmacokinetic PBPK PBPK:8|PB-PK:1 physiologically based pharmacokinetic model PBP PBP:10 progressive bulbar palsy PBP PBP:18 prostatic binding protein PBR PBR:10 parabrachial region PBR PBR:10 peptidebinding region PBR PBR:116|pBR:2 peripheral benzodiazepine receptor PBR PBR:94 peripheraltype benzodiazepine receptor PBS PBS:29 pharmaceutical benefits scheme PBS PBS:45 phosphate buffer solution PBS PBS:9 pulsating bubble surfactometer PBS PBS:3 saline ph PBT PBT:10 peripheral blood t PBT PBT:14|PB-T:1 peripheral blood t cells PBT PBT:13 pulmonary barotrauma PBV PBV:13 balloon valvuloplasty PBV PBV:53 pulmonary blood volume PB PB:12|Pb:3|pB:1 barometric pressure PB PB:24 parabrachial Pb Pb:16 paracoccidioides brasiliensis PB PB:6 particle beam PB PB:101 paucibacillary PB PB:10 pencil beam PB PB:9 pentobarbital sodium PB PB:9 pentobarbitone PB PB:11 peribrachial PB PB:64 periodic breathing PB PB:8 peroneus brevis PB PB:12|Pb:1 phenobarbital sodium PB PB:131|Pb:2 phenobarbitone PB PB:36 phosphate buffer Pb Pb:6|PB:3 plasmodium berghei PB PB:34|P-B:2 poissonboltzmann PB PB:25|Pb:1 polar body PB PB:9|Pb:1 polybrene PB PB:9 postburn PB PB:10 primebond PB PB:9 primed burst PB PB:10|Pb:1 probenecid PB PB:10 prostate brachytherapy PB PB:8 protein breakdown PB PB:21 prussian blue PB PB:13 pulmonary blastoma PB PB:5|Pb:2 rat probasin PB PB:9 sodium phenylbutyrate PC12 PC12:27|PC-12:4 rat phaeochromocytoma PC12 PC12:270|PC-12:23 rat pheochromocytoma PC12 PC12:35|PC-12:9 rat pheochromocytoma cells PC20 PC20:2 fev by of baseline PC20 PC20:5 provocative concentration causing a fall in fev from baseline PC20 PC20:12 provocative concentration of histamine causing a fall in fev PC20 PC20:14 provocative concentration of methacholine causing a fall in fev PC-3 PC-3:9|PC3:5 human prostate PC-3 PC-3:10|PC3:2 human prostate cancer cells PCA PCA:185|pCA:13|p-CA:4|P-CA:1 pchloroamphetamine PCA PCA:8 parietal cell PCA PCA:28 passive cutaneous anaphylactic PCA PCA:425 passive cutaneous anaphylaxis PCA PCA:8 patientcontrolled analgesic PCA PCA:11 pentachloroanisole PCA PCA:4 percent cortical area PCA PCA:64 perchloric acid PCA PCA:15 plate count agar PCA PCA:64 portacaval anastomosis PCA PCA:19 portocaval anastomosis PCA PCA:87 postconceptional age PCA PCA:11 posterior cerebral PCA PCA:19|pCA:1 posterior cortical atrophy PCA PCA:126 posterior cricoarytenoid PCA PCA:32 posterior cricoarytenoid muscle PCA PCA:4 probe competition assay PCA PCA:4 protein fragment complementation assay PCA PCA:15|pca:4|Pca:1 protocatechuate PCA PCA:27 protocatechuic acid PCA PCA:10 weeks postconceptional age PCBs PCBs:14 polychlorinated biphenyl congeners PCBs PCBs:49 polychlorobiphenyls PCB PCB:24 paracervical block PCB PCB:33 phycocyanobilin PCB PCB:8 placentalumbilical cord blood PCB PCB:13 printed circuit board PCB PCB:8 psoas compartment block PCCs PCCs:7 poison control centers PCCs PCCs:21 prothrombin complex concentrates PCC PCC:5 patientcentered care PCC PCC:10 percutaneous cervical cordotomy PCC PCC:9 peripheral cholangiocarcinoma PCC PCC:10|pcc:3 pigeon cytochrome c PCC PCC:5 plasma corticosterone concentration PCC PCC:5|pcc:1 plasma cortisol concentration PCC PCC:10 poison control center PCC PCC:5 postcoital contraception PCC PCC:19 posterior cingulate cortex PCC PCC:181 premature chromosome condensation PCC PCC:35 prematurely condensed chromosomes PCC PCC:5 primary care center PCC PCC:14 primary care centre PCC PCC:9 pyridinium chlorochromate PCDDs PCDDs:336|PCDDS:1 polychlorinated dibenzopdioxins PCDDs PCDDs:31 polychlorinated dibenzodioxins PCDDs PCDDs:7 polychlorinated dioxins PCF PCF:8 photonic crystal fiber PCF PCF:14 platelet contractile force PCF PCF:11 polycationic ferritin PCF PCF:6 polycationized ferritin PCF PCF:10 posterior cranial fossa PCG PCG:25 phonocardiogram PCG PCG:13 plasma cell granuloma PCG PCG:29 primary congenital glaucoma PCH PCH:23 paroxysmal cold hemoglobinuria PCH PCH:8 photon counting histogram PCH PCH:13 pulmonary capillary hemangiomatosis PCI PCI:18 partial coherence interferometry PCI PCI:7 peritoneal cancer index PCI PCI:8 phenomenology of consciousness inventory PCI PCI:12 photochemical internalisation PCI PCI:15 photochemical internalization PCI PCI:25 physiological cost index PCI PCI:61 pneumatosis cystoides intestinalis PCI PCI:11 positive chemical ionization PCI PCI:17 potato carboxypeptidase inhibitor PCI PCI:5 proliferating cell index PCI PCI:123 prophylactic cranial irradiation PCI PCI:113 protein c inhibitor PCL PCL:12 pacing cycle length PCL PCL:19 plasma cell leukaemia PCL PCL:69 plasma cell leukemia PCL PCL:47 polycaprolactone PCL PCL:9 posterior collagenous layer PCL PCL:270 posterior cruciate ligament PCL PCL:13 primary cardiac lymphoma PCL PCL:9 primary cerebral lymphoma PCL PCL:9 ptsd checklist PCL PCL:5 purkinje cell layer PCMBS PCMBS:30|pCMBS:11|p-CMBS:2|pcmbs:1 pchloromercuribenzene sulfonate PCMBS PCMBS:3|pCMBS:3|p-CMBS:1 pchloromercuribenzene sulphonate pCMBS pCMBS:14|PCMBS:6|p-CMBS:3 pchloromercuribenzenesulfonate pCMBS pCMBS:6|PCMBS:3 pchloromercuribenzenesulphonate pCMPS pCMPS:4|PCMPS:3|p-CMPS:1 pchloromercuriphenyl sulfonate pCMPS pCMPS:7|PCMPS:2|p-CMPS:2 pchloromercuriphenylsulfonate PCM PCM:6 pericellular matrix PCM PCM:36 pericentriolar material PCM PCM:4 sera from patients with paracoccidioidomycosis PCN PCN:49 percutaneous nephrostomy PCN PCN:70 pregnenolone alphacarbonitrile PCO PCO:21 photocatalytic oxidation PCO PCO:20 polycystic ovarian PCO PCO:49 posterior capsular opacification PCO PCO:220 posterior capsule opacification PCO PCO:7 potassium channel opener PCO PCO:9 pulp canal obliteration PCPs PCPs:5 peptidyl carrier proteins PCPS PCPS:109 percutaneous cardiopulmonary support PCPS PCPS:21 percutaneous cardiopulmonary support system PCPs PCPs:121 primary care physicians PCPs PCPs:9 primary care practitioners PCPs PCPs:42 primary care providers PCP PCP:12 hphencyclidine PCP PCP:559|pcp:1 pentachlorophenol PCP PCP:20 peptidyl carrier protein PCP PCP:1205 phencyclidine PCP PCP:18 phencyclidine hydrochloride PCP PCP:10 phenolchloroformpetroleum ether PCP PCP:55 planar cell polarity PCP PCP:10 pneumococcal capsular polysaccharide PCP PCP:1042|PcP:10|Pcp:1|pcp:1 pneumocystis carinii pneumonia PCP PCP:14 pneumocystis carinii pneumonitis PCP PCP:42 primary care provider PCP PCP:10|pCP:1 procollagen cproteinase PCP PCP:6 protein c activation peptide PCR-SSP PCR-SSP:18 pcr amplification with sequencespecific primers PCR-SSP PCR-SSP:13 polymerase chain reactionsequencespecific primer PCR-SSP PCR-SSP:33 polymerase chain reaction using sequencespecific primers PCR-SSP PCR-SSP:12 polymerase chain reaction with sequence specific primers pCREB pCREB:10|p-CREB:1 phosphorylated camp response elementbinding protein pCREB pCREB:32|P-CREB:10|p-CREB:9|PCREB:1 phosphorylated creb pCR pCR:15|PCR:2 complete remission PCR PCR:10 enzymatic amplification pCR pCR:38|PCR:7 pathologic complete response PCr PCr:12 phosphocreatinine PCR PCR:8 plaque control record PCr PCr:12|Pcr:7|P-Cr:3|pCr:2 plasma creatinine PCr PCr:6|Pcr:3 plasma creatinine concentration PCR PCR:10 polymerase chain PCR PCR:13 polymerase chain reaction amplification PCR PCR:20 polymerase chain reaction assay PCR PCR:25 polymerase chain reaction method PCR PCR:26 polymerase chain reaction technique PCR PCR:51 principal component regression PCR PCR:97|pcr:10 protein catabolic rate PCR PCR:9 psychiatric case register PCS PCS:7 care services PCS PCS:8 pain catastrophizing scale PCS PCS:6 palliative care service PCS PCS:6 paracingulate sulcus PCS PCS:25 patientcontrolled sedation PCS PCS:44 patterns of care study PCs PCs:10 penicillins PCs PCs:11 pericytes PCS PCS:33 physical PCS PCS:10 physical component scale PCS PCS:11 physical component score PCS PCS:5 physical component summary score PCs PCs:30 phytochelatins PCS PCS:8 phytochelatin synthase PCs PCs:54 plasma cells PCs PCs:198|PCS:2|Pcs:1 platelet concentrates PCS PCS:17 portacaval shunted PCS PCS:10 portacaval shunting PCS PCS:6 postconcussion symptoms PCS PCS:7 postconcussive symptoms PCS PCS:5 premature centromere separation PCS PCS:5 premature chromatid separation PCs PCs:51|PCS:1 principal components PCs PCs:31 proprotein convertases PCs PCs:146 purkinje cells PCTs PCTs:5 clinical trials PCTs PCTs:5 placebocontrolled trials PCTs PCTs:15|Pcts:1 plasmacytomas PCTs PCTs:11 polychlorinated terphenyls PCTs PCTs:9 postcoital tests PCTs PCTs:7 primary care teams PCTs PCTs:36 primary care trusts PCT PCT:4 papillary cystic tumor PCT PCT:17 parasite clearance time PCT PCT:7 perfusion ct PCT PCT:25 photochemical treatment PCT PCT:11 photochemotherapy PCT PCT:18 polychemotherapy PCT PCT:321|Pct:1 porphyria cutanea tarda PCT PCT:22 positron computed tomography PCT PCT:9 postcoital testing PCT PCT:16 primary care trust PCT PCT:6|P-CT:1 primary chemotherapy PCT PCT:25 proximal convoluted PCT PCT:9 pupil cycle time PCU PCU:21 palliative care unit PCU PCU:7|PC-U:3 unawareness PCV2 PCV2:30|PCV-2:6 porcine circovirus PCV2 PCV2:6|PCV-2:1 type porcine circovirus PCV PCV:19 haematocrit PCV PCV:55 parietal cell vagotomy PCV PCV:12 peanut clump virus PCV PcV:5|PCV:5|pcV:3 phenoxymethylpenicillin PCV PCV:27 polypoidal choroidal vasculopathy PCV PCV:52 porcine circovirus PCV PCV:9 pressure control ventilation PCV PCV:33 pressurecontrolled ventilation PCW PCW:8 cell walls PCW PCW:18|Pcw:1 pulmonary capillary wedge PCr/Pi PCr/Pi:14 phosphate ratio PCr/Pi PCr/Pi:14 phosphocreatineinorganic phosphate PCr/Pi PCr/Pi:12 ratio of phosphocreatine to inorganic phosphate PC PC:17 antiphosphocholine PC PC:33 antiphosphorylcholine Pc Pc:53|PC:5 capillary pressure PC PC:8 cells of the parvocellular PC PC:11 cine phasecontrast Pc Pc:7|pc:1 corrected p PC PC:7 egg lecithin PC PC:19 liver parenchymal cells PC PC:17 pachyonychia congenita PC PC:17 pacinian corpuscle PC PC:23 pancreatic carcinoma PC PC:29 paramyotonia congenita PC PC:9 parenchymal PC PC:16 parietal cortex PC PC:11 patients with pancreatic cancer PC PC:10 patients with prostatic cancer PC PC:9 pelvic control PC PC:9 pentose cycle PC PC:20 percutaneous cholecystostomy PC PC:27 peritoneal carcinomatosis PC PC:9 pharyngeal constrictor PC PC:43 phase contrast PC PC:12 phosphocitrate PC PC:19|Pc:1 phycocyanin PC PC:16 pineal calcification PC PC:6 plasma concentrations PC PC:36|Pc:12|pc:5 plastocyanin PC PC:5 pneumotaxic center PC PC:49 polycarbonate PC PC:10 polycarbophil Pc Pc:59|PC:5 polycomb PC PC:11|pc:3|P-C:1 positive control pc pc:12|PC:3 post coitum pc pc:11|PC:6 postcoitus PC PC:11|pc:6 postconception PC PC:5 posterior canal PC PC:29 posterior chamber PC PC:8 posterior compartment PC PC:9 preconditioned PC PC:10 prednicarbate PC PC:5 preoperative complications PC PC:90 primary care PC PC:16 primary closure PC PC:14 procerebral PC PC:14 procerebrum PC PC:9 procollagen PC PC:16 proprotein convertase PC PC:10 propylene carbonate PDA PDA:18 cispiperidine dicarboxylic acid PDA PDA:6 dorsal aortic blood pressure PDA PDA:12 pancreaticoduodenal artery PDA PDA:7 panic disorder and agoraphobia PDA PDA:690 patent ductus arteriosus PDA PDA:28 photodiode array PDA PDA:4 polymorphic delta activity PDA PDA:13 population and community development association PDA PDA:19 posterior descending artery PDA PDA:31 potato dextrose agar PDA PDA:11 prolonged depolarizing afterpotential PDBu PDBu:13|PDBU:2 hphorboldibutyrate PDBu PDBu:11 phorbol ester PDB PDB:21 pagets disease of bone PDB PDB:208 protein data bank PDB PDB:11 protein databank PDC-E2 PDC-E2:7 e component of the pyruvate dehydrogenase complex PDC-E2 PDC-E2:4 e subunit of pyruvate dehydrogenase complex PDCs PDCs:14|pDCs:13 plasmacytoid dcs PDCs PDCs:29|pDCs:28|P-DCs:3 plasmacytoid dendritic cells PDC PDC:10 dialysis capacity PDC PDC:4 parkinsonismdementia complex on guam PDC PDC:19 paroxysmal dystonic choreoathetosis PDC PDC:9 poorly differentiated carcinoma PDDs PDDs:7 depth doses PDDs PDDs:41 pervasive developmental disorders PDD PDD:17 papillomatous digital dermatitis PDD PDD:10 percent depth dose PDD PDD:21 percentage depth dose PDD PDD:25 photodynamic diagnosis PDD PDD:11 prescribed daily dose PDD PDD:15 primary degenerative dementia PDD PDD:8 pulse dye densitometry PDE4 PDE4:28|PDE-4:2 phosphodiesterase type PDE4 PDE4:14|PDE-4:3 type phosphodiesterase PDE PDE:28 campphosphodiesterase PDE PDE:23 cyclic nucleotide phosphodiesterases PDE PDE:20|pde:1 partial differential equation PDE PDE:8 peritoneal dialysate effluent PDE PDE:27 peritoneal dialysis effluent PDE PDE:47 pulsed doppler echocardiography PDFs PDFs:17 peritoneal dialysis fluids PDFs PDFs:18|pdfs:9 probability density functions PDF PDF:46 peptide deformylase PDF PDF:17|pdf:1 pigmentdispersing factor PDF PDF:8 primary dysfunction PDG PDG:17 phenyldiguanide PDG PDG:29 phosphatedependent glutaminase PdG PdG:9|PDG:2 pregnanediol alphaglucuronide PdG PdG:16|PDG:2 pregnanediolglucuronide PdG PdG:15|Pdg:2|PDG:1 pregnanediol glucuronide PdG PdG:9 propanodeoxyguanosine PDH PDH:25 dogs with pituitarydependent hyperadrenocorticism PDH PDH:21 pigmentdispersing hormone PDH PDH:9 progressive disseminated histoplasmosis PDL PDL:14 pancreatic duct ligation PDL PDL:29 polydlysine PDMS PDMS:11 peabody developmental motor scales PDMS PDMS:21|PD-MS:3 plasma desorption mass spectrometry PDQ PDQ:12 personality diagnostic questionnaire PDQ PDQ:22 physician data query PDR PDR:27 desk reference PDR PDR:5 pancreaticoduodenal resection PDR PDR:6 phthalate dioxygenase reductase PDR PDR:20|Pdr:2 pleiotropic drug resistance PDR PDR:285 proliferative diabetic retinopathy PDR PDR:11 proliferative dr PDSS PDSS:9 panic disorder severity scale PDSs PDSs:27 paroxysmal depolarization shifts PDSs PDSs:12 paroxysmal depolarizing shifts PDSS PDSS:9 postpartum depression screening scale PDS PDS:9 dental services PDs PDs:6 paroxysmal discharges PDS PDS:12 pendred syndrome PDS PDS:7 pendred syndrome gene PDS PDS:13 peritoneal dialysis solution PDs PDs:149|PDS:2 personality disorders PDS PDS:23|Pds:6|pds:3 phytoene desaturase PDS PDS:19 pigment dispersion syndrome PDS PDS:40 plasmaderived serum PDS PDS:14 polydioxanon PDS PDS:107 polydioxanone PDS PDS:10 polydioxanone suture PDs PDs:33 population doublings PDS PDS:5 posttraumatic diagnostic scale PDs PDs:11 potential differences PDS PDS:14 power density spectrum PDS PDS:18 power doppler sonography PDs PDs:16 program directors PDS PDS:8 progressive deterioration scale PDS PDS:10 public dental service PDTC PDTC:309 pyrrolidine dithiocarbamate PDTC PDTC:54 pyrrolidinedithiocarbamate PDT PDT:20 pedigree disequilibrium test PDT PDT:42 percutaneous dilatational tracheostomy PDT PDT:6 percutaneous dilatational tracheotomy PDT PDT:33 percutaneous dilational tracheostomy PDT PDT:9 percutaneous dilational tracheotomy PDT PDT:48 photodynamic treatment PDT PDT:9 population doubling time PDV PDV:9 patent ductus venosus PDV PDV:12 phocid distemper virus PDV PDV:29 phocine distemper virus PDV PDV:5 plasmaderived vaccine PDV PDV:70 portaldrained viscera PDZ PDZ:6 largezona occludens PDZ PDZ:9 psddlgazo PDZ PDZ:21 psddlgzo PDI PDI:5 delusions inventory PDI PDI:1 pain and disability index PDI PDI:29 power doppler imaging PDI PDI:16 protein disulphideisomerase PDI PDI:19 psoriasis disability index PEA PEA:6 hreceptor agonist pyridylethylamine PEA PEA:21 palmitoylethanolamide PEA PEA:17 peak endocardial acceleration PEA PEA:19 phacoemulsification and aspiration PEA PEA:10 phenethyl alcohol PEA PEA:9 phenethylamine PEA PEA:8 phenyl ethyl alcohol PEA PEA:28 pulseless electrical activity PEB PEB:1 cisplatin etoposide bleomycin PEB PEB:15 phycoerythrobilin PECs PECs:7 parietal epithelial cells PECS PECS:6 patient evaluation and conference system PECs PECs:57 peritoneal exudate cells PECS PECS:10 picture exchange communication system PECs PECs:11 pigmented epithelial cells PECs PECs:15 predicted environmental concentrations PEC PEC:9|pec:1 phycoerythrocyanin PEC PEC:19 polyelectrolyte complex PEC PEC:10 porcine enteric calicivirus PEC PEC:22 predicted environmental concentration PEDV PEDV:35 porcine epidemic diarrhea virus PEDV PEDV:16 porcine epidemic diarrhoea virus PED PED:40 pediatric emergency department PED PED:32 pigment epithelial detachment PED PED:9 potential energy distribution PEEPi PEEPi:21 intrinsic peep PEEPi PEEPi:64|Peepi:1 intrinsic positive endexpiratory pressure PEEP PEEP:21 positive and expiratory pressure PEEP PEEP:19 positive endexpiratory pressure ventilation PEF PEF:5 belongs to the pentaefhand PEF PEF:17|Pef:5 pefloxacin PEG-SOD PEG-SOD:16 polyethylene glycolconjugated superoxide dismutase PEG-SOD PEG-SOD:11|PEGSOD:1 polyethylene glycolsuperoxide dismutase PEG PEG:11 pegylated PEG PEG:565 percutaneous endoscopic gastrostomy PEG PEG:20 pneumoencephalography PEG PEG:4 polyethylene glycol solution PEG PEG:9 polyethylenglycol PEH PEH:8 papillary endothelial hyperplasia PEH PEH:11 postexercise hypotension PEH PEH:10 pseudoepitheliomatous hyperplasia PEITC PEITC:96 phenethyl isothiocyanate PEITC PEITC:9 phenethylisothiocyanate PEI PEI:7 excretion index PEI PEI:8 patient enablement instrument PEI PEI:231 percutaneous ethanol injection PEI PEI:10 postejaculatory interval PEI PEI:15 prince edward island PELs PELs:18 permissible exposure limits PELs PELs:15 primary effusion lymphomas PEL PEL:15 peritoneal exudate lymphocytes PEL PEL:11 permissible exposure level PEM PEM:19 paraneoplastic encephalomyelitis PEM PEM:31 pediatric emergency medicine PEM PEM:50 peritoneal exudate macrophages PEM PEM:17 polioencephalomalacia PEM PEM:9 polyelectrolyte multilayer PEM PEM:9 positron emission mammography PEM PEM:39 prescriptionevent monitoring PEM PEM:4 protein energy malnourished PEO PEO:9 polyethyleneoxide PEO PEO:55 progressive external ophthalmoplegia PEPI PEPI:20 postmenopausal estrogenprogestin interventions PEPI PEPI:21 preejection period index PEP PEP:14 pepleomycin PEP PEP:18 phosphoenol pyruvate PEP PEP:18 polyestradiol phosphate PEP PEP:45 positive expiratory pressure PEP PEP:7 preejection time PEP PEP:24 primer extension preamplification PEP PEP:5 progestagenassociated endometrial protein PERG PERG:9 pattern electroretinography PERG PERG:18|P-ERG:2 pattern erg PERT PERT:12 productenhanced reverse transcriptase PERT PERT:5 program evaluation and review technique PER PER:61 peak ejection rate PER PER:10 per protein PER PER:10|Per:1 period protein PER PER:21 proboscis extension reflex PER PER:14 proboscis extension response PETCO2 PETCO2:4|PetCO2:2|PEtco2:1|PET-CO2:1|Petco2:1|petCO2:1 endtidal carbon dioxide partial pressure PETCO2 PETCO2:5|PetCO2:2 endtidal co partial pressure PETCO2 PETCO2:12|PetCO2:1 endtidal co pressure PETCO2 PETCO2:14|PetCO2:4 endtidal co tension PETCO2 PETCO2:9|PetCO2:1 endtidal partial pressure of carbon dioxide PET PET:12 functional PET PET:7 pancreatic endocrine tumors PET PET:13 paraffinembedded tissue PET PET:4|pET:2 patulous eustachian tube PET PET:37|PeT:2 photoinduced electron transfer PET PET:10 polyester PET PET:5 polyethylene terephtalate PET PET:15 polyethyleneterephthalate PET PET:21 positron emission tomograph PET PET:201 positron emission tomographic PET PET:11 preeclamptic toxaemia PES PES:9 paclitaxeleluting stents PES PES:16|pes:1 pharyngoesophageal segment PEs PEs:14 phosphatidylethanolamines PEs PEs:7 phthalate esters PES PES:16 polyethersulfone PES PES:6 postenumeration survey PES PES:11 postextrasystolic PES PES:6 preepiglottic space PES PES:9 primary empty sella PES PES:124 programmed electrical stimulation PES PES:15 psychiatric emergency service PE PE:3 ace inhibitor perindopril PE PE:6 after phacoemulsification PE PE:59 agonist phenylephrine PE PE:10 cisplatinetoposide PE PE:11 days postexposure Pe Pe:4|PE:1 early promoter PE PE:19 elastase PE PE:11 element PE PE:11|Pe:2 errors Pe Pe:5 error positivity PE PE:21 parietal endoderm PE PE:13 pectinesterase PE PE:18 pectus excavatum PE PE:9 pemphigus erythematosus PE PE:38 pericardial effusion PE PE:48 peritoneal exudate Pe Pe:4|PE:2 periventricular hypothalamic nucleus PE PE:11 persistent estrus PE PE:13 petroleum ether PE PE:14 pharyngoesophageal PE PE:18 phosphorylethanolamine PE PE:49 physical education PE PE:45 physical examination PE PE:10 physical exercise PE PE:9 phytoestrogens PE PE:16 pigment epithelial PE PE:33 pigment epithelium PE PE:12 pigmented ciliary epithelial PE PE:21 pigmented epithelial PE PE:20 pigmented epithelium PE PE:8 plasma epinephrine PE PE:15 plasma extravasation PE PE:44 plating efficiency PE PE:13 polyelectrolyte PE PE:231 polyethylene PE PE:6 porcine pancreatic endocrine PE PE:9 portoenterostomy PE PE:16|pe:1 postexposure PE PE:13 potential energy PE PE:9 power of exclusion PE PE:10 precedence effect PE PE:9 prediction error PE PE:16 preeclamptic PE PE:40 premature ejaculation PE PE:4 preoperative portal embolization PE PE:11 probability of exclusion PE PE:10 proliferative enteritis PE PE:10 proliferative enteropathy PE PE:8 prolonged exposure PE PE:11 protective efficacy PE PE:114 pseudomonas exotoxin PE PE:55|Pe:1 pulmonary emboli PE PE:45 pulmonary embolus PE PE:18 pulmonary emphysema PF4 PF4:27|PF-4:21 platelet factor PF4 PF4:15|PF-4:3|Pf4:2 platelet factor four PFA-100 PFA-100:21|PFA100:1 platelet function analyser PFA-100 PFA-100:34|PFA100:1 platelet function analyzer PFA PFA:42 phosphonoformate PFA PFA:59 phosphonoformic acid PFA PFA:10 principal factor analysis PFA PFA:10 profunda femoris artery PFB PFB:27 pentafluorobenzyl PFB PFB:10 perflubron PFB PFB:10 pseudofolliculitis barbae PFCs PFCs:28 perfluorocarbons PFCs PFCs:19 perfluorochemicals PFCs PFCs:19 plaqueforming cells PFC PFC:9 pairfed control PFC PFC:12 patientfocused care PFC PFC:21 persistent fetal circulation PFC PFC:10 plasma fibrinogen concentration PFC PFC:24 prefrontal cortical PFDA PFDA:18 perfluorondecanoic acid PFDA PFDA:53 perfluorodecanoic acid PFD PFD:16 paired filtration dialysis PFD PFD:8 pelvic floor dysfunction PFD PFD:20 perfluorodecalin PFD PFD:14 photon flux density PFD PFD:23 proteinfree diet PFE PFE:9 papillary fibroelastoma PFE PFE:6 pressurised fluid extraction PFE PFE:6 pressurized fluid extraction PFG PFG:6 pulsed field gel PFG PFG:52|pfg:1 pulsed field gradient PFH PFH:29 perifornical hypothalamus PFH PFH:15 progressive facial hemiatrophy PFI PFI:18 flow index PFI PFI:32 progressionfree interval PFM PFM:8 peak flow meter PFM PFM:19 pelvic floor muscle PFM PFM:32 porcelainfusedtometal PFOB PFOB:15 perfluoroctylbromide PFOB PFOB:13 perfluorooctyl bromide PFOB PFOB:21 perfluorooctylbromide PFOS PFOS:31 perfluorooctane sulfonate PFOS PFOS:12 perfluorooctane sulfonic acid PFOS PFOS:25 perfluorooctanesulfonate PFO PFO:306 patent foramen ovale PFO PFO:9 perfluoronoctane PFO PFO:20|pfo:1 perfringolysin o PFP PFP:18 patellofemoral pain PFP PFP:12 pentafluoropropionyl PFP PFP:6|Pfp:5|pfp:3 perforin PFP PFP:9 peripheral facial palsy PFP PFP:21 plateletfree plasma PFP PFP:17|Pfp:1 poreforming protein PFR PFR:7 flow rates PFR PFR:14 paraflagellar rod PFR PFR:33 peak flow rate PFR PFR:9 plain film radiography PFs PFs:17|Pfs:1 parallel fibers PFs PFs:9 periplasmic flagella PFS PFS:9 piper fatigue scale PFS PFS:31 primary fibromyalgia syndrome PFS PFS:29 progressionfree PFS PFS:553 progressionfree survival PFs PFs:7 protection factors PFS PFS:14 pyrogenfree saline PF PF:5 added poultry fat PF PF:11 effect was the prevented fraction PF PF:7 fracture face PF PF:4|Pf:4|pf:1 nucleus parafascicularis PF Pf:2|PF:2 nucleus parafascicularis thalami Pf Pf:5 osmotic water Pf Pf:11 osmotic water permeability coefficient PF PF:14 paeoniflorin PF PF:11|pf:1 pair fed PF PF:9 pancreatic fistula Pf Pf:17|PF:14 parafascicular nucleus PF PF:9 parafollicular PF PF:10 pars flaccida PF PF:19|P-F:1 patellofemoral PF PF:27 peak flow PF PF:17 peak force PF PF:11 peak frequency PF PF:11 permeability factor PF PF:9|Pf:1 photofrin PF PF:15 physical function PF PF:38 physical functioning PF PF:6 plasma fibrinogen PF PF:30|Pf:3 pleural fluid PF PF:30 posterior fossa PF PF:6 preterm formula PF PF:13 primary fibromyalgia PF PF:14 proflavine PF PF:14 proteinfree PF PF:11 protoplasmic face PF PF:8 protoplasmic fracture PF PF:38 pulmonary fibrosis PF PF:32 purkinje fibers PF PF:17 purpura fulminans PGA PGA:27 global assessment PGA PGA:35 penicillin g acylase PGA PGA:13 polyglandular autoimmune PGA PGA:8 polyglandular autoimmune syndrome PGA PGA:176|PgA:1 polyglycolic acid PGA PGA:23|PGa:1 polyglycolide PGA PGA:13 propylene glycol alginate PGC PGC:24|-PGC:2 glomerular capillary hydraulic pressure pGC pGC:5|PGC:1 particulate guanylate cyclase pGC pGC:6 particulate guanylyl cyclase PGC PGC:31 porous graphitic carbon PGC PGC:10 porous graphitized carbon PGE PGE:8 eseries prostaglandins PGE PGE:10 graphite electrode PGE PGE:20 primary generalized epilepsy PGE PGE:32|PgE:1 prostaglandins of the e series PGFM PGFM:14 dihydroketoprostaglandin f PGFM PGFM:6 prostaglandin f alpha metabolite PGI2 PGI2:8 ketopgf alpha PGI2 PGI2:14 prostacycline PGI PGI:8 patient generated index PGI PGI:26|PG-I:3|PgI:2 pepsinogen i PGI PGI:6|Pgi:2|pgi:1 phosphoglucoisomerase PGI PGI:77|pgi:7|Pgi:6 phosphoglucose isomerase PGL PGL:5 hereditary paraganglioma PGL PGL:92 persistent generalized lymphadenopathy PGL PGL:9 phenolic glycolipid PGL PGL:25 primary gastric lymphoma PGM PGM:16 gastric mucin PGM PGM:21 peptidoglycan monomer PGN PGN:78 peptidoglycan PGN PGN:10 perigeniculate PGN PGN:27 perigeniculate nucleus PGN PGN:24 proliferative glomerulonephritis PGPH PGPH:8 peptide hydrolyzing PGPH PGPH:7 peptidylglutamylpeptide hydrolyzing P-gp P-gp:7|Pgp:2 antipglycoprotein P-gp P-gp:8|Pgp:2 pglycoprotein PGP PGP:7|PG-P:2 phosphatidylglycerophosphate PGP PGP:30 phosphoglycolate phosphatase PGP PGP:7|pgp:1 prepaid group practice PGP PGP:136 protein gene product PGSE PGSE:10|pgse:1 gradient spinecho PGSE PGSE:20 pulsed gradient spin echo PGST PGST:6|P-GST:1 placental glutathione stransferase PGST PGST:7 placental isozyme of glutathione stransferase PGS PGS:6 gelatin sponge PGS PGS:8 paraglottic space PGs PGs:19 polygalacturonases PGS PGS:9 prostaglandin synthase PGs PGs:23 prothoracic glands PG PG:13 isoprostaglandin PG PG:37 cartilage proteoglycan PG PG:9 glands PG PG:5 glomerular capillary hydrostatic pressure PG PG:10|Pg:1 panax ginseng PG PG:15 pancreatic glucagon PG PG:16 pancreaticogastrostomy PG PG:5 paracervical ganglia PG PG:7 parotid gland PG PG:19 pathological gambling PG PG:25 pemphigoid gestationis PG PG:43|Pg:9 pentagastrin PG PG:10 percutaneous gastrostomy PG PG:14 periglomerular PG PG:13 petrosal ganglion PG PG:6 phenolphthalein glucuronide PG PG:21 phosphatidyl glycerol PG PG:7 pigmentary glaucoma PG PG:11 placebo group PG PG:7|Pg:5 plakoglobin PG PG:127|pg:1 plasma glucose PG PG:72 polygalacturonase PG PG:5 polypoid growth PG PG:12 proguanil PG PG:45 propyl gallate PG PG:226 propylene glycol PG PG:3|pG:3 protein g PG PG:6 proximal gastrectomy PG PG:102 pyoderma gangrenosum PG PG:13 pyogenic granuloma PG PG:29 pyrolytic graphite PG PG:25 serum pepsinogen PHAHs PHAHs:9|pHAHs:1 planar halogenated aromatic hydrocarbons PHAHs PHAHs:23 polyhalogenated aromatic hydrocarbons PHA-LCM PHA-LCM:9 conditioned by leukocytes in the presence of phytohemagglutinin PHA-LCM PHA-LCM:5 medium conditioned by phytohemagglutininstimulated leukocytes pHa pHa:13 arterial blood ph pHa pHa:49 arterial ph PHA PHA:7 persistent primitive hypoglossal artery PHA PHA:15 phaseolus vulgaris PHA PHA:15 phaseolus vulgaris agglutinin PHA PHA:17 phytohaemagglutin PHA PHA:14 phytohaemaglutinin PHA PHA:12 phytohaemoagglutinin PHA PHA:43|pha:1 phytohemagglutin PHA PHA:40 phytohemaglutinin PHA PHA:11 phytohemoagglutinin PHA PHA:12 polybetahydroxyalkanoate PHA PHA:9|pHA:1 porous hydroxyapatite PHA PHA:13 posterior hypothalamic area PHA PHA:9 primary hyperaldosteronism PHA PHA:7 production of polyhydroxyalkanoates PHA PHA:6 proper hepatic artery PHA PHA:35 pseudohypoaldosteronism PHB PHB:17 polybetahydroxybutyric acid PHB PHB:84 polyhydroxybutyrate PHCs PHCs:14 health centers PHCs PHCs:6 primary health centres PHC PHC:521|phc:1 primary health care PHC PHC:7 primary health centers PHC PHC:14 primary health centre PHC PHC:11 primary healthcare PHC PHC:9 primary hepatic cancer PHC PHC:24 primary hepatic carcinoma PHC PHC:9 primary hepatocellular cancer PHC PHC:118 primary hepatocellular carcinoma PHF PHF:30 parathyroid hypertensive factor PHF PHF:13 potomac horse fever PHF PHF:8 precultured heart fragments PHG PHG:23 parahippocampal gyrus PHG PHG:63 portal hypertensive gastropathy PHG PHG:15 pulmonary hyalinizing granuloma PHHI PHHI:11 persistent hyperinsulinaemic hypoglycaemia of infancy PHHI PHHI:55 persistent hyperinsulinemic hypoglycemia of infancy PHN PHN:85|pHN:2 passive heymann nephritis PHN PHN:10 public health nurse PHN PHN:11 public health nursing PHP PHP:24 patients with pseudohypoparathyroidism PHP PHP:19 pyridoxalated hemoglobin polyoxyethylene conjugate PHQ PHQ:24 patient health questionnaire PHQ PHQ:16 phenylhydroquinone PHS PHS:12 pallisterhall syndrome PHS PHS:12 physicians health study PHS PHS:12 pooled human serum PHS PHS:7 prolene hernia system PHS PHS:158 public health service PHS PHS:34 pulmonary hypertension syndrome PHT PHT:6 passive haemagglutination test PHT PHT:21 portal hypertensive PHT PHT:6 postmenopausal hormone therapy PHx PHx:2 after a partial hepatectomy PHx PHx:5 liver regeneration after partial hepatectomy PIBF PIBF:10 progesterone induced blocking factor PIBF PIBF:7 protein named the progesteroneinduced blocking factor PIB PIB:23 partial ileal bypass PIB PIB:16 polyisobutylene PIB PIB:14 propranololinduced bronchoconstriction PICCs PICCs:61 peripherally inserted central catheters PICCs PICCs:16 peripherally inserted central venous catheters PICP PICP:98|P-I-CP:1 carboxyterminal propeptide of type i procollagen PICP PICP:7 i carboxyterminal propeptide PICP PICP:8 procollagen i carboxyterminal propeptide PICP PICP:5 procollagen type i cterminal peptide PICP PICP:8 procollagen type i cterminal propeptide PICP PICP:4 procollagen type i carboxyterminal extension peptide PICP PICP:8 procollagen type i carboxyterminal propeptide PICP PICP:8 type i procollagen carboxyterminal propeptide PICs PICs:7 persistent inward currents PICs PICs:22 preintegration complexes PIC PIC:5 islet cells PIC PIC:10 paediatric intensive care PIC PIC:11 particleincell PIC PIC:25 personality inventory for children PIC PIC:34 phosphoinositidase c PIC PIC:91 polymorphism information content PIC PIC:39 preinitiation complex PID PID:6 phosphotyrosine interaction domain PID PID:9 photoionization detector PID PID:15|pid:2 postinoculation day PID PID:6 preimplantation diagnosis PID PID:11 primary immunodeficiencies PID PID:8 primary immunodeficiency diseases PID PID:34 proportionalintegralderivative PIE PIE:59 positive inotropic effect PIE PIE:10 pulmonary infiltration with eosinophilia PIE PIE:43 pulmonary interstitial emphysema PIF PIF:52 peak inspiratory flow PIF PIF:15 prolactin inhibiting factor PIF PIF:8 pulmonary interstitial fibrosis PIH PIH:7 postinjection hours PIH PIH:7 postinoculation hour PIH PIH:363 pregnancyinduced hypertension PIH PIH:53 pyridoxal isonicotinoyl hydrazone PIIINP PIIINP:35 aminoterminal propeptide of type iii procollagen PIIINP PIIINP:7|P-III-NP:1 aminoterminal propeptide PIIINP PIIINP:4|PII-INP:1 procollagen iii peptide PIIINP PIIINP:8 procollagen type iii aminoterminal peptide PIIINP PIIINP:9|P-III-NP:2 propeptide of procollagen type iii PIIINP PIIINP:12 propeptide of type iii collagen PIIIP PIIIP:10|P-III-P:2 procollagen type iii PIIIP PIIIP:11|P-III-P:9 type iii procollagen peptide PIL PIL:10 patient information leaflet PIL PIL:7 purpose in life test PIMs PIMs:10 phosphatidylinositol mannosides PIMs PIMs:51|PIMS:2 pulmonary intravascular macrophages PINP PINP:14 procollagen type i nterminal propeptide PINP PINP:29 propeptide of type i procollagen PINP PINP:5 type i procollagen aminoterminal propeptide PIN PIN:23 posterior interosseous nerve PIN PIN:9 posterior intralaminar nucleus PIN PIN:375 prostatic intraepithelial neoplasia PIOL PIOL:12 phakic intraocular lens PIOL PIOL:15 primary intraocular lymphoma PI-PLC PI-PLC:283|PIPLC:73|PiPLC:1|piPLC:1 phosphatidylinositolspecific phospholipase c PI-PLC PI-PLC:4|PIPLC:1 phosphatidylinositolspecific plc PIP PIP:5 carboxyterminal propeptide of procollagen type i PIP PIP:10 peak inflation pressures PIP PIP:10|PI-P:1 phosphatidylinositol monophosphate PIP PIP:7 prevention of immune precipitation PIP PIP:14 prolactininducible protein PIP PIP:9 prostatic inhibin peptide PIP PIP:197 proximal interphalangeal PIR PIR:10|Pir:1 piracetam PIR PIR:15 postinhibitory rebound PIR PIR:16 protein information resource PISF PISF:7 periimplant sulcular fluid PISF PISF:6 periimplant sulcus fluid PITC PITC:14 phenyl isothiocyanate PITC PITC:37 phenylisothiocyanate PIT PIT:15 pancreatic islet transplantation PIT PIT:20|pit:7 pituitary PIT PIT:12 plasma iron turnover PIT PIT:9 tosylate PIV PIV:47 particle image velocimetry PIV PIV:13 pulsatility index for veins PIXE PIXE:141 xray emission PIXE PIXE:10 xray emission analysis PKCs PKCs:19 protein kinases c PKCs PKCs:25 protein kinase cs PKD1 PKD1:7 polycystic kidney disease gene PKD1 PKD1:6|Pkd1:1 polycystic kidney disease gene PKD PKD:21 paroxysmal kinesigenic dyskinesia PKD PKD:76 protein kinase d PKI PKI:2 inhibitor of the campdependent protein kinase PKI PKI:9 public key infrastructure PKR PKR:48 doublestranded rnaactivated protein kinase PKR PKR:53|pkr:1 doublestranded rnadependent protein kinase PKR PKR:51 protein kinase r PKU PKU:876 phenylketonuria PKU PKU:35 phenylketonuric PK PK:11 k permeability PK PK:9 perilla ketone PK PK:6 plasma potassium PK PK:6 plasma potassium concentration PK PK:9 potassium permeability PK PK:38 proteinase k PK PK:7 serum pyruvatekinase PLB PLB:9 breathing PLB PLB:6 percutaneous liver biopsy PLB PLB:19 phospholipase b PLB PLB:20 primary lymphoma of bone PLC PLC:5 lung centroid pressure PLC PLC:7 pathological laughing and crying PLC PLC:6 peripheral lymphocyte count PLC PLC:9 pigmented lesion clinic PLC PLC:11 pityriasis lichenoides chronica PLC PLC:5 prelysosomal compartment PLC PLC:162 primary liver cancer PLC PLC:24 primary liver carcinoma PLC PLC:39 propionyllcarnitine PLDR PLDR:9 potentially lethal damage recovery PLDR PLDR:39 potentially lethal damage repair PLD PLD:9 partial lipodystrophy PLD PLD:30 pegylated liposomal doxorubicin PLD PLD:9 pulsed laser deposition PLE PLE:13 liver esterase PLE PLE:14 paraneoplastic limbic encephalitis PLE PLE:16 pressurised liquid extraction PLE PLE:40 pressurized liquid extraction PLE PLE:38 proteinlosing enteropathy PLF PLF:31 perilymphatic fistula PLF PLF:13 peritoneal lavage fluid PLF PLF:20 placental isoferritin PLF PLF:11 posterolateral fusion PLF PLF:19 proliferin PLGA PLGA:12 polyllactidecoglycolide PLGA PLGA:30 polymorphous lowgrade adenocarcinoma PLG PLG:1 coglycolide PLG PLG:24 lprolyllleucylglycinamide PLG PLG:24 prolylleucylglycinamide PLL PLL:31 posterior longitudinal ligament PLL PLL:77 prolymphocytic leukemia PLMs PLMs:12|PLMS:4 periodic leg movements PLMS PLMS:21 periodic leg movements in sleep PLMs PLMs:10|PLMS:2 periodic limb movements PLMS PLMS:33 periodic limb movements in sleep PLM PLM:9 percent labeled mitoses PLM PLM:5 percentage labelled mitoses PLM PLM:28|Plm:1 phospholemman PLM PLM:11 phospholipomannan PLM PLM:21 polarized light microscopy PLP PLP:10 myelin proteolipid PLP PLP:150|Plp:4 myelin proteolipid protein PLP PLP:10 parathyroid hormonelike peptide PLP PLP:36 periodatelysineparaformaldehyde PLP PLP:21 phantom limb pain PLP PLP:22 plasma pyridoxalphosphate PLP PLP:16 proteolipid apoprotein PLP PLP:24|Plp:1 proteolipid protein gene PLRV PLRV:17 potato leafroll luteovirus PLRV PLRV:53 potato leafroll virus PLS PLS:59|PLs:1 papillonlefevre syndrome PLS PLS:11 perpendicular light scatter PLS PLS:46 primary lateral sclerosis PLS PLS:15 projections to latent structures PLS PLS:14 prostaglandinlike substances PLT PLT:10 pancreolauryl test PLT PLT:126|Plt:14|plt:6 platelet PLT PLT:10 posterolateral thoracotomy PLT PLT:32 primed lymphocyte test PLT PLT:9 primed lymphocyte testing PLT PLT:62 primed lymphocyte typing PLV PLV:5|Plv:1 lv pressure PLV PLV:60 partial left ventriculectomy PLV PLV:156 partial liquid ventilation PLZF PLZF:23 promyelocytic leukemia zinc finger PLZF PLZF:7 promyelocytic leukemia zinc finger protein PL PL:7|Pl:1 lateral pulvinar PL PL:6|pl:4|pL:2 leftward promoter PL PL:22 pancreatic lipase PL PL:21 perilymph PL PL:10 perivitelline layer PL PL:26 peroneus longus PL PL:41 persistent lymphocytosis PL PL:66 photoluminescence PL PL:194|pl:43|Pl:4 placebo PL PL:97 placental lactogen PL PL:17|pl:1 plasmin PL PL:29|pl:1 polyllysine PL PL:21|pl:3|P-L:1 posterolateral PL PL:10 poultry litter PL PL:39 preferential looking PL PL:18|pl:2 prelimbic PM10 PM10:11 inhalable particles PM10 PM10:12 particles with a cutoff aerodynamic diameter of microm PM10 PM10:8 particulate air pollution PM10 PM10:5 particulate matter less than microm in aerodynamic diameter PM10 PM10:1 particulate matter of less than microm in diameter PM10 PM10:9 particulate pollution PM2.5 PM2.5:1 microm aerodynamic diameter PM2.5 PM2.5:7 aerodynamic diameter less than microm PM2.5 PM2.5:7|PM-2.5:1 aerodynamic diameter less than or equal to microm PM2.5 PM2.5:5 less than microns in aerodynamic diameter PMA PMA:21 betaphorbolmyristateacetate PMA PMA:11|p-MA:1 pmethoxyamphetamine PMA PMA:12 phorbol myristate PMA PMA:21 phorbol myristic acid PMA PMA:16 phorbolester PMA PMA:47 postmenstrual age PMA PMA:6 premenstrual asthma PMA PMA:9 protein kinase c activator PMCA PMCA:16|Pmca:1 plasma membrane calcium atpase PMCA PMCA:20 plasma membrane calcium pump PMCA PMCA:9 protein misfolding cyclic amplification PMCT PMCT:37 percutaneous microwave coagulation therapy PMCT PMCT:10 postmortem computed tomography PMC PMC:10 papillary microcarcinoma PMC PMC:20 percutaneous mitral commissurotomy PMC PMC:48 peritoneal mast cells PMC PMC:20 pharmacokinetic modulating chemotherapy PMC PMC:21 pontine micturition center PMC PMC:9|pmc:1 primary mesenchyme cell PMC PMC:68 pseudomembranous colitis PMC PMC:6 rat peritoneal mc PMd PMd:10 dorsal premotor PMd PMd:7|PMD:2 dorsal premotor area PMd PMd:32|PMD:1 dorsal premotor cortex PMD PMD:91 pelizaeusmerzbacher disease PMD PMD:8 pellucid marginal degeneration PMD PMD:17 piecemeal degranulation PMD PMD:13 polarization mode dispersion PMD PMD:25 progressive muscular dystrophy PMEA PMEA:17 phosphonomethoxyethyladenine PMEA PMEA:6 phosphonomethoxyethyl adenine PMEs PMEs:17 phosphomonoesters PMEs PMEs:9 progressive myoclonus epilepsies PME PME:14 particle mesh ewald PME PME:12|pme:1 pectin methyl esterase PME PME:49|pme:1 pectin methylesterase PME PME:9 pectinmethylesterase PME PME:9 phosphatidylmonomethylethanolamine PME PME:17 progressive myoclonic epilepsy PMF PMF:39 peptide mass fingerprinting PMF PMF:15 positive matrix factorization PMF PMF:18|pmf:2 potential of mean force PMF PMF:21 primary myelofibrosis PMF PMF:53 progressive massive fibrosis PMF PMF:24|pmf:18 proton motive force PMF PMF:13 pulsed magnetic fields pMHC pMHC:12|P-MHC:1|p-MHC:1 peptidemajor histocompatibility complex pMHC pMHC:13 peptidemhc PMH PMH:23 princess margaret hospital PMH PMH:7 pure motor hemiparesis PMI PMI:12 pain management index PMI PMI:55 perioperative myocardial infarction PMI PMI:39|pmi:2 phosphomannose isomerase PMI PMI:68|pmi:1 postmortem interval PMLS PMLS:21 posteromedial lateral suprasylvian PMLS PMLS:14 posteromedial lateral suprasylvian area PML PML:2 fasting and postmethionine load PML PML:26 paramedian lobule PML PML:13 posterior mitral leaflet PML PML:35 progressive multifocal leucoencephalopathy PML PML:525 progressive multifocal leukoencephalopathy PML PML:135 promyelocytic leukemia PML PML:12 promyelocytic leukemia gene PML PML:75 promyelocytic leukemia protein PMMA PMMA:9 bone cement PMMA PMMA:19 polymethylmetacrylate PMM PMM:26 pentamethylmelamine PMM PMM:34|Pmm:1|pmm:1 phosphomannomutase PMM PMM:9 prevention of maternal mortality PMNL PMNL:14 granulocytes PMNL PMNL:15 neutrophil PMNs PMNs:12 phrenic motoneurons PMNs PMNs:53 polymorphonuclear granulocytes PMNs PMNs:12 polymorphonuclear neutrophil granulocytes PMN PMN:55 human polymorphonuclear PMN PMN:6 polymorphonuclear cell count PMN PMN:17 polymorphonuclear neutrophilic granulocytes PMO PMO:9 phosphorodiamidate morpholino oligomers PMO PMO:17 postmenopausal osteoporosis PMP22 PMP22:8|PMP-22:2 peripheral myelin protein PMP22 PMP22:11|Pmp22:1|PMP-22:1 peripheral myelin protein gene PMPs PMPs:19 patient management problems PMPs PMPs:23 peroxisomal membrane proteins PMP PMP:21 phenylmethylpyrazolone PMP PMP:10|Pmp:1 peroxisomal membrane protein PMP PMP:4 plasma membrane potential PMP PMP:34 pseudomyxoma peritonei PMP PMP:11 pyridoxamine phosphate PMR PMR:7 palmomental reflex PMR PMR:5 percutaneous myocardial laser revascularization PMR PMR:302 polymyalgia rheumatica PMR PMR:26 progressive muscle relaxation PMR PMR:42|pmr:4 proton magnetic resonance PMS PMS:4 iu pregnant mares serum gonadotrophin PMS PMS:13 periodic movements in sleep PMS PMS:7 personal medical services PMS PMS:86 phenazine methosulfate PMS PMS:28 phenazine methosulphate PMs PMs:10 plasma membranes PMs PMs:24 poor metabolisers PMs PMs:124 poor metabolizers PMS PMS:8 premenstrual symptoms PM PM:5|pm:1 intrapulmonary metastasis PM PM:11 medial pulvinar PM PM:9 palatal myoclonus PM PM:9 partial mole PM PM:12|Pm:3 pasteurella multocida PM PM:41 patients with polymyositis PM PM:45|Pm:1 pectoralis major PM PM:8 perfect match PM PM:9 periodontal mechanosensitive PM PM:5 peritoneal mesothelioma PM PM:20 peritrophic matrix PM PM:8 placental malaria PM PM:7 pleural mesothelioma PM PM:10|P-M:1 ponsmedulla PM PM:17 postmenopausal PM PM:7 prediction model PM PM:18 premotor PM PM:16|pM:1 prophylactic mastectomy PM PM:18 prospective memory PM PM:18|pm:1 psoas major PM PM:10 psychological mindedness PM PM:25 pulmonary macrophages PM PM:14 pulmonary metastases PM PM:5 pyogenic meningitis PM PM:38 pyridoxamine PNAd PNAd:9 peripheral lymph node addressin PNAd PNAd:20 peripheral node addressin PnC PnC:17|PNC:1 caudal pontine reticular nucleus PnC PnC:8 pneumococcal cpolysaccharide PNC PNC:13 prenatal care PNC PNC:9 purine nucleotide cycle PND PND:5 nipple discharge PND PND:7 phrenic nerve discharge PND PND:28 postnatal depression PND PND:37 principal neutralizing determinant PND PND:20 principal neutralizing domain PNE PNE:13 nerve evaluation PNE PNE:52|P-NE:4|pNE:3|PNe:2 plasma norepinephrine PNE PNE:37 primary nocturnal enuresis PNE PNE:10 pulmonary neuroendocrine PNF PNF:21 prednisolone farnesylate PNF PNF:29 proprioceptive neuromuscular facilitation PNH PNH:203 paroxysmal nocturnal haemoglobinuria PNH PNH:514 paroxysmal nocturnal hemoglobinuria PNH PNH:15 periventricular nodular heterotopia PNI PNI:9 field of psychoneuroimmunology PNI PNI:14 nerve injury PNI PNI:39|pni:1 perineural invasion PNI PNI:29 prognostic nutritional index PNI PNI:21 protease nexin i PNPase PNPase:82|PNP-ase:1 polynucleotide phosphorylase PNPase PNPase:20 purine nucleoside phosphorylase PNs PNs:11 cc propriospinal neurones PNS PNS:13|Pns:1|PnS:1 panax notoginseng saponins PNS PNS:13 paraneoplastic neurological syndromes PNS PNS:8 perineural spread PNs PNs:12 perineuronal nets PNs PNs:6 persistent nodules PNS PNS:16 primary nephrotic syndrome PNs PNs:29 projection neurons PNs PNs:13 purkinje neurons PNS PNS:8|PnS:1 saponins of panax notoginseng PNU PNU:13 npropylnnitrosourea PNU PNU:7|pnu:1 protein nitrogen units PNA PNA:84 arachis hypogaea PNa PNa:9 na permeability PNA PNA:16 nitrogen appearance pNA pNA:12|PNA:6|p-NA:2 pnitroaniline PNA PNA:721 peanut agglutinin PNA PNA:40 phrenic nerve activity PNA PNA:17|pNA:2|P-NA:1 plasma noradrenaline pNA pNA:7|PNA:6|P-NA:1 plasma noradrenaline concentration PNa PNa:7|P-Na:1|pNa:1 plasma sodium PNa PNa:11|pNa:3 plasma sodium concentration PNA PNA:6 polynitroxyl albumin PNA PNA:19 postnatal age PN PN:5 cerebellar purkinje neurons Pn Pn:10|PN:1 net photosynthesis Pn Pn:13|PN:1 net photosynthetic rate Pn Pn:7|PN:2 pacemaker nucleus PN PN:10 palmerston north PN PN:19 papillary or nodular PN PN:15 parenteral nutrient PN PN:8 partial nephrectomy PN PN:15 partner notification PN PN:4 peripheral lymph nodes PN PN:85 peripheral nerve PN PN:9 peripheral neuroepithelioma PN PN:6|P-N:3 phosphoramidate PN PN:28 phrenic nerve PN PN:30|Pn:1 pontine nuclei PN PN:10 pontine nucleus PN PN:73|pn:5|Pn:1 postnatal PN PN:24 processing negativity PN PN:15 pronuclear PN PN:19 pronuclei PN PN:19 pronucleus PN PN:6 pulp necrosis PN PN:6 purkinje neuron PN PN:27 pyelonephritis Pn Pn:8 streptococcus pneumoniae ra PO/AH PO/AH:12 preopticanterior hypothalamic PO/AH PO/AH:4 preoptic anterior hypothalamus PO/AH PO/AH:9 preoptic area and anterior hypothalamus PO2 PO2:18|pO2:4|Po2:2 partial pressure of o PO2 PO2:4|pO2:2 tissue oxygenation POC POC:23 particulate organic carbon POC POC:6 peroperative cholangiography POC POC:14 products of conception POE POE:19 physician order entry POE POE:27 polyoxyethylene POF POF:13 ossifying fibroma POF POF:220 premature ovarian failure POH POH:32 perillyl alcohol POH POH:5 pressure overload hypertrophy POI POI:15 personal orientation inventory POI POI:15 postoperative ileus POM POM:10 nucleus preopticus medialis POM POM:14 particulate organic matter POM POM:9 pivaloyloxymethyl POM POM:8 polycyclic organic matter POM POM:15 purulent otitis media PON1 PON1:37 human serum paraoxonase PON1 PON1:9|Pon1:1 paraoxonase gene PON PON:12 preoptic nucleus PON PON:7 pretectal olivary nucleus POPC POPC:10 palmitoyloleoylsnglycerophosphatidylcholine POPC POPC:8 membranes composed of palmitoyloleoylsnglycerophosphocholine POPC POPC:9 palmitoyloleoyl phosphatidylcholine POP-Q POP-Q:10|POPQ:8 pelvic organ prolapse quantification POP-Q POP-Q:5|POPQ:4 pelvic organ prolapse quantification system POPs POPs:173 persistent organic pollutants POPs POPs:5 progestinonly pills POP POP:22 pelvic organ prolapse POP POP:10 persistent organic pollutant POP POP:14|PoP:2 plaster of paris POP POP:6 progestogenonly pill POP POP:16|Pop:1 prolyl oligopeptidase PORT PORT:41 patient outcomes research team PORT PORT:10|PoRT:1 postoperative radiotherapy POR POR:20 nadphprotochlorophyllide oxidoreductase POR POR:9|Por:1 porfiromycin POTS POTS:24 postural orthostatic tachycardia syndrome POTS POTS:43 postural tachycardia syndrome POW POW:9 powassan POW POW:8 prisoner of war PP1C PP1C:4|PP1c:3 catalytic subunit of pp PP1C PP-1c:2|PP1C:2|PP1c:1|PP-1C:1 catalytic subunit of protein phosphatase PP1 PP1:8 aminomethylphenyltbutylpyrazolodpyrimidine PP1 PP1:29|PP-1:2 type protein phosphatase PP2Ac PP2Ac:5|PP2A-C:1|PP2AC:1 catalytic subunit of ppa PP2Ac PP2Ac:11|PP2AC:1 catalytic subunit of protein phosphatase a PPC PPC:10|ppc:1 peak plasma concentration PPC PPC:10 phenprocoumon PPC PPC:26 polyenylphosphatidylcholine PPC PPC:10 posterior parietal PPC PPC:100 posterior parietal cortex PPC PPC:9 primary peritoneal carcinoma PPC PPC:14 pushpull cannula PPDK PPDK:14|PPdK:1 pyruvate orthophosphate dikinase PPDK PPDK:26 pyruvate phosphate dikinase PPD PPD:20 pocket probing depth PPD PPD:6 postpartum day PPD PPD:46 postpartum depression PPD PPD:35|ppd:4 proximal pars distalis PPD PPD:3 purified protein derivative from tuberculin PPD PPD:14 purified protein derivative of mycobacterium tuberculosis PPD PPD:9 tuberculin skin test PPE PPE:17 palmarplantar erythrodysesthesia PPE PPE:62 personal protective equipment PPE PPE:28 plasma protein extravasation PPE PPE:96 porcine pancreatic elastase PPE PPE:6 preparticipation physical examination PPE PPE:9 pruritic papular eruption PPF PPF:129|ppf:1 pairedpulse facilitation PPF PPF:13 papillary plasma flow PPF PPF:14 periportal fibrosis PPF PPF:44 photosynthetic photon flux PPF PPF:5 plasmapolymerized film PPF PPF:27 plasma protein fraction PPF PPF:15|ppf:1 propentofylline PPF PPF:7 proplatelet formation PPF PPF:9 pterygopalatine fossa PPG PPG:12 photoplethysmograph PPG PPG:19 photoplethysmographic PPG PPG:69 photoplethysmography PPG PPG:8 postprandial glucose PPG PPG:11 postprandial plasma glucose PPG PPG:10|PpG:1 pterygopalatine ganglion PPG PPG:26 pyloruspreserving gastrectomy PPHN PPHN:37 persistent pulmonary hypertension PPHN PPHN:10 persistent pulmonary hypertension of the neonate PPHN PPHN:151 persistent pulmonary hypertension of the newborn PPIs PPIs:16 patient package inserts PPIs PPIs:10 polyphosphoinositides PPIs PPIs:221 proton pump inhibitors PPK PPK:33|ppk:8|Ppk:1 polyphosphate kinase PPK PPK:11 population pharmacokinetic PPL PPL:10 penicilloylpolylysine PPL PPL:14|pPL:1 porcine pancreatic lipase PPL PPL:10 posterior probability of linkage PPL PPL:6 purified phospholipids PPMS PPMS:21|PP-MS:3 primary progressive ms PPMS PPMS:37|PP-MS:2 primary progressive multiple sclerosis PPN PPN:9 pedunculopontine PPN PPN:61 pedunculopontine nucleus PPN PPN:20 peripheral parenteral nutrition PPO PPO:14 diphenyloxazole PPO PPO:22 peak power output PPO PPO:35|P-PO:1 platelet peroxidase PPO PPO:90 polyphenol oxidase PPO PPO:14 polyphenoloxidase PPO PPO:54 preferred provider organization PPPD PPPD:27|PpPD:1 pyloruspreserving pancreaticoduodenectomy PPPD PPPD:35|PpPD:6 pyloruspreserving pancreatoduodenectomy PPP PPP:9 palatopharyngoplasty PPP PPP:53 palmoplantar pustulosis PPP PPP:96|ppp:1 pentose phosphate pathway PPP PPP:6 plasma proteome project PPP PPP:56 platelet poor plasma PPP PPP:39 polyphloretin phosphate PPP PPP:13 primary proliferative polycythaemia PPP PPP:8 pulmonary perfusion pressure PPP PPP:16 pushpull perfusion PPP PPP:44 pustulosis palmaris et plantaris PPP PPP:14 pustulosis palmoplantaris PPRE PPRE:29 peroxisome proliferator response element PPRE PPRE:17 ppar response element PPR PPR:7 averaged photopalpebral reflex PPR PPR:9 pairedpulse ratio PPR PPR:13 patientpractitionerremedy PPR PPR:12 pentatricopeptide repeat PPR PPR:57 peste des petits ruminants PPR PPR:6 pthpthrp receptor PPS PPS:15 parapharyngeal space PPS PPS:11 pentosan polysulfate sodium PPS PPS:9 pentose phosphate shunt PPS PPS:5 perforant path stimulation PPS PPS:6 peripheral pulmonary stenosis PPs PPs:77 peroxisome proliferators PPs PPs:58|Pps:3 peyers patches PPS PPS:16 postpericardiotomy syndrome PPS PPS:8 preputial separation PPS PPS:282 prospective payment system PPs PPs:15 slow waves or pacesetter potentials PPT PPT:6 paw pressure threshold PPT PPT:15 pedunculopontine tegmental PPT PPT:13 pedunculopontine tegmentum PPT PPT:18 phosphinothricin PPT PPT:29 physical performance test PPT PPT:6 platelet production time PPT PPT:67|ppt:2 polypurine tract PPT PPT:88 preprotachykinin PPT PPT:8 propyl pyrazole triol PPV PPV:10|ppv:1 paroxysmal positional vertigo PPV PPV:151|ppV:4|ppv:1 pars plana vitrectomy PPV PPV:12 patent processus vaginalis PPV PPV:6 phakomatosis pigmentovascularis PPV PPV:6 phobic postural vertigo PPV PPV:31 plum pox potyvirus PPV PPV:84 plum pox virus PPV PPV:24 pneumococcal polysaccharide vaccine PPV PPV:146 porcine parvovirus PPB PPB:13 permanent prostate brachytherapy PPB PPB:26 pleuropulmonary blastoma PPB PPB:22 positive pressure breathing PPI PPI:9 pairedpulse index PPI PPI:8 patient package insert PPI PPI:5 peptidyl prolyl cistrans isomerase PPI PPI:6 postpartum interval PPI PPI:8|ppI:3 preproinsulin PPI PPI:450|ppi:1 prepulse inhibition PPI PPI:11 prepulse inhibition of acoustic startle PPI PPI:33 present pain intensity PPI PPI:7 proteinprotein interaction PPI PPI:8 psychopathic personality inventory PPI PPI:7 pulse polio immunization PPI PPI:13 purified pork insulin PP PP:10 pacesetter potentials PP PP:11|pp:1 pairedpulse PP PP:952|pp:3 pancreatic polypeptide PP PP:7 parkinsonian patients PP PP:7 particulate p PP PP:8 particulate phosphorus PP PP:32 peak power PP PP:19 pentose phosphate PP PP:6|pp:1 percent positivity PP PP:66|pp:2 perforant path PP PP:12|pp:3 perforant pathway PP PP:5 peripeduncular nucleus PP PP:38|pp:6|Pp:1 periportal PP PP:6 plasma perfusion PP PP:11 pleural plaques PP PP:46|Pp:2 pneumoperitoneum PP PP:114|pp:1 polypropylene PP PP:33 posterior pituitary PP PP:6 posterior pretectal nucleus PP PP:63|pp:34 postpartum PP PP:22|pp:9 postprandial PP PP:9 precautionary principle PP PP:23 precocious pubarche PP PP:11 premature pubarche PP PP:6 preparatory period PP PP:11 prepubertal periodontitis PP PP:49 primary progressive PP PP:9 prone position PP PP:8 proteose peptone PP PP:47 protoporphyrin PP PP:7 pulsatile perfusion PP PP:14|pp:1|P-P:1 pulse PP PP:309|Pp:2 pulse pressure PP PP:10 pulsus paradoxus PQ PQ:16 phenanthrenequinone PQ PQ:24 plastoquinone PQ PQ:40 primaquine PR8 PR8:8 apuerto rico PR8 PR8:6|PR-8:1 influenza virus apr PRA PRA:11 participatory rural appraisal PRA PRA:5 pcrrestriction enzyme analysis PRA PRA:10 plaque reduction assay pRb pRb:5|pRB:1 p and retinoblastoma pRb pRb:7|pRB:4 product of the retinoblastoma gene pRb pRb:4|pRB:2 product of the retinoblastoma tumor suppressor gene PRC PRC:13 packed red cells PRC PRC:48 peoples republic of china PRC PRC:13 plasma renin concentrations PRC PRC:11 proximal row carpectomy PRC PRC:9 response curves PRE PRE:9 photoreactivating enzyme PRE PRE:9 positive regulatory element PRE PRE:10 posttranscriptional regulatory element PRE PRE:9 progressive resistance exercise PRE PRE:11 relaxation enhancement PRF PRF:9 partial reinforcement PRF PRF:8 personality research form PRF PRF:44|pRF:12 pontine reticular formation PRF PRF:16 prolactinreleasing factor PRF PRF:20 proton resonance frequency PRF PRF:26|prf:1 pulse repetition frequency PRG PRG:8 pontine respiratory group PRG PRG:8 prolinerich glycoprotein PRINS PRINS:50 primed in situ labeling PRINS PRINS:29 primed in situ labelling PRINS PRINS:7 situ dna synthesis PRISM PRISM:74 pediatric risk of mortality PRISM PRISM:6 pediatric risk of mortality score PRKO PRKO:12 pr knockout PRKO PRKO:16 progesterone receptor knockout PRK PRK:204 excimer laser photorefractive keratectomy PRK PRK:34 phosphoribulokinase PRK PRK:8|pRK:1 primary rabbit kidney PRL PRL:13 photoreactivating light PRL PRL:14 preferred retinal locus PRL PRL:8 prolactin levels PRM PRM:9 particle repositioning maneuver PRM PRM:42 primidone PRN PRN:9|prn:4 asneeded PRN PRN:29 paramedian reticular nucleus PRN PRN:27 plaque reduction neutralization PRN PRN:1 practice and research network PRN PRN:8|prn:7 pro re nata PROM PROM:31 passive range of motion PROM PROM:8 premature rupture of membrane PRP-T PRP-T:1 conjugated with tetanus toxoid PRP-T PRP-T:22 toxoid conjugate PRP PRP:10 haemophilus influenzae type b capsular polysaccharide PRP PRP:7 pacaprelated peptide PRP PRP:73 panretinal photocoagulation PRP PRP:17 penicillinresistant pneumococci PRP PRP:34 pityriasis rubra pilaris PRP PRP:15 polyribosyl ribitol phosphate PRP PRP:30 polyribosylribitol phosphate PRP PRP:9 polyribosylribitolphosphate PRP PRP:39 primary raynauds phenomenon PRP PRP:31 prolinerich polypeptide PRP PRP:29 psychological refractory period PRP PRP:10 pulmonary rehabilitation program PRQ PRQ:10 personal resource questionnaire PRQ PRQ:6 pressurerate quotient PRR PRR:12 parietal reach region PRR PRR:11 pattern recognition receptors PRR PRR:14 postreplication repair PRR PRR:21 prolinerich region PRR PRR:10 water proton relaxation rate PRSS1 PRSS1:23 cationic trypsinogen PRSS1 PRSS1:11 cationic trypsinogen gene PRS PRS:7 parryromberg syndrome PRs PRs:26 partial remissions PRs PRs:195|PRS:1 partial responses PRS PRS:8 phosphoribosylpyrophosphate synthetase PRS PRS:13 photon radiosurgery system PRS PRS:15 pierre robin sequence PRS PRS:36 plasma renin substrate PRS PRS:7 postreperfusion syndrome PRS PRS:7 postribosomal supernatant PRs PRs:138|prs:1 pregnancy rates PRs PRs:11 proteases PRTH PRTH:8 pituitary resistance PRTH PRTH:11 pituitary resistance to thyroid hormone PRT PRT:43 photoradiation therapy PRT PRT:12 plasma recalcification time PRT PRT:19 progressive resistance training PRT PRT:9 proton radiation therapy PrV PrV:16 nucleus principalis PrV PrV:8 principal sensory nucleus PR PR:22 expression of pathogenesisrelated PR PR:9 paeoniae radix PR PR:9 pain relief PR PR:7 panoramic radiography PR PR:9 pars recta PR PR:9 partial regression PR PR:26 partial responders PR PR:8 passive recovery PR PR:9 pattern recognition PR PR:9|pr:2 pattern reversal PR PR:9 perirenal PR PR:17 phenol red PR PR:20 photoreactivation PR PR:25 pityriasis rosea PR PR:5 placental restriction PR PR:9 plain radiography PR PR:10 plaque reduction PR PR:9 pneumatic retinopexy PR PR:15 polymorphic reticulosis Pr Pr:8|PR:2 prealbumin Pr Pr:6|PR:3 pregnant PR PR:94 progressive ratio PR PR:33 projection reconstruction PR PR:10|pr:1 proliferative retinopathy PR PR:10|pr:1 prorenin PR PR:6 protein restriction PR PR:12 pseudorabies PR PR:14 puerto rico PR PR:50 pulmonary regurgitation PR PR:27 pulmonary rehabilitation PR PR:10|Pr:6 release Pr Pr:6|pr:1 release probability PR PR:9 retention PR PR:11 under a progressiveratio PR PR:10 viral proteinase PSA PSA:16 biochemical PSA PSA:15 persistent sciatic artery PSA PSA:21 pisum sativum PSA PSA:15 polar surface area PSA PSA:138 polysialic acid PSA PSA:17 population spike amplitude PSA PSA:10 porcine serum albumin PSA PSA:12 potentiometric stripping analysis PSA PSA:53 power spectral analysis PSA PSA:15 puromycinsensitive aminopeptidase PSB PSB:72 protected specimen brush PSB PSB:10 protected specimen brushing PSB PSB:15|pSB:1 protonated schiff base PSCs PSCs:15 perisynaptic schwann cells PSCs PSCs:12 posterior subcapsular cataracts PSCs PSCs:46 postsynaptic currents PSC PSC:4 echinococcus granulosus protoscoleces PSC PSC:26 pediatric symptom checklist PSC PSC:10 peripheral blood stem cell PSC PSC:13 platelet shape change PSC PSC:37 posterior subcapsular PSC PSC:8 postsynaptic current PSC PSC:535 primary sclerosing cholangitis PSC PSC:12 sdz psc PSD-95 PSD-95:20|PSD95:3 postsynaptic density PSD-95 PSD-95:11|PSD95:4 postsynaptic density protein PSDs PSDs:89|psds:1 postsynaptic densities PSDs PSDs:9 presynaptic dendrites PSD PSD:10 dementia PSD PSD:39 paradoxical sleep deprivation PSD PSD:24 partial sleep deprivation PSD PSD:31 particle size distribution PSD PSD:6|Psd:1|psd:1 phosphatidylserine decarboxylase PSD PSD:5 poststenotic dilatation PSE PSE:44 partial splenic embolization PSE PSE:7 photosensitive epilepsy PSE PSE:12 point of subjective equality PSE PSE:112 present state examination PSE PSE:47 proximal sequence element PSF PSF:9 peak systolic frequency PSF PSF:10 polypyrimidine tractbinding proteinassociated splicing factor PSGs PSGs:14 polysomnograms PSGs PSGs:14 pregnancyspecific glycoproteins PSG PSG:7 peak systolic gradient PSG PSG:6 peak systolic pressure gradient PSG PSG:25 polysomnogram PSG PSG:52|psg:1 polysomnographic PSG PSG:331 polysomnography PSG PSG:9|psg:1 posterior silk gland PSG PSG:4 prostate secretory granules PSK PSK:20 polysaccharide k PSK PSK:28|PS-K:5 proteinbound polysaccharide PSM PSM:6 porcine stomach mucin PSM PSM:4 porcine submaxillary mucin PSM PSM:42|psm:3 presomitic mesoderm PSM PSM:9 propagated sensation along meridians PSN PSN:6 pontosubicular necrosis PSN PSN:6 pontosubicular neuron necrosis PSN PSN:9 principal sensory nucleus of the trigeminal nerve PSN PSN:11 sensory neuropathy PSN PSN:8 splanchnic nerve PSO PSO:10 particle swarm optimization PSO PSO:6 providersponsored organization PSP PSP:26 pancreatic spasmolytic polypeptide PSP PSP:24 pancreatic stone protein PSP PSP:95 paralytic shellfish poisoning PSP PSP:29 parotid secretory protein PSP PSP:19 peak systolic pressure PSP PSP:46 phenolsulfonphthalein PSP PSP:18 phenyl saligenin phosphate PSP PSP:13 phosphoserine phosphatase PSP PSP:11 photostimulable phosphor PSP PSP:11 polysaccharide peptide PSP PSP:6 polystyrene particles PSP PSP:6 postsynaptic potentiation PSP PSP:45 primary spontaneous pneumothorax PSP PSP:662 progressive supranuclear palsy PSP PSP:40|psp:6|PsP:2 pseudopregnancy PSP PSP:23|psp:7 pseudopregnant PSR PSR:10|PS-R:1 phosphatidylserine receptor PSR PSR:18 proliferative sickle retinopathy PSR PSR:19 protein synthesis rate PSSM PSSM:11 polysaccharide storage myopathy PSSM PSSM:8 scoring matrix PSS PSS:32 perceived stress scale PSS PSS:6 phosphatidylserine synthase PSS PSS:33 physiological saline solution PSS PSS:121 physiological salt solution PSs PSs:23 polysaccharides PSs PSs:41 population spikes PSS PSS:6 portosystemic shunting PSS PSS:8 postsystolic shortening pSS pSS:160|PSS:35|pSs:2|p-SS:1|P-SS:1 primary sjogrens syndrome pSS pSS:10|PSS:3|P-SS:1 primary ss PSS PSS:26 progressive systemic scleroderma PSS PSS:465|pss:1 progressive systemic sclerosis PSS PSS:6 severity score PST PST:42|Pst:5 pancreastatin PST PST:7|P-ST:4 phenol st PST PST:10|P-ST:1 phenol sulphotransferase PST PST:26 phenolsulfotransferase pST pST:75|PST:14|pst:1 porcine somatotropin pST pST:7 porcine st PST PST:9 primary systemic therapy Pst Pst:1 pseudomonas syringae pv tomato Pst Pst:7 recoil pressure PSV PSV:9 peak systolic PSV PSV:9 peanut stunt virus PSV PSV:12 primary systemic vasculitides PSV PSV:12 proximal selective vagotomy PSbMV PSbMV:6 pea seedborne mosaic potyvirus PSbMV PSbMV:9 pea seedborne mosaic virus PS PS:5|ps:1 capillary diffusion capacity PS PS:13 contractile properties analyzed included peak shortening PS PS:6 drosophila positionspecific PS PS:10 mutations in the presenilin PS PS:11 pachytene spermatocytes PS PS:12|P-S:4 palmazschatz PS PS:444 paradoxical sleep ps ps:14|PS:4 parallelstranded PS PS:12 partial seizures PS PS:31 pathologic stage PS PS:13|ps:1 pathological stage PS PS:17 peak slope PS PS:10 pentasaccharide PS PS:6 peritoneal sclerosis PS PS:10 phosphatidyllserine PS PS:17 photic stimulation PS PS:10 photostimulation PS PS:122 photosystem PS PS:14 physiological saline PS PS:14 phytosterols ps ps:9 picosecond PS PS:6 planar scintigraphy PS PS:209|Ps:1 polystyrene PS PS:26 polysulphone PS PS:7|pS:2 porcine serum PS PS:6 porcine stable kidney PS PS:10|ps:1 power spectra PS PS:10 power spectrum PS PS:9 pregnenolone sulphate PS PS:11 prenatal stress PS PS:11|P-S:4 prenatally stressed PS PS:5 preparatory signal PS PS:42 pressure support PS PS:9 primary snoring PS PS:15 primitive streak PS PS:12 principal sulcus PS PS:43|Ps:1 protamine sulfate PS PS:10 protamine sulphate PS PS:15|Ps:11 psoriasis PS PS:8 psychogenic seizures PS PS:11 pubertal spurt PS PS:13 pulmonary sequestration PS PS:70 pulmonary stenosis PS PS:38 pulmonary surfactant PS PS:9 pyloric sphincter PS PS:6 pyriform sinus PS PS:11|P-S:2 pyrimethaminesulfadoxine PS PS:10 symptoms PTB PTB:7 patellar tendon bearing PTB PTB:6 phosphotyrosinebinding domain PTB PTB:24 preterm birth PTB PTB:20|pTB:1 pulmonary tb PTCA PTCA:10 percutaneous transluminal coronary angiography PTCA PTCA:18 pyrroletricarboxylic acid PTCR PTCR:15 percutaneous transluminal coronary recanalization PTCR PTCR:7 percutaneous transluminal coronary revascularization PTCs PTCs:34 papillary thyroid carcinomas PTCs PTCs:10 peritubular capillaries PTCs PTCs:29 premature termination codons PTCs PTCs:24 psychophysical tuning curves PTC PTC:9 ability to taste phenylthiocarbamide PTC PTC:19 papillary PTC PTC:21 peptichemio PTC PTC:5 phase transition curve PTC PTC:17 phenylthiocarbamyl PTC PTC:10 plugged telescoping catheter PTC PTC:16 portal triad clamping PTC PTC:19 premature termination codon PTC PTC:6 tuning curve PTD PTD:10 arrowtrerotola percutaneous thrombolytic device PTD PTD:9 peak tension developed PTD PTD:10 percutaneous transhepatic drainage PTD PTD:8 percutaneous transluminal dilatation PTD PTD:16 persistent trophoblastic disease PTD PTD:7 posttetanic depression PTD PTD:17 primary torsion dystonia PTD PTD:21 pyrithiamineinduced thiamine deficiency PTEN PTEN:15 phosphatase and tensin homolog PTEN PTEN:9 phosphatase and tensin homolog deleted on chromosome PTEN PTEN:7 phosphatase and tensin homolog deleted on chromosome ten PTEN PTEN:7 phosphatase and tensin homologue PTE PTE:48 parathyroid extract PTE PTE:21 phosphotriesterase PTE PTE:38 pulmonary thromboendarterectomy PTFE PTFE:9 polytetraflouroethylene PTFE PTFE:59 polytetrafluorethylene PTF PTF:14 patient treatment file PTF PTF:13 primary tissue failure PTF PTF:10 tissue fraction PTHrP PTHrP:242|PTHRP:29|PTH-rP:11|PTHrp:6|PTH-rp:5|PthrP:1|PTH-RP:1|PTHr-P:1|Pthrp:1 parathyroid hormonerelated peptide PTHrP PTHrP:686|PTH-rP:43|PTHRP:20|PTHrp:7|PTH-rp:5|PTH-RP:2 parathyroid hormonerelated protein PTH PTH:214 parathormone PTH PTH:20 parathyrin PTH PTH:4 parathyroid hormone PTH PTH:8 parathyroid hormone gene PTH PTH:11 parathyroid hormone levels Pth Pth:17|PTH:2 peptidyltrna hydrolase PTH PTH:34|Pth:4 phenylthiohydantoin Pth Pth:9 pressure threshold PTNs PTNs:37|PTNS:2 pyramidal tract neurons PTNs PTNs:10 pyramidal tract neurones PTN PTN:103|Ptn:2 pleiotrophin PTN PTN:37 posterior tibial nerve PTO PTO:9 percutaneous transhepatic obliteration PTO PTO:11 person tradeoff PTO PTO:6 portal triad occlusion PTPs PTPs:9 previously treated patients PTPs PTPs:217 protein tyrosine phosphatases PTP PTP:21 percutaneous transhepatic portography PTP PTP:150 permeability transition pore PTP PTP:13 phosphate transport protein pTP pTP:2 precursor to terminal protein pTP pTP:22 preterminal protein PTP PTP:6 pretest probability PTP PTP:9 prohormone thiol protease PTP PTP:12 protein tyrosine phosphorylation PTR PTR:14 pressure transmission ratio PTR PTR:11 prothrombin time ratio PTS PTS:28 pediatric trauma score PTS PTS:9 peroxisome targeting signal PTs PTs:18 phage types PTS PTS:20|Pts:2 phosphotransferase PTs PTs:7 phyllodes tumors PTs PTs:13 physical therapists PTS PTS:8 posttraumatic syringomyelia PTS PTS:16 posttraumatic stress PTs PTs:18 prothrombin times PTS PTS:13 proximal tubular segments PTs PTs:20 proximal tubules PTS PTS:7 proximal tubule segments PTT PTT:10 betapropanoylbetatolyltropane PTT PTT:7 partial thromboplastin PTT PTT:16 posterior tibial tendon PTT PTT:109 protein truncation test PTV PTV:17 patient triggered ventilation PTV PTV:15 punta toro virus PTX PTX:23|PTx:11|Ptx:1 after parathyroidectomy PTX PTX:11 antagonist picrotoxin PTX PTX:58|PTx:2 palytoxin PTX PTX:104|PTx:3|ptx:1 parathyroidectomized PTX PTX:11 picrotoxinin PTX PTX:23 piritrexim PTX PTX:26|Ptx:1 pneumothorax PTZ PTZ:14 pentetrazol PTZ PTZ:459 pentylenetetrazol PTZ PTZ:210 pentylenetetrazole PTZ PTZ:10 pentylentetrazol PTZ PTZ:15 phenothiazine pT pT:5 depth of tumor invasion Pt Pt:6 isometric twitch pt pt:14|PT:1 paralytic tremor PT PT:93|pt:3|Pt:1 pars tuberalis PT PT:45 patellar tendon PT PT:88|pT:1 peak torque PT PT:12 percutaneous tracheostomy PT PT:13 perinuclear theca PT PT:82 permeability transition PT PT:5 permissive temperature PT PT:14 pertussis toxoid PT PT:9 photothermal PT PT:96 physical therapy PT PT:21 physical training PT PT:24 physiotherapy PT PT:9 picrotoxin PT PT:56 planum temporale pt pt:8|Pt:1 plastid Pt Pt:218|PT:2 platinum PT PT:21|pt:4 posttreatment PT PT:10 posterior tibial PT PT:13|Pt:3 pretectum PT PT:37 preterm PT PT:17 primary thrombocythaemia PT PT:10 primary thrombocythemia PT PT:4|pT:1 primary tumour PT PT:54 proficiency testing PT PT:15 proton transfer PT PT:12 proximal PT PT:10 ptaquiloside PT PT:14 pulmonary trunk PT PT:83|Pt:1 pyramidal tract PT PT:16|pT:1 tumors pT pT:6|p-T:1 tumor stage Pt Pt:7|PT:1 twitch force PUBS PUBS:25 percutaneous umbilical blood sampling PUBS PUBS:10 purple urine bag syndrome PUFA PUFA:15 polyunsaturated PUFA PUFA:16 polyunsaturated fa PUF PUF:9|pUF:3 plasma ultrafiltrate PUF PUF:38 polyurethane foam PUs PUs:18 polyurethanes PUs PUs:11 pressure ulcers PUVA PUVA:26 longwave ultraviolet light PUVA PUVA:9 plus uva radiation PUVA PUVA:32 psoralen plus uva PUVA PUVA:11 psoralenuva PUVA PUVA:12 uva irradiation Pu Pu:5 operon promoter PU PU:41 peptic ulcer PU PU:46|pu:2 perfusion units Pu Pu:12|PU:2 plutonium PU PU:15 proteinuria Pu Pu:8 urea permeability PVA PVA:5 pemphigus vulgaris antigen PVA PVA:359 polyvinyl alcohol PVA PVA:7 polyvinyl alcohol particles PVA PVA:46 polyvinylalcohol PVA PVA:122|P-VA:1 pressurevolume area PVCs PVCs:98 premature ventricular complexes PVCs PVCs:147 premature ventricular contractions PVC PVC:9 paravestibular canaliculus PVC PVC:430 polyvinyl chloride PVC PVC:156 polyvinylchloride PVC PVC:8 prevacuolar compartment PVC PVC:12 vaginal cornification PVDF PVDF:148|PVdF:2 polyvinylidene difluoride PVDF PVDF:59 polyvinylidene fluoride PVD PVD:400 peripheral vascular disease PVD PVD:6 portal vein diameter PVD PVD:104 posterior vitreous detachment PVE PVE:7 partial volume effect PVE PVE:10 plasma volume expansion PVE PVE:47 portal vein embolization PVE PVE:149 prosthetic valve endocarditis PVE PVE:17 pseudostratified ventricular epithelium PVF PVF:13 polyvinyl formal PVF PVF:8|PVf:1 primary ventricular fibrillation PVF PVF:49 pulmonary venous flow PVG PVG:10 periventricular gray PVG PVG:6 portal venous gas PVH PVH:23 hypothalamic paraventricular nucleus PVH PVH:25 paraventricular PVH PVH:36 paraventricular hypothalamic nucleus PVH PVH:5|PV-H:3 perivenous hepatocytes PVH PVH:25 periventricular haemorrhage PVH PVH:9 periventricular hemorrhage PVI PVI:24 protracted venous infusion PVI PVI:13 pulmonary vein isolation PVL PVL:20|pvl:1 pantonvalentine leukocidin PVL PVL:257 periventricular leukomalacia PVL PVL:11 periventricular lucency PVL PVL:7 portal hypertension induced by partial portal vein ligation PVL PVL:10 portal veinligated PVL PVL:13 proliferative verrucous leukoplakia PVM PVM:12 parasitophorous vacuolar membrane PVM PVM:26|pvm:1 parasitophorous vacuole membrane PVM PVM:55 pneumonia virus of mice PVM PVM:11 potato virus m PVN PVN:49 hypothalamic paraventricular PVN PVN:5 predictive value negative PvO2 PvO2:23|PVO2:17|PVo2:1 mixed venous oxygen tension PvO2 PvO2:3|pVO2:1 venous oxygen pressure PVOD PVOD:14 pulmonary vascular obstructive disease PVOD PVOD:24 pulmonary venoocclusive disease PVO PVO:27 paraventricular organ PVO PVO:9 portal vein occlusion PVO PVO:14 pulmonary venous obstruction PVP PVP:14 peripheral venous pressure PVP PVP:65 polyvinyl pyrrolidone PVP PVP:13 portal vein pressure PVP PVP:15 portal venous phase PVP PVP:9 positionvestibularpause PVP PVP:45 posteroventral pallidotomy PVP PVP:16 predictive value positive PVR PVR:36|Pvr:3 poliovirus receptor PVR PVR:12 postvoid residual volume PVR PVR:524 proliferative vitreoretinopathy PVR PVR:17 pulmonary valve replacement PVR PVR:20 residual urine PVR PVR:38 residual urine volume PVs PVs:18 papillomaviruses PVS PVS:15 penile vibratory stimulation PVS PVS:17 peritoneovenous shunt PVS PVS:11 perivascular space PVS PVS:24|PvS:1 perivitelline space PVS PVS:71|Pvs:1 persistent vegetative state PVS PVS:9 polyvinyl sulfate PVS PVS:5 portal vein stenosis PVS PVS:13 potato virus s PVS PVS:54 programmed ventricular stimulation PVS PVS:12 pubovaginal sling PVS PVS:6 pulmonary valve stenosis PVs PVs:97 pulmonary veins PVS PVS:12 venous sampling PVTT PVTT:9 portal vein tumor thrombosis PVTT PVTT:14 portal vein tumor thrombus PVT PVT:8 paraventricular nucleus of the thalamus PVT PVT:108 portal vein thrombosis PVT PVT:15 psychomotor vigilance task PV PV:18 parietal ventral area PV PV:44 patients with polycythaemia vera PV PV:6 patients with psoriasis vulgaris PV PV:30|pv:2|pV:1 peak velocity PV PV:287|Pv:3 pemphigus vulgaris PV PV:13 periventricular PV PV:17 peroxide value PV PV:13|pV:3 pervanadate PV PV:11 phenyl valerate PV PV:10 pichinde virus PV PV:15 pityriasis versicolor PV PV:71|pv:2|Pv:1 plasma viscosity PV PV:114 poliovirus PV PV:12|pv:2 postvaccination PV PV:11 pravastatin PV PV:11 processus vaginalis PV PV:14 pulmonary valve PV PV:35 pulmonary venous PV PV:17|P-V:15 static pressurevolume PWA PWA:17 people with aids PWA PWA:9 pulse wave analysis PWA PWA:9 wave amplitude PWC PWC:20|pwc:1 physical work capacity PWC PWC:15 physical working capacity PWD PWD:10 duration of filtered pwave PWD PWD:5 wave doppler PWT PWT:5 paw withdrawal threshold PWT PWT:38 posterior wall thickness PWS PWS:9 paternal PWS PWS:22 praderwilli PWS PWS:462 praderwilli syndrome PWS PWS:9 prince william sound PWS PWS:15 treatment of portwine stains PW PW:45|pW:1 posterior wall PW PW:8 pulse width PW PW:15|pw:2 pulsedwave Px Px:5|PX:1 pancreatectomized Px Px:3|px:1|PX:1 after pancreatectomy Px Px:14 partial pancreatectomy PX PX:47 phox homology PX PX:26|Px:18|px:1 pinealectomy PYP PYP:12 mtcpyrophosphate PYP PYP:94|pyp:2 photoactive yellow protein PYP PYP:11 tcm pyrophosphate PYR PYR:3|P-YR:1|pyr:1 personyears at risk PYR PYR:6|Pyr:5 pyrazole Pyr Pyr:17|PYR:11|pyr:3 pyruvate Pyr Pyr:30|PYR:5|pyr:1 urinary pyridinoline PZA PZA:163|pza:1 pyrazinamide PZA PZA:25 pyrazoloacridine PZ PZ:57 peripheral zone PZ PZ:8|Pz:2 piezoelectric PZ PZ:9 promazine PZ PZ:15 protein z PaCO2 PaCO2:13|Paco2:1 arterial carbon dioxide partial pressure PaCO2 PaCO2:27|paCO2:2|PaCO-2:1|Paco2:1|PACO2:1 arterial carbon dioxide pressure PaCO2 PaCO2:34|Paco2:2 arterial co partial pressure PaCO2 PaCO2:12|Paco2:1 arterial co pressure PaCO2 PaCO2:19|Paco2:2 arterial partial pressure of co PaCO2 PaCO2:14|Paco2:1|PACO2:1 carbon dioxide tensions PaCO2 PaCO2:14|paCO2:1 partial pressure of carbon dioxide in arterial blood PaCO2 PaCO2:11 partial pressure of co in arterial blood PaO(2) PaO(2):21 arterial oxygen tension PaO(2) PaO(2):7 arterial partial pressure of oxygen PaO2 PaO2:27|paO2:1|Pao2:1 arterial o partial pressure PaO2 PaO2:27|Pao2:2|paO2:1|PAO2:1 arterial oxygen partial pressure PaO2 PaO2:22|Pao2:1 arterial oxygenation PaO2 PaO2:1 arterial partial pressure for oxygen PaO2 PaO2:15|Pao2:4 arterial partial pressure of o PaO2 PaO2:18|Pao2:1 partial pressure of oxygen in arterial blood PAP PAP:29|p-AP:5|pAP:5 paminophenol PAP PAP:61 pancreatitisassociated protein Pap Pap:518|PAP:1 papanicolaou Pap Pap:18 papanicolau PAP PAP:10 paraaminophenol PAP PAP:9 phosphatidic acid phosphohydrolase PAP PAP:9 plasminalpha antiplasmin PAP PAP:14 plasminalpha antiplasmin complex PAP PAP:12 plasminantiplasmin PAP PAP:77 pokeweed antiviral protein PAP PAP:61 polya polymerase PAP PAP:8 postactivation potentiation PAP PAP:8 prostatic acid phosphate PAP PAP:138|Pap:1 pulmonary alveolar proteinosis Pap Pap:10|pap:7|PAP:1 pyelonephritisassociated pili PC1 PC1:11 first principal component PC-1 PC-1:6 pancreatic cancer cell line PC-1 PC-1:9 plasma cell membrane glycoprotein PC1 PC1:13|PC-1:1 polycystin PHR PHR:8 percentage hepatic replacement PHR PHR:5 personal health record PIM PIM:7 paediatric index of mortality PIM PIM:10 pediatric index of mortality PIM PIM:21|Pim:4 pimozide PIM PIM:10 polymorphic immunodominant molecule PJ PJ:8 pancreatic juice PJ PJ:19|P-J:1 pancreaticojejunostomy PLA PLA:123 polylactic acid PLA PLA:12 processed lipoaspirate PLA PLA:15 pyogenic liver abscess PMV PMV:6 avian paramyxovirus PMV PMV:17 mosaic virus PMV PMV:12 percutaneous mitral balloon valvotomy PMV PMV:6 percutaneous mitral valvotomy PMV PMV:33 percutaneous mitral valvuloplasty PMV PMV:15 prolonged mechanical ventilation POS POS:11 palliative care outcome scale POS POS:17 photoreceptor outer segments POS POS:14 pointofservice PPA PPA:7 parahippocampal place area PPA PPA:10 passive peritoneal anaphylaxis PPA PPA:127|Ppa:2 phenylpropanolamine PPA PPA:15 phenylpropanolamine hydrochloride PPA PPA:10 phenylpyruvic acid PPA PPA:22 pipemidic acid PPA PPA:28 porcine pancreatic alphaamylase PPA PPA:11 postpartum amenorrhea PPA PPA:56 primary progressive aphasia PRH PRH:7 postocclusive reactive hyperemia PRH PRH:7 primary rat hepatocytes PRP-D PRP-D:10 diphtheria toxoid PRP-D PRP-D:11 toxoid conjugate vaccine PrP-res PrP-res:4|PrPres:1 proteaseresistant isoform PrP-res PrP-res:7|PrPres:3|PrPRES:1 proteaseresistant prp PSTs PSTs:12 paralytic shellfish toxins PSTs PSTs:8|P-STs:1 phenol sulfotransferases PSY PSY:8|Psy:5|psy:4 phytoene synthase PSY PSY:8|Psy:2 psyllium PtiO2 ptiO2:3|PtiO2:3 brain tissue oxygenation PtiO2 PtiO2:6|ptiO2:1 oxygen pressure PTM PTM:7 perceptual template model PTM PTM:8 posttranslational modification PTM PTM:11 pretibial myxedema PTM PTM:17 proximal tibial metaphysis PvCO2 PvCO2:9|PVCO2:7|Pv-CO2:1 mixed venous pco PvCO2 PvCO2:5|PVCO2:3 venous carbon dioxide tension Py Py:16 nmethylpyrrole PY PY:6 peptide y PY PY:13|py:7|p-y:2 per personyears PY PY:14|py:9 person years Py Py:23|PY:2|py:1 polyoma Py Py:16|PY:14|py:1 pyrene PY PY:4|Py:3 pyronin y Py Py:14|PY:1 pyrrole QAP QAP:18 quality assurance program QAP QAP:8 quality assurance project Qa Qa:7 access blood flow Qa Qa:7|QA:3 access flow QA QA:6 electron acceptor QA QA:15 glomerular plasma flow QA QA:26 glomerular plasma flow rate QA QA:5 primary quinone QA QA:6 primary quinone acceptor QA QA:16 quality assessment QA QA:21 quaternary ammonium QB QB:13 quiet breathing QB QB:13 secondary quinone QB QB:4 secondary quinone acceptor QCA QCA:8 quantitative coronary analysis QCA QCA:11 quantitative coronary angiographic QCA QCA:140|qCA:1 quantitative coronary angiography QCA QCA:16 quantitative coronary arteriography QD QD:4|Qd:3 dialysate flow QD QD:8|qd:1 once a day QD QD:17 quantum dot QEEG QEEG:50|qEEG:48 quantitative eeg QEEG QEEG:9|qEEG:8 quantitative electroencephalogram QEEG QEEG:16|qEEG:7 quantitative electroencephalographic QEEG QEEG:34|qEEG:20|q-EEG:2 quantitative electroencephalography QF-PCR QF-PCR:7|QFPCR:1 quantitative fluorescent pcr QF-PCR QF-PCR:16 quantitative fluorescent polymerase chain reaction QF QF:36 quadriceps femoris QF QF:14|Q-F:4 quantityfrequency QGS QGS:6 quantitative gated single photon emission computed tomography QGS QGS:33 quantitative gated spect QI QI:202 quality improvement QI QI:11 quality index QI QI:23 quetelet index QL QL:91|Ql:2 lymph flow QL QL:13 lymph flow rate QM/MM QM/MM:16 quantum mechanicsmolecular mechanics QM/MM QM/MM:30 quantum mechanicalmolecular mechanical QM QM:34 quality management QM QM:11 quantum mechanics QM QM:26 quantum mechanical QM QM:16|Q-M:1 quinacrine mustard QO2 QO2:20|Qo2:1 o delivery QO2 QO2:7|QO-2:1|qO2:1 respiration QPCR QPCR:43|Q-PCR:34|qPCR:27|q-PCR:1 quantitative pcr QPCR QPCR:38|Q-PCR:25|qPCR:18|q-PCR:2 quantitative polymerase chain reaction QRT-PCR QRT-PCR:8|qRT-PCR:5|QRTPCR:1|Q-Rt-PCR:1|Q-RT-PCR:1 quantitative realtime polymerase chain reaction QRT-PCR QRT-PCR:5|qRT-PCR:2|Q-RT-PCR:2 quantitative reverse transcriptionpcr QS QS:9 quiet QS QS:29 quinacrine sterilization QS QS:5 quinidine sulfate QTcd QTcd:6|QTcD:4|QTc-d:2 corrected qt dispersion QTcd QTcd:11|QTcD:1 corrected qtd QTcd QTcd:8|QTc-d:1|QTcD:1 qtc dispersion QTc QTc:9|Q-Tc:1 bazetts formula QTc QTc:11|Q-Tc:1 corrected QTc QTc:128 corrected qt QTc QTc:33|QTC:1 qt interval corrected for heart rate QUIN QUIN:5 agonist quinpirole QUIN QUIN:18|Quin:1 quinolinate QUIS QUIS:8|quis:4 quisqualic QUIS QUIS:32|quis:10|Quis:1 quisqualic acid QUS QUS:15 quantitative ultrasonometry QUS QUS:313|qUS:2 quantitative ultrasound QWB QWB:36 quality of wellbeing QWB QWB:36 quality of wellbeing scale QW QW:3|qw:3 once weekly QW QW:15|Qw:3 quiet wakefulness QW QW:11|Qw:1 quiet waking Qp/Qs Qp/Qs:11 pulmonary to systemic blood flow Qp/Qs Qp/Qs:6|QP/QS:1 pulmonary to systemic blood flow ratio Qp/Qs Qp/Qs:18|QP/QS:1 pulmonary to systemic flow ratio Qp/Qs Qp/Qs:16 ratio of pulmonary to systemic flow Qs/Qt Qs/Qt:10 intrapulmonary shunting Qs/Qt Qs/Qt:17|QS/QT:4|Qs/QT:2|QS/Qt:1 pulmonary shunt R0 R0:6 basic reproduction number R0 R0:25 complete resection R0 R0:29|R-0:1 curative resection R0 R0:8 reproduction ratio R1881 R1881:18|R-1881:1 hmethyltrienolone R1881 R1881:15 synthetic androgen methyltrienolone R18 R18:10|R-18:1 octadecyl rhodamine b chloride R18 R18:12|R-18:1 octadecylrhodamine R18 R18:8 octadecylrhodamine b R18 R18:10 octadecylrhodamine b chloride R5 R5:11 ccrdependent R5 R5:15 ccrusing rAAV rAAV:5 adenoassociated viral vectors rAAV rAAV:40 recombinant aav rAAV rAAV:36 recombinant adenoassociated viral rAAV rAAV:10 recombinant adenoassociated viral vector rAAV rAAV:9 recombinant adenoassociated virus type RAA RAA:10 renal artery aneurysm RAA RAA:78|R-A-A:9 reninangiotensinaldosterone RAA RAA:9 right aortic arch RAA RAA:37 right atrial appendage RACK1 RACK1:8|RACK-1:3 receptor for activated c kinase RACK1 RACK1:11|RACK-1:1 receptor for activated c kinase RAC RAC:20 rabbit articular chondrocytes RAC RAC:11|rac:2 ractopamine RAC RAC:11|rac:1 radial alveolar count RAC RAC:31 recombinant dna advisory committee RAG RAG:15 rat male accessory glands RAG RAG:13 retinoyl betaglucuronide RAI RAI:35 resident assessment instrument RAI RAI:22 ritchie articular index Raji Raji:7 human burkitts lymphoma Raji Raji:5|raji:1 human lymphoblastoid cells RAL RAL:11 relative adduct labeling RAL RAL:14 relative attachment level RAL RAL:10 retinaldehyde RANKL RANKL:167|RANK-L:3 receptor activator of nfkappab ligand RANKL RANKL:18 receptor activator of nuclear factorkappa b ligand RANKL RANKL:66|RANK-L:1 receptor activator of nuclear factorkappab ligand RANTES RANTES:21 regulated on activation normal t cell expressed and secreted RANTES RANTES:5 regulated upon activation normal tcell expressed and secreted RAN RAN:24|Ran:5 ranitidine RAN RAN:14 rapid automatized naming RAO RAO:27 renal artery occlusion RAO RAO:49 right anterior oblique RAO RAO:18 rotational acetabular osteotomy RAPD RAPD:9 amplified polymorphic dna fingerprinting RAPD RAPD:5 arbitrary primers RAPD RAPD:188 random amplification of polymorphic dna RAPD RAPD:873|RAP-D:1 random amplified polymorphic dna RAPD RAPD:19 random amplified polymorphic dna analysis RAPD RAPD:30 relative afferent pupillary defect RAP RAP:194 receptorassociated protein RAP RAP:95 recurrent abdominal pain RAP RAP:11 regional acceleratory phenomenon RAP RAP:8 rehabilitation activities profile RAP RAP:46 renal arterial pressure RAP RAP:5 resistancearea product RAP RAP:10 retinal angiomatous proliferation RARS RARS:15 ra with ring sideroblasts RARS RARS:16 refractory anemia with ring sideroblasts RARS RARS:35 refractory anemia with ringed sideroblasts RAST RAST:12 ige antibodies RAST RAST:11|Rast:1 radioallergosorbenttest RAST RAST:41 radioallergosorbent RAST RAST:16 radioallergosorbent testing RAS RAS:11 aortic strips RAS RAS:9 rate of ankle swelling RAS RAS:91 recurrent aphthous stomatitis RAS RAS:11 renal artery stenoses RAS RAS:253 renal artery stenosis RAS RAS:17 retinoic acid syndrome RA RA:12|Ra:1 afferent arteriolar resistance Ra Ra:10|RA:2 arterial resistance RA RA:32 nucleus robustus archistriatalis RA RA:121 radial artery RA RA:23 radiographic absorptiometry Ra Ra:11 ragged RA RA:77 rapidly adapting RA RA:9 rat aorta RA RA:48|ra:1 rectus abdominis RA RA:93 refractory anaemia RA RA:238 refractory anemia RA RA:11 regional anaesthesia RA RA:10 regional anesthesia RA RA:18 relative anisotropy RA RA:7 repeated acquisition Ra Ra:10 resistance to reabsorption of csf RA RA:8 retinol acetate RA RA:19 retrograde amnesia RA RA:40 rheumatoid RA RA:23 rheumatoid arthritic RA RA:11 rheumatoid arthritis patients RA RA:8 ricin a chain RA RA:12 right RA RA:13 right atria RA RA:11 risk area RA RA:97 robust nucleus of the archistriatum RA RA:58 room air RA RA:30 rotational atherectomy RA RA:12 rounded atelectasis rBCG rBCG:7 bacillus calmetteguerin rBCG rBCG:20 recombinant bcg RBC RBC:59|Rbc:1 ranitidine bismuth citrate RBC RBC:23 rotating biological contactor RBD RBD:13 ras binding domain RBD RBD:25 receptorbinding domain RBD RBD:23 recurrent brief depression RBD RBD:7 regional basic diet RBD RBD:22 right brain damage RBD RBD:26 rna binding domain RBE RBE:12 binding element RBE RBE:18 relative biological efficiency RBE RBE:6 revbinding element RBF RBF:11 blood flows RBF RBF:59 radial basis function RBF RBF:1155|rbf:3 renal blood flow RBM RBM:14 rat bone marrow RBM RBM:8 rnabinding motif RBM RBM:14 roll back malaria RBT RBT:9 random breath testing RBT RBT:19 rifabutin RBT RBT:23 rose bengal test RBV RBV:8 relative bioavailability RBV RBV:13 relative biological value Rb Rb:10 minnesota r rb rb:15|Rb:4 rabbit RB RB:13|Rb:1 rebreathing rb rb:11 recombinant bovine RB RB:28 repetition blindness RB RB:47 respiratory burst Rb Rb:13|RB:11 retinoblastoma susceptibility Rb Rb:20|RB:7 retinoblastoma susceptibility gene product Rb Rb:21|RB:15 retinoblastoma tumor suppressor protein RB RB:14 rhodamine b RB RB:9 rice bran Rb Rb:40 robertsonian RB RB:10|R-B:2 rohonbeard RB RB:104|rb:1|Rb:1 rose bengal RCA RCA:14 red cell aggregation RCA RCA:12 replicationcompetent adenovirus RCA RCA:9 retrochiasmatic area RCA RCA:14 ricinus communis agglutinin i RCA RCA:8 root cause analysis RCA RCA:4|rca:3|Rca:2 rubisco activase RCCs RCCs:10 cell concentrates RCCs RCCs:9 cleft cysts RCCs RCCs:14 rapid cooling contractures RCCs RCCs:177 renal cell carcinomas RCC RCC:8 cell count RCC RCC:8 rapid cooling contracture RCC RCC:14 rathkes cleft cyst RCC RCC:121 renal cell cancer RCE RCE:15 rabbit corneal epithelial RCE RCE:6 relative coefficient of excretion RCE RCE:7 retinoblastoma control element RCF RCF:9 radiochromic film RCF RCF:16 red cell folate RCF RCF:9 refractory ceramic fibres RCF RCF:9 responder cell frequency RCMV RCMV:62|R-CMV:1 rat cytomegalovirus RCMV RCMV:12 red clover mottle virus RCM RCM:16 radiocontrast media RCM RCM:58 radiographic contrast media RCM RCM:7 radiographic contrast medium RCM RCM:36 red cell mass RCM RCM:4 reflectance confocal microscopy RCM RCM:12 reflection contrast microscopy RCM RCM:17 restrictive cardiomyopathy RCNMV RCNMV:11 red clover necrotic mosaic dianthovirus RCNMV RCNMV:20 red clover necrotic mosaic virus RCN RCN:9 raccoon poxvirus RCN RCN:8 radiocontrast nephropathy RCN RCN:16|Rcn:1 royal college of nursing RCP RCP:36 radiochemical purity RCP RCP:11 receptor component protein RCP RCP:9 respiratory compensation point RCP RCP:86 retrograde cerebral perfusion RCP RCP:16 retruded contact position RCP RCP:23 riboflavin carrier protein RCR RCR:27 replicationcompetent retrovirus RCR RCR:10 respiratory control rate RCR RCR:112 respiratory control ratio RCR RCR:14 rolling circle replication Rcs Rcs:8 collateral system Rcs Rcs:12 collateral system resistance RCS RCS:9 rat chondrosarcoma RCs RCs:85 reaction centers RCs RCs:8 reaction centres RCS RCS:20 recombinant congenic strains RCS RCS:7 recurrent carotid stenosis RCs RCs:12 relative contents RCs RCs:10 renal carcinomas RCs RCs:7 renshaw cells RCS RCS:8 repeated cold stress RCs RCs:6 replication complexes RCS RCS:199 royal college of surgeons RCTs RCTs:143 randomized clinical trials RCTs RCTs:26|RCTS:1 randomized controlled clinical trials RCTs RCTs:587|RCTS:1 randomized controlled trials RCT RCT:35 radiochemotherapy RCT RCT:56 randomised controlled trials RCT RCT:8 renal cell tumors RCT RCT:59 reverse cholesterol transport RCT RCT:9 root canal treatment RCV RCV:39 red cell volume RCV RCV:5 replicationcompetent virus RDA RDA:68 recommended daily allowance RDA RDA:161 representational difference analysis RDD RDD:16 random digit dialing RDD RDD:45 rosaidorfman disease RDEB RDEB:10 recessive dystrophic eb RDEB RDEB:63|R-DEB:1 recessive dystrophic epidermolysis bullosa RDE RDE:10 receptordestroying enzyme RDE RDE:17 rotating disk electrode RDI RDI:9 recommended daily intake RDI RDI:225 respiratory disturbance index RDP RDP:10 ribosomal database project RDP RDP:7 rumen degradable protein RDP RDP:7 ruminally degradable protein RDS RDS:8 renal duplex sonography RDS RDS:34 replicative dna synthesis RDS RDS:1161 respiratory distress syndrome RDT RDT:7 regular dialysis therapy RDT RDT:55 regular dialysis treatment RDT RDT:18 regular hemodialysis treatment RDT RDT:9 remaining dentin thickness RDT RDT:7 remaining dentine thickness RDV RDV:12 rice dwarf phytoreovirus RDV RDV:28 rice dwarf virus Rd Rd:36|RD:1 glucose disposal Rd Rd:9 glucose disposal rate RD RD:26 human rhabdomyosarcoma RD RD:25 raphe dorsalis Rd Rd:16 rate of disappearance Rd Rd:10 rate of glucose disappearance RD RD:13 raynauds disease RD RD:13 reading disabled RD RD:14 recession depth RD RD:9 rectal distension RD RD:21 redistribution RD RD:10 reference diameter RD RD:15 regular diet RD RD:9 regulatory domain RD RD:15 reiters disease RD RD:11 relative dispersion RD RD:10 renal dysfunction RD RD:15 residual disease RD RD:19 respiratory distress RD RD:16 rheumatic diseases Rd Rd:15|rd:1 rubredoxin RD RD:7 runt domain REACH REACH:10 reaching for excellence in adolescent care and health REACH REACH:10 resources for enhancing alzheimers caregiver health REA REA:9 rapid epidemiological assessment REA REA:8 repressor of estrogen receptor activity REC REC:15 gingival recession REC REC:9 rabbit ear chamber REC REC:11 rat embryo cells REC REC:20|Rec:3|rec:1 recovery REF REF:8|Ref:3 reference REF REF:9|rEF:8|R-EF:1 regional ejection fraction REF REF:21 restriction endonuclease fingerprinting REM REM:69 rapid eye movement sleep REM REM:24 relative electrophoretic mobility REM REM:14 reticular erythematous mucinosis RER+ RER+:11 replication error phenotype RER+ RER+:12 replication error positive RER RER:14 recurrent exertional rhabdomyolysis RER RER:206 respiratory exchange ratio RER RER:654|rER:135|r-ER:6|rer:6 rough endoplasmic reticulum RES RES:20|res:2|Res:1 reserpine RES RES:23|res:8|Res:1 resveratrol RES RES:447|res:1 reticuloendothelial system RET RET:9|Ret:2 receptor tyrosine kinase RET RET:78 resonance energy transfer RET RET:7|ret:1 ret protooncogene REV-T REV-T:16 reticuloendotheliosis virus REV-T REV-T:12|Rev-T:6 reticuloendotheliosis virus strain t REV REV:10 reverse phase evaporation REV REV:7 reversephase evaporation vesicles REZ REZ:25 root entry zone REZ REZ:12 root exit zone RE RE:6 cells of the reticuloepithelial RE RE:8|Re:2 efferent arteriolar resistance RE RE:6 patients with rasmussen encephalitis RE RE:5 rapid ejaculation RE RE:24 rasmussens encephalitis RE RE:44 reflux esophagitis RE RE:7 rejection episodes RE RE:6 relative enhancement RE RE:26 relative error RE RE:6 removal efficiency RE RE:12 respiratory epithelium RE RE:7 response entropy RE RE:21|Re:1 restriction enzyme RE RE:9 retained energy RE RE:5 reticular nucleus RE RE:6 reticularis thalami RE RE:8 retinal extract RE RE:9 right ear RE RE:9 rolandic epilepsy RE RE:34 running economy RE RE:25 thalamic reticular RFB RFB:7 radialflow bioreactor RFB RFB:16 replication fork barrier RFC RFC:81|RF-C:43 replication factor c RFC RFC:6 residual feed consumption RFI RFI:10 relapsefree interval RFI RFI:14|rFI:1 relative fluorescence intensity RFI RFI:8 renal failure index RFLP RFLP:19 restriction fragment length polymorphic RFLP RFLP:20 restriction fragment length polymorphism analysis RFP RFP:32 request for proposal RFP RFP:11|rfp:1 restriction fragment pattern RFP RFP:5 restrictive filling pattern RFP RFP:11|rfp:4|Rfp:1 ret finger protein RFP RFP:14 rifampin RFR RFR:38 radiofrequency radiation RFR RFR:13 red cell filtration rate RFR RFR:37 renal functional reserve RFS RFS:6 reflux finding score RFS RFS:18 relapsefree RFS RFS:319 relapsefree survival RFs RFs:18 release factors RFs RFs:77 rheumatoid factors RF RF:1266|rf:42|Rf:1 radiofrequency RF RF:15 recirculation fraction RF RF:44 regurgitant fraction RF RF:46 reissners fiber RF RF:14 reissners fibre RF RF:50|Rf:14 respiratory frequency RF RF:7 resting flux RF RF:10 restricted daily feeding RF RF:21 restricted feeding RF RF:13 retroperitoneal fibromatosis RF RF:124 rheumatic fever RGAs RGAs:17 resistance gene analogs RGAs RGAs:12 resistance gene analogues RGDS RGDS:136 argglyaspser RGDS RGDS:9 arginineglycineaspartic acidserine RGD RGD:567 argglyasp RGD RGD:31 arginineglycineaspartate RGD RGD:150 arginineglycineaspartic acid RGM RGM:19 rapidly growing mycobacteria RGM RGM:8 reactive gaseous mercury RGP RGP:5 rabies virus glycoprotein RGP RGP:21 radial growth phase RG RG:24 red gastrocnemius RG RG:8|R-G:6|r-g:2 redgreen RG RG:8|Rg:1 reference group RG RG:22 renormalization group RG RG:10 rhamnogalacturonan Rg Rg:11 rodgers Rg Rg:11 rough rha rha:11 lrhamnose RHA RHA:13 regional health authority rha rha:7|RHA:1|Rha:1 rhamnose RHA RHA:9 right hepatic artery RHA RHA:11 roman high avoidance RHDV RHDV:58 rabbit haemorrhagic disease virus RHDV RHDV:39 rabbit hemorrhagic disease virus RHD RHD:18 rel homology domain RHD RHD:146|Rhd:1 rheumatic heart disease RHD RHD:21 right hemisphere damage RHL RHL:17 recurrent herpes labialis RHL RHL:13 respiratory heat loss RHR RHR:9 rel homology region RHR RHR:7 relative hazard rate RHR RHR:17 renovascular hypertensive rats RHR RHR:10|rHR:1 resting heart rate RHT RHT:15 regional hyperthermia RHT RHT:78 retinohypothalamic tract RHT RHT:10 ruthenium hexammine trichloride RIA RIA:22 radioimmune assay RIA RIA:14 radioimmuno assay RIA RIA:13 radioimmunological assay RIF RIF:11 radiationinduced fibrosis RIF RIF:8 renal interstitial fibrosis RIF RIF:15 renal interstitial fluid RIF RIF:20 rigid internal fixation RIF RIF:6 rosette inhibitory factor RII RII:15 radioimmunoimaging RII RII:13 regulatory RII RII:4|R-II:1 regulatory subunit of type ii campdependent protein kinase RII RII:36|R-II:1 type ii receptor RII RII:19 type ii regulatory subunit RIL RIL:14 rabbit ileal loop RIL RIL:28 recombinant inbred line RIND RIND:10 reversible ischemic neurologic deficit RIND RIND:18 reversible ischemic neurological deficit RIPA RIPA:11 ristocetininduced platelet agglutination RIPA RIPA:28 ristocetininduced platelet aggregation RIP rip:4|RIP:4 nucleus raphe interpositus RIP RIP:9 radioimmune precipitation RIP RIP:70 radioimmunoprecipitation RIP RIP:32 receptorinteracting protein RIP RIP:15|Rip:2 regulated intramembrane proteolysis RIP RIP:55 repeatinduced point mutation RIP RIP:11 respiratory inductance plethysmograph RIP RIP:19 respiratory inductance plethysmography RIP RIP:23 respiratory inductive plethysmograph RIP RIP:57 respiratory inductive plethysmography RIP RIP:6 rnaiiiinhibiting peptide RIP RIP:5 under the control of the rat insulin promoter RIST RIST:13 radioimmunosorbent test RIST RIST:12 rapid insulin sensitivity test RITA RITA:9 intervention treatment of angina RITA RITA:8 radiofrequency interstitial tumor ablation RITA RITA:36 right internal thoracic artery RIT RIT:3|Rit:1 ht antagonist ritanserin RIT RIT:8 repetitive irritation test RIT RIT:13|R-IT:1 rush immunotherapy RJ RJ:11 rio de janeiro RJ RJ:28 royal jelly RLA RLA:8 radioligand assay RLA RLA:8 reninlike activity RLE RLE:27 rat liver epithelial RLE RLE:10 rat lung endothelial RLF RLF:9 rat lung fibroblasts RLF RLF:46 relaxinlike factor RLF RLF:44 retrolental fibroplasia RLKs RLKs:16 receptorlike kinases RLKs RLKs:8 receptorlike protein kinases RLM RLM:7 latex microspheres RLM RLM:14 rat liver mitochondria RLV RLV:7 liver volume RLV RLV:49 rauscher leukemia virus RLS RLS:344 restless legs syndrome RLS RLS:15 righttoleft shunt RL RL:14 form of ringer lactate RL RL:11 latency RL RL:231|Rl:7 lung resistance RL RL:8 red light RL RL:8 reinforcement learning RL RL:6|Rl:1 resistance of the lung RL RL:9 right lateral R-L R-L:8 right minus left R-L R-L:18|RL:2|R--L:1 righttoleft RL RL:71 ringers lactate RL RL:6 ringers lactate solution RMC RMC:10 rat mast cells RMC RMC:11 rat peritoneal mast cells RME RME:8 normal rat mammary epithelial RME RME:41 rapid maxillary expansion RME RME:53|Rme:1 receptormediated endocytosis RME RME:16 resting metabolic expenditure RMF RMF:6|rmf:1 remanent magnetic field RMF RMF:15 ribosome modulation factor RMI RMI:17 reticulocyte maturity index RMI RMI:30 rivermead mobility index RMS40 RMS40:7 ms of the qrs complex RMS40 RMS40:1 voltage in the terminal ms RMSSD RMSSD:13|rMSSD:3 root mean square of successive differences RMSSD RMSSD:4|r-MSSD:3 root mean square successive difference RMS RMS:10 rat milk substitute RMS RMS:12 respiratory muscle strength RMS RMS:55 rostral migratory stream RMS RMS:7 signal amplitude RMT RMT:9 random matrix theory RMT RMT:11 recognition memory test RMT RMT:18|rMT:5 resting motor threshold RNA RNA:735 northern RNA RNA:21 radionuclide angiocardiography RNA RNA:64 renal nerve activity RNA RNA:28 renal sympathetic nerve activity RND RND:35|rND:2 radical neck dissection RND RND:14 resistancenodulationcell division RNFL RNFL:203 retinal nerve fiber layer RNFL RNFL:51 retinal nerve fibre layer RNFLT RNFLT:9 retinal nerve fiber layer thickness RNFLT RNFLT:8 retinal nerve fibre layer thickness RNOS RNOS:8 reactive nitrogen oxide species RNOS RNOS:5 reactive nitrogen oxygen species RNP RNP:6 ribonuclear protein RNP RNP:10 ribonucleoprotein complex RNP RNP:11 rnaprotein RNs RNs:19 recombination nodules RNs RNs:197|RNS:1 registered nurses RNTCP RNTCP:8 revised national tb control programme RNTCP RNTCP:17 revised national tuberculosis control programme ROA ROA:12 radiographic osteoarthritis ROA ROA:27 raman optical activity ROA ROA:11 regurgitant orifice area ROB ROB:5|rOB:2 rat osteoblasts ROB ROB:7 rat osteoblastlike ROCs ROCs:21 receiver operating characteristics ROCs ROCs:9 receptoroperated ca channels ROC ROC:5 receptoroperated channels ROC ROC:5|roc:5 rocuronium ROESY ROESY:10 rotating frame nuclear overhauser effect spectroscopy ROESY ROESY:5 rotating frame nuclear overhauser enhancement spectroscopy ROK ROK:13 republic of korea ROK ROK:12 rhokinase ROM ROM:25 range of movement ROM ROM:10 recurrent otitis media ROM ROM:4 rupture of the membranes ROP ROP:741|RoP:1 retinopathy of prematurity ROP ROP:13 ringopening polymerization Ros Ros:6|ROS:1 oscillatory resistance ROS ROS:10 oxygen radicals ROS ROS:23 rat osteosarcoma ROS ROS:28 reactive oxygen ROS ROS:6 reactive oxygen substances Ros Ros:9 respiratory resistance ROU ROU:13 recurrent oral ulcers ROU ROU:10 recurrent oral ulceration Ro Ro:4 csf outflow resistance Ro Ro:13 net reproductive rate RO RO:15 reality orientation RO RO:20 relative odds RO RO:86 reverse osmosis RPA RPA:9 approach RPA RPA:229 protection assay RPA RPA:8 random phase approximation RPA RPA:9 rapid plate agglutination rPA rPA:7 recombinant pa rPA rPA:16 recombinant protective antigen RPA RPA:56 recursive partitioning analysis RPA RPA:10 recursive partitioning and amalgamation RPA RPA:10 retropharyngeal abscess RPA RPA:15 reversed passive arthus RPA RPA:38|rPA:1 right pulmonary artery RPB1 RPB1:6|Rpb1:1 largest subunit RPB1 RPB1:5|rpb1:2|Rpb1:2 largest subunit of rna polymerase ii RPC RPC:9 peritoneal cells RPC RPC:11 radiological physics center RPC RPC:10 reactive perforating collagenosis RPC RPC:10 recurrent pyogenic cholangitis RPC RPC:24 reversedphase chromatography RPE RPE:450 perceived exertion RPE RPE:13 rapid palatal expansion RPE RPE:866|rpe:1 retinal pigment epithelial RPE RPE:89 retinal pigment epithelial cells RPE RPE:1615|rpe:3 retinal pigment epithelium RPF RPF:11 rate of pacemaker firing RPF RPF:11 renal plasma flow rate RPF RPF:45 retroperitoneal fibrosis RPH RPH:9 retinyl palmitate hydrolase RPH RPH:7 royal perth hospital R-PIA R-PIA:13|RPIA:1 nrphenylisopropyladenosine R-PIA R-PIA:2|RPIA:1 receptor agonist rphenylisopropyl adenosine RPI RPI:5|Rpi:3 ribosephosphate isomerase RPI RPI:8 rna polymerase i RPLC RPLC:10|RP-LC:1 reversedphase liquid chromatographic RPLC RPLC:95|RP-LC:15 reversedphase liquid chromatography RPM RPM:14 rat pleural mesothelial RPM RPM:11 ravens progressive matrices RPM RPM:18|R-PM:1 resident peritoneal macrophages RPO RPO:12 red palm oil RPO RPO:11|rpo:1|Rpo:1 reticularis pontis oralis RPP RPP:20 radical perineal prostatectomy RPP RPP:73 rapidly progressive periodontitis RPP RPP:149 renal perfusion pressure RPR RPR:139 rapid plasma reagin RPR RPR:13 rapid plasma reagin test RPs RPs:9 refractory periods RPs RPs:9 released proteins RPs RPs:12|rps:1 ribosomal proteins RPTC RPTC:15 renal proximal tubular cells RPTC RPTC:13 renal proximal tubule cells RPTE RPTE:7 proximal tubular epithelial RPTE RPTE:6 proximal tubule epithelial RPV RPV:9 rabbit poxvirus RPV RPV:98 rinderpest virus Rp Rp:18|RP:5 peripheral airway resistance Rp Rp:12|RP:8|rP:1 progesterone receptor RP RP:24 radiation pneumonitis RP RP:307 radical prostatectomy RP RP:30 rapid prototyping RP RP:234 raynauds phenomenon RP RP:10 reaction product RP RP:6 reactivity pattern RP RP:38 readiness potential RP RP:20 recognition potential RP RP:10 red pulp RP RP:14 regulatory particle RP RP:9 regulatory peptides RP RP:28 relapse prevention RP RP:11|rp:2 relative potency RP RP:14 relative power RP RP:9 resting pressure RP RP:10 retained placenta RP RP:14 reticulated platelets RP RP:551|rp:1 retinitis pigmentosa RP RP:78|rp:1 retinyl palmitate RP RP:15 retrograde pyelography RP RP:34|Rp:1 retroperitoneal RP RP:6 retruded position RP RP:14|rp:1 reversephase RP RP:106 reversedphase RP RP:11 rheumatoid polyarthritis RP RP:10 rinderpest RP RP:8 rock phosphate RP RP:11 roller pump RRC RRC:8 renal renin content RRC RRC:28 residency review committee RRF RRF:7 raggedred fibres RRF RRF:99 residual renal function RRF RRF:11 retrorubral field RRF RRF:49 ribosome recycling factor RRMS RRMS:6|RR-MS:4 relapsingremitting RRMS RRMS:54|RR-MS:14 relapsingremitting ms RRMS RRMS:83|RR-MS:18 relapsingremitting multiple sclerosis RRMs RRMs:7 retinoidrelated molecules RRMs RRMs:69 rna recognition motifs RRM RRM:6 random regression model RRM RRM:19 reduced renal mass RRM RRM:9|rrm:1 resonant recognition model RRP RRP:184|rrP:1 radical retropubic prostatectomy RRP RRP:34 readily releasable pool RRP RRP:77 recurrent respiratory papillomatosis RRP RRP:15 relative refractory period RRT RRT:27 regimenrelated toxicity RRT RRT:4 relative retention time RRT RRT:298 renal replacement therapy RRV RRV:14 rhesus monkey rhadinovirus RRV RRV:8 rhesus rhadinovirus RRV RRV:41 rhesus rotavirus RRV RRV:57|RRv:4 ross river virus RR RR:27|R-R:1 patients with relapsingremitting RR RR:20 recovery room RR RR:32 relapsing remitting RR RR:7 relative recovery RR RR:5 relative risk of death RR RR:17 renin release RR RR:13 respiratory rates RR RR:10 response regulator RR RR:15 reversal reaction RR RR:21 reverse redistribution RR RR:14 righting reflex RR RR:26 ross river RR RR:9 roundup ready RSA RSA:14 hippocampal rhythmic slow activity RSA RSA:21 hippocampal rhythmical slow activity RSA RSA:39 radiostereometric analysis RSA RSA:17 radiostereometry RSA RSA:13 republic of south africa RSA RSA:228 respiratory sinus arrhythmia RSA RSA:62 roentgen stereophotogrammetric analysis RSCA RSCA:9 reference strand mediated conformation analysis RSCA RSCA:7 reference strandmediated conformational analysis RSDR RSDR:9|RSDr:7 repeatability relative standard deviations RSDR RSDR:19 reproducibility relative standard deviations RSE RSE:20 refractory status epilepticus RSE RSE:14 selfesteem scale RSF RSF:13 raw soya flour RSF RSF:18 rheumatoid synovial fibroblasts RSM RSM:26 radix salviae miltiorrhizae RSM RSM:17|Rsm:1 rapeseed meal RSM RSM:4 receptor surface model RSM RSM:6 response surface method RSM RSM:25 restriction site mutation RSPs RSPs:7 recombinant subviral particles RSPs RSPs:6 restriction site polymorphisms RSP RSP:10 regulated secretory pathway RSP RSP:11 respirable suspended particles RSR RSR:6 relative survival rates RSR RSR:38 renin secretion rate RSS RSS:7 responsive search score RSS RSS:23 russellsilver syndrome RSV RSV:9 regurgitant stroke volume RSV RSV:10 respiratory syncytial viral RSV RSV:617|rsv:1 rous sarcoma virus RSV RSV:9 saphenous vein RS RS:10 arginineserinerich RS RS:9 radical surgery RS RS:34 radiosurgery RS RS:13 raman spectroscopy RS RS:20 rankin scale RS RS:10|rS:1 rat serum rs rs:9 recombinant soluble RS RS:156|R-S:36 reedsternberg RS RS:71 reiters syndrome RS RS:7 related medullary inhibitory reticulospinal RS RS:28|Rs:1 remote sensing RS RS:9 renin secretion RS RS:11 renin substrate RS RS:5 repeated sequences RS RS:98 resistant starch RS RS:9 response signal RS RS:16 restraint scale RS RS:49 reyes syndrome RS RS:16 rio grande do sul RS RS:6|Rs:1 robin sequence RS RS:9 rubrospinal rs rs:10 steadystate fluorescence anisotropy Rs Rs:5|rs:3|RS:1 stokes radii Rs Rs:14|rs:5|RS:5|r-s:1 stokes radius RS RS:15 xlinked juvenile retinoschisis RTA RTA:5 chain of ricin RTA RTA:124 renal tubular acidosis RTA RTA:15|Rta:2 replication and transcription activator RTA RTA:28 retinal thickness analyzer RTA RTA:14 ricin toxin a chain RTA RTA:9 royal thai army RTD RTD:6 rate of torque development RTD RTD:15 renal tubular dysgenesis RTD RTD:16 residence time distribution RTD RTD:5 respiratory tract disease RTD RTD:16 routine test dilution RTE RTE:69 rat tracheal epithelial RTE RTE:39 readytoeat RTE RTE:7 renal tubular epithelium RTF RTF:11 regeneration and tolerance factor RTF RTF:30 rete testis fluid RTIs RTIs:37 reproductive tract infections RTIs RTIs:74 respiratory tract infections RTIs RTIs:22 reverse transcriptase inhibitors RT-PCR RT-PCR:18 chain reaction assay RT-PCR RT-PCR:2993|RT--PCR:1|rt-pcr:1|rt-PCR:1|rtPCR:1|RTPCR:1 reverse transcriptasepolymerase chain reaction RT-PCR RT-PCR:5 reverse transcription and polymerase chain reaction technique RTV RTV:83|Rtv:3|rtv:1 ritonavir RTV RTV:5 roomtemperature vulcanizing RTX RTX:18 hresiniferatoxin RTX RTX:13 raltitrexed RTX RTX:94 resiniferatoxin RTX RTX:11 rituximab RTH RTH:129 resistance to thyroid hormone RTH RTH:9 thyroid hormone resistance RTs RTs:12 respiratory therapists RTs RTs:62 reverse transcriptases RTS RTS:80 revised trauma score RTS RTS:32 rothmundthomson syndrome RTS RTS:45|RTs:1 rubinsteintaybi syndrome Rt Rt:10|RT:1 nucleus rotundus RT RT:8 radiation treatment RT RT:29 radiotherapy alone RT RT:34 reactive thrombocytosis RT RT:12 realtime RT RT:10|rt:1 reciprocal translocations RT RT:7 reciprocating tachycardia RT RT:18 recurrent tonsillitis RT RT:12 relaxation training RT RT:35 resistance training RT RT:17 respiratory tract RT RT:14 response times RT RT:23 resting tension Rt Rt:5|RT:4 reticular RT RT:14 reverse transcribed RT RT:131|rt:4|Rt:2|rT:1 room temperature Rt Rt:4|RT:3 total vascular resistance RT RT:9 tumor RUL RUL:21 right unilateral RUL RUL:20 right upper lobe RUS RUS:5 realtime ultrasonography RUS RUS:5 renal ultrasonography RUS RUS:8 ultrasound spectroscopy RV/TLC RV/TLC:5 ratio of residual volume to total lung capacity RV/TLC RV/TLC:8 residual volumetotal lung capacity RVA RVA:14 retinal vessel analyzer RVA RVA:28|RVa:3 right ventricular apex RVD RVD:22|rVD:1 rat vas deferens RVD RVD:364 regulatory volume decrease RVD RVD:18 renovascular disease RVD RVD:7 right ventricular dimension RVD RVD:11 right ventricular dysfunction RVD RVD:17 right ventricular dysplasia RVF RVF:138 rift valley fever RVF RVF:15 right ventricular failure RVI RVI:90 regulatory volume increase RVI RVI:29 right ventricular infarction RVL RVL:9 nucleus reticularis rostroventrolateralis RVL RVL:9 rostral ventrolateral reticular nucleus RVP RVP:12 rapid ventricular pacing RVP RVP:14 rat ventral prostate RVP RVP:26|RVp:1 right ventricular pressure RVR RVR:8 renal vein renin RVR RVR:14 repetitive ventricular response RVR RVR:9|Rvr:1 resistance to venous return RV RV:24 rappaportvassiliadis RV RV:26 rat virus RV RV:11 renal vein RV RV:6 renal venous RV RV:12 retinal vasculitis RV RV:12 retroviral vector RV RV:21 rheumatoid vasculitis RV RV:104|Rv:2 rotavirus RWM RWM:55 regional wall motion RWM RWM:52 round window membrane RW RW:22 ragweed RW RW:10 relative weight RW RW:61 round window RyR2 RyR2:31|RyR-2:1|RYR-2:1 cardiac ryanodine receptor RyR2 RyR2:4|RYR2:2 ryanodine receptor RY RY:6|R-Y:3 purinepyrimidine RY RY:8|R-Y:2 rouxeny RAF RAF:9 relative activity factor RAF RAF:10 repetitive atrial firing RalGDS RalGDS:7|Ral-GDS:2 ral gdp dissociation stimulator RalGDS RalGDS:9|ralGDS:2 ral guanine nucleotide dissociation stimulator rbcL rbcL:15 carboxylaseoxygenase rbcL rbcL:7 large subunit gene rbcL rbcL:5 large subunit of ribulosebisphosphate carboxylase Renca Renca:8|RENCA:2 murine renal carcinoma Renca Renca:10|RENCA:6|renca:2|RenCa:1 murine renal cell carcinoma Rh Rh:8 antid RH RH:12 radial haemolysis RH RH:21 radical hysterectomy RH RH:11 reactive hyperaemia RH RH:12 reduced haloperidol RH RH:5 rel homology RH RH:7 relative hypoglycemia RH RH:11 renal hypercalciuria RH RH:67 reproductive health RH RH:12 resistant hepatocyte RH RH:4 rgs homology RH Rh:5|RH:5 rhein Rh Rh:62|rh:3|RH:1 rhesus Rh Rh:11|rh:1|RH:1 rhodamine RH RH:11|rh:1 righthanded Rmax Rmax:5 maximum relaxation Rmax Rmax:6 removal rate Rm Rm:57|RM:2|rm:1 membrane resistance Rm Rm:16 membrane resistivity RM RM:13 radical mastectomy RM RM:5 radioactive microspheres RM RM:34|rm:3|Rm:1 raphe magnus RM RM:19 recurrent miscarriage RM RM:10 red marrow RM RM:6 red muscle RM RM:9 reissners membrane Rm Rm:12|RM:3 relative mobility RM RM:9 relative movement RM RM:37 repetition maximum RM RM:9 respiratory muscle RM RM:7 risk management RM RM:4 rough microsomal membranes RM RM:11 rough microsomes RN RN:19 radical nephrectomy RN RN:34|Rn:1 radionuclide RN RN:129 red nucleus RN RN:33 reflux nephropathy RN RN:5 rheumatoid nodules Rrs Rrs:14|RRS:2 resistance of the respiratory system Rrs Rrs:80|RRS:5 respiratory system resistance Rrs Rrs:60 total respiratory resistance RTP RTP:27 replication terminator protein RTP RTP:13 room temperature phosphorescence RTP RTP:18 treatment planning RyRs RyRs:9 release channels RyRs RyRs:168|RYRs:10|ryRs:1 ryanodine receptors RyR3 RyR3:11|RYR3:2|RyR-3:1 ryanodine receptor type RyR3 RyR3:8 type ryanodine receptor S/D S/D:47 systolicdiastolic S/D S/D:19 systolicdiastolic ratio S/D S/D:14 systolic to diastolic S/S S/S:13 solidificationstabilization S/S S/S:10|s/s:3 stabilizationsolidification S1 S1:6 early proximal tubule S1 S1:8 excited singlet S1 S1:24 first heart sound S1 S1:6 first sacral S1 S1:15 first stimulus S1 S1:6|S-1:4 myosin S1 S1:1 myosin and subfragment S1 S1:213|S-1:83 myosin subfragment S1 S1:9 subunit S1 S1:10 warning S2 S2:11 allele S2 S2:16 drosophila schneider S2 S2:19 extrastimulus S2 S2:17 premature stimulus S2 S2:14 second heart sound S2 S2:26 second stimulus S3 S3:9 proximal tubule S3 S3:14 sacral S3 S3:24 third heart sound S4 S4:9 fourth heart sound S4 S4:6 fourth transmembrane segment S9 S9:14|S-9:9 x g supernatant S9 S9:21 metabolic activation S9 S9:6|S-9:3 preparations S9 S9:5|S-9:4 supernatants SAA SAA:21|SaA:1 serum amyloida SAA SAA:6 serum anticholinergic activity SAA SAA:83 severe aplastic anaemia SAA SAA:203|sAA:2 severe aplastic anemia SAA SAA:11 splenic artery aneurysms SAA SAA:20 sulfur amino acid SABP SABP:5 secretory actinbinding protein SABP SABP:14 systemic arterial blood pressure SAB SAB:5 solidadherent bacteria SAB SAB:31 spontaneous abortion SAB SAB:10 spontaneous alternation behavior SAB SAB:21 staphylococcus aureus bacteremia SAB SAB:7 subarachnoid block SACs SACs:19 stretchactivated channels SACs SACs:10 stretchactivated ion channels SAD SAD:14 sagittal abdominal diameter SAD SAD:23 secalonic acid d SAD SAD:15 singlewavelength anomalous diffraction SAD SAD:13 singlewavelength anomalous dispersion SAD SAD:20 sinoaortic baroreceptor denervation SAD SAD:6 source to axis distance SAD SAD:14|sAD:1 sporadic ad SAD SAD:11|sAD:3 sporadic alzheimers disease SAD SAD:8 succinic acid dimethyl ester SAECG SAECG:59|SA-ECG:2 signalaveraged ecg SAECG SAECG:41 signalaveraged electrocardiography SAE SAE:8 signalaveraged electrocardiogram SAE SAE:9 stimulated acoustic emission SAE SAE:24 subcortical arteriosclerotic encephalopathy SAF SAF:9 activating factor SAF SAF:45 scrapieassociated fibrils SAGB SAGB:25 swedish adjustable gastric band SAGB SAGB:7 swedish adjustable gastric banding SAGE SAGE:357 serial analysis of gene expression SAGE SAGE:6 systematic assessment of geriatric drug use via epidemiology SAG SAG:6 sensitive to apoptosis gene SAG SAG:16 sodium antimony gluconate SAG SAG:10|SAg:1 statoacoustic ganglion SAHS SAHS:37 sleep apneahypopnea syndrome SAHS SAHS:44 sleep apnoeahypopnoea syndrome SAH SAH:10 selfassessed health SAH SAH:6 severe alcoholic hepatitis SAH SAH:491 subarachnoid haemorrhage SAH SAH:8 subarachnoid hemorrhages SAH SAH:11 systemic arterial hypertension SAIDS SAIDS:13 simian acquired immune deficiency syndrome SAIDS SAIDS:29|sAIDS:1 simian acquired immunodeficiency syndrome SAI SAI:20|SA-I:1 slowly adapting type i SAI SAI:12|S-AI:1 state anxiety inventory SALS SALS:14|sALS:10|s-ALS:1 sporadic als SALS SALS:23|sALS:12|S-ALS:3 sporadic amyotrophic lateral sclerosis SAL SAL:31|Sal:2 salsolinol SAL SAL:7 sensorineural acuity level SAL SAL:10 short attack latency SAMP8 SAMP8:11|SAM-P8:2 senescenceaccelerated mice SAMP8 SAMP8:12|SAM-P8:1 senescenceaccelerated mouse SAMs SAMs:182|SAMS:2 selfassembled monolayers SAMs SAMs:9 shoot apical meristems SAM SAM:6 activity monitor SAM SAM:26 salicylamide SAM SAM:13 scanning acoustic microscope SAM SAM:26 scanning acoustic microscopy SAM SAM:64 shoot apical meristem SAM SAM:12 sinusoidal amplitude modulation SAM SAM:7 smokingattributable mortality SAM SAM:26 sterile alpha motif SAM SAM:8 substrateattached material SAM SAM:11 surface active material SAM SAM:10 surfaceassociated material SAM SAM:19 synthetic aperture magnetometry SAM SAM:62 systolic anterior motion SAM SAM:19 systolic anterior motion of the mitral valve SAM SAM:10 systolic anterior movement SaO2 SaO2:7 oxygen saturations SaO2 SaO2:4 saturation of oxygen SAO SAO:17 southeast asian ovalocytosis SAO SAO:52 splanchnic artery occlusion SAPS SAPS:49 scale for the assessment of positive symptoms SAPS SAPS:90 simplified acute physiology score SAP SAP:9 assessment of personality SAP SAP:18 sensory action potential SAP SAP:7 serum acid phosphatase SAP SAP:53|sAP:10|S-AP:5|s-AP:2 serum alkaline phosphatase SAP SAP:45 serum amyloid p SAP SAP:83|sAP:1 severe acute pancreatitis SAP SAP:46|sAP:1 stable angina pectoris SAP SAP:34 standard automated perimetry SAP SAP:9 steroidogenesis activator polypeptide SAP SAP:16 stressactivated protein SAP SAP:7 symptom association probability SAP SAP:217|sAP:1 systolic arterial pressure SARA SARA:11 sexually acquired reactive arthritis SARA SARA:12 smad anchor for receptor activation SARA SARA:11 subacute ruminal acidosis SARs SARs:12 scaffoldassociated regions SARs SARs:10 scaffold attachment regions SARs SARs:46 specific absorption rates SAR SAR:3|sar:2 patients with sarcoidosis SAR SAR:16 scaffold attachment region SAR SAR:131 seasonal allergic rhinitis SAR SAR:9 slowly adapting pulmonary stretch receptor SAR SAR:6 slowly adapting receptors SAR SAR:6 slowly adapting stretch receptors SAR SAR:13 synthetic aperture radar SAR SAR:119 systemic acquired resistance SAR SAR:5 systemic anaphylactic reaction SASP SASP:30 salazosulfapyridine SASP SASP:10 salazosulphapyridine SASP SASP:28 salicylazosulfapyridine SASP SASP:1 small acidsoluble proteins SAS SAS:22 selfrating anxiety scale SAS SAS:223 sleep apnea syndrome SAS SAS:19 social adjustment scale SAS SAS:24 subaortic stenosis SAS SAS:32 subarachnoid space SAS SAS:8 surfaceactive substances SAS SAS:15 surface anatomy scanning SAS SAS:26 sympathoadrenal system SAT SAT:11 african territories SAT SAT:6 selfadministered therapy SAT SAT:26 serine acetyltransferase SAT SAT:41 serum agglutination test SAT SAT:11 soil aquifer treatment SAT SAT:33 spontaneous autoimmune thyroiditis SAT SAT:8 subacute stent thrombosis SAT SAT:7 subacute thrombosis SAT SAT:7 substance abuse treatment SA SA:10 cocaine selfadministration SA SA:8 heroin selfadministration SA SA:18|Sa:1 sarcoidosis SA SA:7 satellite association SA SA:9 separation anxiety SA SA:16 septic arthritis SA SA:9 serrated adenoma SA SA:12 serratus anterior SA SA:8 serum aldosterone SA SA:11|S-A:1 shortaxis SA SA:7 sideroblastic anaemia SA SA:50 simulated annealing SA SA:7 sinus arrhythmia SA SA:5 situation awareness SA SA:10 skeletal age SA SA:34 sleep apnea SA SA:12 sleep apnoea SA SA:8 slide agglutination SA SA:76 slowly adapting SA SA:9 sodium alginate SA SA:13 south africa SA SA:16 south african SA SA:19 south australia SA SA:15 spectral analysis SA SA:8 spherical aberration SA SA:15 spinal anaesthesia SA SA:19 spinal anesthesia SA SA:13 splenic artery SA SA:19 spontaneous activity SA SA:11 spontaneous alternation SA SA:52|sa:1 stable angina SA SA:10 state anxiety SA SA:13 status asthmaticus SA SA:35 stearylamine SA SA:61 streptavidin SA SA:21 streptococcal antigen SA SA:36 stretchactivated SA SA:24 substance abuse SA SA:10 succinic anhydride SA SA:40 succinylacetone SA SA:9 sulcus angle SA SA:9 sulfanilamide SA SA:54|Sa:14 surface area SA SA:10 surgery alone SA SA:21 sympathoadrenal SBA SBA:44 glycine max SBA SBA:56 serum bactericidal activity SBA SBA:17 serum bactericidal antibody SBA SBA:12 serum bactericidal assay SBA SBA:19 sheep blood agar SBA SBA:22 sodium benzylidenelascorbate SBA SBA:290 soybean agglutinin SBC SBC:20 selective brain cooling SBC SBC:8|sbc:1 simple bone cyst SBC SBC:7 superficial bladder cancer SBD SBD:15 selective bowel decontamination SBD SBD:15 starchbinding domain SBE SBE:10 starch branching enzyme SBE SBE:34 subacute bacterial endocarditis SBH SBH:5 sabra hypertensionprone SBH SBH:10 saltsensitive SBH SBH:26|SbH:1 sequencing by hybridization SBH SBH:25 southern blot hybridization SBH SBH:21 subcortical band heterotopia SBI SBI:11 screening and brief intervention SBI SBI:15 serious bacterial infection SBI SBI:4 severe brain injury SBI SBI:11 silent brain infarction SBI SBI:6 small bowel injury SBI SBI:30 sulcus bleeding index SBO SBO:6 side branch occlusion SBO SBO:11 spina bifida occulta sBPT sBPT:7|SBPT:1 specific bronchial provocation test sBPT sBPT:7 specific bronchial provocative test SBP SBP:5 serotonin binding proteins SBP SBP:10 soybean peroxidase SBP SBP:187 spontaneous bacterial peritonitis SBP SBP:389|sBP:4 systolic bp SBR SBR:8 salivabinding region SBR SBR:1 scarff bloom and richardson SBR SBR:14 scarffbloomrichardson SBR SBR:60|SBr:1 small bowel resection SBR SBR:9 spontaneous baroreflex SBR SBR:6 stillbirth rate SBR SBR:12 styrenebutadiene rubber SBS SBS:10 secondary bilateral synchrony SBS SBS:113 short bowel syndrome SBS SBS:15 spinobulbospinal SBS SBS:13 stimulated brillouin scattering SBV SBV:7 sacbrood virus SBV SBV:9 shed blood volume SB SB:6|Sb:3 saccharomyces boulardii SB SB:13 schiff base SB SB:11 scleral buckling SB SB:18 serum bilirubin SB SB:37 single bond SB SB:11 singlebreath SB SB:9 sinus bradycardia SB SB:12 sleep bruxism SB SB:34 sleeping beauty SB SB:46|S-B:1 small bowel SB SB:22 southern blot SB SB:14 southern blotting SB SB:4|sb:1 specific binding SB SB:58 spina bifida SB SB:48|sb:1 spontaneous breathing SB SB:8 strand breaks SC115 SC115:26|SC-115:1 shionogi carcinoma SC115 SC115:7 shionogi mouse mammary carcinoma SCAD SCAD:35 shortchain acylcoa dehydrogenase SCAD SCAD:16 spontaneous coronary artery dissection SCAG SCAG:11 sandoz clinical assessment geriatric SCAG SCAG:10 sandoz clinical assessment geriatric scale SCA SCA:10 selective coronary angiography SCA SCA:6 senescent cell antigen SCA SCA:6 sex chromosome abnormalities SCA SCA:6 structural chromosomal aberration SCA SCA:23 sudden cardiac arrest SCA SCA:61 superior cerebellar artery SCA SCA:13 suppressor cell activity SCCE SCCE:11 squamous cell carcinoma of the esophagus SCCE SCCE:23 stratum corneum chymotryptic enzyme SCCM SCCM:6|SC-CM:1 sertoli cellconditioned medium SCCM SCCM:14 society of critical care medicine SCCs SCCs:9 semicircular canals SCCs SCCs:5 solitary chemosensory cells SCCs SCCs:12 squamous cell cancers SCCs SCCs:388 squamous cell carcinomas SCD SCD:27 patients with spinocerebellar degeneration SCD SCD:16 scalp current density SCD SCD:7 sequential compression device SCD SCD:27 sister chromatid differentiation SCD SCD:10 spinocerebellar degenerations SCD SCD:8 spondylocostal dysostosis SCD SCD:9 spreading cortical depression SCD SCD:72|Scd:3|scd:1 stearoylcoa desaturase SCD SCD:5 stromelysin catalytic domain SCD SCD:20 subacute combined degeneration SCD SCD:11 systemic carnitine deficiency SCE SCE:14 specialized columnar epithelium SCE SCE:10 stilescrawford effect SCFE SCFE:10 slipped capital femoral epiphyses SCFE SCFE:138|scfe:2 slipped capital femoral epiphysis SCF SCF:12 selfconsistent field SCF SCF:10 slow coronary flow SCF SCF:9 supercritical fluid SCG SCG:5 alkaline singlecell gel SCG SCG:7 alkaline singlecell gel electrophoresis SCG SCG:24 single cell gel SCG SCG:133 sodium cromoglycate SCG SCG:19 superior cervical SCG SCG:222|scg:1 superior cervical ganglia SCG SCG:528|scg:2 superior cervical ganglion SCID SCID:18|scid:2 cb scidscid SCID SCID:124|scid:27 severe combined immune deficiency SCID SCID:101|scid:3 severe combined immunodeficiency disease SCID SCID:12|scid:1 severe combined immunodeficiency syndrome SCID SCID:704|scid:75|Scid:5 severe combined immunodeficient SCID SCID:8 severe combined immunodeficient mice SCID SCID:14 structured clinical interview for dsmiii SCI SCI:44 science citation index SCI SCI:20 silent cerebral infarction SCI SCI:7 spinal cord impairment SCI SCI:11 spinal cord ischemia SCJ SCJ:24 squamocolumnar junction SCJ SCJ:19 sternoclavicular joint SCLCs SCLCs:19 small cell lung cancers SCLCs SCLCs:28 small cell lung carcinomas SCLE SCLE:25 subacute cutaneous le SCLE SCLE:99 subacute cutaneous lupus erythematosus SCLs SCLs:11 soft contact lenses SCLs SCLs:9 synthetic combinatorial libraries SCL SCL:13|SCl:1 serum copper levels SCL SCL:69 sinus cycle length SCL SCL:75 skin conductance level SCL SCL:7 spindle cell lipoma SCL SCL:27|scl:1 stem cell leukemia SCMC SCMC:9 mucus contact SCMC SCMC:47 spontaneous cellmediated cytotoxicity SCMV SCMV:9 simian cytomegalovirus SCMV SCMV:12 sugarcane mosaic virus SCM SCM:11 secretory cell metaplasia SCM SCM:9 serumcontaining medium SCM SCM:5 solidscorrected milk SCM SCM:9 spleen conditioned medium SCM SCM:16|scm:1 split cord malformation SCM SCM:80 sternocleidomastoid SCM SCM:38 sternocleidomastoid muscle SCM SCM:7 streptococcal cell membrane SCM SCM:1 structuredness of the cytoplasmic matrix SCM SCM:7 surface complexation model SCN SCN:13 severe chronic neutropenia SCN SCN:67 severe congenital neutropenia SCN SCN:18 solid cell nests SCN SCN:12 soybean cyst nematode SCN SCN:12 special care nursery SCN SCN:40 suprachiasmatic SCN SCN:562 suprachiasmatic nuclei SCN SCN:10 suprachiasmatic nuclei of the hypothalamus SCN SCN:25 suprachiasmatic nucleus of the hypothalamus SCOD SCOD:13|sCOD:1 soluble chemical oxygen demand SCOD SCOD:9 soluble cod SCORAD SCORAD:13 scoring of atopic dermatitis SCORAD SCORAD:2 scoring of atopic dermatitis index SCO SCO:6|Sco:1 antagonist scopolamine SCO SCO:5 sertoli cell only syndrome SCO SCO:164 subcommissural organ SCPs SCPs:28|SCPS:1 slow cortical potentials SCPs SCPs:18 small cardioactive peptides SCP SCP:73 selective cerebral perfusion SCP SCP:10 sheep choroid plexus SCP SCP:11 single cell protein SCP SCP:12 small cardioactive peptide SCP SCP:15 supercooling point sCR1 sCR1:23 soluble complement receptor sCR1 sCR1:35 soluble complement receptor type sCR1 sCR1:13 soluble cr SCRs SCRs:65 short consensus repeats SCRs SCRs:62 skin conductance responses SCR SCR:14|scr:2 scarecrow SCR SCR:14 selective catalytic reduction SCR SCR:9 shumiya cataract rat SCT SCT:5 cell tumors sCT sCT:252|SCT:87|S-CT:5|sCt:4|s-CT:4 salmon calcitonin sCT sCT:17|SCT:3|s-CT:1 salmon ct SCT SCT:5 silica clotting time SCT SCT:13 social cognitive theory SCT SCT:8 solid and cystic tumor SCT SCT:18 spinal cord transection SCT SCT:9 spinocerebellar tract SCT SCT:30|SCt:1 spinocervical tract SCT SCT:36|sCT:2|S-CT:2 spiral computed tomography SCT SCT:20|sCT:2|S-CT:1 spiral ct SCT SCT:7 subcutaneous connective tissue SCV SCV:19 salmonellacontaining vacuole SCV SCV:33 sensory conduction velocity SCV SCV:11|ScV:1 subclavian vein SCV SCV:10 variants SCH SCH:9|Sch:1 cell hyperplasia SCH SCH:9|Sch:1 sch SCH SCH:8 spinal cord homogenate SCH SCH:5 suprachoroidal hemorrhage SCS SCS:9 saethrechotzen syndrome SCs SCs:113|Scs:3 schwann cells SCS SCS:7 selfcontrol schedule SCS SCS:23 somatic cell score SCS SCS:8 spatial contrast sensitivity SCS SCS:244 spinal cord stimulation SCS SCS:8 spinal cord stimulator SCS SCS:14|Scs:1 succinylcoa synthetase SCs SCs:86 synaptonemal complexes SC SC:36|sc:20 administered subcutaneously SC SC:8|sc:1 c disease SC SC:10 cortex SC SC:10 culture SC Sc:3|SC:3 immature rat sertoli cells SC SC:4|sc:1 nucleus subcoeruleus SC SC:7 scatter correction SC SC:25 schlemms canal SC SC:14 sclerosing cholangitis SC SC:42 scrotal circumference SC SC:9 sebaceous carcinoma SC SC:12 selenite cystine SC SC:7|sc:1|Sc:1 selfcompatible SC SC:11 semicarbazide SC SC:7|sc:1 semicircular canal SC SC:15 seroconversion SC SC:13 sickle cellhaemoglobin c SC SC:12 sigmoid colon SC SC:7 sildenafil citrate SC SC:5 specific concordance SC SC:10 speech produced during simultaneous communication SC SC:22 standard care SC SC:23 stem cell SC SC:9 stepped care SC SC:11 stomach cancer SC SC:393|sc:5 stratum corneum SC SC:8|sc:1 subtilisin carlsberg SC SC:25|sc:11 supercoiled SC SC:12 superconducting SC SC:11|sc:3 supercritical SC SC:25 superior colliculi SC SC:11 supportive counseling SC SC:24 sydenhams chorea SC SC:9 synovial chondromatosis SC SC:13 tcm sulfur colloid SDAT SDAT:1 senile dementia alzheimertype SDAT SDAT:196|sDAT:1 senile dementia of the alzheimer type SDA SDA:16 sabouraud dextrose agar SDA SDA:19 sexually dimorphic area SDA SDA:20 sialodacryoadenitis SDA SDA:7 sodium diacetate SDA SDA:18 specific dynamic action SDA SDA:8 stepwise discriminant analysis SDA SDA:34 strand displacement amplification SDC SDC:36|sdc:1 salivary duct carcinoma SDC SDC:28 serum digoxin concentration SDD SDD:85 selective decontamination of the digestive tract SDD SDD:30 selective digestive decontamination SDD SDD:29 smallest detectable difference SDD SDD:4 standard deviation of differences SDD SDD:11 standard deviation of the difference SDD SDD:2 subantimicrobial dose of doxycycline SDE SDE:7 simultaneous distillation extraction SDE SDE:8 standarddose epinephrine SDE SDE:13 subdural empyema SDG SDG:18 secoisolariciresinol diglucoside SDG SDG:19 secoisolariciresinol diglycoside SDG SDG:18 sucrose density gradient SDH SDH:19 serine dehydratase SDH SDH:18 stepdown heating SDH SDH:182|sdh:1 succinic dehydrogenase SDH SDH:9 succinodehydrogenase SDH SDH:12|sDH:1 superficial dorsal horn SDI SDI:7 lupus international collaborating clinicsamerican college of rheumatology damage index SDI SDI:46 succinate dehydrogenase inhibition SDL SDL:15 selfdirected learning SDL SDL:8 statedependent learning SDL SDL:6 stepdown latency SDM SDM:12 shared decision making SDM SDM:12 sitedirected mutagenesis SDM SDM:47 sulfadimethoxine SDM SDM:14 sulphadimethoxine SDRs SDRs:10 shortchain dehydrogenasesreductases SDRs SDRs:6 specificitydetermining residues SDRs SDRs:10 spraguedawley rats SDR SDR:40 selective dorsal rhizotomy SDR SDR:6 shortduration response SDR SDR:9 social disruption SDR SDR:6 spatial delayed response SDR SDR:13 spontaneous dwarf rat SDS SDS:20 height sd score SDS SDS:157 selfrating depression scale SDS SDS:24 severity of dependence scale SDS SDS:35 shwachmandiamond syndrome SDS SDS:38 shydrager syndrome SDS SDS:445 sodium dodecyl sulphate SDS SDS:165 sodium dodecylsulfate SDS SDS:52 sodium dodecylsulphate SDS SDS:6 stent delivery system SDS SDS:35 sudden death syndrome SDS SDS:24 symptom distress scale SD SD:6 children with speech delay SD SD:9 depletion SD SD:125|S-D:18 male spraguedawley SD SD:21 seborrheic dermatitis SD SD:11 seborrhoeic dermatitis SD SD:26|Sd:1 segregation distorter SD SD:13 selective decontamination SD SD:20 selfdirectedness SD SD:28 semantic dementia SD SD:8|S-D:2 semantic differential SD SD:18 serologically defined SD SD:21 sexual dysfunction SD SD:108|S-D:4 shinedalgarno SD SD:5 sleep disorders SD SD:8 social desirability SD SD:9 solid dispersion SD SD:2 solvent and detergent SD SD:26 somatization disorder SD SD:39 spasmodic dysphonia SD SD:22 spatial disorientation SD SD:11|Sd:6|sd:1 spermidine SD SD:14 splice donor SD SD:284 spreading depression SD SD:9 stable SD SD:360 stable disease SD SD:12 standard diet SD SD:10 steroiddependent SD SD:6 striated duct SD SD:6 stroke distance SD SD:13 sudden deafness SD SD:61 sudden death SD SD:23 swine dysentery SEAR SEAR:12 southeast asia region SEAR SEAR:9 surfactantenhanced aquifer remediation SEA SEA:7 patients with stable exertional angina SEA SEA:4 schistosoma mansoni eggs SEA SEA:5 soluble egg antigen preparation SEA SEA:5|--SEA:1 southeast asia SEA SEA:9|--SEA:1 southeast asian SEA SEA:28 spinal epidural abscess SEA SEA:5 spontaneous electrical activity SEA SEA:6 statistical energy analysis SEB SEB:8|SE-B:1 enterotoxinb SEB SEB:549|seb:2 staphylococcal enterotoxin b SEB SEB:7 surrogate endpoint biomarker SECM SECM:18 scanning electrochemical microscope SECM SECM:82 scanning electrochemical microscopy SED SED:16 serious emotional disturbance SED SED:27 spondyloepiphyseal dysplasia SED SED:12|SE-D:1 staphylococcal enterotoxin d SED SED:15 strain energy density SEEG SEEG:12 stereoelectroencephalographic SEEG SEEG:15 stereoelectroencephalography SEE SEE:11 salisbury eye evaluation SEE SEE:7 standard error of estimation SEE SEE:12 staphylococcal enterotoxin e SEF SEF:4 salivary excretion fraction SEF SEF:10 sclerosing epithelioid fibrosarcoma SEF SEF:10 sinusoidal endothelial fenestrae SEF SEF:48 spectral edge frequency SEF SEF:7 staphylococcal enterotoxin f SEF SEF:5 suction effusion fluid SEF SEF:7 supplementary eye fields SEH SEH:18 spinal epidural hematoma SEH SEH:8 subependymal hemorrhage SEK SEK:14 swedish crowns SEK SEK:28 swedish kronor SELEX SELEX:47 systematic evolution of ligands by exponential enrichment SELEX SELEX:6 vitro selection SEL SEL:8 size exclusion limit SEL SEL:15 socioeconomic level SEL SEL:10 spinal epidural lipomatosis SEL SEL:24 subependymal layer sEMG sEMG:20|SEMG:17 surface electromyographic sEMG sEMG:14|SEMG:9 surface emg SEMS SEMS:6|S-EMS:1 metallic stent SEMS SEMS:6 selfexpandable metallic stents SEMS SEMS:14 selfexpanding metal stents SEMS SEMS:8 selfexpanding metallic stents SEM SEM:1 avs and simultaneously extracted metals SEM SEM:16 scanning electron SEM SEM:21 scanning electron micrographs SEM SEM:203|sEM:1 scanning electron microscopic SEM SEM:14 scanning electronmicroscopy SEM SEM:6 standard error of measurements SEM SEM:4|SEm:1 standard error of the measurement SEM SEM:14 structural equation model SEM SEM:82 structural equation modeling SEM SEM:23 structural equation modelling SEM SEM:2 studied with scanning SEM SEM:9 subendothelial matrix SEPs SEPs:6 somatosensory evoked responses SEPS SEPS:25 subfascial endoscopic perforator surgery SEPS SEPS:14 subfascial endoscopic perforator vein surgery SEPs SEPs:18 syringe exchange programs SEP SEP:35 sclerosing encapsulating peritonitis SEP SEP:19 socioeconomic position SEP SEP:37 standard error of prediction SEP SEP:11 syringe exchange program SES SES:5 rosenberg selfesteem scale SES SES:17 socioeconomic SES SES:1009|ses:1 socioeconomic status SET SET:9 single electron transfer SET SET:16 single embryo transfer SE SE:16 clearfil se bond SE SE:51 conventional spinecho SE SE:9 energy SE SE:9 exposure SE SE:14 extraction SE SE:16 mean standard error SE SE:141|Se:2 salmonella enteritidis SE SE:18 secondary electron SE SE:9 secondary erythrocytosis Se Se:14|SE:1|se:1 secretor Se Se:1045|SE:13|-Se:1 selenium SE SE:24 selfefficacy SE SE:27 selfesteem SE SE:12 serine esterase SE SE:6 shannon entropy SE SE:74 shared epitope SE SE:9 side effects SE SE:6 silicone elastomer SE SE:14 sleep efficiency SE SE:16 southeast SE SE:203 spin echo SE SE:13 spongiform encephalopathy SE SE:20 squalene epoxidase SE SE:8 standard errors SE SE:14 staphylococcal exotoxins SE SE:18|Se:4 staphylococcus epidermidis SE SE:14|S-E:5 starredwards SE SE:10 state entropy SE SE:502 status epilepticus SE SE:20 stress echocardiography SE SE:11 subendothelium SE SE:29 t and tweighted spinecho SE SE:76 tweighted spinecho SF2 SF2:6 superfamily SF2 SF2:2 surviving fraction to gy SF-36 SF-36:9 item shortform SF-36 SF-36:10|SF36:1 functioning SF-36 SF-36:11 instrument SF-36 SF-36:83 medical outcomes study item shortform health survey SF-36 SF-36:22 medical outcomes study short form SF-36 SF-36:6 medical outcomes study short form item questionnaire SF-36 SF-36:16 shortform SF-36 SF-36:11|SF36:2 short form health survey questionnaire SF-36 SF-36:9 short form item SF-36 SF-36:11 short form questionnaire SF-36 SF-36:7|SF36:2 short form health survey questionnaire sFas sFas:134|s-Fas:1|sFAS:1 soluble fas sFas sFas:8|sFAS:1 soluble fas antigen SFA SFA:7 feed arteries SFA SFA:11 saturated fa SFA SFA:9 spike frequency adaptation SFA SFA:9 suppressive factor of allergy SFEMG SFEMG:26|SF-EMG:1 singlefiber electromyography SFEMG SFEMG:16 single fiber emg SFEMG SFEMG:17 single fibre electromyography SFE SFE:224 supercritical fluid extraction SFE SFE:6|sfe:2 surface free energy SFF SFF:5 solid freeform fabrication SFF SFF:23 speaking fundamental frequency SFG SFG:8|SfG:5 scope for growth SFG SFG:93 spotted fever group SFG SFG:22 sum frequency generation SFG SFG:10 superior frontal gyrus SFI SFI:4 effect of shenfu injection SFI SFI:21 sciatic function index SFI SFI:33 sciatic functional index SFMC SFMC:21 soluble fibrin monomer complexes SFMC SFMC:38 synovial fluid mononuclear cells SFM SFM:25 scanning force microscope SFM SFM:74 scanning force microscopy SFM SFM:12 screenfilm mammography SFM SFM:19 serumfree media SFM SFM:70 serumfree medium SFM SFM:14|SfM:1 structurefrommotion SFP SFP:28|sfp:1 screen filtration pressure SFP SFP:35 stopflow pressure SFS SFS:12 social functioning scale SFs SFs:8 stress fibers SFS SFS:13 synchronous fluorescence spectrophotometry SFS SFS:10 synchronous fluorescence spectroscopy SFs SFs:10 synovial fluids SFT SFT:6 sabinfeldman test SFT SFT:25 skinfold thickness SFV SFV:482 semliki forest virus SFV SFV:8 simian foamy viruses sFv sFv:15|SFv:1 singlechain antibody sFv sFv:36|SFv:1 singlechain fv SFV SFV:24 superficial femoral vein SF SF:17 fibers SF SF:7|S-F:2 screenfilm SF SF:6 seizure free SF SF:130|sF:2|S-f:1 serum ferritin SF SF:10|s-F:2 serum folate SF SF:41|S-F:1|sf:1 serumfree SF SF:7 sexual function SF SF:11 sham feeding SF SF:10 shortterm fluctuation SF SF:53 shortening fraction SF SF:27 silk fibroin SF SF:9 slaframine SF SF:21 social functioning SF SF:21 sodium ferulate SF SF:6 soluble fiber SF SF:36|sF:1 soluble fibrin SF SF:13|sf:1 sorbitolfermenting SF SF:8 space flight SF SF:46|sf:1 spatial frequency SF SF:15 spotted fever SF SF:21 stone formers SF SF:9 superficial SF SF:8|Sf:1 surfactant SF SF:19 surviving fraction SF SF:5 sustained field SF SF:11 sylvian fissure SF SF:11|S-F:1 symphysisfundus SGA SGA:16 small for gestational age infants SGA SGA:96 subjective global assessment SGC SGC:9 gland carcinoma SGC SGC:14 small granulecontaining SGC SGC:5|sgc:1 softgel capsule sGC sGC:221|SGC:5|s-GC:1 soluble guanylate cyclase sGC sGC:210|SGC:7 soluble guanylyl cyclase SGC SGC:14|sgc:1 stratum griseum centrale SGD SGD:11 granule deficiency SGD SGD:17 saccharomyces genome database SGD SGD:13 specific growth delay SGF SGF:39 simulated gastric fluid SGF SGF:6 slow graft function SGO SGO:11 society of gynecologic oncologists SGO SGO:7 splanchnic glucose output SGP SGP:5 cell surface sialoglycopeptide SGP SGP:15|Sgp:1 sialoglycoprotein SGP SGP:9 strain gauge plethysmography SGP SGP:10 stratum griseum profundum SGs SGs:8|SGS:1 salivary glands SGS SGS:68 stratum griseum superficiale SGs SGs:14 stress granules SGS SGS:28 subglottic stenosis SGs SGs:8 sweat glands SG SG:9|Sg:3 glucose effectiveness at basal insulin SG SG:13|sg:4|Sg:1 pneumophila serogroup SG SG:9 santa gertrudis SG SG:14 sarcoglycan SG SG:9 sclareol glycol SG SG:5 soybeanderived sterylglucoside SG SG:66|sg:1 specific gravity SG SG:27 spiral ganglion sg sg:12|SG:1 staggerer SG SG:27 stellate ganglion SG SG:15 stratum granulosum sg sg:38|SG:5 subgenomic SG SG:99 substantia gelatinosa SG SG:11 subtotal gastrectomy SG SG:11 superficial gastritis SG SG:12|Sg:9 suprageniculate nucleus SG SG:13 sympathetic ganglia sham sham:8|SHAM:2 shamadrenalectomized sham sham:5|SHAM:4|Sham:2 shamoperated animals sham sham:6|SHAM:1 shamoperated group sham sham:12|SHAM:9 shamoperated rats SHA SHA:6 humic acid SHA SHA:13|sHA:11|S-HA:7 salivacoated hydroxyapatite SHA SHA:15 sinusoidal harmonic acceleration SHC SHC:14 spontaneously hypercholesterolemic SHC SHC:15|shc:1 squalenehopene cyclase SHC SHC:3|Shc:3 src homology and collagen protein SHE SHE:23 subclinical hepatic encephalopathy SHE SHE:230 syrian hamster embryo SHF SHF:10 schistosomal hepatic fibrosis SHF SHF:11 simian hemorrhagic fever SHF SHF:8 systolic heart failure SHG SHG:20 sonohysterography SHG SHG:7 static handgrip SHG SHG:9 sustained handgrip SHI SHI:15 health insurance SHI SHI:11 second harmonic imaging SHI SHI:33 severe head injury SHP SHP:18 schonleinhenoch purpura SHP SHP:19 short heterodimer partner SHP SHP:33|Shp:1 small heterodimer partner SHP SHP:16 summertype hypersensitivity pneumonitis SHRSP SHRSP:6|SHR-SP:2|SHRsp:1 spontaneously hypertensive strokeprone SHRSP SHRSP:26|SHR-SP:10|SHRsp:2 strokeprone spontaneously hypertensive SHR SHR:11 okamoto strain SHR SHR:20 rats with spontaneous hypertension SHR SHR:9 spontaneous histamine release SHR SHR:3 spontaneously hypertensive rats of the munster strain SHR SHR:7 spontaneously hypertensive rate SHS SHS:21 secondhand smoke SHS SHS:17 sliding hip screw SHS SHS:17 strong heart study SHS SHS:15 swollen head syndrome SH SH:11 hepatitis SH SH:8|Sh:1 hypotension SH SH:8 sclerosing hemangioma SH SH:9 secondary hypertension SH SH:9 severe hypoglycaemia SH SH:19 severe hypoglycemia SH SH:8 sima de los huesos SH SH:6 simple hyperplasia SH SH:16 sinus histiocytosis SH SH:18 sitting height SH SH:51 small hydrophobic SH SH:8 soybean hulls SH SH:11 spigelian hernia SH SH:259 spontaneously hypertensive SH SH:6 squamous hyperplasia SH SH:39 standard heparin SH SH:13|Sh:1 sternohyoid SH SH:10 subcortical hyperintensities SH SH:5 subtractive hybridization SH SH:25|-SH:10 sulphydryl SH SH:8 systemic hypertension SIADH SIADH:127 syndrome of inappropriate antidiuretic hormone secretion SIADH SIADH:19 syndrome of inappropriate secretion of adh SIADH SIADH:214 syndrome of inappropriate secretion of antidiuretic hormone SIB SIB:16 severe impairment battery SIB SIB:11 simultaneous integrated boost SICH SICH:5|sICH:1 spontaneous intracerebral hemorrhage SICH SICH:4|sICH:2 symptomatic intracranial hemorrhage SICU SICU:17 surgical icu SICU SICU:173|sICU:2 surgical intensive care unit SIC SIC:11 specific inhalation challenge SIC SIC:10|Sic:8 streptococcal inhibitor of complement SIF SIF:8 serum inhibitory factors SIF SIF:109 small intensely fluorescent SIH SIH:12 salicylaldehyde isonicotinoyl hydrazone SIH SIH:55 spontaneous intracranial hypotension SIH SIH:20 stressinduced hyperthermia SII SII:5 bilateral second sensory cortices SII SII:12|S-II:1 second somatosensory SII SII:25 second somatosensory cortex SII SII:14 secondary somatosensory SII SII:9 secondary somatosensory cortices SII SII:18 speech intelligibility index SIMCA SIMCA:23 soft independent modeling of class analogy SIMCA SIMCA:14 soft independent modelling of class analogy SIMS SIMS:147|SI-MS:5 secondary ion mass spectrometry SIMS SIMS:17 secondary ion mass spectroscopy SIM SIM:11 sandimmune SIM SIM:251 selected ion monitoring SIM SIM:10 selected ion monitoring mode SIM SIM:18 specialized intestinal metaplasia SIN-1 SIN-1:7 morpholino sydnonimine SIN-1 SIN-1:22|SIN1:1 morpholinosydnonimine hydrochloride SIN-1 SIN-1:8 morpholinosydnonimine nethylcarbamide SIN-1 SIN-1:4 donor morpholinosydnoniminenethylcarbamide SIN-1 SIN-1:21|Sin-1:1 linsidomine SIN-1 SIN-1:10 linsidomine chlorhydrate SIN-1 SIN-1:5 nitric oxide donor morpholinosydnonimine SIN SIN:10 salpingitis isthmica nodosa SIN SIN:29|sin:1|Sin:1 selfinactivating SIN SIN:25 septation initiation network SIP SIP:45 scheduleinduced polydipsia SIP SIP:12 selectively infective phage SIP SIP:344 sickness impact profile SIP SIP:10 steroidogenesisinducing protein SIP SIP:8 sympathetically independent pain SIRS SIRS:50 soluble immune response suppressor SIRs SIRs:37 standardised incidence ratios SIRs SIRs:163 standardized incidence ratios SIRS SIRS:10 structured interview of reported symptoms SIRS SIRS:549 systemic inflammatory response syndrome SIR SIR:7|Sir:5 silent information regulator SIR SIR:14 single isomorphous replacement SIR SIR:10 speech intelligibility rating SIR SIR:87 standardised incidence ratio SIR SIR:6 standardized incidence rate SIS SIS:8 impingement syndrome SIS SIS:7 secretory immune system SIS SIS:9 skin immune system SIS SIS:101 small intestinal submucosa SIS SIS:27|sis:1 small intestine submucosa SIS SIS:11 stroke impact scale SIS SIS:7 suicidal intent scale SIS SIS:6 suicide intent scale SITA SITA:10 swedish interactive threshold algorithm SITA SITA:7 swedish interactive thresholding algorithm SITS SITS:6 acetamidoisothiocyanodisulfonic stilbene SITS SITS:11 acetamidoisothiocyanostilbenedisulfonate SITS SITS:65 acetamidoisothiocyanostilbenedisulfonic acid SITS SITS:8 acid stilbene SIT SIT:9 small intestinal transit SIT SIT:10 small intestinal transplantation SIT SIT:9 social identity theory SIT SIT:27 sperm immobilization test SIT SIT:24 sterile insect technique SIT SIT:6 stress inoculation training SIG SIG:11 special interest group SIG SIG:9 strong ion gap SI SI:11 first somatic sensory area SI SI:8 first somatosensory area SI SI:90|si:1 sacroiliac SI SI:14 sacroiliitis SI SI:83 selfincompatibility SI SI:13 selfincompatible SI SI:8 sensory integration SI SI:9 sequential injection SI SI:43|Si:1 serum iron si si:10 short interfering SI SI:9 silent ischemia Si Si:14|SI:4 silica Si Si:91|SI:1 silicon SI SI:21 simulated ischemia SI SI:11 situs inversus si si:12 small interfering SI SI:19 small intestinal SI SI:35 social interaction SI SI:7 social isolation SI SI:5 somatosensory area i SI SI:31 special intervention SI SI:6 specific insulin SI SI:40 spectroscopic imaging SI SI:11 spinal cord isolation SI SI:15 splenic irradiation SI SI:11 sputum induction SI SI:39 stimulation indices SI SI:8 stoichiometry of inhibition SI SI:14 stress incontinence SI SI:58 substantia innominata SI SI:110|S-I:5 sucraseisomaltase SI SI:11 suicidal ideation SI SI:13 syncytiainducing SK SK:18 seborrheic keratosis SK SK:9|S-K:7|s-K:4 serum potassium SK SK:7|S-K:5 shwachmankulczycki SK SK:11|sK:1 small conductance SK SK:6 smallconductance caactivated k SK SK:8 small conductance caactivated k SK SK:9 solar keratoses SK SK:12 solar keratosis SK SK:7 stromal keratitis SLAM SLAM:28 signaling lymphocytic activation molecule SLAM SLAM:47 systemic lupus activity measure SLAP SLAP:6|Slap:2 srclike adaptor protein SLAP SLAP:6 superior labral anterior posterior SLAP SLAP:3 superior labrum anterior and posterior SLAP SLAP:9 superior labrum anteriorposterior SLA SLA:1 sandblasted largegrit acidetched SLA SLA:1 sandblasted acidetched SLA SLA:15 soluble liver antigen SLA SLA:30 specific leaf area SLA SLA:22 spontaneous locomotor activity SLC SLC:9 small luteal cells SLC SLC:38 sodiumlithium countertransport SLC SLC:6 sodiumlithium countertransport activity SLC SLC:6|Slc:1 solute carrier SLC SLC:9 synovial lining cells SLD SLD:13 sexlinked dwarf SLD SLD:36 sublethal damage SLEDAI SLEDAI:9 disease activity SLEDAI SLEDAI:127|SLE-DAI:1 sle disease activity index SLEDAI SLEDAI:52 systemic lupus erythematosus disease activity index SLE SLE:159 louis encephalitis SLE SLE:16 slit lamp examination SLE SLE:22 systemic le SLE SLE:14 systemic lupus SLE SLE:27|sLE:1 systemic lupus erythematodes SLE SLE:69 systemic lupus erythematosis SLE SLE:28 systemic lupus erythematous SLE SLE:9 systemic lupus erythmatosus SLI SLI:173 children with specific language impairment SLI SLI:9 language impaired SLI SLI:10 specific language impairments SLI SLI:10 specifically languageimpaired SLL SLL:42 secondlook laparotomy SLL SLL:47 small lymphocytic lymphoma SLM SLM:12 spatial light modulator SLM SLM:20 supported liquid membrane SLNs SLNs:19 solid lipid nanoparticles SLNs SLNs:14|SLN-s:1 superior laryngeal nerves SLN SLN:19 sarcolipin SLN SLN:9 solid lipid nanospheres SLN SLN:10 superior laryngeal SLO SLO:155 scanning laser ophthalmoscope SLO SLO:25 scanning laser ophthalmoscopy SLO SLO:30 smithlemliopitz SLP-76 SLP-76:6 domaincontaining leukocyte protein of kda SLP-76 SLP-76:9|Slp-76:1 phosphoprotein of kda SLPI SLPI:9 secretory leucocyte proteinase inhibitor SLPI SLPI:134 secretory leukocyte protease inhibitor SLPI SLPI:26 secretory leukocyte proteinase inhibitor SLPI SLPI:52 secretory leukoprotease inhibitor SLPs SLPs:6 slayer proteins SLPs SLPs:33|S-LPs:1 speechlanguage pathologists SLPs SLPs:10 surface layer proteins SLP SLP:46 scanning laser polarimetry SLP SLP:7 silkworm larvae plasma SLP SLP:10 speechlanguage pathologist SLP SLP:8 spontaneous lymphocyte proliferation SLR SLR:10 shinnarle roux SLR SLR:5 shortlatency response SLR SLR:13 straight leg raise SLR SLR:20 straight leg raising SLR SLR:8 subthalamic locomotor region SLs SLs:8|SLS:1 sarcomere lengths SLS SLS:12 segmentlongspacing SLS SLS:12 selective laser sintering SLs SLs:14 sensation levels SLs SLs:16|Sls:5 sesquiterpene lactones SLS SLS:59 sjogrenlarsson syndrome SLS SLS:227 sodium lauryl sulfate SLS SLS:145 sodium lauryl sulphate SLs SLs:10 sphingolipids SLS SLS:19 static light scattering SLS SLS:30 streptolysin s SLTs SLTs:22 shigalike toxins SLTs SLTs:25 speech and language therapists SLT SLT:21 selective laser trabeculoplasty SLT SLT:7 single lung transplant SLT SLT:10 specificlocus test SLT SLT:32 speech and language therapy SLT SLT:12 split liver transplantation SL SL:13 cardiac sarcolemma SL SL:19 cardiac sarcolemmal SL SL:9 db sensation level SL SL:14 layer SL SL:20 scapholunate SL SL:6 sham laparotomy SL SL:8 short latency SL SL:11 sleep latency SL SL:16 smyth line SL SL:6 sodium lactate SL SL:6 spin lock SL SL:13 spiral ligament SL SL:104|sl:1 spliced leader SL SL:16 stemloop SL SL:9 stereolithographic SL SL:24 stride length SL SL:10 structured lipids SL SL:26|sl:2 sublingual SL SL:9 surface laplacian SL SL:8 surrogate light SL SL:11 suspensory ligament SMAF SMAF:13 functional autonomy measurement system SMAF SMAF:9 superior mesenteric artery flow SMAS SMAS:59 superficial musculoaponeurotic system SMAS SMAS:22 superior mesenteric artery syndrome SMA SMA:182|sma:2|-SMA:1 muscle actin SMA SMA:8 shape memory alloy SMA SMA:9 small mesenteric arteries SMA SMA:17 snow mountain agent SMA SMA:13 specific methanogenic activity SMA SMA:5 spontaneous mechanical activities SMA SMA:58 spontaneous motor activity SMA SMA:22 styrene maleic anhydride SMA SMA:21 superior mesenteric SMA SMA:10 superior mesenteric arterial SMA SMA:9 supplementary motor SMA SMA:9 supplementary motor cortex SMB SMB:16 behavior SMB SMB:39 simulated moving bed SMB SMB:13|SmB:3 somatomedin b SMB SMB:17 suckling mouse brain SMB SMB:10 syncromateb SMCD SMCD:12 schmid metaphyseal chondrodysplasia SMCD SMCD:36 systemic mast cell disease SMCP SMCP:8 sheep mast cell proteinase SMCP SMCP:10 submucous cleft palate SMC SMC:11 sialomucin complex SMC SMC:10 sinusoidal modulated currents SMG SMG:10 streptococcus milleri group SMG SMG:20 submandibular ganglion SMG SMG:11 submandibular salivary glands SMG SMG:9 superior mesenteric ganglion SMG SMG:12|SmG:2 supramarginal gyrus SMM SMM:12 smethylmethionine SMM SMM:36 scintimammography SMM SMM:14|S-MM:1 smoldering multiple myeloma SMM SMM:14 stepwise mutation model SMM SMM:12|Smm:1 sulfamonomethoxine SMM SMM:9 sulphamonomethoxine SMN SMN:2|Smn:1 survival motor neuron protein SMN SMN:38 survival of motor neurons SMON SMON:9 subacute myelooptic neuropathy SMON SMON:33 subacute myeloopticoneuropathy SMP SMP:24|smp:1 bovine heart submitochondrial particles SMP SMP:13 schwann cell myelin protein SMP SMP:14 skim milk powder SMP SMP:13 soluble microbial products SMP SMP:6 submucous plexus SMP SMP:31 sympathetically maintained pain SMRs SMRs:114 standardised mortality ratios SMRs SMRs:254 standardized mortality ratios SMR SMR:13 sensorimotor rhythm SMR SMR:13 severe mental retardation SMR SMR:56 sleeping metabolic rate SMR SMR:9 small multidrug resistance SMR SMR:9 standard mortality rate SMR SMR:7 submucous resection SMS SMS:71 smithmagenis syndrome SMS SMS:40 space motion sickness SMS SMS:6 sphingomyelin synthase SMS SMS:45 stiffman syndrome SMT SMT:28 smethylisothiourea SMT SMT:19 smethylisothiourea sulfate SMT SMT:6 second malignant tumors SMT SMT:31 spinal manipulative therapy SMT SMT:6 stress management training SMVT SMVT:7 sodiumdependent multivitamin transporter SMVT SMVT:25 sustained monomorphic ventricular tachycardia SMV SMV:17 skeletal muscle ventricle SMV SMV:20 soybean mosaic virus SMV SMV:78 superior mesenteric vein SNAP-25 SNAP-25:9|SNAP25:1 kda synaptosomalassociated protein SNAP-25 SNAP-25:7 synaptosomalassociated protein SNAP-25 SNAP-25:11|SNAP25:2 synaptosomeassociated protein SNAP-25 SNAP-25:37|SNAP25:4|Snap25:1 synaptosomeassociated protein of kda SNAP SNAP:12 snitrosonacetylpenicillamine SNAP SNAP:22 donor snitrosonacetylpenicillamine SNAP SNAP:10 nitric oxide donor snitrosonacetylpenicillamine SNAP SNAP:30 snitrosonacetyl penicillamine SNAP SNAP:11 snitrosonpenicillamine SNAP SNAP:10 schedule for nonadaptive and adaptive personality SNAP SNAP:33 score for neonatal acute physiology SNA SNA:31 sambucus nigra SNA SNA:45 sambucus nigra agglutinin SNA SNA:9 sinus node artery SNA SNA:208 sympathetic nerve activity SNB SNB:102 sentinel node biopsy SNB SNB:133 spinal nucleus of the bulbocavernosus SND SND:16 selective neck dissection SND SND:18 sinus node disease SND SND:42 sinus node dysfunction SND SND:66 striatonigral degeneration SND SND:122 sympathetic nerve discharge SNOM SNOM:18 scanning nearfield optical microscope SNOM SNOM:35 scanning nearfield optical microscopy SNRPN SNRPN:7 polypeptide n gene SNRPN SNRPN:11 small nuclear ribonucleoprotein polypeptide n SNR SNR:45 signaltonoise SNR SNR:9 supernumerary ribs SNV SNV:52 sin nombre virus SNV SNV:67 spleen necrosis virus SNV SNV:11 systemic necrotizing vasculitis SN SN:9 nerves SN SN:12 neurons SN SN:23 secretoneurin SN SN:12 selection negativity SN SN:9 semantic network SN SN:10 sensory neuron SN SN:38|sN:7 sentinel lymph node SN SN:14 serum neutralisation SN SN:25 serum neutralizing SN SN:16 sin nombre SN SN:15 single nephron SN SN:65 sinus node SN SN:6 spitz nevus SN SN:26 spontaneous nystagmus SN SN:17 streptonigrin SN SN:18|Sn:2 sural nerve SOCS SOCS:154|Socs:3 cytokine signaling SOCS SOCS:28 cytokine signalling SOCs SOCs:11 organic compounds SOCs SOCs:16 storeoperated ca channels SOCs SOCs:30 storeoperated channels SOC SOC:13 selforganized criticality SOC SOC:146|SoC:1 sense of coherence SOC SOC:15 sense of coherence scale SOC SOC:11 shamoperated control SOC SOC:20 soil organic carbon SOC SOC:11 stage of change SOC SOC:11 standard of care SOC SOC:7 storeoperated ca channel SOC SOC:15 storeoperated calcium SOC SOC:101 superior olivary complex SODA SODA:7 sequential occupational dexterity assessment SODA SODA:7 severity of dyspepsia assessment SOD SOD:29 septooptic dysplasia SOD SOD:43 sphincter of oddi dysfunction SOD SOD:32 superoxide dismutase activity SOD SOD:5 superoxide dismutase enzyme SOFA SOFA:18 sepsisrelated organ failure assessment SOFA SOFA:55 sequential organ failure assessment SOL SOL:22 sleep onset latency SOL SOL:30|Sol:10|sol:1 soleus muscle SOL SOL:5 spaceoccupying lesions SOM SOM:139 secretory otitis media SOM SOM:59 soil organic matter SOM SOM:21 sphincter of oddi manometry SOM SOM:9 superior oblique myokymia SOPs SOPs:9 sensory organ precursors SOPs SOPs:25 standard operating procedures SOP SOP:21 sensory organ precursor SOP SOP:7 superior oblique palsy SOS SOS:13 sucrose octasulfate SOS SOS:36 swedish obese subjects SOT SOT:6 annual meeting of the society of toxicology SOT SOT:26 sensory organization test SOT SOT:10 squamous odontogenic tumor SOA SOA:23 secondary organic aerosol SOA SOA:145 stimulus onset asynchrony SOA SOA:18 sucrose octaacetate SO SO:9 output SO SO:11 significant other SO SO:9 sleep onset SO SO:11 slow oscillator SO SO:13 slowoxidative SO SO:204 sphincter of oddi SO SO:50 stratum opticum SO SO:10 stratum oriens SO SO:23 styrene oxide SO SO:17 sulfite oxidase SO SO:27 superior oblique SO SO:15 supraoptic nucleus SO SO:16 sympathetic ophthalmia SP1 SP1:16|SP-1:1|sp-1:1 pregnancyspecific betaglycoprotein SP1 SP1:26|SP-1:2 schwangerschaftsprotein SPAP SPAP:4|sPAP:1 secreted placental alkaline phosphatase SPAP SPAP:6|sPAP:5|s-PAP:1 systolic pulmonary arterial pressure SPAP SPAP:17|sPAP:6 systolic pulmonary artery pressure SpA SpA:20|SPA:1 patients with spondyloarthropathy SPA SPA:9 polysaccharide antigen SpA SpA:12 protein a of staphylococcus aureus SPA SPA:7 protein antigen SPA SPA:77 scintillation proximity assay SPA SPA:19 serum plate agglutination SPA SPA:1 sheep with pulmonary adenomatosis SPA SPA:6 soluble protective antigen SPA SPA:91 sperm penetration assay SpA SpA:10 spondyloarthritides SpA SpA:17 spondyloarthritis SpA SpA:71|SPA:2 spondyloarthropathies SPA SPA:17 spontaneous physical activity SPA SPA:45 spontaneous platelet aggregation SPA SPA:6 standard peritoneal permeability analysis SPA SPA:21 stimulationproduced analgesia SPA SPA:10 subperiosteal abscess SPA SPA:7 suprapubic aspiration SP-A SP-A:8|SPA:1 surfactant apoprotein SP-A SP-A:13 surfactant protein SP-A SP-A:62 surfactant proteina SPB SPB:18 solitary plasmacytoma of bone SPB SPB:153 spindle pole body SPC SPC:8 salivary protein complex SPC SPC:25 saturated phosphatidylcholine SPC SPC:4 second primary cancer SPC SPC:14 soy protein concentrate SPC SPC:9|spc:1 spermatocytes SPC SPC:9 sphingosylphosphocholine SPC SPC:82 sphingosylphosphorylcholine SPC SPC:15 standard plate count SPC SPC:35 statistical process control SPC SPC:10 subtilisinlike proprotein convertase SPC SPC:12 summary of product characteristics SPD SPD:12 lstepholidine SPD SPD:83 schizotypal personality disorder SPD SPD:13 stepholidine SPD SPD:32 storage pool deficiency SPD SPD:8 storage pool disease SPD SPD:17 subcorneal pustular dermatosis SPD SPD:15 synpolydactyly SPECT SPECT:7 myocardial scintigraphy SPECT SPECT:88 single photon emission ct SPECT SPECT:9 tomographic imaging SPECT SPECT:11 tomoscintigraphy SPE SPE:15 serum protein electrophoresis SPE SPE:9 solar particle events SPE SPE:878 solidphase extraction SPE SPE:7 substance p endopeptidase SPE SPE:27 sucrose polyester SPGR SPGR:22 spoiled gradientecho SPGR SPGR:2 spoiled gradient recalled acquisition in steady state SPGR SPGR:14 spoiled grass SPG SPG:57 schizophyllan SPG SPG:29 sizofiran SPG SPG:9 spastic paraplegia SPG SPG:12 spermatogonia SPG SPG:17 sphenopalatine ganglion SP-IR SP-IR:15|SP-ir:3|sP-IR:1|SPir:1 substance pimmunoreactive SP-IR SP-IR:7|SP-ir:3|SPIR:1 substance p immunoreactivity SPI SPI:7 singlepoint imaging SPI SPI:82 soy protein isolate SPK SPK:17 simultaneous pancreas and kidney SPK SPK:14 simultaneous pancreas and kidney transplantation SPK SPK:63 simultaneous pancreaskidney SPK SPK:24 simultaneous pancreaskidney transplantation SPK SPK:16 transplant SPL SPL:7 phage lysate SPL SPL:26 superior parietal lobule SPMS SPMS:32|SP-MS:6 secondary progressive ms SPMS SPMS:15|SP-MS:1 secondary progressive multiple sclerosis SPMs SPMs:20 statistical parametric maps SPMs SPMs:21 synaptic plasma membranes SpO2 SpO2:14|SPO2:1 oxygen saturation by pulse oximetry SpO2 SpO2:9|Spo2:1 pulse oxymetry SPPS SPPS:32 solidphase peptide synthesis SPPS SPPS:9 stable plasma protein solution SPP SPP:12 signal peptide peptidase SPP SPP:17 skin perfusion pressure SPP SPP:10 sodium pentosan polysulphate SPP SPP:8 stromal processing peptidase SPQ SPQ:23 methoxynsulfopropylquinolinium SPQ SPQ:28 schizotypal personality questionnaire SPRs SPRs:5 prevalence ratios SPRs SPRs:5 scattertoprimary ratios SPR SPR:25 selective posterior rhizotomy SPR SPR:9 skin potential reflex SPR SPR:10 skin potential response SPR SPR:14 slide positivity rate SPR SPR:17|SP-R:1 sp receptor SPR SPR:670 surface plasmon resonance SPTs SPTs:13 second primary tumors SPTs SPTs:74|SPTS:1 skin prick tests SPTs SPTs:17 subjectperformed tasks SPT SPT:5 psulfophenyl theophylline SPT SPT:7 second primary tumor SPT SPT:47 serine palmitoyltransferase SPT SPT:9 singleparticle tracking SPT SPT:6 sleep period time SPT SPT:32 supportive periodontal therapy SPT SPT:8 supportive periodontal treatment SPV SPV:106|spV:2|SpV:1 selective proximal vagotomy SPV SPV:8 stratum periventriculare SPV SPV:11 swinepox virus SPV SPV:22 systolic pressure variation SPS SPS:8 semipermeable surface SPs SPs:87 senile plaques SPs SPs:11 silent periods SPS SPS:18 simple partial seizures SPS SPS:9 simulated public speaking SPs SPs:11 slow potentials SPS SPS:9 sodium polyanetholesulfonate SPs SPs:64 standardized patients SPS SPS:25 stiffperson syndrome SPs SPs:9|sps:6 stress proteins SPS SPS:10 suicide probability scale SPs SPS:3|SPs:3 sulfated polysaccharides SQDG SQDG:12 sulfoquinovosyl diacylglycerol SQDG SQDG:19 sulfoquinovosyldiacylglycerol SQ SQ:11 quality SQ SQ:10 semiquinone SQ SQ:10 speed quotient SQ SQ:15|Sq:1 squalene SQ SQ:21 symptom questionnaire SR-PGA SR-PGA:16 selfreinforced polyglycolic acid SR-PGA SR-PGA:21 selfreinforced polyglycolide SR-PLLA SR-PLLA:9 selfreinforced polyllactic acid SR-PLLA SR-PLLA:38 selfreinforced polyllactide SRA SRA:13 regression analysis SRA SRA:9 serum resistance associated SRA SRA:12|sra:1 specific radioactivity SRA SRA:14 steroid receptor rna activator SRBC SRBC:20 antisheep erythrocyte SRBC SRBC:114|sRBC:4|Srbc:1 sheep red blood cell SR-BI SR-BI:5 class b type i scavenger receptor SR-BI SR-BI:39|SRBI:1 scavenger receptor bi SR-BI SR-BI:118|SRB-I:1|SRBI:1 scavenger receptor class b type i SRB SRB:9 senegal river basin SRB SRB:7 sex ratio at birth SRB SRB:114 sulfatereducing bacteria SRB SRB:9 sulfatereducing bacterium SRB SRB:47 sulforhodamine b SRCA SRCA:17 specific red cell adherence SRCA SRCA:83 subrenal capsule assay SRC SRC:5 scid repopulating cells SRC SRC:21 scleroderma renal crisis SRC SRC:18 sheep red cells SRC SRC:18 steroid receptor coactivator SRC SRC:22 stimulusresponse compatibility SRC SRC:32|src:2 subrenal capsule SRD SRD:5 sarcinricin domain SRD SRD:5 signal response domain SRD SRD:24 subnucleus reticularis dorsalis SRD SRD:5 substancerelated disorder SRD SRD:14 sucroserich diet SREs SREs:31 serum response elements SREs SREs:16 skeletalrelated events SRE SRE:9 skeletalrelated event SRE SRE:10|SR-E:2 syringomycin e SRF SRF:11 repetitive firing SRF SRF:375 serum response factor SRF SRF:11 specific resistance to filtration SRF SRF:7 split renal function SRF SRF:43 subretinal fluid SRF SRF:10 subretrofacial SRF SRF:12 subretrofacial nucleus SRH SRH:46 selfrated health SRH SRH:38 single radial haemolysis SRH SRH:15 single radial hemolysis SRH SRH:5 subretinal hemorrhage SRI SRI:32 serotonin reuptake inhibitor SRI SRI:21 strain rate imaging SRI SRI:38 surface regularity index SRK SRK:8 s locus receptor kinase SRK SRK:10 s receptor kinase SRK SRK:13 shaking rat kawasaki SRO SRO:12 shortest region of overlap SRO SRO:24 smallest region of overlap SRP SRP:110 scaling and root planing SRP SRP:7 signal recognition protein SRP SRP:30 soluble reactive phosphorus SRR SRR:8 skin resistance response SRR SRR:7 steroidresistant rejection SRS SRS:26 savannah river site SRS SRS:9 scoliosis research society SRS SRS:18 sex reassignment surgery SRS SRS:55 silverrussell syndrome SRS SRS:7 simple random sampling SRS SRS:94 somatostatin receptor scintigraphy SRS SRS:14 stimulated raman scattering SRS SRS:15 subretinal space SRS SRS:4 supervision rating scale SRT SRT:10 reaction time task SRT SRT:15 selective reminding test SRT SRT:65|srt:1 simple reaction time SRT SRT:33 sludge retention time SRT SRT:25 solids retention time SRT SRT:67 stereotactic radiotherapy SRT SRT:11 surfactant replacement therapy SRT SRT:11|S-RT:1|SR-T:1 sustainedrelease theophylline SRT SRT:9 symptom rating test SRV SRV:15 simian retrovirus SRV SRV:6 street rabies virus SRY SRY:6|Sry:2 region y gene SRY SRY:2 sex determining region of the y SRY SRY:18|Sry:2 sexdetermining region of the y chromosome SRY SRY:20 sexdetermining region y SR SR:15 racer SR SR:10 saccharopolyspora rectivirgula SR SR:11 salt resistant SR SR:47 sarcoplasmic reticular SR SR:6 sarcoplasmic reticulum membranes SR SR:14 saturation recovery SR SR:12 selfreinforced SR SR:8 sensory rhodopsin SR SR:37 serineargininerich SR SR:12 sex ratio SR SR:7 shift reagent SR SR:20 silicone rubber SR SR:258 sinus rhythm SR SR:8 skin resistance SR SR:9 spontaneous regression SR SR:6 spontaneous remission SR SR:7 spontaneous respiration SR SR:7 stapedial reflex SR SR:9 stapedius reflex SR SR:48 stochastic resonance SR SR:5 storage phosphor radiography SR SR:33 strain rate SR SR:27|sr:1 stratum radiatum SR SR:7 stretch reflex SR SR:19 superior rectus SR SR:15 sustained responders SR SR:43 sustained response SR SR:19 synaptic ribbons SR SR:32 synchrotron radiation SR SR:13 systematic review SSA SSA:14 senile systemic amyloidosis SSA SSA:29 singlestrand annealing SSA SSA:8 skin nerve sympathetic activity SSA SSA:67 social security administration SSA SSA:13 specific surface area SSA SSA:41|sSA:2 subsaharan africa SSA SSA:14 succinic semialdehyde SSA SSA:10 sulfosalicylic acid SSA SSA:8 superoxide scavenging activity SSB SSB:6|ssb:1 escherichia coli singlestrand binding SSB SSB:16 escherichia coli singlestranded dna binding protein SSB SSB:10 short spike bursts SSB SSB:4|ssb:1 single strand breakage SSB SSB:65|ssb:2|Ssb:1 singlestranded dnabinding protein SSC SSC:11 porcine chromosome SSC SSC:6 scientific and standardization committee SSC SSC:26 stretchshortening cycle SSD SSD:18 sexual size dimorphism SSD SSD:16 sourcesurface distance SSD SSD:17 sourcetosurface distance SSD SSD:7 sterolsensing domain SSE SSE:16 skin selfexamination SSE SSE:4 sodium salicylate extract SSE SSE:8 stage selector element SSF SSF:48 simultaneous saccharification and fermentation SSF SSF:9 skinfolds SSF SSF:49 solidstate fermentation SSF SSF:12 soluble suppressor factor SSG SSG:9 salivary gland SSG SSG:21 sodium stibogluconate SSH SSH:29|Ssh:1 snowshoe hare SSH SSH:205 suppression subtractive hybridization SSI SSI:6 scale for suicide ideation SSI SSI:8 strength strain index SSI SSI:71 streptomyces subtilisin inhibitor SSI SSI:5 stress strain index SSI SSI:147 supplemental security income SSI SSI:18 synthetic sentence identification SSM SSM:7 scaled subprofile model SSM SSM:19 skinsparing mastectomy SSM SSM:6 slippedstrand mispairing SSM SSM:10 subsarcolemmal mitochondria SSN SSN:9 social security number SSN SSN:14 superior salivatory nucleus SSO SSO:5|sso:2 singlestrand origin SSO SSO:17 sunflower seed oil SSP SSP:5 inhibitor staurosporine SSP SSP:8 sagittal sinus pressure SSP SSP:11 secondary spontaneous pneumothorax SSP SSP:14 sequencespecific primer SSP SSP:12 slice sensitivity profile SSP SSP:5|Ssp:1|ssp:1 stringent starvation protein SSRs SSRs:84 simple sequence repeats SSRs SSRs:28 sympathetic skin responses SSR SSR:8 signal sequence receptor SSR SSR:19 spinal stretch reflex SSS SSS:11 saltsugar solution SSS SSS:46 scandinavian stroke scale SSS SSS:160|sss:1 sick sinus syndrome SSS SSS:45 stanford sleepiness scale SSS SSS:16 summed stress score SSS SSS:103 superior sagittal sinus SSS SSS:11 synthetic serum substitute SST SST:10 sclerosing stromal tumor SST SST:17 sea surface temperature SST SST:14 shosaikoto SST SST:12 short synacthen test SST SST:10 simple shoulder test SST SST:17 social skills training SST SST:11 sperm storage tubules SST SST:12 submacular surgery trials SSVEP SSVEP:6 steadystate visual evoked potential SSVEP SSVEP:7 steadystate visually evoked potential SSV SSV:18 short saphenous vein SSV SSV:54 simian sarcoma virus SS SS:5 glands from patients with sjogrens syndrome SS SS:6 salbutamol sulfate SS SS:10 salmonellashigella SS SS:14 salt sensitive SS SS:13 scleroderma systematica SS SS:8 segmental shortening SS SS:77 selfstimulation SS SS:18 septic shock SS SS:9 serum SS SS:8 sewage sludge SS SS:12 short stature SS SS:16 sidestream smoke SS SS:20 simple spike SS SS:12 social support SS SS:9 spermatocytic seminoma SS SS:84|ss:2|Ss:1 stainless steel SS SS:11 starch synthase SS SS:14|Ss:2 steroidsensitive SS SS:8 straight sinus SS SS:9 stresssusceptible SS SS:24 subsarcolemmal SS SS:10 supersaturation SS SS:11 supraspinatus SS SS:10 sympathetic stimulation SS SS:13 synchronized sleep SS SS:5 systolic segment shortening SS SS:10 systolic shortening STa STa:6 escherichia coli heatstable toxin STa STa:10|STA:2 heatstable enterotoxin of escherichia coli STA STA:8 solanum tuberosum agglutinin STA STA:15 spiketriggered averaging STA STA:9 standard tube agglutination STA STA:80 superficial temporal artery STA STA:25 systematic toxicological analysis STB STB:11 serum total bilirubin STB STB:10 stobadine STCs STCs:11 serum theophylline concentrations STCs STCs:12 suppression tuning curves STC STC:5|sTC:2 serum total cholesterol STC STC:75 stanniocalcin STC STC:7 subtotal colectomy STDP STDP:41 plasticity STDP STDP:8 shortterm dynamic psychotherapy STEMI STEMI:11 patients with stelevation myocardial infarction STEMI STEMI:64 stsegment elevation myocardial infarction STF STF:12 seminiferous tubule fluid sTF sTF:11 soluble tf STF STF:8 soluble thymic factor sTF sTF:10 soluble tissue factor STF STF:9 subeschar tissue fluid STIs STIs:347 sexually transmitted infections STIs STIs:18 structured treatment interruptions STIs STIs:35 systolic time intervals STI STI:16 speech transmission index STI STI:13 stereotactic irradiation STM STM:7 salmonella typhimurium mitogen STM STM:62 scanning tunneling microscope STM STM:140 scanning tunneling microscopy STM STM:15 scanning tunnelling microscope STM STM:36 scanning tunnelling microscopy STM STM:15|stm:2 shoot meristemless STM STM:9 shootmeristemless STM STM:130 shortterm memory STM STM:29 signaturetagged mutagenesis STM STM:8 symptothermal method stn stn:7|Stn:2 salmonella enterotoxin stn stn:10|STN:1 stomatogastric nerve STP STP:63 shortterm potentiation STP STP:7 soil test phosphorus STP STP:11 stiripentol STP STP:12 superior temporal polysensory area STP STP:9 supratemporal plane STs STs:11 cytosolic sulfotransferases STS STS:6 selegiline transdermal system STs STs:38 sequence types STS STS:33 sittostand STS STS:27 society of thoracic surgeons STS STS:13 sodium tetradecyl sulfate STS STS:80 sodium thiosulfate STS STS:6 sodium thiosulphate STS STS:116|Sts:5 steroid sulfatase STS STS:28|Sts:2 steroid sulphatase STS STS:15 stilbene synthase STS STS:5 subthreshold stimulation STS STS:120|STs:3|sts:1 superior temporal sulcus STT STT:17 schirmer tear test STT STT:6 shortterm tests STT STT:15 soft tissue tumors STT STT:19 spinothalamic STT STT:126 spinothalamic tract STZ-D STZ-D:13 streptozocininduced diabetes STZ-D STZ-D:28 streptozocininduced diabetic STZ STZ:85 streptozocin STZ STZ:24 streptozotocininduced STZ STZ:7 streptozotocininduced diabetic ST ST:11 heat stable ST ST:31|st:2 heatstable toxin ST ST:2 pkc inhibitor staurosporine ST ST:7 saturation transfer ST ST:19 scala tympani ST ST:13 secondary thrombocytosis ST ST:7 seizure threshold ST ST:10 selftranscendence ST ST:14 seminiferous tubules ST ST:73|St:8 semitendinosus ST ST:9 septal thickness ST ST:17 sequence type ST ST:4|st:3|S-T:1 serum testosterone ST ST:6|St:1 shell thickness ST ST:8|st:1 shortterm ST ST:36|S-T:3 sialyltransferase ST ST:9 signal transduction ST ST:5 silent thyroiditis ST ST:14 sinus tachycardia ST ST:6 skin testing ST ST:8|st:7 small t antigen ST ST:10 solid tumors ST ST:36 spasmodic torticollis ST ST:3|-ST:2 stsegment depression ST ST:5 stsegment elevation ST ST:7|st:1 standard therapy ST ST:8 standard treatment ST ST:11 stanozolol ST ST:11|St:1 starch ST ST:45 sterigmatocystin ST ST:35 strength training ST ST:49|st:1 stria terminalis ST ST:8|St:6 styrene ST ST:59|St:1 sulfotransferase ST ST:9 supportive therapy ST ST:9 surgical tracheostomy ST ST:9 swine testicular ST ST:14 swine testis ST ST:36 syncytiotrophoblast ST ST:11 synovial tissues SUA SUA:58|SUa:1|sUA:1 serum uric acid SUA SUA:34 single umbilical artery SUDEP SUDEP:37 sudden unexpected death in epilepsy SUDEP SUDEP:12 sudden unexplained death in epilepsy SUDs SUDs:8 singleuse devices SUDs SUDs:36|SUDS:1 substance use disorders SUR1 SUR1:33|Sur1:1 sulfonylurea receptor SUR1 SUR1:26 sulfonylurea receptor SUVs SUVs:70 small unilamellar vesicles SUVs SUVs:83 standardized uptake values SUZI SUZI:34 subzonal insemination SUZI SUZI:9 subzonal sperm injection SVA SVA:5 simvastatin hydroxy acid SVA SVA:11 supraventricular arrhythmias SVCO SVCO:13 superior vena cava obstruction SVCO SVCO:9 superior vena caval obstruction SVC SVC:19 slow vital capacity SVC SVC:466 superior vena cava SVC SVC:27 superior vena caval SVD SVD:14 single vessel disease SVD SVD:151 singular value decomposition SVD SVD:21 small vessel disease SVD SVD:35 structural valve deterioration SVD SVD:9 subcortical vascular dementia SVD SVD:25 swine vesicular disease SVE SVE:14 soil vapor extraction SVE SVE:10 subcortical vascular encephalopathy SVF SVF:7 seminal vesicle fluid SVF SVF:6 stromavascular fraction SVR SVR:11 surgical ventricular restoration SVR SVR:36 sustained viral response SVR SVR:42 sustained virologic response SVR SVR:89 sustained virological response SVR SVR:36 systemic SVT SVT:5 sinus venous thrombosis SVT SVT:12 superficial vein thrombosis SVT SVT:7 superficial venous thrombosis SVT SVT:9 supraventricular SVV SVV:54 simian varicella virus SVV SVV:6 small vessel vasculitis SVV SVV:37|svv:1 subjective visual vertical SVs SVs:9 splice variants SVs SVs:43 synaptic vesicles SV SV:18 scala vestibuli SV SV:7 selective vagotomy SV SV:13 shell vial SV SV:22 simple virilizing SV SV:9 single ventricle SV SV:10 slow vacuolar SV SV:27 spontaneous ventilation SV SV:39 stria vascularis SV SV:23 systemic vasculitis SWAP SWAP:8 adult worm antigens SWAP SWAP:8 soluble adult worm antigenic preparation SWAP SWAP:24 worm antigen preparation SWDs SWDs:13 spikeandwave discharges SWDs SWDs:4 spike wave discharges SWM SWM:10 segmental wall motion SWM SWM:22 spatial working memory SWs SWs:13 sex workers SWs SWs:18 slow waves SWS SWS:39 sturgeweber syndrome SWS SWS:9 stuvewiedemann syndrome SWT SWT:10 shuttle walk test SWT SWT:10 shuttle walking test SWT SWT:14|sWT:3 systolic wall thickening SW SW:5 forced swimming SW SW:6 generalized spike and wave SW S-W:3|SW:3 generalized spikewave SW SW:20 saltwasting SW SW:10|sw:1 spikeandwave SW SW:8 stab wounds SW SW:10 steroid withdrawal SW SW:73 stroke work SW SW:31|Sw:4 swainsonine SXA SXA:10 single energy xray absorptiometry SXA SXA:14 single xray absorptiometry SAC SAC:5 ion channels SAC SAC:18 sallyl cysteine SAC SAC:24 sallylcysteine SAC SAC:27 seasonal allergic conjunctivitis SAC SAC:6 segmental antigen challenge SAC SAC:9 spindle assembly checkpoint SAC SAC:29 splenic adherent cells SAC SAC:15|Sac:1 staphylococcus aureus cowan SAC SAC:27 staphylococcus aureus cowan SAC SAC:16 staphylococcus aureus cowan i strain SAC SAC:7 staphylococcus aureus cowan strain SAC SAC:14 staphylococcus aureus cowan strain SAC SAC:48 staphylococcus aureus cowan strain i SAC SAC:34 systemic arterial compliance SAN SAN:9 sinoatrial SAN SAN:11 spinal accessory nerve SCAP SCAP:9 severe communityacquired pneumonia SCAP SCAP:35 srebp cleavageactivating protein SCAP SCAP:13 syringocystadenoma papilliferum Sf9 Sf9:8|SF9:1 expressed in insect Sf9 Sf9:12|SF9:2|Sf-9:1 spodoptera frugiperda cells SGE SGE:8 generalized epilepsy SGE SGE:6 starch gel electrophoresis SIA SIA:20 sequential injection analysis SIA SIA:53 stressinduced analgesia SIA SIA:9 stressinduced antinociception SIA SIA:10 strip immunoblot assay SIA SIA:25 surgically induced astigmatism Skuse Skuse:8 aedes notoscriptus Skuse Skuse:6 ochlerotatus notoscriptus SMI SMI:11 effect of shenmai injection SmI SmI:5 rat somatosensory SMI SMI:7 respimat soft mist inhaler SMI SMI:26 serious mental illness SMI SMI:9 seriously mentally ill SMI SMI:11 severely mentally ill SMI SMI:17 silent myocardial ischaemia SmI SmI:21 somatosensory cortex SMI SMI:20 sperm motility index SMI SMI:11 structure model index SMD SMD:7 meningococcal disease SMD SMD:18 senile macular degeneration SMD SMD:7 spondylometaphyseal dysplasia SMD SMD:21 standardized mean differences SMD SMD:9 steered molecular dynamics SPM SPM:17 scanning probe microscopy SPM SPM:14 spontaneous pneumomediastinum SPM SPM:196 statistical parametric mapping SPM SPM:97 suspended particulate matter SP SP:7 cd or cd singlepositive SP SP:19 cd singlepositive SP SP:9 plate SP SP:7|Sp:2 power Sp Sp:22|sp:4|SP:1 schizosaccharomyces pombe SP SP:14|sp:1 sclerosing peritonitis SP SP:7 secondary polycythemia SP SP:80|Sp:1 seminal plasma SP SP:37 senile plaque SP SP:7|Sp:2 septum SP SP:10|Sp:1 seropositive SP SP:79 side population SP SP:61|sp:1 single positive SP SP:8 sleep paralysis SP SP:28 slow pathway SP SP:26 smooth pursuit SP SP:61|Sp:1 social phobia SP SP:10 sodium pentobarbital SP SP:8|sp:2 solid phase SP SP:8|Sp:5 spasmolytic polypeptide Sp Sp:8|SP:4|sp:1 spectinomycin Sp Sp:11|SP:2 spectrin Sp Sp:13|SP:5 spermine Sp Sp:12 spiroiminodihydantoin SP SP:25|Sp:7 spleen SP SP:13|Sp:1 splenius Sp Sp:35 splotch SP SP:51|Sp:9 spontaneous pneumothorax SP SP:9|Sp:2 spore photoproduct SP SP:8 storage phosphor SP SP:16 stratum pyramidale SP SP:11|S-P:4 streptavidinperoxidase SP SP:9 subplate SP SP:44 sulfapyridine SP SP:14 sulphadoxinepyrimethamine SP SP:16 sulphapyridine SP SP:17 superficial peroneal SP SP:7 supine position SP SP:8 synthetic peptides SP SP:11 synthetic pyrethroid SP SP:48 systolic pressure STD STD:21 saturation transfer difference STD STD:7 seminiferous tubular diameter STD STD:14 shortterm depression StAR StAR:190|Star:1|STAR:1|star:1|stAR:1 steroidogenic acute regulatory StAR StAR:303|STAR:4|stAR:2|Star:1|star:1 steroidogenic acute regulatory protein SU SU:16 stroke unit SU SU:11|Su:3 sucrose SU SU:48|Su:5 sulfonylurea SU SU:13|Su:1 sulphonylurea SU SU:6|Su:1 surface envelope glycoprotein SU SU:7 surface envelope protein SU SU:29|Su:1 surface glycoprotein SU SU:5 surface subunit SU SU:17 surface unit SU SU:8|S-U:1 swimup T/N T/N:7 normal tissue T/N T/N:12 tumornormal T0 T0:8|t0:2 operation T0 T0:7|t0:2|T-0:1 study T1 T1:14 month T1 T1:20 first response T1 T1:8|T-1:1 first thoracic T1 T1:50 first twitch T1 T1:3 first twitch of the tof T1 T1:7 first twitch of the trainoffour T1 T1:14 longitudinal relaxation T1 T1:4 lowest excited triplet T1 T1:12 spinlattice relaxation T2 T2:7|t2:2 months later T2 T2:7|t2:2 minutes T2 T2:17 mitochondrial acetoacetylcoa thiolase T2 T2:7 second target T2 T2:7 second thoracic T2 T2:6 spinspin relaxation T2 T2:6 stage b T2 T2:16|t2:1 years later T3 T3:11 itriiodothyronine T3 T3:9 advanced T3 T3:15|t3:3 after T3 T3:7 thyroid hormone triiodolthyronine T3 T3:6 total t T3 T3:19 triidothyronine T3 T3:12|t3:1 triiodothyronin T3 T3:14 triiodothyroxine T3 T3:13 triodothyronine T4 T4:14 locally advanced T4 T4:452|T-4:5 serum thyroxine T4 T4:6 thyroxine level T4 T4:13 tripchlorolide TAA TAA:7 tertamyl alcohol TAA TAA:12|-TAA:1 thoracoabdominal aneurysm TAA TAA:12 thoracoabdominal aortic aneurysm TAA TAA:7 thoracoabdominal asynchrony TAA TAA:26 total antioxidant activity TAA TAA:8 tumorassociated ag TAA TAA:11 tumorassociated ags TAB TAB:9 temporal artery biopsy TAB TAB:13 total androgen blockade Tac Tac:9|TAC:3 interleukin receptor Tac Tac:5 interleukin receptor alpha chain TAC TAC:14 teller acuity cards TAC TAC:9 total abdominal colectomy TAC TAC:10 transformationcompetent artificial chromosome TAC TAC:25 transverse aortic constriction TAD TAD:29 thiazolecarboxamide adenine dinucleotide TAD TAD:40 transactivation domain TAD TAD:13 transcription activation domain TAD TAD:11 transcriptional activation domain TAD TAD:13 transient acantholytic dermatosis TAE TAE:10 tilt aftereffect TAE TAE:384 transcatheter arterial embolization TAE TAE:11 transcatheter arterial embolization therapy TAE TAE:1 treated by either transarterial embolization TAFIa TAFIa:14 activated tafi TAFIa TAFIa:9 fibrinolysis inhibitor TAF TAF:10 aspirate fluid TAF TAF:10 studies on the function of concentration maintenance TAF TAF:14 thoughtaction fusion TAI TAI:5 thoracoabdominal irradiation TAI TAI:19 timed artificial insemination TAI TAI:10 transcatheter arterial infusion TAI TAI:19 traumatic axonal injury TAL TAL:9 taste aversion learning TAL TAL:5 tendoachilles lengthening TAL TAL:8 thin agar layer TAL TAL:9|tal:2 transaldolase TAMs TAMs:8 thymidine analogue mutations TAMs TAMs:29 tumorassociated macrophages TAM TAM:11|Tam:1 tamoxifen citrate TAM TAM:22 total active motion TAM TAM:23 transient abnormal myelopoiesis TAO TAO:53 thromboangiitis obliterans TAO TAO:17 thyroidassociated orbitopathy TAO TAO:41 triacetyloleandomycin TAO TAO:44|Tao:1 troleandomycin TAO TAO:14 trypanosome alternative oxidase TAP TAP:11 triaminopyrimidine TAP TAP:9 peptide transporter TAP TAP:30 tandem affinity purification TAP TAP:29 tick anticoagulant peptide TAP TAP:13|tap:1 tracheal antimicrobial peptide TAP TAP:8 transmembrane action potential TAP TAP:38 transporter associated with antigen presentation TAP TAP:232 transporter associated with antigen processing TAP TAP:12 treatment of agerelated macular degeneration with photodynamic therapy TAP TAP:15 tricuspid annuloplasty TAR TAR:10 tat protein with the transactivation responsive region TAR TAR:8 thoracic aortic rupture TAR TAR:7 thrombocytopeniaabsent radius TAR TAR:10 thrombocytopenia and absent radii TAR TAR:2 thrombocytopenia and absent radius TAR TAR:19 tissueair ratio TAR TAR:5|tar:3 transactivation responsive element TAR TAR:21 transformationassociated recombination TAR TAR:12 traumatic aortic rupture TAS TAS:4 termination associated sequence TAS TAS:138 total antioxidant status TAS TAS:16 transabdominal sonography Tat Tat:3|TAT:1 hiv transactivator TAT TAT:37 thematic apperception test TAT TAT:101|T-AT:1 thrombinantithrombin TAT TAT:101|T-AT:2 thrombinantithrombin iii TAT TAT:7 total adipose tissue Tat Tat:11|tat:11|TAT:2 transactivator TAT TAT:9|Tat:5 transactivator of transcription TAT TAT:37 tray agglutination test TAT TAT:32 turnaround time TAT TAT:9 tyrosine amino transferase TAT TAT:283|Tat:3 tyrosine aminotransferase TAV TAV:11 time average velocity TAV TAV:20 tomato aspermy virus Ta Ta:14|ta:1|TA:1 air temperatures TA TA:7 patients with takayasu arteritis TA TA:5|Ta:3 t cells Ta Ta:35 tabby TA TA:87 takayasus arteritis TA TA:61 tannic acid Ta Ta:14 tantalum TA TA:10 technology assessment TA TA:7 teichoic acids TA TA:64 telomerase activity TA TA:5 temporal artery TA TA:21 thoracic aorta TA TA:16 thyroarytenoid muscle TA TA:647|ta:1|Ta:1 tibialis anterior TA TA:32 tibialis anterior muscle TA TA:13 titratable acidity TA TA:22 tonic accommodation TA TA:9|Ta:1 total area TA TA:10 toxic adenoma TA TA:9 tracheal agenesis TA TA:26 transabdominal TA TA:11 transactivation TA TA:6 transient absorption TA TA:5 transit amplifying TA TA:10 transplant arteriosclerosis TA TA:16 triamterene TA TA:17 tricuspid annulus TA TA:22 tricuspid atresia TA TA:17 truncus arteriosus TA TA:5|Ta:2 tryptamine TA TA:5 tumour antigens TA TA:17 tunica albuginea TBAR TBAR:5 thiobarbituric acid reactive products TBAR TBAR:6 thiobarbituric acid reactive substances TBC TBC:8|tBC:1 tertbutylcatechol TBC TBC:5 tertiary butyl catechol TBC TBC:7 total bacterial count TBE TBE:12 tracheobronchial epithelial TBE TBE:17 trisborateedta TBF TBF:13 terbinafine TBF TBF:9 tertbutyl formate TBF TBF:8 thermal biofeedback TBF TBF:19 tickborne fever TBF TBF:59 total body fat TBG TBG:326 thyroxinebinding globulin TBG TBG:11 trophoblastic beta glycoprotein TBHQ tBHQ:4|TBHQ:4|t-BHQ:2 tbutylhydroquinone TBHQ TBHQ:4|t-BHQ:3 tertbutyl hydroquinone TBHQ TBHQ:38|tBHQ:31|t-BHQ:6|t-b-HQ:1 tertbutylhydroquinone TBHQ TBHQ:9 tertiary butylhydroquinone TBIAb TBIAb:8|TBI-ab:1 inhibiting antibodies TBIAb TBIAb:4 tsh binding inhibiting antibody TBII TBII:8 thyrotrophin binding inhibiting immunoglobulins TBII TBII:12 thyrotropin binding inhibiting immunoglobulins TBII TBII:17 thyrotropin binding inhibitor immunoglobulin TBI TBI:24 brain injured TBI TBI:12 traumatic braininjured TBI TBI:13 traumatically braininjured TBI TBI:7 tsh binding inhibition TBM TBM:12 total body mass TBM TBM:7 trabecular bone mass TBM TBM:13 tracheobronchomalacia TBM TBM:17 tumorbearing mice TBPS TBPS:12 binding of stbutylbicyclophosphorothionate TBPS TBPS:31 tbutylbicyclophosphorothionate TBPS TBPS:9 tertbutylbicyclophosphorothionate TBP TBP:443|tbp:1 tatabinding protein TBP TBP:5 tata boxbinding polypeptide TBP TBP:9 trinbutyl phosphate TBP TBP:29 tributyl phosphate TBSA TBSA:244|tbsa:1 total body surface area TBSA TBSA:10 tuberculostearic acid TBT TBT:5 effects of trinbutyltin chloride TBT TBT:7 template bleeding time TBT TBT:13 trinbutyltin TBT TBT:296 tributyltin TBV TBV:64 total blood volume TBV TBV:51 trabecular bone volume TBW TBW:524 total body water TBW TBW:53 total body weight TCAs TCAs:10 thalamocortical axons TCAs TCAs:432|TCAS:1 tricyclic antidepressants TCAs TCAs:10 tricyclic antidepressant drugs TCA TCA:10 trichloroanisole TCA TCA:6 temporal clustering analysis TCA TCA:8 total circulatory arrest TCA TCA:25 total colonic aganglionosis TCA TCA:35 transluminal coronary angioplasty TCA TCA:321|tca:1 tricarboxylic acid TCA TCA:19 tricarboxylic acid cycle TCA TCA:14 tricyclic TCBS TCBS:6 citrate bile salts sucrose TCBS TCBS:8 thiosulfatecitratebile saltssucrose TCBS TCBS:6 thiosulphatecitratebile saltssucrose TCCS TCCS:20 transcranial colorcoded realtime sonography TCCS TCCS:22 transcranial colorcoded sonography TCC TCC:10 bladder cancer TCC TCC:18 tai chi chuan TCC TCC:6 total cell count TCC TCC:6 total coliform counts TCC TCC:9 total contact cast TCC TCC:10 total contact casting TCC TCC:9 transcervical cell TCC TCC:30 transitional cell cancer TCC TCC:23 transitional cell carcinoma of the bladder TCC TCC:10 transitional cell carcinoma of the urinary bladder TCD50 TCD50:7 control dose TCD50 TCD50:8|TCD-50:1 tumor control dose TCDD TCDD:11 htetrachlorodibenzopdioxin TCDD TCDD:13 tetrachlorodibenzoparadioxin TCDD TCDD:10 tetrachlorodibenzodioxin TCDO TCDO:17 tetrachlorodecaoxide TCDO TCDO:5 tetrachlorodecaoxygen anion complex TCD TCD:601|TcD:1 transcranial doppler TCD TCD:239|TcD:1 transcranial doppler sonography TCD TCD:115 transcranial doppler ultrasonography TCD TCD:101 transcranial doppler ultrasound TCD TCD:13 transverse cerebellar diameter TCE TCE:15 control element TCE TCE:5 metabolites trichloroethanol TCF TCF:9 temperature coefficient of frequency TCF TCF:17 tissue cage fluid TCF TCF:8 tissue chamber fluid TCI TCI:163 temperament and character inventory TCI TCI:7 testicular circulatory isolation TCI TCI:7 transcobalamin i TCI TCI:17 transcutaneous immunization TCI TCI:7 transitory cognitive impairment T-CLL T-CLL:7|TCLL:1 tcell chronic lymphocytic leukaemia T-CLL T-CLL:30 tcell chronic lymphocytic leukemia TCL TCL:9 tcell lymphoma TCL TCL:7 tachycardia cycle length TCL TCL:16 transverse carpal ligament TCM TCM:16 tissue culture medium TCM TCM:12 trichlormethiazide TCM TCM:11 trichloromethane TCP TCP:14 thienylcyclohexylpiperidine TCP TCP:28 trichloropyridinol TCP TCP:6 inhibitor tranylcypromine TCP TCP:13 piperidine TCP TCP:10|tcp:2|Tcp:1 toxin coregulated pilus TCP TCP:17 toxincoregulated pili TCP TCP:8 transcutaneous cardiac pacing TCP TCP:134 tricalcium phosphate TCP TCP:9 tricalciumphosphate TCP TCP:11 tricresylphosphate TCP TCP:10 tropical calcific pancreatitis TCRB TCRB:10 trichlorobetadribofuranosylbenzimidazole TCRB TCRB:10|Tcrb:1 receptor beta chain Tcr Tcr:6|TcR:1 resistance to tetracycline TCR TCR:6 t cell antigen receptor complex TCR TCR:28|TcR:1 t cell receptor for antigen Tcr Tcr:10 t complex responder Tcr Tcr:9|TcR:1 tetracyclineresistant TCR TCR:15 transcriptional control region TCT TCT:24 thyrocalcitonin TCT TCT:16 tracheal cytotoxin TCT TCT:28 transmission computed tomography TCT TCT:9 transmission ct TCT TCT:6 tube coagulase test TCV TCV:10 t cell vaccination TCV TCV:10 tall cell variant TCV TCV:24 turkey coronavirus TCV TCV:63 turnip crinkle virus TCS TCS:8 magnetic transcranial stimulation TCS TCS:26 tethered cord syndrome TCs TCs:27 tetracyclines TCs TCs:11 tetracycline antibiotics TCS TCS:17 transcranial sonography TCS TCS:71 trichosanthin TCs TCs:12 tuning curves tcu-PA tcu-PA:7 active twochain upa tcu-PA tcu-PA:4|tcuPA:2|Tc-uPA:2|tc-u-PA:1 twochain urokinase tcu-PA tcu-PA:8 twochain urokinasetype plasminogen activator Tc Tc:13|tc:1|TC:1 cell cycle TC TC:9 cellobiose Tc Tc:18|TC:3|T-c:1 colonic Tc Tc:51|TC:5 cytotoxic t TC TC:6 human teratocarcinoma Tc Tc:13 t cytotoxic TC TC:18 taurocholic acid Tc Tc:5 taxuyunnanine c Tc Tc:22|tc:1|TC:1 technetium TC TC:22 temporal cortex TC TC:42 terminal cisternae TC TC:35 testicular cancer TC TC:10 testosterone cypionate TC TC:95|T-C:6 thalamocortical TC TC:72 therapeutic community TC TC:8 thoracic circumference TC TC:16 thyroid cancer TC TC:12 thyroid carcinoma TC TC:14|Tc:9|tc:7 time constant TC TC:9|Tc:1 tinospora cordifolia TC TC:31 tissue culture TC TC:17 total carbon TC TC:19 total carnitine TC TC:10 transcarboxylase TC TC:15 transcervical TC TC:40 transcobalamin Tc Tc:11 transition temperatures TC TC:11 trauma center TC TC:6|Tc:3 tubocurarine TC TC:14 tumoral calcinosis TD50 TD50:9 carcinogenic potency TD50 TD50:10 median toxic dose TDC TDC:40 taurodeoxycholate TDC TDC:9 titanocene dichloride TDC TDC:17|Tdc:5|tdc:1 tryptophan decarboxylase TDD TDD:6 thiamine deficient diet TDD TDD:12 thoracic duct drainage TDF TDF:11 tenofovir TDF TDF:17 testisdetermining factor TDF TDF:1 time dose and fractionation TDF TDF:55 total dietary fiber TDF TDF:9 total dietary fibre TDF TDF:10 transdermal fentanyl TDH TDH:18 texas department of health TDH TDH:4|tdh:2|Tdh:1 threonine dehydrogenase TDI TDI:15 thought disorder index TDI TDI:131|TDi:1 tissue doppler imaging TDI TDI:68 tolerable daily intake TDI TDI:8 total dose infusion TDI TDI:9 transition dyspnea index TDLUs TDLUs:6 terminal duct lobular units TDLUs TDLUs:7 terminal ductal lobular units TDL TDL:18 thoracic duct lymph TDL TDL:96 thoracic duct lymphocytes TDM TDM:310 therapeutic drug monitoring TDM TDM:9 tomodensitometry TDM TDM:56 trehalose dimycolate TDO TDO:9 toluene dioxygenase TDO TDO:8 trichodentoosseous syndrome TDO TDO:25|TdO:6 tryptophan dioxygenase TDP TDP:10 tetradecapeptide TDP TDP:12 timedependent potentiation TDS TDS:10 testicular dysgenesis syndrome TDS TDS:13 timedependent sensitization TDS TDS:21 total defect score TDS TDS:12 total diet study TDS TDS:28 total dissolved solids TDS TDS:17 transdermal delivery system TDS TDS:8 trichuris dysentery syndrome Td Td:14 denaturation temperature Td Td:27|TD:13|td:6 doubling time TD TD:27 tdependent TD TD:39 tangier disease TD TD:561 tardive dyskinesia TD TD:8 temporal difference Td Td:8 tetanus and diphtheria toxoids Td Td:9|TD:1|td:1 tetanusdiphtheria Td Td:5 tetanusdiphtheria toxoid TD TD:36 thanatophoric dysplasia TD TD:72|Td:1 thermodilution TD TD:29 thiamine deficiency TD TD:5 thiamine deficient TD TD:22 thoracic duct td td:10 thymidylate synthase gene TD TD:97 tibial dyschondroplasia TD TD:12|Td:1|td:1 time delay TD TD:26 tissue doppler TD TD:14 total deviation TD TD:8 total dose TD TD:24 tourettes disorder TD TD:7|td:2 transdermal td td:18 transformationdefective TD TD:11 travelers diarrhea Td Td:8 treponema denticola TD TD:9 triple dose TD TD:24|tD:3 true digestibility TD TD:11 true protein digestibility TD TD:13 tryptophan depletion TD TD:5 typical development TD TD:26 typically developing TEAM TEAM:7 transfemoral endovascular aneurysm management TEAM TEAM:8 trauma evaluation and management TEA TEA:10 ctetraethylammonium TEA TEA:7 carotid thromboendarterectomy TEA TEA:14 tetraethylammonium bromide TEA TEA:137 tetraethylammonium chloride TEA TEA:16 thoracic epidural anaesthesia TEA TEA:48 thoracic epidural analgesia TEA TEA:59 thoracic epidural anesthesia TEA TEA:8 total elbow arthroplasty TEA TEA:33|tea:1 triethanolamine TEA TEA:79 triethylamine TEB TEB:12 terminal end bud TEB TEB:28 thoracic electrical bioimpedance TEB TEB:11 transient electric birefringence TED TED:23 thromboembolic disease TED TED:30 thyroid eye disease TEE TEE:226 total energy expenditure TEE TEE:25 transesophageal echocardiogram TEE TEE:60 transesophageal echocardiographic TEE TEE:13 transesophageal echography TEF-1 TEF-1:18 transcription enhancer factor TEF-1 TEF-1:19 transcriptional enhancer factor TEFRA TEFRA:9 tax equity and fiscal responsibility act TEFRA TEFRA:9 tax equity and fiscal responsibility act of TEF TEF:23 thermic effect of feeding TEF TEF:58 thermic effect of food TEF TEF:26 toxic equivalency factor TEF TEF:7 tracheoesophageal fistulas TEGDMA TEGDMA:46|TEG-DMA:1 triethylene glycol dimethacrylate TEGDMA TEGDMA:23 triethyleneglycol dimethacrylate TEGDMA TEGDMA:9 triethyleneglycoldimethacrylate TEG TEG:5 tetraethylene glycol TEG TEG:10 thrombelastogram TEG TEG:28 thrombelastograph TEG TEG:63 thrombelastography TEG TEG:15 thromboelastogram TEG TEG:18 thromboelastograph TEG TEG:65 thromboelastography TEG TEG:5 triethylene glycol TEL TEL:8|Tel:2 telencephalon TEL TEL:13 tetraethyl lead TEMPO TEMPO:16|Tempo:4|TEM-PO:1 tetramethylpiperidineoxyl TEMPO TEMPO:7|Tempo:1 tetramethylpiperidinenoxyl TEM TEM:1 technical error measurement TEM TEM:25 thermic effect of a meal TEM TEM:85 transanal endoscopic microsurgery TEM TEM:45|tem:1 transendothelial migration TEM TEM:281 transmission electron microscope TEM TEM:103 transmission electron microscopic TEM TEM:25 transverse electromagnetic TEM TEM:66|tem:1 triethylenemelamine TEN TEN:36 total enteral nutrition TEN TEN:240 toxic epidermal necrolysis TEOAEs TEOAEs:89 transient evoked otoacoustic emissions TEOAEs TEOAEs:43 transiently evoked otoacoustic emissions TEP TEP:11 endoscopic totally extraperitoneal inguinal hernioplasty TEP TEP:8 extraperitoneal approach TEP TEP:17 total extraperitoneal TEP TEP:43 totally extraperitoneal TEP TEP:40 tracheoesophageal puncture TES TES:7 total error score TES TES:17 transthoracic endoscopic sympathectomy TES TES:6 treadmill exercise score TEV TEV:29 tobacco etch potyvirus TEV TEV:86|Tev:1 tobacco etch virus TE TE:6|Te:2|te:1 duration of expiration TE TE:71 testosterone enanthate TE TE:23|Te:2 thioesterase TE TE:18 thromboembolic TE TE:56 thromboembolism TE TE:38|T-E:1 thymic epithelial TE TE:8 thymic epithelium TE TE:5 time to echo TE TE:15 tissue engineering TE TE:5 tonic extension TE TE:5 total energy TE TE:10 toxic encephalopathy TE TE:28 toxoplasma encephalitis TE TE:62 toxoplasmic encephalitis TE TE:14 trabeculectomy TE TE:11 tracheal epithelial TE TE:59|T-E:2|t-e:1 tracheoesophageal TE TE:18 tropoelastin TFA TFA:6 timefrequency analysis TFA TFA:4|TFa:3 tissue factor activity TFA TFA:29|tFA:1|t-FA:1 trans fatty acids TFA TFA:12 trifluoroacetate TFA TFA:17|Tfa:1 trifluoroacetyl TFC TFC:27 thyroid follicular cells TFC TFC:10 timi frame count TFC TFC:31 triangular fibrocartilage TFE TFE:20 tetrafluoroethylene TFE TFE:9 watertrifluoroethanol TFI TFI:7 treatmentfree interval TFI TFI:15 tubal factor infertility TFL TFL:15 tensor fascia lata TFL TFL:9 tensor fasciae latae TFP TFP:11 mitochondrial trifunctional protein TFP TFP:405|tfp:1|Tfp:1 trifluoperazine TFTs TFTs:9 thyroid function tests TFTs TFTs:10 transistors TFT TFT:7 thin film transistor TFT TFT:13 thought field therapy TFT TFT:5 thyroid function test TFT TFT:57 trifluorothymidine TFX TFX:22 thymus extract TFX TFX:11 thymus factor x TF TF:20|Tf:2 mtctetrofosmin TF TF:7 inhibition of the nociceptive tailflick TF TF:70 tail flick TF TF:6 tailflick reflex TF TF:12|Tf:1 tetrofosmin TF TF:9 thickening fraction TF TF:54 thomsenfriedenreich TF TF:10 tibiofemoral TF TF:12|T-F:2|t-f:2 timefrequency TF TF:8 total fat TF TF:18 transfer factors TF TF:12 transfer function TF TF:6 transport fraction TF TF:8 treatment failure TF TF:9 tubular fluid TF TF:19 typhoid fever TGA TGA:11 thioglycolic acid TGA TGA:136 transient global amnesia TGA TGA:262 transposition of the great arteries TGEV TGEV:54 transmissible gastroenteritis coronavirus TGEV TGEV:249 transmissible gastroenteritis virus TGFA TGFA:21|TGFa:3|Tgfa:2|TGF-a:2 transforming growth factor alpha TGFA TGFA:13|TG-FA:2 triglyceride fatty acids TGI TGI:5 thyroid growth stimulating immunoglobulins TGI TGI:49 tracheal gas insufflation TGM TGM:12 total gaseous mercury TGM TGM:3|Tgm:3|TgM:2 transgenic mouse TGT TGT:7 thrombin generation time TGT TGT:31|Tgt:4|tgt:1 trnaguanine transglycosylase TGT TGT:6 tumor growth time TGr TGr:5|TGR:1 thioguanine resistant TGr TGr:7 frequency of thioguanineresistant TGR TGR:4 hypertensive tgrmren rats TGR TGR:11 tgrmren TG TG:4|Tg:1 fc receptors for igg Tg Tg:9 glass transition TG TG:13|Tg:1 glucuronide TG TG:7 low density lipoprotein vldltriglyceride TG TG:27|Tg:1 plasma triacylglycerol TG TG:254|Tg:1 plasma triglyceride Tg Tg:221|TG:26|tg:2 serum thyroglobulin Tg Tg:12|tg:6|TG:1 tcrtransgenic TG TG:10 tetragastrin TG TG:12 thermogravimetric TG TG:23|Tg:1 thioglycollate TG TG:11 thrombin generation Tg Tg:16|TG:11 thymine glycol TG TG:23 thyroid gland TG TG:38 total gastrectomy TG TG:13 training group Tg Tg:10|tg:7|TG:3 transgene TG TG:17 treatment group TG TG:9 trigeminal TG TG:84 trigeminal ganglia TG TG:6 triglyceride concentration TG TG:7 triglyceride levels TG TG:11 tumour growth TG TG:12 typhus group THB THB:17 tetrahydroberberine THB THB:19 toddhewitt broth THC THC:9 delta tetrahydrocannabinol THC THC:110 tetrahydrocannabinol THC THC:10 tetrahydrocurcumin THC THC:18 total haemocyte count THC THC:9 total hydrocarbon THE THE:31 tetrahydrocortisone THE THE:14 tonic hindlimb extension THE THE:29 transhiatal esophagectomy THF THF:9 monotetrahydrofuran THF THF:12 tetrahydrofolic acid THF THF:177|thf:2 tetrahydrofuran THF THF:9 thymic hormone THF THF:28 thymic humoral factor TH-IR TH-IR:22|TH-ir:13|THir:3|THIR:1 thimmunoreactive TH-IR TH-IR:15|TH-ir:4|THir:2|THIR:1 tyrosine hydroxylase immunoreactivity THI THI:10 acetyltetrahydroxybutylimidazole THI THI:16 temperaturehumidity index THI THI:17 tinnitus handicap inventory THI THI:47 tissue harmonic imaging THI THI:11 traumatic head injury THL THL:19 tetrahydrolipstatin THL THL:14 transvaginal hydrolaparoscopy THL THL:9 true histiocytic lymphoma THP-1 THP-1:7 human monocytes THP-1 THP-1:6 human monocytic THP-1 THP-1:15|THP1:1 monocytic cells THP-1 THP-1:9 monocytic leukemia THP THP:9 rotetrahydropyranyladriamycin THP THP:9 otetrahydropyranyladriamycin THP THP:77 pirarubicin THP THP:10 tetrahydropalmatine THP THP:52 tetrahydropapaveroline THP THP:20 trihexyphenidyl THR THR:8 transient hyperaemic response THR THR:6 transient hyperemic response T-H T-H:5|TH:4 after traumahemorrhage T-H T-H:6 following traumahemorrhage Th Th:115|TH:15 helper t Th Th:7|TH:3 helper t lymphocytes TH TH:12 homogenate TH TH:5 nicotinamide nucleotide transhydrogenase TH TH:12|T-H:2 tammhorsfall TH TH:23 target height TH TH:9 tec homology TH TH:18 tension headache TH TH:19|Th:12 thalamus Th Th:14 thorium TH TH:13 triamcinolone hexacetonide TH TH:10 tyrosine hydroxylase gene TIA-1 TIA-1:11|TIA1:1|Tia-1:1 intracellular antigen TIA-1 TIA-1:16 tcell intracellular antigen TIA TIA:15 thin layer immunoassay TIA TIA:11 thrombosisinducing activity TIA TIA:10 thymidine incorporation assay TIA TIA:5 trabeculariris angle TIA TIA:15 trypsin inhibitor activity TIA TIA:15 turbidimetric immunoassay TIBC TIBC:7 serum iron and total iron binding capacity TIBC TIBC:86 total ironbinding capacity TIC TIC:5 intensity curve TIC TIC:8 thyroid iodine content TIC TIC:18|Tic:1 ticarcillin TIC TIC:22 trypsin inhibitory capacity TIDA TIDA:31 tuberoinfundibular dopamine TIDA TIDA:122|TI-DA:1 tuberoinfundibular dopaminergic TIE TIE:15 inhibitory element TIE TIE:34 toxicity identification evaluation TIGR TIGR:12 glucocorticoid response protein TIGR TIGR:7 trabecular meshwork inducible glucocorticoid response TIMI TIMI:465 thrombolysis in myocardial infarction TIMI TIMI:16 thrombolysis in myocardial infarction trial TIMI TIMI:9 thrombolysis in myocardial ischemia TIMPs TIMPs:7 tissue inhibitors of matrix metalloproteinase TIMPs TIMPs:12 tissue inhibitors of metalloproteases TIMPs TIMPs:19 tissue inhibitors of metalloproteinase TIN TIN:18 testicular intraepithelial neoplasia TIN TIN:70 tubulointerstitial nephritis TIPS TIPS:24 transjugular intrahepatic portosystemic shunting TIPS TIPS:22 transjugular intrahepatic portosystemic stentshunt TIP TIP:12 tonoplast intrinsic protein TIP TIP:9 tubularized incised plate TIR TIR:19 tollinterleukin receptor TIR TIR:22 total internal reflection TIR TIR:20 translation initiation region TIS TIS:9 information services TIS TIS:7 total irritation score TIS TIS:21|tis:1 transcription initiation site TIVA TIVA:76 total intravenous anaesthesia TIVA TIVA:96 total intravenous anesthesia TIV TIV:14 tipula iridescent virus TIV TIV:8 total intracranial volume TIV TIV:4 trivalent inactivated influenza vaccine Ti Ti:7|TI:5 duration of inspiration TI TI:65|Ti:12|ti:3 inspiratory duration Ti Ti:5 t cell antigen receptor Ti Ti:6 t cell receptor TI TI:25|T-I:1 tindependent TI TI:8 thalassaemia intermedia TI TI:13 thalassemia intermedia TI TI:10 theca interna TI TI:40 therapeutic index TI TI:9 thermodynamic integration TI TI:7 thoracic electrical impedance TI TI:10 thoracic irradiation TI TI:5 threshold intensity TI TI:8 thymic irradiation Ti Ti:1 time in inspiration Ti Ti:13|TI:1 titanium alloy TI TI:67 tonic immobility TI TI:8|Ti:1 transcallosal inhibition TI TI:8 treatment interruption TI TI:9 tricuspid incompetence TI TI:24 tricuspid insufficiency TI TI:11 true insulin TI TI:13 tuberoinfundibular TI TI:19|ti:1 tubulointerstitial TK- TK-:23|tk-:3 thymidine kinasedeficient TK- TK-:18|tk-:2|Tk-:1 thymidine kinasenegative TKs TKs:28|Tks:1 tachykinins TKs TKs:25 tyrosine kinases TLA TLA:5 thetalike activity TLA TLA:7 total lesion area TLA TLA:23 toxoplasma lysate antigen TLCO TLCO:36|Tlco:1 carbon monoxide transfer factor TLCO TLCO:5|TLco:2 diffusion capacity TLCO TLCO:8 lung transfer factor for co TLCO TLCO:27|Tlco:1|TLco:1|TlCO:1 transfer factor for carbon monoxide TLC TLC:19 taurolithocholate TLC TLC:14 thinlayer TLC TLC:744|tlc:2 thinlayer chromatography TLC TLC:20 total leukocyte count TLC TLC:595 total lung capacity TLDs TLDs:22|TLDS:1 thermoluminescence dosemeters TLDs TLDs:15 thermoluminescent detectors TLD TLD:30 thermoluminescence dosimetry TLD TLD:58 thermoluminescent dosimetry TLE TLE:774 temporal lobe epilepsy TLE TLE:10 transducinlike enhancer of split TLI TLI:41|T-LI:4 thymidine labeling index TLI TLI:21 thymidine labelling index TLI TLI:247 total lymphoid irradiation TLI TLI:21 trypsinlike immunoreactivity TLN TLN:9|tln:1 telencephalin TLN TLN:15 thermolysin TLS TLS:22 translesion dna synthesis TLS TLS:45 translesion synthesis TLS TLS:10 trnalike structure TLS TLS:58 tumor lysis syndrome TLV TLV:8 tidal liquid ventilation TLV TLV:10 total liquid ventilation TLV TLV:7 total liver volume TLV TLV:10 total lung volume TLV TLV:20 twolung ventilation TLM TLM:12 thiolactomycin TLM TLM:5 triplelayer model TLM TLM:16 twolayer method TL TL:14 tail length TL TL:12 temporal lobectomy TL TL:102 thermoluminescence TL TL:51 thermoluminescent TL TL:11|T-L:3 thoracolumbar TL TL:11 thymus leukemia antigen TL TL:7 thyroid lymphoma TL TL:9 tomato lectin TL TL:8 tonsillar lymphocytes TL TL:18 total laryngectomy TL TL:22 total length TL TL:9 tracheal ligation TL TL:10 transfer latency TL TL:11 tubal ligation TMA-DPH TMA-DPH:12 trimethylaminodiphenylhexatriene TMA-DPH TMA-DPH:8 trimethylammonium diphenylhexatriene TMAO TMAO:50|TMA-O:1 trimethylamine oxide TMAO TMAO:23 trimethylarsine oxide TMA TMA:12 trimethylangelicin TMA TMA:11 thermomechanical analysis TMA TMA:12 thyroid microsomal antibodies TMA TMA:143 trimellitic anhydride TMA TMA:113 trimethylamine TMB-8 TMB-8:18 trimethoxybenzoate hydrochloride TMB-8 TMB-8:14 trimethoxybenzoic acid diethylaminooctyl ester TMB-8 TMB-8:3 intracellular ca antagonist nndiethylaminooctyltrimethoxybenzoate TMC TMC:17 ntrimethyl chitosan chloride TMC TMC:8 tonsillar mononuclear cells TMC TMC:9 trapeziometacarpal TMC TMC:9 trimethylene carbonate t-MDS t-MDS:13|tMDS:3 therapyrelated myelodysplasia t-MDS t-MDS:21|tMDS:3 therapyrelated myelodysplastic syndrome TMD TMD:5 membrane disease TMD TMD:9|tMD:1 targeted molecular dynamics TMD TMD:39 temporomandibular dysfunction TMD TMD:10 tibial muscular dystrophy TMD TMD:14 total mood disturbance TMD TMD:30 transient myeloproliferative disorder TME TME:146 total mesorectal excision TME TME:35 transmissible mink encephalopathy TME TME:10 true metabolisable energy TME TME:25 true metabolizable energy TMH TMH:5 tata memorial hospital TMH TMH:17 transmembrane helix TMI TMI:18 three mile island TMI TMI:9 transient myocardial ischemia TMI TMI:8 transmandibular implant TMI TMI:8 transmural myocardial infarction TMPD TMPD:43 nnnntetramethylpphenylenediamine TMPD TMPD:13 tetramethylpphenylenediamine TMPase TMPase:11 thiamine monophosphatase TMPase TMPase:12|Tm-Pase:1 trimetaphosphatase TMP TMP:16 trimethylpentane TMP TMP:13 effects of tetramethylpyrazine TMP TMP:13 thiamine monophosphate TMP TMP:7 tocopherolmediated peroxidation TMP TMP:41 transmembrane potential TMP TMP:31 transmembrane pressure TMP TMP:16 trimetaphan TMP TMP:235|Tmp:16 trimethoprim TMP TMP:16 trimethylpsoralen TMR TMR:23 tetramethylrhodamine TMR TMR:10 topical magnetic resonance TMR TMR:36 transmyocardial revascularization TMR TMR:12 transverse microradiography TMS TMS:11 nnntrimethylsphingosine TMS TMS:9 transcranial magnetic TMS TMS:9 transcranial magnetic stimuli TMs TMs:7 transmembrane helices TMS TMS:142|-TMS:1 trimethylsilyl TMs TMs:13|Tms:3|tms:1 tropomyosins TMT TMT:9 tarsometatarsal TMT TMT:19 thiol methyltransferase TMT TMT:74 trail making test TMT TMT:209 trimethyltin TMT TMT:24 trimethyltin chloride TMV TMV:19 tobacco mosaic tobamovirus TMV TMV:537 tobacco mosaic virus TMV TMV:21 tracheal mucus velocity TMZ TMZ:112 temozolomide TMZ TMZ:83|Tmz:1 trimetazidine TNFR1 TNFR1:7|TNF-R1:3 tnf receptor type TNFR1 TNFR1:7|TNFR-1:3|TNF-R1:3 tumor necrosis factor receptor type TNFbp TNFbp:8|TNF-BP:4|TNF-bp:3 tnf binding protein TNFbp TNFbp:5|TNF-BP:3|TNF-bp:1 tumor necrosis factor binding protein TNF TNF:16 tnfalpha TNF TNF:19 tumor necrosis factorcachectin TNM TNM:2 nodes and metastases TNM TNM:62 tetranitromethane TNP-LPS TNP-LPS:26 trinitrophenyllipopolysaccharide TNP-LPS TNP-LPS:15 trinitrophenylated lipopolysaccharide TNP TNP:5|Tnp:1 hapten trinitrophenyl TNP TNP:25 trinitrophenol TNP TNP:123 trinitrophenyl TNP TNP:6 trinitrophenyl hapten TNP TNP:28 trinitrophenylated TNS TNS:2 fluorescent probe ptoluidinylnaphthalenesulfonate TNS TNS:7 transdermal nicotine system TNS TNS:23 transient neurologic symptoms TNS TNS:11 tumor necrosis serum TNZ TNZ:10 thermoneutral zone TNZ TNZ:8|Tnz:1 tinidazole TOC Toc:5|TOC:5 tocopherol TOC TOC:272 total organic carbon TOC TOC:7 total organic carbon content TOC TOC:8 turkey osteomyelitis complex TOC TOC:4 tylosis oesophageal cancer TOF TOF:34|ToF:2 time of flight TOF TOF:7 trainoffour stimulation TOH TOH:17|ToH:1 tower of hanoi TOH TOH:18 transient osteoporosis of the hip TOI TOI:15 tissue oxygenation index TOI TOI:11 trial outcome index TOM TOM:10 toxic oxygen metabolites TOM TOM:8 translocase of the outer membrane TOM TOM:7|Tom:2 translocase of the outer mitochondrial membrane TOPV TOPV:14 trivalent oral polio vaccine TOPV TOPV:11 trivalent oral poliovirus vaccine TOP TOP:81 termination of pregnancy TOP TOP:12 thimet oligopeptidase TOS TOS:154 thoracic outlet syndrome TOS TOS:76 toxic oil syndrome TO TO:36 thiazole orange TO TO:12 timeout TO TO:44 tracheal occlusion TO TO:18 tracheobronchopathia osteochondroplastica TO TO:30 triolein TO TO:18 tryptophan oxygenase TO TO:18 turbulence onset TP-5 TP-5:36|TP5:22 thymopentin TP-5 TP-5:15|TP5:6 thymopoietin pentapeptide TPA TPA:16 otetradecanoylacetate tPA tPA:8|t-PA:6|TPA:3 alteplase TPA TPA:7 phorbol diester TPA TPA:17 phorbol ester tetradecanoylphorbolacetate TPA TPA:15 terephthalic acid TPA TPA:126 tetradecanoyl phorbol acetate TPA TPA:84 tetradecanoylphorbol acetate TPA TPA:12 texture profile analysis TPA TPA:14 timeresolved phosphorescence anisotropy t-PA t-PA:3|tPA:1 tissue activator of plasminogen tPA tPA:15|t-PA:14|TPA:1 tissue type t-PA t-PA:4|tPA:2 tissuetype plasminogen t-PA t-PA:1222|tPA:482|TPA:60|tPa:3|T-PA:3|t-pA:2|t-pa:1|tpA:1 tissuetype plasminogen activator TPA TPA:10 tripropylamine TPA TPA:10 tumor promoter TPA TPA:13 twophoton absorption TPC TPC:8|TPc:1 nucleus tegmenti pedunculopontinus pars compacta TPC TPC:13 total peripheral conductance TPC TPC:6 total phenolic content TPC TPC:20 total plasma cholesterol TPC TPC:8 total plate count TPE TPE:17 position effect TPE TPE:69 therapeutic plasma exchange TPE TPE:13 total pelvic exenteration TPE TPE:51 tropical pulmonary eosinophilia TPE TPE:10 twophoton excitation TPG TPG:11|tpg:1 total product generated TPG TPG:13 transpulmonary gradient TPHA TPHA:19 treponema pallidum haemagglutination TPHA TPHA:36 treponema pallidum haemagglutination assay TPHA TPHA:7 treponema pallidum haemagglutination test TPHA TPHA:25 treponema pallidum hemagglutination TPHA TPHA:15 treponema pallidum hemagglutination assay TPI TPI:13 treatment priority index TPI TPI:16 triphosphoinositide TPI TPI:12 tumor profile index T-PLL T-PLL:16 tcell prolymphocytic leukaemia T-PLL T-PLL:38 tcell prolymphocytic leukemia T-PLL T-PLL:14 tprolymphocytic leukaemia T-PLL T-PLL:19 tprolymphocytic leukemia TPMT TPMT:11 thiopurine methyl transferase TPMT TPMT:172 thiopurine methyltransferase TPMT TPMT:73 thiopurine smethyltransferase TPM TPM:217 topiramate TPM TPM:34 total particulate matter TPN TPN:5 total parenteral TPN TPN:32 total parenteral nutrient TPN TPN:1964 total parenteral nutrition TPP TPP:7 sodium tripolyphosphate TPP TPP:11 tegmental pedunculopontine nucleus TPP TPP:14 tetraphenylphosphonium TPP TPP:41|Tpp:1 thiamin pyrophosphate TPP TPP:85 thiamine pyrophosphate TPP TPP:8 threephase partitioning TPP TPP:7 thrust plate prosthesis TPP TPP:41 thyrotoxic periodic paralysis TPP TPP:15 tolpa peat preparation TPP TPP:16 total plasma protein TPP TPP:9 transpulmonary pressure TPP TPP:11 triphenyl phosphate TPP TPP:18 triphenyl phosphite TPP TPP:9 triphenylphosphate TPP TPP:13 triphenylphosphine TPP TPP:6 tympanometric peak pressure TPQ TPQ:18 trihydroxyphenylalanine quinone TPQ TPQ:11 topaquinone TPQ TPQ:115 tridimensional personality questionnaire TPR TPR:13 tetratricopeptide TPR TPR:9 total peripheral TPS TPS:9 specific TPS TPS:6 theta pulse stimulation TPS TPS:15 thinplate spline TPS TPS:6 time to peak shortening TPS TPS:4|tPS:3 total protein s TPTX TPTX:169|T-PTX:3|TPTx:1 thyroparathyroidectomized TPTX TPTX:50|TPTx:1|T-PTX:1 thyroparathyroidectomy TPT TPT:7 tactual performance test TPT TPT:79|Tpt:2 topotecan TPT TPT:5 triose phosphatephosphate translocator TPT TPT:9 triphalangeal thumb TPT TPT:9 triphenyltin chloride TP TP:10|t-p:1 tail pinch TP TP:18 tea polyphenols TP TP:16 tender points TP TP:8 tensor palatini TP TP:60 terminal protein TP TP:629|Tp:8|tp:1 testosterone propionate TP TP:23 thinprep TP TP:9 thinprep pap test TP TP:17 thrombocytopenia TP TP:11 thrombocytopenic purpura TP TP:6 thromboxane aprostaglandin endoperoxide TP TP:11 thromboxane receptor TP TP:13|Tp:1 thymopoietin TP TP:15 tibialis posterior TP TP:20 tooth pulp TP TP:9 torsades de pointes TP TP:22|tP:2 total p TP TP:13 total pancreatectomy TP TP:105|T-P:6 total phosphorus TP TP:50 total power TP TP:7|Tp:1 transit peptide TP TP:10 transperitoneal TP TP:8 tryptophan pyrrolase TP TP:10 tube precipitin TP TP:11|Tp:1 turning point TP TP:7|Tp:4 tyrophagus putrescentiae TQ TQ:27 thymoquinone TQ TQ:6 tinnitus questionnaire TRAF6 TRAF6:6|Traf6:2 tnf receptorassociated factor TRAF6 TRAF6:19|TRAF-6:1 tumor necrosis factor receptorassociated factor TRAM TRAM:23 transverse rectus abdominis muscle TRAM TRAM:147 transverse rectus abdominis musculocutaneous TRAM TRAM:101 transverse rectus abdominis myocutaneous TRAMP TRAMP:24 transgenic adenocarcinoma of the mouse prostate TRAMP TRAMP:5 tyrosinerich acidic matrix protein TRANCE TRANCE:9 tnfrelated activationinduced cytokine TRANCE TRANCE:5|trance:1 tumor necrosis factorrelated activationinduced cytokine TRAP TRAP:8 tartrateresistant acid phosphatase activity TRAP TRAP:248|Trap:1 telomeric repeat amplification protocol TRAP TRAP:29 thrombin receptor agonist peptide TRAP TRAP:16 thrombospondinrelated adhesive protein TRAP TRAP:32 thrombospondinrelated anonymous protein TRAP TRAP:18 total radicaltrapping antioxidant parameter TRAP TRAP:27 total radicaltrapping antioxidant potential TRAP TRAP:16 total reactive antioxidant potential TRAP TRAP:39 trp rnabinding attenuation protein TRAP TRAP:28 twin reversed arterial perfusion TRA TRA:6 repeat array TRA TRA:32 theory of reasoned action TRA TRA:5 timereversing array TRA TRA:8 traumatic rupture of the aorta TRA TRA:8 traumatic rupture of the thoracic aorta TRC TRC:8 total renin concentration TRC TRC:11 total ridge count TRD TRD:9 traction retinal detachment TRD TRD:11 tractional retinal detachment TRD TRD:12 transcriptional repression domain TRD TRD:25|trd:1 transmission ratio distortion TRD TRD:11|TrD:2 trinidad donkey TRF TRF:21 restriction fragments TRF TRF:21 terminal renal failure TRF TRF:55|T-RF:7 terminal restriction fragment TRF TRF:30 thyrotropinreleasing factor TRF TRF:11 timeresolved fluorescence TRF TRF:12 tocotrienolrich fraction TRG TRG:8 receptor gamma TRG TRG:9 regression grade TRG TRG:9 trigeminal root ganglion TRH TRH:14 protirelin trh trh:6|TRH:1 thermostable direct hemolysinrelated hemolysin TRH TRH:116 thyroliberin TRH TRH:158 thyrotrophin releasing hormone trh trh:8|Trh:1 trachealess TRM TRM:147 transplantrelated mortality TRM TRM:57 treatmentrelated mortality TRNOE TRNOE:20|trNOE:6|TR-NOE:1|TrNOE:1 transferred nuclear overhauser effect TRNOE TRNOE:8|trNOE:1 transferred nuclear overhauser enhancement TRPV1 TRPV1:7 transient receptor potential vanilloid receptor TRPV1 TRPV1:8|TRPV-1:1 transient receptor potential vanilloid type TRs TRs:7 tandem repeats TRs TRs:13|trs:1 terminal repeats TRs TRs:148 thyroid hormone receptors TRS TRS:5 timeresolved spectroscopy TRS TRS:12 transrectal sonography TRS TRS:9 treatmentresistant schizophrenia TRS TRS:24 tubuloreticular structures TRT TRT:21 thoracic radiation therapy TRT TRT:27 thoracic radiotherapy TRT TRT:18 tinnitus retraining therapy TRT TRT:17 turkey rhinotracheitis TRUS TRUS:294 transrectal ultrasound TRUS TRUS:9 transrectal us TR TR:14 repetition TR TR:18 taste reactivity tr tr:8|TR:1 temperatureresistant TR TR:10 texas red TR TR:6 thiazin red TR TR:18 tiazofurin TR TR:9 timeresolved tr tr:6|TR:3 trachea TR TR:21|tr:7 trained TR TR:7 transitional region TR TR:10 trapezius TR TR:15 treadmill running tr tr:10|Tr:6 trembler TR TR:213 tricuspid regurgitation TR TR:6 trp repressor TR TR:42 trypanothione reductase TR TR:5|tr:4 trypsin TR TR:5|tr:1 turnover rates TSAb TSAb:5 stimulating autoantibodies TSAb TSAb:4|TSAB:2 thyroid stimulating TSA TSA:6 thyroidstimulating activity TSA TSA:12 total shoulder arthroplasty TSA TSA:70 total sialic acid TSA TSA:38 tryptic soy agar TSA TSA:6|Tsa:1 typespecific antigen TSA TSA:42 tyramide signal amplification TSBAb TSBAb:11|TSBab:1|TSBAB:1 blocking antibodies TSBAb TSBAb:20|TSBAB:1 thyroid stimulation blocking antibody TSB TSB:33 total serum bilirubin TSB TSB:70 tryptic soy broth TSB TSB:54 trypticase soy broth TSC TSC:8 sulfur colloid TSC TSC:14 thiosemicarbazide TSC TSC:8 thymic stromal cells TSC TSC:13 total serum cholesterol TSC TSC:234 tuberous sclerosis complex TSD TSD:76 taysachs disease TSD TSD:33 temperaturedependent sex determination TSD TSD:96 total sleep deprivation TSF TSF:13 triceps skin fold TSF TSF:36 triceps skinfold TSF TSF:6 twelvestep facilitation TSH TSH:12 antithyrotropin tsh tsh:7 gene teashirt TSH TSH:38 serum thyrotrophin tsh tsh:5|Tsh:4 temperaturesensitive hemagglutinin TSH TSH:11 thyrotropic TSH TSH:2181 thyrotropin TSH TSH:10 thyrotropine TSI TSI:6 thromboxane synthetase inhibitor TSI TSI:9 tobramycin solution for inhalation TSI TSI:13 transferrin saturation index TSMCs TSMCs:13 canine cultured tracheal smooth muscle cells TSMCs TSMCs:8 cultured canine tracheal smooth muscle cells TSM TSM:10 microscope TSM TSM:10 thickness shear mode TSM TSM:125 tracheal smooth muscle TSP/HAM TSP/HAM:8 tropical spastic paraparesishtlv associated myelopathy TSP/HAM TSP/HAM:26 tropical spastic paraparesishtlviassociated myelopathy TSP TSP:11 temperaturesensitive period TSP TSP:18 thermospray TSP TSP:21|tsp:1 total serum protein TSP TSP:33 total suspended particles TSP TSP:16 total suspended particulate matter TSP TSP:12 traveling salesman problem TSP TSP:29 trisodium phosphate TSR TSR:7 thrombospondin type repeat TSR TSR:16 total systemic resistance TSS TSS:73 total suspended solids TSS TSS:26 total symptom score TSS TSS:262 toxic shock syndrome TSS TSS:26 transsphenoidal surgery TST TST:19 tail skin temperature TST TST:107 total sleep time TST TST:5 transition state theory TST TST:16 triple stimulation technique TST TST:23 tuberculin skin testing TSWV TSWV:16 tomato spotted wilt tospovirus TSWV TSWV:82 tomato spotted wilt virus TT4 TT4:15|tT4:2 total thyroxin TT4 TT4:93|tT4:9|t-T4:1 total thyroxine TTA TTA:42 tetradecylthioacetic acid TTA TTA:7 transtibial amputation TTA TTA:36 transtracheal aspiration TTD TTD:7 thought translation device TTD TTD:6 time to detection TTD TTD:92 trichothiodystrophy TTE TTE:18 transthoracic echocardiographic TTE TTE:260 transthoracic echocardiography TTF TTF:32 tetrathiafulvalene TTF TTF:98 time to treatment failure TTKG TTKG:11 transtubular potassium concentration gradient TTKG TTKG:8 transtubular potassium gradient TTM TTM:8 tensor tympani muscle TTM TTM:12 total tumor mass TTM TTM:63 transtheoretical model TTM TTM:16 trichotillomania TTN TTN:10 transient tachypnea of the newborn TTN TTN:7 transient tachypnoea of the newborn TTN TTN:10 triakontatetraneuropeptide TTO TTO:21 tea tree oil TTO TTO:9 time to occlusion TTO TTO:8 time trade off TTO TTO:18 time tradeoff TTP TTP:10 protein tristetraprolin TTP TTP:9 thiamin triphosphate TTP TTP:766 thrombotic thrombocytopenic purpura TTP TTP:30 time to pregnancy TTP TTP:219|TtP:1 time to progression TTP TTP:53 time to tumor progression TTP TTP:8 tolpa torf preparation TTS TTS:18 tarsal tunnel syndrome TTS TTS:8 twintotwin transfusion syndrome TTS TTS:36 type iii secretion TTT TTT:5 tear thinning time TTT TTT:7 thymol turbidity test TTT TTT:111 transpupillary thermotherapy TT TT:4|Tt:1 breath duration TT TT:10|tt:1 genotype TT TT:7 talar tilt TT TT:6 test treatment TT TT:10 testicular torsion TT TT:12 tetrathionate TT TT:41 therapeutic touch TT TT:17 thiotepa TT TT:8 thrombin times TT TT:38 thrombolytic therapy TT TT:22 thrombotest TT TT:5|Tt:2 tissue thickness TT TT:67|tT:3|T-T:1 total testosterone TT TT:29 total thyroidectomy TT TT:28 tracheal tube TT TT:9 tube thoracostomy TT TT:64 tuberculoid TT TT:16 tuberculoid leprosy TUG TUG:14 timed up and go TUG TUG:5 timed up and go test TUG TUG:7 timed upgo TUG TUG:5 timed upgo test TUNEL TUNEL:14|Tunel:1 dutp nickendlabeling TUNEL TUNEL:5 nick end labeling assay TUNEL TUNEL:63 nick endlabelling TUNEL TUNEL:14 tdtmediated dutpbiotin nick endlabeling TUNEL TUNEL:15 terminal deoxynucleotidyl transferasemediated dutp nickend labelling TURBT TURBT:3|TUR-Bt:2 transurethral bladder tumor resection TURBT TURBT:20|TUR-Bt:16|TUR-BT:9|TURBt:2|TUR-bt:1 transurethral resection of bladder tumor TURBT TURBT:1 transurethral resection of the bladder tumour TURP TURP:17 transurethral prostate resection TURP TURP:85|TUR-P:10 transurethral prostatectomy TURP TURP:19|TUR-P:2 transurethral prostatic resection TURP TURP:616|TUR-P:58 transurethral resection of the prostate TU TU:7 tuberculin units TU TU:56 testosterone undecanoate TU TU:17 thiouracil TU TU:30|tu:1|Tu:1 thiourea TU TU:7 toxic unit TVP TVP:18 tensor veli palatini TVP TVP:7 textured vegetable protein TVP TVP:14 truncal vagotomy and pyloroplasty TVR TVR:77 target vessel revascularization TVR TVR:39 tonic vibration reflex TVR TVR:45 tricuspid valve replacement TVS TVS:9 transplant vascular sclerosis TVS TVS:146 transvaginal sonography TVS TVS:11 tubulovesicular structures TVT TVT:212 tensionfree vaginal tape TVT TVT:10 tensionfree vaginal tape procedure TVT TVT:10 trivittatus TW TW:7 tap water TW TW:15 total work TW TW:14 tripterygium wilfordii TW TW:6 tympanometric width Tw Tw:3 water at temperatures Tw Tw:13|TW:1 water temperature Tx Tx:8|TX:2 after kidney transplantation Tx Tx:25|TX:4|tx:1 after renal transplantation Tx Tx:28|tx:5|TX:1 after transplantation Tx Tx:6|TX:2|tx:1 kidney transplants Tx Tx:9|TX:1 rats were thyroidectomized Tx Tx:18|TX:6 thymectomized Tx Tx:38|TX:25 thyroidectomy Tx Tx:7|TX:3 transplant recipients Tx Tx:5|TX:5 transplanted TACE TACE:37 tnfalpha converting enzyme TACE TACE:6 transarterial chemoembolisation TACE TACE:36 tumor necrosis factoralpha converting enzyme TBS TBS:20 bethesda system TBS TBS:18 tensile bond strength TBS TBS:11 total body scan TBS TBS:18 townesbrocks syndrome TBS TBS:9 trisbuffered saline Tb Tb:14 terbium TB TB:9 testosterone buciclate TB TB:26|Tb:3 theobromine TB TB:12 thiobenzamide TB TB:15|Tb:2 thoroughbred TB TB:9 tissue basophils TB TB:37 toluidine blue TB TB:47 total body TB TB:21|T-B:2 tracheobronchial TB TB:13 trapezoid body TB TB:9 tributyrin TB TB:42 triceps brachii TB TB:10 trisborate TB TB:45|Tb:1 trypan blue Tb Tb:9 trypanosoma brucei TB TB:35|Tb:1 tuberculous TB TB:75 tumorbearing TDR TDR:17 special program for research and training in tropical diseases TDR TDR:11 time domain reflectometry TDR TDR:37 transmural dispersion of repolarization TDT TDT:7 transmission disequilibrium TDT TDT:13 transmission disequilibrium testing TDT TDT:5 transmission test for linkage disequilibrium TDT TDT:12|Tdt:1 tumor doubling time TEQ TEQ:12 toxic equivalence TEQ TEQ:19 toxic equivalency TEQ TEQ:8 toxic equivalent quantity tetr TetR:13|tetr:13|tetR:3 tet repressor tetr tetr:25|Tetr:1 tetracycline repressor Tfm Tfm:34|tfm:5|TFM:4 testicular feminization Tfm Tfm:11|tfm:3 testicular feminization mutation Tfm Tfm:28|tfm:3 testicular feminized Tfm Tfm:3|TFM:2|tfm:2 testicular feminized male TGB TGB:86 tiagabine TGB TGB:24 triple gene block Th1 Th1:13 ifngamma Th1 Th1:5|Th-1:3|TH1:2 proinflammatory Th1 Th1:5|TH1:1 type t helper cell Th2 Th2:5 thelper cell Th2 Th2:44|TH2:3 t helper cell type Th2 Th2:6 type cells Th2 Th2:4|TH2:2 type helper t cells THAM THAM:1 tris hydroxymethyl aminomethane THAM THAM:17 tromethamine Thy Thy:11|T-hy:1 hypothalamic Thy Thy:28 hypothalamic temperature Tmax Tmax:9 maximum temperature Tmax Tmax:5|tmax:3 peak plasma concentrations Tmax Tmax:2|tmax:1 time at which cmax was reached Tmax Tmax:7|tmax:7 time to peak plasma concentration TNAP TNAP:9|TN-AP:1 tissue nonspecific alkaline phosphatase TNAP TNAP:8|tnAP:1|TN-AP:1 tissuenonspecific alkaline phosphatase TNA TNA:19 total nutrient admixture TNA TNA:10 transthoracic needle aspiration TN TN:109|Tn:23 tenascin TN TN:30|tn:1 terminal nerve TN TN:26 tetranectin TN TN:13 thermoneutral TN TN:8 thyroid nodules TN TN:11 tibial nerve TN TN:77|T-N:13|tN:1 total nitrogen TN TN:20 toxin neutralization TN TN:11 triple negative TN TN:18 true negative TN TN:8 tumor necrosis TOR TOR:67|Tor:5|ToR:1 target of rapamycin TOR TOR:27|Tor:8 toremifene TPD TPD:9 temperatureprogrammed desorption TPD TPD:22 tidal peritoneal dialysis TRIM TRIM:15 trifluoromethylphenyl imidazole TRIM TRIM:16 tripartite motif Tris-BP Tris-BP:8 flame retardant trisdibromopropylphosphate Tris-BP Tris-BP:5|tris-bp:1 trisdibromopropyl phosphate TrkA TrkA:11|trkA:10 ngf receptor TrkA TrkA:3|trkA:2 tyrosine kinase receptor TSE TSE:31 testicular selfexamination TSE TSE:13 transition state ensemble TSE TSE:5 trophoblastspecific element TSV TSV:30 taura syndrome virus TSV TSV:5|TsV:3 tityus serrulatus venom TSV TSV:17 tobacco streak virus TTR TTR:11 thermotolerance ratio TTR TTR:584|ttr:3 transthyretin Tty Tty:17 tympanic Tty Tty:33|TTY:1 tympanic temperature TuMV TuMV:10 turnip mosaic potyvirus TuMV TuMV:34 turnip mosaic virus TV TV:6 tacaribe virus TV TV:65 television TV TV:13 transvaginal TV TV:30|Tv:5 trichomonas vaginalis TV TV:47 tricuspid valve TV TV:25 truncal vagotomy Tyr Tyr:10|tyr:2 ltyrosine tyr tyr:32|Tyr:19 tyrosinase tyr tyr:9|Tyr:1 tyrosinase gene Tyr Tyr:13|tyr:1 tyrosinated U46619 U46619:7 thromboxane a analog U46619 U46619:7|U-46619:6 thromboxane analogue U46619 U46619:5|U-46619:2 thromboxane mimetic UAC UAC:17 umbilical artery catheter UAC UAC:13 urinary albumin concentration UAE UAE:127 united arab emirates UAE UAE:323|U-AE:1 urinary albumin excretion UAE UAE:8 urinary excretion of albumin UAE UAE:94 uterine artery embolization UASB UASB:29 upflow anaerobic sludge bed UASB UASB:128 upflow anaerobic sludge blanket UAS UAS:10 ultrasonically activated scalpel UAS UAS:21 upstream activation site UAS UAS:33 upstream activator sequence UA UA:20 umbilical arterial UA UA:15|uA:2 undifferentiated arthritis UA UA:15 uranyl acetate UA UA:244|Ua:2 uric acid UA UA:15 urinalysis UA UA:11 urinary amylase UA UA:9|Ua:1 uterine arteries UBC UBC:8|Ubc:6 ubiquitinconjugating enzyme UBC UBC:8 unipolar brush cell UBC UBC:13 university of british columbia UBC UBC:9 urinary bladder cancer UBM UBM:18 ultrasound biomicroscope UBM UBM:164 ultrasound biomicroscopy UCA UCA:18 contrast agent UCA UCA:17 transurocanic acid UCA UCA:10 ultrasound contrast agents UCA UCA:50 urocanic acid UCM UCM:12 uncontrolled manifold UCM UCM:16 unresolved complex mixture UCVA UCVA:11 uncorrected UCVA UCVA:238 uncorrected visual acuity UC UC:12|uc:1 ultracentrifugation UC UC:34 umbilical cord UC UC:12 undifferentiated carcinoma UC UC:42 unesterified cholesterol UC UC:15 university of california UC UC:13 urothelial carcinoma UC UC:88 usual care UC UC:12 uterine contractions UDPGT UDPGT:8|UDP-GT:3 microsomal udpglucuronyltransferase UDPGT UDPGT:3|UDP-GT:2|UDPG-T:1 uridine diphosphate glucuronyltransferase UDPG UDPG:9 uridine diphosphate glucose UDPG UDPG:15|UDPg:1 uridine diphosphoglucose UD UD:15 ulcer disease UD UD:7|ud:3 ultradistal UEDVT UEDVT:10 deep vein thrombosis UEDVT UEDVT:11 upper extremity deep venous thrombosis UES UES:5 undifferentiated embryonal sarcoma UES UES:148 upper esophageal sphincter UFC UFC:103|U-FC:1 urinary free cortisol UFC UFC:8 urinary free cortisol excretion UFT UFT:1 tegafur with uracil UFT UFT:23 uracil and tegafur UF UF:27|uf:2|Uf:2 ultrafiltrate UF UF:324|uf:3 ultrafiltration UF UF:34 unfractionated UF UF:15 urinary flow uGH uGH:10|U-GH:2|u-GH:2 urinary gh uGH uGH:9|U-GH:6|UGH:5|u-GH:3 urinary growth hormone UGT UGT:10 udpglucuronosyl transferase UGT UGT:4 uridine diphosphate glucuronosyl transferase UGT1A1 UGT1A1:6 bilirubin udpglucuronosyltransferase UGT1A1 UGT1A1:5 bilirubin udpglucuronosyltransferase gene UGT1A1 UGT1A1:7 phenol udpglucuronosyltransferase UGT1A1 UGT1A1:6|UGT-1A1:2 udpglucuronosyltransferase UGTs UGTs:125|UGTS:1 udpglucuronosyltransferases UGTs UGTs:6 uridine diphosphate glucuronosyltransferases UG UG:17 unleaded gasoline UG UG:45|Ug:1 uteroglobin UHC UHC:11 university healthsystem consortium UHC UHC:10 university hospital consortium UH UH:9 unfavorable histology UH UH:14 university hospital UIC UIC:9 university of illinois at chicago UIC UIC:11 urinary iodine concentration UIP UIP:14 undegradable intake protein UIP UIP:141 usual interstitial pneumonia UI UI:22 ulcer index UI UI:11 unexplained infertility UI UI:16 unsaturation index UI UI:275 urinary incontinence UI UI:21 urinary iodine UI UI:28 urotensin i UKM UKM:9 universiti kebangsaan malaysia UKM UKM:13|UkM:1 urea kinetic model UKM UKM:30 urea kinetic modeling UKM UKM:12 urea kinetic modelling ULO ULO:30 unilateral ovariectomy ULO ULO:15 unilaterally ovariectomized ULV ULV:11 ultralow volume ULV ULV:31 upper limit of vulnerability UM UM:22 utilization management UM UM:10 uveal melanoma UNDP UNDP:7 un development program UNDP UNDP:6 united nations development program UNE UNE:19|UN-E:1 ulnar neuropathy at the elbow UNE UNE:5|UNe:2|U-NE:1 urinary norepinephrine UNFPA UNFPA:9 un fund for population activities UNFPA UNFPA:49 un population fund UNFPA UNFPA:16 united nations fund for population activities UNFPA UNFPA:56 united nations population fund uNK uNK:26|unk:1|u-NK:1 uterine natural killer uNK uNK:10 uterine nk UNaV UNaV:10 sodium excretion rate UNaV UNaV:38 urinary excretion of sodium UN UN:12 undernourished UN UN:40 united nations UN UN:32 uranyl nitrate UN UN:47 urea nitrogen uPA uPA:12|u-PA:5 urokinase pa uPA uPA:386|u-PA:72|UPA:9 urokinase plasminogen activator uPA uPA:951|u-PA:420|UPA:25|U-PA:2|uPa:2|u-Pa:1 urokinasetype plasminogen activator UPP UPP:17 ubiquitinproteasome pathway UPP UPP:18 urethral pressure profilometry UP UP:27|up:1 unipolar UP UP:21 universal precautions UP UP:10|Up:1 upstream UP UP:7 ureteral pressure UP UP:24 urticaria pigmentosa UP UP:14 uttar pradesh URE URE:15 upstream regulatory element URE URE:9 urethane URR URR:69 upstream regulatory region URR URR:75 urea reduction ratio URS URS:8 upstream repression sequence URS URS:19 ureterorenoscopy URS URS:26 ureteroscopy UR UR:9|Ur:1 uridine UR UR:10 urinary retention UR UR:36 utilization review USAID USAID:21 united states agency for international development USAID USAID:69 us agency for international development USC USC:12 university of southern california USC USC:13 uterine serous carcinoma USE USE:18 ultrasonic examination USE USE:14 upstream sequence element USH1 USH1:8|USH-1:1 usher syndrome type USH1 USH1:11 usher syndrome type i USI USI:7 ultrasonic investigation USI USI:9 ultrasound investigation USI USI:10 universal salt iodization USI USI:30 urinary stress incontinence USI USI:12 urodynamic stress incontinence uSpA uSpA:12|USpA:2 undifferentiated spa uSpA uSpA:12|USpA:4|uSpa:1|USpa:1 undifferentiated spondyloarthropathy USPIO USPIO:53 ultrasmall superparamagnetic iron oxide USPIO USPIO:8 ultrasmall superparamagnetic iron oxide particles USP USP:7 ultraspiracle protein USP USP:61 united states pharmacopeia USP USP:21 united states pharmacopoeia US US:8|Us:5 short unique US US:34 sonographic US US:102 sonography US US:38 ultrasonic US US:20 ultrasonographically US US:13 ultrasound examination US US:8 ultrasound imaging UTC UTC:14 ultrasonic tissue characterization UTC UTC:10 undifferentiated thyroid carcinoma UTR UTR:301|utr:2 untranslated region UTR UTR:14 and untranslated regions UTS UTS:51 ullrichturner syndrome UTS UTS:46 ultimate tensile strength UT UT:92 untrained UT UT:19 untrained subjects UT UT:26 untreated UT UT:12 utricular UUI UUI:12 urge urinary incontinence UUI UUI:5 urinary urge incontinence UVA UVA:19|UV-A:2 longwave ultraviolet UVA UVA:42|UV-A:22 ultravioleta UV UV:6 ultraviolet absorption UV UV:71|Uv:2|uv:2 umbilical vein UV UV:6 urinary flow rate UV UV:24|Uv:1|uV:1 urinary volume UV UV:73|Uv:1 urine volume UW UW:17 university of washington UW UW:460 university of wisconsin UB UB:5 ultimobranchial body UB UB:5 upper body UB UB:27 ureteric bud UB UB:24 urinary bladder UKA UKA:23 unicompartmental knee arthroplasty UKA UKA:8 urinary kallikrein activity UL UL:9 tolerable upper intake level UL UL:61 unilateral labyrinthectomy UL UL:25 unique long UL UL:8 upper limb V1 V1:22 central compartment V1 V1:26 primary visual area V1 V1:271|V-1:1 primary visual cortex V1 V1:72 striate cortex V1 V1:18 vascular V1 V1:16|V-1:1 vasopressor V2R V2R:14|V2-R:1 v vasopressin receptor V2R V2R:15 vasopressin v receptor V2 V2:25 antidiuretic V2 V2:24 second visual area V2 V2:7 visual area V2 V2:3 volume of the peripheral compartment V3 V3:1 mandibular division of the trigeminal nerve V3 V3:47 third variable V3 V3:26|v3:1 third variable domain V3 V3:31 third variable region V3 V3:10 variable region V79 V79:23|V-79:5 chinese hamster cells V79 V79:9|V-79:2 chinese hamster fibroblasts VADs VADs:21 venous access devices VADs VADs:96|VADS:1 ventricular assist devices VAD VAD:9 vascular atherosclerotic disease VAD VAD:14 vertebral artery dissection VAD VAD:19 vibroacoustic disease VAD VAD:11 vincristineadriamycindexamethasone VAD VAD:63 vitamin a deficiency VAPS VAPS:9 visual analog pain scale VAPS VAPS:7 visual analog pain score VAS VAS:7 vagal afferent stimulation VAs VAs:13|VAS:1 ventricular arrhythmias VAS VAS:15 ventricular assist system VAs VAs:18 vertebral arteries VAS VAS:10 vibroacoustic stimulation VAS VAS:24 visual analog score VAS VAS:15 visual analogue VAS VAS:5 visual analogue scale of pain VAs VAs:8 volatile anesthetics VATS VATS:279|Vats:1 videoassisted thoracic surgery VATS VATS:15 videoassisted thoracic surgical VATS VATS:261 videoassisted thoracoscopic surgery VATS VATS:8 videoassisted thoracoscopic surgical VATS VATS:19 videoassisted thoracoscopy VAT VAT:20 variable antigen type VAT VAT:5 variant antigenic type VAT VAT:10 vascular access thrombosis VAT VAT:35 ventilatory anaerobic threshold VAT VAT:10 ventricular activation time VAT VAT:14 vestibular autorotation test VAT VAT:90 visceral adipose tissue VA VA:8 adenovirus virusassociated VA VA:65|Va:4 alveolar ventilation VA VA:5|Va:4 apical membrane voltage VA VA:5 patients with vasospastic angina VA VA:6|V-A:4 retrograde VA VA:9 vaccenic acid VA VA:9 vacuum aspiration VA VA:13 variant angina VA VA:32 vascular access VA VA:21 ventral anterior VA VA:11 ventral anterior nucleus VA VA:10 ventralis anterior VA VA:6 ventricular aneurysm VA VA:10|V-A:1 ventriculoarterial VA VA:27 veratryl alcohol VA VA:23 verbal autopsy VA VA:23|Va:1 vessel area VA VA:24 vestibular aqueduct VA VA:166 veterans administration VA VA:15 villous atrophy VA VA:18 vinyl acetate VA VA:9 viscum album VA VA:552|Va:1 visual acuity VA VA:11 voluntary activation VBAC VBAC:13 vaginal birth after caesarean VBAC VBAC:43 vaginal birth after cesarean VBAC VBAC:12 vaginal birth after cesarean delivery VBAC VBAC:23 vaginal birth after cesarean section VBI VBI:10 ventral blood island VBI VBI:40 vertebrobasilar insufficiency VBM VBM:3|V-B-M:1 bleomycin and methotrexate VBM VBM:8 vascular basement membrane VBM VBM:8 visual backward masking VBM VBM:72 voxelbased morphometry VBS VBS:7 vertebrobasilar system VBS VBS:9 visible burrow system VCA VCA:7 vero cell assay VCA VCA:6 viral capsid VCC VCC:8 vibrio cholerae cytolysin VCC VCC:8 vienna challenge chamber VCD VCD:13 vinylcyclohexene diepoxide VCD VCD:7 vacuum constriction device VCD VCD:18 vibrational cd VCD VCD:93 vibrational circular dichroism VCD VCD:10 vitreous chamber depth VCD VCD:27 vocal cord dysfunction VCI VCI:28 vascular cognitive impairment VCI VCI:8|vci:1 vena cava inferior VCM VCM:17 vancomycin hydrochloride VCM VCM:63 vinyl chloride monomer VCN VCN:105 ventral cochlear nucleus VCN VCN:33 vibrio cholerae neuraminidase VCP VCP:31 vaccinia virus complement control protein VCP VCP:26 valosincontaining protein VCP VCP:11 ventriculocisternal perfusion VCP VCP:14 vocal cord paralysis VCR VCR:15 vestibulocollic reflex VCR VCR:4 video cassette recorder VCR VCR:24 vincristine sulfate VCS VCS:5 closure system VCS VCS:8 vaginalcervical stimulation VCS VCS:14 vaginocervical stimulation VCS VCS:11 vascular closure staple VCS VCS:13 visual contrast sensitivity VCT VCT:17 voluntary counseling and testing VCT VCT:30 voluntary counselling and testing VCV VCV:12 volumecontrolled ventilation VCV VCV:17|V-C-V:2|v-c-v:1 vowelconsonantvowel Vc Vc:23 trigeminal subnucleus caudalis VC VC:11 vapnikchervonenkis VC VC:9 variance components VC VC:13 variation coefficient VC VC:6 vascular calcification VC VC:6 vehicle control VC VC:12 veiled cells VC VC:17|Vc:1 vena cava VC VC:9 venous capacitance VC VC:32 verrucous carcinoma Vc Vc:7|VC:3 vibrio cholerae VC VC:21 vinyl carbamate VC VC:17 virtual colonoscopy VC VC:93 visual cortex VC VC:65|Vc:6|V-C:1 vitamin c VC VC:16|vc:2 vitelline coat Vc Vc:7|VC:2 voltage VD/VT VD/VT:16|Vd/Vt:2 dead space to tidal volume VD/VT VD/VT:19|Vd/Vt:4|VD/Vt:1 dead space to tidal volume ratio VD/VT VD/VT:4|Vd/Vt:1 ventilation fraction VDRL VDRL:116 venereal disease research laboratory VDRL VDRL:8 venereal disease research laboratory test VDR VDR:6 dihydroxyvitamin d receptors VDR VDR:23 vitamin d receptor gene VDS VDS:6 ventral derotation spondylodesis VDS VDS:8 verbal descriptor scale VDS VDS:117 vindesine VDS VDS:9 vindesine sulfate VDT VDT:28 display terminals VDT VDT:62 video display terminal VDT VDT:49 visual display terminal VDT VDT:12 volume doubling time VDU VDU:12 display units VDU VDU:34 visual display unit VE/VCO2 VE/VCO2:7|VE/VCo2:1|VE/Vco2:1 carbon dioxide production VE/VCO2 VE/VCO2:7 ventilatory equivalent for carbon dioxide VE/VO2 VE/VO2:8 ventilatory equivalent VE/VO2 VE/VO2:11 ventilatory equivalent for o VE/VO2 VE/VO2:16|Ve/VO2:1 ventilatory equivalent for oxygen VEE VEE:143 venezuelan equine encephalitis VEE VEE:91 venezuelan equine encephalomyelitis VEGFR VEGFR:24|VEGF-R:5|VEGF-r:1 vascular endothelial growth factor receptor VEGFR VEGFR:12 vegf receptors VES VES:31|VEs:4 ventricular extrasystoles VES VES:7 visual erotic stimulation VES VES:36 vitamin e succinate VET VET:10 ventricular ejection time VET VET:12 vietnam era twin VE VE:19 vaccine effectiveness VE VE:29 vaccine efficacy VE VE:10 variable error VE VE:15 vascular endothelial VE VE:27 venezuelan encephalitis VE VE:22|Ve:1 ventilatory VE VE:30|vE:1 virtual endoscopy VE VE:39 virtual environment VE VE:21 visceral endoderm VE VE:10 vital exhaustion VE VE:152|vE:1|V-E:1 vitamin e VE VE:38 vitelline envelope VE VE:94 volume expansion VFI VFI:21 venous filling index VFI VFI:17 voluntary food intake VFP VFP:18 ventricular fluid pressure VFP VFP:19 vibrating flow pump VFP VFP:9 vocal fold paralysis VFs VFs:10 virulence factors VFs VFs:11 visual fields VFT VFT:153 ventricular fibrillation threshold VFT VFT:8 verbal fluency test VF VF:6|Vf:1 fresh gas flow VF VF:5|Vf:2 ventilatory frequency VF VF:9 ventral funiculus VF VF:6 ventricular function VF VF:12 verbal fluency VF VF:7 vesicular fluid VF VF:5 virulence factor VF VF:21 visceral fat VF VF:80 visual field VF VF:7 vitreous fluid VHD VHD:41 valvular heart disease VHD VHD:15 viral haemorrhagic disease VHF VHF:8 high frequency VHF VHF:13 viral hemorrhagic fever VHF VHF:18 visual halffield VHL VHL:6|Vhl:1 von hippellindau gene VHL VHL:18|vHL:3 von hippellindau syndrome VHL VHL:11|vhl:1 von hippellindau tumor suppressor gene VHS VHS:13 veterans health study VHS VHS:30 viral haemorrhagic septicaemia VHS VHS:17 viral hemorrhagic septicemia vhs vhs:42|Vhs:7|VHS:1 virion host shutoff vhs vhs:8|Vhs:1 virion host shutoff protein VH VH:9 heavy chain variable domain VH VH:27 vaginal hysterectomy VH VH:5 variable genes VH VH:29 variable heavy chain VH VH:5 variable region heavy chain VH VH:20 vehicle VH VH:9 ventral hippocampal VH VH:11 ventral horn VH VH:42 viral hepatitis VH VH:13 visual hallucinations VH VH:6 vitreous hemorrhage VH VH:12 vitreous humor VIA VIA:10 video image analysis VIA VIA:7 virus infection associated VIA VIA:2 visual inspection using acetic acid Vim Vim:9|VIM:3 ventral intermediate Vim Vim:10|VIM:8 ventral intermediate nucleus Vim Vim:6|VIM:1 ventral intermediate nucleus of the thalamus Vim Vim:21|VIM:10 ventralis intermedius VIN VIN:24 vulval intraepithelial neoplasia VIN VIN:106 vulvar intraepithelial neoplasia VIP VIP:3161 vasoactive intestinal peptide VIP VIP:2409|vip:1 vasoactive intestinal polypeptide VIP VIP:26 ventral intraparietal area VIP VIP:12 visual immunoprecipitate assay VIP VIP:9 visual impairment project VIQ VIQ:11 verbal intelligence quotient VIQ VIQ:44 verbal iq VKH VKH:22 vogtkoyanagiharada disease VKH VKH:10|V-K-H:1 vogtkoyanagiharada syndrome VLA VLA:12 late activation VLA VLA:5 late activation antigens VLDL VLDL:9 lipoprotein cholesterol VLDL VLDL:25 verylowdensity VLED VLED:9 low energy diet VLED VLED:18 verylowenergy diet VLF VLF:37 low frequency VLF VLF:29 ventrolateral funiculus VLF VLF:9 verylowfrequency VLM VLM:8 ventrolateral medulla oblongata VLM VLM:29 visceral larva migrans vlPAG vlPAG:8|VLPAG:1 ventrolateral pag vlPAG vlPAG:29|VLPAG:2 ventrolateral periaqueductal gray VLPO VLPO:13|vLPO:1 ventrolateral preoptic area VLPO VLPO:13 ventrolateral preoptic nucleus VLC VLC:10 long chain VLC VLC:18 visible lightcured VLS VLS:47 vascular leak syndrome VLS VLS:9 ventrolateral striatum VL VL:7 light chain variable domain VL VL:11 light chain variable region VL VL:16|Vl:1 variable VL VL:17 vastus lateralis muscle VL VL:17 ventral lateral nucleus VL VL:94|vl:9|Vl:1 ventrolateral VL VL:24 ventrolateral nucleus VL VL:3 ventrolateral nucleus of the thalamus VL VL:11 ventrolateral thalamic nucleus VMD VMD:7 vertebral mineral density VMD VMD:6|VmD:1 volume median diameter VMH VMH:12 hypothalamic ventromedial nucleus VMH VMH:137 ventromedial hypothalamic VMH VMH:10 ventromedial hypothalamic nuclei VMH VMH:395|VmH:1 ventromedial hypothalamus VMO VMO:10 vaccinia melanoma oncolysate VMO VMO:20 vastus medialis oblique VMO VMO:23 vastus medialis obliquus VMR VMR:22 vasomotor reactivity VMR VMR:8 vasomotor rhinitis VMs VMs:9 vascular malformations VMs VMs:13 venous malformations VMS VMS:36 ventral medullary surface VMS VMS:1 ventral surface of medulla VNC VNC:27|vNC:1 ventral nerve cord VNC VNC:24 vestibular nuclear complex VNC VNC:19 vestibular nucleus complex VNP VNP:10 vasonatrin peptide VNP VNP:12 ventricular natriuretic peptide VNS VNS:176 vagus nerve stimulation VNS VNS:11 vomeronasal system VNT VNT:12 virus neutralisation test VNT VNT:14 virus neutralization test VN VN:8 vagus nerve VN VN:10 vestibular neuritis VN VN:34|Vn:2 vestibular nuclei VN VN:16 vestibular nucleus VN VN:24 virus neutralisation VN VN:9 virus neutralising VN VN:19|vn:1 vomeronasal VO2max VO2max:57|Vo2max:1 maximal aerobic capacity VO2max VO2max:5|Vo2max:1 maximal exercise VO2max VO2max:85|Vo2max:4 maximal o consumption VO2max VO2max:22|Vo2max:1 maximal oxygen intake VO2max VO2max:95|Vo2max:3 maximum oxygen consumption VO2 VO2:38|Vo2:2 metabolic rate VO2 VO2:9 o intake VO2 VO2:250|Vo2:17 o uptake VO2 VO2:15|Vo2:3 oxygen consumption per beat VO2 VO2:11 oxygen intake VOCs VOCs:35 volatile organic chemicals VOCs VOCs:518 volatile organic compounds VOC VOC:18 vasoocclusive crisis VOC VOC:10 voltageoperated ca channel VOD VOD:258 venoocclusive disease VOD VOD:23 venoocclusive disease of the liver VOT VOT:8 hooper visual organization test VOT VOT:8 venous occlusion test Vo Vo:11 subnucleus oralis Vo Vo:10 trigeminal nucleus oralis VO VO:49 vaginal opening Vo Vo:6 velocity of shortening VO VO:40|vo:1 venous occlusion VO VO:8 venous outflow Vo Vo:16|VO:1 void volume Vo Vo:5|VO:1 volume intercept VPA VPA:10 vaginal pulse amplitude VPA VPA:6 valproate sodium VPA VPA:4|v-PA:4|vPA:1 vascular plasminogen activator VPA VPA:10 vigorous physical activity VPCs VPCs:111 ventricular premature complexes VPCs VPCs:63 ventricular premature contractions VPCs VPCs:25 vulval precursor cells VPL VPL:2 nucleus of thalamus VPL VPL:25 nucleus ventralis posterolateralis VPL VPL:22 ventral posterior lateral VPL VPL:18 ventral posterior lateral nucleus VPL VPL:16 ventral posterolateral VPL VPL:17 ventral posterolateral nucleus VPL VPL:32 ventroposterolateral VPL VPL:19 ventroposterolateral nucleus VPL VPL:10 vertical partial laryngectomy VPT VPT:66 vibration perception threshold VPT VPT:20 vibratory perception threshold VPI VPI:8|VPi:1 inferior VPI VPI:9|VPi:1 inferior nucleus VPI VPI:30 velopharyngeal incompetence VPI VPI:51 velopharyngeal insufficiency VPI VPI:11 vibrio pathogenicity island VPI VPI:18 visible plaque index Vp Vp:5 correction for the residual plasma volume Vp Vp:6|VP:1 principal sensory trigeminal nucleus VP VP:52 variegate porphyria VP VP:27 vascular parkinsonism VP VP:32 vascular permeability VP VP:21|V-P:2|v-p:1 velopharyngeal VP VP:10|Vp:1 ventral VP VP:69 ventral pallidum VP VP:6 ventral posterior VP VP:83 ventral prostate VP VP:5 ventralis posterior VP VP:15 ventroposterior VP VP:10 ventroposterior nucleus VP VP:7 viral protein VP VP:10 vulnerable period VR1 VR1:10 vanilloid VR1 VR1:29 vanilloid receptor subtype VR1 VR1:20|VR-1:2 vanilloid receptor type VRE VRE:17 vancomycinresistant enterococcal VRE VRE:412 vancomycinresistant enterococci VRE VRE:86 vancomycinresistant enterococcus VRS VRS:8 verbal rating score VRS VRS:11 volume reduction surgery VRT VRT:12 virtual reality therapy VRT VRT:9 visual reaction time VRT VRT:11 volume rendering technique VR VR:9 valsalva ratio VR VR:28 valve replacement VR VR:11 vascular reactivity VR VR:16 venous return VR VR:10 ventilation rate VR VR:7 ventilatory response VR VR:18|vr:1 ventral root VR VR:11 ventricular rate VR VR:8 vesamicol receptor VR VR:241 virtual reality VR VR:9 visual reproduction VR VR:30 vocational rehabilitation VR VR:32 volume rendering VSA VSA:32 vasospastic angina VSA VSA:26 ventral septal area VSA VSA:10 volatile substance abuse VSD VSD:12 vaccine safety datalink VSD VSD:16 vascular surface density VSD VSD:17 virtually safe dose VSD VSD:9 voltagesensitive dye VSR VSR:21 ventricular septal rupture VSR VSR:15 vestibulospinal reflex VSV-G VSV-G:35|VSVG:3 vesicular stomatitis virus VSV-G VSV-G:12|VSVG:3 vesicular stomatitis virus g VSV-G VSV-G:21|VSVG:5 vesicular stomatitis virus g protein VSV-G VSV-G:36|VSVG:7|VSVg:2 vesicular stomatitis virus glycoprotein VSV-NJ VSV-NJ:6 vesicular stomatitis virus new jersey VSV-NJ VSV-NJ:3 vesicular stomatitis virus new jersey serotype VT/TI VT/TI:88|VT/Ti:14|VT/tI:3|Vt/Ti:1 mean inspiratory flow VT/TI VT/TI:17|VT/Ti:4|Vt/Ti:1|VT/tI:1 mean inspiratory flow rate VT/VF VT/VF:24 ventricular tachycardiafibrillation VT/VF VT/VF:13 ventricular tachycardiaventricular fibrillation VTA VTA:8 ventral tegmental VTA VTA:1133|vta:1 ventral tegmental area VTA VTA:12 ventral tegmental area of tsai VTEC VTEC:1 verocytotoxinproducing e coli VTEC VTEC:1 verotoxinproducing e coli VTs VTs:10 ventricular tachyarrhythmias VTs VTs:44 ventricular tachycardias VTs VTs:17 verotoxins VT VT:4 exposure to the trichothecene vomitoxin VT VT:5 insertion of ventilation tubes VT VT:46 vasotocin VT VT:37|vT:1 venous thrombosis VT VT:5 venous tone VT VT:6 ventilating tubes VT VT:12 ventilation tube VT VT:8 ventral tegmentum VT VT:15 vero cytotoxin VT VT:25 verocytotoxin VT VT:5 vocational training VT VT:5 volume transmission VVF VVF:11 vesicovaginal fistula VVF VVF:6 vesicovaginal fistulae VVI VVI:26 ventricular VVI VVI:19 ventricular demand VVI VVI:4 ventricular demand pacemaker VVI VVI:19 ventricular inhibited VVS VVS:29 vasovagal syncope VVS VVS:34 vulvar vestibulitis syndrome VV VV:7|Vv:4 vascular volume VV VV:12 venous volume VWM VWM:6|vWM:1 verbal working memory VWM VWM:11 white matter VX VX:11 methylphosphonothioate VX VX:15 methylphosphonothiolate VX VX:13 verruciform xanthoma VB VB:78|Vb:1 ventrobasal VB VB:67|Vb:1 ventrobasal complex VB VB:4 ventrobasal nucleus of the thalamus VB VB:10 ventrobasal thalamus VB VB:28 vertebral body VB VB:15|V-B:2 vertebrobasilar VB VB:13 virtual bronchoscopy VCO2 VCO2:13|Vco2:1 carbon dioxide excretion VCO2 VCO2:24|Vco2:1 co elimination VCO2 VCO2:12|Vco2:2 co excretion VD VD:11|Vd:1 dead space volume VD VD:18 vaginal delivery VD VD:20 vas deferens VD VD:10 vascular density VD VD:22 ventricular dilator VD VD:6 vessel diameter VD VD:9|vd:1 vessel disease VD VD:5 voiding dysfunction VEC VEC:9|vec:1|Vec:1 vecuronium VEC VEC:12 velocityencoded cine VEC VEC:6 videoenhanced contrast VG VG:8|Vg:3 glomerular volume VG VG:9 graft VG VG:6 vein grafts VG VG:9 ventriculography VG VG:12 vestibular ganglion Vmax Vmax:7 expiratory flow rates Vmax Vmax:25 maximal activity Vmax Vmax:10 maximal expiratory flow Vmax Vmax:26 maximal rate Vmax Vmax:21 maximal rate of depolarization Vmax Vmax:9 maximal rate of transport Vmax Vmax:13|vmax:1 maximal transport capacity Vmax Vmax:6 maximal uptake rate Vmax Vmax:6 maximal velocity of uptake Vmax Vmax:15 maximum expiratory flow Vmax Vmax:45 maximum rate of depolarization Vmax Vmax:10 maximum rate of metabolism Vmax Vmax:47 maximum rate of rise Vmax Vmax:12 maximum rate of rise of action potential Vmax Vmax:7 maximum rate of rise of the action potential upstroke Vmax Vmax:6 maximum rate of uptake Vmax Vmax:9 maximum uptake rate Vmax Vmax:3 maximum velocity of reaction Vmax Vmax:29 maximum velocity of shortening Vmax Vmax:5 maximum velocity of transport Vmax Vmax:16 phase depolarization Vmax Vmax:15 upstroke velocity of the action potential VM VM:15 vacuolar myelopathy VM VM:44 valsalva maneuver VM VM:14 valsalva manoeuvre VM VM:39 ventral mesencephalic VM VM:57 ventral mesencephalon VM VM:11 ventricular muscle VM VM:12|Vm:2 ventromedial thalamic nucleus VPM VPM:7|VPm:1 nucleus of the thalamus VPM VPM:15 nucleus ventralis posteromedialis VPM VPM:28 ventral posterior medial VPM VPM:13 ventral posterior medial nucleus VPM VPM:8 ventral posteromedial thalamic nucleus VPM VPM:7|VPm:3 ventroposterior medial VSP VSP:13|vsp:2 short patch VSP VSP:10 variantspecific surface protein VSP VSP:7 variant surface protein VSP VSP:36 ventricular septal perforation VSS VSS:6 vancouver scar scale VSS VSS:10 visual sexual stimulation VSS VSS:30 volatile suspended solids VS VS:5 gain of the vestibulospinal VS VS:6 vagal nerve stimulation VS VS:12|Vs:2 vagal stimulation VS VS:25 vegetative state VS VS:14 ventral striatum VS VS:19 ventricular septum VS VS:7 vibration syndrome VS VS:10 viridans streptococci VS VS:9 visual scoring VS VS:31 volatile solids W/A W/A:10|w/a:1 weightage W/A W/A:10|w/a:1 weight for age w/o/w w/o/w:6|W/O/W:5 emulsion w/o/w w/o/w:44|W/O/W:32 waterinoilinwater W-7 W-7:18|W7:2 calmodulin antagonist W-7 W-7:1 calmodulin antagonist naminohexylchloronaphthalenesulfonamide W-7 W-7:15|W7:4 naminohexylchloronaphthalene sulfonamide W-7 W-7:4|W7:2 naminohexylchloronaphthalene sulphonamide W-7 W-7:16|W7:2 naminohexylchloronaphthalenesulfonamide hydrochloride WAI WAI:16 work ability index WAI WAI:7 working alliance inventory WAP WAP:119|Wap:4|wap:1 whey acidic protein WAP WAP:8 wireless application protocol WAS WAS:21 ward atmosphere scale WAS WAS:15 waste activated sludge WAS WAS:251 wiskottaldrich syndrome WBA WBA:8 whole blood assay WBA WBA:12 wholebody autoradiography WBCs WBCs:24 leukocytes WBCs WBCs:182|wbcs:1 white blood cells WBCs WBCs:10 white blood cell counts WBC WBC:70 white blood count WBC WBC:9 wholebody counter WBRT WBRT:8 whole brain irradiation WBRT WBRT:27 whole brain radiation therapy WBS WBS:23 warnerbratzler shear WBS WBS:15 whole blood serum WBS WBS:9 wholebody scanning WBS WBS:9|wbs:1 whole body scintigraphy WBS WBS:36 wiedemannbeckwith syndrome WBS WBS:61 williamsbeuren syndrome WBS WBS:11 wound breaking strength WB WB:11 weightbearing WB WB:98|Wb:1|wb:1 western blotting WB WB:10 western immunoblot WB WB:11 western immunoblotting WB WB:49|Wb:2 wheat bran WB WB:7 white bread WCH WCH:41 white coat hypertension WCH WCH:6 womens and childrens hospital WCST WCST:17 wisconsin card sorting task WCST WCST:332 wisconsin card sorting test WC WC:13 tungsten carbide WC WC:8 warm controls WC WC:20|W-C:4 watsoncrick WC WC:10 weight cycling WC WC:25 white carneau WC WC:11 white composite WC WC:29 workers compensation WC WC:9 writers cramp WDTC WDTC:11 welldifferentiated thyroid cancer WDTC WDTC:9 welldifferentiated thyroid carcinoma WD WD:9 trpasp WD WD:20 wallerian degeneration WD WD:14 water deprivation WD WD:5 western diet WD WD:16 winter dysentery WEE WEE:59 western equine encephalitis WEE WEE:6 western equine encephalitis virus WEE WEE:62 western equine encephalomyelitis WFA WFA:9 wistaria floribunda WFA WFA:10 wistaria floribunda agglutinin WFA WFA:25 wisteria floribunda agglutinin WFS WFS:9 wolfram syndrome WFS WFS:40 world fertility survey WF WF:9 donortype WF WF:9 weilfelix WF WF:52 working formulation WF WF:10 wound fluid WGA-HRP WGA-HRP:19 horseradish peroxidase conjugated with wheat germ agglutinin WGA-HRP WGA-HRP:7 wheat germ agglutininconjugated hrp WGA-HRP WGA-HRP:120 wheat germ agglutinin conjugated to horseradish peroxidase WGA-HRP WGA-HRP:163 wheat germ agglutininhorseradish peroxidase WGA-HRP WGA-HRP:22 wheat germ agglutininhorseradish peroxidase conjugate WGA-HRP WGA-HRP:8 wheat germ agglutininhrp WGA WGA:13 triticum vulgare WGA WGA:81 triticum vulgaris WGA WGA:17 whole genome amplification WG WG:595|W-G:1 wegeners granulomatosis WG WG:19 weight gain WG WG:10 wheat gluten WG WG:9 white WG WG:28 white gastrocnemius WG WG:5 working group WHHL WHHL:29 watanabe heritable hyperlipidaemic WHHL WHHL:228 watanabe heritable hyperlipidemic WHO WHO:8 grade iii WHO WHO:238 world health organisation WHR WHR:5 ratio of waisttohip circumference WHR WHR:6 waist to hip circumference WHR WHR:10 waisttohip ratios WKY WKY:2 normotensive control the wistarkyoto rat WKY WKY:4 normotensive rats of the wistarkyoto strain WKY WKY:8 wistarkyoto control WKY WKY:40 wistar kyoto rat WK WK:11 wistar kyoto WK WK:8 wistarkyoto rats WLB WLB:17 western ligand blot WLB WLB:30 western ligand blotting WL WL:5 waitlist control WL WL:7 waiting list WL WL:27 weight loss WL WL:42 white leghorn WL WL:15 white light WL WL:12 working length WMC WMC:15 white matter changes WMC WMC:8 working memory capacity WMD WMD:20 weapons of mass destruction WMD WMD:10 white matter damage WMD WMD:7 white muscle disease WMS WMS:30 wall motion score WMS WMS:59 wechsler memory scale WMS WMS:17 williams syndrome WMS WMS:8 wriggle mouse sagami WM WM:27 waldenstroms macroglobulinaemia WM WM:27 water maze WM WM:17 western medicine WM WM:10 wheat middlings WM WM:11 white men WM WM:9 whole milk WM WM:266 working memory WM WM:19|Wm:2 wortmannin WN WN:10 wellnourished WN WN:14|wN:1 white noise WOMAC WOMAC:41 western ontario and mcmaster universities WOMAC WOMAC:8 western ontario and mcmaster universities osteoarthritis WOMAC WOMAC:75 western ontario and mcmaster universities osteoarthritis index WOMAC WOMAC:8 western ontario mcmaster WPW WPW:276|W-P-W:5 wolffparkinsonwhite WPW WPW:69|W-P-W:2 wolffparkinsonwhite syndrome WP WP:1 increase in number of the weibelpalade WP WP:26 washed platelets WP WP:13 water placebo WP WP:19 wettable powder WP WP:7 whey protein WP WP:6 wolfgram protein WRN WRN:11 werner protein WRN WRN:21 werner syndrome WRN WRN:7 werner syndrome gene WRN WRN:15 werner syndrome protein WR WR:11 waldeyers ring WR WR:23 walter reed WR WR:8 water absorption response WR WR:20 western reserve WR WR:11 wheel running WR WR:6 wild running WR WR:25 wistar rats WR WR:41 work rate WS WS:15 wall stress WS WS:9 warning signal WS WS:15|W-S:4 warthinstarry WS WS:14 wheat straw WS WS:6|Ws:3 withania somnifera WT1 WT1:6|WT-1:1 tumor gene WT1 WT1:5|WT-1:2 wilms tumor gene product WT1 WT1:7|wt1:2 wilms tumor suppressor WT1 WT1:29|WT-1:4|wt1:3|Wt-1:1 wilms tumor suppressor gene WW WW:20 watchful waiting WW WW:6 weaning weights WA WA:10 wall area WA WA:9 warmacclimated WA WA:2 weight age WA WA:85|Wa:7 western australia WA WA:9 western australian WI WI:5 t and tweighted images WI WI:24|Wi:1 warm ischemia WI WI:86 water immersion WI WI:10 weight index Wmax Wmax:13|WMAX:1 maximal workload Wmax Wmax:8 maximum work capacity X4 X4:14 cxcr X4 X4:9 cxcrdependent X4 X4:10 cxcrusing XAS XAS:9 xray absorption XAS XAS:9 xray absorption spectroscopic XAS XAS:114 xray absorption spectroscopy XD XD:9 xanthoma disseminatum XD XD:10 xenodiagnosis XG XG:14 xanthan gum XG XG:21 xyloglucan XLA XLA:50|X-LA:2 xlinked agammaglobulinaemia XLA XLA:182|X-LA:5 xlinked agammaglobulinemia XLP XLP:29 xlinked lymphoproliferative XLP XLP:82 xlinked lymphoproliferative disease XLP XLP:52 xlinked lymphoproliferative syndrome XN XN:9 night blindness XN XN:13|Xn:1 xanthohumol XPD XPD:6|XP-D:5 xeroderma pigmentosum complementation group d XPD XPD:13|XP-D:5 xeroderma pigmentosum group d XP-E XP-E:3|XPE:2 xeroderma pigmentosum complementation group e XP-E XP-E:6|XPE:2 xeroderma pigmentosum group e XPS XPS:13 xray photoelectron spectroscopic XPS XPS:470 xray photoelectron spectroscopy XTT XTT:13 hydroxide XTT XTT:5 tetrazolium salt YAP YAP:5 alu polymorphism YAP YAP:16|Yap:1 yesassociated protein YES YES:22 yeast estrogen screen YES YES:9 yeast extract sucrose YSM YSM:56|ysm:1 years since menopause YSM YSM:15 yolk sac membrane Yq Yq:5 long arm of the y chromosome Yq Yq:10 y chromosome long arm YS YS:36 yolk sac YS YS:10 yoshida sarcoma ZAP-70 ZAP-70:9|ZAP70:1 zetaassociated protein ZAP-70 ZAP-70:7|Zap-70:1 zetaassociated protein of kda ZD ZD:12 zenkers diverticulum ZD ZD:17 zinc deficiency ZE ZE:13|Z-E:4 zollingerellison ZE ZE:17 zone electrophoresis ZIO ZIO:18 zinciodideosmium ZIO ZIO:19 zinc iodideosmium tetroxide ZP3 ZP3:7|Zp3:1 zona pellucida ZP3 ZP3:8 zona pellucida glycoprotein ZP ZP:9 zeta potential ZP ZP:374|zp:5|Zp:1 zona pellucida ZF ZF:74|zF:2|zf:1 zona fasciculata ZF ZF:14 zucker fatty [3H]NMS [3H]NMS:13 nhmethylscopolamine [3H]NMS [3H]NMS:8 nmethylhscopolamine [Ca(2+)](i) [Ca(2+)](i):12 intracellular calcium levels [Ca(2+)](i) [Ca(2+)](i):53 intracellular free ca concentration [Ca2+]c [Ca2+]c:10 cytoplasmic free calcium concentration [Ca2+]c [Ca2+]c:15 cytosolic calcium concentration [Ca2+]i [Ca2+]i:6 calcium transients [Ca2+]i [Ca2+]i:1 concentration in cytosol [Ca2+]i [Ca2+]i:39 cytosolic ca concentrations [Ca2+]i [Ca2+]i:34 cytosolic ca level [Ca2+]i [Ca2+]i:123 cytosolic free ca [Ca2+]i [Ca2+]i:31 cytosolic free ca concentrations [Ca2+]i [Ca2+]i:13 cytosolic free calcium levels [Ca2+]i [Ca2+]i:25 free cytosolic ca [Ca2+]i [Ca2+]i:21 free cytosolic calcium [Ca2+]i [Ca2+]i:5 increase cytosolic ca concentration [Ca2+]i [Ca2+]i:19 increase in cytosolic ca [Ca2+]i [Ca2+]i:18 intracellular ca activity [Ca2+]i [Ca2+]i:19 intracellular ca levels [Ca2+]i [Ca2+]i:14 intracellular calcium activity [Ca2+]i [Ca2+]i:27 intracellular free ca concentrations [Cl-]i [Cl-]i:8|[Cl]i:2 intracellular chloride concentration [Cl-]i [Cl-]i:3 intracellular cl [Mg2+]i [Mg2+]i:6 free mg concentrations [Mg2+]i [Mg2+]i:4 intracellular free magnesium [Mg2+]i [Mg2+]i:9 intracellular free magnesium concentration [Mg2+]i [Mg2+]i:13 intracellular free mg [Mg2+]i [Mg2+]i:13 intracellular mg concentration [Mg2+]o [Mg2+]o:11 extracellular magnesium ions [Mg2+]o [Mg2+]o:10 extracellular mg concentration [Na+]o [Na+]o:6 external na [Na+]o [Na+]o:23 extracellular na concentration [Na+]o [Na+]o:9 extracellular sodium concentration A2 A2:5 atrial extrastimulus A2 A2:8 component of the second heart sound ACL ACL:11 adenocarcinoma of the lung ACL ACL:21 adjective check list ACL ACL:77 american cutaneous leishmaniasis ACL ACL:12 anterior cruciate aCL aCL:17 anticardiolipin antibody aCL aCL:18|a-CL:2|ACL:2|A-CL:1 antibodies to cardiolipin A-LAK A-LAK:8|ALAK:2|aLAK:1 adherent lak A-LAK A-LAK:17|ALAK:1 adherent lymphokineactivated killer A-LAK A-LAK:6 adherent lymphokineactivated killer cells aPKC aPKC:17 atypical pkc aPKC aPKC:47|a-PKC:1 atypical protein kinase c ACA ACA:20 acetoxychavicol acetate ACA ACA:54 acrodermatitis chronica atrophicans ACA ACA:15 active cutaneous anaphylaxis ACA ACA:4 adaptive conjoint analysis aca aca:4|ACA:4 adenylyl cyclase ACA ACA:6|Aca:2 aminocaproic acid ACA ACA:6 anticentromere autoantibodies ACA ACA:10|aca:2 anticomplementary activity aca aca:6|ACA:2 automatic clinical analyzer ADD ADD:6 acute diarrheal disease ADD ADD:14 afterdischarge duration ADD ADD:9 androstadienedione ADD ADD:11 anterior disc displacement ADD ADD:174|add:5 attention deficit disorder ADD ADD:5 surgical induction of anterior disk displacement ADN ADN:13 associate degree nursing ADN ADN:11 electrical stimulation of the aortic depressor nerve adr adr:5 adrenergic receptor adr adr:12 adrenodoxin reductase AGEs AGEs:125 advanced glycation endproducts AGEs AGEs:88|ages:3 advanced glycosylation end products AH AH:9 abdominal hysterectomy AH AH:13 abductor hallucis AH AH:12 absolute humidity AH AH:21 absorptive hypercalciuria AH AH:6 adenoid hypertrophy AH AH:60 adenomatous hyperplasia AH AH:10 adult height AH AH:43 alcoholic hepatitis AH AH:10 alveolar hemorrhage AH AH:10 ancestral haplotype AH AH:5 aniline hydrochloride AH AH:7 anterior horn AH AH:11 anterior hypothalamic AH AH:17 aqueous humour Ah Ah:43|AH:12 aromatic hydrocarbon AH AH:21 artificial heart Ah Ah:161|AH:19 aryl hydrocarbon AH AH:16 assisted hatching AH AH:10 ataxic hemiparesis AH AH:14|A-H:6 atriohis AH AH:48 atypical hyperplasia AH AH:9 autonomic hyperreflexia AH AH:3 paf acetylhydrolase AH AH:19 patients with acute hepatitis AH AH:6 rat ascites hepatoma AI AI:12 acute ileus AI AI:15|ai:2 adequate intake AI AI:6|ai:2 adrenal incidentalomas AI AI:14|ai:3 adrenal insufficiency ai ai:6 airway inflammation AI AI:68|ai:6 amelogenesis imperfecta AI AI:14|ai:4 anchorageindependent AI AI:13|ai:1 aortic incompetence AI AI:80|ai:8 aortic insufficiency AI AI:7|ai:4 apoptotic AI AI:256|ai:48|Ai:2 apoptotic index AI AI:55|ai:8 artificial intelligence AI AI:21|ai:5 artificially inseminated AI AI:6|ai:3 associationinduction AI AI:4|ai:3 astragalus injection ai ai:9|AI:4 axonal injury AI AI:6|ai:2 primary auditory area AI AI:12|ai:1 primary auditory field AK AK:34|A-K:1|ak:1 aboveknee AK AK:12|ak:1 acanthamoeba keratitis AK AK:91 actinic keratosis AK AK:23 activated killer AK AK:18|ak:2 astigmatic keratotomy aK aK:4|ak:2 extracellular potassium activity aK aK:4|AK:2|ak:2 k activity alpha alpha:7 calcium absorption alpha alpha:8 intrinsic activity alpha alpha:7 molecular polarizability alpha alpha:8 separation factors alum alum:10 aluminium hydroxide gel alum alum:19 aluminum hydroxide gel alum alum:14 aluminum sulfate anergy anergy:8 functional inactivation anergy anergy:20 unresponsiveness APT APT:26|apt:2 applied potential tomography APT APT:36 atopy patch test ara-A ara-A:49|araA:19|Ara-A:7|ARA-A:5|AraA:3 betadarabinofuranosyladenine ara-A ara-A:34|Ara-A:27|ARA-A:11|araA:4|AraA:3|Ara-a:1 adenine arabinoside ara-A ara-A:5|Ara-A:2|araA:2 arabinosyladenine ara-A ara-A:9|Ara-A:3|AraA:1 vidarabine Ara-C Ara-C:12|ara-C:8|ARA-C:5|araC:3 arabinosyl cytosine Ara-C Ara-C:122|ara-C:121|ARA-C:33|AraC:31|araC:14|ara-c:5|ARAC:2 cytarabine Ara-C AraC:4|Ara-C:4|ARA-C:2|araC:2|ara-C:1 cytosinebetadarabinofuranoside ARMS ARMS:29 alveolar rhabdomyosarcoma ARMS ARMS:125|arms:1 amplification refractory mutation system AW AW:7|Aw:3 active wakefulness AW AW:12|Aw:1|aW:1 active waking AW AW:8 anterior wall AW AW:5 ash weight b/b b/b:10 belgrade b/b b/b:18 belgrade laboratory bDNA bDNA:7 branched dna signal amplification bDNA bDNA:5 versant hcv rna assay bGH bGH:86 bovine gh bGH bGH:190|BGH:13|b-GH:2 bovine growth hormone bNED bNED:10 biochemical no evidence of disease bNED bNED:8 freedom from biochemical failure BPE BPE:35 benign prostatic enlargement BPE BPE:34|bPE:1 bovine pituitary extract bTSH bTSH:7 bovine thyroidstimulating hormone bTSH bTSH:15|b-TSH:3 bovine thyrotropin bZIP bZIP:64|bZip:14|b-Zip:3 basic leucine zipper bZIP bZIP:8|b-ZIP:1|B-ZIP:1 leucinezipper baPWV baPWV:26|BAPWV:1|ba-PWV:1 brachialankle pulse wave velocity baPWV baPWV:14 brachialankle pwv beta beta:10 buffer capacity beta beta:14 buffering power beta beta:20 elimination beta beta:7 human fibroblast beta beta:12|Beta:1 regression coefficient beta beta:18 skeletofusimotor beta beta:5 spectral exponent beta beta:7 stiffness index beta beta:7 stiffness parameter BRA BRA:9 bilateral renal agenesis BRA BRA:9 boneresorbing activity BUT BUT:5 biopsy urease test BUT BUT:20|but:1 tear film breakup time cALL cALL:11|c-ALL:5|C-ALL:4 common acute lymphoblastic leukaemia cALL cALL:22|c-ALL:6|C-ALL:4|CALL:1 common acute lymphoblastic leukemia cAMP cAMP:1085|camp:2 adenosine cyclic monophosphate cAMP cAMP:10 cyclic amp cAMP cAMP:7 monophosphoric acid c-ANCA c-ANCA:5|C-ANCA:3|cANCA:1 cytoplasmic pattern c-ANCA c-ANCA:4|C-ANCA:4|cANCA:3 cytoplasmic staining pattern cDNA cDNA:19 complementary cDNA cDNA:90 complementary deoxyribonucleic acid cDNA cDNA:1189|CDNA:2 complementary dna cDNA cDNA:18 dna complementary to rna cGH cGH:6 canine gh cGH cGH:11 chicken gh cICAM-1 cICAM-1:11 circulating icam cICAM-1 cICAM-1:29 circulating intercellular adhesion molecule cLPM cLPM:17 canalicular cLPM cLPM:10 canalicular liver plasma membrane cNOS cNOS:88 constitutive nitric oxide synthase cNOS cNOS:34|c-NOS:1 constitutive no synthase cNOS cNOS:50|c-NOS:3 constitutive nos CAPE CAPE:144|cape:1 caffeic acid phenethyl ester CAPE CAPE:8 clifton assessment procedures for the elderly CAPS CAPS:10 activator protein for secretion CAPs CAPs:7|CAPS:1 air particles CAPS CAPS:21 cardiac arrhythmia pilot study CAPs CAPs:7 cardioacceleratory peptides CAPS CAPS:19 catastrophic antiphospholipid syndrome CAPs CAPs:7 clathrinassociated proteins CAPs CAPs:116|cAPs:5|caps:3 compound action potentials CAPs CAPs:7 effects of subchronic exposures to concentrated ambient particles CARDIA CARDIA:106|cardia:2 coronary artery risk development in young adults CARDIA CARDIA:5 coronary artery risk development in young adults study CARP CARP:13|carp:2 cardiac ankyrin repeat protein CARP CARP:10 catchrelaxing peptide CART CART:9 classification and regression tree analysis CART CART:123 cocaine and amphetamineregulated transcript CART CART:5 combination antiretroviral therapy CAT CAT:8|cat:2 agglutination test CAT CAT:5 carnitine acyltransferase cat cat:6|CAT:3 catalase activity cat cat:13|Cat:3 cathepsin cat cat:13|CAT:2 cationic amino acid transporter CAT CAT:7 chlamydia antibody testing cat cat:28|CAT:24 chloramphenicol acetyltransferase gene CAT CAT:8 chloramphenicol acyltransferase CAT CAT:5|cat:2 cognitive analytic therapy CAT CAT:5|cat:1 column agglutination technology CAT CAT:43|cat:5 computed axial tomography CAT CAT:20 computer assisted tomography CAT CAT:9|cat:3 computerized adaptive testing CAT CAT:11|cat:2 computerized axial tomographic CAT CAT:116|cat:9 computerized axial tomography CAV CAV:11 canine adenovirus CAV CAV:116 cardiac allograft vasculopathy CAV CAV:38 chicken anaemia virus CAV CAV:51 chicken anemia virus CBT CBT:7 caffeine breath test CBT CBT:7 childhood brain tumors CBT CBT:211 cognitivebehavioral therapy CBT CBT:45 cognitivebehavioral treatment CBT CBT:12 computerbased training CBT CBT:31|cBT:3 core body temperature CCC CCC:5 child care center CCC CCC:13 chlorocholine chloride CCC CCC:9 chronic calculous cholecystitis CCC CCC:5 chronic chagas disease cardiomyopathy CCC CCC:10 chronic chagasic cardiomyopathy CCC CCC:16 clear cell carcinoma CCC CCC:13 concordance correlation coefficient CCC CCC:12 confronting cisternae CCC CCC:12 continuous circular capsulorhexis CCC CCC:64 continuous curvilinear capsulorhexis CCC CCC:6 continuous curvilinear capsulorrhexis CDE CDE:5 cholinedeficient ethioninesupplemented CDE CDE:6 convectiondispersion equation CDE CDE:15 dust extract CDE CDE:12 ethionine CE-MRA CE-MRA:35|CEMRA:5|ce-MRA:1 contrastenhanced magnetic resonance angiography CE-MRA CE-MRA:11|ceMRA:4|CEMRA:3 contrastenhanced mr angiography CE-MRA CE-MRA:8|CEMRA:3|ce-MRA:2 contrastenhanced mra CFU/ml CFU/ml:4|cfu/mL:1|cfu/ml:1 colony forming unitsml CFU/ml CFU/ml:10|CFU/mL:5|cfu/ml:5|cfu/mL:2 colonyforming units per milliliter CHART CHART:31 continuous hyperfractionated accelerated radiotherapy CHART CHART:32 craig handicap assessment and reporting technique CHI CHI:11 contrast harmonic imaging CHI CHI:11 creatinine height index CHR CHR:4|chr:1 calgary health region CHR CHR:7|chr:2 complete hematologic remission CHR CHR:13|chr:4 complete hematologic response CHR CHR:6|chr:1 complete hematological remission CHR CHR:16 contact hypersensitivity reaction CHR CHR:12 homology region COL2A1 COL2A1:36|Col2a1:5|col2a1:1 type ii collagen gene COL2A1 COL2A1:23|Col2a1:1 type ii procollagen COL2A1 COL2A1:22|Col2a1:1 type ii procollagen gene con con:42|Con:2 concentric con con:10 control trial CPs CPs:7 capsid proteins CPS CPS:39 carbamoyl phosphate synthetase CPS CPS:14 carbamoylphosphate synthetase CPS CPS:16 carbamyl phosphate synthetase CPS CPS:7 cardioplegic solution CPS CPS:32 cardiopulmonary support CPS CPS:10 cerebral protein synthesis CPs CPs:18 chlorophenols CPS CPS:7 clinical pharmacokinetic service CPS CPS:7 clinical prediction of survival CPS CPS:6 coagulasepositive staphylococci CPs CPs:14 coat proteins CPS CPS:12 cognitive performance scale CPS CPS:21 contact photosensitivity CPS CPS:61 current population survey CPs CPs:17 cysteine proteinases CPS CPS:6 diphosphate synthase CPS CPS:5 patients with chest pain syndrome CPS CPS:17 synthetase i CRIB CRIB:10 cdcrac interactive binding CRIB CRIB:29 clinical risk index for babies CRP CRP:12 canalith repositioning procedure CRP CRP:10 cardiac rehabilitation program CRP CRP:36 collagenrelated peptide CRP CRP:12 confluent and reticulated papillomatosis cryo-EM cryo-EM:43|cryoEM:5|Cryo-EM:1 cryoelectron microscopy cryo-EM cryo-EM:5|cryoEM:5 electron cryomicroscopy cya cya:7 adenyl cyclase cya cya:10 adenylate cyclase gene dHGF dHGF:11 deleted form of hepatocyte growth factor dHGF dHGF:5 deletion variant of hepatocyte growth factor dNTP dNTP:48 deoxynucleoside triphosphate dNTP dNTP:57 deoxyribonucleoside triphosphate dNTP dNTP:14 deoxyribonucleotide dSSc dSSc:9 diffuse cutaneous systemic sclerosis dSSc dSSc:10 diffuse ssc DTF DTF:15 directed transfer function DTF DTF:9 dorsal tegmental field DTC DTC:94 differentiated thyroid cancer DTC DTC:37 directtoconsumer DTC DTC:8 disseminated tumor cells DTC DTC:8|dtc:2 dithiocarbamate dUMP dUMP:9 deoxyuridinemonophosphate dUMP dUMP:15 deoxyuridine monophosphate dUMP dUMP:9 deoxyuridylate db/db db/db:8 diabetic mouse db/db db/db:59|DB/DB:1 genetically diabetic DBT DBT:10 deep body temperature DBT DBT:26 dialectical behavior therapy DBT DBT:78 dibenzothiophene DBT DBT:6 dibutyltin dichloride DD-PCR DD-PCR:19|ddPCR:10|DDPCR:6 differential display pcr DD-PCR DD-PCR:16|ddPCR:8|DDPCR:6 differential display polymerase chain reaction delta delta:12 chemical shifts delta delta:7 electrical distance DFR DFR:25 delayed footpad reaction DFR DFR:10 dihydroflavonol reductase DLK DLK:54 diffuse lamellar keratitis DLK DLK:9 dual leucine zipperbearing kinase dmPGE2 dmPGE2:14|DMPGE2:3|dm-PGE2:1 dimethyl pge dmPGE2 dmPGE2:38|DMPGE2:13|dm-PGE2:3|DmPGE2:3 dimethyl prostaglandin e Dmin Dmin:5 minimum diameter Dmin Dmin:5 minimum target dose DNs DNs:6 descending neurons DNs DNs:18 district nurses DNS DNS:14 dysplastic naevus syndrome DNS DNS:38 dysplastic nevus syndrome DNs DNs:20 dysplastic nodules DO DO:8|do:1 days open DO DO:22|do:1 detrusor overactivity DO DO:212|do:15 dissolved oxygen DO DO:63|do:4 distraction osteogenesis DO DO:7|do:2 hlado dP/dt dP/dt:5|dP/dT:3|dp/dt:3 cardiac contractility dP/dt dP/dt:7|Dp/Dt:1|DP/Dt:1|dp/dt:1 left ventricular contractility dP/dt dP/dt:5 pressure with respect to time dP/dt dP/dt:4|dp/dt:3 rate of left ventricular pressure rise dP/dt dP/dt:10|dp/dt:1 rate of rise of left ventricular pressure DRA DRA:60|dra:1 dialysisrelated amyloidosis DRA DRA:13|Dra:1 downregulated in adenoma DRM DRM:18 deeseroedigermcdermott DRM DRM:9 doramectin dsDNA dsDNA:10|ds-DNA:1 deoxyribonucleic acid dsDNA dsDNA:9 doublestranded dsDNA dsDNA:336|ds-DNA:16|DSDNA:3 doublestranded dna dsRNA dsRNA:7|ds-RNA:2 doublestranded ribonucleic acid dsRNA dsRNA:629|ds-RNA:7|dsRna:1|DSRNA:1 doublestranded rna ds ds:10|DS:1 antidouble stranded DS DS:6 dahl saltsensitive hypertensive DS DS:23 dahl saltsensitive rats ds DS:5|ds:5 decayed surfaces DS DS:8 depressive symptoms DS DS:198|ds:9 dermatan sulfate DS DS:66|ds:2 dermatan sulphate DS DS:22 desynchronized sleep DS DS:78|ds:17 dextran sulfate DS DS:12|ds:1 diagnostic score DS DS:28|ds:1 diameter stenosis DS DS:9|ds:1 diazepamsensitive DS DS:18 digital subtraction DS DS:14 direct stenting DS DS:6 direction selectivity DS DS:7 directional selectivity DS DS:29|ds:2 directionally selective DS DS:12|ds:1 disseminated sclerosis DS DS:6 distribution space DS DS:10|ds:1 doppler sonography DS DS:15 duodenal switch DS DS:9 duplex sonography DS DS:8|ds:3 dyad symmetry EH EH:37 eclosion hormone EH EH:19 endometrial hyperplasia Eh Eh:9|EH:4 entamoeba histolytica EH EH:8 environmental heating EH EH:6 episodic hypoxia EH EH:8 epoxide hydrase EH EH:33 eps homology EH EH:11 essential hyperhidrosis EH EH:13 essential hypertensive patients Eh Eh:10|eH:1|EH:1 oxidationreduction potential eIF4GI eIF4GI:7 eukaryotic initiation factor gi eIF4GI eIF4GI:7 eukaryotic translation initiation factor gi EI EI:9 early intervention EI EI:10|Ei:1 electron impact ionization EI EI:8 electron ionisation EI EI:73 electron ionization EI EI:20 emotional intelligence EI EI:33 enzyme i EI EI:10 enzymeinhibitor complex EI EI:10 erythema infectiosum ePTFE ePTFE:21|e-PTFE:7|E-PTFE:1 expanded polytetrafluorethylene ePTFE ePTFE:4|e-PTFE:3 expanded polytetrafluoroethylene membrane ear ear:8 allergeninduced early EAR EAR:11|ear:1 aneurysm repair ear ear:13 early asthmatic reaction ear ear:28|EAR:1 early asthmatic response EAR EAR:26|ear:2 estimated average requirement ECoG ECoG:44|ECOG:2 electrocortical ECoG ECoG:20|ECOG:2 electrocortical activity ECoG ECoG:73 electrocorticographic ECoG ECoG:26|ECOG:1 intraoperative electrocorticography EGG EGG:23 electrogastrographic EGG EGG:155 electrogastrography EGG EGG:9 electroglottograph EGG EGG:23 electroglottographic EGG EGG:28 electroglottography env env:406|Env:6|ENV:1 envelope env env:23 envelope gene env env:8 envelope glycoprotein complex epg epg:12|EPG:10|EpG:1 egg counts epg epg:43|EPG:31 eggs per gram epg epg:19|EPG:13 eggs per gram of faeces epg epg:13|EPG:12 eggs per gram of feces epg epg:4|EPG:3 eggs per gram of stool EPG EPG:10 electropalatographic EPG EPG:38 electropalatography EPG EPG:14 ethanolamine phosphoglycerides exp exp:10|Exp:2 experimental exp exp:6 two experiments FH FH:35|fH:22 factor h FH FH:234 familial hypercholesterolaemia FH FH:15 familial hypercholesterolaemic FH FH:24 familial hypercholesterolemic FH FH:25 favorable histology FH FH:9 fibrous histiocytoma FH FH:18|F-H:3 ficollhypaque FH FH:52 final height FH FH:10 follicular hyperplasia FH FH:14 formin homology FH FH:7 frankfort horizontal FH FH:51 fulminant hepatitis FH FH:18 fumarate hydratase FH FH:8|Fh:2 recovery ratio fMRI fMRI:2225|FMRI:54|f-MRI:4|FM-RI:1 functional magnetic resonance imaging fMRI fMRI:463|FMRI:7|f-MRI:2 functional mri FADD FADD:72 fasassociated death domain FADD FADD:56 fasassociated death domain protein FADD FADD:14 fasassociated protein with death domain FADD FADD:7 fasassociating protein with death domain FAST FAST:29 focused abdominal sonography for trauma FAST FAST:15 functional assessment staging FISH FISH:387|fish:2 fluorescence in situ hybridisation FISH FISH:7 fluorescence in situ hybridization technique FISH FISH:108 fluorescent in situ hybridisation FISH FISH:10 situ hybridization analysis free free:9 nonproteinbound free free:15 unconjugated free free:13 unesterified GCG GCG:5|GCg:3 gallocatechin gallate GCG GCG:6 genetics computer group GADA GADA:7 gad antibody GADA GADA:5|GAD-A:1 glutamic acid decarboxylase autoantibodies ghosts ghosts:21|Ghosts:1 erythrocyte membranes ghosts ghosts:4 red cell membranes glu glu:816|Glu:42|GLU:13 glutamate glu glu:98|Glu:2|-GLU:1|GLU:1 glutamic acid Glx Glx:15 glutamateglutamine Glx Glx:9 glutamine and glutamate GL GL:10|gl:2 gastrocnemius lateralis gl gl:28 glomerular layer gl gl:19 glucose gl gl:11|GL:1 glycolipid gl gl:12 glycoprotein l gl gl:12 glycyrrhizic acid GL GL:9|gl:1 human granulosaluteal GL GL:14 pulmonary conductance GSA GSA:15|gsa:2 glutamate semialdehyde GSA GSA:8|gsa:3|GS-A:1 groupspecific antigen GSA GSA:46 guanidinosuccinic acid hAAT hAAT:11 human alpha antitrypsin hAAT hAAT:11 human alphaantitrypsin hANP hANP:103|h-ANP:8|HANP:6 human atrial natriuretic peptide hANP hANP:15 human atrial natriuretic polypeptide hGHRH hGHRH:10 human ghreleasing hormone hGHRH hGHRH:8|hGH-RH:3|h-GH-RH:1 human growth hormonereleasing hormone hH1 hH1:5 cardiac sodium channels hH1 hH1:14 human heart hH1 hH1:7 na channel HLH HLH:36 haemophagocytic lymphohistiocytosis HLH HLH:236|H-L-H:3|hlh:1|h-l-h:1 helixloophelix HLH HLH:88 hemophagocytic lymphohistiocytosis hLH hLH:87|HLH:8 human luteinizing hormone hLH hLH:12 human lutropin HLT HLT:19|H-LT:1 heartlung transplant HLT HLT:31 heartlung transplantation hOB hOB:29|HOB:9 human osteoblastlike hOB hOB:9|HOB:4 human osteoblastic hOB HOB:4|hOB:4 human osteoblastic cells hOGG1 hOGG1:3|hOgg1:2 human oxoguanine dna glycosylase hOGG1 hOGG1:7 human oxoguanine dna glycosylase HPG HPG:90|H-P-G:3 hypothalamicpituitarygonadal HPG HPG:25 hypothalamopituitarygonadal HPG HPG:9 hypothalamuspituitarygonadal HPL HPL:8 fatty acid hydroperoxide lyase HPL HPL:25|hPL:3 human pancreatic lipase HPL HPL:15 human peripheral lymphocytes HpSA HpSA:16 helicobacter pylori stool antigen HpSA HpSA:14|HPSA:1 stool antigen test hTERT hTERT:17 catalytic subunit of human telomerase hTERT hTERT:37|hTert:1 human telomerase catalytic subunit hTERT hTERT:5|hTert:2 human telomerase gene hTERT hTERT:11 telomerase reverse transcriptase gene hTPO hTPO:12 human thrombopoietin hTPO hTPO:20 human thyroid peroxidase HDP HDP:10 human dental pulp HDP HDP:7 hypertensive disorders of pregnancy HELP HELP:10 extracorporeal lowdensity lipoprotein precipitation HELP HELP:23 heparininduced extracorporeal ldl precipitation HELP HELP:7 hospitalized elderly longitudinal project HIM HIM:19 health information management HIM HIM:9 hyperigm HIM HIM:11 inductive microenvironment HLOD HLOD:12|H-LOD:2|hlod:1 heterogeneity lod HLOD HLOD:8 heterogeneity lod score hnRNP hnRNP:5|HnRNP:1 heterogeneous nuclear ribonucleoprotein particles hnRNP hnRNP:14 heterogeneous nuclear rnp HOG HOG:10 glycerol response HOG HOG:9 human oligodendroglioma HOSE HOSE:28|hOSE:3 human ovarian surface epithelial HOSE HOSE:12 human ovarian surface epithelium hs-CRP hs-CRP:81|hsCRP:50|HSCRP:4|HS-CRP:2|hsC-rp:1 highsensitivity creactive protein hs-CRP hs-CRP:16|hsCRP:9 highsensitivity crp hsp70 hsp70:3|hsp-70:2|HSP-70:1 heat shock gene hsp70 hsp70:4|HSP70:1 heat shock protein gene HSP70 HSP70:3|HSP-70:2|Hsp70:2|hsp70:1 heat shock protein kd HSP70 HSP70:4|hsp70:1 heat shock protein family HUT HUT:170 headup tilt HUT HUT:12 headup tilt testing HUT HUT:8 hyperplasia of usual type HUT HUT:7 tilt table testing i.a. i.a.:22 artery i.a. i.a.:9 injected intraarterially i.c.v. i.c.v.:141|I.C.V.:1 administered intracerebroventricularly i.c.v. i.c.v.:14 pretreatment i.c. i.c.:27 after intracerebral i.c. i.c.:6 carotid artery i.c. i.c.:12 injected intracisternally i.c. i.c.:15 intracutaneous i.c. i.c.:6 mice injected intracerebrally i.c. i.c.:5 mice inoculated intracerebrally i.d. i.d.:9 intraduodenal administration i.d. i.d.:5 mgkg intraduodenally i.g. i.g.:97|I.G.:2 intragastric i.g. i.g.:46|I.G.:1 intragastrically i.pl. i.pl.:68 intraplantar i.pl. i.pl.:18 intrapleural i.t. i.t.:43 injected intrathecally i.t. i.t.:6 injected intratumorally i.t. i.t.:9 injection i.t. i.t.:13 intrathoracic i.v. i.v.:177|I.V.:3 administered intravenously i.v. i.v.:12 injections i.v. i.v.:14 intravenous administration i.v. i.v.:26 intravenous injection I/M I/M:11 inspection and maintenance I/M I/M:6 intimamedia ratio I/M I/M:11 intimatomedia I/M I/M:9 intimalmedial ICGN ICGN:11 icrderived glomerulonephritis ICGN ICGN:11|IC-GN:3 immune complex glomerulonephritis iCGRP iCGRP:17|i-CGRP:1 immunoreactive calcitonin generelated peptide iCGRP iCGRP:11|i-CGRP:3 immunoreactive cgrp ICT ICT:47|Ict:1 contraction time ICT ICT:22 immunochromatographic test iCT iCT:59|ICT:4|I-CT:1|i-CT:1 immunoreactive calcitonin iCT iCT:9 immunoreactive ct ICT ICT:9 impression cytology with transfer ICT ICT:8|iCT:1 initial collecting tubule ICT ICT:5 intensified conventional therapy ICT ICT:7 intensified conventional treatment ICT ICT:5 intraoral cariogenicity test ICT ICT:17|IC-T:1 intracoronary thrombolysis ICT ICT:19 intramolecular charge transfer iPTH iPTH:10|IPTH:2 immunoreactive parathormone iPTH iPTH:55|i-PTH:2|IPTH:2 immunoreactive pth iPTH iPTH:23|I-PTH:1 intact parathormone ICER ICER:59 incremental costeffectiveness ratio ICER ICER:62 inducible camp early repressor icv icv:1 administered either intracerebroventricularly ICV ICV:18 ileocecal valve ICV ICV:5 internal cerebral vein ICV ICV:25 intracranial volume icv icv:3|ICV:2 third cerebroventricle IDE IDE:6|ide:3 erythropoiesis IDE IDE:8|ide:1 inner dental epithelium IDE IDE:14|ide:4 investigational device exemption indels indels:15 insertions and deletions indels indels:8|INDELs:1|InDels:1 insertionsdeletions indels indels:4|InDels:1 insertiondeletion polymorphisms ind ind:12 indapamide ind ind:7|Ind:2 indeterminate IND IND:8|ind:2 inflammatory neurological diseases IND IND:47|ind:6 intestinal neuronal dysplasia IND IND:37|ind:2 investigational new drug IND IND:19 investigational new drug application IQ IQ:10 aminomethylhimidazofquinoline IQ IQ:25 aminomethylimidazofquinoline IQ IQ:12 fquinoline IQ IQ:10 ilimaquinone IQ IQ:39|iq:1 intelligence IQ IQ:11 interquartile ir-TRH ir-TRH:7|IR-TRH:2 immunoreactive thyrotropinreleasing hormone ir-TRH ir-TRH:22|IR-TRH:12 immunoreactive trh IR-ANP IR-ANP:23|irANP:16|ir-ANP:10|IrANP:1 immunoreactive anp IR-ANP IR-ANP:5|irANP:3|ir-ANP:2|IrANP:2 plasma levels of immunoreactive atrial natriuretic peptide IVC IVC:1134 inferior vena cava IVC IVC:64 inferior vena caval IVC IVC:27 inspiratory vital capacity IVC IVC:30 intravenous cholangiography IVT IVT:8|ivt:1 ventricle IVT IVT:8 ventricular tachycardia k(cat) k(cat):12 catalytic constant k(cat) k(cat):8 catalytic rate constant K1 K1:5 ligand transport K1 K1:13 phylloquinone Kv Kv:18|KV:2 voltagegated Kv Kv:51|KV:3 voltagegated potassium KBP KBP:4 kainate binding protein KBP KBP:9 kallikreinbinding protein kcat kcat:7|Kcat:2 catalytic rate kcat kcat:5|Kcat:1 turnover rate Kg Kg:5|KG:4 glucose disappearance Kg Kg:6|KG:3|kg:1 glucose disappearance constant lambda lambda:12 population growth rate lambda lambda:14 reorganization energy lev lev:39|Lev:4 levamisole lev lev:59|Lev:20 levetiracetam LGG LGG:8|L-GG:2 lactobacillus gg LGG LGG:12 lactobacillus rhamnosus gg LGG LGG:7 lactobacillus rhamnosus strain gg LIPID LIPID:15 longterm intervention with pravastatin in ischaemic disease LIPID LIPID:12|lipid:2 longterm intervention with pravastatin in ischemic disease LLR LLR:6 longlatency reflexes LLR LLR:8 lower lip retraction LOAD LOAD:25 lateonset ad LOAD LOAD:34 lateonset alzheimers disease LSP LSP:22 life skills profile LSP LSP:12|lsp:1 liverspecific lipoprotein LSP LSP:15 liverspecific membrane lipoprotein LTK LTK:17 laser thermal keratoplasty LTK LTK:17 laser thermokeratoplasty LTK LTK:8|ltk:1 leukocyte tyrosine kinase lung lung:7 remote organ lung lung:6 target organ m/z m/z:13|M/Z:1 masscharge m/z m/z:19 masstocharge m/z m/z:14 masstocharge ratio MCG MCG:27 magnetocardiogram MCG MCG:29 magnetocardiographic MCG MCG:44 magnetocardiography MCG MCG:8 mast cell granules MCG MCG:13 medical college of georgia MCG MCG:9 membranecoating granules MCG MCG:25 midbrain central gray MCS MCS:20 mechanical circulatory support MCS MCS:6 mental component scale MCS MCS:11 mental component score MCS MCS:7 mesocaval shunt MCS MCS:13 minimally conscious state MCS MCS:20 motor cortex stimulation MCS MCS:8 multicellular spheroids MCS MCS:12 multiple chemical sensitivity syndrome MF MF:12 fibres MF MF:4 increase in mutation frequency MF MF:5 marrow fibrosis MF MF:9 medium fat MF MF:24 membrane filter MF MF:11|mF:1 membrane filtration MF MF:4|mf:1 membrane fractions MF MF:31 methyl farnesoate MF MF:28 microfilament mf mf:7|MF:4|Mf:1 microfilaremia mf mf:70|MF:13|Mf:7|mF:1 microfilaria mf mf:28|Mf:5|MF:4 microfilarial MF MF:38 microfiltration MF MF:7|Mf:5 micropolyspora faeni MF MF:9 midfrequency MF MF:7 milk fat MF MF:9 mitotic figures MF MF:6 mitral flow MF MF:44 mometasone furoate MF MF:14 morphogenetic furrow MF MF:9 mossy fibre MF MF:9 motherfed MF MF:11 muscle fibers MF MF:503|Mf:1 mycosis fungoides MF MF:9 myelinated fibers MF MF:6 sequential methotrexate and fluorouracil mGnRH mGnRH:23|m-GnRH:1 mammalian gnrh mGnRH mGnRH:14|MGnRH:1 mammalian gonadotropinreleasing hormone mIgM mIgM:31 membrane igm mIgM mIgM:10 membrane immunoglobulin m mRNA mRNA:14 gene expression mRNA mRNA:889|m-RNA:2|MRNA:1 messenger ribonucleic acid MAN MAN:11|man:1 magnocellular nucleus of the anterior neostriatum MAN MAN:10 medial articular nerve MAN MAN:7|man:2 methacrylonitrile mdx mdx:9|MDX:1 dystrophic mouse mdx mdx:26|MDX:1 dystrophindeficient mdx mdx:5 dystrophindeficient mice MeCCNU MeCCNU:10|Me-CCNU:3 chloroethylmethylcyclohexylnitrosourea MeCCNU MeCCNU:8|Me-CCNU:1 chloroethyltransmethylcyclohexylnitrosourea min min:9 minutes min min:33 medial interlaminar nucleus MKP-1 MKP-1:36 map kinase phosphatase MKP-1 MKP-1:35 mapk phosphatase MKP-1 MKP-1:7 mitogenactivated protein kinase phosphatase MMHg MMHg:6 monomethyl mercury MMHg MMHg:9 monomethylmercury MM-LDL MM-LDL:9|mmLDL:3|mm-LDL:2 minimally modified ldl MM-LDL MM-LDL:4|mmLDL:1|MmLDL:1|mm-LDL:1 minimally oxidized ldl MOM MOM:11 metalonmetal MOM MOM:10 midecamycin acetate MOM MOM:15 miocamycin MOM MOM:13 miokamycin MOM MOM:9 mucoid otitis media mo mo:20 ab initio molecular orbital MO MO:4|mo:1 excitant and inflammatory irritant mustard oil MO MO:14|mo:8 medulla oblongata MO MO:14|mo:3 membrane oxygenator MO MO:50|mo:13 menhaden oil MO MO:7|mo:6 methyl orange mo mo:93|Mo:7 molybdenum mo mo:35|Mo:2 monocyte mo mo:18|Mo:1 monocytesmacrophages mo mo:9|Mo:1 monoolein mo mo:8|Mo:6 morbid obesity mo mo:11|Mo:1 morbidly obese mo mo:9 mottled mo mo:5 sodium molybdate MRCA MRCA:20 magnetic resonance coronary angiography MRCA MRCA:22 recent common ancestor MS-PCR MS-PCR:9 mutagenically separated pcr MS-PCR MS-PCR:11 mutagenically separated polymerase chain reaction MuSK MuSK:27|MUSK:1 musclespecific kinase MuSK MuSK:21 musclespecific receptor tyrosine kinase MU MU:54|mu:3 million units mu mu:9 attenuation coefficient mu mu:13 dipole moment MU MU:7|mu:2 megaunits MU MU:18|mu:8|Mu:2 monitor unit mu mu:66|MU:63 motor unit mu mu:26|Mu:1 murine mu mu:6|Mu:3 robertsons mutator mu mu:5 shear elastic modulus N2 N2:15 dinitrogen N2 N2:6 nitrogen gas NH NH:10 amide NH NH:11 neonatal hemochromatosis NH NH:25 neonatal hepatitis NH NH:28|Nh:2 neurohypophysis NH NH:5 nodular hyperplasia NH NH:10 norharman NH NH:18 normal host nPNA nPNA:8 normalized protein equivalent of nitrogen appearance nPNA nPNA:6|NPNA:1 normalized protein nitrogen appearance NRBCs NRBCs:10 nucleated erythrocytes NRBCs NRBCs:41|nRBCs:5 nucleated red blood cells NcAMP NcAMP:8|ncAMP:2 nephrogenous camp NcAMP NcAMP:9|N-cAMP:1 nephrogenous cyclic adenosine monophosphate NcAMP NcAMP:15|N-cAMP:1|N-CAMP:1 nephrogenous cyclic amp NPR-A NPR-A:11|NPRA:2|Npra:1|NPr-A:1 natriuretic peptide receptor NPR-A NPR-A:19|NPRA:4 natriuretic peptide receptora NRP NRP:5 national registry of patients NRP NRP:15 neonatal resuscitation program nu/+ nu/+:9 heterozygote nu/+ nu/+:6|Nu/+:2 heterozygous littermates nu/+ nu/+:9 normal littermates nu/nu nu/nu:99|Nu/Nu:3 athymic nude nu/nu nu/nu:39|Nu/Nu:3 congenitally athymic nude nude:6 congenitally thymusdeficient nude nude:9 hypothymic nude nude:10 immunodeficient nvCJD nvCJD:8 new variant cjd nvCJD nvCJD:8|nv-CJD:1 new variant of creutzfeldtjakob disease OAT OAT:15|O-AT:5 oacetyltransferase OAT OAT:10|o-AT:1 oaminoazotoluene OAT OAT:28 oligoasthenoteratozoospermia OAT OAT:48|oat:1 oral anticoagulant therapy OAT OAT:18 oral anticoagulant treatment OAT OAT:21|Oat:2|oat:1 organic anion transporter OAT OAT:88 ornithine aminotransferase OAT OAT:16 ornithinedeltaaminotransferase ob/ob ob/ob:219|Ob/Ob:1 genetically obese ob/ob ob/ob:14 genetically obese mice ob/ob ob/ob:28 leptindeficient ob/ob ob/ob:33 obese hyperglycaemic one one:14 bleeding one one:9 leukemia one one:9 obstruction one one:9 pancreatitis oriT oriT:75 origin of transfer oriT oriT:12 transfer origin or or:6|OR:3 nadphcytochrome p reductase or or:9 ocular retardation or or:12|OR:3 odds ration or or:32 odorant receptor or or:24 oestrogen receptor or or:58 olfactory receptor or or:12|OR:5 open repair or or:12|OR:2 operations research or or:8 opioid receptors or or:8|OR:1 optical rotation or or:6 orienting reaction or or:14 orienting reflex or or:53 orienting response or or:4|OR:1 outflow resistance or or:19|OR:6 ovulation rate or or:4|OR:2 relative risk or or:8 right operator p.i. p.i.:6 weeks postinoculation p.i. p.i.:7 days postinjection p.i. p.i.:32 post injection p.i. p.i.:14 postimmunization p.o. p.o.:16 oral administration p.o. p.o.:14 oral gavage p.o. p.o.:15 perorally pANCA pANCA:15|p-ANCA:9|P-ANCA:6 perinuclear anca pANCA pANCA:5|p-ANCA:2|P-ANCA:2 perinuclear staining pattern pAVP pAVP:14|PAVP:12|Pavp:1|p-AVP:1 plasma arginine vasopressin pAVP PAVP:4|pAVP:4|Pavp:1 plasma arginine vasopressin concentration PCMB PCMB:70|pCMB:29|p-CMB:10 pchloromercuribenzoate PCMB PCMB:30|pCMB:12|p-CMB:5 pchloromercuribenzoic acid PCMB PCMB:4|p-CMB:2|pCMB:1 pchloromercuric benzoate PEMT PEMT:8|PeMT:1 phosphatidylethanolamine methyltransferase PEMT PEMT:24|PeMT:3 phosphatidylethanolamine nmethyltransferase pFSH pFSH:13 porcine folliclestimulating hormone pFSH pFSH:12 porcine fsh PGH PGH:9 phosphoglycolohydroxamate pGH pGH:29 porcine gh pGH pGH:68|PGH:6 porcine growth hormone PGH PGH:22 prostaglandin endoperoxide PH1 PH1:73|PH-1:2 primary hyperoxaluria type PH1 PH1:7|PH-1:1 primary hyperoxaluria type i PHMB PHMB:6|p-HMB:1 phydroxymercuribenzoic acid PHMB PHMB:35 polyhexamethylene biguanide PHM PHM:13 partial hydatidiform mole PHM PHM:9 peptide histidinemethionine PHM PHM:35 peptidylglycine alphahydroxylating monooxygenase PHI PHI:10 peptide hi PHI PHI:16 peptide histidineisoleucine PHI PHI:2 peptide with nterminal histidine and cterminal isoleucine amide PHI PHI:58|Phi:3 phosphohexose isomerase PHI PHI:10 phosphohexoseisomerase PHI PHI:10 private health insurance PHV PHV:59 peak height velocity PHV PHV:11 peptide histidine valine PHV PHV:11 prosthetic heart valves pH pH:15|PH:1 acidity PH PH:8|-PH:1 history pH pH:16|PH:1 hydrogen ion concentration PH PH:18 hyperplasia PH PH:17 palmar hyperhidrosis PH PH:9 partially hepatectomized PH PH:8 peak height PH PH:9 periventricular heterotopia PH PH:12|Ph:8 phenol PH PH:509|Ph:6 pleckstrin homology PH PH:54 posterior hypothalamus PH PH:20 postural hypotension PH PH:24|Ph:2 prepositus hypoglossi PH PH:17 proportional hazards PH PH:10|Ph:1 pubic hair PH PH:21 pulmonary hemorrhage PH PH:24 pulmonary hypoplasia pIgR pIgR:36|pIg-R:1 polymeric ig receptor pIgR pIgR:94|PIGR:5|PIgR:4|pIg-R:4|pigR:1 polymeric immunoglobulin receptor PIs PIs:20 phosphoinositides PIs PIs:343 protease inhibitors PI PI:3|P-I:2 days postirradiation PI PI:27|pi:7 hr postinoculation PI PI:6 hydrolysis of hphosphatidylinositol PI PI:16 hydrolysis of phosphoinositides PI PI:14|Pi:1 inferior pulvinar Pi Pi:27 inorganic orthophosphate Pi Pi:14 inorganic p PI PI:17 inositol phospholipid Pi Pi:10 interstitial fluid hydrostatic pressure PI PI:13 padua inventory PI PI:18 pain intensity PI PI:30 pancreatic insufficiency PI PI:10 pars intercerebralis PI PI:80|pi:3|Pi:3 pars intermedia PI PI:9 peak intensity PI PI:15 performance improvement PI PI:9 peripheral iridectomy PI PI:64|pi:2 persistently infected PI PI:11 phosphatidylinositide PI PI:21 phosphoinositol PI PI:9 phosphotyrosine interaction PI PI:24 plaque PI PI:12 plasma insulin PI PI:31 pneumatosis intestinalis PI PI:17 polyphosphoinositide PI PI:9 porcine insulin PI PI:5 positive ion PI PI:17|pi:5 postinjection PI PI:10 primary isolates PI PI:16 principal investigator PI PI:42|Pi:1 proactive interference PI PI:38|Pi:2 proinsulin PI PI:13 proliferation indices PI PI:767|Pi:6|pI:1 propidium iodide PI PI:13 protein i PI PI:10 pulmonary insufficiency PI PI:6 pulsatility indexes PI PI:34 pulse interval PI PI:8 putatively immune PI PI:12|pi:5 weeks postinoculation PI PI:5|P-I:1 weeks postirradiation PKA PKA:28 prekallikrein activator PKA PKA:21|PK-A:7 protein kinasea pMDIs pMDIs:39|pMDIS:1 metered dose inhalers pMDIs pMDIs:14|p-MDIs:1 pressurized metereddose inhalers PMT PMT:7 pacemakermediated tachycardia PMT PMT:7 parent management training PMT PMT:39|Pm-T:1 pasteurella multocida toxin PMT PMT:9 percutaneous mechanical thrombectomy PMT PMT:34 photomultiplier tube PMT PMT:18 premenstrual tension PMT PMT:7 premotor time PMT PMT:17 protection motivation theory PMT PMT:15 putrescine nmethyltransferase PNP PNP:95|pNP:23|p-NP:16|pnp:1 pnitrophenol PNP PNP:5|pNP:4 paranitrophenol PNP PNP:66 paraneoplastic pemphigus PNP PNP:14 pediatric nurse practitioner PNP PNP:8 platelet neutralization procedure PNP PNP:9 poissonnernstplanck PNP PNP:14 posterior neuropore PNP PNP:12 pyridoxine phosphate PNSP PNSP:1 penicillinnonsusceptible s pneumoniae PNSP PNSP:7 penicillinnonsusceptible streptococcus pneumoniae POA POA:33|poa:1 pancreatic oncofetal antigen POA POA:7|Poa:1 phenoxyacetic acid POA POA:10 preoptic POA POA:1 preoptic and anterior hypothalamus POA POA:7 preoptic area of the hypothalamus POA POA:10 pyrazinoic acid pQCT pQCT:9 peripheral qct pQCT pQCT:251|PQCT:5|pQ-CT:1 peripheral quantitative computed tomography pVHL pVHL:20 vhl protein pVHL pVHL:16 von hippellindau protein PACE PACE:9|PA-CE:1 electrophoresis PACE PACE:38 program of allinclusive care for the elderly PCD PCD:9|pcd:1 detection PCD PCD:18 papillary collecting duct PCD PCD:82|pcd:1 paraneoplastic cerebellar degeneration PCD PCD:25 percutaneous catheter drainage PCD PCD:14 plasma cell dyscrasia PCD PCD:28 premature centromere division PCD PCD:107 primary ciliary dyskinesia PCD PCD:705|pcd:6 programmed cell death PCD PCD:8 pterinacarbinolamine dehydratase PDP PDP:11 pachydermoperiostosis PDP PDP:16 parallel distributed processing PDP PDP:2 population and development program PDP PDP:6 process dissociation procedure PDP PDP:11 pyruvate dehydrogenase phosphatase PD PD:10 after pancreaticoduodenectomy PD PD:14 after pancreatoduodenectomy PD PD:8 along the proximodistal PD PD:7 cell membrane potential PD PD:6 coronary artery Pd Pd:5|PD:2 diastolic pressure PD PD:11 disease of bone PD PD:10 disease progression PD PD:17 paired domain PD PD:16 pancreas divisum PD PD:15 pancreatic duct PD PD:417|Pd:1 panic disorder PD PD:10 parkinsonian PD PD:9 parkinsonism PD PD:64|Pd:1|pd:1 pars distalis PD PD:9 perfusion defect PD PD:9 peripheral dose PD PD:13 peritoneal dialysate PD PD:1388|pd:1 peritoneal dialysis PD PD:8 peritoneal drainage PD PD:12 persistent diarrhea PD PD:12 persistent diarrhoea PD PD:9 pharmacokinetic pkpharmacodynamic PD PD:23 phosphate depletion PD PD:11 plasma desorption PD PD:12|Pd:7 plasmodesmata PD PD:6 platelet deposition PD PD:7 pneumatic dilatation PD PD:9 pneumatic dilation PD PD:11 postural drainage PD PD:9 potential difference across the cell membrane PD PD:12 power density PD PD:49 power doppler PD PD:7|Pd:1|pd:1 preferred direction PD PD:8|pd:1 prism dioptres PD PD:11 prisoners dilemma PD PD:20|Pd:1 probing pocket depth PD PD:11 progressed PD PD:8 prolidase deficiency PD PD:13 protein degradation PD PD:5 protein deposition PD PD:33 proton density PD PD:9|P-D:5 proximaldistal PD PD:10|Pd:4|pd:2 pseudodeficiency Pd Pd:14|PD:3 psychopathic deviate PD PD:22 pulsed doppler PD PD:10 pupillary diameter PD PD:47 pyloric dilator phox phox:6|Phox:1 phagocyte nadph oxidase phox phox:12 phagocyte oxidase PIA PIA:10 nlphenylisopropyladenosine PIA PIA:40 nphenylisopropyladenosine PIA PIA:34 phenylisopropyladenosine PIA PIA:25 polysaccharide intercellular adhesin PIA PIA:6 pontine inhibitory area PIA PIA:23 pristaneinduced arthritis PIA PIA:9 processingindependent analysis PIA PIA:5 receptor agonist nphenylisopropyladenosine PODs PODs:25 pml oncogenic domains PODs PODs:42 postoperative days polh polh:13|Polh:2 polyhedrin polh polh:8 polyhedrin gene po po:7|PO:2 administered PO PO:3|po:1 granulosa cells of preovulatory Po Po:6|po:3 maximum isometric force Po Po:7|po:3 maximum isometric tension Po Po:5|po:3 maximum isometric tetanic force PO PO:19|po:6 palm oil po po:6|PO:3 parietooccipital PO PO:11 peanut oil PO PO:6|po:1 perceptual organization PO PO:6 personality organization PO PO:7|po:4 phenol oxidase PO PO:48|po:19 phenoloxidase PO PO:26|po:15|P-O:1 phosphodiester po po:9 polyolefin po po:6 posterior complex po po:10 posterior group of thalamic nuclei po po:12 posterior nuclear group po po:8 posterior nucleus PO PO:11|po:5 principal olive Po Po:6|po:1 probability of being open Po Po:7|po:3 probability of channel opening po po:5|Po:1 probability of opening Po Po:3|po:2 probability of the channel being open PO PO:5 prostate only PO PO:8|po:4 protein oxidation ppGpp ppGpp:23 guanosine bispyrophosphate ppGpp ppGpp:12 guanosine diphosphate diphosphate ppGpp ppGpp:68 guanosine tetraphosphate PPH PPH:4|PP-H:3 periportal hepatocytes PPH PPH:24 postpartum haemorrhage PPH PPH:26 postpartum hemorrhage PPH PPH:31 postprandial hypotension PPH PPH:417 primary pulmonary hypertension PPM PPM:14 polypropylene mesh PPM PPM:7 professional practice model psi psi:8|Psi:1 packaging Psi Psi:6|psi:5 packaging signal PSI PSI:24 parenting stress index PSI PSI:8 paul scherrer institute PSI PSI:26 pneumonia severity index PSI PSI:16 population services international psi psi:8|PSI:1 pounds per square inch psi psi:46|Psi:20|PSI:1 pseudouridine Psi Psi:5|psi:4 water potential PTA PTA:12 pancreas transplantation alone PTA PTA:13 parallel tubular arrays PTA PTA:6 patellar tilt angle PTA PTA:23 peritonsillar abscess PTA PTA:12|pta:5 persistent truncus arteriosus PTA PTA:71|pta:2 phosphotungstic acid PTA PTA:4 pontine taste area PTA PTA:20 predicted transmitting abilities PTA PTA:7 prothymosin alpha PTI PTI:3|pti:2 pancreatic trypsin inhibitor PTI PTI:9|PtI:1 pressuretime integral PUN PUN:16 plasma urea n PUN PUN:37 plasma urea nitrogen R2 R2:10|r2:1 variability R2 R2:10|r2:3 variation rCBF rCBF:4|r-CBF:2 cerebral perfusion rCBF rCBF:113|r-CBF:1|RCBF:1 regional cbf rCBF rCBF:8 regional cerebral bloodflow RCL RCL:19 reactive center loop RCL RCL:10 reactive centre loop RC RC:22 fetal rat calvaria RC RC:11 radical cystectomy RC RC:5 rapid cycling RC RC:17 reaction centre RC RC:14 recombinant congenic RC RC:5 rectal cancer RC RC:8 referred care RC RC:17 regenerated cellulose RC RC:7 reliable change RC RC:12 replication complex RC RC:24 respiratory chain RC RC:29 resting zone RC RC:49|rc:1 rib cage RC RC:9 rotator cuff rDNA rDNA:4 genes coding for rrna rDNA rDNA:710 ribosomal dna rEpo rEpo:5|rEPO:3|r-epo:2|r-EPO:1 recombinant epo rEpo rEpo:25|rEPO:21|r-EPO:15|r-Epo:3|R-EPO:1 recombinant erythropoietin rFSH rFSH:15|r-FSH:6 recombinant follicle stimulating hormone rFSH rFSH:48 recombinant fsh rFVIII rFVIII:25|r-FVIII:1 recombinant factor viii rFVIII rFVIII:23|r-FVIII:1 recombinant fviii rG-CSF rG-CSF:11|rGCSF:2 granulocyte colony stimulating factor rG-CSF rG-CSF:48|rGCSF:1 recombinant granulocyte colonystimulating factor rGM-CSF rGM-CSF:14 granulocytemacrophage colony stimulating factor rGM-CSF rGM-CSF:12 recombinant gmcsf rGM-CSF rGM-CSF:40 recombinant granulocytemacrophage colonystimulating factor rHDL rHDL:43|R-HDL:2|r-HDL:1 reconstituted hdl rHDL rHDL:6|R-HDL:1 reconstituted highdensity lipoprotein ri ri:7|Ri:2 internal longitudinal resistance ri ri:5|Ri:1 internal radius RI RI:37 radioisotope RI RI:6 radionuclide imaging RI RI:330|ri:1|Ri:1 recombinant inbred RI RI:8 recurrent inhibition RI RI:9 regular insulin RI RI:18 relapse incidence RI RI:12 renal impairment RI RI:36|Ri:1 renal insufficiency RI RI:7 reperfusion injury RI RI:24 replicative intermediate RI RI:8 resistance indexes RI RI:9 respiratory insufficiency RI RI:9 retroactive interference RI RI:18|Ri:9 ribonuclease inhibitor RI RI:4|Ri:2 ribonuclease inhibitor protein RI RI:5|R-I:1 type i campdependent protein kinase RI RI:6|R-I:1 type i regulatory RI RI:14|R-I:1 type i regulatory subunit RK RK:157 radial keratotomy RK RK:18 remnant kidney rTFPI rTFPI:14 recombinant tfpi rTFPI rTFPI:14|r-TFPI:1 recombinant tissue factor pathway inhibitor rTMS rTMS:37|RTMS:1 repetitive tms rTMS rTMS:440|RTMS:5|r-TMS:1 repetitive transcranial magnetic stimulation rTNF rTNF:8 necrosis factor alpha rTNF rTNF:18 recombinant tnf rTNF rTNF:53|RTNF:1|r-TNF:1 recombinant tumor necrosis factor rt-PA rt-PA:22 recombinant tpa rt-PA rt-PA:280|rtPA:104|rTPA:38|r-TPA:19|r-tPA:12|rt-Pa:2|rtpa:1|Rt-PA:1 recombinant tissue plasminogen activator rt-PA rt-PA:292|rTPA:17|rtPA:14|r-tPA:5|r-t-PA:2|r-TPA:1|RTPA:1|rT-PA:1 recombinant tissuetype plasminogen activator RADS RADS:41 reactive airways dysfunction syndrome RADS RADS:11 reynolds adolescent depression scale RAD RAD:6|rad:1 reactive airway disease RAD RAD:9 renal tubule assist device RAGE RAGE:7 age receptor RAGE RAGE:19 receptor for advanced glycation endproducts RAM RAM:36 radial arm maze RAM RAM:10|ram:3 random access memory RAM RAM:21 restricted access material RAM RAM:10 restricted access media RANK RANK:7 receptor activator of nfkappa b RANK RANK:8 receptor activator of nuclear factor kappa b RARE RARE:64 rapid acquisition with relaxation enhancement RARE RARE:17 recaassisted restriction endonuclease rat rat:1 allogeneic or a xenogeneic rat rat:8 animal model rat rat:10 heterologous rat rat:12 homologous rat rat:36 mammalian rbGH rbGH:10 recombinant bovine gh rbGH rbGH:9|r-bGH:3 recombinant bovine growth hormone reg reg:15|Reg:1 regenerating reg reg:12 regenerating gene rep-PCR rep-PCR:13|REP-PCR:1|Rep-PCR:1 repetitive element sequencebased pcr rep-PCR rep-PCR:9|REP-PCR:1 repetitive sequencebased pcr rhBMP-2 rhBMP-2:28 recombinant human bmp rhBMP-2 rhBMP-2:16 recombinant human bone morphogenetic protein rhFSH rhFSH:6|r-hFSH:2|r-HFSH:1 recombinant human follicle stimulating hormone rhFSH rhFSH:34|r-hFSH:17 recombinant human fsh rhGH rhGH:9|r-hGH:4 recombinant hgh rhGH rhGH:135|r-hGH:5|rh-GH:1|rHGH:1 recombinant human gh rhGH rhGH:446|r-hGH:28|rHGH:12|rh-GH:3|R-hGH:1|r-hgh:1|RHGH:1|RH-GH:1 recombinant human growth hormone rhHGF rhHGF:10|r-hHGF:3|rh-HGF:2 recombinant human hepatocyte growth factor rhHGF rhHGF:14|rh-HGF:2 recombinant human hgf rhIGF-1 rhIGF-1:9 recombinant human igf rhIGF-1 rhIGF-1:8 recombinant human insulinlike growth factor rhM-CSF rhM-CSF:9 recombinant human mcsf rhM-CSF rhM-CSF:33|rhMCSF:1 recombinant human macrophage colonystimulating factor rhNGF rhNGF:28 recombinant human nerve growth factor rhNGF rhNGF:13 recombinant human ngf rhSOD rhSOD:3|rh-SOD:2|r-h-SOD:1 recombinant human sod rhSOD rhSOD:7|r-hSOD:6|rh-SOD:4|r-h-SOD:3|r-HSOD:3|RH-SOD:2|rH-SOD:1|rHSOD:1 recombinant human superoxide dismutase rhTPO rhTPO:20|rhTpo:2 recombinant human thrombopoietin rhTPO rhTPO:11|rhTpo:2 recombinant human tpo rhTSH rhTSH:22 recombinant human thyroidstimulating hormone rhTSH rhTSH:26 recombinant human thyrotropin rhTSH rhTSH:58 recombinant human tsh rho rho:9 conductance ratio rho rho:13|Rho:4 correlation rho rho:11|Rho:2 rhodamine rho rho:30|Rho:8|RHO:1 rhomboid riMLF riMLF:1 rostral interstitial nucleus of mlf riMLF riMLF:40 rostral interstitial nucleus of the medial longitudinal fasciculus RIN RIN:27|rin:2 rat insulinoma RIN RIN:4|rin:2 rat insulinoma cell line RIS RIS:75 radioimmunoscintigraphy RIS RIS:6|RIs:1 recombinant inbred strains RIs RIs:11 replication intermediates RIs RIs:11 replicative intermediates RIs RIs:8 resistive indexes ris ris:15|Ris:1 risedronate ris ris:16|RIS:3 risperidone ROD ROD:11|rod:2 relative optical density ROD ROD:55|rod:1 renal osteodystrophy ROLL ROLL:8 occult lesion localization ROLL ROLL:7 radioguided occult lesion localisation RP-HPLC RP-HPLC:13|RPHPLC:1 reversephase hplc RP-HPLC RP-HPLC:22|rpHPLC:2|RPHPLC:2 reversedphase hplc rpoB rpoB:6 beta subunit of rna polymerase rpoB rpoB:8 rna polymerase beta subunit rpoB rpoB:11 rna polymerase gene rscu-PA rscu-PA:5 recombinant singlechain upa rscu-PA rscu-PA:13|r-scu-PA:4 recombinant singlechain urokinasetype plasminogen activator sAML sAML:4|s-AML:3 secondary acute myeloid leukemia sAML sAML:7|SAML:3|s-AML:1 secondary aml SBT SBT:12 sequencing based typing SBT SBT:5 short blessed test SBT SBT:26 sulbactam sCJD sCJD:18 sporadic cjd sCJD sCJD:36 sporadic creutzfeldtjakob disease SDNA SDNA:9 standard deviation of nuclear area SDNA SDNA:7|SD-NA:1 standard deviation of nucleolar area sEPSCs sEPSCs:15 spontaneous epscs sEPSCs sEPSCs:51|SEPSCs:2 spontaneous excitatory postsynaptic currents sFlt-1 sFlt-1:4|SFlt-1:1 soluble receptor sFlt-1 sFlt-1:5|sFlt1:1 soluble vegf receptor sHLA-I sHLA-I:8|S-HLA-I:1 class i antigens sHLA-I sHLA-I:16|S-HLA-I:1|sHLAI:1 soluble hla class i sIL-2R sIL-2R:8|SIL-2R:1 soluble interleukin receptor levels sIL-2R sIL-2R:4 soluble receptors for il sIPSCs sIPSCs:59 spontaneous inhibitory postsynaptic currents sIPSCs sIPSCs:23 spontaneous ipscs sIgM sIgM:67 surface igm sIgM sIgM:11 surface immunoglobulin m S-ODNs S-ODNs:10|sODNs:2|S-ODns:1 phosphorothioate oligodeoxynucleotides S-ODNs S-ODNs:15|SODNs:1 phosphorothioate oligonucleotides sTNFR1 sTNFR1:9|sTNF-R1:2|STNFR1:1 soluble tnf receptor sTNFR1 sTNF-R1:3|sTNFR1:3 soluble tumor necrosis factor receptor sTNF-RI sTNF-RI:3|sTNFRI:2|sTNFR-I:1|sTNFr-I:1 necrosis factor receptor type i sTNF-RI sTNF-RI:3|sTNFR-I:2|sTNFRI:2 soluble tnf receptor i sTNF-RI sTNF-RI:7|sTNFRI:2|sTNF-rI:1 soluble tumor necrosis factor receptor i SX SX:13|Sx:1 sympathectomized SX SX:9|Sx:2 syndrome x scFvs scFvs:13|ScFvs:1 singlechain antibodies scFvs scFvs:11 singlechain antibody fragments scFvs scFvs:9 singlechain fv fragments scFvs scFvs:14 singlechain fvs scFvs scFvs:9 singlechain variable fragments SCC SCC:7|scc:6 cholesterol sidechain cleavage SCC SCC:214|scc:5 shortcircuit current SCC SCC:29 spinal cord compression SCC SCC:4 squamous cell carcinoma of the cervix SCC SCC:7 squamous cell carcinoma of the skin SCC SCC:16 squamous cell carcinomarelated antigen scu-PA scu-PA:14 singlechain upa scuPA scuPA:3|scu-PA:1 single chain upa scuPA scuPA:7|scu-PA:4|Sc-uPA:1 singlechain urokinase scu-PA scu-PA:66|scuPA:7|sc-uPA:2|Sc-uPA:1|SCU-PA:1 singlechain urokinasetype plasminogen activator sec sec:8|SEC:1 secretin sec sec:21 secretory SEC SEC:25 series elastic component SEC SEC:9 serpinenzyme complex SEC SEC:6|sec:1 sizeexclusion chromatographic SEC SEC:58|sec:5 spontaneous echo contrast SEC SEC:15|sec:2 spontaneous echocardiographic contrast SEC SEC:9 standard error of calibration sec sec:3|SEC:3 superficial esophageal carcinoma SEC SEC:11 surface epithelial cells SEC SEC:11 swine endothelial cell SER SER:8|ser:1 scanning equalization radiography SER SER:20|ser:1 sebum excretion rate SER SER:26|ser:3 sensitizer enhancement ratio SER SER:275|ser:32|sER:16|Ser:7|s-ER:1|S-ER:1 smooth endoplasmic reticulum SER SER:9 spherical equivalent refraction SH2 SH2:15 src homology SH2 SH2:6 src homology domain shock shock:6 acute circulatory failure shock shock:4|SHOCK:3 emergently revascularize occluded coronaries for cardiogenic shock sigma sigma:20 standard deviation sigma sigma:6 surface charge density sm sm:11 expression of alphasmooth muscle SM SM:8|sm:2 margin SM SM:10 memory Sm Sm:29|SM:2|sm:1 nucleus submedius SM SM:9|Sm:1|sm:1 salmeterol SM SM:20|sm:7|Sm:4 salvia miltiorrhiza SM SM:9 scala media Sm Sm:5|SM:3 schistosoma mansoni sm sm:12 selective mutism SM SM:10 selfmonitoring SM SM:45|Sm:1|sm:1 semimembranosus SM SM:10|Sm:3|sm:1 serum somatomedin SM SM:13|sm:1 skim milk SM SM:8|Sm:2 slow myosin Sm Sm:5|sm:1 smith antigen sm sm:9 smokers Sm Sm:9 sparsomycin SM SM:12 standard model SM SM:11 steatocystoma multiplex SM SM:10 sternomastoid Sm Sm:4|SM:4 streptococcus mutans SM SM:8|sm:2 streptomycin sulfate SM SM:6 stress management SM SM:12 submandibular SM SM:9|sm:8 submucosal SM SM:9 syringomyelia SM SM:48|sm:7 systemic mastocytosis snRNPs snRNPs:129 small nuclear ribonucleoproteins snRNPs snRNPs:72 small nuclear ribonucleoprotein particles snRNPs snRNPs:12 small nuclear rnps SNGFR SNGFR:9|sngfr:1 filtration rates SNGFR SNGFR:113|sngfr:1 single nephron glomerular filtration rate SNs SNs:6 culture supernatants SNs SNs:29 sensory neurons SNs SNs:30 sentinel nodes SOF SOF:11|sof:1 serum opacity factor SOF SOF:9 soluble organic fraction SOF SOF:33 synthetic oviduct fluid SOF SOF:18 synthetic oviductal fluid SPF SPF:3 cells in sphase SPF SPF:39|SpF:1 dna ploidy and sphase fraction SPF SPF:8 sphase cells SPF SPF:14 sphase fractions SPF SPF:4|Spf:3 subparafascicular thalamic nucleus SPF SPF:14 supernatant protein factor SPH SPH:11|sPH:1 secondary pulmonary hypertension SPH SPH:10 superporous hydrogel SRL SRL:11 skin resistance level SRL SRL:25|sRL:13 specific lung resistance ssDNA ssDNA:10 singlestranded ssDNA ssDNA:467|ss-DNA:15|SSDNA:2 singlestranded dna STEM STEM:1 scanning and transmission electron microscope STEM STEM:111|stem:5 scanning transmission electron microscopy STG STG:4|sTG:2|S-Tg:1 serum triglycerides STG STG:100 stomatogastric ganglion STG STG:96 superior temporal gyrus STR STR:32|str:2 scotopic threshold response STR STR:5 stsegment resolution str str:7|Str:3 strictosidine synthase str str:24|Str:4 strychnine STR STR:16 subtotal resection SUs SUs:6 stroke units SUs SUs:11 sulfonylureas syn syn:5 activities of glycogen synthase syn syn:18 syncytial t1/2 t1/2:28|T1/2:5 elimination halflives t1/2 t1/2:68|T1/2:26 half life t1/2 t1/2:8 halflife of elimination t1/2 t1/2:9|T1/2:4 half lives t-AML t-AML:28|tAML:1 therapyrelated acute myeloid leukemia t-AML t-AML:13|tAML:2 therapyrelated aml TBA TBA:51|tBA:1 tertbutyl alcohol TBA TBA:14 tertiary butyl alcohol TBA TBA:44 tetrabutylammonium TBA TBA:20|tBA:1 total bile acids TBA TBA:9 transluminal balloon angioplasty TBA TBA:30|TbA:1 trenbolone acetate tHcy tHcy:9 total homocysteine tHcy tHcy:9 total homocysteine concentration tHcy tHcy:81|tHCY:1|tHCy:1|t-Hcy:1 total plasma homocysteine tRNA tRNA:35 transfer ribonucleic acid tRNA tRNA:157 transfer rna TACI TACI:4 caml interactor TACI TACI:8 cyclophilin ligand interactor tau tau:28|Tau:1 circadian period tau tau:10 decay rate tau tau:5 dosing interval tau tau:14 efficacy tau tau:32 freerunning period tau tau:8 period length tau tau:22|Tau:4 pressure decay tau tau:5 tau protein tau tau:7 time constant of decay tau tau:29|Tau:1 time constant of isovolumic relaxation tau tau:12|Tau:1 time constant of lv relaxation tau tau:10|TAU:2|Tau:1 time constant of relaxation TcPO2 TcPO2:6|TcpO2:4|TCPO2:2|tcPO2:2|tcpO2:1 transcutaneous oximetry TcPO2 TcPO2:6|tcpO2:3|tcPO2:3|TcPo2:1|TCPO2:1 transcutaneous partial pressure of oxygen TEC TEC:9 total eosinophil count TEC TEC:37 transient erythroblastopenia of childhood TEC TEC:19|tec:1 transluminal extraction catheter TEC TEC:24 triethyl citrate TET TET:8 transcutaneous energy transfer TET TET:12 treadmill exercise test TET TET:10 triethyl tin TET TET:72 triethyltin TET TET:13 triethyltin bromide TET TET:21 tubal embryo transfer thal thal:24 betathalassemia thal thal:9|Thal:1 thalassemia theta theta:16 conduction velocity theta theta:5 contact angles theta theta:9 hippocampal theta theta theta:7 rhythmic slow activity TIF TIF:7 transcription initiation factor TIF TIF:12 tubulointerstitial fibrosis Tlim Tlim:6|tlim:4|TLIM:1 endurance time Tlim Tlim:6|tlim:4 time to exhaustion TM TM:15 landsat thematic mapper Tm Tm:10 melting point Tm Tm:6|tm:2|TM:1 midpoint TM TM:2 neurons of the tuberomammillary Tm Tm:7 phase transition TM TM:11|tm:2 tail moment TM TM:47|tm:1|Tm:1 tectorial membrane TM TM:27 testicular microlithiasis TM TM:17|tm:1 thalassaemia major TM TM:31|tm:2 thalassemia major TM TM:613|Tm:8|tm:4 thrombomodulin TM TM:20 thrombotic microangiopathy TM TM:9|tm:1 timolol maleate TM TM:7|tm:4 tooth mobility TM TM:183|tm:3 trabecular meshwork TM TM:60|tm:3 transcendental meditation TM TM:17 transformed migraine TM TM:12 transitional mucosa TM TM:643|tm:7|Tm:4 transmembrane TM TM:12 transmembrane region TM TM:9 transmembrane subunit Tm Tm:30|TM:3|tm:1 transport maximum TM TM:24 transverse myelitis TM TM:41|tm:2 treadmill TM TM:90|Tm:75 tropomyosin TM TM:8 tuberomamillary nucleus TM TM:9|tm:1 tubular myelin TM TM:5 tumour markers TM TM:101|tm:10|Tm:4 tunicamycin TONE TONE:7 tilted optimized nonsaturating excitation TONE TONE:12 trial of nonpharmacologic interventions in the elderly TorA TorA:4|torA:1 tmao reductase TorA TorA:8|torA:1 trimethylamine noxide reductase TRI TRI:9|tri:3 toxics release inventory TRI TRI:16 transient radicular irritation TRI TRI:6 transradial coronary intervention TRI TRI:23 tubuloreticular inclusions TrkB TrkB:10|trkB:2 receptor tyrosine kinase b TrkB TrkB:4|trkB:3|Trk-B:1 tyrosine receptor kinase b TRPC TRPC:17 canonical transient receptor potential TRPC TRPC:11|TrpC:1 transient receptor potential channel TRP TRP:184|trp:39|Trp:19 transient receptor potential TRP TRP:8 tubular reabsorption of phosphorus TRP TRP:9 tyrosinaserelated protein TS TS:5|ts:2 alphatocopheryl hemisuccinate ts Ts:10|ts:10|TS:5 dna synthesis time Ts Ts:6|ts:3 duration of s phase ts ts:12 patients with turners syndrome Ts Ts:10|TS:3 sphase duration Ts Ts:53|ts:19|TS:2 suppressor t Ts Ts:6|ts:2 suppressor t lymphocytes Ts Ts:57|ts:32|TS:13 t suppressor Ts Ts:18|ts:4|TS:2 t suppressor cells Ts Ts:8|ts:3 tailshort TS TS:7|T-S:3|ts:1 takagisugeno ts ts:10|TS:1 temperature sensitivity TS TS:13|Ts:2|ts:2 tensile strength TS TS:12|ts:2 test stimulus TS TS:6|ts:4 tetanic stimulation TS TS:5|Ts:3|ts:2 thermal sensation ts ts:22|Ts:3|TS:3 thermosensitive TS TS:24|ts:4 thermostable TS TS:9|ts:1 threshold shift TS TS:65|ts:27 thymidylate synthetase ts TS:3|ts:3 thyroid scintigraphy TS TS:17|ts:11 tobacco smoke ts ts:10|TS:5 tokishakuyakusan TS TS:12|ts:7 torus semicircularis TS TS:8 total sleep TS TS:26|ts:7 total solids TS TS:19|ts:5 tractus solitarius TS TS:9|ts:4 transcribed strand TS TS:32|ts:17 transition state TS TS:6|ts:4 transmural stimulation TS TS:4|ts:1 transthoracic sonography TS TS:35|ts:20 trauma score TS TS:10|ts:7 triangularis sterni ts ts:25|TS:24 triceps surae ts ts:9|Ts:4|TS:1 trichinella spiralis TS TS:6|ts:2 tricuspid stenosis TS TS:17 trophoblast stem TS TS:4 trypanosoma cruzi transsialidase TTX-S TTX-S:45|TTXs:3|TTX-s:2 tetrodotoxinsensitive TTX-S TTX-S:18|TTXs:2|TTX-s:1 ttxsensitive TUNA TUNA:41 transurethral needle ablation TUNA TUNA:12 transurethral needle ablation of the prostate uPAR uPAR:7|UPAR:2|uPA-R:1 receptor for upa uPAR uPAR:18|u-PAR:5|uPA-R:4 receptor for urokinasetype plasminogen activator vCJD vCJD:35 variant cjd vCJD vCJD:14|V-CJD:4 variant of creutzfeldtjakob disease VAR VAR:6 venoarteriolar reflex VAR VAR:15 venoarteriolar response WHI WHI:5 weightforheight index WHI WHI:124|whi:13 womens health initiative WPC WPC:10 weighted pairwise correlation WPC WPC:28|wpc:1 whey protein concentrate WT WT:4 inhibitor wortmannin WT WT:9 walking test WT WT:52 wavelet transform WT WT:3|wt:2 wildtype cbl WT WT:11 wildtype controls WT WT:13|Wt:2 wildtype littermates WT WT:35|Wt:2 wildtype mice WT WT:7|wt:1 wildtype protein XIAP XIAP:19|X-IAP:1|Xiap:1|xiap:1 xlinked iap XIAP XIAP:49 xlinked inhibitor of apoptosis XIAP XIAP:59|Xiap:8|X-IAP:1 xlinked inhibitor of apoptosis protein xid xid:6|Xid:2 xlinked immune deficiency xid xid:48|Xid:11|XID:4 xlinked immunodeficiency xid xid:22|XID:7|Xid:7 xlinked immunodeficient 15d-PGJ(2) 15d-PGJ(2):29|15-d-PGJ(2):2|15dPGJ(2):2 deoxydeltapgj 15d-PGJ(2) 15d-PGJ(2):36|15dPGJ(2):4|15-d-PGJ(2):2 deoxydeltaprostaglandin j 5-HTTLPR 5-HTTLPR:7 functional polymorphism in the upstream regulatory region of the serotonin transporter gene 5-HTTLPR 5-HTTLPR:10 polymorphism in the promoter region of the serotonin transporter gene 5-HTTLPR 5-HTTLPR:7 serotonin transporter promoter polymorphism 8-OH-DPAT 8-OH-DPAT:4 hta receptor agonist 8-OH-DPAT 8-OH-DPAT:11 hydroxydinpropylaminotetralin hydrobromide 8-OH-DPAT 8-OH-DPAT:10 hydroxydinpropylaminotetraline 8-OH-DPAT 8-OH-DPAT:6 agonist hydroxydinpropylaminotetralin 8-OH-DPAT 8-OH-DPAT:4 receptor agonist hydroxydinpropylaminotetralin 8-OH-DPAT 8-OH-DPAT:3 receptor agonist hydroxydipropylaminotetralin 99mTc-DTPA 99mTc-DTPA:10 diethylene triamine pentaacetic acid 99mTc-DTPA 99mTc-DTPA:13|99mTcDTPA:2|99mTC-DTPA:2 diethylenetriamine pentaacetic acid ADAS-Cog ADAS-Cog:10|ADAS-cog:6 cognitive subscale of the alzheimers disease assessment scale ADAS-Cog ADAS-Cog:5|ADAS-cog:4|ADAScog:1|ADAS-COG:1 disease assessment scalecognitive AML/TMDS AML/TMDS:4 acute myeloid leukemia with trilineage myelodysplasia AML/TMDS AML/TMDS:6 aml with trilineage myelodysplasia Avitene Avitene:12 microfibrillar collagen Avitene Avitene:15 microfibrillar collagen hemostat BS-RNase BS-RNase:32|BSRNase:1 bovine seminal ribonuclease BS-RNase BS-RNase:7|BSRNase:1 bovine seminal rnase CADASIL CADASIL:17 cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy CADASIL CADASIL:170|cadasil:1|CA-DASIL:1 cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy CFU-GEMM CFU-GEMM:2 erythroid macrophage megakaryocyte CFU-GEMM CFU-GEMM:8|CFUGEMM:1 pluripotent hemopoietic progenitors CHSE-214 CHSE-214:11 chinook salmon embryo CHSE-214 CHSE-214:6 chinook salmon embryo cells CIBIC-Plus CIBIC-Plus:4|CIBIC-plus:3 clinicians interviewbased impression of change plus caregiver input CIBIC-Plus CIBIC-Plus:3|CIBIC-plus:2 interviewbased impression of change with caregiver input CRABP-II CRABP-II:6|CRABPII:2|CrabpII:1 cellular retinoic acidbinding protein ii CRABP-II CRABP-II:5 retinoic acid binding proteinii CYP11B2 CYP11B2:97 aldosterone synthase CYP11B2 CYP11B2:26|Cyp11b2:1 aldosterone synthase gene DNA-PKcs DNA-PKcs:19 catalytic subunit of dnapk DNA-PKcs DNA-PKcs:42|dna-pkcs:1|DNA-PKCS:1 dnadependent protein kinase catalytic subunit DNA-PKcs DNA-PKcs:21 dnapk catalytic subunit ELISPOT ELISPOT:13|ELISpot:2 enzymelinked immunosorbent spot ELISPOT ELISPOT:224|ELISpot:22|Elispot:6|elispot:2|ELIspot:2|ELI-spot:1|ELI-Spot:1|ELI-SPOT:1 enzymelinked immunospot ELISPOT ELISPOT:38|ELISpot:1|Elispot:1 enzymelinked immunospot assay FEF25-75 FEF25-75:7 forced expiratory flow between and of vital capacity FEF25-75 FEF25-75:2 forced expiratory flow during the middle half of fvc FEF25-75 FEF25-75:9 forced midexpiratory flow G-proteins G-proteins:52 guanine nucleotidebinding proteins G-proteins G-proteins:14 guanine nucleotide regulatory proteins GBV-C/HGV GBV-C/HGV:2 gb virus c and hepatitis g virus GBV-C/HGV GBV-C/HGV:68 gb virus chepatitis g virus H(+)-ATPase H(+)-ATPase:15 hadenosinetriphosphatase H(+)-ATPase H(+)-ATPase:7 plasma membrane proton pump HIV/AIDS HIV/AIDS:32 human immunodeficiency virusacquired immune deficiency syndrome HIV/AIDS HIV/AIDS:54|HIV/Aids:1 human immunodeficiency virusacquired immunodeficiency syndrome HIV/AIDS HIV/AIDS:8 human immunodeficiency virus and acquired immunodeficiency syndrome HTLV-I/II HTLV-I/II:8 human tcell lymphotropic virus types i and ii HTLV-I/II HTLV-I/II:8 human tlymphotropic virus types i and ii HTLV-III/LAV HTLV-III/LAV:10 human tcell lymphotropic virus type iiilymphadenopathyassociated virus HTLV-III/LAV HTLV-III/LAV:25 human tlymphotropic virus type iiilymphadenopathyassociated virus HTLV-III HTLV-III:7 human tlymphotropic retrovirus HTLV-III HTLV-III:5|HTLVIII:1 human tlymphotropic virus HTLV-III HTLV-III:75 human tlymphotropic virus type iii IalphaI IalphaI:26|I-alpha-I:1 interalphainhibitor IalphaI IalphaI:9|I-alpha-I:2 interalphatrypsin inhibitor MERIT-HF MERIT-HF:7 metoprolol crxl randomized intervention trial in chronic heart failure MERIT-HF MERIT-HF:7 metoprolol crxl randomized intervention trial in heart failure Matrigel Matrigel:12|matrigel:2 basement membrane extract Matrigel Matrigel:32|matrigel:2 basement membrane matrix Matrigel Matrigel:12|matrigel:1 basement membrane proteins Matrigel Matrigel:118|matrigel:20 reconstituted basement membrane NG108-15 NG108-15:25 neuroblastoma x glioma NG108-15 NG108-15:17 neuroblastoma x glioma hybrid NOD/SCID NOD/SCID:25|NOD/scid:2 nonobese diabeticsevere combined immunodeficiency NOD/SCID NOD/SCID:47 nonobese diabeticsevere combined immunodeficient Neuro-2a Neuro-2a:6|Neuro-2A:4|neuro-2A:3|neuro-2a:3|Neuro2a:2 neuroblastoma cells Neuro-2a Neuro-2A:3|Neuro-2a:3|Neuro2a:2|Neuro2A:2|neuro-2a:2|neuro2a:1 neuroblastoma cell line O-GlcNAc O-GlcNAc:14 olinked betanacetylglucosamine O-GlcNAc O-GlcNAc:52 olinked nacetylglucosamine P450c17 P450c17:21|P-450c17:4 alphahydroxylase P450c17 P450c17:12|P450C17:1 alphahydroxylase cytochrome p P450c17 P450c17:5 cytochrome p alphahydroxylase P450scc P450scc:1 cytochrome p for side chain cleavage P450scc P450scc:17|p450scc:2|P-450SCC:1 side chain cleavage enzyme PA-TCH-SP PA-TCH-SP:13 periodatethiocarbohydrazidesilver proteinate PA-TCH-SP PA-TCH-SP:30 periodic acidthiocarbohydrazidesilver proteinate PEP/LVET PEP/LVET:4 ratio of the preejection period to left ventricular ejection time PEP/LVET PEP/LVET:10 ventricular ejection time ratio PTH/PTHrP PTH/PTHrP:7 parathyroid hormoneparathyroid hormonerelated peptide PTH/PTHrP PTH/PTHrP:6 parathyroid hormoneparathyroid hormonerelated protein RASSF1A RASSF1A:10 ras association domain family a RASSF1A RASSF1A:7 ras association domain family a gene Rp-cAMPS Rp-cAMPS:7 adenosine cyclic monophosphothioate Rp-cAMPS Rp-cAMPS:9|RpcAMPs:1 adenosine cyclic phosphorothioate Rp-cAMPS Rp-cAMPS:7 rpadenosine cyclic monophosphothioate Rp-cAMPS Rp-cAMPS:6|Rp-cAMPs:2 rpadenosine cyclic monophosphothioate triethylamine Rubisco Rubisco:19|RubisCO:3|RuBisCo:2|rubisco:1|RuBisCO:1 ribulosebisphosphate carboxylase Rubisco Rubisco:7|RuBisCO:4|RUBISCO:1 ribulose bisphosphate carboxylase SAPK/JNK SAPK/JNK:17 stressactivated protein kinase SAPK/JNK SAPK/JNK:37 stressactivated protein kinasecjun nterminal kinase SDS-PAGE SDS-PAGE:11 polyacrylamide gel electrophoresis in sodium dodecyl sulfate SDS-PAGE SDS-PAGE:5 polyacrylamide gel electrophoresis in the presence of sds SDS-PAGE SDS-PAGE:24 polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate SDS-PAGE SDS-PAGE:8 sodium dodecyl sulfatepolyacrylamide gels V-PYRRO/NO V-PYRRO/NO:1 donor ovinyl pyrrolidinyldiazeniumdiolate V-PYRRO/NO V-PYRRO/NO:6 ovinyl pyrrolidinyldiazeniumdiolate WAIS-III WAIS-III:16 wechsler adult intelligence scaleiii WAIS-III WAIS-III:9 wechsler adult intelligence scalethird edition [35S]GTPgammaS [35S]GTPgammaS:8|[35S]GTP-gammaS:1 sguanosineothiotriphosphate [35S]GTPgammaS [35S]GTPgammaS:15 guanosineosthiotriphosphate allo-BMT allo-BMT:8|alloBMT:4 allogeneic bone marrow transplant allo-BMT allo-BMT:91|alloBMT:44|AlloBMT:10|Allo-BMT:3|ALLOBMT:1|ALLO-BMT:1 allogeneic bone marrow transplantation allo-SCT allo-SCT:6|alloSCT:3|AlloSCT:1 allogeneic stem cell transplant allo-SCT allo-SCT:57|alloSCT:27|AlloSCT:3|Allo-SCT:1 allogeneic stem cell transplantation alpha-hANP alpha-hANP:62 alphahuman atrial natriuretic peptide alpha-hANP alpha-hANP:81|alpha-HANP:1 alphahuman atrial natriuretic polypeptide alphaCTD alphaCTD:8 cterminal domain of the rna polymerase alpha subunit alphaCTD alphaCTD:5 rna polymerase alpha subunit cterminal domain alpha-MG alpha-MG:12|alphaMG:3 alphamethyldglucopyranoside alpha-MG alpha-MG:10|alphaMG:1 alphamethyldglucoside anti-CCP anti-CCP:8 anticyclic citrullinated peptide antibodies anti-CCP anti-CCP:30|Anti-CCP:1 citrullinated peptide anti-HAV anti-HAV:59 antibody to hepatitis a virus anti-HAV anti-HAV:6 hepatitis a antibodies anti-HAV anti-HAV:8 hepatitis a virus antibody anti-HBs anti-HBs:146|antiHBs:3|anti-HBS:2|anti-HB-s:1|anti--HBS:1 antibody to hepatitis b surface antigen anti-HBs anti-HBs:6|Anti-HBs:1 b surface antibodies bHLH-Zip bHLH-Zip:4|bHLH-ZIP:3|bHLHZip:2|bHLHZIP:2|bHLHzip:2|b-HLH-zip:1|bHLH-zip:1 basic helixloophelix leucine zipper bHLH-Zip bHLH-Zip:6 encodes a member of the basichelixloophelixleucine zipper beta-gal beta-gal:9|beta-Gal:6 betadgalactosidase beta-gal beta-gal:11 betagalactosidase gene compomers compomers:5 polyacidmodified composite resins compomers compomers:9 polyacidmodified resin composites control control:8 administered at dietary levels of control control:11 fed diets containing control control:4 sixweekold male spraguedawley rats were fed either normal rat chow dUTPase dUTPase:13 deoxyuridine triphosphatase dUTPase dUTPase:21 deoxyuridine triphosphate nucleotidohydrolase dUTPase dUTPase:9 dutp pyrophosphatase dP/dtmax dP/dtmax:5|dp/dtmax:2 left ventricular pressure rise dP/dtmax dP/dtmax:1 rate of rise in left ventricular pressure eIF2alpha eIF2alpha:6 alphasubunit of eukaryotic initiation factor eIF2alpha eIF2alpha:5|eIF-2alpha:5 alpha subunit of eukaryotic translation initiation factor eIF2alpha eIF2alpha:7|eIF-2alpha:2 phosphorylation of the alpha subunit of eukaryotic initiation factor mitoK(ATP) mitoK(ATP):14 mitochondrial atpsensitive k mitoK(ATP) mitoK(ATP):11|mito-K(ATP):1 mitochondrial atpsensitive potassium mitoK(ATP) mitoK(ATP):4 mitochondrial atpsensitive potassium channels p75NGFR p75NGFR:6|p75-NGFR:3|p75NGFr:2 low affinity nerve growth factor receptor p75NGFR p75NGFR:9|p75NGF-R:1 lowaffinity ngf receptor rMuIFN-gamma rMuIFN-gamma:11 recombinant murine gamma interferon rMuIFN-gamma rMuIFN-gamma:14|rmuIFN-gamma:2 recombinant murine interferongamma rhDNase rhDNase:32|rhDNAse:1 recombinant human deoxyribonuclease rhDNase rhDNase:15|rh-DNase:1 recombinant human deoxyribonuclease i rhDNase rhDNase:19 recombinant human dnase rhDNase rhDNase:11 recombinant human dnase i rhGM-CSF rhGM-CSF:11 granulocytemacrophage csf rhGM-CSF rhGM-CSF:27 recombinant human gmcsf sIL-1RII sIL-1RII:5 soluble il receptor ii sIL-1RII sIL-1RII:8 soluble il receptor type ii serpins serpins:51|SERPINS:1 serine protease inhibitors serpins serpins:46|Serpins:3|SERPINS:2 serine proteinase inhibitors statins statins:6 hydroxymethylglutaryl coenzyme a reductase statins statins:7 inhibitors of hmgcoa reductase V-ATPase V-ATPase:15 vacuolar protontranslocating atpase V-ATPase V-ATPase:27 vacuolartype hatpase